<SEC-DOCUMENT>0001360604-23-000096.txt : 20231103
<SEC-HEADER>0001360604-23-000096.hdr.sgml : 20231103
<ACCEPTANCE-DATETIME>20231103063442
ACCESSION NUMBER:		0001360604-23-000096
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		79
CONFORMED PERIOD OF REPORT:	20230930
FILED AS OF DATE:		20231103
DATE AS OF CHANGE:		20231103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Healthcare Realty Trust Inc
		CENTRAL INDEX KEY:			0001360604
		STANDARD INDUSTRIAL CLASSIFICATION:	REAL ESTATE INVESTMENT TRUSTS [6798]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35568
		FILM NUMBER:		231374428

	BUSINESS ADDRESS:	
		STREET 1:		3310 WEST END AVENUE,  SUITE 700
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-269-8175

	MAIL ADDRESS:	
		STREET 1:		3310 WEST END AVENUE,  SUITE 700
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HEALTHCARE TRUST OF AMERICA, INC.
		DATE OF NAME CHANGE:	20160802

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Healthcare Trust of America Holdings, Inc.
		DATE OF NAME CHANGE:	20160802

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Healthcare Trust of America Holdings, LP
		DATE OF NAME CHANGE:	20160802
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>hr-20230930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:73dbfdf1-2054-4a25-8023-7c5130a0cc11,g:80064ddd-1403-40d2-9d20-e881ce80ef55,d:f827fac591d74a508bffd01ca16da4c0--><html xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:hr="http://healthcarerealty.com/20230930" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ecd="http://xbrl.sec.gov/ecd/2023" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:srt="http://fasb.org/srt/2023" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hr-20230930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-26">0001360604</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="f-27">12/31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-28">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-29">Q3</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-30">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-5" name="us-gaap:TypeOfRevenueExtensibleList" id="f-129">http://fasb.org/us-gaap/2023#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:TypeOfRevenueExtensibleList" id="f-130">http://fasb.org/us-gaap/2023#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="c-6" name="us-gaap:TypeOfRevenueExtensibleList" id="f-131">http://fasb.org/us-gaap/2023#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="c-7" name="us-gaap:TypeOfRevenueExtensibleList" id="f-132">http://fasb.org/us-gaap/2023#ServiceMember</ix:nonNumeric><ix:nonNumeric contextRef="c-269" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-1276">P3Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hr-20230930.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-10-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="property"><xbrli:measure>hr:property</xbrli:measure></xbrli:unit><xbrli:unit id="state"><xbrli:measure>hr:state</xbrli:measure></xbrli:unit><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">hr:RealEstatePropertiesHeldInJointVenturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hr:PropertyEntitiesNotDeterminedToBeVIEsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hr:HealthcareTrustofAmericaHoldingsLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustofAmericaHoldingsLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:NonControllingInterestHoldersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustofAmericaHoldingsLPMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:NonControllingInterestHoldersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="variable_interest_entity"><xbrli:measure>hr:variable_interest_entity</xbrli:measure></xbrli:unit><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hr:VariableInterestEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="note_receivable"><xbrli:measure>hr:note_receivable</xbrli:measure></xbrli:unit><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hr:VariableInterestEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="joint_venture"><xbrli:measure>hr:joint_venture</xbrli:measure></xbrli:unit><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:HoustonTexasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:PowayCAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:ColumbusOHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MezzanineLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="financing_receivable"><xbrli:measure>hr:financing_receivable</xbrli:measure></xbrli:unit><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:MiscellaneousMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:MiscellaneousMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:MiscellaneousMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:MiscellaneousMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthCareRealtyTrustIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustOfAmericaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustOfAmericaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-20</xbrli:startDate><xbrli:endDate>2022-07-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthCareRealtyTrustIncorporatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-20</xbrli:startDate><xbrli:endDate>2022-07-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hr:LegacyHTAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-20</xbrli:startDate><xbrli:endDate>2022-07-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustOfAmericaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustOfAmericaIncMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-20</xbrli:startDate><xbrli:endDate>2022-07-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-20</xbrli:startDate><xbrli:endDate>2022-07-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">hr:MedicalOfficeBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:TampaFLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-10</xbrli:startDate><xbrli:endDate>2023-03-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">hr:MedicalOfficeBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:TampaFLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:ColoradoSpringsCOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">hr:MedicalOfficeBuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-28</xbrli:startDate><xbrli:endDate>2023-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:ColoradoSpringsCOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">hr:MedicalOfficeBuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hr:RealEstateAcquisitionsAndMortgageNoteFinancingAxis">hr:RealEstateAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hr:RealEstateAcquisitionsAndMortgageNoteFinancingAxis">hr:RealEstateAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:LimitedLiabilityCompanyOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:TampaFLMiamiFLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:TampaFLMiamiFLMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-12</xbrli:startDate><xbrli:endDate>2023-01-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:DallasTXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-01-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:DallasTXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-30</xbrli:startDate><xbrli:endDate>2023-01-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:STLouisMoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-10</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:STLouisMoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-10</xbrli:startDate><xbrli:endDate>2023-02-10</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-23</xbrli:startDate><xbrli:endDate>2023-03-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-30</xbrli:startDate><xbrli:endDate>2023-03-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-12</xbrli:startDate><xbrli:endDate>2023-05-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AlbanyNYMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AlbanyNYMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-30</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:HoustonTXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:HoustonTXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-02</xbrli:startDate><xbrli:endDate>2023-08-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AtlantaGAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AtlantaGAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-22</xbrli:startDate><xbrli:endDate>2023-08-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:DallasTXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:DallasTXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-15</xbrli:startDate><xbrli:endDate>2023-09-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:HoustonTXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-18</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:HoustonTXMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-18</xbrli:startDate><xbrli:endDate>2023-09-18</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:ChicagoILMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:ChicagoILMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-09-27</xbrli:startDate><xbrli:endDate>2023-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hr:RealEstateDispositionsAndMortgageNoteRepaymentsAxis">hr:RealEstateDispositionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hr:RealEstateDispositionsAndMortgageNoteRepaymentsAxis">hr:RealEstateDispositionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="disposition_transaction"><xbrli:measure>hr:disposition_transaction</xbrli:measure></xbrli:unit><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AlbanyNYMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="acre"><xbrli:measure>utr:acre</xbrli:measure></xbrli:unit><xbrli:unit id="entity"><xbrli:measure>hr:entity</xbrli:measure></xbrli:unit><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lease"><xbrli:measure>hr:lease</xbrli:measure></xbrli:unit><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:UnsecuredCreditFacilityOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:UnsecuredCreditFacilityOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDueMay2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDueMay2024Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDueJuly2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDueJuly2024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoandue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoandue2026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2030Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-26</xbrli:startDate><xbrli:endDate>2023-04-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CO</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:MortgagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:MortgagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-01</xbrli:startDate><xbrli:endDate>2023-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:GA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:MortgagesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="derivative"><xbrli:measure>hr:derivative</xbrli:measure></xbrli:unit><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringJanuary152024Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringMay12026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringJune12026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringDecember12026Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringJune12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringDecember12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapEffectiveNovember12023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="transaction"><xbrli:measure>hr:transaction</xbrli:measure></xbrli:unit><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringJune12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringDecember12027Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringMay312026Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:ActiveInterestRateSwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:SettledInterestRateSwapsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">hr:ActiveDevelopmentPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">hr:RedevelopmentPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">hr:CompletedDevelpomentAndRedevelopmentPropertiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">hr:MedicalOfficeBuildingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:ScottsdaleArizonaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-30</xbrli:startDate><xbrli:endDate>2023-10-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hr:DirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:LongTermIncentiveProgramDUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="director"><xbrli:measure>hr:director</xbrli:measure></xbrli:unit><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hr:DirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hr:DirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:LongTermIncentiveProgramDUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hr:NewEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:LongTermIncentiveProgramDUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-04</xbrli:startDate><xbrli:endDate>2023-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-04</xbrli:startDate><xbrli:endDate>2023-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-04</xbrli:startDate><xbrli:endDate>2023-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-04</xbrli:startDate><xbrli:endDate>2023-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:PerformanceConditionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-04</xbrli:startDate><xbrli:endDate>2023-01-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hr:DirectorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:PerformanceConditionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-01-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-07-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001360604</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="if827fac591d74a508bffd01ca16da4c0_1"></div><div style="min-height:18pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:9pt;font-weight:400;line-height:140%">  </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:12pt;font-weight:400;line-height:140%"> UNITED STATES SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:9pt;font-weight:400;line-height:120%">_______________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Bold',sans-serif;font-size:12pt;font-weight:400;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:490.50pt"><tr><td style="width:1.0pt"></td><td style="width:18.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:121.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:345.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(Mark One)</span></div><div><span><br/></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">For the quarterly period ended: </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">September 30, 2023</ix:nonNumeric></span></td></tr><tr style="height:14pt"><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:0.3pt;text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:9pt;font-weight:400;line-height:100%">OR</span></div></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:2pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the transition period from &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to</span></div><div><span><br/></span></div></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:140%">Commission File Number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-35568</ix:nonNumeric> (Healthcare Realty Trust Incorporated)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Bold',sans-serif;font-size:12pt;font-weight:400;line-height:140%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">HEALTHCARE REALTY TRUST INCORPORATED</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its charter)&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.194%"><tr><td style="width:1.0%"></td><td style="width:19.013%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.076%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.611%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Maryland</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">20-4738467</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(State or other jurisdiction of Incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:140%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">3310 West End Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-10">Suite 700</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:140%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">Nashville</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-12">Tennessee</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">37203</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:140%">(Address of principal executive offices)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:140%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">615</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">269-8175</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:140%">(Registrant's telephone number, including area code)</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:24.583%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">www.healthcarerealty.com</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(Internet address)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Securities Registered Pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.472%"><tr><td style="width:1.0%"></td><td style="width:39.167%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.353%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.731%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.318%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of Each Class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading Symbol</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of Each Exchange on Which Registered</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Class A Common Stock, $0.01 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">HR</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Sections&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.  &#160;</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:123.00pt"><tr><td colspan="3" style="display:none"></td><td style="width:1.0pt"></td><td style="width:22.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:34.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:10.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:48.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:12pt"><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9746; </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-19">Yes</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">No</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;&#160;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:22.777%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.656%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.754%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9746; </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-20">Yes</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">No</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act. </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.194%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:3.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.482%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.496%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9746; </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-21">Large accelerated filer</ix:nonNumeric> </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Accelerated filer </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Non-accelerated filer </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.888%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.147%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.910%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.147%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.396%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Smaller reporting company </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-23">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Emerging growth company </span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:4.444%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom">&#9744;</td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act).</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:22.638%"><tr><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:18.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.961%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.006%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-24">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">Yes</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%">No</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Century',serif;font-size:8pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7pt;font-weight:400;line-height:140%">As of October&#160;27, 2023, the Registrant had <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-25">380,874,078</ix:nonFraction></span><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7pt;font-weight:400;line-height:140%"> s</span><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7pt;font-weight:400;line-height:140%">hares of Common Stock outstanding.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.348%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div></div></div><div id="if827fac591d74a508bffd01ca16da4c0_10"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Explanatory Note </span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On July 20, 2022, pursuant to that certain Agreement and Plan of Merger dated as of February 28, 2022 (the &#8220;Merger Agreement&#8221;), by and among Healthcare Realty Trust Incorporated, a Maryland corporation (now known as HRTI, LLC, a Maryland limited liability company) (&#8220;Legacy HR&#8221;), Healthcare Trust of America, Inc., a Maryland corporation (now known as Healthcare Realty Trust Incorporated) (&#8220;Legacy HTA&#8221;), Healthcare Trust of America Holdings, LP, a Delaware limited partnership (now known as Healthcare Realty Holdings, L.P.) (the &#8220;OP&#8221;), and HR Acquisition 2, LLC, a Maryland limited liability company (&#8220;Merger Sub&#8221;), Merger Sub merged with and into Legacy HR, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA (the &#8220;Merger&#8221;).  Immediately following the Merger, Legacy HR converted to a Maryland limited liability company and changed its name to &#8220;HRTI, LLC&#8221; and Legacy HTA changed its name to &#8220;Healthcare Realty Trust Incorporated&#8221;.  In addition, the equity interests of Legacy HR were contributed by means of a contribution and assignment agreement to the OP, and Legacy HR became a wholly-owned subsidiary of the OP. As a result, Legacy HR became a part of an umbrella partnership REIT (&#8220;UPREIT&#8221;) structure, which is intended to align the corporate structure of the combined company after giving effect to the Merger and the UPREIT reorganization and to provide a platform for the combined company to more efficiently acquire properties in a tax-deferred manner. The combined company operates under the name &#8220;Healthcare Realty Trust Incorporated&#8221; and its shares of class A common stock, $0.01 par value per share, trade on the New York Stock Exchange under the ticker symbol &#8220;HR&#8221;.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For accounting purposes, the Merger was treated as a &#8220;reverse acquisition&#8221; in which Legacy HR was considered the accounting acquirer.  As a result, the historical financial statements of the accounting acquirer, Legacy HR, became the historical financial statements of the Company, as defined below. Periodic reports for periods ending following the Merger reflect financial and other information of the Company. The acquisition was accounted for using the acquisition method of accounting in accordance with Accounting Standards Codification 805, </span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:140%">Business Combinations</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> (&#8220;ASC 805&#8221;), which requires, among other things, the assets acquired and the liabilities assumed to be recognized at their acquisition date fair value. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For purposes of this Quarterly Report on Form 10-Q, references to the &#8220;Company&#8221; are to Legacy HR for periods prior to the closing of the Merger and thereafter to the combined company after giving effect to the Merger. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In addition, the OP has issued unsecured notes described in Note 5 to the Company's Condensed Consolidated Financial Statements included in this report. All unsecured notes are fully and unconditionally guaranteed by the Company, and the OP is 98.8% owned by the Company. Effective January 4, 2021, the Securities and Exchange Commission (the &#8220;SEC&#8221;) adopted amendments to the financial disclosure requirements which permit subsidiary issuers of obligations guaranteed by the parent to omit separate financial statements if the consolidated financial statements of the parent company have been filed, the subsidiary obligor is a consolidated subsidiary of the parent company, the guaranteed security is debt or debt-like, and the security is guaranteed fully and unconditionally by the parent. Accordingly, separate consolidated financial statements of the OP have not been presented. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Additionally, as permitted under Rule 13-01(a)(4)(vi) of Regulation S-X, the Company has excluded the summarized financial information for the OP because the assets, liabilities, and results of operations of the OP are not materially different than the corresponding amounts in the Company's consolidated financial statements and management believes such summarized financial information would be repetitive and would not provide incremental value to investors. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.348%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr></table></div></div></div><div id="if827fac591d74a508bffd01ca16da4c0_13"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">HEALTHCARE REALTY TRUST INCORPORATED</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">September&#160;30, 2023 </span></div><div style="margin-bottom:6pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:12pt"><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Table of Contents</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#160;&#160;&#160;&#160;&#160;</span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.006%"><tr><td style="width:1.0%"></td><td style="width:13.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.486%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.438%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">PART I - FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_19">Item&#160;1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_19">Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_19">1</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_22">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_22">1</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_28">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_28">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_31">Condensed Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_31">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_34">Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests</a> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_34">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_40">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_40">6</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_43">Notes to the Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_43">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_82">Item&#160;2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_82">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_82">26</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_97">Item 3</a>&#160;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_97">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_97">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_100">Item 4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_100">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_100">39</a></span></div></td></tr><tr style="height:14pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">PART II - OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_106">Item&#160;1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_106">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_106">39</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_109">Item&#160;1A</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_109">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_109">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_112">Item 2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_112">Unregistered Sales of Equity and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_112">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Item 5</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Other Information</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_115">40</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_118">Item 6</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_118">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_118">40</a></span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">SIGNATURE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_121">42</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt"><span><br/></span></div></div></div><div id="if827fac591d74a508bffd01ca16da4c0_16"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">PART I - FINANCIAL INFORMATION</span></div><div id="if827fac591d74a508bffd01ca16da4c0_19"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;1.  Financial Statements</span></div><div id="if827fac591d74a508bffd01ca16da4c0_22"></div><div><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Healthcare Realty Trust Incorporated</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Amounts in thousands, except per share data</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.498%"><tr><td style="width:1.0%"></td><td style="width:62.502%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.100%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Unaudited</span></div><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SEPTEMBER 30, 2023</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DECEMBER 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Real estate properties</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="f-31">1,387,821</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="f-32">1,439,798</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="f-33">11,004,195</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="f-34">11,332,037</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangibles</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherFiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-35">890,273</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherFiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-36">959,998</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Personal property</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="hr:PersonalProperty" format="ixt:num-dot-decimal" scale="3" id="f-37">12,686</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="hr:PersonalProperty" format="ixt:num-dot-decimal" scale="3" id="f-38">11,907</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investment in financing receivable, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-39">120,975</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-40">120,236</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-41">82,613</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-42">83,824</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:DevelopmentInProcess" format="ixt:num-dot-decimal" scale="3" id="f-43">85,644</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:DevelopmentInProcess" format="ixt:num-dot-decimal" scale="3" id="f-44">35,560</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land held for development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LandAvailableForDevelopment" format="ixt:num-dot-decimal" scale="3" id="f-45">59,871</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LandAvailableForDevelopment" format="ixt:num-dot-decimal" scale="3" id="f-46">74,265</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total real estate properties</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAtCost" format="ixt:num-dot-decimal" scale="3" id="f-47">13,644,078</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAtCost" format="ixt:num-dot-decimal" scale="3" id="f-48">14,057,625</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Less accumulated depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="f-49">2,093,952</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="f-50">1,645,271</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total real estate properties, net</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="f-51">11,550,126</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="f-52">12,412,354</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-53">24,668</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-54">60,961</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets held for sale, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="hr:AssetsHeldForSaleAndDiscontinuedOperationsNet" format="ixt:num-dot-decimal" scale="3" id="f-55">57,638</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="hr:AssetsHeldForSaleAndDiscontinuedOperationsNet" format="ixt:num-dot-decimal" scale="3" id="f-56">18,893</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-57">323,759</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-58">336,983</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-59">325,453</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-60">327,248</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-61">250,530</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-62">223,202</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-63">571,554</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-64">469,990</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total assets</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-65">13,103,728</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-66">13,849,631</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS' EQUITY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Notes and bonds payable</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-67">5,227,413</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-68">5,351,827</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-69">204,947</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-70">244,033</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities of assets held for sale</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="f-71">3,814</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="3" id="f-72">437</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-73">273,319</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-74">279,895</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-75">74,087</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-76">72,939</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-77">211,365</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-78">218,668</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-79">5,994,945</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-80">6,167,799</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-81"></ix:nonFraction></td><td colspan="3" style="padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-82"></ix:nonFraction></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Redeemable non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-83">3,195</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-84">2,014</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Stockholders' equity</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-85"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-86">.01</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-87"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-88">200,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-89"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="f-90"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="f-91"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="f-92">none</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> issued and outstanding</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-93">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="f-94">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Class A Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-95"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-96">.01</ix:nonFraction></ix:nonFraction> par value per share; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-97"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="f-98">1,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-99"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-100">380,860</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="f-101"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-102">380,590</ix:nonFraction></ix:nonFraction> shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="f-103">3,809</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:num-dot-decimal" scale="3" id="f-104">3,806</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-105">9,597,629</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-106">9,587,637</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accumulated other comprehensive income </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-107">17,079</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-108">2,140</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cumulative net income attributable to common stockholders</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="hr:CumulativeNetIncomeAttributableToCommonStockholders" format="ixt:num-dot-decimal" scale="3" id="f-109">1,069,327</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="hr:CumulativeNetIncomeAttributableToCommonStockholders" format="ixt:num-dot-decimal" scale="3" id="f-110">1,307,055</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cumulative dividends</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CumulativeDividends" format="ixt:num-dot-decimal" scale="3" id="f-111">3,684,144</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CumulativeDividends" format="ixt:num-dot-decimal" scale="3" id="f-112">3,329,562</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-113">7,003,700</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-114">7,571,076</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-controlling interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-115">101,888</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="f-116">108,742</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total equity</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-117">7,105,588</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-118">7,679,818</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total liabilities and equity</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-119">13,103,728</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-120">13,849,631</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022, are an integral part of these financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="if827fac591d74a508bffd01ca16da4c0_28"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Healthcare Realty Trust Incorporated</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">For the Three and Nine Months Ended September&#160;30, 2023 and 2022 </span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Amounts in thousands, except per share data</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Unaudited</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.131%"><tr><td style="width:1.0%"></td><td style="width:52.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.477%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.477%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.477%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.478%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>September 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Revenues</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Rental income</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-121">333,335</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-122">298,931</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-123">987,109</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-124">578,052</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-125">4,264</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-126">3,366</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-127">12,711</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-128">7,253</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-129"><span style="-sec-ix-hidden:f-130"><span style="-sec-ix-hidden:f-131"><span style="-sec-ix-hidden:f-132">Other operating</span></span></span></span></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-133">4,661</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-134">4,057</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-135">13,508</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-136">9,270</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-137">342,260</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-138">306,354</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-139">1,013,328</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-140">594,575</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Expenses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Property operating</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment" format="ixt:num-dot-decimal" scale="3" id="f-141">131,639</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment" format="ixt:num-dot-decimal" scale="3" id="f-142">112,473</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment" format="ixt:num-dot-decimal" scale="3" id="f-143">379,074</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment" format="ixt:num-dot-decimal" scale="3" id="f-144">226,947</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-145">13,396</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-146">16,741</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-147">43,796</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-148">38,317</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Acquisition and pursuit costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AcquisitionCosts" scale="3" id="f-149">769</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AcquisitionCosts" scale="3" id="f-150">482</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="f-151">1,725</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="f-152">3,137</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Merger-related costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="hr:MergerRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="f-153">7,450</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="hr:MergerRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="f-154">79,402</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="hr:MergerRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="f-155">3,366</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:MergerRelatedCosts" format="ixt:num-dot-decimal" scale="3" id="f-156">92,603</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-157">182,989</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-158">158,117</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-159">550,661</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-160">267,889</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="hr:OperatingExpensesandCostofGoodsSold" format="ixt:num-dot-decimal" scale="3" id="f-161">336,243</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="hr:OperatingExpensesandCostofGoodsSold" format="ixt:num-dot-decimal" scale="3" id="f-162">367,215</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:OperatingExpensesandCostofGoodsSold" format="ixt:num-dot-decimal" scale="3" id="f-163">971,890</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:OperatingExpensesandCostofGoodsSold" format="ixt:num-dot-decimal" scale="3" id="f-164">628,893</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other income (expense)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gain on sales of real estate properties</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="f-165">48,811</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="f-166">143,908</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="f-167">56,974</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GainsLossesOnSalesOfInvestmentRealEstate" format="ixt:num-dot-decimal" scale="3" id="f-168">197,188</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-169">66,304</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-170">53,044</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-171">195,397</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-172">82,248</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gain (loss) on extinguishment of debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="f-173">62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-174">1,091</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="f-175">62</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-176">2,520</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Impairment of real estate properties and credit loss reserves</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="hr:ImpairmentOfRealEstateAndCreditLossReserves" format="ixt:num-dot-decimal" scale="3" id="f-177">56,873</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="hr:ImpairmentOfRealEstateAndCreditLossReserves" format="ixt:fixed-zero" scale="3" id="f-178">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:ImpairmentOfRealEstateAndCreditLossReserves" format="ixt:num-dot-decimal" scale="3" id="f-179">143,510</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="hr:ImpairmentOfRealEstateAndCreditLossReserves" scale="3" id="f-180">25</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Equity loss from unconsolidated joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-181">456</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-182">124</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-183">1,253</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-184">776</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest and other income (expense), net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-185">139</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-186">172</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-187">1,278</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-188">378</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-189">74,621</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-190">89,477</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-191">281,846</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-192">111,291</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #242424;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net (loss) income </span></td><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-193">68,604</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-194">28,616</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-195">240,408</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-196">76,973</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net loss (income) attributable to non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-197">760</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-198">312</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-199">2,680</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-200">312</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #242424;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net (loss) income attributable to common stockholders</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-201">67,844</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-202">28,304</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-203">237,728</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #242424;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #242424;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-204">76,661</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #242424;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Basic earnings per common share </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-205">0.18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-206">0.08</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-207">0.63</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-208">0.36</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Diluted earnings per common share </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-209">0.18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-210">0.08</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-211">0.63</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-212">0.35</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-213">378,925</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-214">328,805</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-215">378,886</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="f-216">209,807</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-217">378,925</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-218">332,031</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-219">378,886</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-220">210,944</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022, are an integral part of these financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="if827fac591d74a508bffd01ca16da4c0_31"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Healthcare Realty Trust Incorporated</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Income</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">For the Three and Nine Months Ended September&#160;30, 2023 and 2022 </span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Amounts in thousands</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Unaudited</span></div><div style="margin-top:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.235%"><tr><td style="width:1.0%"></td><td style="width:56.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.531%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.534%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED<br/>&#160;September 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net (loss) income </span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-221">68,604</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-222">28,616</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-223">240,408</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-224">76,973</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other comprehensive income </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Reclassification adjustments for (gains) losses included in net income (interest expense)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-225">4,168</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-226">763</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-227">9,874</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-228">2,672</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gains arising during the period on interest rate swaps</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-229">12,016</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-230">6,083</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-231">24,999</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-232">12,905</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-233">7,848</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-234">6,846</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-235">15,125</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-236">15,577</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Comprehensive (loss) income </span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-237">60,756</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-238">35,462</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-239">225,283</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-240">92,550</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Less: comprehensive loss (income) attributable to non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="f-241">663</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="f-242">384</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-243">2,494</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="f-244">384</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Comprehensive (loss) income attributable to common stockholders</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-245">60,093</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-246">35,078</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-247">222,789</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-248">92,166</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> </span></div><div style="margin-bottom:6pt;margin-top:14pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022, are an integral part of these financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="if827fac591d74a508bffd01ca16da4c0_34"></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Healthcare Realty Trust Incorporated</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">For the Three Months Ended September&#160;30, 2023 and 2022</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Amounts in thousands, except per share data</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Unaudited</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.870%"><tr><td style="width:1.0%"></td><td style="width:22.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.471%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.334%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Common<br/>Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative <br/>Net Income </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative<br/>Dividends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Stockholders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Non-controlling Interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Redeemable Non-controlling Interests</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at June 30, 2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-249">3,808</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-250">9,595,033</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-251">9,328</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-252">1,137,171</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-253">3,565,941</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-254">7,179,399</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-255">104,018</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-256">7,283,417</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-257">2,487</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock, net of issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-258">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-259">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-260">33</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock redemptions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-261">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-262">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-263">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-264">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-265">2,555</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-266">2,556</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-267">2,556</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-268">67,844</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-269">67,844</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="us-gaap:ProfitLoss" scale="3" id="f-270">760</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-271">68,604</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Reclassification adjustments for gains included in net income (interest expense)<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-272">4,118</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-273">4,118</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-274">50</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-275">4,168</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gains arising during the period on interest rate swaps <br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-276">11,869</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-277">11,869</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="f-278">147</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-279">12,016</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Contributions from redeemable non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease" scale="3" id="f-280">710</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividends to common stockholders and distributions to non-controlling interest holders ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-281">0.31</ix:nonFraction> per share)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-282">118,203</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-283">118,203</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-284">1,467</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-285">119,670</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjustments to redemption value of redeemable non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" scale="3" id="f-286">2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at September 30, 2023</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-287">3,809</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-288">9,597,629</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-289">17,079</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-290">1,069,327</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-291">3,684,144</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-292">7,003,700</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-293">101,888</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-294">7,105,588</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-295">3,195</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Common<br/>Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative<br/>Net Income</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative<br/>Dividends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Stockholders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Non-controlling Interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Redeemable Non-controlling Interests</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at June 30, 2022</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-296">1,516</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-297">4,002,525</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-298">1,250</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-299">1,314,515</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-300">3,139,440</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-301">2,177,866</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-302">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-303">2,177,866</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:fixed-zero" scale="3" id="f-304">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock, net of issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-305">84</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-306">84</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-307">84</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Merger consideration transferred</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="hr:MergerConsiderationTransferred" format="ixt:num-dot-decimal" scale="3" id="f-308">2,289</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="hr:MergerConsiderationTransferred" format="ixt:num-dot-decimal" scale="3" id="f-309">5,574,174</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="hr:MergerConsiderationTransferred" format="ixt:num-dot-decimal" scale="3" id="f-310">5,576,463</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="hr:MergerConsiderationTransferred" format="ixt:num-dot-decimal" scale="3" id="f-311">110,702</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="hr:MergerConsiderationTransferred" format="ixt:num-dot-decimal" scale="3" id="f-312">5,687,165</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-controlling interests acquired </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="f-313">1,266</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="f-314">1,266</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock redemptions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-315">41</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-316">41</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-317">41</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-318">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-319">9,716</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-320">9,717</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-321">9,717</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Redemption of non-controlling interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" sign="-" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-322">98</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" sign="-" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-323">98</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-324">97</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-325">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-326">28,304</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-327">28,304</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="f-328">312</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-329">28,616</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Reclassification adjustments for losses included in net income (interest expense)<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-330">755</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-331">755</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-332">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-333">763</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gains arising during the period on interest rate swaps<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-334">6,019</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-335">6,019</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="f-336">64</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-337">6,083</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividends to common stockholders and distributions to non-controlling interest holders ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-338">0.31</ix:nonFraction> per share)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-339">72,052</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-340">72,052</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:DividendsCommonStockCash" scale="3" id="f-341">442</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-342">72,494</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-343">3,806</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-344">9,586,556</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-345">5,524</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-346">1,342,819</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-347">3,211,492</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-348">7,727,213</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-349">111,813</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-350">7,839,026</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:fixed-zero" scale="3" id="f-351">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022, are an integral part of these financial statements.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:58.5pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><span><br/></span></div><div style="margin-top:14pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Healthcare Realty Trust Incorporated</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">For the Nine Months Ended September&#160;30, 2023 and 2022</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Amounts in thousands, except per share data</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Unaudited</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.576%"><tr><td style="width:1.0%"></td><td style="width:22.587%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.141%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.410%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.119%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.701%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Common<br/>Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative <br/>Net Income </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative<br/>Dividends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Stockholders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Non-controlling Interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Redeemable Non-controlling Interests</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at December 31, 2022</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-352">3,806</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-353">9,587,637</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-354">2,140</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-355">1,307,055</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-356">3,329,562</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-357">7,571,076</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-358">108,742</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-359">7,679,818</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-360">2,014</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock, net of issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-361">112</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-362">112</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-363">112</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock redemptions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-364">1,587</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-365">1,587</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="f-366">1,587</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-367">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-368">11,467</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-369">11,470</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-370">11,470</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-371">237,728</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-372">237,728</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-373">2,680</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-374">240,408</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Reclassification adjustments for gains included in net income (interest expense)<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-375">9,757</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-376">9,757</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-377">117</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-378">9,874</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gains arising during the period on interest rate swaps <br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-379">24,696</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-380">24,696</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="f-381">303</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-382">24,999</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Contributions from redeemable non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease" format="ixt:num-dot-decimal" scale="3" id="f-383">1,210</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividends to common stockholders and distributions to non-controlling interest holders ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-384">0.93</ix:nonFraction> per share)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-385">354,582</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-386">354,582</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-387">4,360</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-388">358,942</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjustments to redemption value of redeemable non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:TemporaryEquityAccretionToRedemptionValue" scale="3" id="f-389">29</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at September 30, 2023</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-390">3,809</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-391">9,597,629</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-392">17,079</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-393">1,069,327</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-394">3,684,144</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-395">7,003,700</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-396">101,888</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-397">7,105,588</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="3" id="f-398">3,195</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Common<br/>Stock</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Accumulated<br/>Other<br/>Comprehensive<br/>Income (Loss)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative<br/>Net Income</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Cumulative<br/>Dividends</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Stockholders&#8217;<br/>Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Non-controlling Interests</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Total<br/>Equity</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Redeemable Non-controlling Interests</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-399">1,505</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-400">3,972,917</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-401">9,981</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-402">1,266,158</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-403">3,045,483</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-76" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-404">2,185,116</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="f-405">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-406">2,185,116</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:fixed-zero" scale="3" id="f-407">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock, net of issuance costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-408">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-409">22,847</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-410">22,855</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-411">22,855</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Merger consideration transferred</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="hr:MergerConsiderationTransferred" format="ixt:num-dot-decimal" scale="3" id="f-412">2,289</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="hr:MergerConsiderationTransferred" format="ixt:num-dot-decimal" scale="3" id="f-413">5,574,174</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="hr:MergerConsiderationTransferred" format="ixt:num-dot-decimal" scale="3" id="f-414">5,576,463</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="hr:MergerConsiderationTransferred" format="ixt:num-dot-decimal" scale="3" id="f-415">110,702</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:MergerConsiderationTransferred" format="ixt:num-dot-decimal" scale="3" id="f-416">5,687,165</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-controlling interests acquired</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="f-417">1,266</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="f-418">1,266</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock redemptions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-419">248</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-420">248</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" scale="3" id="f-421">248</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-422">4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-423">16,768</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-424">16,772</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-425">16,772</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Redemption of non-controlling interest</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" sign="-" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-426">98</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" sign="-" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-427">98</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-428">97</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="f-429">1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-430">76,661</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-431">76,661</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:ProfitLoss" scale="3" id="f-432">312</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-433">76,973</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Reclassification adjustments for losses included in net income (interest expense)<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-434">2,664</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-435">2,664</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-436">8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-437">2,672</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gains arising during the period on interest rate swaps<br/></span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-438">12,841</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-439">12,841</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="3" id="f-440">64</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-441">12,905</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividends to common stockholders and distributions to non-controlling interest holders ($<ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-442">0.93</ix:nonFraction> per share)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-443">166,009</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-444">166,009</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:DividendsCommonStockCash" scale="3" id="f-445">442</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="3" id="f-446">166,451</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance at September 30, 2022</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-447">3,806</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-448">9,586,556</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-449">5,524</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-450">1,342,819</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-451">3,211,492</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-452">7,727,213</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-453">111,813</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-454">7,839,026</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:fixed-zero" scale="3" id="f-455">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022, are an integral part of these financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="if827fac591d74a508bffd01ca16da4c0_40"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Healthcare</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> </span><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Realty Trust Incorporated</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">For the Nine Months Ended September&#160;30, 2023 and 2022 </span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Amounts in thousands</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Unaudited</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.168%"><tr><td style="width:1.0%"></td><td style="width:75.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.571%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net (loss) income</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-456">240,408</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-457">76,973</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-458">550,661</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-459">267,889</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherAmortizationOfDeferredCharges" format="ixt:num-dot-decimal" scale="3" id="f-460">33,822</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherAmortizationOfDeferredCharges" format="ixt:num-dot-decimal" scale="3" id="f-461">11,875</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-462">11,470</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-463">16,772</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of straight-line rent receivable (lessor)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:StraightLineRentReceivable" format="ixt:num-dot-decimal" scale="3" id="f-464">29,320</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:StraightLineRentReceivable" format="ixt:num-dot-decimal" scale="3" id="f-465">12,267</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of straight-line rent on operating leases (lessee)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:StraightlineRentLiability" format="ixt:num-dot-decimal" scale="3" id="f-466">4,600</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:StraightlineRentLiability" format="ixt:num-dot-decimal" scale="3" id="f-467">2,016</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gain on sales of real estate properties</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="f-468">56,974</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="f-469">197,188</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(Gain) loss on extinguishment of debt</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="f-470">62</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-471">2,520</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Impairment of real estate properties and credit loss reserves</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" format="ixt:num-dot-decimal" scale="3" id="f-472">143,510</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="hr:ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" scale="3" id="f-473">25</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Equity loss from unconsolidated joint ventures </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-474">1,253</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-475">776</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Distributions from unconsolidated joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" format="ixt:num-dot-decimal" scale="3" id="f-476">4,366</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:EquityMethodInvestmentDividendsOrDistributions" scale="3" id="f-477">893</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-cash interest from financing and notes receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:InterestIncomeFinancingReceivableNoncash" format="ixt:num-dot-decimal" scale="3" id="f-478">1,067</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:InterestIncomeFinancingReceivableNoncash" format="ixt:num-dot-decimal" scale="3" id="f-479">1,901</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, including right-of-use-assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="f-480">34,632</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" format="ixt:num-dot-decimal" scale="3" id="f-481">19,230</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-482">32,060</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-483">35,769</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-484">17,345</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-485">58,213</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-486">372,504</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-487">126,659</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Acquisitions of real estate</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="3" id="f-488">48,106</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToAcquireRealEstate" format="ixt:num-dot-decimal" scale="3" id="f-489">376,924</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Development of real estate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToDevelopRealEstateAssets" format="ixt:num-dot-decimal" scale="3" id="f-490">31,318</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToDevelopRealEstateAssets" format="ixt:num-dot-decimal" scale="3" id="f-491">17,572</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Additional long-lived assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireOtherProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-492">156,871</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToAcquireOtherProductiveAssets" format="ixt:num-dot-decimal" scale="3" id="f-493">97,797</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Funding of mortgages and notes receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireNotesReceivable" format="ixt:num-dot-decimal" scale="3" id="f-494">14,597</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToAcquireNotesReceivable" format="ixt:num-dot-decimal" scale="3" id="f-495">3,441</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInJointVenture" format="ixt:num-dot-decimal" scale="3" id="f-496">3,824</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInJointVenture" format="ixt:num-dot-decimal" scale="3" id="f-497">99,586</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investment in financing receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireFinanceReceivables" scale="3" id="f-498">310</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromCollectionOfFinanceReceivables" scale="3" id="f-499">167</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Contributions from redeemable non-controlling interests</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:ProceedsFromContributionsFromRedeemableNoncontrollingInterests" scale="3" id="f-500">710</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:ProceedsFromContributionsFromRedeemableNoncontrollingInterests" format="ixt:fixed-zero" scale="3" id="f-501">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Proceeds from sales of real estate properties and additional long-lived assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyHeldForSale" format="ixt:num-dot-decimal" scale="3" id="f-502">366,779</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromSaleOfPropertyHeldForSale" format="ixt:num-dot-decimal" scale="3" id="f-503">870,806</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Proceeds from notes receivable repayments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable" format="ixt:fixed-zero" scale="3" id="f-504">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable" scale="3" id="f-505">500</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash assumed in Merger, including restricted cash for special dividend payment</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:CashAcquiredInMerger" format="ixt:fixed-zero" scale="3" id="f-506">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:CashAcquiredInMerger" format="ixt:num-dot-decimal" scale="3" id="f-507">1,149,681</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net cash provided by investing activities</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-508">112,463</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-509">1,425,834</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net repayments on unsecured credit facility</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-510">149,000</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:ProceedsFromRepaymentsOfLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="f-511">154,400</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Borrowings on term loans</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfMediumTermNotes" format="ixt:fixed-zero" scale="3" id="f-512">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfMediumTermNotes" format="ixt:num-dot-decimal" scale="3" id="f-513">666,500</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repayment on term loan</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfMediumTermNotes" format="ixt:fixed-zero" scale="3" id="f-514">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RepaymentsOfMediumTermNotes" format="ixt:num-dot-decimal" scale="3" id="f-515">718,500</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Repayments of notes and bonds payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-516">11,988</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-517">18,880</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Redemption of notes and bonds payable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EarlyRepaymentOfSeniorDebt" format="ixt:fixed-zero" scale="3" id="f-518">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:EarlyRepaymentOfSeniorDebt" format="ixt:num-dot-decimal" scale="3" id="f-519">2,184</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividends paid</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-520">354,171</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsOfDividendsCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-521">165,735</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Special dividend paid in relation to the Merger</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:PaymentOfSpecialDividendMergerRelated" format="ixt:fixed-zero" scale="3" id="f-522">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:PaymentOfSpecialDividendMergerRelated" format="ixt:num-dot-decimal" scale="3" id="f-523">1,123,648</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net proceeds from issuance of common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="f-524">110</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-525">22,851</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Common stock redemptions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-526">1,834</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="f-527">894</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 23.5pt;text-align:left;text-indent:-22.5pt;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Distributions to non-controlling interest holders</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="f-528">3,836</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" scale="3" id="f-529">442</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Debt issuance and assumption costs</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="3" id="f-530">529</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsOfDebtIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-531">12,753</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Payments made on finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="f-532">12</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" format="ixt:fixed-zero" scale="3" id="f-533">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-534">521,260</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-535">1,508,085</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(Decrease) increase in cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-536">36,293</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-537">44,408</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-538">60,961</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-539">13,175</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-540">24,668</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-541">57,583</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.168%"><tr><td style="width:1.0%"></td><td style="width:75.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.571%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Supplemental Cash Flow Information</span></td><td colspan="6" style="background-color:#000000;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED<br/>September 30,</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-542">185,402</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-543">83,382</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Mortgage note receivable taken in connection with sale of real estate</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:MortgageLoanRelatedToPropertySales1" format="ixt:num-dot-decimal" scale="3" id="f-544">45,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:MortgageLoanRelatedToPropertySales1" format="ixt:fixed-zero" scale="3" id="f-545">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Invoices accrued for construction, tenant improvements and other capitalized costs</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="f-546">32,590</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="f-547">52,840</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Mortgage note payable assumed in connection with acquisition of real estate, net</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:TransferMortgagePayable" format="ixt:num-dot-decimal" scale="3" id="f-548">5,284</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:TransferMortgagePayable" format="ixt:fixed-zero" scale="3" id="f-549">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Capitalized interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidCapitalized" format="ixt:num-dot-decimal" scale="3" id="f-550">2,077</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InterestPaidCapitalized" scale="3" id="f-551">848</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The accompanying notes, together with the Notes to the Consolidated Financial Statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022, are an integral part of these financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="if827fac591d74a508bffd01ca16da4c0_43"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 1. <ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-552" continuedAt="f-552-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><div id="if827fac591d74a508bffd01ca16da4c0_46"></div><ix:continuation id="f-552-1" continuedAt="f-552-2"><ix:nonNumeric contextRef="c-1" name="hr:NatureOfOperationsPolicyTextBlock" id="f-553" continuedAt="f-553-1" escape="true"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Business Overview</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Healthcare Realty Trust Incorporated is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September&#160;30, 2023, the Company had gross investments of approximately $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-8" name="hr:InvestmentInRealEstatePropertiesAndMortgageNotes" format="ixt:num-dot-decimal" scale="9" id="f-554">13.6</ix:nonFraction>&#160;billion in </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:nonFraction unitRef="property" contextRef="c-3" decimals="INF" name="hr:NumberOfRealEstateInvestments" scale="0" id="f-555">663</ix:nonFraction> wholly-owned real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property.  The Company's <ix:nonFraction unitRef="property" contextRef="c-3" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="f-556">663</ix:nonFraction> re</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">al estate properties are located in <ix:nonFraction unitRef="state" contextRef="c-3" decimals="INF" name="hr:RealEstateInvestmentsPropertyOwnedInNumberOfStates" scale="0" id="f-557">35</ix:nonFraction> states and total approxima</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">tely <ix:nonFraction unitRef="sqft" contextRef="c-3" decimals="-5" name="hr:ApproximateSquareFeetInvestedInByCompany" format="ixt:num-dot-decimal" scale="6" id="f-558">39.1</ix:nonFraction>&#160;million </span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">square feet. The Company provided leasing and property management services to approximat</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">ely <ix:nonFraction unitRef="sqft" contextRef="c-3" decimals="-5" name="hr:ApproximateSquareFeetProvidedByCompany" format="ixt:num-dot-decimal" scale="6" id="f-559">38.6</ix:nonFraction> million sq</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">uare feet nationwide.   </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In addition, as of September&#160;30, 2023, the Company had a weighted average ownership interest of approxima</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">tely <ix:nonFraction unitRef="number" contextRef="c-86" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="f-560">44</ix:nonFraction>%</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> in </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:nonFraction unitRef="property" contextRef="c-3" decimals="INF" name="hr:NumberOfBuildingsOwnedByJointVenture" scale="0" id="f-561">34</ix:nonFraction> re</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">al estate properties held in joint ventures. See Note 3 below for more details regarding the Company's unconsolidated joint ventures. </span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-553-1">Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the Company's Condensed Consolidated Financial Statements, are outside the scope of our independent registered public accounting firm&#8217;s review.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-562" escape="true"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For purposes of this Quarterly Report on Form 10-Q, references to the &#8220;Company&#8221; are to Legacy HR for periods prior to the closing of the Merger and thereafter to Legacy HR and Legacy HTA as the combined company after giving effect to the Merger.  The Merger is described in more detail in Note 2 to these Condensed Consolidated Financial Statements.  The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. However, except as disclosed herein and specific disclosures included as a result of the Merger, management believes there has been no material change in the information disclosed in the Notes to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022. All material intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">This interim financial information should be read in conjunction with the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December&#160;31, 2023 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-563" continuedAt="f-563-1" escape="true"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Principles of Consolidation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s Condensed Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (&#8220;VIEs&#8221;). Accounting Standards Codification (&#8220;ASC&#8221;) Topic 810, Consolidation broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity&#8217;s economic performance or (ii) the equity investment at risk is insufficient to finance that entity&#8217;s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity&#8217;s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE&#8217;s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Condensed Consolidated Financial Statements. </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-552-2" continuedAt="f-552-3"><ix:continuation id="f-563-1" continuedAt="f-563-2"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company may change its original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity&#8217;s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns <ix:nonFraction unitRef="number" contextRef="c-87" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-564">100</ix:nonFraction>% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than <ix:nonFraction unitRef="number" contextRef="c-3" decimals="INF" name="hr:EquityOwnershipForConsolidationPercent" scale="-2" id="f-565">100</ix:nonFraction>% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities&#8217; activities based upon the terms of the respective entities&#8217; ownership agreements. </span></div></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-563-2">Healthcare Realty Holdings, L.P., a Delaware limited partnership (the "OP"), is <ix:nonFraction unitRef="number" contextRef="c-88" decimals="3" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="f-566">98.8</ix:nonFraction>% owned by the Company.  Holders of operating partnership units (&#8220;OP Units&#8221;) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of September&#160;30, 2023, there were approximately <ix:nonFraction unitRef="shares" contextRef="c-89" decimals="-5" name="us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding" format="ixt:num-dot-decimal" scale="6" id="f-567">4.7</ix:nonFraction>&#160;million OP Units, or <ix:nonFraction unitRef="number" contextRef="c-90" decimals="3" name="us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" scale="-2" id="f-568">1.2</ix:nonFraction>% of OP units issued and outstanding, held by non-controlling interest holders.  Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates the interests in the OP.</ix:continuation>  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of September&#160;30, 2023, the Company had <ix:nonFraction unitRef="variable_interest_entity" contextRef="c-3" decimals="INF" name="hr:NumberOfVariableInterestEntities" format="ixt-sec:numwordsen" scale="0" id="f-569">four</ix:nonFraction> consolidated VIEs, in addition to the OP, consisting of joint venture investments in which the Company is the primary beneficiary of the VIE based on the combination of operational control and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures.  <ix:nonNumeric contextRef="c-1" name="srt:ScheduleOfCondensedBalanceSheetTableTextBlock" id="f-570" continuedAt="f-570-1" escape="true">Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate:</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><ix:continuation id="f-570-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:45.259%"><tr><td style="width:1.0%"></td><td style="width:66.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SEPTEMBER 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net real estate investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="f-571">72,756</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-572">1,766</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Receivables and other assets</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="hr:ReceivablesAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-573">2,594</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total assets</span></div></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-574">77,116</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities:</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:AccountsPayableAndOtherAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-575">16,909</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total equity</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-576">60,207</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total liabilities and equity</span></div></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-577">77,116</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of September&#160;30, 2023, the Company had <ix:nonFraction unitRef="variable_interest_entity" contextRef="c-92" decimals="INF" name="hr:NumberOfVariableInterestEntities" format="ixt-sec:numwordsen" scale="0" id="f-578">three</ix:nonFraction> unconsolidated VIEs consisting of <ix:nonFraction unitRef="note_receivable" contextRef="c-92" decimals="INF" name="hr:NumberOfNotesReceivable" format="ixt-sec:numwordsen" scale="0" id="f-579">two</ix:nonFraction> notes receivables and <ix:nonFraction unitRef="joint_venture" contextRef="c-93" decimals="INF" name="hr:NumberOfJointVentures" format="ixt-sec:numwordsen" scale="0" id="f-580">one</ix:nonFraction> joint venture.  The Company does not have the power or economic interests to direct the activities of the VIEs on a stand-alone basis, and therefore it was determined that the Company was not the primary beneficiary.  <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="f-581" continuedAt="f-581-1" escape="true">As a result, the Company accounts for the <ix:nonFraction unitRef="note_receivable" contextRef="c-92" decimals="INF" name="hr:NumberOfNotesReceivable" format="ixt-sec:numwordsen" scale="0" id="f-582">two</ix:nonFraction> notes receivables as amortized cost and a joint venture arrangement under the equity method.  See below for additional information regarding the Company's unconsolidated VIEs.</ix:nonNumeric></span></div><ix:continuation id="f-581-1"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.119%"><tr><td style="width:1.0%"></td><td style="width:21.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands) ORIGINATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SOURCE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING AMOUNT </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM EXPOSURE TO LOSS</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="hr:NotesReceivableCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-583">30,797</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="3" id="f-584">31,150</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Charlotte, NC </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="hr:NotesReceivableCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-585">5,743</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="3" id="f-586">6,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="hr:JointVentureCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-587">63,579</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" format="ixt:num-dot-decimal" scale="3" id="f-588">63,579</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Assumed mortgage note receivable in connection with the Merger.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes investments in <ix:nonFraction unitRef="property" contextRef="c-96" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-589">seven</ix:nonFraction> properties.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-552-3" continuedAt="f-552-4"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationVariableInterestEntityPolicy" id="f-590" escape="true">As of September&#160;30, 2023, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities.</ix:nonNumeric>  See Note 3 below for more details regarding the Company's unconsolidated joint ventures.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-591" escape="true"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Use of Estimates in the Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.</span></div></ix:nonNumeric><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"><ix:nonNumeric contextRef="c-1" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="f-592" continuedAt="f-592-1" escape="true">Reclassifications </ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-592-1">Certain reclassifications have been made on the Company's prior year Condensed Consolidated Balance Sheet to conform to current year presentation. Previously, the Company's Lease intangibles were included in Building, improvements and lease intangibles and Goodwill was included with Other assets, net. These amounts are now classified as separate line items on the Company's Condensed Consolidated Balance Sheets.</ix:continuation> </span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:140%">                                            &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="f-593" continuedAt="f-593-1" escape="true">Redeemable Non-Controlling Interests</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-593-1">The Company accounts for redeemable equity securities in accordance with ASC Topic 480: Accounting for Redeemable Equity Instruments, which requires that equity securities redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders&#8217; equity.  The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Condensed Consolidated Balance Sheets.  Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest&#8217;s share of net income or loss and distributions) or the redemption value.  We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest.</ix:continuation>  As of September&#160;30, 2023, the Company had redeemable non-controlling interests of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" format="ixt:num-dot-decimal" scale="6" id="f-594">3.2</ix:nonFraction>&#160;million.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="f-595" continuedAt="f-595-1" escape="true">Asset Impairment</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-595-1">The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever the occurrence of an event or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company&#8217;s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its tenants.</ix:continuation>  During the three and nine months ended September&#160;30, 2023, the Company recognized real estate impairments totaling $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ImpairmentOfRealEstate" format="ixt:num-dot-decimal" scale="6" id="f-596">56.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ImpairmentOfRealEstate" format="ixt:num-dot-decimal" scale="6" id="f-597">138.3</ix:nonFraction>&#160;million, respectively, as a result of completed or planned disposition activity.  </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"><ix:nonNumeric contextRef="c-1" name="us-gaap:LessorLeasesPolicyTextBlock" id="f-598" continuedAt="f-598-1" escape="true">Investments in Leases - Financing Receivables, Net </ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-598-1" continuedAt="f-598-2">In accordance with ASC Topic 842: Leases, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC Topic 310: Receivables.</ix:continuation> <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="f-599" continuedAt="f-599-1" escape="true">See below for additional information regarding the Company's financing receivables.</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><ix:continuation id="f-599-1" continuedAt="f-599-2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.241%"><tr><td style="width:1.0%"></td><td style="width:26.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.667%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands) ORIGINATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">INTEREST RATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE as of SEPTEMBER 30, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Poway, CA</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-97" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="f-600">5.73</ix:nonFraction>%</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-3" name="us-gaap:SaleLeasebackTransactionNetBookValue" format="ixt:num-dot-decimal" scale="3" id="f-601">113,634</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">November 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Columbus, OH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-98" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="f-602">6.48</ix:nonFraction>%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-3" name="us-gaap:SaleLeasebackTransactionNetBookValue" format="ixt:num-dot-decimal" scale="3" id="f-603">7,341</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:SaleLeasebackTransactionNetBookValue" format="ixt:num-dot-decimal" scale="3" id="f-604">120,975</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-552-4" continuedAt="f-552-5"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"><ix:continuation id="f-598-2" continuedAt="f-598-3">Real Estate Notes Receivable</ix:continuation></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-598-3" continuedAt="f-598-4">Real estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower&#8217;s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held-to-maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses.</ix:continuation>  As of September&#160;30, 2023, real estate notes receivable, net, which are included in Other assets on the Company's Condensed Consolidated Balance Sheets, totaled $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="hr:RealEstateNotesReceivableNet" format="ixt:num-dot-decimal" scale="6" id="f-605">155.0</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:6pt"><ix:continuation id="f-599-2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"><tr><td style="width:1.0%"></td><td style="width:15.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.942%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">ORIGINATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">STATED INTEREST RATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM LOAN COMMITMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OUTSTANDING as of <br/>SEPT 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">ALLOWANCE FOR CREDIT LOSSES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE DISCOUNT AND FEES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE as of SEPT 30, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mezzanine loans</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-99" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="f-606">8.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="f-607">54,119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-608">54,119</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-609">5,196</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" format="ixt:num-dot-decimal" scale="3" id="f-610">3,067</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-611">45,856</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mortgage loans </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/30/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/31/2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-100" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="f-612">7.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="f-613">31,150</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-614">31,150</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-615">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" scale="3" id="f-616">353</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-617">30,797</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">North Carolina</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-101" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="f-618">8.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="f-619">6,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-620">6,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-621">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" scale="3" id="f-622">257</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-623">5,743</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5/17/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2/27/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-102" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="f-624">6.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="f-625">65,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-626">27,651</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-627">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" scale="3" id="f-628">49</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-629">27,602</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">California</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/30/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/29/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-103" decimals="INF" name="hr:NotesReceivableInterestRate" scale="-2" id="f-630">6.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="f-631">45,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-632">45,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-633">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" format="ixt:fixed-zero" scale="3" id="f-634">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-635">45,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="f-636">147,150</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-637">109,801</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-638">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" scale="3" id="f-639">659</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-640">109,142</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="hr:NotesReceivableMaximumLoanCommitment" format="ixt:num-dot-decimal" scale="3" id="f-641">201,269</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-642">163,920</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-643">5,196</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" format="ixt:num-dot-decimal" scale="3" id="f-644">3,726</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-645">154,998</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><ix:continuation id="f-598-4" continuedAt="f-598-5"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Allowance for Credit Losses</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Pursuant to ASC Topic 326, Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under ASC Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#8217;s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. </span></div></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-598-5" continuedAt="f-598-6">In its assessment of current expected credit losses for real estate notes receivable, the Company utilizes past payment history of its borrowers, current economic conditions, and forecasted economic conditions through the maturity date of each note to estimate a probability of default and a resulting loss for each real estate note receivable.</ix:continuation>  During the first quarter of 2023, the Company determined that the risk of credit loss on its mezzanine loans was no longer remote and recorded a credit loss reserve of $<ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="hr:FinancingReceivableAllowanceForCreditLossReserves" format="ixt:num-dot-decimal" scale="6" id="f-646">5.2</ix:nonFraction>&#160;million.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" id="f-647" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table summarizes the Company's allowance for credit losses on real estate notes receivable:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.672%"><tr><td style="width:1.0%"></td><td style="width:59.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.631%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">TWELVE MONTHS ENDED DECEMBER 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Allowance for credit losses, beginning of period</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-648">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-649">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Credit loss reserves</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:FinancingReceivableAllowanceForCreditLossReserves" format="ixt:num-dot-decimal" scale="3" id="f-650">5,196</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="hr:FinancingReceivableAllowanceForCreditLossReserves" format="ixt:fixed-zero" scale="3" id="f-651">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Allowance for credit losses, end of period</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="f-652">5,196</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="f-653">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:continuation id="f-598-6"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Interest Income</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Income from Lease Financing Receivables</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognized the related income from <ix:nonFraction unitRef="financing_receivable" contextRef="c-3" decimals="INF" name="hr:NumberOfRecognizedLeaseFinancialReceivables" format="ixt-sec:numwordsen" scale="0" id="f-654">two</ix:nonFraction> financing receivables totaling $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="f-655">2.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="f-656">6.2</ix:nonFraction>&#160;million, respectively, for the three and nine months ended September&#160;30, 2023, and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="f-657">2.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable" format="ixt:num-dot-decimal" scale="6" id="f-658">5.9</ix:nonFraction>&#160;million, respectively for the three and nine months ended September&#160;30, 2022, based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable in any particular period will not equal the cash payments from the lease agreement in that period. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Interest income over the life of the lease.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-552-5"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Income from Real Estate Notes Receivable</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the three and nine months ended September&#160;30, 2023, the Company recognized interest income of $<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:InterestIncomeOperating" format="ixt:num-dot-decimal" scale="6" id="f-659">2.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:InterestIncomeOperating" format="ixt:num-dot-decimal" scale="6" id="f-660">6.5</ix:nonFraction>&#160;million, respectively, related to real estate notes receivable. The Company recognizes interest income on an accrual basis unless the Company has determined that collectability of contractual amounts is not reasonably assured, at which point the note is placed on non-accrual status and interest income is recognized on a cash basis.  As of January 1, 2023, the Company placed <ix:nonFraction unitRef="financing_receivable" contextRef="c-109" decimals="INF" name="hr:NumberOfRealEstateNotesReceivable" format="ixt-sec:numwordsen" scale="0" id="f-661">two</ix:nonFraction> of its real estate notes receivable with principal balances of $<ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:FinancingReceivableExcludingAccruedInterestNonaccrual" format="ixt:num-dot-decimal" scale="6" id="f-662">48.9</ix:nonFraction>&#160;million on non-accrual status and accordingly did not recognize any interest income for the three and nine month periods ended September&#160;30, 2023. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-663" continuedAt="f-663-1" escape="true"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Revenue from Contracts with Customers (ASC Topic 606)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognizes certain revenue under the core principle of Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of Topic 606. To achieve the core principle, the Company applies the five step model specified in the guidance. </span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-663-1" continuedAt="f-663-2">Revenue that is accounted for under Topic 606 is segregated on the Company&#8217;s Condensed Consolidated Statements of Operations in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income.</ix:continuation> <ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-664" continuedAt="f-664-1" escape="true">Below is a detail of the amounts by category:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:5pt"><ix:continuation id="f-664-1" continuedAt="f-664-2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.385%"><tr><td style="width:1.0%"></td><td style="width:33.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>September 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Type of Revenue</span></td><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Parking income</span></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-665">2,751</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-666">2,428</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-667">7,511</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-668">6,100</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Management fee income</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-669">1,552</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-670">1,426</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-671">5,122</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-672">2,864</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Miscellaneous</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-673">358</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-674">203</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-675">875</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-676">306</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-677">4,661</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-678">4,057</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-679">13,508</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-680">9,270</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"><ix:continuation id="f-664-2">1     Includes the recovery of certain expenses under the financing receivable as outlined in the management agreement.</ix:continuation>           </span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-663-2">The Company&#8217;s major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time, and the Company recognizes revenue monthly based on this principle.</ix:continuation></span></div></ix:continuation><div id="if827fac591d74a508bffd01ca16da4c0_49"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 2. <ix:nonNumeric contextRef="c-1" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="f-681" continuedAt="f-681-1" escape="true">Merger with HTA </ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="f-681-1" continuedAt="f-681-2"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On July 20, 2022 (the &#8220;Closing Date&#8221;), pursuant to the Agreement and Plan of Merger dated as of February 28, 2022 (the &#8220;Merger Agreement&#8221;), by and among Healthcare Realty Trust Incorporated, a Maryland corporation (now known as HRTI, LLC, a Maryland limited liability company) (&#8220;Legacy HR&#8221;), Healthcare Trust of America, Inc., a Maryland corporation (now known as Healthcare Realty Trust Incorporated) (&#8220;Legacy HTA&#8221;), the OP, and HR Acquisition 2, LLC, a Maryland limited liability company (&#8220;Merger Sub&#8221;), Merger Sub merged with and into Legacy HR, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA (the &#8220;Merger&#8221;).</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On the Closing Date, each outstanding share of Legacy HR common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-122" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-682">0.01</ix:nonFraction> par value per share (the &#8220;Legacy HR Common Stock&#8221;), was cancelled and converted into the right to receive <ix:nonFraction unitRef="shares" contextRef="c-123" decimals="INF" name="hr:BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" format="ixt-sec:numwordsen" scale="0" id="f-683">one</ix:nonFraction> share of Legacy HTA class A common stock at a fixed ratio of <ix:nonFraction unitRef="shares" contextRef="c-123" decimals="INF" name="hr:BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" scale="0" id="f-684">1.00</ix:nonFraction> to 1.00. Per the terms of the Merger Agreement, Legacy HTA declared a special dividend of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-124" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-685">4.82</ix:nonFraction> (the &#8220;Special Dividend&#8221;) for each outstanding share of Legacy HTA class A common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-123" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-686">0.01</ix:nonFraction> par value per share ( the &#8220;Legacy HTA Common Stock&#8221;), and the OP declared a corresponding distribution to the holders of its partnership units, payable to Legacy HTA stockholders and OP unitholders of record on July 19, 2022. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Immediately following the Merger, Legacy HR converted to a Maryland limited liability company and changed its name to HRTI, LLC and Legacy HTA changed its name to &#8220;Healthcare Realty Trust Incorporated&#8221;. In addition, the equity interests of Legacy HR were contributed by Legacy HTA by means of a contribution and assignment agreement to the OP, and Legacy HR became a wholly-owned subsidiary of the OP.  The Company operates under the </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-681-2" continuedAt="f-681-3"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">name &#8220;Healthcare Realty Trust Incorporated&#8221; and its shares of class A common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-125" decimals="2" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-687">0.01</ix:nonFraction> par value per share, trade on the New York Stock Exchange under the ticker symbol &#8220;HR&#8221;.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For accounting purposes, the Merger was treated as a &#8220;reverse acquisition&#8221; in which Legacy HTA was considered the legal acquirer and Legacy HR was considered the accounting acquirer based on various factors, including, but not limited to: (i) the composition of the board of directors of the combined company following the Merger, (ii) the composition of senior management of the combined company following the Merger, and (iii) the premium transferred to the Legacy HTA stockholders. As a result, the historical financial statements of the accounting acquirer, Legacy HR, became the historical financial statements of the Company. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The acquisition was accounted for using the acquisition method of accounting in accordance with ASC 805, Business Combinations, which requires, among other things, the assets acquired and the liabilities assumed and non-controlling interests, if any, to be recognized at their acquisition date fair value. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock" id="f-688" continuedAt="f-688-1" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The implied consideration transferred on the Closing Date is as follows: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.495%"><tr><td style="width:1.0%"></td><td style="width:77.702%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.098%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands, except for per share data</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-123" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" id="f-689">228,520,990</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Exchange ratio</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-123" decimals="2" name="hr:RecapitalizationExchangeRatio" id="f-690">1.00</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Implied shares of Legacy HR Common Stock issued</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-126" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" format="ixt:num-dot-decimal" id="f-691">228,520,990</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjusted closing price of Legacy HR Common Stock on July 20, 2022</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(b)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-127" decimals="2" name="us-gaap:SaleOfStockPricePerShare" id="f-692">24.37</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Value of implied Legacy HR Common Stock issued</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="hr:ReverseRecapitalizationNet" format="ixt:num-dot-decimal" scale="3" id="f-693">5,569,057</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:700;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="hr:BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices" format="ixt:num-dot-decimal" scale="3" id="f-694">7,406</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Consideration transferred</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="f-695">5,576,463</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(a) The number of shares of Legacy HTA Common Stock presented above was based on <ix:nonFraction unitRef="shares" contextRef="c-127" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" id="f-696">228,857,717</ix:nonFraction> total shares of Legacy HTA Common Stock outstanding as of the Closing Date, less <ix:nonFraction unitRef="shares" contextRef="c-124" decimals="INF" name="hr:CommonStockFractionalShares" scale="0" id="f-697">192</ix:nonFraction> Legacy HTA fractional shares that were cancelled in lieu of cash and less <ix:nonFraction unitRef="shares" contextRef="c-129" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-698">336,535</ix:nonFraction> shares of Legacy HTA restricted stock (net of <ix:nonFraction unitRef="shares" contextRef="c-130" decimals="INF" name="hr:CommonStockSharesWithheld" format="ixt:num-dot-decimal" scale="0" id="f-699">215,764</ix:nonFraction> shares of Legacy HTA restricted stock withheld). For accounting purposes, these shares were converted to Legacy HR Common Stock, at an exchange ratio of <ix:nonFraction unitRef="number" contextRef="c-123" decimals="2" name="hr:RecapitalizationExchangeRatio" scale="0" id="f-700">1.00</ix:nonFraction> share of Legacy HR Common Stock per share of Legacy HTA Common Stock. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(b) For accounting purposes, the fair value of Legacy HR Common Stock issued to former holders of Legacy HTA Common Stock was based on the per share closing price of Legacy HR Common Stock on July 20, 2022.</span></div></ix:nonNumeric><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"><ix:continuation id="f-688-1">(c) Represents the fair value of Legacy HTA restricted shares which fully vested prior to the closing of the Merger or became fully vested as a result of the closing of the Merger and which are attributable to pre-combination services.</ix:continuation> </span></div></ix:continuation><div><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">13</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-681-3" continuedAt="f-681-4"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Final Purchase Price Allocation </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="f-701" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the Closing Date: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.553%"><tr><td style="width:1.0%"></td><td style="width:36.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.748%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">&#160;CUMULATIVE MEASUREMENT PERIOD ADJUSTMENTS</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">AMOUNTS RECOGNIZED ON THE CLOSING DATE <br/>(as adjusted)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">ASSETS</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Real estate investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" format="ixt:num-dot-decimal" scale="3" id="f-702">985,926</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand" format="ixt:num-dot-decimal" scale="3" id="f-703">18,359</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" format="ixt:num-dot-decimal" scale="3" id="f-704">1,004,285</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" format="ixt:num-dot-decimal" scale="3" id="f-705">6,960,418</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements" format="ixt:num-dot-decimal" scale="3" id="f-706">119,135</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" format="ixt:num-dot-decimal" scale="3" id="f-707">6,841,283</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangible assets</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-708">831,920</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-709">1,839</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-710">833,759</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-711">9,874</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-712">3,146</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-713">13,020</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" format="ixt:num-dot-decimal" scale="3" id="f-714">10,071</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress" format="ixt:num-dot-decimal" scale="3" id="f-715">6,744</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" format="ixt:num-dot-decimal" scale="3" id="f-716">3,327</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land held for development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" format="ixt:num-dot-decimal" scale="3" id="f-717">46,538</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" format="ixt:num-dot-decimal" scale="3" id="f-718">46,538</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total real estate investments</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" format="ixt:num-dot-decimal" scale="3" id="f-719">8,844,747</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments" format="ixt:num-dot-decimal" scale="3" id="f-720">102,535</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" format="ixt:num-dot-decimal" scale="3" id="f-721">8,742,212</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets held for sale, net </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" format="ixt:num-dot-decimal" scale="3" id="f-722">707,442</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet" format="ixt:num-dot-decimal" scale="3" id="f-723">7,946</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" format="ixt:num-dot-decimal" scale="3" id="f-724">699,496</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-725">67,892</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-726">67,892</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-727">26,034</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-728">11,403</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-729">37,437</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Restricted cash </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" format="ixt:num-dot-decimal" scale="3" id="f-730">1,123,647</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash" format="ixt:num-dot-decimal" scale="3" id="f-731">1,247</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" format="ixt:num-dot-decimal" scale="3" id="f-732">1,122,400</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-733">198,261</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-734">16,370</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" format="ixt:num-dot-decimal" scale="3" id="f-735">214,631</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(b) (c)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-736">209,163</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-737">3,840</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-738">205,323</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total assets acquired</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="3" id="f-739">11,177,186</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired" format="ixt:num-dot-decimal" scale="3" id="f-740">87,795</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="3" id="f-741">11,089,391</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">LIABILITIES</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Notes and bonds payable </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-742">3,991,300</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-743">3,991,300</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-744">1,227,570</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-745">17,374</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-746">1,244,944</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities of assets held for sale</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" format="ixt:num-dot-decimal" scale="3" id="f-747">28,677</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale" format="ixt:num-dot-decimal" scale="3" id="f-748">3,939</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" format="ixt:num-dot-decimal" scale="3" id="f-749">24,738</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-750">173,948</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-751">10,173</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-752">184,121</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-753">10,720</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities" scale="3" id="f-754">855</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-755">9,865</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-756">203,210</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-757">8,909</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-758">194,301</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total liabilities assumed</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-759">5,635,425</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed" format="ixt:num-dot-decimal" scale="3" id="f-760">13,844</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-761">5,649,269</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net identifiable assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-762">5,541,761</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" sign="-" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" format="ixt:num-dot-decimal" scale="3" id="f-763">101,639</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="f-764">5,440,122</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-controlling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" format="ixt:num-dot-decimal" scale="3" id="f-765">110,702</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" format="ixt:num-dot-decimal" scale="3" id="f-766">110,702</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-767">145,404</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" format="ixt:num-dot-decimal" scale="3" id="f-768">101,639</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="f-769">247,043</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(a) The weighted average amortization period for the acquired lease intangible assets is approximately <ix:nonNumeric contextRef="c-127" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:duryear" id="f-770">6</ix:nonNumeric> years.</span></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(b) Includes $<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:BusinessCombinationAcquiredReceivablesGrossContractualAmount" format="ixt:num-dot-decimal" scale="6" id="f-771">15.9</ix:nonFraction> million of contractual accounts receivable, which approximates fair value.</span></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(c) Includes $<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="hr:BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount" format="ixt:num-dot-decimal" scale="6" id="f-772">78.7</ix:nonFraction> million of gross contractual real estate notes receivable, the fair value of which was $<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="hr:GrossContractualRealEstateNotesReceivableFairValue" format="ixt:num-dot-decimal" scale="6" id="f-773">74.8</ix:nonFraction> million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date.</span></div></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The cumulative measurement period adjustments recorded through June 30, 2023 are final and primarily resulted from updated valuations related to the Company&#8217;s real estate assets and liabilities and additional information obtained by the Company related to the properties acquired in the Merger and their respective tenants, and resulted in an increase to goodwill of $<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="hr:BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete" format="ixt:num-dot-decimal" scale="6" id="f-774">101.6</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Based on the final purchase price allocation of fair value, approximately $<ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="f-775">247.0</ix:nonFraction>&#160;million has been allocated to goodwill. Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired and liabilities assumed. The recognized goodwill is attributable to expected synergies and benefits arising from the Merger, including anticipated general and administrative cost savings and potential economies of scale benefits in both tenant and vendor relationships following the closing of the Merger.  <ix:nonFraction unitRef="usd" contextRef="c-127" decimals="INF" name="us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" format="ixt:fixed-zero" scale="0" id="f-776">None</ix:nonFraction> of the goodwill recognized is expected to be deductible for tax purposes. During the third quarter of 2023, the Company experienced a sustained decline in the price per share of its common stock, which it identified as an indicator of goodwill impairment.  As a result, the Company performed an interim goodwill evaluation. The fair value of the Company&#8217;s single reporting unit </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">14</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-681-4"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">was estimated using a combination of discounted cash flow models and earnings multiples techniques. The quantitative assessment as of September 30, 2023 indicated goodwill was not impaired.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Merger-related Costs</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company incurred Merger-related costs of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="hr:MergerRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="f-777">7.5</ix:nonFraction> million and $(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="hr:MergerRelatedCosts" scale="6" id="f-778">3.4</ix:nonFraction>) million, respectively, during the three and nine months ended September&#160;30, 2023, which were included within Merger-related costs in results of operations. The Merger-related costs primarily consist of legal, consulting, severance, and banking services and for the nine months ended September&#160;30, 2023 including a refund of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="hr:BusinessCombinationRefundOfTransferTaxesPaid" format="ixt:num-dot-decimal" scale="6" id="f-779">17.8</ix:nonFraction>&#160;million for transfer taxes paid during the year ended December&#160;31, 2022.</span></div></ix:continuation><div id="if827fac591d74a508bffd01ca16da4c0_52"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 3. <ix:nonNumeric contextRef="c-1" name="hr:AcquisitionsAndDispositionsTextBlock" id="f-780" continuedAt="f-780-1" escape="true">Real Estate Investments</ix:nonNumeric></span></div><ix:continuation id="f-780-1" continuedAt="f-780-2"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">2023 Acquisition Activity</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%"> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" id="f-781" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table details the Company's real estate acquisition activity for the nine months ended September&#160;30, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.941%"><tr><td style="width:1.0%"></td><td style="width:24.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.890%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.836%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.306%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.101%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DATE ACQUIRED</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PURCHASE PRICE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MORTGAGE NOTES PAYABLE, NET</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CASH<br/>CONSIDERATION </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">REAL <br/>ESTATE </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OTHER </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE FOOTAGE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Tampa, FL</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/10/23</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="f-782">31,500</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:fixed-zero" scale="3" id="f-783">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="f-784">30,499</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" format="ixt:num-dot-decimal" scale="3" id="f-785">30,596</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" sign="-" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" scale="3" id="f-786">97</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-134" decimals="0" name="hr:BusinessAcquisitionPurchasePriceAllocationSquareFootage" format="ixt:num-dot-decimal" scale="0" id="f-787">115,867</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Colorado Springs, CO</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/28/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="f-788">11,450</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="3" id="f-789">5,284</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="f-790">6,024</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" format="ixt:num-dot-decimal" scale="3" id="f-791">11,416</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" sign="-" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" scale="3" id="f-792">108</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-136" decimals="0" name="hr:BusinessAcquisitionPurchasePriceAllocationSquareFootage" format="ixt:num-dot-decimal" scale="0" id="f-793">42,770</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total real estate acquisitions</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="f-794">42,950</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred" format="ixt:num-dot-decimal" scale="3" id="f-795">5,284</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="f-796">36,523</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" format="ixt:num-dot-decimal" scale="3" id="f-797">42,012</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" sign="-" name="hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" scale="3" id="f-798">205</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="sqft" contextRef="c-138" decimals="0" name="hr:BusinessAcquisitionPurchasePriceAllocationSquareFootage" format="ixt:num-dot-decimal" scale="0" id="f-799">158,637</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition.</span></div></ix:nonNumeric><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In the third quarter of 2023, the Company acquired a parcel of land previously under a ground lease for $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsToAcquireLand" format="ixt:num-dot-decimal" scale="6" id="f-800">0.8</ix:nonFraction>&#160;million and an additional interest in an operating property for $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" format="ixt:num-dot-decimal" scale="6" id="f-801">0.6</ix:nonFraction>&#160;million.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Unconsolidated Joint Ventures</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:EquityMethodInvestmentsTextBlock" id="f-802" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's investment in and loss recognized for the three and nine months ended September&#160;30, 2023 and 2022 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.094%"><tr><td style="width:1.0%"></td><td style="width:55.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>September 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures, beginning of period </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-803">327,245</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-804">210,781</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-805">327,248</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-806">161,942</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">New investment during the period </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" format="ixt:fixed-zero" scale="3" id="f-807">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" format="ixt:num-dot-decimal" scale="3" id="f-808">117,880</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" format="ixt:num-dot-decimal" scale="3" id="f-809">3,824</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" format="ixt:num-dot-decimal" scale="3" id="f-810">167,479</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Equity loss recognized during the period </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-811">456</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-812">124</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" format="ixt:num-dot-decimal" scale="3" id="f-813">1,253</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="f-814">776</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Owner distributions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" format="ixt:num-dot-decimal" scale="3" id="f-815">1,336</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-3" name="us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" scale="3" id="f-816">785</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" format="ixt:num-dot-decimal" scale="3" id="f-817">4,366</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-3" name="us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" scale="3" id="f-818">893</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures, end of period </span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-819">325,453</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-820">327,752</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-821">325,453</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-3" name="us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" format="ixt:num-dot-decimal" scale="3" id="f-822">327,752</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">In 2023, this was an additional investment in an existing joint venture in which the Company retained a <ix:nonFraction unitRef="number" contextRef="c-149" decimals="2" name="hr:JointVentureOwnershipPercentage" scale="-2" id="f-823">40</ix:nonFraction>% ownership interest. The investment consisted of the Company's sale of a property in Dallas, Texas to the joint venture.  See 2023 Real Estate Asset Dispositions below for additional information.</span></div></ix:nonNumeric></ix:continuation><div style="margin-top:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">15</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-780-2"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">2023 Real Estate Asset Dispositions </span></div><ix:nonNumeric contextRef="c-1" name="hr:AssetDispositionsTableTextBlock" id="f-824" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table details the Company's dispositions for the nine months ended September&#160;30, 2023:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DATE DISPOSED</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SALE PRICE</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CLOSING ADJUSTMENTS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">COMPANY-FINANCED MORTGAGE NOTES</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NET PROCEEDS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NET REAL ESTATE INVESTMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OTHER (INCLUDING RECEIVABLES) </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">GAIN/(IMPAIRMENT)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE FOOTAGE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Tampa/Miami, FL</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/12/23</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="f-825">93,250</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" format="ixt:num-dot-decimal" scale="3" id="f-826">5,875</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:fixed-zero" scale="3" id="f-827">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-828">87,375</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-829">87,302</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" sign="-" name="hr:RealEstateOther" scale="3" id="f-830">888</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="f-831">961</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-150" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-832">224,037</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dallas, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="f-833">19,210</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" scale="3" id="f-834">141</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:fixed-zero" scale="3" id="f-835">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-836">19,069</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-837">18,986</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="hr:RealEstateOther" scale="3" id="f-838">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="f-839">40</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-152" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-840">36,691</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">St. Louis, MO</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2/10/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="hr:DispositionSalesPrice" scale="3" id="f-841">350</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" scale="3" id="f-842">18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:fixed-zero" scale="3" id="f-843">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" scale="3" id="f-844">332</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" scale="3" id="f-845">398</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="hr:RealEstateOther" format="ixt:fixed-zero" scale="3" id="f-846">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="f-847">66</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-154" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-848">6,500</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/23/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="f-849">21,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" scale="3" id="f-850">526</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:fixed-zero" scale="3" id="f-851">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-852">20,474</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-853">20,610</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="hr:RealEstateOther" scale="3" id="f-854">52</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="f-855">188</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-156" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-856">37,165</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">4</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="f-857">75,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" format="ixt:num-dot-decimal" scale="3" id="f-858">8,079</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:num-dot-decimal" scale="3" id="f-859">45,000</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-860">21,921</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-861">88,624</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" sign="-" name="hr:RealEstateOther" scale="3" id="f-862">803</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-863">20,900</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-158" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-864">147,078</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">5</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/12/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="f-865">3,300</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" scale="3" id="f-866">334</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:fixed-zero" scale="3" id="f-867">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-868">2,966</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-869">3,268</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="hr:RealEstateOther" format="ixt:fixed-zero" scale="3" id="f-870">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" scale="3" id="f-871">302</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-160" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:fixed-zero" scale="0" id="f-872">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Albany, NY</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="f-873">10,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" format="ixt:num-dot-decimal" scale="3" id="f-874">1,229</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:fixed-zero" scale="3" id="f-875">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-876">8,771</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-877">2,613</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" sign="-" name="hr:RealEstateOther" format="ixt:num-dot-decimal" scale="3" id="f-878">1,040</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-879">7,198</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-162" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-880">40,870</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/2/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="f-881">8,320</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" scale="3" id="f-882">285</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:fixed-zero" scale="3" id="f-883">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-884">8,035</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-885">4,567</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="hr:RealEstateOther" scale="3" id="f-886">194</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-887">3,274</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-164" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-888">57,170</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Atlanta, GA</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/22/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="f-889">25,142</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" scale="3" id="f-890">66</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:fixed-zero" scale="3" id="f-891">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-892">25,076</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-893">23,226</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" sign="-" name="hr:RealEstateOther" scale="3" id="f-894">536</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-895">2,386</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-166" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-896">55,195</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dallas, TX</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9/15/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="f-897">115,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" format="ixt:num-dot-decimal" scale="3" id="f-898">1,504</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:fixed-zero" scale="3" id="f-899">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-900">113,496</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-901">64,183</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="hr:RealEstateOther" format="ixt:num-dot-decimal" scale="3" id="f-902">6,094</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-903">43,219</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-168" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-904">161,264</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9/18/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="hr:DispositionSalesPrice" scale="3" id="f-905">250</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" scale="3" id="f-906">24</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:fixed-zero" scale="3" id="f-907">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" scale="3" id="f-908">226</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-909">1,998</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="hr:RealEstateOther" format="ixt:fixed-zero" scale="3" id="f-910">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-911">1,772</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-170" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-912">52,040</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Chicago, IL</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9/27/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="f-913">59,950</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" scale="3" id="f-914">870</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:fixed-zero" scale="3" id="f-915">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-916">59,080</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-917">74,710</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" sign="-" name="hr:RealEstateOther" scale="3" id="f-918">380</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" sign="-" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-919">15,250</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-172" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-920">104,912</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total dispositions</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="hr:DispositionSalesPrice" format="ixt:num-dot-decimal" scale="3" id="f-921">430,772</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="hr:ClosingAdjustmentsDisposedEntity" format="ixt:num-dot-decimal" scale="3" id="f-922">18,951</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="hr:FinanceMortgageNotes" format="ixt:num-dot-decimal" scale="3" id="f-923">45,000</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" name="us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment" format="ixt:num-dot-decimal" scale="3" id="f-924">366,821</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="hr:RealEstateInvestmentNetDisposedOfDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="f-925">390,485</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" name="hr:RealEstateOther" format="ixt:num-dot-decimal" scale="3" id="f-926">2,736</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" name="us-gaap:GainLossOnDispositionOfAssets" format="ixt:num-dot-decimal" scale="3" id="f-927">18,600</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="sqft" contextRef="c-174" decimals="0" name="hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" format="ixt:num-dot-decimal" scale="0" id="f-928">922,922</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Includes straight-line rent receivables, leasing commissions and lease inducements.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes <ix:nonFraction unitRef="property" contextRef="c-150" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" format="ixt-sec:numwordsen" scale="0" id="f-929">two</ix:nonFraction> properties, sold in <ix:nonFraction unitRef="disposition_transaction" contextRef="c-150" decimals="INF" name="hr:NumberOfPropertyDispositions" format="ixt-sec:numwordsen" scale="0" id="f-930">two</ix:nonFraction> separate transactions to the same buyer on the same date.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">The Company sold this property to a joint venture in which it retained a <ix:nonFraction unitRef="number" contextRef="c-153" decimals="2" name="hr:JointVentureOwnershipPercentage" scale="-2" id="f-931">40</ix:nonFraction>% interest. Sales price and square footage reflect the total sales price paid by the joint venture and total square footage of the property.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">4</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.81pt">The Company entered into a mortgage note agreement with the buyer for $<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-6" name="hr:MortgageNote" format="ixt:num-dot-decimal" scale="6" id="f-932">45</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">5</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.18pt">The Company sold a land parcel totaling <ix:nonFraction unitRef="acre" contextRef="c-176" decimals="2" name="us-gaap:AreaOfLand" scale="0" id="f-933">0.34</ix:nonFraction> acres.</span></div></ix:nonNumeric><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Assets Held for Sale</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company had <ix:nonFraction unitRef="property" contextRef="c-3" decimals="INF" name="hr:NumberOfPropertiesClassifiedAsHeldForSale" id="f-934">17</ix:nonFraction> properties and <ix:nonFraction unitRef="entity" contextRef="c-3" decimals="INF" name="hr:NumberOfCorporateEntityClassifiedAsHeldForSale" format="ixt-sec:numwordsen" scale="0" id="f-935">one</ix:nonFraction> corporate entity classified as assets held for sale as of September&#160;30, 2023. The net real estate assets held for sale includes the impact of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="hr:ImpairmentChargeOnRealEstateAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="f-936">15.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="hr:ImpairmentChargeOnRealEstateAssetsHeldForSale" format="ixt:num-dot-decimal" scale="6" id="f-937">46.4</ix:nonFraction>&#160;million, respectively, of impairment charges for the three and nine months ended September&#160;30, 2023.  The Company had <ix:nonFraction unitRef="property" contextRef="c-4" decimals="INF" name="hr:NumberOfPropertiesClassifiedAsHeldForSale" format="ixt-sec:numwordsen" scale="0" id="f-938">one</ix:nonFraction> property classified as assets held for sale as of December&#160;31, 2022, which was sold in the first quarter of 2023.  <ix:nonNumeric contextRef="c-1" name="hr:ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" id="f-939" continuedAt="f-939-1" escape="true">The table below reflects the assets and liabilities classified as held for sale as of September&#160;30, 2023 and December&#160;31, 2022:</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><ix:continuation id="f-939-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"><tr><td style="width:1.0%"></td><td style="width:41.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance Sheet data:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="f-940">14,282</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:Land" format="ixt:num-dot-decimal" scale="3" id="f-941">1,700</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="f-942">41,538</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:InvestmentBuildingAndBuildingImprovements" format="ixt:num-dot-decimal" scale="3" id="f-943">15,164</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangibles</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="hr:LeaseIntangibles" format="ixt:num-dot-decimal" scale="3" id="f-944">12,938</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="hr:LeaseIntangibles" format="ixt:num-dot-decimal" scale="3" id="f-945">1,986</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAtCost" format="ixt:num-dot-decimal" scale="3" id="f-946">68,758</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAtCost" format="ixt:num-dot-decimal" scale="3" id="f-947">18,850</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:num-dot-decimal" scale="3" id="f-948">13,634</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation" format="ixt:fixed-zero" scale="3" id="f-949">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate assets held for sale, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="f-950">55,124</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:RealEstateInvestmentPropertyNet" format="ixt:num-dot-decimal" scale="3" id="f-951">18,850</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="f-952">585</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:fixed-zero" scale="3" id="f-953">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-954">1,929</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets" scale="3" id="f-955">43</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets held for sale, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="hr:AssetsHeldForSaleAndDiscontinuedOperationsNet" format="ixt:num-dot-decimal" scale="3" id="f-956">57,638</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="hr:AssetsHeldForSaleAndDiscontinuedOperationsNet" format="ixt:num-dot-decimal" scale="3" id="f-957">18,893</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-958">1,716</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" scale="3" id="f-959">282</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-960">1,020</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-961">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-962">1,078</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" scale="3" id="f-963">155</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities of assets held for sale</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" format="ixt:num-dot-decimal" scale="3" id="f-964">3,814</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" scale="3" id="f-965">437</ix:nonFraction>&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">16</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="if827fac591d74a508bffd01ca16da4c0_55"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 4. <ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeFinanceLeasesTextBlock" id="f-966" continuedAt="f-966-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-967" continuedAt="f-967-1" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="f-966-1" continuedAt="f-966-2"><ix:continuation id="f-967-1" continuedAt="f-967-2"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Lessor Accounting</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s properties generally are leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide tenants with fixed rent renewal terms while others have market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company&#8217;s single-tenant net leases generally require the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's leases typically have escalators that are either based on a stated percentage or an index such as the consumer price index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three and nine months ended September&#160;30, 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="6" id="f-968">333.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="6" id="f-969">987.1</ix:nonFraction> million, respectively.  Lease income for the Company's operating leases recognized for the three and nine months ended September 30, 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="6" id="f-970">298.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseLeaseIncome" format="ixt:num-dot-decimal" scale="6" id="f-971">578.1</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" id="f-972" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Future lease payments under the non-cancelable operating leases, excluding any reimbursements and one sale-type lease, as of September&#160;30, 2023 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"><tr><td style="width:1.0%"></td><td style="width:42.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="f-973">231,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-974">874,750</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears" format="ixt:num-dot-decimal" scale="3" id="f-975">770,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears" format="ixt:num-dot-decimal" scale="3" id="f-976">666,294</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears" format="ixt:num-dot-decimal" scale="3" id="f-977">552,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="hr:LessorOperatingLeasePaymenttobeReceivedafterYearFour" format="ixt:num-dot-decimal" scale="3" id="f-978">1,918,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LessorOperatingLeasePaymentsToBeReceived" format="ixt:num-dot-decimal" scale="3" id="f-979">5,014,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Lessee Accounting </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of September&#160;30, 2023, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company&#8217;s ground leases. As of September&#160;30, 2023, the Company had <ix:nonFraction unitRef="property" contextRef="c-3" decimals="INF" name="us-gaap:NumberOfPropertiesSubjectToGroundLeases" scale="0" id="f-980">240</ix:nonFraction> properties totaling <ix:nonFraction unitRef="sqft" contextRef="c-1" decimals="-5" name="hr:SquareFeetSubjecttoGroundLeases" format="ixt:num-dot-decimal" scale="6" id="f-981">17.4</ix:nonFraction> million square feet that were held under ground leases. Some of the ground lease renewal terms are based on fixed rent renewal terms and others have market rent renewal terms. These ground leases typically have initial terms of <ix:nonNumeric contextRef="c-179" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-982">40</ix:nonNumeric> to <ix:nonNumeric contextRef="c-180" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="f-983">99</ix:nonNumeric> years with expiration dates through 2119. Any rental increases related to the Company&#8217;s ground leases are generally either stated or based on CPI. The Company had <ix:nonFraction unitRef="lease" contextRef="c-1" decimals="INF" name="hr:NumberofGroundLeasesPrepaid" scale="0" id="f-984">75</ix:nonFraction> prepaid ground leases as of September&#160;30, 2023. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="hr:AmortizationofPrepaidRent" format="ixt:num-dot-decimal" scale="6" id="f-985">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="hr:AmortizationofPrepaidRent" format="ixt:num-dot-decimal" scale="6" id="f-986">0.1</ix:nonFraction>&#160;million of the Company&#8217;s rental expense for the three months ended September&#160;30, 2023 and 2022, respectively, and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="hr:AmortizationofPrepaidRent" format="ixt:num-dot-decimal" scale="6" id="f-987">1.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="hr:AmortizationofPrepaidRent" format="ixt:num-dot-decimal" scale="6" id="f-988">0.4</ix:nonFraction>&#160;million for the nine months ended September&#160;30, 2023 and 2022, respectively.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">17</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-966-2"><ix:continuation id="f-967-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-989" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="f-990" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s future lease payments (primarily for its <ix:nonFraction unitRef="lease" contextRef="c-3" decimals="INF" name="hr:NumberofGroundLeasesExcludingPrepaidLeases" scale="0" id="f-991">165</ix:nonFraction> non-prepaid ground leases) as of September&#160;30, 2023 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FINANCING</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" format="ixt:num-dot-decimal" scale="3" id="f-992">3,288</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="f-993">513</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-994">14,062</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-995">2,182</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-996">14,253</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-997">2,218</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-998">14,392</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-999">2,255</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-1000">14,630</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-1001">2,294</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="hr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="f-1002">922,019</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="hr:FinanceLeaseLiabilityToBePaidAfterYearFour" format="ixt:num-dot-decimal" scale="3" id="f-1003">396,397</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-1004">982,644</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-1005">405,859</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-1006">709,325</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-1007">331,772</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Lease liabilities</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1008">273,319</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1009">74,087</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-1010" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides details of the Company's total lease expense for the three and nine months ended September&#160;30, 2023 and 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>September 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Operating lease cost</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1011">5,312</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1012">4,204</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1013">15,748</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1014">6,613</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Variable lease expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1015">2,417</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1016">1,061</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1017">6,788</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1018">3,123</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Finance lease cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-1019">387</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-1020">381</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" format="ixt:num-dot-decimal" scale="3" id="f-1021">1,161</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="f-1022">884</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="f-1023">928</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="f-1024">861</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-1025">2,770</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-1026">1,913</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total lease expense</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1027">9,044</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1028">6,507</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1029">26,467</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-1030">12,533</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-1031">5,281</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-1032">3,847</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-1033">16,475</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="f-1034">8,443</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-1035">524</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="f-1036">476</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" format="ixt:num-dot-decimal" scale="3" id="f-1037">1,592</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" format="ixt:num-dot-decimal" scale="3" id="f-1038">1,262</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="hr:FinanceLeasePrincipalOnlyPayments" scale="3" id="f-1039">7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="hr:FinanceLeasePrincipalOnlyPayments" scale="3" id="f-1040">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="hr:FinanceLeasePrincipalOnlyPayments" scale="3" id="f-1041">12</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:FinanceLeasePrincipalOnlyPayments" scale="3" id="f-1042">3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new finance lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-1043">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1044">9,874</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-1045">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1046">50,463</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-1047">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1048">198,261</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-1049">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-1050">198,261</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1051">47.5</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-56" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1052">50.2</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1053">58.2</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-56" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1054">60.1</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1055">5.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-56" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1056">5.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-3" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1057">5.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-56" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1058">5.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="if827fac591d74a508bffd01ca16da4c0_61"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 5. <ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-1059" continuedAt="f-1059-1" escape="true">Notes and Bonds Payable</ix:nonNumeric></span></div><ix:continuation id="f-1059-1" continuedAt="f-1059-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtTableTextBlock" id="f-1060" continuedAt="f-1060-1" escape="true"><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below details the Company&#8217;s notes and bonds payable as of September 30, 2023 and December 31, 2022.&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.522%"><tr><td style="width:1.0%"></td><td style="width:39.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.091%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY DATES </span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">BALANCE </span><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:3.73pt;font-weight:700;line-height:120%;position:relative;top:-2.01pt;vertical-align:baseline">1</span><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"> AS OF  </span></div></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EFFECTIVE INTEREST RATE <br/>as of 9/30/2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">9/30/2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">12/31/2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-181" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="f-1061">1.5</ix:nonFraction> billion Unsecured Credit Facility </span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10/25</span></td><td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1062">236,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1063">385,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-181" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1064">6.24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-183" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-1065">200</ix:nonFraction> million Unsecured Term Loan </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/24</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1066">199,845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1067">199,670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-183" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1068">6.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-185" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-1069">350</ix:nonFraction> million Unsecured Term Loan </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/24</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1070">349,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1071">349,114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-185" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1072">6.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-187" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-1073">300</ix:nonFraction> million Unsecured Term Loan </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10/25</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1074">299,952</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1075">299,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-187" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1076">6.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-189" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-1077">150</ix:nonFraction> million Unsecured Term Loan</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/26</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1078">149,606</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1079">149,495</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-189" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1080">6.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-191" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-1081">200</ix:nonFraction> million Unsecured Term Loan </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/27</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1082">199,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1083">199,362</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-191" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1084">6.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usd" contextRef="c-193" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-1085">300</ix:nonFraction> million Unsecured Term Loan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/28</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1086">298,184</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1087">297,869</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-193" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1088">6.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/25</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1089">249,391</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1090">249,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-195" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1091">4.12</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2026</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/26</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1092">577,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1093">571,587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-197" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1094">4.94</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2027 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/27</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1095">482,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1096">479,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-199" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1097">4.76</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/28</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1098">297,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1099">296,852</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-201" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1100">3.85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2030 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2/30</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1101">572,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1102">565,402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-203" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1103">5.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/30</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1104">296,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1105">296,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-205" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1106">2.72</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2031 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/31</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1107">295,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1108">295,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-207" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1109">2.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2031 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/31</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1110">645,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1111">632,693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-209" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1112">5.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Mortgage notes payable</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12/23-12/26</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1113">77,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1114">84,247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-213" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1115">3.57</ix:nonFraction>%-<ix:nonFraction unitRef="number" contextRef="c-214" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1116">6.88</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1117">5,227,413</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-1118">5,351,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable.</span></div></ix:nonNumeric><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"><ix:continuation id="f-1060-1" continuedAt="f-1060-2">2</ix:continuation></span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"><ix:continuation id="f-1060-2">On April 26, 2023, the Company exercised its option to extend the maturity date for <ix:nonNumeric contextRef="c-215" name="hr:DebtInstrumentExtensionPeriodForMaturityDate" format="ixt-sec:durwordsen" id="f-1119">one year</ix:nonNumeric> for a fee of approximately $<ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-5" name="us-gaap:DebtInstrumentFeeAmount" format="ixt:num-dot-decimal" scale="6" id="f-1120">0.4</ix:nonFraction>&#160;million.</ix:continuation>   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Changes in Mortgage Notes Payable</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On July 28, 2023, the Company assumed a mortgage note payable of $<ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="f-1121">5.6</ix:nonFraction>&#160;million in connection with the acquisition of a <ix:nonFraction unitRef="sqft" contextRef="c-217" decimals="0" name="hr:SquareFeetSubjectToMortgageNotesPayable" format="ixt:num-dot-decimal" scale="0" id="f-1122">42,770</ix:nonFraction> square foot property in Colorado Springs, Colorado.  The note bears interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-218" decimals="3" name="hr:PercentageOfInterestBearingInMortgageNotesPayable" scale="-2" id="f-1123">4.5</ix:nonFraction>% per annum and matures on April 1, 2026.</span></div></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:continuation id="f-1059-2">On August 1, 2023, the Company repaid in full at maturity a mortgage note payable bearing interest at a rate of <ix:nonFraction unitRef="number" contextRef="c-219" decimals="4" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-1124">3.31</ix:nonFraction>% per annum with an outstanding principal of $<ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="6" id="f-1125">9.8</ix:nonFraction>&#160;million. The mortgage note encumbered a <ix:nonFraction unitRef="sqft" contextRef="c-221" decimals="0" name="hr:ExtinguishmentOfDebtEncumberedSquareFootage" format="ixt:num-dot-decimal" scale="0" id="f-1126">66,984</ix:nonFraction> square foot property in Marietta, Georgia.</ix:continuation> </span></div><div id="if827fac591d74a508bffd01ca16da4c0_67"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 6. <ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="f-1127" continuedAt="f-1127-1" escape="true">Derivative Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="f-1127-1" continuedAt="f-1127-2"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Risk Management Objective of Using Derivatives</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company&#8217;s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company&#8217;s known or expected cash receipts and its known or expected cash payments principally related to the Company&#8217;s borrowings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Cash Flow Hedges of Interest Rate Risk</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">19</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-1127-2" continuedAt="f-1127-3"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">life of the agreements without exchange of the underlying notional amount. Such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For derivatives designated, and that qualify, as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income (Loss) ("AOCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings. Amounts reported in AOCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-1128" continuedAt="f-1128-1" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of September&#160;30, 2023, the Company had <ix:nonFraction unitRef="derivative" contextRef="c-3" decimals="INF" name="us-gaap:NumberOfInterestRateDerivativesHeld" scale="0" id="f-1129">14</ix:nonFraction> outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.978%"><tr><td style="width:1.0%"></td><td style="width:41.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EXPIRATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">AMOUNT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">WEIGHTED <br/>AVERAGE RATE</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">January 15, 2024</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1130">200,000</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-222" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-1131">1.21</ix:nonFraction>&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1132">100,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-223" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-1133">2.15</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1134">150,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-224" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-1135">3.83</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1136">150,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-225" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-1137">3.84</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 1, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1138">150,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-226" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-1139">4.13</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 1, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1140">250,000</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-227" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-1141">3.79</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="3" id="f-1142">1,000,000</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-228" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-1143">3.17</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Subsequent Activity</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On October 19, 2023, the Company entered into <ix:nonFraction unitRef="transaction" contextRef="c-229" decimals="INF" name="hr:NumberOfSwapTransactions" format="ixt-sec:numwordsen" scale="0" id="f-1144">two</ix:nonFraction> swap transactions totaling $<ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-1145">100.0</ix:nonFraction>&#160;million.  The notional amounts were $<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-1146"><ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-1147">50.0</ix:nonFraction></ix:nonFraction>&#160;million each with fixed rates of <ix:nonFraction unitRef="number" contextRef="c-230" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-1148">4.71</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-231" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-1149">4.67</ix:nonFraction>%. The swap agreements have effective dates of November 1, 2023 and termination dates of June 1, 2027 and December 1, 2027, respectively. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On October 23, 2023, the Company entered into <ix:nonFraction unitRef="transaction" contextRef="c-232" decimals="INF" name="hr:NumberOfSwapTransactions" format="ixt-sec:numwordsen" scale="0" id="f-1150">two</ix:nonFraction> swap transactions totaling $<ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="f-1151">100.0</ix:nonFraction>&#160;million with an aggregate fixed rate of <ix:nonFraction unitRef="number" contextRef="c-232" decimals="4" name="us-gaap:DerivativeFixedInterestRate" scale="-2" id="f-1152">4.73</ix:nonFraction>%. The swap agreements have effective dates of November 1, 2023 and termination dates of May 31, 2026. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Tabular Disclosure of Fair Values of Derivative Instruments on the Balance Sheet</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="f-1153" continuedAt="f-1153-1" escape="true">The table below presents the fair value of the Company's derivative financial instruments, as well as their classification on the Condensed Consolidated Balance Sheet as of September&#160;30, 2023.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:5pt"><ix:continuation id="f-1153-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.394%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.859%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">BALANCE AT SEPTEMBER 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">BALANCE SHEET LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeLiability" format="ixt:num-dot-decimal" scale="3" id="f-1154">21,499</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">   </span></div></ix:continuation><div><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">20</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div></div><ix:continuation id="f-1127-3"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Tabular Disclosure of the Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss)</span></div><ix:continuation id="f-1128-1"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below presents the effect of cash flow hedge accounting on AOCI during the three and nine months ended September&#160;30, 2023 and 2022 related to the Company's outstanding interest rate swaps.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"><tr><td style="width:1.0%"></td><td style="width:24.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.940%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECOGNIZED IN <br/>AOCI ON DERIVATIVE<br/>three months ended September 30,</span></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECLASSIFIED FROM <br/>AOCI INTO INCOME<br/>three months ended September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="f-1155">12,016</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="f-1156">6,083</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-236" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-1157">4,317</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-1158">614</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled treasury hedges</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="f-1159">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-239" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="f-1160">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-1161">107</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-1162">107</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled interest rate swaps</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="f-1163">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="f-1164">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-1165">42</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-1166">42</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="f-1167">12,016</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="f-1168">6,083</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-1169">4,168</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-1170">763</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"><tr><td style="width:1.0%"></td><td style="width:24.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.940%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECOGNIZED IN <br/>AOCI ON DERIVATIVE<br/>nine months ended September 30,</span></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECLASSIFIED FROM <br/>AOCI INTO INCOME<br/>nine months ended September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="f-1171">24,999</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="f-1172">12,905</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-1173">10,320</ix:nonFraction>)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-1174">2,226</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled treasury hedges</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="f-1175">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="f-1176">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-1177">126</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-1178">320</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled interest rate swaps</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="f-1179">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="3" id="f-1180">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-1181">320</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="3" id="f-1182">126</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="f-1183">24,999</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:num-dot-decimal" scale="3" id="f-1184">12,905</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-1185">9,874</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" format="ixt:num-dot-decimal" scale="3" id="f-1186">2,672</ix:nonFraction>&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company estimates that an additional $<ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-5" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="f-1187">14.1</ix:nonFraction> million related to active interest rate swaps will be reclassified from AOCI as a decrease to interest expense over the next 12 months, and that an additional $<ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-5" sign="-" name="us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" format="ixt:num-dot-decimal" scale="6" id="f-1188">0.6</ix:nonFraction>&#160;million related to settled interest rate swaps will be amortized from AOCI as an increase to interest expense over the next 12 months.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Credit-risk-related Contingent Features</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's agreements with each of its derivative counterparties contain a cross-default provision under which the Company could be declared in default of its derivative obligations if&#160;repayment of the underlying&#160;indebtedness is accelerated by the lender due to the Company's&#160;default on the indebtedness.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of September&#160;30, 2023, the fair value of derivatives in a net asset position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was&#160;$<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="hr:DerivativeNetAssetPositionAggregateFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1189">21.5</ix:nonFraction>&#160;million. As of September&#160;30, 2023, the Company had not posted any collateral related to these agreements and was not in breach of any agreement.</span></div></ix:continuation><div id="if827fac591d74a508bffd01ca16da4c0_70"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 7. <ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-1190" continuedAt="f-1190-1" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-1190-1"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Legal Proceedings</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is, from time to time, involved in litigation arising in the ordinary course of business. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company&#8217;s consolidated financial position, results of operations or cash flows.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Development and Redevelopment Activity</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For the nine months ended September 30, 2023, the Company invested $<ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-5" name="hr:ConstructionActivityTotalFundingDuringthePeriod" format="ixt:num-dot-decimal" scale="6" id="f-1191">55.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-5" name="hr:ConstructionActivityTotalFundingDuringthePeriod" format="ixt:num-dot-decimal" scale="6" id="f-1192">15.4</ix:nonFraction> million toward active development and redevelopment of properties, respectively, and $<ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-5" name="hr:ConstructionActivityTotalFundingDuringthePeriod" format="ixt:num-dot-decimal" scale="6" id="f-1193">9.2</ix:nonFraction>&#160;million toward recently completed development and redevelopment projects.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In the second quarter of 2023, the Company entered into a joint venture agreement for the development of a medical office building in Scottsdale, Arizona.  The Company holds a <ix:nonFraction unitRef="number" contextRef="c-263" decimals="2" name="hr:JointVentureOwnershipPercentage" scale="-2" id="f-1194">90</ix:nonFraction>% interest in the joint venture and determined the arrangement meets the criteria to be consolidated.  The joint venture acquired an $<ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-5" name="us-gaap:PaymentsToAcquireLand" format="ixt:num-dot-decimal" scale="6" id="f-1195">8.8</ix:nonFraction>&#160;million land parcel to be developed with the Company contributing cash of $<ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="f-1196">8.3</ix:nonFraction>&#160;million. This is included in the Company's investment toward active development properties for the nine months ended September 30, 2023.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">21</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="if827fac591d74a508bffd01ca16da4c0_73"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 8. <ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="f-1197" continuedAt="f-1197-1" escape="true">Stockholders' Equity</ix:nonNumeric></span></div><ix:continuation id="f-1197-1" continuedAt="f-1197-2"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Common Stock&#160;&#160;&#160;&#160;</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" id="f-1198" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the nine months ended September&#160;30, 2023 and the twelve months ended December&#160;31, 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.981%"><tr><td style="width:1.0%"></td><td style="width:55.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">TWELVE MONTHS ENDED DECEMBER 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-57" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1199">380,589,894</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-71" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1200">150,457,433</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-66" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-1201">7,397</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-264" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-1202">229,618,304</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-vested share-based awards, net of withheld shares </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-66" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-1203">262,821</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-264" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-1204">514,157</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance, end of period</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1205">380,860,112</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-57" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1206">380,589,894</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">At-The-Market Equity Offering Program</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:700;line-height:130%"> </span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company has equity distribution agreements with various sales agents with respect to the at-the-market (&#8220;ATM&#8221;) equity offering program of common stock with an aggregate sales amount of up to $<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="INF" name="hr:EquityOfferingProgramAvailableForIssuance" format="ixt:num-dot-decimal" scale="6" id="f-1207">750.0</ix:nonFraction> million.  As of September&#160;30, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="INF" name="hr:EquityOfferingProgramAvailableForIssuance" format="ixt:num-dot-decimal" scale="6" id="f-1208">750.0</ix:nonFraction> million remained available for issuance under our current ATM equity offering program.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the nine months ended September&#160;30, 2023, the Company did not sell any shares or enter into any forward sale agreements to sell shares of common stock through its ATM equity offering program.</span></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Common Stock Dividends</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the nine months ended September&#160;30, 2023, the Company declared and paid common stock dividends totaling $<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="INF" name="us-gaap:CommonStockDividendsPerShareCashPaid" scale="0" id="f-1209">0.93</ix:nonFraction> per share.  On October 30, 2023, the Company declared a quarterly common stock dividend in the amount of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-265" decimals="INF" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="f-1210">0.31</ix:nonFraction> per share payable on November 30, 2023 to stockholders of record on November 14, 2023.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Earnings Per Common Share</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company uses the two-class method of computing net earnings per common shares. The Company's non-vested share-based awards are considered participating securities pursuant to the two-class method. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-1211" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table sets forth the computation of basic and diluted earnings per common share for the three and nine months ended September&#160;30, 2023 and 2022.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED SEPTEMBER 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands, except per share data</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="f-1212">380,857,560</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="f-1213">330,788,997</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="f-1214">380,828,004</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesIssuedBasic" format="ixt:num-dot-decimal" scale="0" id="f-1215">211,740,767</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-vested shares</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="f-1216">1,932,221</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="f-1217">1,983,742</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="f-1218">1,941,897</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesRestrictedStock" format="ixt:num-dot-decimal" scale="0" id="f-1219">1,933,957</ix:nonFraction>)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1220">378,925,339</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1221">328,805,255</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1222">378,886,107</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1223">209,806,810</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1224">378,925,339</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1225">328,805,255</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1226">378,886,107</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1227">209,806,810</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dilutive effect of forward equity shares</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements" format="ixt:fixed-zero" scale="0" id="f-1228">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements" format="ixt:fixed-zero" scale="0" id="f-1229">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements" format="ixt:fixed-zero" scale="0" id="f-1230">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements" format="ixt:fixed-zero" scale="0" id="f-1231">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dilutive effect of OP Units</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" format="ixt:fixed-zero" scale="0" id="f-1232">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" format="ixt:num-dot-decimal" scale="0" id="f-1233">3,167,668</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" format="ixt:fixed-zero" scale="0" id="f-1234">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" format="ixt:num-dot-decimal" scale="0" id="f-1235">1,067,493</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dilutive effect of employee stock purchase plan</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="hr:IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" format="ixt:fixed-zero" scale="0" id="f-1236">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="hr:IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="0" id="f-1237">58,461</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="hr:IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" format="ixt:fixed-zero" scale="0" id="f-1238">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="hr:IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="0" id="f-1239">69,687</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1240">378,925,339</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1241">332,031,384</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1242">378,886,107</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1243">210,943,990</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Net (loss) income</span></td><td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-1244">68,604</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-1245">28,616</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-1246">240,408</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="f-1247">76,973</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Income allocated to participating securities</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="f-1248">636</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" scale="3" id="f-1249">610</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:num-dot-decimal" scale="3" id="f-1250">1,868</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:num-dot-decimal" scale="3" id="f-1251">1,817</ix:nonFraction>)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Loss (income) attributable to non-controlling interest</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-1252">760</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-1253">312</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1254">2,680</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="f-1255">312</ix:nonFraction>)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" scale="3" id="f-1256">29</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" format="ixt:fixed-zero" scale="3" id="f-1257">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" scale="3" id="f-1258">122</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" format="ixt:fixed-zero" scale="3" id="f-1259">&#8212;</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net (loss) income applicable to common stockholders - basic</span></td><td style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1260">68,509</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1261">27,694</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1262">239,718</ix:nonFraction>)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1263">74,844</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Basic earnings per common share - net income</span></td><td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1264">0.18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1265">0.08</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1266">0.63</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1267">0.36</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Diluted earnings per common share - net income</span></td><td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1268">0.18</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1269">0.08</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1270">0.63</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1271">0.35</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The effect of OP units totaling <ix:nonFraction unitRef="shares" contextRef="c-266" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" format="ixt:num-dot-decimal" scale="0" id="f-1272">4,042,993</ix:nonFraction> shares and options under the Company's Employee Stock Purchase Plan (the "ESPP") to purchase the Company's common stock totaling <ix:nonFraction unitRef="shares" contextRef="c-267" decimals="INF" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1273">26,678</ix:nonFraction> shares for the three months ended September&#160;30, </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">22</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><ix:continuation id="f-1197-2" continuedAt="f-1197-3"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">2023 were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive due to the loss from continuing operations incurred during that period.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Incentive Plans</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Equity Awards</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the nine months ended September&#160;30, 2023, the Company made the following equity awards:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">During the first quarter of 2023, the Company granted non-vested stock awards to its named executive officers and other members of senior management and employees with a grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-5" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1274">5.4</ix:nonFraction>&#160;million, which consisted of an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-268" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1275">270,494</ix:nonFraction> non-vested shares with vesting periods ranging from <span style="-sec-ix-hidden:f-1276">three</span> to <ix:nonNumeric contextRef="c-270" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1277">eight years</ix:nonNumeric>.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">During the second quarter of 2023, the Company granted to its <ix:nonFraction unitRef="director" contextRef="c-271" decimals="INF" name="hr:NumberOfDirectors" scale="0" id="f-1278">12</ix:nonFraction> independent directors an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-272" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1279">42,768</ix:nonFraction> shares of non-vested stock awards with a grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-5" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1280">0.7</ix:nonFraction>&#160;million, and an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-273" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1281">57,868</ix:nonFraction> LTIP Series D units with a grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-5" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1282">1.1</ix:nonFraction>&#160;million.  The Company also granted a non-vested stock award to a new employee, which consisted of <ix:nonFraction unitRef="shares" contextRef="c-274" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="f-1283">508</ix:nonFraction> non-vested shares. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="f-1284" continuedAt="f-1284-1" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">A summary of the activity under the Company's share-based incentive plans for the three and nine months ended September&#160;30, 2023 and 2022 is included in the table below.</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.847%"><tr><td style="width:1.0%"></td><td style="width:47.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.613%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED SEPTEMBER 30,</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Share-based awards, beginning of period</span></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-275" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1285">1,932,221</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-276" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1286">1,941,709</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-277" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1287">1,795,128</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-278" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1288">1,562,028</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-279" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="0" id="f-1289">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-280" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1290">71,852</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-281" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1291">313,770</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-282" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1292">513,876</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-279" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:fixed-zero" scale="0" id="f-1293">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-280" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1294">7,434</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-281" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1295">152,314</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-282" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1296">68,481</ix:nonFraction>)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-279" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="0" id="f-1297">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-280" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1298">4,130</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-281" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1299">24,363</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-282" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1300">5,426</ix:nonFraction>)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Share-based awards, end of period</span></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-283" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1301">1,932,221</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-284" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1302">2,001,997</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-283" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1303">1,932,221</ix:nonFraction>&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-284" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1304">2,001,997</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the nine months ended September&#160;30, 2023 and 2022, the Company withheld <ix:nonFraction unitRef="shares" contextRef="c-285" decimals="INF" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-1305">38,632</ix:nonFraction> and</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> <ix:nonFraction unitRef="shares" contextRef="c-286" decimals="INF" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="0" id="f-1306">8,745</ix:nonFraction> </span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">shares of common stock, respectively, from participants to pay estimated withholding taxes related to shares that vested. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Restricted Stock Units</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Prior to 2022, the Company granted long-term incentive awards, comprised of restricted stock, based on backward-looking performance measured at the end of the calendar year. The Company adopted a new incentive compensation structure effective January 2022, comprised of restricted stock and restricted stock units ("RSUs"). The RSUs are granted at the beginning of the year with <ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1307">three-year</ix:nonNumeric> forward-looking performance targets. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On January 4, 2023, the Company granted RSUs to members of senior management, with a grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-5" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1308">3.7</ix:nonFraction> million, which consisted of an aggregate <ix:nonFraction unitRef="shares" contextRef="c-287" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1309">165,174</ix:nonFraction> RSUs with a <ix:nonNumeric contextRef="c-288" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1310">five-year</ix:nonNumeric> vesting period. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Approximately <ix:nonFraction unitRef="number" contextRef="c-288" decimals="2" name="hr:PercentageOfRestrictedStockUnits" scale="-2" id="f-1311">43</ix:nonFraction>% of the RSUs vest based on two market performance conditions. Relative and absolute total shareholder return ("TSR") awards containing these market performance conditions were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-289" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="f-1312">24.23</ix:nonFraction> for the absolute TSR component and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-290" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="f-1313">27.84</ix:nonFraction> for the relative TSR component for the January 2023 grant using the following assumptions:</span></div><div style="margin-bottom:6pt;text-align:justify"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="f-1314" continuedAt="f-1314-1" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"><tr><td style="width:1.0%"></td><td style="width:56.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:41.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31, </span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-288" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1315">34.0</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividend assumption</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expected term </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-288" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1316">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-288" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1317">4.42</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock price (per share)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-288" decimals="2" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" scale="0" id="f-1318">20.21</ix:nonFraction></span></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The remaining <ix:nonFraction unitRef="number" contextRef="c-291" decimals="2" name="hr:PercentageOfRestrictedStockUnits" scale="-2" id="f-1319">57</ix:nonFraction>% of the RSUs vest based upon certain operating performance conditions.  With respect to the operating performance conditions of the January 4, 2023 grant, the grant date fair value was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-291" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="f-1320">20.21</ix:nonFraction> based on the Company's share price on the date of grant. The combined weighted average grant date fair value of the January RSUs was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-288" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="f-1321">22.55</ix:nonFraction> per share.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">23</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><ix:continuation id="f-1197-3" continuedAt="f-1197-4"><ix:continuation id="f-1284-1"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following is a summary of the RSU activity during the three and nine months ended September&#160;30, 2023:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.379%"><tr><td style="width:1.0%"></td><td style="width:35.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.261%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED SEPTEMBER 30, </span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Restricted Stock Units</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Restricted Stock Units</span></td><td colspan="3" style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Non-vested, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-292" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1322">363,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-292" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1323">28.57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-293" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1324">294,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-293" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1325">33.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-294" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="0" id="f-1326">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-294" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-1327">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-295" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1328">165,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-295" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1329">22.55</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Vested/Forfeited</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-294" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:fixed-zero" scale="0" id="f-1330">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-294" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-1331">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-295" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1332">17,606</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-295" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1333">33.04</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Probability adjustment of 2022 &amp; 2023 RSUs </span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-294" decimals="INF" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1334">47,196</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-294" decimals="2" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1335">20.21</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-295" decimals="INF" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1336">126,446</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-295" decimals="2" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1337">27.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Non-vested, end of period</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-296" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1338">316,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-296" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1339">27.77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-296" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1340">316,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-296" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1341">27.77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">LTIP Series C Units</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In January 2023, the Company modified its incentive compensation structure to award LTIP Series C units ("LTIP-C units) in the OP to named executive officers in lieu of RSUs. The LTIP-C units were granted with <ix:nonNumeric contextRef="c-297" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" format="ixt-sec:durwordsen" id="f-1342">three-year</ix:nonNumeric> forward-looking performance targets, with a grant date fair value of $<ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:num-dot-decimal" scale="6" id="f-1343">7.1</ix:nonFraction>&#160;million, which consisted of an aggregate <ix:nonFraction unitRef="shares" contextRef="c-299" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1344">448,249</ix:nonFraction> LTIP-C units with a <ix:nonNumeric contextRef="c-299" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1345">five-year</ix:nonNumeric> vesting period. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Approximately <ix:nonFraction unitRef="number" contextRef="c-297" decimals="2" name="hr:PercentageOfRestrictedStockUnits" scale="-2" id="f-1346">43</ix:nonFraction>% of the LTIP-C units vest based on two market performance conditions. Relative and absolute TSR awards containing these market performance conditions were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-300" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="f-1347">12.24</ix:nonFraction> for the absolute TSR component and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-301" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="f-1348">13.98</ix:nonFraction> for the relative TSR component for the January 2023 grant using the following assumption:</span></div><div style="margin-bottom:6pt;text-align:justify"><ix:continuation id="f-1314-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"><tr><td style="width:1.0%"></td><td style="width:56.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:41.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31, </span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-297" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1349">34.0</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividend assumption</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expected term </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-297" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1350">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-297" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1351">4.42</ix:nonFraction>&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock price (per share)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-297" decimals="2" name="hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" scale="0" id="f-1352">20.21</ix:nonFraction></span></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The remaining <ix:nonFraction unitRef="number" contextRef="c-302" decimals="2" name="hr:PercentageOfRestrictedStockUnits" scale="-2" id="f-1353">57</ix:nonFraction>% of the LTIP-C units vest based upon certain operating performance conditions.  With respect to the operating performance conditions of the January 4, 2023 grant, the grant date fair value was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-302" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="f-1354">20.21</ix:nonFraction> based on the Company's share price on the date of grant. The combined weighted average grant date fair value of the January LTIP-C units was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-297" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" scale="0" id="f-1355">15.85</ix:nonFraction> per share.  The Company records amortization expense based on the probability of achieving certain operating performance conditions, which is evaluated throughout the performance period.  </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Legacy HR maintained an ESPP prior to the completion of the Merger. The outstanding options to purchase shares of the common stock of Legacy HR became options to purchase class A common stock of the Company upon completion of the Merger. No new options will be granted under the ESPP. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" id="f-1356" continuedAt="f-1356-1" escape="true">A summary of the activity under the ESPP for the three and nine months ended September&#160;30, 2023 and 2022 is included in the table below.</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><ix:continuation id="f-1356-1"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.847%"><tr><td style="width:1.0%"></td><td style="width:47.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.613%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED SEPTEMBER 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Outstanding and exercisable, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-303" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1357">179,369</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-304" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1358">405,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-305" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1359">340,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-306" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1360">348,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-307" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="f-1361">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-308" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="f-1362">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-309" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:fixed-zero" scale="0" id="f-1363">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-310" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="f-1364">255,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-307" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1365">2,580</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-308" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1366">4,576</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-309" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1367">7,397</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-310" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-1368">17,094</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-307" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1369">4,680</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-308" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1370">37,628</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-309" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1371">28,471</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-310" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1372">83,417</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-307" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:fixed-zero" scale="0" id="f-1373">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-308" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:fixed-zero" scale="0" id="f-1374">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-309" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1375">132,999</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-310" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1376">140,633</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Outstanding and exercisable, end of period</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-311" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1377">172,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-312" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1378">363,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-311" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1379">172,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-312" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-1380">363,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></ix:continuation></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">24</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Table of Contents</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS, cont.</span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><ix:continuation id="f-1197-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" id="f-1381" escape="true"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table represents expected amortization of the Company's non-vested shares issued as of September&#160;30, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.321%"><tr><td style="width:1.0%"></td><td style="width:48.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FUTURE AMORTIZATION <br/>of non-vested shares</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" scale="6" id="f-1382">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" scale="6" id="f-1383">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" scale="6" id="f-1384">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" scale="6" id="f-1385">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour" scale="6" id="f-1386">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" scale="6" id="f-1387">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="f-1388">39.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="if827fac591d74a508bffd01ca16da4c0_76"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Note 9. <ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-1389" continuedAt="f-1389-1" escape="true">Fair Value of Financial Instruments</ix:nonNumeric></span></div><ix:continuation id="f-1389-1"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following methods and assumptions were used to estimate the fair value of each class of financial instrument for which it is practical to estimate that value.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Cash and cash equivalents</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"> - The carrying amount approximates fair value (level 1 inputs) due to the short term maturity of these investments. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Real estate notes receivabl</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%">e - Real estate notes receivable are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.  Fair value is estimated using cash flow analyses, based on current interest rates for similar types of arrangements.</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Borrowings under the Unsecured Credit Facility and the Term Loans Due 2024 and 2026</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"> - The carrying amount approximates fair value because the borrowings are based on variable market interest rates.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Senior Notes and Mortgage Notes payable</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"> - The fair value of notes and bonds payable is estimated using cash flow analyses, based on the Company&#8217;s current interest rates for similar types of borrowing arrangements.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Interest rate swap agreements</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"> - Interest rate swap agreements are recorded in other liabilities on the Company's Condensed Consolidated Balance Sheets at fair value. Fair value is estimated by utilizing pricing models, level 2 inputs, that consider forward yield curves and discount rates.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueByBalanceSheetGroupingTextBlock" id="f-1390" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at September&#160;30, 2023 and December&#160;31, 2022.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.697%"><tr><td style="width:1.0%"></td><td style="width:26.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">September 30, 2023</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Notes and bonds payable </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1391">5,227.4</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1392">4,941.2</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1393">5,351.8</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1394">5,149.6</ix:nonFraction>&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate notes receivable </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-5" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" scale="6" id="f-1395">155.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-5" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" scale="6" id="f-1396">151.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-5" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" scale="6" id="f-1397">99.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-5" name="us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet" scale="6" id="f-1398">99.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Level 2 &#8211; model-derived valuations in which significant inputs and significant value drivers are observable in active markets.</span></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">25</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="if827fac591d74a508bffd01ca16da4c0_82"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;2.  Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div id="if827fac591d74a508bffd01ca16da4c0_85"></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Disclosure Regarding Forward-Looking Statements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:140%">This report and other materials the Company has filed or may file with the SEC, as well as information included in oral statements or other written statements made, or to be made, by management of the Company, contain, or will contain, disclosures that are &#8220;forward-looking statements.&#8221; Forward-looking statements include all statements that do not relate solely to historical or current facts and can be identified by the use of words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;target,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;continue,&#8221; &#8220;should,&#8221; &#8220;could," "budget" and other comparable terms. These forward-looking statements are based on the Company's current plans, objectives, estimates, expectations and intentions and inherently involve significant risks and uncertainties. Such risks and uncertainties include, among other things, the following: the Company&#8217;s expected results may not be achieved; failure to realize the expected benefits of the Merger; the risk that the Company&#8217;s and HTA&#8217;s respective businesses will not be integrated successfully or that such integration may be more difficult, time-consuming or costly than expected; risks related to future opportunities and plans for the Company, including the uncertainty of expected future financial performance and results of the Company; the possibility that, if the Company does not achieve the perceived benefits of the Merger as rapidly or to the extent anticipated by financial analysts or investors, the market price of the Company&#8217;s common stock could decline; pandemics or other health crises, such as COVID-19; increases in interest rates; the availability and cost of capital at expected rates; competition for quality assets; negative developments in the operating results or financial condition of the Company's tenants, including, but not limited to, their ability to pay rent; the Company's ability to reposition or sell facilities with profitable results; the Company's ability to release space at similar rates as vacancies occur; the Company's ability to renew expiring leases; government regulations affecting tenants' Medicare and Medicaid reimbursement rates and operational requirements; unanticipated difficulties and/or expenditures relating to future acquisitions and developments; changes in rules or practices governing the Company's financial reporting; the Company may be required under purchase options to sell properties and may not be able to reinvest the proceeds from such sales at rates of return equal to the return received on the properties sold; uninsured or underinsured losses related to casualty or liability; the incurrence of impairment charges on its real estate properties or other assets; other legal and operational matters; and other risks and uncertainties affecting the Company, including those described from time to time under the caption &#8220;Risk Factors&#8221; and elsewhere in the Company&#8217;s filings and reports with the SEC, including the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022. Moreover, other risks and uncertainties of which the Company is not currently aware may also affect the Company's forward-looking statements and may cause actual results and the timing of events to differ materially from those anticipated. The forward-looking statements made in this communication are made only as of the date hereof or as of the dates indicated in the forward-looking statements, even if they are subsequently made available by the Company on its website or otherwise. The Company undertakes no obligation to update or supplement any forward-looking statements to reflect actual results, new information, future events, changes in its expectations or other circumstances that exist after the date as of which the forward-looking statements were made, except as required by law.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:140%">Stockholders and investors are cautioned not to unduly rely on such forward-looking statements when evaluating the information presented in the Company&#8217;s filings and reports, including, without limitation, estimates and projections regarding the performance of development projects the Company is pursuing.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:140%">For a detailed discussion of the Company&#8217;s risk factors, please refer to the Company's filings with the SEC, including this report and the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022.</span></div><div id="if827fac591d74a508bffd01ca16da4c0_88"></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Merger with Healthcare Trust of America</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Completed Merger&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On July 20, 2022, Legacy HR, Legacy HTA, the OP and Merger Sub completed the Merger in accordance with the terms of the Merger Agreement. Immediately following the Merger, Legacy HR converted to a Maryland limited liability company and changed its name to &#8220;HRTI, LLC&#8221; and Legacy HTA changed its name to &#8220;Healthcare Realty Trust Incorporated&#8221;. In addition, the equity interests of Legacy HR were contributed by Legacy HTA by means of a contribution and assignment agreement to the OP such that Legacy HR became a wholly-owned subsidiary of the OP. As a result, Legacy HR became a part of an UPREIT structure, which is intended to align the corporate structure of the combined company after giving effect to the Merger and the UPREIT reorganization and to provide a platform for the combined company to more efficiently acquire properties in a tax-deferred manner. The Company operates under the name &#8220;Healthcare Realty Trust Incorporated&#8221; and its shares of class A common stock, $0.01 par value per share, trade on the New York Stock Exchange (the &#8220;NYSE&#8221;) under the ticker symbol &#8220;HR&#8221;.  For additional information on the Merger, see Note 2 to the Condensed Consolidated Financial Statements.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Because Legacy HR was the accounting acquirer under GAAP in the transaction, its historical financial statements became the historical financial statements of the Company.  For additional information, please refer to the Explanatory Note in this report.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">26</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Sources and Uses of Cash</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s primary sources of cash include rent receipts from its real estate portfolio based on contractual arrangements with its tenants, proceeds from the sales of real estate properties, joint ventures, and proceeds from public or private debt or equity offerings.  As of September&#160;30, 2023, the Company had $1.3 billion available to be drawn on its Unsecured Credit Facility and $24.7 million in cash.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company expects to continue to meet its liquidity needs, including funding additional investments, paying dividends, and funding debt service, through cash flows from operations and liquidity sources, including the Unsecured Credit Facility. Management believes that the Company's liquidity and sources of capital are adequate to satisfy its cash requirements. The Company cannot, however, be certain that these sources of funds will be available at a time and upon terms acceptable to the Company in sufficient amounts to meet its liquidity needs. </span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Investing Activities </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Cash flows provided by investing activities for the nine months ended September&#160;30, 2023 were approximately $112.5 million. Below is a summary of significant investing activities. </span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Acquisitions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table details the Company's acquisition activity for the nine months ended September&#160;30, 2023:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.813%"><tr><td style="width:1.0%"></td><td style="width:23.282%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.102%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.599%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">ASSOCIATED HEALTH SYSTEM/TENANCY </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DATE ACQUIRED</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PURCHASE PRICE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE FOOTAGE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MILES TO CAMPUS</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Tampa, FL</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">BayCare Health</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/10/23</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">31,500&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">115,867</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">0.06</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Colorado Springs, CO</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">UC Health</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/28/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,450&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1.30</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total real estate acquisitions</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42,950&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">158,637&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Includes buildings located on-campus, adjacent and off-campus that are anchored by healthcare systems or located within two miles of a hospital campus.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In the third quarter of 2023, the Company acquired a parcel of land previously under a ground lease for $0.8&#160;million and an additional interest in an operating property for $0.6&#160;million.</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Dispositions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company disposed of 12 properties during the nine months ended September&#160;30, 2023 for a total sales price of $430.8 million, including cash proceeds of $366.8 million. The following table details these dispositions for the nine months ended September 30, 2023:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.351%"><tr><td style="width:1.0%"></td><td style="width:35.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.673%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.645%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.792%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Date Disposed</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Sales Price</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Square Footage</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Tampa, FL &amp; Miami, FL </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/12/23</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">93,250&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">224,037</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dallas, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">19,210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">36,691</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">St. Louis, MO</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2/10/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,500</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/23/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">21,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">37,165</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">147,078</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">4</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/12/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Albany, NY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">40,870</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/2/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,320&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">57,170</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Atlanta, GA</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/22/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">25,142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">55,195</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dallas, TX</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9/15/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">115,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">161,264</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9/18/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">52,040</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Chicago, IL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9/27/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">59,950&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">104,912</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total dispositions</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">430,772&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">922,922&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Includes two properties sold in two separate transactions to the same buyer on the same date.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">The Company sold this property to a joint venture in which it retained a 40% interest. Sales price and square footage reflect the total sales price paid by the joint venture and total square footage of the property.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">The Company entered into a mortgage note agreement with the buyer for $45&#160;million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">4</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.81pt">The Company sold a land parcel totaling 0.34 acres.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">27</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Capital Expenditures</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the nine months ended September&#160;30, 2023, the Company incurred capital expenditures totaling $188.1 million for the following:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">$70.7&#160;million toward active development and redevelopment of properties; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">$9.2 million toward completed development and redevelopment of properties;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">$32.1 million toward first generation tenant improvements and planned capital expenditures for acquisitions; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">$45.4 million toward second generation tenant improvements; and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">$30.7 million toward capital expenditures.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Financing Activities </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Cash flows used in financing activities for the nine months ended September&#160;30, 2023 were approximately $521.3 million.  See Notes 5 and 8 to the Condensed Consolidated Financial Statements accompanying this report for more information about capital markets and financing activities. </span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Common Stock Issuances</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">At-The-Market Equity Offering Program</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%">The Company has equity distribution agreements with various sales agents with respect to our ATM equity offering program of common stock with an aggregate sales amount of up to $750.0 million. As of September&#160;30, 2023, $750.0 million remained available for issuance under our current ATM equity offering program.</span></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Debt Activity</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of September 30, 2023, the Company had outstanding interest rate derivatives totaling $1.0 billion to hedge one-month Term SOFR. The following details the amount and rate of each swap (dollars in thousands):</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.672%"><tr><td style="width:1.0%"></td><td style="width:42.133%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.480%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EXPIRATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">AMOUNT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">WEIGHTED <br/>AVERAGE RATE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">January 15, 2024</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1.21&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 1, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 1, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,000,000&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.17&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%">During the third quarter of 2023, the Company assumed a mortgage note payable of $5.6&#160;million in connection with the acquisition of a 42,770 square foot property in Colorado Springs, Colorado.  The note bears interest at a rate of 4.5% per annum and matures on April 1, 2026. Additionally, the Company repaid in full at maturity a mortgage note payable bearing interest at a rate of 3.31% per annum with an outstanding principal of $9.8 million. The mortgage note encumbered a 66,984 square foot property in Marietta, Georgia. </span></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Subsequent Debt Activity</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On October 19, 2023, the Company entered into two swap transactions totaling $100.0&#160;million.  The notional amounts were $50.0&#160;million each with fixed rates of 4.71% and 4.67%. The swap agreements have effective dates of November 1, 2023 and termination dates of June 1, 2027 and December 1, 2027, respectively. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On October 23, 2023, the Company entered into two swap transactions totaling $100.0&#160;million with an aggregate fixed rate of 4.73%. The swap agreements have effective dates of November 1, 2023 and termination dates of May 31, 2026.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Operating Activities </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Cash flows provided by operating activities increased from $126.7 million for the nine months ended September&#160;30, 2022 to $372.5 million for the nine months ended September&#160;30, 2023. Items impacting cash flows from operations include, but are not limited to, the Merger, cash generated from property operations, interest payments and the timing related to the payment of invoices and other expenses.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company may, from time to time, sell properties and redeploy cash from property sales into new investments or to repay indebtedness. The income from the new investments or reduction in interest expense could be less than the income from properties sold which would adversely affect the Company's results of operations and cash flows.</span></div><div id="if827fac591d74a508bffd01ca16da4c0_91"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Trends and Matters Impacting Operating Results</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Management monitors factors and trends important to the Company and the REIT industry to gauge the potential impact on the operations of the Company. In addition to the matters discussed in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022, below are some of the factors and trends that management believes may impact future operations of the Company.  </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Economic and Market Conditions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Rising interest rates and increased volatility in the capital markets have increased the Company&#8217;s cost and availability of debt and equity capital. Limited availability and increases in the cost of capital could adversely impact the Company&#8217;s ability to finance operations and acquire and develop properties. To the extent the Company&#8217;s tenants experience increased costs or financing difficulties due to the economic and market conditions, they may be unable or unwilling to make payments or perform their obligations when due. Additionally, increased interest rates may also result in less liquid property markets, limiting the Company&#8217;s ability to sell existing assets or obtain joint venture capital. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company reviews goodwill for impairment annually as of December 31 of each year or whenever events or changes in circumstances indicate that an impairment may exist. During the third quarter of 2023, management identified qualitative factors indicating that an impairment may exist, including the sustained decrease in stock price. As a result, the Company performed a quantitative assessment, and the fair value of the Company&#8217;s single reporting unit was estimated using a combination of discounted cash flow models and earnings multiples techniques. The determination of fair value using the discounted cash flow model technique requires the use of estimates and assumptions related to revenue and expense growth rates, capitalization rates, discount rates, capital expenditures and working capital levels. The determination of fair value using the earnings multiples technique requires assumptions to be made in relation to maintainable earnings and earnings multipliers. These forecasts and assumptions are highly subjective, and while we believe our assumptions are reasonable, changes in these assumptions may have a material impact on our financial results. Although the quantitative assessment as of September 30, 2023 indicated goodwill was not impaired, given the results of our quantitative assessment, the Company is at risk for future goodwill impairment because it is reasonably possible that, among other factors, continual stock price volatility and downward pressure on the Company's market capitalization could have a material impact on one or more of the estimates and assumptions used to evaluate goodwill.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Expiring Leases</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company expects that approximately</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> 15% o</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">f its leases will expire each year in the ordinary course of business. There are 476 leases totaling</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> 1.2 million</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> square feet that will expire during the remainder of 2023.  Approximately </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">73% of t</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">he leases expiring during the remainder of 2023 are for space in buildings located on or adjacent to hospital campuses, are distributed throughout the portfolio, and are not concentrated with any one tenant, health system or market area. The Company typically expects to retain 75% to 90% of tenants upon expiration, and the retention ratio for the first nine months of the year was within this range. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Operating Expenses</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company historically has experienced increases in property taxes throughout its portfolio as a result of increasing assessments and tax rates levied across the country. The Company continues its efforts to appeal property tax increases and manage the impact of the increases. In addition, the Company historically has incurred variability in portfolio utilities expense based on seasonality, with the first and third quarters usually reflecting greater amounts. The effects of these operating expense increases are mitigated in leases that have provisions for operating expense reimbursement. As of September&#160;30, 2023, leases for approximatel</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">y 92% of the Company's total leased square footage allow for some recovery of operating expenses, with approximately 27% having modified gross lease structures and approximately 65% having</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> net lease structures.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">29</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Purchase Options</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Information about the Company's unexercised purchase options and the amount and basis for determination of the purchase price is detailed in the table below (dollars in thousands): </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.024%"><tr><td style="width:1.0%"></td><td style="width:36.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.145%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.114%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">YEAR EXERCISABLE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NUMBER OF PROPERTIES</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">GROSS REAL ESTATE INVESTMENT AS OF </span></div><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SEPTEMBER 30, 2023 </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Current </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">112,271&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">105,251&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">181,636&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">110,388&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">133,911&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2029</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">81,815&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2030</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2031</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">108,894&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2032</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">24,626&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2033 and thereafter </span><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">317,650&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,176,442&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Includes three properties totaling $45.3 million with stated purchase prices or prices based on fixed capitalization rates. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">These purchase options have been exercisable for an average of 13.6 years.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">Includes two medical office buildings that are recorded in the line item Investment in financing receivable, net on the Company's Condensed Consolidated Balance Sheet.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures and Key Performance Indicators</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Management considers certain non-GAAP financial measures and key performance indicators to be useful supplemental measures of the Company's operating performance. A non-GAAP financial measure is generally defined as one that purports to measure financial performance, financial position or cash flows, but excludes or includes amounts that would not be so adjusted in the most comparable measure determined in accordance with GAAP. Set forth below are descriptions of the non-GAAP financial measures management considers relevant to the Company's business and useful to investors, as well as reconciliations of these measures to the most directly comparable GAAP financial measures.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The non-GAAP financial measures and key performance indicators presented herein are not necessarily identical to those presented by other real estate companies due to the fact that not all real estate companies use the same definitions. These measures should not be considered as alternatives to net income, as indicators of the Company's financial performance, or as alternatives to cash flow from operating activities as measures of the Company's liquidity, nor are these measures necessarily indicative of sufficient cash flow to fund all of the Company's needs. Management believes that in order to facilitate a clear understanding of the Company's historical consolidated operating results, these measures should be examined in conjunction with net income and cash flows from operations as presented in the Condensed Consolidated Financial Statements and other financial data included elsewhere in this Quarterly Report on Form 10-Q.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Funds from Operations ("FFO"), Normalized FFO and Funds Available for Distribution ("FAD")</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">FFO and FFO per share are operating performance measures adopted by the National Association of Real Estate Investment Trusts (&#8220;NAREIT&#8221;). NAREIT defines FFO as the most commonly accepted and reported measure of a REIT&#8217;s operating performance equal to &#8220;net income (computed in accordance with GAAP), excluding gains (or losses) from sales of property, plus depreciation and amortization, impairment, and after adjustments for unconsolidated partnerships and joint ventures.&#8221;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In addition to FFO, the Company presents Normalized FFO and FAD. Normalized FFO is presented by adding to FFO acquisition-related costs, acceleration of debt issuance costs, debt extinguishment costs and other Company-defined normalizing items to evaluate operating performance. FAD is presented by adding to Normalized FFO non-real estate depreciation and amortization, non-cash financing receivable amortization, loan origination cost </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">30</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">amortization, deferred financing fees amortization, stock-based compensation expense and rent reserves, net; and subtracting maintenance capital expenditures, including second generation tenant improvements and leasing commissions paid and straight-line rent income, net of expense. The Company's definition of these terms may not be comparable to that of other real estate companies as they may have different methodologies for computing these amounts. FFO, Normalized FFO and FAD should not be considered as an alternative to net income as an indicator of the Company's financial performance or to cash flow from operating activities as an indicator of the Company's liquidity. FFO, Normalized FFO and FAD should be reviewed in connection with GAAP financial measures.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Management believes FFO, Normalized FFO, FFO per common share, Normalized FFO per share and FAD ("Non-GAAP Measures") provide an understanding of the operating performance of the Company&#8217;s properties without giving effect to certain significant non-cash items, primarily depreciation and amortization expense. Historical cost accounting for real estate assets in accordance with GAAP assumes that the value of real estate assets diminishes predictably over time. However, real estate values instead have historically risen or fallen with market conditions. The Company believes that by excluding the effect of depreciation, amortization, impairments and gains or losses from sales of real estate, all of which are based on historical costs and which may be of limited relevance in evaluating current performance, Non-GAAP Measures can facilitate comparisons of operating performance between periods. The Company reports Non-GAAP Measures because these measures are observed by management to also be the predominant measures used by the REIT industry and by industry analysts to evaluate REITs. For these reasons, management deems it appropriate to disclose and discuss these Non-GAAP Measures. However, none of these measures represent cash generated from operating activities determined in accordance with GAAP and are not necessarily indicative of cash available to fund cash needs. Further, these measures should not be considered as an alternative to net income as an indicator of the Company&#8217;s operating performance or as an alternative to cash flow from operating activities as a measure of liquidity. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below reconciles net income to FFO, Normalized FFO and FAD for the three and nine months ended September&#160;30, 2023 and 2022.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED SEPTEMBER 30,</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;border-right:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Amounts in thousands, except per share data</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Net (loss) income attributable to common stockholders</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(67,844)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28,304&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(237,728)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">76,661&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:700;line-height:120%">Net (loss) income attributable to common stockholders per diluted share </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:4.87pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">(0.18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.63)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:100%">0.35&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Gain on sales of real estate properties</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(48,811)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(143,908)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(56,974)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(197,188)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Impairment of real estate properties</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">56,873&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">138,314&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(25)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate depreciation and amortization</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">185,143&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">159,643&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">556,255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">272,634&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-controlling (loss) income from operating partnership units</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(841)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,935)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">377&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Proportionate share of unconsolidated joint ventures</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,421&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,526&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">13,674&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,702&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">FFO adjustments</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">196,785&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">19,638&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">648,334&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">84,500&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:100%">FFO adjustments per common share - diluted </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">7</span></div></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.51&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.06&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">1.69&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.40&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">FFO attributable to common stockholders</span></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">128,941&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">47,942&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">410,606&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">161,161&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:700;line-height:100%">FFO attributable to common stockholders per common share - diluted </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:4.87pt;font-style:italic;font-weight:700;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">7</span></div></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.14&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">1.07&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.76&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Acquisition and pursuit costs </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,725&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,137&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Merger-related costs </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7,450&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">79,402&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3,366)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">92,603&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Merger-related fair value of debt instruments</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10,667&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">32,085&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangible amortization</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">213&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">891&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-routine legal costs/forfeited earnest money received </span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">346&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Allowance for credit losses </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">4</span></div></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,599&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Debt financing costs</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(62)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,091&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(62)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,520&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Unconsolidated JV normalizing items </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">5</span></div></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">154&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Normalized FFO adjustments</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">19,127&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">81,473&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">40,156&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">100,060&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:100%">Normalized FFO adjustments per common share - diluted </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-style:italic;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">8</span></div></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.05&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.24&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.10&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.47&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Normalized FFO attributable to common stockholders</span></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">148,068&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">129,415&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">450,762&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">261,221&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:700;line-height:120%">Normalized FFO attributable to common stockholders per common share - diluted </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:4.87pt;font-style:italic;font-weight:700;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">8</span></div></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">0.39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">1.18&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-style:italic;font-weight:400;line-height:120%">1.23&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-real estate depreciation and amortization</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,881&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,593&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-cash interest amortization </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">6</span></div></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,402&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,924&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,703&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10,382&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Rent reserves, net</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">442&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">457&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,759&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Straight-line rent, net</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(8,470)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(7,715)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(24,720)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(10,251)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Share-based compensation </span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,556&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,666&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10,224&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10,721&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">Unconsolidated JV non-cash items </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">7</span></div></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(231)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(377)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(828)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(890)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Normalized FFO adjusted for non-cash items</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">144,242&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">134,947&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">442,781&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">273,392&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2nd generation TI</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(21,248)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(10,147)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(47,366)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(20,097)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Leasing commissions paid</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(8,907)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(8,283)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(21,413)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(15,525)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Capital additions</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(14,354)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(16,067)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(31,949)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(23,244)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">FAD</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">99,733&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">100,450&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">342,053&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">214,526&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">FFO weighted average common shares outstanding - diluted</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:700;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 8</span></div></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">383,428&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">332,819&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">383,390&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">211,746&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Potential common shares are not included in the computation of diluted earnings per share when a loss exists as the effect would be an antidilutive per share amount.</span></div><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Acquisition and pursuit costs include third-party and travel costs related to the pursuit of acquisitions and developments. </span></div><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">Includes costs incurred related to the Merger. For the nine months ended September 30, 2023, merger costs are net of a refund of $17.8 million for transfer taxes paid during the year ended December 31, 2022.</span></div><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">4</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.81pt">For the nine months ended September 30, 2023, includes a $5.2 million credit allowance for a mezzanine loan included in "Impairment of real estate and credit loss reserves" on the Statement of Operations and $3.4 million reserve included in &#8220;Rental Income&#8221; on the Statement of Operations for previously deferred rent and straight line rent for three skilled nursing facilities.</span></div><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">5</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.18pt">Includes the Company's proportionate share of acquisition and pursuit costs related to unconsolidated joint ventures.</span></div><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">6</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.96pt">Includes the amortization of deferred financing costs, discounts and premiums, and non-cash financing receivable amortization.</span></div><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">7</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.28pt">Includes the Company's proportionate share of straight-line rent, net related to unconsolidated joint ventures.</span></div><div style="margin-bottom:1pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">8</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.07pt">The Company utilizes the treasury stock method which includes the dilutive effect of nonvested share-based awards outstanding of 432,597 and 426,940, respectively, for the three and nine months ended September 30, 2023, and the diluted impact of 4,042,993 OP units outstanding for the three and nine months ended September 30, 2023. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">32</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Cash Net Operating Income ("NOI") and Merger Combined Same Store Cash NOI</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Cash NOI and Merger Combined Same Store Cash NOI are key performance indicators. Management considers these to be supplemental measures that allow investors, analysts and Company management to measure unlevered property-level operating results. The Company defines Cash NOI as rental income, interest from financing receivables less property operating expenses. Cash NOI excludes non-cash items such as above and below market lease intangibles, straight-line rent, lease inducements, financing receivable amortization, tenant improvement amortization and leasing commission amortization. The Company also excludes cash lease termination fees. Cash NOI is historical and not necessarily indicative of future results. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Merger Combined Same Store Cash NOI compares Cash NOI for stabilized properties. Stabilized properties are properties that have been included in operations for the duration of the year-over-year comparison period presented. Accordingly, stabilized properties exclude properties that were recently acquired or disposed of, properties classified as held for sale or intended for sale, properties undergoing redevelopment, and newly redeveloped or developed properties. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Legacy HTA properties that met the same store criteria are included in both periods shown as if they were owned by the Company for the full analysis period.  The Legacy HR same store pool represented approximately 35% of the NOI of the combined company at the time of the Merger. Management believes that continued reporting of the same store portfolio of only the pre-Merger accounting acquirer (i.e., Legacy HR) offered little value to the investor who was seeking to understand the operating performance and growth potential of the combined company.  The Company was provided access to the underlying financial statements of Legacy HTA (which financial statements had been audited or, in the case of interim periods, reviewed) and other detailed information about each property, such as the acquisition date.  Based on this available information, the Company was able to consistently apply its same store definition across the combined portfolio, resulting in approximately 85% of the combined portfolio being represented in the same store presentation.   </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company utilizes the redevelopment classification for properties where management has approved a change in strategic direction for such properties through the application of additional resources including an amount of capital expenditures significantly above routine maintenance and capital improvement expenditures.  </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Any recently acquired property will be included in the merger combined same store pool once the Company has owned the property for eight full quarters. Newly developed or redeveloped properties will be included in the merger combined same store pool eight full quarters after substantial completion. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table reflects the Company's Merger Combined Same Store Cash NOI for the nine months ended September&#160;30, 2023 and 2022. </span></div><div style="margin-bottom:6pt;margin-top:14pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.486%"><tr><td style="width:1.0%"></td><td style="width:37.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.878%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.269%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.272%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NUMBER OF PROPERTIES</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">GROSS INVESTMENT<br/>at September 30, 2023</span></td><td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">MERGER COMBINED SAME STORE CASH NOI for the nine months ended September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Merger combined same store properties</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,868,621&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">538,486&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">524,066&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture same store properties</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">185,274&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7,617&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7,138&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">33</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following tables reconcile net income to Merger Combined Same Store NOI and the merger combined same store property metrics to the total owned real estate portfolio for the nine months ended September&#160;30, 2023 and 2022:</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Reconciliations of Legacy HR and Merger Combined Same Store Cash NOI  </span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.926%"><tr><td style="width:1.0%"></td><td style="width:57.418%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-style:italic;font-weight:700;line-height:100%">MERGER COMBINED SAME STORE RECONCILIATION</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net (loss) income attributable to common stockholders</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(237,728)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">76,661&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other expense (income)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">281,846&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(111,291)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">43,796&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">38,317&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">550,661&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">267,889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other expenses</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7,753&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">103,622&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Straight-line rent revenue, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(24,720)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(10,251)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture properties</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,418&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,480&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other revenue</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 2</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(14,091)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(9,247)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">621,935&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">364,180&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Pre-Merger Legacy HTA NOI</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">282,502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Cash NOI</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">621,935&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">646,682&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash NOI not included in same store</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(75,832)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(115,478)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Same store joint venture properties</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(7,617)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(7,138)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Merger combined same store cash NOI</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">538,486&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">524,066&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1.</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.25pt">Includes acquisition and pursuit costs, Merger-related costs, rent reserves, above and below market ground lease intangible amortization, leasing commission amortization and ground lease straight-line rent expense.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2.</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:12.74pt">Includes management fee income, interest, above and below market lease intangible amortization, lease inducement amortization, lease terminations and tenant improvement overage amortization.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:64.373%"><tr><td style="width:1.0%"></td><td style="width:55.194%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.752%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.754%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-style:italic;font-weight:700;line-height:100%">LEGACY HR SAME STORE RECONCILIATION</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net (loss) income attributable to common stockholders</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(237,728)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">76,661&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other expense (income)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">281,846&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(111,291)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">43,796&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">38,317&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Depreciation and amortization expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">550,661&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">267,889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other expenses</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7,753&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">103,622&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Straight-line rent revenue, net</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(24,720)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(10,251)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture properties</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,418&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,480&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other revenue</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 2</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(14,091)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(9,247)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">621,935&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">364,180&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash NOI not included in same store</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(383,036)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(134,761)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Legacy HR same store cash NOI</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:120%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">238,899&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">229,419&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Includes acquisition and pursuit costs, Merger-related costs, rent reserves, above and below market ground lease intangible amortization, leasing commission amortization and ground lease straight-line rent expense.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes management fee income, interest, above and below market lease intangible amortization, lease inducement amortization, lease terminations and tenant improvement overage amortization.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">Legacy HR same store cash NOI includes 221 properties.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">34</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Reconciliation of Merger Combined Same Store Properties</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.415%"><tr><td style="width:1.0%"></td><td style="width:45.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.846%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.814%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.188%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">AS OF SEPTEMBER 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars and square feet in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PROPERTY COUNT</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">GROSS INVESTMENT </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE <br/>FEET</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OCCUPANCY</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Merger combined same store properties </span></div></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,868,621&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">34,798&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">89.2&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture same store properties</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">185,274&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">998&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">87.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Wholly owned and joint venture acquisitions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">977,461&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,895&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">90.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Development completions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">151,775&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">405&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">73.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Redevelopments</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">408,316&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,368&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">51.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Planned Dispositions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">137,017&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">71.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total </span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">697&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">13,728,464&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">41,046&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">87.6&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture properties</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">358,015&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,949&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">86.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total owned real estate properties</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">13,370,449&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">39,097&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">87.6&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Excludes assets held for sale, construction in progress, land held for development, corporate property and financing lease right-of-use assets unrelated to an imputed lease arrangement as a result of a sale leaseback transaction.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div id="if827fac591d74a508bffd01ca16da4c0_94"></div><div style="margin-top:18pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Three Months Ended September&#160;30, 2023 Compared to Three Months Ended September&#160;30, 2022 </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s results of operations for the three months ended September&#160;30, 2023 compared to the same period in 2022 were impacted by the Merger, acquisitions, developments, dispositions, gains on sale, and capital markets transactions. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Revenues</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Rental income increased $34.4 million, or 11.5%, for the three months ended September&#160;30, 2023 compared to the prior year period. This increase is primarily comprised of the following:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Acquisitions in 2022 and 2023 contributed $3.7 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Leasing activity, including contractual rent increases, contributed $9.1 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Dispositions in 2022 and 2023 resulted in a decrease of $5.7 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Impact from the Merger contributed $27.3 million.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Interest income increased $0.9 million, or 26.7%, for the three months ended September&#160;30, 2023 compared to the prior year period primarily as a result of a note receivable entered into with a buyer upon disposition of a property in the first quarter of 2023.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Other operating income increased $0.6 million, or 14.9%, for the three months ended September&#160;30, 2023 compared to the prior year period primarily as a result of variable parking and management fees.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Expenses</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Property operating expenses increased $19.2 million, or 17.0%, for the three months ended September&#160;30, 2023 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Acquisitions in 2022 and 2023 resulted in an increase of $1.8 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Increases in portfolio operating expenses as follows: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Utilities expense of $1.6 million;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Administrative, leasing commissions, and other legal expense of $0.7 million;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Maintenance and repair expense of $0.5 million;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Property taxes of $0.5 million;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Janitorial expense of $0.4 million; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Security expense of $0.2 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Insurance expense decreased $0.4 million.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">35</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Dispositions in 2022 and 2023 resulted in a decrease of $5.2 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Impact from the Merger resulted in an increase of $19.1 million.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">General and administrative expenses decreased approximately $3.3 million, or 20.0%, for the three months ended September&#160;30, 2023 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Decrease in payroll and payroll related expenses of approximately $3.1 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Decrease in cash compensation incentive expense of $0.6 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Decrease in non-cash compensation incentive expense of $1.0 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Net increases, primarily due to impacts from the Merger, including professional fees, audit services, insurance and other administrative costs, of $1.4 million.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Merger-related costs decreased $72.0 million, or 90.6%, for the three months ended September&#160;30, 2023 compared to the prior year period primarily due to a reduction in legal and consulting services in connection with the Merger including a refund of $17.8 million related to state transfer taxes.</span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Depreciation and amortization expense increased $24.9 million, or 15.7%, for the three months ended September&#160;30, 2023 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Acquisitions in 2022 and 2023 resulted in an increase of $1.5 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Various building and tenant improvement expenditures resulted in an increase of $7.0 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Dispositions in 2022 and 2023 resulted in a decrease of $5.7 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Assets that became fully depreciated resulted in a decrease of $4.9 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Impact from the Merger resulted in an increase of $27.0 million.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Other Income (Expense)</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Gains on sale of real estate properties</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In the third quarter of 2023, the Company recognized gains of approximately $48.8 million.  In the third quarter of 2022, the Company recognized gains of approximately $143.9 million.</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Interest expense</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Interest expense increased $13.3 million, or 25.0%, for the three months ended September&#160;30, 2023 compared to the prior year period. The components of interest expense are as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:82.415%"><tr><td style="width:1.0%"></td><td style="width:45.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.846%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.848%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED SEPTEMBER 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">CHANGE</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Contractual interest</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">53,911&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42,019&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,892&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">28.3&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net discount/premium accretion</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,785&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7,617&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,168&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">28.5&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Debt issuance costs amortization</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,338&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,341&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of interest rate swap settlement</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of treasury hedge settlement</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Fair value derivative</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">988&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,732&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(744)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(43.0)</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest cost capitalization</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(795)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(703)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(92)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">928&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">889&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">66,304&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">53,044&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">13,260&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:7pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Contractual interest expense increased $11.9 million, or 28.3%, for the three months ended September&#160;30, 2023 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Senior notes and unsecured term loans assumed in the Merger accounted for an increase of approximately $3.3 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">New unsecured term loans executed with the amended credit facility accounted for an increase of approximately $8.4 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">The Company's Unsecured Term Loans due 2024 and 2026 accounted for an increase of approximately $2.7 million.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">36</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">The Unsecured Credit Facility accounted for an increase of approximately $2.0 million due to an increased weighted average balance outstanding and an increase in the weighted average interest rate.  </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Active interest rate derivatives accounted for a decrease of $4.4 million. </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Mortgage note repayments, net of assumptions, accounted for a decrease of approximately $0.1 million.</span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%">  </span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Impairment of Real Estate Properties</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In the third quarter of 2023, the Company recognized impairments totaling $56.9 million primarily due to the sale of two properties, 12 properties classified into held for sale, and six properties with changes in the expected holding periods. </span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Equity loss from unconsolidated joint ventures</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognized its proportionate share of losses from its unconsolidated joint ventures. These losses are primarily attributable to non-cash depreciation expense.  See Note 3 to the Condensed Consolidated Financial Statements accompanying this report for more details regarding the Company's unconsolidated joint ventures.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Nine Months Ended September&#160;30, 2023 Compared to Nine Months Ended September&#160;30, 2022 </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s results of operations for the nine months ended September&#160;30, 2023 compared to the same period in 2022 were impacted by the Merger, acquisitions, developments, dispositions, gains on sale, and capital markets transactions. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Revenues</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Rental income increased $409.1 million, or 70.8%, for the nine months ended September&#160;30, 2023 compared to the prior year period. This increase is primarily comprised of the following:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Acquisitions in 2022 and 2023 contributed $17.4 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Leasing activity, including contractual rent increases, contributed $4.5 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Dispositions in 2022 and 2023 resulted in a decrease of $20.0 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Impact from the Merger contributed $407.2 million.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Interest income increased $5.5 million, or 75.3%, from the prior year period primarily as result of notes receivables assumed in the Merger and a note receivable entered into with a buyer upon disposition of a property in the first quarter of 2023.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Other operating income increased $4.2 million, or 45.7%, from the prior year period primarily as a result of variable parking and asset management fees assumed in the Merger.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Expenses</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Property operating expenses increased $152.1 million, or 67.0%, for the nine months ended September&#160;30, 2023 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Acquisitions in 2022 and 2023 resulted in an increase of $7.8 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Increases in portfolio operating expenses as follows: </span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Utilities expense of $5.4 million;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Maintenance and repair of $2.2 million;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Administrative, leasing commissions, and other legal expense of $2.1 million;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Janitorial expense of $1.5 million;</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Insurance expense of $0.3 million; and</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#9702;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:14.81pt">Security expense of $0.1 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Dispositions in 2022 and 2023 resulted in a decrease of $9.7 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Payroll expense resulted in a decrease of $1.0 million.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Impact from the Merger resulted in an increase of $143.4 million.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">37</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">General and administrative expenses increased approximately $5.5 million, or 14.3%, for the nine months ended September&#160;30, 2023 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Decrease in payroll and payroll related expenses of $1.2 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Decrease in incentive-based awards of $1.1 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Decrease in non-cash compensation incentive expense of $0.7 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Net increases, primarily due to impacts from the Merger, including professional fees, audit services, insurance, travel and other administrative costs, of $8.5 million.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Merger-related costs decreased $96.0 million, or 103.6%, for the nine months ended September&#160;30, 2023 primarily due to a reduction in legal and consulting services in connection with the Merger, including a refund of $17.8 million related to state transfer taxes.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Depreciation and amortization expense increased $282.8 million, or 105.6%, for the nine months ended September&#160;30, 2023 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Acquisitions in 2022 and 2023 resulted in an increase of $9.3 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Various building and tenant improvement expenditures resulted in an increase of $15.9 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Dispositions in 2022 and 2023 resulted in a decrease of $4.7 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Assets that became fully depreciated resulted in a decrease of $15.7 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Impact from the Merger including a reset for fair value resulted in an increase of $278.0 million.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Other Income (Expense)</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Gains on sale of real estate properties</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Gains on the sale of real estate properties for the nine months ended September&#160;30, 2023 and 2022 totaled $57.0 million and $197.2 million, respectively.</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Interest expense</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Interest expense increased $113.1 million, or 137.6%, for the nine months ended September&#160;30, 2023 compared to the prior year period. The components of interest expense are as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:78.440%"><tr><td style="width:1.0%"></td><td style="width:43.149%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.403%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">CHANGE</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">$  </span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Contractual interest</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">157,443&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">68,470&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">88,973&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">129.9&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net discount/premium accretion</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">29,025&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7,747&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">21,278&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">274.7&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Debt issuance costs amortization</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,376&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,760&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,616&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">58.6&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of interest rate swap settlement</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of treasury hedge settlement</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Fair value derivative</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,414&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,732&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,682&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">97.1&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest cost capitalization</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,077)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(848)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,229)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">144.9&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,941&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">829&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42.7&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">195,397&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">82,248&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">113,149&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">137.6&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:7pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Contractual interest expense increased $89.0 million, or 129.9%, for the nine months ended September&#160;30, 2023 compared to the prior year period primarily as a result of the following activity:</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Senior notes and unsecured term loans assumed with the Merger accounted for an increase of approximately $55.8 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">New unsecured term loans executed with the amended credit facility accounted for an increase of approximately $27.3 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">The Company's Unsecured Term Loans due 2024 and 2026, net of swaps, accounted for an increase of approximately $10.4 million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">The Unsecured Credit Facility accounted for an increase of approximately $10.1 million due to an increased weighted average balance outstanding and an increase in the weighted average interest rate.  </span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Interest rate derivatives accounted for a decrease of $14.4 million. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">38</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">Mortgage note repayments, net of assumptions, accounted for a decrease of approximately $0.2 million.</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Impairment of Real Estate Properties and Credit Loss Reserves</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the nine months ended September&#160;30, 2023, the Company recognized impairments totaling $138.3 million relating to six properties that were sold, one land parcel that was sold, 17 properties reclassified to held for sale and five additional properties due to changes in the expected holding periods.  In addition, the Company recorded $5.2 million in credit loss reserves related to notes receivables. See Note 1 to the Condensed Consolidated Financial Statements accompanying this report for more details regarding the Company's notes receivables and credit loss reserves.</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Equity loss from unconsolidated joint ventures</span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%">The Company recognized its proportionate share of losses from its unconsolidated joint ventures, These losses are primarily attributable to non-cash depreciation expense.  See Note 3 to the Condensed Consolidated Financial Statements accompanying this report for more details regarding the Company's unconsolidated joint ventures.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div id="if827fac591d74a508bffd01ca16da4c0_97"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;3.  Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is exposed to market risk in the form of changing interest rates on its debt and mortgage notes. Management uses regular monitoring of market conditions and analysis techniques to manage this risk. During the nine months ended September&#160;30, 2023, there were no material changes in the quantitative and qualitative disclosures about market risks presented in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022.</span></div><div id="if827fac591d74a508bffd01ca16da4c0_100"></div><div><span><br/></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;4.  Controls and Procedures</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Disclosure Controls and Procedures </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s management, with the participation of the Company&#8217;s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company&#8217;s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), as of the end of the period covered by this report. Based on this evaluation, the Company&#8217;s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company&#8217;s disclosure controls and procedures were effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by the Company in the reports it files or submits under the Exchange Act.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">There have not been any changes in the Company&#8217;s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div id="if827fac591d74a508bffd01ca16da4c0_103"></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">PART II - OTHER INFORMATION</span></div><div id="if827fac591d74a508bffd01ca16da4c0_106"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;1. Legal Proceedings</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is, from time to time, involved in litigation arising in the ordinary course of business. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company&#8217;s consolidated financial position, results of operations or cash flows.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">39</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="if827fac591d74a508bffd01ca16da4c0_109"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;1A.  Risk Factors</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In addition to the other information set forth in this report, an investor should carefully consider the factors discussed in Part I, &#8220;Item 1A. Risk Factors&#8221; in the Company&#8217;s  Annual Report on Form 10-K for the year ended December&#160;31, 2022, which could materially affect the Company&#8217;s business, financial condition or future results. The risks, as described in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022, are not the only risks facing the Company. Additional risks and uncertainties not currently known to management or that management currently deems immaterial also may materially, adversely affect the Company&#8217;s business, financial condition, operating results or cash flows.</span></div><div><span><br/></span></div><div id="if827fac591d74a508bffd01ca16da4c0_112"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;2.  Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2023, the Company withheld and canceled shares of Company common stock to satisfy employee tax withholding obligations payable upon the vesting of non-vested shares, as follows:</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.401%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">PERIOD</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">TOTAL NUMBER OF SHARES PURCHASED</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">AVERAGE PRICE PAID per share</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">TOTAL NUMBER OF SHARES purchased as part of publicly announced plans or programs</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">MAXIMUM NUMBER OF SHARES that may yet be purchased under the plans or programs</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">January 1 - January 31</span></div></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">February 1 - February 28</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">38,632&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">21.71&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">March 1 - March 31</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">April 1 - April 30</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 1 - May 31</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 1 - June 30</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">July 1 - July 31</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">August 1 - August 31</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">September 1 - September 30</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total</span></td><td colspan="2" style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">38,632&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">21.71&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr></table></div><div id="if827fac591d74a508bffd01ca16da4c0_115"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;5. Other Information</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the three months ended September 30, 2023, no director or officer of the Company <ix:nonNumeric contextRef="c-5" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1399"><ix:nonNumeric contextRef="c-5" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1400">adopted</ix:nonNumeric></ix:nonNumeric> or <ix:nonNumeric contextRef="c-5" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1401"><ix:nonNumeric contextRef="c-5" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1402">terminated</ix:nonNumeric></ix:nonNumeric> a "Rule 10b5-1 trading agreement" or "non-Rule 10b5-1 trading agreement," as each term is defined in Item 408(a) of Regulation S-K.</span></div><div id="if827fac591d74a508bffd01ca16da4c0_118"></div><div style="-sec-extract:summary;margin-bottom:12pt"><span style="color:#000000;font-family:'Gotham Light',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Item&#160;6. Exhibits</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.933%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.181%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EXHIBIT</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DESCRIPTION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 3.1</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1360604/000136060423000083/hr-2023630xex31.htm">Fifth Articles of Amendment and Restatement of the Company, as amended</a><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1360604/000136060423000083/hr-2023630xex31.htm">.</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 3.2</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1360604/000136060420000037/ex31.htm">Fourth Amended and Restated Bylaws of the Company.</a></span><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:140%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 4.1</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1360604/000136060423000083/hr-2023630xex41.htm">Description of the Registrant's securities registered pursuant to Section 12 of the Securities and Exchange Act of 1934</a><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="http://www.sec.gov/Archives/edgar/data/1360604/000136060423000083/hr-2023630xex41.htm">.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2023930xex311.htm">Exhibit 22</a>.1</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2023930xex221.htm">Subsidiary Issuers of Guaranteed Securities</a><a style="-sec-extract:exhibit;background-color:#ffffff;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2023930xex221.htm"> </a>(filed herewith).</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2023930xex311.htm">Exhibit 31.1</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2023930xex311.htm">Certification of the Chief Executive Officer of Healthcare Realty Trust Incorporated pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)</a>.</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2023930xex32.htm">Exhibit&#160;31.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2023930xex312.htm">Certification of the Chief Financial Officer of Healthcare Realty Trust Incorporated pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)</a>.</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2023930xex32.htm">Exhibit&#160;32</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%;text-decoration:none" href="hr-2023930xex32.htm">Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)</a>.</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">40</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.586%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:73.933%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.181%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 101.INS</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 101.SCH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">XBRL Taxonomy Extension Schema Document (furnished electronically herewith)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 101.CAL</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">XBRL Taxonomy Extension Calculation Linkbase Document (furnished electronically herewith)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 101.LAB</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">XBRL Taxonomy Extension Labels Linkbase Document (furnished electronically herewith)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 101.DEF</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">XBRL Taxonomy Extension Definition Linkbase Document (furnished electronically herewith)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">Exhibit 101.PRE</span></td><td colspan="3" style="border-bottom:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:140%">XBRL Taxonomy Extension Presentation Linkbase Document (furnished electronically herewith)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"> 1   Filed as an exhibit to the Company'a (File No. 001-35568) Form 10-Q filed with the SEC on August 8, 2023 and hereby incorporated by reference.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"> 2  Filed as an exhibit to Legacy HTA's (File No. 001-35568) Form 8-K filed with the SEC on April 29, 2020 and hereby incorporated by reference.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="-sec-extract:summary;text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">41</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div><div id="if827fac591d74a508bffd01ca16da4c0_121"></div><hr style="page-break-after:always"/><div style="min-height:63pt;width:100%"><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%;text-decoration:none" href="#if827fac591d74a508bffd01ca16da4c0_13">Table of Contents</a></span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.847%"><tr><td style="width:1.0%"></td><td style="width:40.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.427%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">HEALTHCARE REALTY TRUST INCORPORATED</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">/s/ J. CHRISTOPHER DOUGLAS</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">J. Christopher Douglas</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">November 3, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span><br/></span></div><div style="text-align:right"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">42</span></div><div style="margin-bottom:6pt;text-align:right"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-22.1
<SEQUENCE>2
<FILENAME>hr-2023930xex221.htm
<DESCRIPTION>EX-22.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ia62bdc7962a946178c1017d766ea0d92_1"></div><div style="min-height:72pt;width:100%"><div style="padding-left:396pt;text-indent:36pt"><font><br></font></div><div style="padding-left:396pt;text-indent:36pt"><font><br></font></div><div style="padding-left:396pt;text-indent:36pt"><font><br></font></div><div style="padding-left:396pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 22.1</font></div></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:107%">LIST OF SUBSIDIARY ISSUERS OF GUARANTEED SECURITIES</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:107%">As of September 30, 2023, Healthcare Realty Trust Incorporated is the guarantor of the outstanding debt securities of its subsidiaries, as listed below.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.679%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Debt Instrument</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:112%;text-decoration:underline">Issuer</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.88% Senior Notes due 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.50% Senior Notes due 2026</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.75% Senior Notes due 2027</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.63% Senior Notes due 2028</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">3.10% Senior Notes due 2030</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">2.40% Senior Notes due 2030</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">2.05% Senior Notes due 2031</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">2.00% Senior Notes due 2031</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Healthcare Realty Holdings, L.P.</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>hr-2023930xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ic0c399adb04f413b8de0744f0ee32c45_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div></div><div style="-sec-extract:summary;margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302</font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Healthcare Realty Trust Incorporated</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certification</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:3pt;text-align:center"><font><br></font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, Todd J. Meredith, certify that&#58;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">I have reviewed this quarterly report on Form 10-Q of Healthcare Realty Trust Incorporated&#59;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.76pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.76pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.76pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 3, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; TODD J. MEREDITH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Todd J. Meredith</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></div></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>hr-2023930xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i7b052b43081144eca4fac8d636f53fec_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div></div><div style="-sec-extract:summary;margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302</font></div><div style="margin-bottom:3pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Healthcare Realty Trust Incorporated</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certification</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Pursuant to Section&#160;302 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">I, J. Christopher Douglas, certify that&#58;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">I have reviewed this quarterly report on Form 10-Q of Healthcare Realty Trust Incorporated&#59;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.76pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.76pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.76pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.140%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 3, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#47;s&#47; J. CHRISTOPHER DOUGLAS</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">J. Christopher Douglas</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></div></td></tr></table></div><div style="margin-bottom:3pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>5
<FILENAME>hr-2023930xex32.htm
<DESCRIPTION>EX-32
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i8187919f9072421ea331f7be5d197bc5_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div></div><div style="-sec-extract:summary;margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATIONS PURSUANT TO 18 U.S.C. SECTION 1350 SECTION 906</font></div><div style="margin-bottom:3pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exhibit 32</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Healthcare Realty Trust Incorporated</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Certification Pursuant to</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">18 U.S.C. Section&#160;1350,</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">as Adopted Pursuant to</font></div><div style="margin-bottom:3pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="margin-bottom:3pt;text-align:center"><font><br></font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In connection with the Quarterly Report of Healthcare Realty Trust Incorporated (the &#8220;Company&#8221;) on Form 10-Q for the quarter ended September&#160;30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I, Todd J. Meredith, President and Chief Executive Officer of the Company, and I, J. Christopher Douglas, Executive Vice President and Chief Financial Officer of the Company, each certify, pursuant to 18 U.S.C. Section&#160;1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that&#58;</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:11.25pt">Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:3pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:4.170%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.804%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.726%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">November 3, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; TODD J. MEREDITH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Todd J. Meredith</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; J. CHRISTOPHER DOUGLAS</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">J. Christopher Douglas</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></div></td></tr></table></div><div style="margin-bottom:3pt"><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>hr-20230930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:73dbfdf1-2054-4a25-8023-7c5130a0cc11,g:80064ddd-1403-40d2-9d20-e881ce80ef55-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hr="http://healthcarerealty.com/20230930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://healthcarerealty.com/20230930">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2023" schemaLocation="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hr-20230930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hr-20230930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hr-20230930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hr-20230930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://healthcarerealty.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>0000002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>0000004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncome" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome">
        <link:definition>0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests">
        <link:definition>0000006 - Statement - Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterestsParenthetical" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterestsParenthetical">
        <link:definition>0000007 - Statement - Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>0000008 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000009 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergerwithHTA" roleURI="http://healthcarerealty.com/role/MergerwithHTA">
        <link:definition>0000010 - Disclosure - Merger with HTA</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestments" roleURI="http://healthcarerealty.com/role/RealEstateInvestments">
        <link:definition>0000011 - Disclosure - Real Estate Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://healthcarerealty.com/role/Leases">
        <link:definition>0000012 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesandBondsPayable" roleURI="http://healthcarerealty.com/role/NotesandBondsPayable">
        <link:definition>0000013 - Disclosure - Notes and Bonds Payable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstruments" roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstruments">
        <link:definition>0000014 - Disclosure - Derivative Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://healthcarerealty.com/role/CommitmentsandContingencies">
        <link:definition>0000015 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://healthcarerealty.com/role/StockholdersEquity">
        <link:definition>0000016 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstruments" roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstruments">
        <link:definition>0000017 - Disclosure - Fair Value of Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>9954472 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergerwithHTATables" roleURI="http://healthcarerealty.com/role/MergerwithHTATables">
        <link:definition>9954473 - Disclosure - Merger with HTA (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestmentsTables" roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsTables">
        <link:definition>9954474 - Disclosure - Real Estate Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://healthcarerealty.com/role/LeasesTables">
        <link:definition>9954475 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesandBondsPayableTables" roleURI="http://healthcarerealty.com/role/NotesandBondsPayableTables">
        <link:definition>9954476 - Disclosure - Notes and Bonds Payable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsTables" roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables">
        <link:definition>9954477 - Disclosure - Derivative Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://healthcarerealty.com/role/StockholdersEquityTables">
        <link:definition>9954478 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsTables" roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables">
        <link:definition>9954479 - Disclosure - Fair Value of Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesDetails" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails">
        <link:definition>9954480 - Disclosure - Summary of Significant Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails">
        <link:definition>9954481 - Disclosure - Summary of Significant Accounting Policies - Consolidated balance sheets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesVariableinterestentityDetails" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails">
        <link:definition>9954482 - Disclosure - Summary of Significant Accounting Policies - Variable interest entity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails">
        <link:definition>9954483 - Disclosure - Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails">
        <link:definition>9954484 - Disclosure - Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails">
        <link:definition>9954485 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergerwithHTANarrativeDetails" roleURI="http://healthcarerealty.com/role/MergerwithHTANarrativeDetails">
        <link:definition>9954486 - Disclosure - Merger with HTA - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergerwithHTADetails" roleURI="http://healthcarerealty.com/role/MergerwithHTADetails">
        <link:definition>9954487 - Disclosure - Merger with HTA (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails" roleURI="http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails">
        <link:definition>9954488 - Disclosure - Merger with HTA - Schedule of Fair Values of the Assets Acquired And Liabilities Assumed (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestmentsRealEstateAcquisitionsDetails" roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails">
        <link:definition>9954489 - Disclosure - Real Estate Investments -Real Estate Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestmentsNarrativeDetails" roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsNarrativeDetails">
        <link:definition>9954490 - Disclosure - Real Estate Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails" roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails">
        <link:definition>9954491 - Disclosure - Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestmentsDispositionsDetails" roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails">
        <link:definition>9954492 - Disclosure - Real Estate Investments - Dispositions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RealEstateInvestmentsAssetsHeldforSaleDetails" roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails">
        <link:definition>9954493 - Disclosure - Real Estate Investments - Assets Held for Sale (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseIncomeDetails" roleURI="http://healthcarerealty.com/role/LeasesLeaseIncomeDetails">
        <link:definition>9954494 - Disclosure - Leases - Lease Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLessorAccountingDetails" roleURI="http://healthcarerealty.com/role/LeasesLessorAccountingDetails">
        <link:definition>9954495 - Disclosure - Leases - Lessor Accounting (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesGroundLeasesDetails" roleURI="http://healthcarerealty.com/role/LeasesGroundLeasesDetails">
        <link:definition>9954496 - Disclosure - Leases - Ground Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesFutureMinimumLeasePaymentsDetails" roleURI="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails">
        <link:definition>9954497 - Disclosure - Leases - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesFutureMinimumLeasePaymentsDetails_1" roleURI="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1">
        <link:definition>9954497 - Disclosure - Leases - Future Minimum Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCostDetails" roleURI="http://healthcarerealty.com/role/LeasesLeaseCostDetails">
        <link:definition>9954498 - Disclosure - Leases - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesandBondsPayableDetails" roleURI="http://healthcarerealty.com/role/NotesandBondsPayableDetails">
        <link:definition>9954499 - Disclosure - Notes and Bonds Payable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NotesandBondsPayableNarrativeDetails" roleURI="http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails">
        <link:definition>9954500 - Disclosure - Notes and Bonds Payable - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails" roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails">
        <link:definition>9954501 - Disclosure - Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails" roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails">
        <link:definition>9954502 - Disclosure - Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails" roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails">
        <link:definition>9954503 - Disclosure - Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails">
        <link:definition>9954504 - Disclosure - Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesNarrativeDetails" roleURI="http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails">
        <link:definition>9954505 - Disclosure - Commitment and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails">
        <link:definition>9954506 - Disclosure - Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockTransactionsNarrativeDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails">
        <link:definition>9954507 - Disclosure - Stockholders' Equity - Stock Transactions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails">
        <link:definition>9954508 - Disclosure - Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails">
        <link:definition>9954509 - Disclosure - Stockholders' Equity - Summary of the Activity Under the Incentive Plan and RSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails">
        <link:definition>9954510 - Disclosure - Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails">
        <link:definition>9954511 - Disclosure - Stockholders' Equity - Summary of Activity under Employee Stock Purchase Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails" roleURI="http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails">
        <link:definition>9954512 - Disclosure - Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueofFinancialInstrumentsDetails" roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails">
        <link:definition>9954513 - Disclosure - Fair Value of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ApproximateSquareFeetProvidedByCompany" abstract="false" name="ApproximateSquareFeetProvidedByCompany" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:areaItemType"/>
  <xs:element id="hr_RecapitalizationExchangeRatio" abstract="false" name="RecapitalizationExchangeRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" abstract="false" name="EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_TermLoanDue2027Member" abstract="true" name="TermLoanDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_AtlantaGAMember" abstract="true" name="AtlantaGAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_SettledInterestRateSwapsMember" abstract="true" name="SettledInterestRateSwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_SeniorNotesdue2025Member" abstract="true" name="SeniorNotesdue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_ColumbusOHMember" abstract="true" name="ColumbusOHMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_MarketCondition2Member" abstract="true" name="MarketCondition2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_HoustonTXMember" abstract="true" name="HoustonTXMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ClosingAdjustmentsDisposedEntity" abstract="false" name="ClosingAdjustmentsDisposedEntity" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_InvestmentInRealEstatePropertiesAndMortgageNotes" abstract="false" name="InvestmentInRealEstatePropertiesAndMortgageNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NotesReceivableInterestRate" abstract="false" name="NotesReceivableInterestRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="hr_NumberOfVariableInterestEntities" abstract="false" name="NumberOfVariableInterestEntities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_NumberOfBuildingsOwnedByJointVenture" abstract="false" name="NumberOfBuildingsOwnedByJointVenture" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_RealEstateDispositionsMember" abstract="true" name="RealEstateDispositionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_HealthcareTrustofAmericaHoldingsLPMember" abstract="true" name="HealthcareTrustofAmericaHoldingsLPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" abstract="false" name="ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="hr_BusinessCombinationRefundOfTransferTaxesPaid" abstract="false" name="BusinessCombinationRefundOfTransferTaxesPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hr_NumberofGroundLeasesPrepaid" abstract="false" name="NumberofGroundLeasesPrepaid" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_TampaFLMiamiFLMember" abstract="true" name="TampaFLMiamiFLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_CommonStockSharesWithheld" abstract="false" name="CommonStockSharesWithheld" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_SeniorNotesDue2026Member" abstract="true" name="SeniorNotesDue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_PercentageOfInterestBearingInMortgageNotesPayable" abstract="false" name="PercentageOfInterestBearingInMortgageNotesPayable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="hr_NumberOfPropertyDispositions" abstract="false" name="NumberOfPropertyDispositions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis" abstract="true" name="RealEstateAcquisitionsAndMortgageNoteFinancingAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="hr_NonControllingInterestHoldersMember" abstract="true" name="NonControllingInterestHoldersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ImpairmentChargeOnRealEstateAssetsHeldForSale" abstract="false" name="ImpairmentChargeOnRealEstateAssetsHeldForSale" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" abstract="false" name="AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:areaItemType"/>
  <xs:element id="hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" abstract="false" name="EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_MedicalOfficeBuildingMember" abstract="true" name="MedicalOfficeBuildingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" abstract="false" name="IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hr_RealEstateInvestmentNetDisposedOfDuringPeriod" abstract="false" name="RealEstateInvestmentNetDisposedOfDuringPeriod" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="hr_NumberOfSwapTransactions" abstract="false" name="NumberOfSwapTransactions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_SeniorNotesDue2031Member" abstract="true" name="SeniorNotesDue2031Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_CumulativeNetIncomeAttributableToCommonStockholders" abstract="false" name="CumulativeNetIncomeAttributableToCommonStockholders" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_InterestRateSwapExpiringJune12027Member" abstract="true" name="InterestRateSwapExpiringJune12027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_LimitedLiabilityCompanyOneMember" abstract="true" name="LimitedLiabilityCompanyOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_HealthCareRealtyTrustIncMember" abstract="true" name="HealthCareRealtyTrustIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_ManagementFeeIncomeMember" abstract="true" name="ManagementFeeIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount" abstract="false" name="BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_DirectorsMember" abstract="true" name="DirectorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_JointVentureCarryingAmount" abstract="false" name="JointVentureCarryingAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NumberOfDirectors" abstract="false" name="NumberOfDirectors" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_LeaseIntangibles" abstract="false" name="LeaseIntangibles" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_CumulativeDividendsMember" abstract="true" name="CumulativeDividendsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_MergerConsiderationTransferred" abstract="false" name="MergerConsiderationTransferred" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" abstract="false" name="RealEstateInvestmentsPropertyOwnedInNumberOfStates" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NumberOfRealEstateNotesReceivable" abstract="false" name="NumberOfRealEstateNotesReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_EquityOwnershipForConsolidationPercent" abstract="false" name="EquityOwnershipForConsolidationPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ExtinguishmentOfDebtEncumberedSquareFootage" abstract="false" name="ExtinguishmentOfDebtEncumberedSquareFootage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:areaItemType"/>
  <xs:element id="hr_PerformanceConditionsMember" abstract="true" name="PerformanceConditionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_AssetDispositionsTableTextBlock" abstract="false" name="AssetDispositionsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="hr_DebtInstrumentExtensionPeriodForMaturityDate" abstract="false" name="DebtInstrumentExtensionPeriodForMaturityDate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="hr_FinancingReceivableAllowanceForCreditLossReserves" abstract="false" name="FinancingReceivableAllowanceForCreditLossReserves" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_CumulativeNetIncomeMember" abstract="true" name="CumulativeNetIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" abstract="true" name="SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NumberOfCorporateEntityClassifiedAsHeldForSale" abstract="false" name="NumberOfCorporateEntityClassifiedAsHeldForSale" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_AlbanyNYMember" abstract="true" name="AlbanyNYMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_OperatingPartnershipPerformanceUnitsMember" abstract="true" name="OperatingPartnershipPerformanceUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_MiscellaneousMember" abstract="true" name="MiscellaneousMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_PersonalProperty" abstract="false" name="PersonalProperty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_PaymentOfSpecialDividendMergerRelated" abstract="false" name="PaymentOfSpecialDividendMergerRelated" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_GrossContractualRealEstateNotesReceivableFairValue" abstract="false" name="GrossContractualRealEstateNotesReceivableFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_DispositionSalesPrice" abstract="false" name="DispositionSalesPrice" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_AmortizationofPrepaidRent" abstract="false" name="AmortizationofPrepaidRent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" abstract="false" name="EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ScottsdaleArizonaMember" abstract="true" name="ScottsdaleArizonaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" abstract="false" name="BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests" abstract="false" name="ProceedsFromContributionsFromRedeemableNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_SquareFeetSubjecttoGroundLeases" abstract="false" name="SquareFeetSubjecttoGroundLeases" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:areaItemType"/>
  <xs:element id="hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" abstract="false" name="LessorOperatingLeasePaymenttobeReceivedafterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hr_ApproximateSquareFeetInvestedInByCompany" abstract="false" name="ApproximateSquareFeetInvestedInByCompany" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:areaItemType"/>
  <xs:element id="hr_NatureOfOperationsPolicyTextBlock" abstract="false" name="NatureOfOperationsPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="hr_ConstructionActivityTotalFundingDuringthePeriod" abstract="false" name="ConstructionActivityTotalFundingDuringthePeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_DerivativeNetAssetPositionAggregateFairValue" abstract="false" name="DerivativeNetAssetPositionAggregateFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ScheduleOfRealEstateDispositionsTable" abstract="true" name="ScheduleOfRealEstateDispositionsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="hr_InterestRateSwapExpiringJune12026Member" abstract="true" name="InterestRateSwapExpiringJune12026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_CompletedDevelpomentAndRedevelopmentPropertiesMember" abstract="true" name="CompletedDevelpomentAndRedevelopmentPropertiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NumberofGroundLeasesExcludingPrepaidLeases" abstract="false" name="NumberofGroundLeasesExcludingPrepaidLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_AcquisitionsAndDispositionsTextBlock" abstract="false" name="AcquisitionsAndDispositionsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="hr_SeniorNotesdue2028Member" abstract="true" name="SeniorNotesdue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_FinanceLeasePrincipalOnlyPayments" abstract="false" name="FinanceLeasePrincipalOnlyPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_InterestRateSwapExpiringJanuary152024Member" abstract="true" name="InterestRateSwapExpiringJanuary152024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_ImpairmentOfRealEstateAndCreditLossReserves" abstract="false" name="ImpairmentOfRealEstateAndCreditLossReserves" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NumberOfRealEstateInvestments" abstract="false" name="NumberOfRealEstateInvestments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_RealEstateOther" abstract="false" name="RealEstateOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NotesReceivableMaximumLoanCommitment" abstract="false" name="NotesReceivableMaximumLoanCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_PercentageOfRestrictedStockUnits" abstract="false" name="PercentageOfRestrictedStockUnits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="hr_TermLoanDueMay2024Member" abstract="true" name="TermLoanDueMay2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_InterestRateSwapExpiringDecember12027Member" abstract="true" name="InterestRateSwapExpiringDecember12027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour" abstract="false" name="EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_PowayCAMember" abstract="true" name="PowayCAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_FinanceLeaseLiabilityToBePaidAfterYearFour" abstract="false" name="FinanceLeaseLiabilityToBePaidAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_StockIssuanceProgramAxis" abstract="true" name="StockIssuanceProgramAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="hr_NonVestedStockAwardMember" abstract="true" name="NonVestedStockAwardMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_LosAngelesCaliforniaMember" abstract="true" name="LosAngelesCaliforniaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" abstract="false" name="EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NumberOfPropertiesClassifiedAsHeldForSale" abstract="false" name="NumberOfPropertiesClassifiedAsHeldForSale" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" abstract="false" name="AssetsHeldForSaleAndDiscontinuedOperationsNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_CommonStockFractionalShares" abstract="false" name="CommonStockFractionalShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hr_ColoradoSpringsCOMember" abstract="true" name="ColoradoSpringsCOMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" abstract="true" name="ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices" abstract="false" name="BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_InterestRateSwapEffectiveNovember12023Member" abstract="true" name="InterestRateSwapEffectiveNovember12023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_HealthcareTrustOfAmericaIncMember" abstract="true" name="HealthcareTrustOfAmericaIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_StockIncentivePlanMember" abstract="true" name="StockIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_RealEstateNotesReceivableNet" abstract="false" name="RealEstateNotesReceivableNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_MortgageNotesPayableNetMember" abstract="true" name="MortgageNotesPayableNetMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_EquityMethodInvestmentsRollForward" abstract="true" name="EquityMethodInvestmentsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hr_ReverseRecapitalizationNet" abstract="false" name="ReverseRecapitalizationNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain" abstract="true" name="RealEstateAcquisitionsAndMortgageNoteFinancingDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_LongTermIncentiveProgramDUnitsMember" abstract="true" name="LongTermIncentiveProgramDUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_SeniorNotesdue2030Member" abstract="true" name="SeniorNotesdue2030Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_BusinessOverviewAbstract" abstract="true" name="BusinessOverviewAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hr_NumberOfNotesReceivable" abstract="false" name="NumberOfNotesReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_SeniorNotesDue2027Member" abstract="true" name="SeniorNotesDue2027Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_MortgageNote" abstract="false" name="MortgageNote" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NumberOfJointVentures" abstract="false" name="NumberOfJointVentures" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_JointVentureOwnershipPercentage" abstract="false" name="JointVentureOwnershipPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="hr_TermLoanDue2025Member" abstract="true" name="TermLoanDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" abstract="false" name="GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ActiveDevelopmentPropertiesMember" abstract="true" name="ActiveDevelopmentPropertiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" abstract="false" name="ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_HealthCareRealtyTrustIncorporatedMember" abstract="true" name="HealthCareRealtyTrustIncorporatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_TermLoanDueJuly2024Member" abstract="true" name="TermLoanDueJuly2024Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_TermLoandue2026Member" abstract="true" name="TermLoandue2026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_FinanceMortgageNotes" abstract="false" name="FinanceMortgageNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" abstract="true" name="RealEstateDispositionsAndMortgageNoteRepaymentsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="hr_ActiveInterestRateSwapsMember" abstract="true" name="ActiveInterestRateSwapsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" abstract="true" name="SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" abstract="false" name="IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" abstract="false" name="InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_ParkingIncomeMember" abstract="true" name="ParkingIncomeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NotesReceivableCarryingAmount" abstract="false" name="NotesReceivableCarryingAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_RealEstateAcquisitionsMember" abstract="true" name="RealEstateAcquisitionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_STLouisMoMember" abstract="true" name="STLouisMoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_ReceivablesAndOtherAssets" abstract="false" name="ReceivablesAndOtherAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_RedevelopmentPropertiesMember" abstract="true" name="RedevelopmentPropertiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" abstract="true" name="RealEstateDispositionsAndMortgageNoteRepaymentsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_SquareFeetSubjectToMortgageNotesPayable" abstract="false" name="SquareFeetSubjectToMortgageNotesPayable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:areaItemType"/>
  <xs:element id="hr_StraightLineRentReceivable" abstract="false" name="StraightLineRentReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage" abstract="false" name="BusinessAcquisitionPurchasePriceAllocationSquareFootage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:areaItemType"/>
  <xs:element id="hr_UnsecuredCreditFacilityOneMember" abstract="true" name="UnsecuredCreditFacilityOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_PropertyEntitiesNotDeterminedToBeVIEsMember" abstract="true" name="PropertyEntitiesNotDeterminedToBeVIEsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" abstract="false" name="NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NumberOfRecognizedLeaseFinancialReceivables" abstract="false" name="NumberOfRecognizedLeaseFinancialReceivables" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_OperatingExpensesandCostofGoodsSold" abstract="false" name="OperatingExpensesandCostofGoodsSold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_CashAcquiredInMerger" abstract="false" name="CashAcquiredInMerger" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_TermLoanDue2028Member" abstract="true" name="TermLoanDue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_InterestRateSwapExpiringMay12026Member" abstract="true" name="InterestRateSwapExpiringMay12026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract" abstract="true" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="hr_StraightlineRentLiability" abstract="false" name="StraightlineRentLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_DallasTXMember" abstract="true" name="DallasTXMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_ExecutiveIncentiveProgramMember" abstract="true" name="ExecutiveIncentiveProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_InterestRateSwapExpiringDecember12026Member" abstract="true" name="InterestRateSwapExpiringDecember12026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_RealEstatePropertiesHeldInJointVenturesMember" abstract="true" name="RealEstatePropertiesHeldInJointVenturesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_HoustonTexasMember" abstract="true" name="HoustonTexasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_MergerRelatedCosts" abstract="false" name="MergerRelatedCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_MortgageLoanMember" abstract="true" name="MortgageLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet" abstract="false" name="BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_TampaFLMember" abstract="true" name="TampaFLMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_MarketCondition1Member" abstract="true" name="MarketCondition1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_InterestIncomeFinancingReceivableNoncash" abstract="false" name="InterestIncomeFinancingReceivableNoncash" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_VariableInterestEntityMember" abstract="true" name="VariableInterestEntityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_LegacyHTAMember" abstract="true" name="LegacyHTAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_StockIssuanceProgramDomain" abstract="true" name="StockIssuanceProgramDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_EquityOfferingProgramAvailableForIssuance" abstract="false" name="EquityOfferingProgramAvailableForIssuance" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_NewEmployeeMember" abstract="true" name="NewEmployeeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_InterestRateSwapExpiringMay312026Member" abstract="true" name="InterestRateSwapExpiringMay312026Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_ChicagoILMember" abstract="true" name="ChicagoILMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="hr_MezzanineLoanMember" abstract="true" name="MezzanineLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" abstract="false" name="EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="hr_RealEstateDispositionsLineItems" abstract="true" name="RealEstateDispositionsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>hr-20230930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:73dbfdf1-2054-4a25-8023-7c5130a0cc11,g:80064ddd-1403-40d2-9d20-e881ce80ef55-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="hr-20230930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost_3a790704-e4e8-48bc-bb7b-38ececce9f70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_f3afee8b-92f8-40ec-b9bb-d81e219faa27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Land"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_3a790704-e4e8-48bc-bb7b-38ececce9f70" xlink:to="loc_us-gaap_Land_f3afee8b-92f8-40ec-b9bb-d81e219faa27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_c1df4654-9f4f-4b89-8a4d-ce1a71196904" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_3a790704-e4e8-48bc-bb7b-38ececce9f70" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_c1df4654-9f4f-4b89-8a4d-ce1a71196904" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross_2a35e5c5-07cb-4100-9ff7-b5fa8c2d99f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_3a790704-e4e8-48bc-bb7b-38ececce9f70" xlink:to="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross_2a35e5c5-07cb-4100-9ff7-b5fa8c2d99f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PersonalProperty_a5ddb097-3b25-4eee-b19d-7c64964739ba" xlink:href="hr-20230930.xsd#hr_PersonalProperty"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_3a790704-e4e8-48bc-bb7b-38ececce9f70" xlink:to="loc_hr_PersonalProperty_a5ddb097-3b25-4eee-b19d-7c64964739ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_cd10f0f1-1204-4fcb-9edb-1582f18bfec7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_3a790704-e4e8-48bc-bb7b-38ececce9f70" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_cd10f0f1-1204-4fcb-9edb-1582f18bfec7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_40df8fe5-ca13-4362-97da-c9cc53a9fee9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_3a790704-e4e8-48bc-bb7b-38ececce9f70" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_40df8fe5-ca13-4362-97da-c9cc53a9fee9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess_36eaf5cd-6fd1-4dc2-adeb-05734282dcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopmentInProcess"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_3a790704-e4e8-48bc-bb7b-38ececce9f70" xlink:to="loc_us-gaap_DevelopmentInProcess_36eaf5cd-6fd1-4dc2-adeb-05734282dcb8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAvailableForDevelopment_89e0432c-ba9d-445a-8a73-d2c708dfa5de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandAvailableForDevelopment"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_3a790704-e4e8-48bc-bb7b-38ececce9f70" xlink:to="loc_us-gaap_LandAvailableForDevelopment_89e0432c-ba9d-445a-8a73-d2c708dfa5de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_058c8260-ca1d-4490-be3e-8a664a6a0103" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_e7def47e-a76a-45ce-90df-69cf9de0950d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_058c8260-ca1d-4490-be3e-8a664a6a0103" xlink:to="loc_us-gaap_Liabilities_e7def47e-a76a-45ce-90df-69cf9de0950d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_6369fa2c-7ad4-49ab-86c5-89b5920c834b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_058c8260-ca1d-4490-be3e-8a664a6a0103" xlink:to="loc_us-gaap_CommitmentsAndContingencies_6369fa2c-7ad4-49ab-86c5-89b5920c834b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4962c31a-b939-4787-bed4-3058f89f4aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_058c8260-ca1d-4490-be3e-8a664a6a0103" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_4962c31a-b939-4787-bed4-3058f89f4aeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_8c598e74-cd1a-4445-a8a5-4f73da4fe0fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_058c8260-ca1d-4490-be3e-8a664a6a0103" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_8c598e74-cd1a-4445-a8a5-4f73da4fe0fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7f218047-65a0-45b5-a92e-425b427330ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeDividends_9b4d71e1-68c2-45e2-aa20-b289094d2bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CumulativeDividends"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7f218047-65a0-45b5-a92e-425b427330ce" xlink:to="loc_us-gaap_CumulativeDividends_9b4d71e1-68c2-45e2-aa20-b289094d2bc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetIncomeAttributableToCommonStockholders_cd5952c9-d251-4c89-b13f-fd9e7ce4d523" xlink:href="hr-20230930.xsd#hr_CumulativeNetIncomeAttributableToCommonStockholders"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7f218047-65a0-45b5-a92e-425b427330ce" xlink:to="loc_hr_CumulativeNetIncomeAttributableToCommonStockholders_cd5952c9-d251-4c89-b13f-fd9e7ce4d523" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_9c4176ad-bcc2-4b94-bae8-04cfe0623648" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7f218047-65a0-45b5-a92e-425b427330ce" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_9c4176ad-bcc2-4b94-bae8-04cfe0623648" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2617f02e-c6e8-4115-93d4-4e9ff501e3b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7f218047-65a0-45b5-a92e-425b427330ce" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_2617f02e-c6e8-4115-93d4-4e9ff501e3b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_3ad5b2d3-04e9-4af0-84d4-3193ae2899c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7f218047-65a0-45b5-a92e-425b427330ce" xlink:to="loc_us-gaap_CommonStockValue_3ad5b2d3-04e9-4af0-84d4-3193ae2899c2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_ce4a128d-f132-4833-bd7c-8bcebe3936c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_7f218047-65a0-45b5-a92e-425b427330ce" xlink:to="loc_us-gaap_PreferredStockValue_ce4a128d-f132-4833-bd7c-8bcebe3936c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_efae5714-369a-42cd-a74e-b3a652146045" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5a29ceec-6343-4733-aeba-fb374b77c721" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_efae5714-369a-42cd-a74e-b3a652146045" xlink:to="loc_us-gaap_LongTermDebt_5a29ceec-6343-4733-aeba-fb374b77c721" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_9b90a991-b0f3-4341-9c8b-bd2a3767d315" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_efae5714-369a-42cd-a74e-b3a652146045" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_9b90a991-b0f3-4341-9c8b-bd2a3767d315" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_2829a56f-ebb5-41ec-9783-d996c404ce8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_efae5714-369a-42cd-a74e-b3a652146045" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_2829a56f-ebb5-41ec-9783-d996c404ce8b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e7f4bf57-488f-4091-83a5-b4df3efe4322" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_efae5714-369a-42cd-a74e-b3a652146045" xlink:to="loc_us-gaap_OperatingLeaseLiability_e7f4bf57-488f-4091-83a5-b4df3efe4322" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_6f5ae9ed-03d8-4848-bd28-fc3ee7d7d2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_efae5714-369a-42cd-a74e-b3a652146045" xlink:to="loc_us-gaap_FinanceLeaseLiability_6f5ae9ed-03d8-4848-bd28-fc3ee7d7d2d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_1e081207-677f-49cc-93a5-63ed48f96edd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_efae5714-369a-42cd-a74e-b3a652146045" xlink:to="loc_us-gaap_OtherLiabilities_1e081207-677f-49cc-93a5-63ed48f96edd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_92a3e017-32a6-4276-9e9e-78313a2d255d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost_1d5eb717-0a75-4111-a562-75bcffb124ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet_92a3e017-32a6-4276-9e9e-78313a2d255d" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAtCost_1d5eb717-0a75-4111-a562-75bcffb124ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_19e7e8a9-99b6-45b6-a3a5-903b6fa0baa9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet_92a3e017-32a6-4276-9e9e-78313a2d255d" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_19e7e8a9-99b6-45b6-a3a5-903b6fa0baa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d40b7409-e5de-49a4-97b8-b3f349eeeb14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_63a22f1b-45b2-4bb9-9f9a-fb254bd20cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d40b7409-e5de-49a4-97b8-b3f349eeeb14" xlink:to="loc_us-gaap_StockholdersEquity_63a22f1b-45b2-4bb9-9f9a-fb254bd20cc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_add23b83-bdec-4f68-9459-3f3fb501f523" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d40b7409-e5de-49a4-97b8-b3f349eeeb14" xlink:to="loc_us-gaap_MinorityInterest_add23b83-bdec-4f68-9459-3f3fb501f523" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6c3f358c-6b23-4172-87ca-9d2f2914657f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_52ac31c8-a0ad-4524-a131-9d5f93e99b53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6c3f358c-6b23-4172-87ca-9d2f2914657f" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_52ac31c8-a0ad-4524-a131-9d5f93e99b53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8d64db50-dce0-4faa-a962-650ef853a00f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6c3f358c-6b23-4172-87ca-9d2f2914657f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8d64db50-dce0-4faa-a962-650ef853a00f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_2d7f272f-97d9-487c-80bd-ab37d69c69d2" xlink:href="hr-20230930.xsd#hr_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6c3f358c-6b23-4172-87ca-9d2f2914657f" xlink:to="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_2d7f272f-97d9-487c-80bd-ab37d69c69d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_5888829b-88f4-49da-9a5a-9fd7b45c66e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6c3f358c-6b23-4172-87ca-9d2f2914657f" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_5888829b-88f4-49da-9a5a-9fd7b45c66e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_e883d1b4-e16e-4c7c-9239-d53c546e4392" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6c3f358c-6b23-4172-87ca-9d2f2914657f" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_e883d1b4-e16e-4c7c-9239-d53c546e4392" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_8aae0096-62e3-4908-8efd-785424c4f890" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6c3f358c-6b23-4172-87ca-9d2f2914657f" xlink:to="loc_us-gaap_Goodwill_8aae0096-62e3-4908-8efd-785424c4f890" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_6ddaad72-6d3e-4e09-8697-31645fe6348e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6c3f358c-6b23-4172-87ca-9d2f2914657f" xlink:to="loc_us-gaap_OtherAssets_6ddaad72-6d3e-4e09-8697-31645fe6348e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="hr-20230930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingExpensesandCostofGoodsSold_a8626b80-9679-48a6-8e3b-e267a7673847" xlink:href="hr-20230930.xsd#hr_OperatingExpensesandCostofGoodsSold"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment_21c91237-28a5-4a05-9d9a-e09523521ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_OperatingExpensesandCostofGoodsSold_a8626b80-9679-48a6-8e3b-e267a7673847" xlink:to="loc_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment_21c91237-28a5-4a05-9d9a-e09523521ed8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_c4659149-99db-4638-a531-dcbe1dce273e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_OperatingExpensesandCostofGoodsSold_a8626b80-9679-48a6-8e3b-e267a7673847" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_c4659149-99db-4638-a531-dcbe1dce273e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCosts_43654f2a-135d-4da5-9c2e-e3f08b4a81f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquisitionCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_OperatingExpensesandCostofGoodsSold_a8626b80-9679-48a6-8e3b-e267a7673847" xlink:to="loc_us-gaap_AcquisitionCosts_43654f2a-135d-4da5-9c2e-e3f08b4a81f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MergerRelatedCosts_07e6358f-c432-470b-9e49-cecfd35e800c" xlink:href="hr-20230930.xsd#hr_MergerRelatedCosts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_OperatingExpensesandCostofGoodsSold_a8626b80-9679-48a6-8e3b-e267a7673847" xlink:to="loc_hr_MergerRelatedCosts_07e6358f-c432-470b-9e49-cecfd35e800c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_ec63e9ae-733f-4ae9-9e4b-3ae595adae87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_OperatingExpensesandCostofGoodsSold_a8626b80-9679-48a6-8e3b-e267a7673847" xlink:to="loc_us-gaap_DepreciationAndAmortization_ec63e9ae-733f-4ae9-9e4b-3ae595adae87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_147c9f2a-f657-490c-8d85-e04f452d9ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_b9e1f89f-f12d-4e9a-899d-42fbda709048" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_147c9f2a-f657-490c-8d85-e04f452d9ca0" xlink:to="loc_us-gaap_ProfitLoss_b9e1f89f-f12d-4e9a-899d-42fbda709048" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_cd8dc52e-dab1-4171-a051-3595d17ba7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_147c9f2a-f657-490c-8d85-e04f452d9ca0" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_cd8dc52e-dab1-4171-a051-3595d17ba7a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_e4c00a99-c616-412e-89b5-25f17ab8771a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_96840694-98fe-4f05-b140-55a74125ad71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_e4c00a99-c616-412e-89b5-25f17ab8771a" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_96840694-98fe-4f05-b140-55a74125ad71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss_89b302ed-2e46-4c00-bd03-7b9721620108" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_e4c00a99-c616-412e-89b5-25f17ab8771a" xlink:to="loc_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss_89b302ed-2e46-4c00-bd03-7b9721620108" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_be85038d-0ba3-4693-b308-73de3b40d875" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_e4c00a99-c616-412e-89b5-25f17ab8771a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_be85038d-0ba3-4693-b308-73de3b40d875" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_121d761d-f9ea-4b84-b7a5-a79fb1ff21be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_d05bdd43-07c7-4e4e-a54a-dc8289c52088" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_121d761d-f9ea-4b84-b7a5-a79fb1ff21be" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_d05bdd43-07c7-4e4e-a54a-dc8289c52088" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c969a4dd-3771-410d-a0da-895e4cede9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_121d761d-f9ea-4b84-b7a5-a79fb1ff21be" xlink:to="loc_us-gaap_Revenues_c969a4dd-3771-410d-a0da-895e4cede9e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingExpensesandCostofGoodsSold_8ce3ae16-401f-40d6-b142-4df0a3acad84" xlink:href="hr-20230930.xsd#hr_OperatingExpensesandCostofGoodsSold"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_121d761d-f9ea-4b84-b7a5-a79fb1ff21be" xlink:to="loc_hr_OperatingExpensesandCostofGoodsSold_8ce3ae16-401f-40d6-b142-4df0a3acad84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_86ae2412-e23d-4273-9c34-88ade87892a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_cbf3ba99-3799-4413-8cb9-749f5d5ecf91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_86ae2412-e23d-4273-9c34-88ade87892a1" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_cbf3ba99-3799-4413-8cb9-749f5d5ecf91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d44e9fac-16b0-4735-b667-0f548b53dd3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_86ae2412-e23d-4273-9c34-88ade87892a1" xlink:to="loc_us-gaap_InterestExpense_d44e9fac-16b0-4735-b667-0f548b53dd3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_885570d1-db3b-4335-9742-e397614bffc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_86ae2412-e23d-4273-9c34-88ade87892a1" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_885570d1-db3b-4335-9742-e397614bffc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentOfRealEstateAndCreditLossReserves_8fa61b7f-20ab-4525-acc7-400f6d71928e" xlink:href="hr-20230930.xsd#hr_ImpairmentOfRealEstateAndCreditLossReserves"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_86ae2412-e23d-4273-9c34-88ade87892a1" xlink:to="loc_hr_ImpairmentOfRealEstateAndCreditLossReserves_8fa61b7f-20ab-4525-acc7-400f6d71928e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_fe1bc2c9-8ee1-469e-80df-33987f2b2942" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_86ae2412-e23d-4273-9c34-88ade87892a1" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_fe1bc2c9-8ee1-469e-80df-33987f2b2942" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1d8f2301-346e-4253-8302-9c41539e0fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_86ae2412-e23d-4273-9c34-88ade87892a1" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_1d8f2301-346e-4253-8302-9c41539e0fc9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="hr-20230930.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4944cf95-fe70-4a89-a257-50e50c2d3df0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8f3efb87-cc90-45d1-ba4d-e58d93545220" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4944cf95-fe70-4a89-a257-50e50c2d3df0" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_8f3efb87-cc90-45d1-ba4d-e58d93545220" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_e63877e7-90f5-4176-b271-cfc9aa968a82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_4944cf95-fe70-4a89-a257-50e50c2d3df0" xlink:to="loc_us-gaap_ProfitLoss_e63877e7-90f5-4176-b271-cfc9aa968a82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_6314eb53-7816-484b-a701-ad75d4744147" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fa369ead-d7c8-4368-a92c-d12371033fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6314eb53-7816-484b-a701-ad75d4744147" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_fa369ead-d7c8-4368-a92c-d12371033fcd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_62f34fc9-1021-46d4-ab75-c16770c4f13d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_6314eb53-7816-484b-a701-ad75d4744147" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_62f34fc9-1021-46d4-ab75-c16770c4f13d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_715cebf7-a6cd-4a7f-b1ff-9daf6e066376" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_86410b7e-f6da-4fdf-83ea-da9c696e4d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_715cebf7-a6cd-4a7f-b1ff-9daf6e066376" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_86410b7e-f6da-4fdf-83ea-da9c696e4d2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_24f6e48c-37d3-412c-81e6-4a761be7c2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_715cebf7-a6cd-4a7f-b1ff-9daf6e066376" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_24f6e48c-37d3-412c-81e6-4a761be7c2d0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="hr-20230930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bf2e0885-1426-4870-a87f-5787acca64dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRealEstate_9a60a8ba-9890-4e77-be2d-b495d01eddc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireRealEstate"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bf2e0885-1426-4870-a87f-5787acca64dc" xlink:to="loc_us-gaap_PaymentsToAcquireRealEstate_9a60a8ba-9890-4e77-be2d-b495d01eddc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets_b7a9f5bf-8c64-4946-8bd5-ed61f3ca13a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bf2e0885-1426-4870-a87f-5787acca64dc" xlink:to="loc_us-gaap_PaymentsToDevelopRealEstateAssets_b7a9f5bf-8c64-4946-8bd5-ed61f3ca13a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_aedc179e-ec43-48a1-af9b-f9f9cd56e5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bf2e0885-1426-4870-a87f-5787acca64dc" xlink:to="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_aedc179e-ec43-48a1-af9b-f9f9cd56e5e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable_cd93b340-4ac7-4560-b57d-49ad0693f5f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bf2e0885-1426-4870-a87f-5787acca64dc" xlink:to="loc_us-gaap_PaymentsToAcquireNotesReceivable_cd93b340-4ac7-4560-b57d-49ad0693f5f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_dd67e5f3-4053-496c-ae18-a2599b8a28cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bf2e0885-1426-4870-a87f-5787acca64dc" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_dd67e5f3-4053-496c-ae18-a2599b8a28cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireFinanceReceivables_52847718-3328-4907-8ca5-3416aa676aaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireFinanceReceivables"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bf2e0885-1426-4870-a87f-5787acca64dc" xlink:to="loc_us-gaap_PaymentsToAcquireFinanceReceivables_52847718-3328-4907-8ca5-3416aa676aaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests_196fd658-bcd0-4d71-a547-9a227a1fefe6" xlink:href="hr-20230930.xsd#hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bf2e0885-1426-4870-a87f-5787acca64dc" xlink:to="loc_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests_196fd658-bcd0-4d71-a547-9a227a1fefe6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_db392dcb-4619-4f23-a92d-7e9679999373" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollectionOfFinanceReceivables"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bf2e0885-1426-4870-a87f-5787acca64dc" xlink:to="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_db392dcb-4619-4f23-a92d-7e9679999373" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_fa6344cb-aba7-4795-8347-430351d57223" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bf2e0885-1426-4870-a87f-5787acca64dc" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_fa6344cb-aba7-4795-8347-430351d57223" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CashAcquiredInMerger_a89c37f1-ee2f-467a-a663-bc7f5be67b70" xlink:href="hr-20230930.xsd#hr_CashAcquiredInMerger"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bf2e0885-1426-4870-a87f-5787acca64dc" xlink:to="loc_hr_CashAcquiredInMerger_a89c37f1-ee2f-467a-a663-bc7f5be67b70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_3f769280-a8ae-4982-959f-8a01b139dc40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_bf2e0885-1426-4870-a87f-5787acca64dc" xlink:to="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_3f769280-a8ae-4982-959f-8a01b139dc40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f45432d0-2ad8-4ba7-9ff7-d58ff99ff0d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_240c5cea-3643-405b-bffc-fac85743adf7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f45432d0-2ad8-4ba7-9ff7-d58ff99ff0d4" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_240c5cea-3643-405b-bffc-fac85743adf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_bf5008f8-89d5-4428-8c56-4a627ac875e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f45432d0-2ad8-4ba7-9ff7-d58ff99ff0d4" xlink:to="loc_us-gaap_RepaymentsOfDebt_bf5008f8-89d5-4428-8c56-4a627ac875e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarlyRepaymentOfSeniorDebt_1f1c4f73-4703-4230-9ef6-e387799994a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarlyRepaymentOfSeniorDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f45432d0-2ad8-4ba7-9ff7-d58ff99ff0d4" xlink:to="loc_us-gaap_EarlyRepaymentOfSeniorDebt_1f1c4f73-4703-4230-9ef6-e387799994a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_4439708c-f9d3-43ef-b36c-16fda5f5a812" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f45432d0-2ad8-4ba7-9ff7-d58ff99ff0d4" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_4439708c-f9d3-43ef-b36c-16fda5f5a812" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f5af7d8f-3338-43e4-a91c-650e2298b483" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f45432d0-2ad8-4ba7-9ff7-d58ff99ff0d4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_f5af7d8f-3338-43e4-a91c-650e2298b483" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_9210e22a-1bf6-4201-8e78-9dbe0245ad64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f45432d0-2ad8-4ba7-9ff7-d58ff99ff0d4" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_9210e22a-1bf6-4201-8e78-9dbe0245ad64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_5ad74079-52fe-423a-9976-61b7e02d3719" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f45432d0-2ad8-4ba7-9ff7-d58ff99ff0d4" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_5ad74079-52fe-423a-9976-61b7e02d3719" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_03fb2f05-3718-469c-8fa5-ba89d914d5aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f45432d0-2ad8-4ba7-9ff7-d58ff99ff0d4" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_03fb2f05-3718-469c-8fa5-ba89d914d5aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_9906e65f-ec6b-4116-b77c-4dd6aecd4173" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f45432d0-2ad8-4ba7-9ff7-d58ff99ff0d4" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_9906e65f-ec6b-4116-b77c-4dd6aecd4173" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_b4d68768-e0dc-4460-830a-0d1eaaf17280" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfMediumTermNotes"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f45432d0-2ad8-4ba7-9ff7-d58ff99ff0d4" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_b4d68768-e0dc-4460-830a-0d1eaaf17280" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes_1cb3fa77-5bc7-4837-93bd-617ff1233f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfMediumTermNotes"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f45432d0-2ad8-4ba7-9ff7-d58ff99ff0d4" xlink:to="loc_us-gaap_RepaymentsOfMediumTermNotes_1cb3fa77-5bc7-4837-93bd-617ff1233f0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PaymentOfSpecialDividendMergerRelated_ef8ee4a3-0c1f-4a2b-8a7f-48f79a2c20b3" xlink:href="hr-20230930.xsd#hr_PaymentOfSpecialDividendMergerRelated"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f45432d0-2ad8-4ba7-9ff7-d58ff99ff0d4" xlink:to="loc_hr_PaymentOfSpecialDividendMergerRelated_ef8ee4a3-0c1f-4a2b-8a7f-48f79a2c20b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_768347ba-72a7-47e6-bb19-23da6e2e41b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_fb8d93bd-0959-47f1-afa9-4057fc8da8da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_768347ba-72a7-47e6-bb19-23da6e2e41b4" xlink:to="loc_us-gaap_ProfitLoss_fb8d93bd-0959-47f1-afa9-4057fc8da8da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_dc39d4cd-dae7-46a6-afa2-f80ad253bbdc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_768347ba-72a7-47e6-bb19-23da6e2e41b4" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_dc39d4cd-dae7-46a6-afa2-f80ad253bbdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_e681b5e7-657a-4d61-b22f-06783cf70ece" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_768347ba-72a7-47e6-bb19-23da6e2e41b4" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_e681b5e7-657a-4d61-b22f-06783cf70ece" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_04c14d74-0135-44d8-928c-74875f980293" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_768347ba-72a7-47e6-bb19-23da6e2e41b4" xlink:to="loc_us-gaap_ShareBasedCompensation_04c14d74-0135-44d8-928c-74875f980293" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StraightLineRentReceivable_254cbeb4-dd35-4f91-9de9-e2dc005387e3" xlink:href="hr-20230930.xsd#hr_StraightLineRentReceivable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_768347ba-72a7-47e6-bb19-23da6e2e41b4" xlink:to="loc_hr_StraightLineRentReceivable_254cbeb4-dd35-4f91-9de9-e2dc005387e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StraightlineRentLiability_64a0b9d5-cfe9-4ee2-a22c-d7a04daaf81c" xlink:href="hr-20230930.xsd#hr_StraightlineRentLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_768347ba-72a7-47e6-bb19-23da6e2e41b4" xlink:to="loc_hr_StraightlineRentLiability_64a0b9d5-cfe9-4ee2-a22c-d7a04daaf81c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation_2405d747-84bd-408d-abe0-6d1ab98d27b1" xlink:href="hr-20230930.xsd#hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_768347ba-72a7-47e6-bb19-23da6e2e41b4" xlink:to="loc_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation_2405d747-84bd-408d-abe0-6d1ab98d27b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_cd460002-8828-4eba-a0a3-b651f2d899e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_768347ba-72a7-47e6-bb19-23da6e2e41b4" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_cd460002-8828-4eba-a0a3-b651f2d899e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_13af9e3b-a9f3-439f-99df-0946d172202f" xlink:href="hr-20230930.xsd#hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_768347ba-72a7-47e6-bb19-23da6e2e41b4" xlink:to="loc_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_13af9e3b-a9f3-439f-99df-0946d172202f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_592a3439-b511-4fd5-b300-bea3daa6fb6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_768347ba-72a7-47e6-bb19-23da6e2e41b4" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_592a3439-b511-4fd5-b300-bea3daa6fb6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_3b8b65f5-4196-4a7d-b73e-e3c1082805ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_768347ba-72a7-47e6-bb19-23da6e2e41b4" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_3b8b65f5-4196-4a7d-b73e-e3c1082805ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestIncomeFinancingReceivableNoncash_9a18639e-09ae-46f8-8322-ad139e672187" xlink:href="hr-20230930.xsd#hr_InterestIncomeFinancingReceivableNoncash"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_768347ba-72a7-47e6-bb19-23da6e2e41b4" xlink:to="loc_hr_InterestIncomeFinancingReceivableNoncash_9a18639e-09ae-46f8-8322-ad139e672187" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_b9656033-6f99-4c1e-9ea3-768f97080b63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_768347ba-72a7-47e6-bb19-23da6e2e41b4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_b9656033-6f99-4c1e-9ea3-768f97080b63" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_54a542e8-ff76-4e69-af34-5fe0172215f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_768347ba-72a7-47e6-bb19-23da6e2e41b4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_54a542e8-ff76-4e69-af34-5fe0172215f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_1dba2990-a284-445d-8c8a-508957381e81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_768347ba-72a7-47e6-bb19-23da6e2e41b4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_1dba2990-a284-445d-8c8a-508957381e81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c004f4f3-baf1-4f8f-8631-cda8e9d40a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95b83d64-66ba-4ecb-92d5-c37c74ba254f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c004f4f3-baf1-4f8f-8631-cda8e9d40a6e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_95b83d64-66ba-4ecb-92d5-c37c74ba254f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fe82a1b7-195a-4511-a6cc-3d01f851e123" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c004f4f3-baf1-4f8f-8631-cda8e9d40a6e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_fe82a1b7-195a-4511-a6cc-3d01f851e123" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_828c65b3-370c-4444-a0aa-a5efc2470f87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c004f4f3-baf1-4f8f-8631-cda8e9d40a6e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_828c65b3-370c-4444-a0aa-a5efc2470f87" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f0af3138-7d3d-4efb-b9ba-d6fd5557b11a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_ff412792-9297-464e-ae5b-679cc9a9ae2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f0af3138-7d3d-4efb-b9ba-d6fd5557b11a" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_ff412792-9297-464e-ae5b-679cc9a9ae2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d01a6151-f3c4-40fc-999a-965618315b78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f0af3138-7d3d-4efb-b9ba-d6fd5557b11a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d01a6151-f3c4-40fc-999a-965618315b78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReceivablesAndOtherAssets_66c579d2-c145-4f86-962c-995b8937b84c" xlink:href="hr-20230930.xsd#hr_ReceivablesAndOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f0af3138-7d3d-4efb-b9ba-d6fd5557b11a" xlink:to="loc_hr_ReceivablesAndOtherAssets_66c579d2-c145-4f86-962c-995b8937b84c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_d9bac3bf-7f45-465b-a0f0-3298143366bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities_a087a57c-e1d2-435b-93ba-d78f1b527f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d9bac3bf-7f45-465b-a0f0-3298143366bc" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities_a087a57c-e1d2-435b-93ba-d78f1b527f8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6e32fb78-59a5-4051-81dc-075324ceea37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_d9bac3bf-7f45-465b-a0f0-3298143366bc" xlink:to="loc_us-gaap_StockholdersEquity_6e32fb78-59a5-4051-81dc-075324ceea37" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_18a5d0eb-0668-4b14-bb81-baf9c4d2e53c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_492f00ed-c984-4b4d-9f08-9e08a9e3e4aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_18a5d0eb-0668-4b14-bb81-baf9c4d2e53c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_492f00ed-c984-4b4d-9f08-9e08a9e3e4aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_d125c387-36f9-43ce-9061-1be5f4867c71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_18a5d0eb-0668-4b14-bb81-baf9c4d2e53c" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_d125c387-36f9-43ce-9061-1be5f4867c71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_08c531ce-9462-4b09-b789-56ada6fda8f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale_bd0c56e5-1bc2-4978-b978-05146a889616" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_08c531ce-9462-4b09-b789-56ada6fda8f9" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale_bd0c56e5-1bc2-4978-b978-05146a889616" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_27b5589c-cf4c-4e96-bed6-99e3ffbf7155" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_08c531ce-9462-4b09-b789-56ada6fda8f9" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_27b5589c-cf4c-4e96-bed6-99e3ffbf7155" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets_e364a60a-1bab-401c-9fed-07ed54e739ea" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_08c531ce-9462-4b09-b789-56ada6fda8f9" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets_e364a60a-1bab-401c-9fed-07ed54e739ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_33be73d8-6c03-4902-a94d-c1e41345168e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_08c531ce-9462-4b09-b789-56ada6fda8f9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_33be73d8-6c03-4902-a94d-c1e41345168e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_b4f5b871-d620-4dec-a40f-b9e2c13da0f1" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_08c531ce-9462-4b09-b789-56ada6fda8f9" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_b4f5b871-d620-4dec-a40f-b9e2c13da0f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures_21c91daf-3b73-41ef-ba1a-294cc5270dd1" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_08c531ce-9462-4b09-b789-56ada6fda8f9" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures_21c91daf-3b73-41ef-ba1a-294cc5270dd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_ec00b379-1af5-4bcd-a508-47272f0b6e2d" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_08c531ce-9462-4b09-b789-56ada6fda8f9" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_ec00b379-1af5-4bcd-a508-47272f0b6e2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_fe48dec0-8206-4f00-8b36-bedbf775de38" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_2f4f35a0-c706-4cba-8c64-0cb094afe746" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_fe48dec0-8206-4f00-8b36-bedbf775de38" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_2f4f35a0-c706-4cba-8c64-0cb094afe746" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_ac2c287f-2157-4ace-8688-95953df7a55d" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_fe48dec0-8206-4f00-8b36-bedbf775de38" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_ac2c287f-2157-4ace-8688-95953df7a55d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_7ab6bebf-8a8f-44db-aff5-fa51adee4a2c" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_1bf9df3d-3b1c-4d91-82b0-ea9287b209ea" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_7ab6bebf-8a8f-44db-aff5-fa51adee4a2c" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_1bf9df3d-3b1c-4d91-82b0-ea9287b209ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet_708f523b-17ee-4030-96e8-87a3cf2feed7" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_7ab6bebf-8a8f-44db-aff5-fa51adee4a2c" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet_708f523b-17ee-4030-96e8-87a3cf2feed7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_ea934709-1063-4d7e-a394-87f82757a710" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_7ab6bebf-8a8f-44db-aff5-fa51adee4a2c" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_ea934709-1063-4d7e-a394-87f82757a710" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash_1cc50106-9760-45fd-b4a9-9be8f138a097" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_7ab6bebf-8a8f-44db-aff5-fa51adee4a2c" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash_1cc50106-9760-45fd-b4a9-9be8f138a097" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_0b8b75f5-c50e-411c-a5ce-bc5dfb7ced4a" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_7ab6bebf-8a8f-44db-aff5-fa51adee4a2c" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_0b8b75f5-c50e-411c-a5ce-bc5dfb7ced4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet_4a6652bb-6dd2-4bfa-a46d-62f94af0d0b0" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_7ab6bebf-8a8f-44db-aff5-fa51adee4a2c" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet_4a6652bb-6dd2-4bfa-a46d-62f94af0d0b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_20f301b2-3f94-442f-9268-e5ce97d07706" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities_e49049c5-aecc-4c04-9cda-6da487ffdd2e" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_20f301b2-3f94-442f-9268-e5ce97d07706" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities_e49049c5-aecc-4c04-9cda-6da487ffdd2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities_7db3d0e9-4365-40ba-b0a1-e8f0cbb1ed03" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_20f301b2-3f94-442f-9268-e5ce97d07706" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities_7db3d0e9-4365-40ba-b0a1-e8f0cbb1ed03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities_2deeb5fe-3a7e-4a4c-929c-dbd14050d6b1" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_20f301b2-3f94-442f-9268-e5ce97d07706" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities_2deeb5fe-3a7e-4a4c-929c-dbd14050d6b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_1b5a7b6e-e062-4f82-bb1c-8d95f78a2690" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_20f301b2-3f94-442f-9268-e5ce97d07706" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_1b5a7b6e-e062-4f82-bb1c-8d95f78a2690" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale_0cb58d58-4336-4832-96a2-a904a34f6118" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_20f301b2-3f94-442f-9268-e5ce97d07706" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale_0cb58d58-4336-4832-96a2-a904a34f6118" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ea3898df-e8d2-41a6-8f6f-47ee988d9724" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_7d46095a-daf6-4745-9687-1fd61dbbb74b" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ea3898df-e8d2-41a6-8f6f-47ee988d9724" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_7d46095a-daf6-4745-9687-1fd61dbbb74b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_51eadc1d-d8f2-44f6-b5d3-bbc321848a33" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ea3898df-e8d2-41a6-8f6f-47ee988d9724" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_51eadc1d-d8f2-44f6-b5d3-bbc321848a33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale_c9bdffac-0b33-48b4-8974-b8b762739283" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ea3898df-e8d2-41a6-8f6f-47ee988d9724" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale_c9bdffac-0b33-48b4-8974-b8b762739283" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities_18f00827-4ab0-4dc7-aba7-74150b92276a" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ea3898df-e8d2-41a6-8f6f-47ee988d9724" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities_18f00827-4ab0-4dc7-aba7-74150b92276a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_09bd8d24-da7b-4f26-81f3-d4dc389ac484" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ea3898df-e8d2-41a6-8f6f-47ee988d9724" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_09bd8d24-da7b-4f26-81f3-d4dc389ac484" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities_8e043d28-323b-43d9-b747-d397185240ee" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_ea3898df-e8d2-41a6-8f6f-47ee988d9724" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities_8e043d28-323b-43d9-b747-d397185240ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_609d85d9-3ba3-41a9-bdd7-5f38bb9f59dd" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_93b727be-cfca-4d37-a8bb-7662db127fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_609d85d9-3ba3-41a9-bdd7-5f38bb9f59dd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_93b727be-cfca-4d37-a8bb-7662db127fe3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_ccca5447-cea4-42b1-9c94-3712fc637cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_609d85d9-3ba3-41a9-bdd7-5f38bb9f59dd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_ccca5447-cea4-42b1-9c94-3712fc637cf2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment_ac53e76b-39c5-4c7e-a059-2e4e6027ee67" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_609d85d9-3ba3-41a9-bdd7-5f38bb9f59dd" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment_ac53e76b-39c5-4c7e-a059-2e4e6027ee67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress_0a83d9b6-b34d-42eb-a2a8-0c8bf3a671a0" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_609d85d9-3ba3-41a9-bdd7-5f38bb9f59dd" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress_0a83d9b6-b34d-42eb-a2a8-0c8bf3a671a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_b7385a19-7fd4-44ff-9b49-7bcbdd751249" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_609d85d9-3ba3-41a9-bdd7-5f38bb9f59dd" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_b7385a19-7fd4-44ff-9b49-7bcbdd751249" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets_35489790-f8fe-4d1d-a03d-3c7c107fea46" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_609d85d9-3ba3-41a9-bdd7-5f38bb9f59dd" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets_35489790-f8fe-4d1d-a03d-3c7c107fea46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_4ab789db-bd00-46b9-bb80-54064246f1e5" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand_e44b6c9c-0f73-4bb5-b20c-c30794f51fa0" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_4ab789db-bd00-46b9-bb80-54064246f1e5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand_e44b6c9c-0f73-4bb5-b20c-c30794f51fa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements_221d38c4-70e4-4cba-8fd8-f4c1fac4864b" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_4ab789db-bd00-46b9-bb80-54064246f1e5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements_221d38c4-70e4-4cba-8fd8-f4c1fac4864b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets_b4d8aea8-7b4a-4e5e-8172-c2673722c4b4" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_4ab789db-bd00-46b9-bb80-54064246f1e5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets_b4d8aea8-7b4a-4e5e-8172-c2673722c4b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets_4fb84b65-2be2-40be-a7b9-7233fb0f5bd6" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_4ab789db-bd00-46b9-bb80-54064246f1e5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets_4fb84b65-2be2-40be-a7b9-7233fb0f5bd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress_3c63df30-43a8-4940-acfa-a2e431ae5e1a" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_4ab789db-bd00-46b9-bb80-54064246f1e5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress_3c63df30-43a8-4940-acfa-a2e431ae5e1a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#RealEstateInvestmentsAssetsHeldforSaleDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_13feefec-85ac-4214-9f4b-b83c1683a968" xlink:href="hr-20230930.xsd#hr_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_02ed1fcd-124c-44a6-bc30-7a757eb04630" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_13feefec-85ac-4214-9f4b-b83c1683a968" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_02ed1fcd-124c-44a6-bc30-7a757eb04630" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_39ab5afc-4fbd-494b-b6c7-d2010b418b22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_13feefec-85ac-4214-9f4b-b83c1683a968" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_39ab5afc-4fbd-494b-b6c7-d2010b418b22" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_9a682a46-5d51-4a1b-8328-bb4daf68635e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_13feefec-85ac-4214-9f4b-b83c1683a968" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_9a682a46-5d51-4a1b-8328-bb4daf68635e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_355f5ebc-d7dd-4d7d-8bca-f01559159384" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_4d9dff3c-91d4-4024-ad3a-a8f5fe152073" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_355f5ebc-d7dd-4d7d-8bca-f01559159384" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_4d9dff3c-91d4-4024-ad3a-a8f5fe152073" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_022f2588-f87b-4d0a-821a-05016f1201dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_355f5ebc-d7dd-4d7d-8bca-f01559159384" xlink:to="loc_us-gaap_OperatingLeaseLiability_022f2588-f87b-4d0a-821a-05016f1201dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_dc299c93-eaa9-40cd-ba7b-1672e73b5f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_355f5ebc-d7dd-4d7d-8bca-f01559159384" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_dc299c93-eaa9-40cd-ba7b-1672e73b5f2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost_b5cc2541-4c1f-41f4-bdbf-6bd218733e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_4d8157cf-678c-49db-9f14-f2abfeef86c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Land"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_b5cc2541-4c1f-41f4-bdbf-6bd218733e0c" xlink:to="loc_us-gaap_Land_4d8157cf-678c-49db-9f14-f2abfeef86c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_ad0d8357-b17f-4e0f-9e88-74470ea23f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_b5cc2541-4c1f-41f4-bdbf-6bd218733e0c" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_ad0d8357-b17f-4e0f-9e88-74470ea23f5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LeaseIntangibles_b61c176b-c3dd-4f8f-87c9-12f5f35e09dd" xlink:href="hr-20230930.xsd#hr_LeaseIntangibles"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost_b5cc2541-4c1f-41f4-bdbf-6bd218733e0c" xlink:to="loc_hr_LeaseIntangibles_b61c176b-c3dd-4f8f-87c9-12f5f35e09dd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesLessorAccountingDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#LeasesLessorAccountingDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/LeasesLessorAccountingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_42299769-c774-45e6-96a6-9875b55103d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_6d23b0ff-a83d-4358-a1d6-97a508c480b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_42299769-c774-45e6-96a6-9875b55103d4" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_6d23b0ff-a83d-4358-a1d6-97a508c480b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_856ca6ad-e15f-48c3-b0e9-df0048b86664" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_42299769-c774-45e6-96a6-9875b55103d4" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_856ca6ad-e15f-48c3-b0e9-df0048b86664" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_f4e57fd2-b4ed-412d-acb7-1f62d1a7b448" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_42299769-c774-45e6-96a6-9875b55103d4" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_f4e57fd2-b4ed-412d-acb7-1f62d1a7b448" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_6691eaac-396d-41ea-b779-2f87b18dee70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_42299769-c774-45e6-96a6-9875b55103d4" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_6691eaac-396d-41ea-b779-2f87b18dee70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_e35d1b6c-59a8-4a46-985b-518c1d5d5218" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_42299769-c774-45e6-96a6-9875b55103d4" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_e35d1b6c-59a8-4a46-985b-518c1d5d5218" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_d4740d91-b671-437d-ba26-0a94c85b9b85" xlink:href="hr-20230930.xsd#hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_42299769-c774-45e6-96a6-9875b55103d4" xlink:to="loc_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_d4740d91-b671-437d-ba26-0a94c85b9b85" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#LeasesFutureMinimumLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9d354906-3124-4679-afe5-63c159615702" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_a112d030-3590-495a-bcf0-d821882483a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9d354906-3124-4679-afe5-63c159615702" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_a112d030-3590-495a-bcf0-d821882483a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_74caf298-cea0-417b-80e9-48c5600465b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9d354906-3124-4679-afe5-63c159615702" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_74caf298-cea0-417b-80e9-48c5600465b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_eb6ee4e0-d667-49a9-85d6-b60df9fa11ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9d354906-3124-4679-afe5-63c159615702" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_eb6ee4e0-d667-49a9-85d6-b60df9fa11ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_31f0143e-b7d3-43c7-b534-47c3ef3f83a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9d354906-3124-4679-afe5-63c159615702" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_31f0143e-b7d3-43c7-b534-47c3ef3f83a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_e8610262-ff65-4358-888f-7e1dea6a5aea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9d354906-3124-4679-afe5-63c159615702" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_e8610262-ff65-4358-888f-7e1dea6a5aea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_0e9fd3b1-344b-45b6-b159-ac84e67bda13" xlink:href="hr-20230930.xsd#hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9d354906-3124-4679-afe5-63c159615702" xlink:to="loc_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_0e9fd3b1-344b-45b6-b159-ac84e67bda13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6de6e0b1-7d24-4a42-8681-5cb7e0ce15f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_98cab9bc-ae9b-405d-994d-d51c6f3d09e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6de6e0b1-7d24-4a42-8681-5cb7e0ce15f0" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_98cab9bc-ae9b-405d-994d-d51c6f3d09e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_da3023d8-c55a-467c-a608-bbe4ddec4722" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_6de6e0b1-7d24-4a42-8681-5cb7e0ce15f0" xlink:to="loc_us-gaap_FinanceLeaseLiability_da3023d8-c55a-467c-a608-bbe4ddec4722" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="hr-20230930.xsd#LeasesFutureMinimumLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9600b9ce-49d3-475c-8ecf-dfc51da7afca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e2d59b59-b684-4e2f-81f0-ed4f25b931cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9600b9ce-49d3-475c-8ecf-dfc51da7afca" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e2d59b59-b684-4e2f-81f0-ed4f25b931cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_0f28a940-cbc5-4f01-a909-22d3e9f69490" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9600b9ce-49d3-475c-8ecf-dfc51da7afca" xlink:to="loc_us-gaap_OperatingLeaseLiability_0f28a940-cbc5-4f01-a909-22d3e9f69490" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1278bba9-d551-4c87-ba5e-13361c52a38c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_c1edf697-e141-4831-b58f-2088b55332a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1278bba9-d551-4c87-ba5e-13361c52a38c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_c1edf697-e141-4831-b58f-2088b55332a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_44bd0734-61de-4a76-9c6f-1e12389d313d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1278bba9-d551-4c87-ba5e-13361c52a38c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_44bd0734-61de-4a76-9c6f-1e12389d313d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_257cde16-c6f2-420d-9f23-e388a6dc2d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1278bba9-d551-4c87-ba5e-13361c52a38c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_257cde16-c6f2-420d-9f23-e388a6dc2d5c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_77cd41df-b382-4979-8342-426657595682" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1278bba9-d551-4c87-ba5e-13361c52a38c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_77cd41df-b382-4979-8342-426657595682" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_1d94ed09-0d2b-418b-836e-f1fff21d2eac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1278bba9-d551-4c87-ba5e-13361c52a38c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_1d94ed09-0d2b-418b-836e-f1fff21d2eac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_9c9fb41c-a63e-4e23-9eb2-08d1f5d02b2d" xlink:href="hr-20230930.xsd#hr_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_1278bba9-d551-4c87-ba5e-13361c52a38c" xlink:to="loc_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_9c9fb41c-a63e-4e23-9eb2-08d1f5d02b2d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#LeasesLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_6f572a40-1c34-439e-bca0-3f5a0429ccaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_459c27f1-6294-4d89-948b-b4c1aff52c27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_6f572a40-1c34-439e-bca0-3f5a0429ccaa" xlink:to="loc_us-gaap_OperatingLeaseCost_459c27f1-6294-4d89-948b-b4c1aff52c27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_1db10867-aa34-4cd6-92c6-7a2f64680f98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_6f572a40-1c34-439e-bca0-3f5a0429ccaa" xlink:to="loc_us-gaap_VariableLeaseCost_1db10867-aa34-4cd6-92c6-7a2f64680f98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_00ab0868-d27a-421b-a392-f6f95bc49acb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_6f572a40-1c34-439e-bca0-3f5a0429ccaa" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_00ab0868-d27a-421b-a392-f6f95bc49acb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_81449a91-cdbf-4323-a213-ec279de92342" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_6f572a40-1c34-439e-bca0-3f5a0429ccaa" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_81449a91-cdbf-4323-a213-ec279de92342" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_c420d3a9-5fe1-4fa4-8d8f-3dba3c0a44e7" xlink:href="hr-20230930.xsd#hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f17286ac-b901-4cb1-ab8a-6321db714825" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_c420d3a9-5fe1-4fa4-8d8f-3dba3c0a44e7" xlink:to="loc_us-gaap_ProfitLoss_f17286ac-b901-4cb1-ab8a-6321db714825" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_fad4cbee-0da8-4b72-a4cb-d3231e92b20d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_c420d3a9-5fe1-4fa4-8d8f-3dba3c0a44e7" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_fad4cbee-0da8-4b72-a4cb-d3231e92b20d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_99033ad6-04f2-4e67-be85-0abe429c8c51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_c420d3a9-5fe1-4fa4-8d8f-3dba3c0a44e7" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_99033ad6-04f2-4e67-be85-0abe429c8c51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_cf19681d-25fd-4a44-a82b-daa2ae971808" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_c420d3a9-5fe1-4fa4-8d8f-3dba3c0a44e7" xlink:to="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_cf19681d-25fd-4a44-a82b-daa2ae971808" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_50c1a34a-410e-4a4a-8720-a4a8e2b911e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_92b78064-cce4-4cfc-9ad4-daa529f32394" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_50c1a34a-410e-4a4a-8720-a4a8e2b911e3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_92b78064-cce4-4cfc-9ad4-daa529f32394" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_cf0c8656-50e4-4d81-84a3-b83f27511f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_50c1a34a-410e-4a4a-8720-a4a8e2b911e3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_cf0c8656-50e4-4d81-84a3-b83f27511f0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_112ee858-5791-4253-bab7-c049d88b2310" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b9f257f5-e786-4c95-b91e-57678ffb6598" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_112ee858-5791-4253-bab7-c049d88b2310" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_b9f257f5-e786-4c95-b91e-57678ffb6598" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements_7affb07b-a9f7-4d04-82ee-b61947f2349e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_112ee858-5791-4253-bab7-c049d88b2310" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements_7affb07b-a9f7-4d04-82ee-b61947f2349e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits_f5c02819-0ace-4768-aab9-85139da08334" xlink:href="hr-20230930.xsd#hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_112ee858-5791-4253-bab7-c049d88b2310" xlink:to="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits_f5c02819-0ace-4768-aab9-85139da08334" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan_a3988099-5ef7-4fd6-bb71-f1a91575d729" xlink:href="hr-20230930.xsd#hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_112ee858-5791-4253-bab7-c049d88b2310" xlink:to="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan_a3988099-5ef7-4fd6-bb71-f1a91575d729" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"/>
  <link:calculationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3b734655-088b-4c88-985a-6385a7a9f9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_73992f97-a78b-4b55-b9a1-525da89652e1" xlink:href="hr-20230930.xsd#hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3b734655-088b-4c88-985a-6385a7a9f9e1" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_73992f97-a78b-4b55-b9a1-525da89652e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour_31f04758-a6c8-46b4-b867-9b37ce3d4101" xlink:href="hr-20230930.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3b734655-088b-4c88-985a-6385a7a9f9e1" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour_31f04758-a6c8-46b4-b867-9b37ce3d4101" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_50964a6f-1cf9-4051-9a75-d9c7ba473fec" xlink:href="hr-20230930.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3b734655-088b-4c88-985a-6385a7a9f9e1" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_50964a6f-1cf9-4051-9a75-d9c7ba473fec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_87b816ed-4e5d-4b2c-951b-e12ea4654f57" xlink:href="hr-20230930.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3b734655-088b-4c88-985a-6385a7a9f9e1" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_87b816ed-4e5d-4b2c-951b-e12ea4654f57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_d6c6fa94-d876-406b-8701-7b1796391914" xlink:href="hr-20230930.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3b734655-088b-4c88-985a-6385a7a9f9e1" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_d6c6fa94-d876-406b-8701-7b1796391914" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_f91bfa4c-369a-45f5-9e08-8af19c82d1ab" xlink:href="hr-20230930.xsd#hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3b734655-088b-4c88-985a-6385a7a9f9e1" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_f91bfa4c-369a-45f5-9e08-8af19c82d1ab" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>hr-20230930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:73dbfdf1-2054-4a25-8023-7c5130a0cc11,g:80064ddd-1403-40d2-9d20-e881ce80ef55-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="hr-20230930.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3c85da37-dcf5-43d3-9edc-0f27f804760c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3d88c5b1-aebb-4e3d-8fbf-72b1b5c1b4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c85da37-dcf5-43d3-9edc-0f27f804760c" xlink:to="loc_us-gaap_ProfitLoss_3d88c5b1-aebb-4e3d-8fbf-72b1b5c1b4f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_61153cd0-60db-4b78-8f90-a8cd1f04a214" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c85da37-dcf5-43d3-9edc-0f27f804760c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_61153cd0-60db-4b78-8f90-a8cd1f04a214" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_e47a8753-aeff-4166-a6c2-b26a5855613f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_61153cd0-60db-4b78-8f90-a8cd1f04a214" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_e47a8753-aeff-4166-a6c2-b26a5855613f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b70f4b03-0434-43b4-ac2a-a72cabc8768d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_e47a8753-aeff-4166-a6c2-b26a5855613f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b70f4b03-0434-43b4-ac2a-a72cabc8768d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_1a1584ac-c5b1-4ded-8799-c312571b7538" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_e47a8753-aeff-4166-a6c2-b26a5855613f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_1a1584ac-c5b1-4ded-8799-c312571b7538" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_651e749f-d1b5-4972-bbe3-a2933372dd5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_61153cd0-60db-4b78-8f90-a8cd1f04a214" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_651e749f-d1b5-4972-bbe3-a2933372dd5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_30ecdcf8-a34c-4315-8664-fa29c0a222d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c85da37-dcf5-43d3-9edc-0f27f804760c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_30ecdcf8-a34c-4315-8664-fa29c0a222d4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d31a528d-2088-46a4-995d-45e9b1011262" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c85da37-dcf5-43d3-9edc-0f27f804760c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d31a528d-2088-46a4-995d-45e9b1011262" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0511f859-0db0-4e27-9ff2-679933e761d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3c85da37-dcf5-43d3-9edc-0f27f804760c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_0511f859-0db0-4e27-9ff2-679933e761d6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3640c62a-ae21-4df7-ad43-3272f5d777a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3c85da37-dcf5-43d3-9edc-0f27f804760c" xlink:to="loc_us-gaap_StatementTable_3640c62a-ae21-4df7-ad43-3272f5d777a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_cdf6b758-af0b-4da7-a7ef-a814902bfa47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_3640c62a-ae21-4df7-ad43-3272f5d777a1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_cdf6b758-af0b-4da7-a7ef-a814902bfa47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cdf6b758-af0b-4da7-a7ef-a814902bfa47_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cdf6b758-af0b-4da7-a7ef-a814902bfa47" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cdf6b758-af0b-4da7-a7ef-a814902bfa47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3c21451b-095a-4c5b-883c-2f453a39c4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cdf6b758-af0b-4da7-a7ef-a814902bfa47" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3c21451b-095a-4c5b-883c-2f453a39c4d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_637a1411-5d31-4908-ab03-6023fa4ff536" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3c21451b-095a-4c5b-883c-2f453a39c4d2" xlink:to="loc_us-gaap_InterestRateSwapMember_637a1411-5d31-4908-ab03-6023fa4ff536" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests" xlink:type="simple" xlink:href="hr-20230930.xsd#CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5f4de548-c452-4dbb-94bc-07a1032aac4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5f4de548-c452-4dbb-94bc-07a1032aac4a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_73f662fa-ff3c-476a-b573-46315d998f60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_73f662fa-ff3c-476a-b573-46315d998f60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_bea54fad-a452-41a5-8134-4a9a9b981170" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_bea54fad-a452-41a5-8134-4a9a9b981170" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MergerConsiderationTransferred_803adc0c-1cd8-48d2-8ed5-0cd72d4c87e9" xlink:href="hr-20230930.xsd#hr_MergerConsiderationTransferred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_hr_MergerConsiderationTransferred_803adc0c-1cd8-48d2-8ed5-0cd72d4c87e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_2da0c6cb-6ee7-4f96-8e2e-b0183b458c60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_2da0c6cb-6ee7-4f96-8e2e-b0183b458c60" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_5ecb2148-a776-48c6-b383-f95fb5467499" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_5ecb2148-a776-48c6-b383-f95fb5467499" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cf06672d-0eed-47ba-be0a-3142d2d726fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cf06672d-0eed-47ba-be0a-3142d2d726fe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_187de80d-e5f7-482f-969b-6e02efaaba39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_187de80d-e5f7-482f-969b-6e02efaaba39" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_698a03cc-4ffb-4dca-968e-ec26a3076fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_ProfitLoss_698a03cc-4ffb-4dca-968e-ec26a3076fc9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_cc6acdd1-6471-4ff7-ae88-cf219d9b0aff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_cc6acdd1-6471-4ff7-ae88-cf219d9b0aff" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b9205324-99e7-4524-a5a3-de64180efbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b9205324-99e7-4524-a5a3-de64180efbf9" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_8f7e750d-51fa-4592-a80f-034df4446b23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_DividendsCommonStockCash_8f7e750d-51fa-4592-a80f-034df4446b23" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70e94fa3-527d-4817-a9f9-916afb9270d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_aa0b2aa7-fe99-49a1-a8e0-7122f3432199" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_5f4de548-c452-4dbb-94bc-07a1032aac4a" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_aa0b2aa7-fe99-49a1-a8e0-7122f3432199" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6d5f26b8-39de-4745-a933-e76da6b348bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_aa0b2aa7-fe99-49a1-a8e0-7122f3432199" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6d5f26b8-39de-4745-a933-e76da6b348bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_fd02e9eb-c4b6-44f5-b67a-b557b08feae8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_aa0b2aa7-fe99-49a1-a8e0-7122f3432199" xlink:to="loc_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_fd02e9eb-c4b6-44f5-b67a-b557b08feae8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_8ebb781c-92ed-4d64-9c50-91ae9241d97a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_aa0b2aa7-fe99-49a1-a8e0-7122f3432199" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_8ebb781c-92ed-4d64-9c50-91ae9241d97a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_93a5ce15-d76b-4288-aa90-f59f8c2c98e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7a009f35-2df7-4c7b-9b52-165df7160f05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_5f4de548-c452-4dbb-94bc-07a1032aac4a" xlink:to="loc_us-gaap_StatementTable_7a009f35-2df7-4c7b-9b52-165df7160f05" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5bf8be55-86f8-448c-bd65-6801bb43e8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7a009f35-2df7-4c7b-9b52-165df7160f05" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5bf8be55-86f8-448c-bd65-6801bb43e8e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5bf8be55-86f8-448c-bd65-6801bb43e8e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5bf8be55-86f8-448c-bd65-6801bb43e8e6" xlink:to="loc_us-gaap_EquityComponentDomain_5bf8be55-86f8-448c-bd65-6801bb43e8e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d97c93d0-1c49-492c-8403-888604d4f343" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5bf8be55-86f8-448c-bd65-6801bb43e8e6" xlink:to="loc_us-gaap_EquityComponentDomain_d97c93d0-1c49-492c-8403-888604d4f343" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_58d74d97-3d75-4297-837a-105e3ebee5be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d97c93d0-1c49-492c-8403-888604d4f343" xlink:to="loc_us-gaap_ParentMember_58d74d97-3d75-4297-837a-105e3ebee5be" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f74ffdbd-50ed-4149-a0a7-d9ec7bd66198" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_58d74d97-3d75-4297-837a-105e3ebee5be" xlink:to="loc_us-gaap_CommonStockMember_f74ffdbd-50ed-4149-a0a7-d9ec7bd66198" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_29e66c91-cfa4-4e9c-9ba1-0dba8741fcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_58d74d97-3d75-4297-837a-105e3ebee5be" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_29e66c91-cfa4-4e9c-9ba1-0dba8741fcd3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e7d06fe1-5837-4062-bff7-d6d6f4f3610f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_58d74d97-3d75-4297-837a-105e3ebee5be" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e7d06fe1-5837-4062-bff7-d6d6f4f3610f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetIncomeMember_731dd8d0-4cf3-43ad-89f1-b0f47fee9129" xlink:href="hr-20230930.xsd#hr_CumulativeNetIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_58d74d97-3d75-4297-837a-105e3ebee5be" xlink:to="loc_hr_CumulativeNetIncomeMember_731dd8d0-4cf3-43ad-89f1-b0f47fee9129" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeDividendsMember_e95e2ee3-d866-4ce6-99e8-fcd5f79b0be2" xlink:href="hr-20230930.xsd#hr_CumulativeDividendsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ParentMember_58d74d97-3d75-4297-837a-105e3ebee5be" xlink:to="loc_hr_CumulativeDividendsMember_e95e2ee3-d866-4ce6-99e8-fcd5f79b0be2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_0b147a1e-4491-4409-8bde-1d2a4fc79634" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_d97c93d0-1c49-492c-8403-888604d4f343" xlink:to="loc_us-gaap_NoncontrollingInterestMember_0b147a1e-4491-4409-8bde-1d2a4fc79634" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstatePropertiesLineItems_de923268-daf0-4a87-86cd-68ad3635838d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstatePropertiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:href="hr-20230930.xsd#hr_BusinessOverviewAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_de923268-daf0-4a87-86cd-68ad3635838d" xlink:to="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_616490ec-70d5-4c26-be63-3868ffe13563" xlink:href="hr-20230930.xsd#hr_InvestmentInRealEstatePropertiesAndMortgageNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:to="loc_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_616490ec-70d5-4c26-be63-3868ffe13563" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRealEstateInvestments_5fe9a722-cdff-48b8-b1e2-7387ad30abe2" xlink:href="hr-20230930.xsd#hr_NumberOfRealEstateInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:to="loc_hr_NumberOfRealEstateInvestments_5fe9a722-cdff-48b8-b1e2-7387ad30abe2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_24660275-4b6c-4e42-a9a0-915797924206" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_24660275-4b6c-4e42-a9a0-915797924206" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_373b650b-e2f8-4901-b259-36ab64da78d2" xlink:href="hr-20230930.xsd#hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:to="loc_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_373b650b-e2f8-4901-b259-36ab64da78d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ApproximateSquareFeetInvestedInByCompany_b32a1bc1-aef5-4588-9322-b8cc06d7d393" xlink:href="hr-20230930.xsd#hr_ApproximateSquareFeetInvestedInByCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:to="loc_hr_ApproximateSquareFeetInvestedInByCompany_b32a1bc1-aef5-4588-9322-b8cc06d7d393" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ApproximateSquareFeetProvidedByCompany_ab52a398-3d4a-40fa-96b7-877fa2239e9c" xlink:href="hr-20230930.xsd#hr_ApproximateSquareFeetProvidedByCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:to="loc_hr_ApproximateSquareFeetProvidedByCompany_ab52a398-3d4a-40fa-96b7-877fa2239e9c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_fac4df48-e541-40af-acf5-8885a83dd16e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_fac4df48-e541-40af-acf5-8885a83dd16e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfBuildingsOwnedByJointVenture_570d7f31-285c-45bc-aeb2-441cb1475872" xlink:href="hr-20230930.xsd#hr_NumberOfBuildingsOwnedByJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:to="loc_hr_NumberOfBuildingsOwnedByJointVenture_570d7f31-285c-45bc-aeb2-441cb1475872" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8edb56-448a-4410-af02-aae18b03eb29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_de923268-daf0-4a87-86cd-68ad3635838d" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8edb56-448a-4410-af02-aae18b03eb29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_d69d2a13-8722-4127-aeb0-7465bd47acaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8edb56-448a-4410-af02-aae18b03eb29" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_d69d2a13-8722-4127-aeb0-7465bd47acaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityOwnershipForConsolidationPercent_7af1710f-fa79-4e32-8a9a-57d2a8f4ea0f" xlink:href="hr-20230930.xsd#hr_EquityOwnershipForConsolidationPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8edb56-448a-4410-af02-aae18b03eb29" xlink:to="loc_hr_EquityOwnershipForConsolidationPercent_7af1710f-fa79-4e32-8a9a-57d2a8f4ea0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_90a10aa8-5441-4fab-85df-2927b3ac4b53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8edb56-448a-4410-af02-aae18b03eb29" xlink:to="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_90a10aa8-5441-4fab-85df-2927b3ac4b53" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_c0728b33-4e12-4248-a91b-3d266104bb23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8edb56-448a-4410-af02-aae18b03eb29" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_c0728b33-4e12-4248-a91b-3d266104bb23" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfVariableInterestEntities_b4b3eb2e-7d05-431c-a27a-4601e5e682e1" xlink:href="hr-20230930.xsd#hr_NumberOfVariableInterestEntities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8edb56-448a-4410-af02-aae18b03eb29" xlink:to="loc_hr_NumberOfVariableInterestEntities_b4b3eb2e-7d05-431c-a27a-4601e5e682e1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfNotesReceivable_5522f417-e9db-4aab-acb3-8a3b25bec889" xlink:href="hr-20230930.xsd#hr_NumberOfNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8edb56-448a-4410-af02-aae18b03eb29" xlink:to="loc_hr_NumberOfNotesReceivable_5522f417-e9db-4aab-acb3-8a3b25bec889" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfJointVentures_252c5eb4-e52a-4593-b0b1-18ab52d689d5" xlink:href="hr-20230930.xsd#hr_NumberOfJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8edb56-448a-4410-af02-aae18b03eb29" xlink:to="loc_hr_NumberOfJointVentures_252c5eb4-e52a-4593-b0b1-18ab52d689d5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_4704bc08-035a-43a3-96a5-ddb4076ea6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_de923268-daf0-4a87-86cd-68ad3635838d" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_4704bc08-035a-43a3-96a5-ddb4076ea6eb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_732c2fb5-9b84-4b3f-a63c-eac4a0f020e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_4704bc08-035a-43a3-96a5-ddb4076ea6eb" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_732c2fb5-9b84-4b3f-a63c-eac4a0f020e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentChargesAbstract_de894449-a310-4b02-be86-4cffeff05903" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentChargesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_de923268-daf0-4a87-86cd-68ad3635838d" xlink:to="loc_us-gaap_AssetImpairmentChargesAbstract_de894449-a310-4b02-be86-4cffeff05903" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfRealEstate_a9b7dc0a-508a-43fb-9d98-cca6b68f2cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfRealEstate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetImpairmentChargesAbstract_de894449-a310-4b02-be86-4cffeff05903" xlink:to="loc_us-gaap_ImpairmentOfRealEstate_a9b7dc0a-508a-43fb-9d98-cca6b68f2cbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateAbstract_e86ae8f8-0b45-4247-9b74-4f0f1e52a5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_de923268-daf0-4a87-86cd-68ad3635838d" xlink:to="loc_us-gaap_RealEstateAbstract_e86ae8f8-0b45-4247-9b74-4f0f1e52a5e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateNotesReceivableNet_a940853a-686e-444d-b83f-a8d7e1fa11ee" xlink:href="hr-20230930.xsd#hr_RealEstateNotesReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstateAbstract_e86ae8f8-0b45-4247-9b74-4f0f1e52a5e2" xlink:to="loc_hr_RealEstateNotesReceivableNet_a940853a-686e-444d-b83f-a8d7e1fa11ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f960bd28-2748-4cab-bbee-829d3e22e8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_de923268-daf0-4a87-86cd-68ad3635838d" xlink:to="loc_us-gaap_LeasesAbstract_f960bd28-2748-4cab-bbee-829d3e22e8cd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_9ba3c86e-a294-4dfa-9b1c-0ddcb7e4d97d" xlink:href="hr-20230930.xsd#hr_FinancingReceivableAllowanceForCreditLossReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_f960bd28-2748-4cab-bbee-829d3e22e8cd" xlink:to="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_9ba3c86e-a294-4dfa-9b1c-0ddcb7e4d97d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRecognizedLeaseFinancialReceivables_6ab68298-9fde-402e-affa-1d80f8671cca" xlink:href="hr-20230930.xsd#hr_NumberOfRecognizedLeaseFinancialReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_f960bd28-2748-4cab-bbee-829d3e22e8cd" xlink:to="loc_hr_NumberOfRecognizedLeaseFinancialReceivables_6ab68298-9fde-402e-affa-1d80f8671cca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable_c12dc974-ed41-4284-b861-8db007c76390" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_f960bd28-2748-4cab-bbee-829d3e22e8cd" xlink:to="loc_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable_c12dc974-ed41-4284-b861-8db007c76390" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_7fc8d938-3144-4b3b-9ce6-35361238a9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOperating"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_f960bd28-2748-4cab-bbee-829d3e22e8cd" xlink:to="loc_us-gaap_InterestIncomeOperating_7fc8d938-3144-4b3b-9ce6-35361238a9d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRealEstateNotesReceivable_aa1f0eb5-da94-416d-8eba-d90a78e82916" xlink:href="hr-20230930.xsd#hr_NumberOfRealEstateNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_f960bd28-2748-4cab-bbee-829d3e22e8cd" xlink:to="loc_hr_NumberOfRealEstateNotesReceivable_aa1f0eb5-da94-416d-8eba-d90a78e82916" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual_b4c1efe2-f9f7-43ea-aace-8576779c23fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeasesAbstract_f960bd28-2748-4cab-bbee-829d3e22e8cd" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual_b4c1efe2-f9f7-43ea-aace-8576779c23fb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_26294caa-9b7f-4ae9-b444-c9af26df90ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRealEstatePropertiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_de923268-daf0-4a87-86cd-68ad3635838d" xlink:to="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_26294caa-9b7f-4ae9-b444-c9af26df90ff" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_da37fd9d-8d44-4fd3-8405-f947cdadebc1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_26294caa-9b7f-4ae9-b444-c9af26df90ff" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_da37fd9d-8d44-4fd3-8405-f947cdadebc1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_da37fd9d-8d44-4fd3-8405-f947cdadebc1_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_da37fd9d-8d44-4fd3-8405-f947cdadebc1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_da37fd9d-8d44-4fd3-8405-f947cdadebc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_fbf4ce4b-bf73-47ca-9d30-b56450f082b9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_da37fd9d-8d44-4fd3-8405-f947cdadebc1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_fbf4ce4b-bf73-47ca-9d30-b56450f082b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstatePropertiesHeldInJointVenturesMember_bfba883e-9e8e-40c0-be12-0239c07d5ab0" xlink:href="hr-20230930.xsd#hr_RealEstatePropertiesHeldInJointVenturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_fbf4ce4b-bf73-47ca-9d30-b56450f082b9" xlink:to="loc_hr_RealEstatePropertiesHeldInJointVenturesMember_bfba883e-9e8e-40c0-be12-0239c07d5ab0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a6ec16c0-d9d1-408f-8063-33ab0ea83366" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_26294caa-9b7f-4ae9-b444-c9af26df90ff" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a6ec16c0-d9d1-408f-8063-33ab0ea83366" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6ec16c0-d9d1-408f-8063-33ab0ea83366_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a6ec16c0-d9d1-408f-8063-33ab0ea83366" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_a6ec16c0-d9d1-408f-8063-33ab0ea83366_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c7072b9-605c-4740-8ef0-41385f138f03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a6ec16c0-d9d1-408f-8063-33ab0ea83366" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c7072b9-605c-4740-8ef0-41385f138f03" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_b1ea158a-59f6-4eba-8835-137cc8df3ac6" xlink:href="hr-20230930.xsd#hr_PropertyEntitiesNotDeterminedToBeVIEsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c7072b9-605c-4740-8ef0-41385f138f03" xlink:to="loc_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_b1ea158a-59f6-4eba-8835-137cc8df3ac6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_8b06d62a-59ef-464f-a6c0-bcc5495b3258" xlink:href="hr-20230930.xsd#hr_HealthcareTrustofAmericaHoldingsLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c7072b9-605c-4740-8ef0-41385f138f03" xlink:to="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_8b06d62a-59ef-464f-a6c0-bcc5495b3258" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_0e3498dc-0d46-42d7-8aec-4b326b1b2efe" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_26294caa-9b7f-4ae9-b444-c9af26df90ff" xlink:to="loc_srt_OwnershipAxis_0e3498dc-0d46-42d7-8aec-4b326b1b2efe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_0e3498dc-0d46-42d7-8aec-4b326b1b2efe_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_0e3498dc-0d46-42d7-8aec-4b326b1b2efe" xlink:to="loc_srt_OwnershipDomain_0e3498dc-0d46-42d7-8aec-4b326b1b2efe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_7cc91184-c53b-450e-9e5d-582c609bf8a6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_0e3498dc-0d46-42d7-8aec-4b326b1b2efe" xlink:to="loc_srt_OwnershipDomain_7cc91184-c53b-450e-9e5d-582c609bf8a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonControllingInterestHoldersMember_9f0ec48c-8953-4f97-b0b7-21d814cdeed5" xlink:href="hr-20230930.xsd#hr_NonControllingInterestHoldersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_7cc91184-c53b-450e-9e5d-582c609bf8a6" xlink:to="loc_hr_NonControllingInterestHoldersMember_9f0ec48c-8953-4f97-b0b7-21d814cdeed5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c4fb46fa-70bc-4ece-99a8-abdd2ee8b10e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_26294caa-9b7f-4ae9-b444-c9af26df90ff" xlink:to="loc_dei_LegalEntityAxis_c4fb46fa-70bc-4ece-99a8-abdd2ee8b10e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c4fb46fa-70bc-4ece-99a8-abdd2ee8b10e_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_c4fb46fa-70bc-4ece-99a8-abdd2ee8b10e" xlink:to="loc_dei_EntityDomain_c4fb46fa-70bc-4ece-99a8-abdd2ee8b10e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b32949aa-a680-486d-9745-a3f2a902b833" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_c4fb46fa-70bc-4ece-99a8-abdd2ee8b10e" xlink:to="loc_dei_EntityDomain_b32949aa-a680-486d-9745-a3f2a902b833" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_9344df70-add3-4cf0-b0c3-28b318ef1d6b" xlink:href="hr-20230930.xsd#hr_HealthcareTrustofAmericaHoldingsLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_b32949aa-a680-486d-9745-a3f2a902b833" xlink:to="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_9344df70-add3-4cf0-b0c3-28b318ef1d6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_48a04202-065f-4996-93f3-4bae205d9015" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_26294caa-9b7f-4ae9-b444-c9af26df90ff" xlink:to="loc_srt_ConsolidatedEntitiesAxis_48a04202-065f-4996-93f3-4bae205d9015" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_48a04202-065f-4996-93f3-4bae205d9015_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_48a04202-065f-4996-93f3-4bae205d9015" xlink:to="loc_srt_ConsolidatedEntitiesDomain_48a04202-065f-4996-93f3-4bae205d9015_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_59a16bfa-0632-4ab7-ada2-41cb96276ff4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_48a04202-065f-4996-93f3-4bae205d9015" xlink:to="loc_srt_ConsolidatedEntitiesDomain_59a16bfa-0632-4ab7-ada2-41cb96276ff4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_VariableInterestEntityMember_610b7a46-3360-41e4-8f9b-1052382d29ef" xlink:href="hr-20230930.xsd#hr_VariableInterestEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_59a16bfa-0632-4ab7-ada2-41cb96276ff4" xlink:to="loc_hr_VariableInterestEntityMember_610b7a46-3360-41e4-8f9b-1052382d29ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_b1f97320-62ce-485d-bc80-0e506b0b0deb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_26294caa-9b7f-4ae9-b444-c9af26df90ff" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_b1f97320-62ce-485d-bc80-0e506b0b0deb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b1f97320-62ce-485d-bc80-0e506b0b0deb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b1f97320-62ce-485d-bc80-0e506b0b0deb" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b1f97320-62ce-485d-bc80-0e506b0b0deb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_100452d5-ab77-4e19-95a4-29c7038ee57d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b1f97320-62ce-485d-bc80-0e506b0b0deb" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_100452d5-ab77-4e19-95a4-29c7038ee57d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_29f25f1c-8437-40ab-b18f-1ed2e50e71da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_100452d5-ab77-4e19-95a4-29c7038ee57d" xlink:to="loc_us-gaap_NotesReceivableMember_29f25f1c-8437-40ab-b18f-1ed2e50e71da" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_2b4705e4-4cce-4aaf-b7e3-c740a5f81d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_d0e57ed9-5776-410b-82c1-dbfadd7ad3c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2b4705e4-4cce-4aaf-b7e3-c740a5f81d1c" xlink:to="loc_us-gaap_AssetsAbstract_d0e57ed9-5776-410b-82c1-dbfadd7ad3c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_f4767c66-f954-40c1-af07-98cfdf4c00ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_d0e57ed9-5776-410b-82c1-dbfadd7ad3c5" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_f4767c66-f954-40c1-af07-98cfdf4c00ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4b90f386-9eb4-4076-84b0-827b93a23162" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_d0e57ed9-5776-410b-82c1-dbfadd7ad3c5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4b90f386-9eb4-4076-84b0-827b93a23162" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReceivablesAndOtherAssets_a46bf91f-bc94-461f-864d-8fcee67ac29a" xlink:href="hr-20230930.xsd#hr_ReceivablesAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_d0e57ed9-5776-410b-82c1-dbfadd7ad3c5" xlink:to="loc_hr_ReceivablesAndOtherAssets_a46bf91f-bc94-461f-864d-8fcee67ac29a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0a75096a-555a-44b0-b56d-779583a2691a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_d0e57ed9-5776-410b-82c1-dbfadd7ad3c5" xlink:to="loc_us-gaap_Assets_0a75096a-555a-44b0-b56d-779583a2691a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_26c77fc8-9d4b-41e7-b0f8-2b90def1887d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2b4705e4-4cce-4aaf-b7e3-c740a5f81d1c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_26c77fc8-9d4b-41e7-b0f8-2b90def1887d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities_8b401c28-8881-46df-b977-326fad34a251" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_26c77fc8-9d4b-41e7-b0f8-2b90def1887d" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities_8b401c28-8881-46df-b977-326fad34a251" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_161a1826-8f2e-4707-a387-da4505b768e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_26c77fc8-9d4b-41e7-b0f8-2b90def1887d" xlink:to="loc_us-gaap_StockholdersEquity_161a1826-8f2e-4707-a387-da4505b768e5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e7f8e9de-3ad2-4bf4-89b1-11a369a20550" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_26c77fc8-9d4b-41e7-b0f8-2b90def1887d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_e7f8e9de-3ad2-4bf4-89b1-11a369a20550" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fde54fb5-cba5-4b1e-9437-a667d10447bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2b4705e4-4cce-4aaf-b7e3-c740a5f81d1c" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fde54fb5-cba5-4b1e-9437-a667d10447bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_33ae5cfc-379a-4075-9966-d0599890123d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fde54fb5-cba5-4b1e-9437-a667d10447bf" xlink:to="loc_srt_ConsolidatedEntitiesAxis_33ae5cfc-379a-4075-9966-d0599890123d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_33ae5cfc-379a-4075-9966-d0599890123d_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_33ae5cfc-379a-4075-9966-d0599890123d" xlink:to="loc_srt_ConsolidatedEntitiesDomain_33ae5cfc-379a-4075-9966-d0599890123d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_dc20eef4-c039-41e0-884f-b3b49b15969f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_33ae5cfc-379a-4075-9966-d0599890123d" xlink:to="loc_srt_ConsolidatedEntitiesDomain_dc20eef4-c039-41e0-884f-b3b49b15969f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_657194db-4925-421d-86d1-50c6944d3dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_dc20eef4-c039-41e0-884f-b3b49b15969f" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_657194db-4925-421d-86d1-50c6944d3dc6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_20d0edc5-0892-48ba-9afb-4fd0676f0e64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfNotesReceivable_395182ee-dca7-48a3-906a-bf7d405e37e9" xlink:href="hr-20230930.xsd#hr_NumberOfNotesReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_20d0edc5-0892-48ba-9afb-4fd0676f0e64" xlink:to="loc_hr_NumberOfNotesReceivable_395182ee-dca7-48a3-906a-bf7d405e37e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableCarryingAmount_b10df1ac-c189-4f27-ba23-7eea3074cdfa" xlink:href="hr-20230930.xsd#hr_NotesReceivableCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_20d0edc5-0892-48ba-9afb-4fd0676f0e64" xlink:to="loc_hr_NotesReceivableCarryingAmount_b10df1ac-c189-4f27-ba23-7eea3074cdfa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureCarryingAmount_819636b2-ef59-4ade-b612-a585928f4b82" xlink:href="hr-20230930.xsd#hr_JointVentureCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_20d0edc5-0892-48ba-9afb-4fd0676f0e64" xlink:to="loc_hr_JointVentureCarryingAmount_819636b2-ef59-4ade-b612-a585928f4b82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_1f454c99-31bf-4501-a24d-9f92f796838c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_20d0edc5-0892-48ba-9afb-4fd0676f0e64" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_1f454c99-31bf-4501-a24d-9f92f796838c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_9c474a04-7a6c-4bbd-a7ba-c4d4396960fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_20d0edc5-0892-48ba-9afb-4fd0676f0e64" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_9c474a04-7a6c-4bbd-a7ba-c4d4396960fe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_2fdce399-bae8-4b11-8a22-8c4a669141ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_20d0edc5-0892-48ba-9afb-4fd0676f0e64" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_2fdce399-bae8-4b11-8a22-8c4a669141ab" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8f383e02-b014-4b6f-928c-48684de84542" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_2fdce399-bae8-4b11-8a22-8c4a669141ab" xlink:to="loc_srt_StatementGeographicalAxis_8f383e02-b014-4b6f-928c-48684de84542" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8f383e02-b014-4b6f-928c-48684de84542_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_8f383e02-b014-4b6f-928c-48684de84542" xlink:to="loc_srt_SegmentGeographicalDomain_8f383e02-b014-4b6f-928c-48684de84542_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_882c9cfb-34ab-4285-a43a-5b1a2bda3874" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_8f383e02-b014-4b6f-928c-48684de84542" xlink:to="loc_srt_SegmentGeographicalDomain_882c9cfb-34ab-4285-a43a-5b1a2bda3874" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HoustonTexasMember_0fe41854-aadd-4ed0-90ef-0c6a3404ffbc" xlink:href="hr-20230930.xsd#hr_HoustonTexasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_882c9cfb-34ab-4285-a43a-5b1a2bda3874" xlink:to="loc_hr_HoustonTexasMember_0fe41854-aadd-4ed0-90ef-0c6a3404ffbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NC_ada46036-81bb-4a8f-a197-2dc1002be52f" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_NC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_882c9cfb-34ab-4285-a43a-5b1a2bda3874" xlink:to="loc_stpr_NC_ada46036-81bb-4a8f-a197-2dc1002be52f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_50579b79-947b-44be-bc0a-724c9646c5ac" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_TX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_882c9cfb-34ab-4285-a43a-5b1a2bda3874" xlink:to="loc_stpr_TX_50579b79-947b-44be-bc0a-724c9646c5ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_11cdcde1-b6a8-4b59-8417-a8dbae1bd293" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_2fdce399-bae8-4b11-8a22-8c4a669141ab" xlink:to="loc_srt_ConsolidatedEntitiesAxis_11cdcde1-b6a8-4b59-8417-a8dbae1bd293" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_11cdcde1-b6a8-4b59-8417-a8dbae1bd293_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_11cdcde1-b6a8-4b59-8417-a8dbae1bd293" xlink:to="loc_srt_ConsolidatedEntitiesDomain_11cdcde1-b6a8-4b59-8417-a8dbae1bd293_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_303bfa46-dd53-497f-9705-d8b71e8a427f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_11cdcde1-b6a8-4b59-8417-a8dbae1bd293" xlink:to="loc_srt_ConsolidatedEntitiesDomain_303bfa46-dd53-497f-9705-d8b71e8a427f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_VariableInterestEntityMember_29b7110e-3615-4611-ab8b-beec2a42db28" xlink:href="hr-20230930.xsd#hr_VariableInterestEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_303bfa46-dd53-497f-9705-d8b71e8a427f" xlink:to="loc_hr_VariableInterestEntityMember_29b7110e-3615-4611-ab8b-beec2a42db28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_fd98e0d6-2912-412a-bef5-2bb493388168" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_303bfa46-dd53-497f-9705-d8b71e8a427f" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_fd98e0d6-2912-412a-bef5-2bb493388168" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_74aa0ddb-11f6-44e8-807f-3db9a5dc7cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableInterestRate_c4eb31a3-ec30-4d30-83a2-1dc2ab774a19" xlink:href="hr-20230930.xsd#hr_NotesReceivableInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_74aa0ddb-11f6-44e8-807f-3db9a5dc7cf4" xlink:to="loc_hr_NotesReceivableInterestRate_c4eb31a3-ec30-4d30-83a2-1dc2ab774a19" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleLeasebackTransactionNetBookValue_9b387056-c4ff-4472-a348-ce13ca2fb050" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleLeasebackTransactionNetBookValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_74aa0ddb-11f6-44e8-807f-3db9a5dc7cf4" xlink:to="loc_us-gaap_SaleLeasebackTransactionNetBookValue_9b387056-c4ff-4472-a348-ce13ca2fb050" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableMaximumLoanCommitment_59cba514-c8e0-4c57-b949-b2ce513141e6" xlink:href="hr-20230930.xsd#hr_NotesReceivableMaximumLoanCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_74aa0ddb-11f6-44e8-807f-3db9a5dc7cf4" xlink:to="loc_hr_NotesReceivableMaximumLoanCommitment_59cba514-c8e0-4c57-b949-b2ce513141e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_c0d73f24-ec97-4c16-b1cb-42f78dfb677d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_74aa0ddb-11f6-44e8-807f-3db9a5dc7cf4" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_c0d73f24-ec97-4c16-b1cb-42f78dfb677d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_fe6ec2a4-2dbd-45bd-99ea-aeb5e86e9bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_74aa0ddb-11f6-44e8-807f-3db9a5dc7cf4" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_fe6ec2a4-2dbd-45bd-99ea-aeb5e86e9bfe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount_41206fc1-7b5b-45ff-91f4-eb631f1c6de9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_74aa0ddb-11f6-44e8-807f-3db9a5dc7cf4" xlink:to="loc_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount_41206fc1-7b5b-45ff-91f4-eb631f1c6de9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_130b6068-77bc-4407-8ffc-9fabcf0031ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_74aa0ddb-11f6-44e8-807f-3db9a5dc7cf4" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_130b6068-77bc-4407-8ffc-9fabcf0031ff" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_e3e83bff-cefb-4fec-a55c-f4bc92f1283d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_74aa0ddb-11f6-44e8-807f-3db9a5dc7cf4" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_e3e83bff-cefb-4fec-a55c-f4bc92f1283d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_5d02fb48-6ed0-4fee-b30c-905d420e5d20" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_e3e83bff-cefb-4fec-a55c-f4bc92f1283d" xlink:to="loc_srt_StatementGeographicalAxis_5d02fb48-6ed0-4fee-b30c-905d420e5d20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_5d02fb48-6ed0-4fee-b30c-905d420e5d20_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_5d02fb48-6ed0-4fee-b30c-905d420e5d20" xlink:to="loc_srt_SegmentGeographicalDomain_5d02fb48-6ed0-4fee-b30c-905d420e5d20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_620429bd-02a4-491b-9391-7795bf79fab2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_5d02fb48-6ed0-4fee-b30c-905d420e5d20" xlink:to="loc_srt_SegmentGeographicalDomain_620429bd-02a4-491b-9391-7795bf79fab2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PowayCAMember_7ec3c56b-1816-420c-a446-fde5cd68b973" xlink:href="hr-20230930.xsd#hr_PowayCAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_620429bd-02a4-491b-9391-7795bf79fab2" xlink:to="loc_hr_PowayCAMember_7ec3c56b-1816-420c-a446-fde5cd68b973" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ColumbusOHMember_20c148b5-8e5f-478c-827d-3a91a687655f" xlink:href="hr-20230930.xsd#hr_ColumbusOHMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_620429bd-02a4-491b-9391-7795bf79fab2" xlink:to="loc_hr_ColumbusOHMember_20c148b5-8e5f-478c-827d-3a91a687655f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_db9b55b0-624a-4afb-9254-8007a80929fa" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_TX"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_620429bd-02a4-491b-9391-7795bf79fab2" xlink:to="loc_stpr_TX_db9b55b0-624a-4afb-9254-8007a80929fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NC_357ff417-3ce2-4242-bd63-1c28857f3d05" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_NC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_620429bd-02a4-491b-9391-7795bf79fab2" xlink:to="loc_stpr_NC_357ff417-3ce2-4242-bd63-1c28857f3d05" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_bd239a91-93e9-4938-9b58-4553b91cf7ce" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_FL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_620429bd-02a4-491b-9391-7795bf79fab2" xlink:to="loc_stpr_FL_bd239a91-93e9-4938-9b58-4553b91cf7ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_d930ad4b-b596-4d5d-ad5a-c759f458501d" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_620429bd-02a4-491b-9391-7795bf79fab2" xlink:to="loc_stpr_CA_d930ad4b-b596-4d5d-ad5a-c759f458501d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_b59ff2a5-1c81-451b-8f47-75d7917ef18d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_e3e83bff-cefb-4fec-a55c-f4bc92f1283d" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_b59ff2a5-1c81-451b-8f47-75d7917ef18d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b59ff2a5-1c81-451b-8f47-75d7917ef18d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b59ff2a5-1c81-451b-8f47-75d7917ef18d" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_b59ff2a5-1c81-451b-8f47-75d7917ef18d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_90b2e04e-6347-4f4b-8e61-4ec6b94ed5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b59ff2a5-1c81-451b-8f47-75d7917ef18d" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_90b2e04e-6347-4f4b-8e61-4ec6b94ed5b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MezzanineLoanMember_1ca6222f-b2cb-43b4-ba53-1b0288692792" xlink:href="hr-20230930.xsd#hr_MezzanineLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_90b2e04e-6347-4f4b-8e61-4ec6b94ed5b1" xlink:to="loc_hr_MezzanineLoanMember_1ca6222f-b2cb-43b4-ba53-1b0288692792" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanMember_b59cd336-a152-4540-adf6-8eff9a438c44" xlink:href="hr-20230930.xsd#hr_MortgageLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_90b2e04e-6347-4f4b-8e61-4ec6b94ed5b1" xlink:to="loc_hr_MortgageLoanMember_b59cd336-a152-4540-adf6-8eff9a438c44" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_847439d2-c73e-461b-bd5e-869307cef110" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ddcc0e3-4d68-4e5f-90f2-5327cca139fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_847439d2-c73e-461b-bd5e-869307cef110" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ddcc0e3-4d68-4e5f-90f2-5327cca139fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_458726e6-2eb6-4063-8f9d-f55bd06c70b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_847439d2-c73e-461b-bd5e-869307cef110" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_458726e6-2eb6-4063-8f9d-f55bd06c70b1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_22624cdd-10af-4b15-9718-9a0264a3e3a8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_458726e6-2eb6-4063-8f9d-f55bd06c70b1" xlink:to="loc_srt_ProductOrServiceAxis_22624cdd-10af-4b15-9718-9a0264a3e3a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_22624cdd-10af-4b15-9718-9a0264a3e3a8_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_22624cdd-10af-4b15-9718-9a0264a3e3a8" xlink:to="loc_srt_ProductsAndServicesDomain_22624cdd-10af-4b15-9718-9a0264a3e3a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8ba99c3f-5539-499e-b408-1c24657d6898" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_22624cdd-10af-4b15-9718-9a0264a3e3a8" xlink:to="loc_srt_ProductsAndServicesDomain_8ba99c3f-5539-499e-b408-1c24657d6898" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ParkingIncomeMember_f87cb718-be38-4535-9e22-815e72b0c602" xlink:href="hr-20230930.xsd#hr_ParkingIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8ba99c3f-5539-499e-b408-1c24657d6898" xlink:to="loc_hr_ParkingIncomeMember_f87cb718-be38-4535-9e22-815e72b0c602" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ManagementFeeIncomeMember_6dcfd8a8-7d66-4f72-b454-276d74249aa6" xlink:href="hr-20230930.xsd#hr_ManagementFeeIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8ba99c3f-5539-499e-b408-1c24657d6898" xlink:to="loc_hr_ManagementFeeIncomeMember_6dcfd8a8-7d66-4f72-b454-276d74249aa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MiscellaneousMember_299c386d-9c2b-4287-8e30-b384deee132a" xlink:href="hr-20230930.xsd#hr_MiscellaneousMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_8ba99c3f-5539-499e-b408-1c24657d6898" xlink:to="loc_hr_MiscellaneousMember_299c386d-9c2b-4287-8e30-b384deee132a" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/MergerwithHTANarrativeDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#MergerwithHTANarrativeDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/MergerwithHTANarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_feb67831-df9d-4015-a6bc-c9e639cb6123" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_feb67831-df9d-4015-a6bc-c9e639cb6123" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio_487017e4-db5d-4187-bc77-0ac0da51daee" xlink:href="hr-20230930.xsd#hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:to="loc_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio_487017e4-db5d-4187-bc77-0ac0da51daee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_efeed96d-e784-4045-acfc-9a8c85f8aa69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_efeed96d-e784-4045-acfc-9a8c85f8aa69" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete_eb95197e-dbb5-4bca-8963-f9b602ab6937" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete_eb95197e-dbb5-4bca-8963-f9b602ab6937" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c632d64f-9360-4f84-b098-8646e735573b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:to="loc_us-gaap_Goodwill_c632d64f-9360-4f84-b098-8646e735573b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_53be3560-0246-4a0b-89d1-b581f465456c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_53be3560-0246-4a0b-89d1-b581f465456c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MergerRelatedCosts_e20ab283-9cee-4c79-9958-25ce055ec4f9" xlink:href="hr-20230930.xsd#hr_MergerRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:to="loc_hr_MergerRelatedCosts_e20ab283-9cee-4c79-9958-25ce055ec4f9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRefundOfTransferTaxesPaid_cfd4db17-cacb-46ce-8f03-18de0458ffdd" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRefundOfTransferTaxesPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:to="loc_hr_BusinessCombinationRefundOfTransferTaxesPaid_cfd4db17-cacb-46ce-8f03-18de0458ffdd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b1d2cbea-2a4b-4827-9232-d766212cbdf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b1d2cbea-2a4b-4827-9232-d766212cbdf2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_bcfafd4f-a08c-4204-a537-467a42bd7a63" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b1d2cbea-2a4b-4827-9232-d766212cbdf2" xlink:to="loc_dei_LegalEntityAxis_bcfafd4f-a08c-4204-a537-467a42bd7a63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_bcfafd4f-a08c-4204-a537-467a42bd7a63_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_bcfafd4f-a08c-4204-a537-467a42bd7a63" xlink:to="loc_dei_EntityDomain_bcfafd4f-a08c-4204-a537-467a42bd7a63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_93dbdf40-3206-40aa-bf7e-13c14f61cfb5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_bcfafd4f-a08c-4204-a537-467a42bd7a63" xlink:to="loc_dei_EntityDomain_93dbdf40-3206-40aa-bf7e-13c14f61cfb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthCareRealtyTrustIncorporatedMember_2e3d0fa9-695b-4b72-8d90-d35867eea784" xlink:href="hr-20230930.xsd#hr_HealthCareRealtyTrustIncorporatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_93dbdf40-3206-40aa-bf7e-13c14f61cfb5" xlink:to="loc_hr_HealthCareRealtyTrustIncorporatedMember_2e3d0fa9-695b-4b72-8d90-d35867eea784" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthCareRealtyTrustIncMember_e06a58e2-96a8-4173-a19d-bf0e3c239a81" xlink:href="hr-20230930.xsd#hr_HealthCareRealtyTrustIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_HealthCareRealtyTrustIncorporatedMember_2e3d0fa9-695b-4b72-8d90-d35867eea784" xlink:to="loc_hr_HealthCareRealtyTrustIncMember_e06a58e2-96a8-4173-a19d-bf0e3c239a81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustOfAmericaIncMember_4a372377-182b-49d7-a636-186b5c74a5df" xlink:href="hr-20230930.xsd#hr_HealthcareTrustOfAmericaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_HealthCareRealtyTrustIncorporatedMember_2e3d0fa9-695b-4b72-8d90-d35867eea784" xlink:to="loc_hr_HealthcareTrustOfAmericaIncMember_4a372377-182b-49d7-a636-186b5c74a5df" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_76d4dd51-c036-4d87-9f6b-d56f6f96072a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b1d2cbea-2a4b-4827-9232-d766212cbdf2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_76d4dd51-c036-4d87-9f6b-d56f6f96072a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_76d4dd51-c036-4d87-9f6b-d56f6f96072a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_76d4dd51-c036-4d87-9f6b-d56f6f96072a" xlink:to="loc_us-gaap_ClassOfStockDomain_76d4dd51-c036-4d87-9f6b-d56f6f96072a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_80d126ab-e018-4cdb-8033-e715432ee919" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_76d4dd51-c036-4d87-9f6b-d56f6f96072a" xlink:to="loc_us-gaap_ClassOfStockDomain_80d126ab-e018-4cdb-8033-e715432ee919" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_5e1392c3-a52f-4d10-bd05-9215f475c7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_80d126ab-e018-4cdb-8033-e715432ee919" xlink:to="loc_us-gaap_CommonClassAMember_5e1392c3-a52f-4d10-bd05-9215f475c7c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_4643fe2f-bd84-462f-a9b7-fc0325ff2d0a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b1d2cbea-2a4b-4827-9232-d766212cbdf2" xlink:to="loc_srt_RestatementAxis_4643fe2f-bd84-462f-a9b7-fc0325ff2d0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_4643fe2f-bd84-462f-a9b7-fc0325ff2d0a_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_4643fe2f-bd84-462f-a9b7-fc0325ff2d0a" xlink:to="loc_srt_RestatementDomain_4643fe2f-bd84-462f-a9b7-fc0325ff2d0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_c4b4873e-3d1a-4a7c-a992-d133dd8b714d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_4643fe2f-bd84-462f-a9b7-fc0325ff2d0a" xlink:to="loc_srt_RestatementDomain_c4b4873e-3d1a-4a7c-a992-d133dd8b714d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_b509b523-329e-4926-8729-1b3f1439ee4e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_c4b4873e-3d1a-4a7c-a992-d133dd8b714d" xlink:to="loc_srt_RestatementAdjustmentMember_b509b523-329e-4926-8729-1b3f1439ee4e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/MergerwithHTADetails" xlink:type="simple" xlink:href="hr-20230930.xsd#MergerwithHTADetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/MergerwithHTADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_031792e6-110f-4db0-814f-2305531e5767" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_031792e6-110f-4db0-814f-2305531e5767" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RecapitalizationExchangeRatio_d766f17c-c206-4016-8eb7-7d78bdb0843b" xlink:href="hr-20230930.xsd#hr_RecapitalizationExchangeRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_hr_RecapitalizationExchangeRatio_d766f17c-c206-4016-8eb7-7d78bdb0843b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_a85cee74-c2a1-46aa-a6e6-3a8675000651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_a85cee74-c2a1-46aa-a6e6-3a8675000651" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_01279fa9-f9bc-4af2-9897-4fcd30fd9681" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_01279fa9-f9bc-4af2-9897-4fcd30fd9681" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReverseRecapitalizationNet_469a8cba-7503-40de-9ee5-9c546e497831" xlink:href="hr-20230930.xsd#hr_ReverseRecapitalizationNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_hr_ReverseRecapitalizationNet_469a8cba-7503-40de-9ee5-9c546e497831" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices_80c58135-78b0-4ded-857e-46a1d8f92634" xlink:href="hr-20230930.xsd#hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices_80c58135-78b0-4ded-857e-46a1d8f92634" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ef14be4d-2cce-438d-800c-edfada40da69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ef14be4d-2cce-438d-800c-edfada40da69" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CommonStockFractionalShares_1a19751f-9fb1-41d8-9219-8cf0d741237d" xlink:href="hr-20230930.xsd#hr_CommonStockFractionalShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_hr_CommonStockFractionalShares_1a19751f-9fb1-41d8-9219-8cf0d741237d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CommonStockSharesWithheld_50a4b523-2c5b-44c9-9b44-1dba628d38d2" xlink:href="hr-20230930.xsd#hr_CommonStockSharesWithheld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_hr_CommonStockSharesWithheld_50a4b523-2c5b-44c9-9b44-1dba628d38d2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e3a4ed51-df7a-4c8e-991c-796230fab72a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e3a4ed51-df7a-4c8e-991c-796230fab72a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_35cd44c2-3e87-4956-bc3b-7466dcab9e0e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e3a4ed51-df7a-4c8e-991c-796230fab72a" xlink:to="loc_dei_LegalEntityAxis_35cd44c2-3e87-4956-bc3b-7466dcab9e0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_35cd44c2-3e87-4956-bc3b-7466dcab9e0e_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_35cd44c2-3e87-4956-bc3b-7466dcab9e0e" xlink:to="loc_dei_EntityDomain_35cd44c2-3e87-4956-bc3b-7466dcab9e0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_48dd74ab-a324-4328-aa8f-36bf374ffc1b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_35cd44c2-3e87-4956-bc3b-7466dcab9e0e" xlink:to="loc_dei_EntityDomain_48dd74ab-a324-4328-aa8f-36bf374ffc1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustOfAmericaIncMember_333558c5-0e47-43aa-a402-4d3e88161b10" xlink:href="hr-20230930.xsd#hr_HealthcareTrustOfAmericaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_48dd74ab-a324-4328-aa8f-36bf374ffc1b" xlink:to="loc_hr_HealthcareTrustOfAmericaIncMember_333558c5-0e47-43aa-a402-4d3e88161b10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_09182d76-8afb-419b-b22b-2891ed7cc6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e3a4ed51-df7a-4c8e-991c-796230fab72a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_09182d76-8afb-419b-b22b-2891ed7cc6ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_09182d76-8afb-419b-b22b-2891ed7cc6ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_09182d76-8afb-419b-b22b-2891ed7cc6ab" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_09182d76-8afb-419b-b22b-2891ed7cc6ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4292900a-1c48-4fd4-a52c-f21a2727216b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_09182d76-8afb-419b-b22b-2891ed7cc6ab" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4292900a-1c48-4fd4-a52c-f21a2727216b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LegacyHTAMember_79a37470-fcb6-4a1f-a198-2a809ba440ce" xlink:href="hr-20230930.xsd#hr_LegacyHTAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4292900a-1c48-4fd4-a52c-f21a2727216b" xlink:to="loc_hr_LegacyHTAMember_79a37470-fcb6-4a1f-a198-2a809ba440ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b6c7c423-179e-469f-8970-d5bc8bab62ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e3a4ed51-df7a-4c8e-991c-796230fab72a" xlink:to="loc_us-gaap_AwardTypeAxis_b6c7c423-179e-469f-8970-d5bc8bab62ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6c7c423-179e-469f-8970-d5bc8bab62ff_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b6c7c423-179e-469f-8970-d5bc8bab62ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b6c7c423-179e-469f-8970-d5bc8bab62ff_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53a1c9ef-dee2-4bcc-9131-76a8152bbccd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b6c7c423-179e-469f-8970-d5bc8bab62ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53a1c9ef-dee2-4bcc-9131-76a8152bbccd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_a7f13bd9-2e44-444e-bab2-34d68a4a627d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53a1c9ef-dee2-4bcc-9131-76a8152bbccd" xlink:to="loc_us-gaap_RestrictedStockMember_a7f13bd9-2e44-444e-bab2-34d68a4a627d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_dc75db30-e205-4e5b-9db1-86ac7a256ab7" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_dc75db30-e205-4e5b-9db1-86ac7a256ab7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_3d2a413a-7c4b-4508-b7b1-42a3caa1e6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_dc75db30-e205-4e5b-9db1-86ac7a256ab7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_3d2a413a-7c4b-4508-b7b1-42a3caa1e6fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_8402385a-ca20-4e98-9545-45914eb78f09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_dc75db30-e205-4e5b-9db1-86ac7a256ab7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_8402385a-ca20-4e98-9545-45914eb78f09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_cfcebc11-e2bc-4b3f-b45c-81a100251fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_dc75db30-e205-4e5b-9db1-86ac7a256ab7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_cfcebc11-e2bc-4b3f-b45c-81a100251fc9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets_092cbec4-effc-4640-bb44-1ccf21c81d8d" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_dc75db30-e205-4e5b-9db1-86ac7a256ab7" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets_092cbec4-effc-4640-bb44-1ccf21c81d8d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress_c55617d7-a2b8-485a-a3d6-0d5e6539f46e" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_dc75db30-e205-4e5b-9db1-86ac7a256ab7" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress_c55617d7-a2b8-485a-a3d6-0d5e6539f46e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment_c3bf6e39-cd86-4409-a8f4-7de587b3cf90" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_dc75db30-e205-4e5b-9db1-86ac7a256ab7" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment_c3bf6e39-cd86-4409-a8f4-7de587b3cf90" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_b08b783e-1a7f-4581-b995-be2d1186bab2" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_b08b783e-1a7f-4581-b995-be2d1186bab2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale_4a83c468-5f84-4e95-bc27-1c140b1814f2" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale_4a83c468-5f84-4e95-bc27-1c140b1814f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures_b07a3a69-ab50-4c09-ac68-26d68caf78e8" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures_b07a3a69-ab50-4c09-ac68-26d68caf78e8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_683e7719-38ed-4d51-9d92-eca27e0cfea4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_683e7719-38ed-4d51-9d92-eca27e0cfea4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_4b3c1fd2-7560-48bb-8df9-f2225ccabe2d" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_4b3c1fd2-7560-48bb-8df9-f2225ccabe2d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_15a21812-e16d-41f2-be51-4ae5ce33ce19" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_15a21812-e16d-41f2-be51-4ae5ce33ce19" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets_2bb5c15d-0380-4263-84d0-32439c03bd68" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets_2bb5c15d-0380-4263-84d0-32439c03bd68" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_71972c83-d345-47b8-86af-a181f1ba866d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_71972c83-d345-47b8-86af-a181f1ba866d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_7be29eab-2c89-4c86-aca6-859b78f6c8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_7be29eab-2c89-4c86-aca6-859b78f6c8f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_65aec9e6-a7ec-4ad2-b697-88c70eceff75" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_7be29eab-2c89-4c86-aca6-859b78f6c8f5" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_65aec9e6-a7ec-4ad2-b697-88c70eceff75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities_ee8776a9-eab1-44aa-9367-2325c576950b" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_7be29eab-2c89-4c86-aca6-859b78f6c8f5" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities_ee8776a9-eab1-44aa-9367-2325c576950b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale_f688bea6-6fca-4555-920b-2ebab2a26b79" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_7be29eab-2c89-4c86-aca6-859b78f6c8f5" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale_f688bea6-6fca-4555-920b-2ebab2a26b79" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_d379efb0-d621-43b6-8a4c-82eb12b4e98c" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_7be29eab-2c89-4c86-aca6-859b78f6c8f5" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_d379efb0-d621-43b6-8a4c-82eb12b4e98c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities_85e69047-e2af-40da-99a1-0cf4e97de86c" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_7be29eab-2c89-4c86-aca6-859b78f6c8f5" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities_85e69047-e2af-40da-99a1-0cf4e97de86c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_8414a814-0e42-4e85-b954-3a987a4d4656" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_7be29eab-2c89-4c86-aca6-859b78f6c8f5" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_8414a814-0e42-4e85-b954-3a987a4d4656" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_96282f0d-d45e-4757-97df-7b3c476dfeaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_7be29eab-2c89-4c86-aca6-859b78f6c8f5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_96282f0d-d45e-4757-97df-7b3c476dfeaf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1fb3d958-4ca0-4016-82fa-dc4bcd62593d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1fb3d958-4ca0-4016-82fa-dc4bcd62593d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_12b34487-22cf-406b-adeb-e2d84c04e9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_12b34487-22cf-406b-adeb-e2d84c04e9e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_180a57c1-4bee-4f7a-8ee0-69e83331a3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_us-gaap_Goodwill_180a57c1-4bee-4f7a-8ee0-69e83331a3a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_72973e98-97ba-4545-acf8-056b61963b69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_72973e98-97ba-4545-acf8-056b61963b69" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount_06797e6e-510e-45d0-9800-3b9b2df760eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount_06797e6e-510e-45d0-9800-3b9b2df760eb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount_5fbdc1a5-65cf-4d81-8fc8-328bf2c6dded" xlink:href="hr-20230930.xsd#hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount_5fbdc1a5-65cf-4d81-8fc8-328bf2c6dded" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GrossContractualRealEstateNotesReceivableFairValue_ede64bd7-f5e7-44c2-ac1a-9197a1c20e1d" xlink:href="hr-20230930.xsd#hr_GrossContractualRealEstateNotesReceivableFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_hr_GrossContractualRealEstateNotesReceivableFairValue_ede64bd7-f5e7-44c2-ac1a-9197a1c20e1d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand_1e3da188-282f-47d5-a809-62be6fb620c6" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand_1e3da188-282f-47d5-a809-62be6fb620c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements_5d41cbb3-642c-4cd0-b917-a3a894e5fabd" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements_5d41cbb3-642c-4cd0-b917-a3a894e5fabd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets_dc7038f2-3b03-4042-b047-4b7d8d32f745" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets_dc7038f2-3b03-4042-b047-4b7d8d32f745" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets_23cb7a4b-784b-4141-b972-9e5657cd07d2" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets_23cb7a4b-784b-4141-b972-9e5657cd07d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress_f9bfe047-121e-48f7-88c4-0675937d80f1" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress_f9bfe047-121e-48f7-88c4-0675937d80f1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_1e7ac0c5-b69a-4bf7-91cd-0a2484d69667" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_1e7ac0c5-b69a-4bf7-91cd-0a2484d69667" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet_fc94330b-da6a-48bc-9bfa-e7feb932f2d5" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet_fc94330b-da6a-48bc-9bfa-e7feb932f2d5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_f22ff50f-0ee9-42ef-ad3e-1242c62cdd2c" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_f22ff50f-0ee9-42ef-ad3e-1242c62cdd2c" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash_b007e5c6-fd4c-4077-8372-617b6bf07faf" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash_b007e5c6-fd4c-4077-8372-617b6bf07faf" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_59be3172-d4e3-4aac-bcc5-5f11ee012e80" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_59be3172-d4e3-4aac-bcc5-5f11ee012e80" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet_e9b22ac3-41bd-40b3-a639-9cdb42f54271" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet_e9b22ac3-41bd-40b3-a639-9cdb42f54271" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_760a55b5-96f2-4092-9a4e-9ab2c4f292cc" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_760a55b5-96f2-4092-9a4e-9ab2c4f292cc" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities_6140c741-e6ca-4130-9e30-856aaa8c04a4" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities_6140c741-e6ca-4130-9e30-856aaa8c04a4" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale_7b94ca35-af52-4ec2-87c8-f9f45ea372e8" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale_7b94ca35-af52-4ec2-87c8-f9f45ea372e8" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities_ab4f035c-b9f7-4dcc-becf-b8582120306f" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities_ab4f035c-b9f7-4dcc-becf-b8582120306f" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities_847626a2-4845-49d3-9201-30768b294848" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities_847626a2-4845-49d3-9201-30768b294848" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_67d443c9-1acc-4249-87b5-2fbfe13f940b" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_67d443c9-1acc-4249-87b5-2fbfe13f940b" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_2b12310b-640c-480d-9398-1857676aa4d9" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_2b12310b-640c-480d-9398-1857676aa4d9" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_d0638d38-8858-4626-8065-14849cd280bc" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_d0638d38-8858-4626-8065-14849cd280bc" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_d72be496-67f2-4a15-91e1-b11b772cf120" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_d72be496-67f2-4a15-91e1-b11b772cf120" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0cb27e21-15e4-4ef3-831e-5c9d519a4b48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0cb27e21-15e4-4ef3-831e-5c9d519a4b48" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_f208801f-c76e-4a80-a8df-c16b782ff4ac" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0cb27e21-15e4-4ef3-831e-5c9d519a4b48" xlink:to="loc_srt_RestatementAxis_f208801f-c76e-4a80-a8df-c16b782ff4ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_f208801f-c76e-4a80-a8df-c16b782ff4ac_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_f208801f-c76e-4a80-a8df-c16b782ff4ac" xlink:to="loc_srt_RestatementDomain_f208801f-c76e-4a80-a8df-c16b782ff4ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_24f096a9-ade8-4c1e-a678-5476c78f3c4e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_f208801f-c76e-4a80-a8df-c16b782ff4ac" xlink:to="loc_srt_RestatementDomain_24f096a9-ade8-4c1e-a678-5476c78f3c4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_1106226d-4e5f-49a0-a10c-f66074f0f279" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_24f096a9-ade8-4c1e-a678-5476c78f3c4e" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_1106226d-4e5f-49a0-a10c-f66074f0f279" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#RealEstateInvestmentsRealEstateAcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_869c4b3b-8829-4816-96b8-6a8edae40f48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1d368502-7f04-45bc-a970-0efca18aac72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_869c4b3b-8829-4816-96b8-6a8edae40f48" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1d368502-7f04-45bc-a970-0efca18aac72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_663198a4-0a9c-4bc7-80ff-d7a69d3bc6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_869c4b3b-8829-4816-96b8-6a8edae40f48" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_663198a4-0a9c-4bc7-80ff-d7a69d3bc6e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_a3eda5fe-19b3-4815-be51-057426e332ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_869c4b3b-8829-4816-96b8-6a8edae40f48" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_a3eda5fe-19b3-4815-be51-057426e332ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty_d5ede9e0-4907-40cd-829c-076a968ca0b6" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_869c4b3b-8829-4816-96b8-6a8edae40f48" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty_d5ede9e0-4907-40cd-829c-076a968ca0b6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther_e3b7a7b5-4330-4ef5-9ff9-2aba7fefd6a9" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_869c4b3b-8829-4816-96b8-6a8edae40f48" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther_e3b7a7b5-4330-4ef5-9ff9-2aba7fefd6a9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage_032daa73-4460-47d9-bed8-35a24cac59a0" xlink:href="hr-20230930.xsd#hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_869c4b3b-8829-4816-96b8-6a8edae40f48" xlink:to="loc_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage_032daa73-4460-47d9-bed8-35a24cac59a0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_10e07c50-ddb2-4cf3-8c7f-0fed13503a21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_869c4b3b-8829-4816-96b8-6a8edae40f48" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_10e07c50-ddb2-4cf3-8c7f-0fed13503a21" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ac414d3b-9c6d-4996-a0e3-3e656fffe352" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_10e07c50-ddb2-4cf3-8c7f-0fed13503a21" xlink:to="loc_srt_StatementGeographicalAxis_ac414d3b-9c6d-4996-a0e3-3e656fffe352" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ac414d3b-9c6d-4996-a0e3-3e656fffe352_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ac414d3b-9c6d-4996-a0e3-3e656fffe352" xlink:to="loc_srt_SegmentGeographicalDomain_ac414d3b-9c6d-4996-a0e3-3e656fffe352_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3edfa526-2dac-4b72-8ff1-e9cce5238b6d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ac414d3b-9c6d-4996-a0e3-3e656fffe352" xlink:to="loc_srt_SegmentGeographicalDomain_3edfa526-2dac-4b72-8ff1-e9cce5238b6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TampaFLMember_dcc03705-d6ab-4c50-a55a-f5a57cc46336" xlink:href="hr-20230930.xsd#hr_TampaFLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3edfa526-2dac-4b72-8ff1-e9cce5238b6d" xlink:to="loc_hr_TampaFLMember_dcc03705-d6ab-4c50-a55a-f5a57cc46336" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ColoradoSpringsCOMember_4c004897-5901-438c-98b2-86ea0805bff0" xlink:href="hr-20230930.xsd#hr_ColoradoSpringsCOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3edfa526-2dac-4b72-8ff1-e9cce5238b6d" xlink:to="loc_hr_ColoradoSpringsCOMember_4c004897-5901-438c-98b2-86ea0805bff0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_f23c5554-7830-4fcb-a726-7169457cb087" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_10e07c50-ddb2-4cf3-8c7f-0fed13503a21" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_f23c5554-7830-4fcb-a726-7169457cb087" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_f23c5554-7830-4fcb-a726-7169457cb087_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_f23c5554-7830-4fcb-a726-7169457cb087" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_f23c5554-7830-4fcb-a726-7169457cb087_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_78e75a8c-b7a5-4d40-9a1c-fbdfa134c484" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_f23c5554-7830-4fcb-a726-7169457cb087" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_78e75a8c-b7a5-4d40-9a1c-fbdfa134c484" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MedicalOfficeBuildingMember_751e6f70-7a8e-4060-99ae-b9bb672694bc" xlink:href="hr-20230930.xsd#hr_MedicalOfficeBuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_78e75a8c-b7a5-4d40-9a1c-fbdfa134c484" xlink:to="loc_hr_MedicalOfficeBuildingMember_751e6f70-7a8e-4060-99ae-b9bb672694bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis_2bbccc06-eda4-4fe1-8f91-f161f9e3fc16" xlink:href="hr-20230930.xsd#hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_10e07c50-ddb2-4cf3-8c7f-0fed13503a21" xlink:to="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis_2bbccc06-eda4-4fe1-8f91-f161f9e3fc16" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain_2bbccc06-eda4-4fe1-8f91-f161f9e3fc16_default" xlink:href="hr-20230930.xsd#hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis_2bbccc06-eda4-4fe1-8f91-f161f9e3fc16" xlink:to="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain_2bbccc06-eda4-4fe1-8f91-f161f9e3fc16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain_13f9f80f-920d-484e-a4ab-35e66feafaf7" xlink:href="hr-20230930.xsd#hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis_2bbccc06-eda4-4fe1-8f91-f161f9e3fc16" xlink:to="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain_13f9f80f-920d-484e-a4ab-35e66feafaf7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateAcquisitionsMember_d953f357-f8df-492a-85ce-3dabee544f38" xlink:href="hr-20230930.xsd#hr_RealEstateAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain_13f9f80f-920d-484e-a4ab-35e66feafaf7" xlink:to="loc_hr_RealEstateAcquisitionsMember_d953f357-f8df-492a-85ce-3dabee544f38" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLineItems_a42f37d2-aeed-4ba2-b860-e7f6df44ed1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityMethodInvestmentsRollForward_13176b4f-6946-42b8-9f95-af08acd3d813" xlink:href="hr-20230930.xsd#hr_EquityMethodInvestmentsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstateLineItems_a42f37d2-aeed-4ba2-b860-e7f6df44ed1b" xlink:to="loc_hr_EquityMethodInvestmentsRollForward_13176b4f-6946-42b8-9f95-af08acd3d813" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_c4bf9213-1d97-4d77-a1d9-96ae5a0c0464" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_13176b4f-6946-42b8-9f95-af08acd3d813" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_c4bf9213-1d97-4d77-a1d9-96ae5a0c0464" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_eac234d2-9b61-47c2-bbe2-51f176392210" xlink:href="hr-20230930.xsd#hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_13176b4f-6946-42b8-9f95-af08acd3d813" xlink:to="loc_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_eac234d2-9b61-47c2-bbe2-51f176392210" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_8abb1337-9617-4391-a23f-9b5bdc1388e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_13176b4f-6946-42b8-9f95-af08acd3d813" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_8abb1337-9617-4391-a23f-9b5bdc1388e5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared_ce52f9f1-4acf-419f-b2bd-b9303732ad9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_13176b4f-6946-42b8-9f95-af08acd3d813" xlink:to="loc_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared_ce52f9f1-4acf-419f-b2bd-b9303732ad9a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_814b890d-9793-4dbc-801a-6182abf83562" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureOwnershipPercentage_389fe3e5-640a-4dce-b4bb-813913624d9d" xlink:href="hr-20230930.xsd#hr_JointVentureOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RealEstateLineItems_a42f37d2-aeed-4ba2-b860-e7f6df44ed1b" xlink:to="loc_hr_JointVentureOwnershipPercentage_389fe3e5-640a-4dce-b4bb-813913624d9d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateTable_41c05517-e313-4818-9a12-d03104aed133" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RealEstateLineItems_a42f37d2-aeed-4ba2-b860-e7f6df44ed1b" xlink:to="loc_us-gaap_RealEstateTable_41c05517-e313-4818-9a12-d03104aed133" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d02a53de-44bb-4ab1-8371-fb32c5d89e4c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RealEstateTable_41c05517-e313-4818-9a12-d03104aed133" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d02a53de-44bb-4ab1-8371-fb32c5d89e4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d02a53de-44bb-4ab1-8371-fb32c5d89e4c_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d02a53de-44bb-4ab1-8371-fb32c5d89e4c" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_d02a53de-44bb-4ab1-8371-fb32c5d89e4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_4afdaa0b-50cb-41f2-840b-2df838f969cd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d02a53de-44bb-4ab1-8371-fb32c5d89e4c" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_4afdaa0b-50cb-41f2-840b-2df838f969cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OtherPropertyMember_82a186c8-e778-4921-a5bf-66a046113810" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OtherPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_4afdaa0b-50cb-41f2-840b-2df838f969cd" xlink:to="loc_srt_OtherPropertyMember_82a186c8-e778-4921-a5bf-66a046113810" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_80b8c407-4322-4af6-870d-9b1eca0dd624" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RealEstateTable_41c05517-e313-4818-9a12-d03104aed133" xlink:to="loc_srt_StatementGeographicalAxis_80b8c407-4322-4af6-870d-9b1eca0dd624" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_80b8c407-4322-4af6-870d-9b1eca0dd624_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_80b8c407-4322-4af6-870d-9b1eca0dd624" xlink:to="loc_srt_SegmentGeographicalDomain_80b8c407-4322-4af6-870d-9b1eca0dd624_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_628c8203-7549-45ec-8e71-4e552678e328" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_80b8c407-4322-4af6-870d-9b1eca0dd624" xlink:to="loc_srt_SegmentGeographicalDomain_628c8203-7549-45ec-8e71-4e552678e328" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LosAngelesCaliforniaMember_0912ace9-a076-4fab-bea6-ec7fe3cf0f15" xlink:href="hr-20230930.xsd#hr_LosAngelesCaliforniaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_628c8203-7549-45ec-8e71-4e552678e328" xlink:to="loc_hr_LosAngelesCaliforniaMember_0912ace9-a076-4fab-bea6-ec7fe3cf0f15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_e808e70c-e61d-426c-b689-0a30fc85607b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RealEstateTable_41c05517-e313-4818-9a12-d03104aed133" xlink:to="loc_srt_OwnershipAxis_e808e70c-e61d-426c-b689-0a30fc85607b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_e808e70c-e61d-426c-b689-0a30fc85607b_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_e808e70c-e61d-426c-b689-0a30fc85607b" xlink:to="loc_srt_OwnershipDomain_e808e70c-e61d-426c-b689-0a30fc85607b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_cab3c979-773c-468c-9828-218156b5ed14" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_e808e70c-e61d-426c-b689-0a30fc85607b" xlink:to="loc_srt_OwnershipDomain_cab3c979-773c-468c-9828-218156b5ed14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LimitedLiabilityCompanyOneMember_20d5901a-55e4-4f46-98c9-68d78c3e0b0a" xlink:href="hr-20230930.xsd#hr_LimitedLiabilityCompanyOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_cab3c979-773c-468c-9828-218156b5ed14" xlink:to="loc_hr_LimitedLiabilityCompanyOneMember_20d5901a-55e4-4f46-98c9-68d78c3e0b0a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#RealEstateInvestmentsDispositionsDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:href="hr-20230930.xsd#hr_RealEstateDispositionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DispositionSalesPrice_f8d680cc-4b49-4eb0-8492-01c998175741" xlink:href="hr-20230930.xsd#hr_DispositionSalesPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_DispositionSalesPrice_f8d680cc-4b49-4eb0-8492-01c998175741" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ClosingAdjustmentsDisposedEntity_82f9086d-7cbc-4848-807d-eac8fe37d160" xlink:href="hr-20230930.xsd#hr_ClosingAdjustmentsDisposedEntity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_ClosingAdjustmentsDisposedEntity_82f9086d-7cbc-4848-807d-eac8fe37d160" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceMortgageNotes_9624466c-c2b9-4615-935c-2377daaed4e9" xlink:href="hr-20230930.xsd#hr_FinanceMortgageNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_FinanceMortgageNotes_9624466c-c2b9-4615-935c-2377daaed4e9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_f54de941-f746-4723-aff4-f272a6c3af1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_f54de941-f746-4723-aff4-f272a6c3af1b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_b6adc08d-da2d-422c-af31-aa3ada8f2d6b" xlink:href="hr-20230930.xsd#hr_RealEstateInvestmentNetDisposedOfDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_b6adc08d-da2d-422c-af31-aa3ada8f2d6b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateOther_03183315-4e55-4337-838f-88ece716cea1" xlink:href="hr-20230930.xsd#hr_RealEstateOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_RealEstateOther_03183315-4e55-4337-838f-88ece716cea1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_6776b336-4653-4bff-a781-1b5b730f1143" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_6776b336-4653-4bff-a781-1b5b730f1143" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_72afb055-573f-435d-9221-cec863f61f8e" xlink:href="hr-20230930.xsd#hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_72afb055-573f-435d-9221-cec863f61f8e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_84d1f57a-3403-4623-9c7b-99623a89cea7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_84d1f57a-3403-4623-9c7b-99623a89cea7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertyDispositions_b114569d-4888-41dc-90b4-3f9b795d228e" xlink:href="hr-20230930.xsd#hr_NumberOfPropertyDispositions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_NumberOfPropertyDispositions_b114569d-4888-41dc-90b4-3f9b795d228e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureOwnershipPercentage_6a222ebd-a97a-48d8-aee0-cf284a3c556b" xlink:href="hr-20230930.xsd#hr_JointVentureOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_JointVentureOwnershipPercentage_6a222ebd-a97a-48d8-aee0-cf284a3c556b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageNote_73692597-4e15-45f8-ba19-573236be131f" xlink:href="hr-20230930.xsd#hr_MortgageNote"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_MortgageNote_73692597-4e15-45f8-ba19-573236be131f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfLand_abb46edb-c42b-4bff-ae7e-30c6828650ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AreaOfLand"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_us-gaap_AreaOfLand_abb46edb-c42b-4bff-ae7e-30c6828650ca" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ScheduleOfRealEstateDispositionsTable_67235c83-334d-4bf3-b70a-63f53097f893" xlink:href="hr-20230930.xsd#hr_ScheduleOfRealEstateDispositionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_ScheduleOfRealEstateDispositionsTable_67235c83-334d-4bf3-b70a-63f53097f893" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f4fbfa87-37bf-45ea-8469-a36ae50cac2b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable_67235c83-334d-4bf3-b70a-63f53097f893" xlink:to="loc_srt_StatementGeographicalAxis_f4fbfa87-37bf-45ea-8469-a36ae50cac2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f4fbfa87-37bf-45ea-8469-a36ae50cac2b_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f4fbfa87-37bf-45ea-8469-a36ae50cac2b" xlink:to="loc_srt_SegmentGeographicalDomain_f4fbfa87-37bf-45ea-8469-a36ae50cac2b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f4fbfa87-37bf-45ea-8469-a36ae50cac2b" xlink:to="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TampaFLMiamiFLMember_1dd452a6-631a-410a-b45e-25b56fa82f6e" xlink:href="hr-20230930.xsd#hr_TampaFLMiamiFLMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:to="loc_hr_TampaFLMiamiFLMember_1dd452a6-631a-410a-b45e-25b56fa82f6e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DallasTXMember_66495ccf-e0b6-495d-a1d4-dd0f3026d309" xlink:href="hr-20230930.xsd#hr_DallasTXMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:to="loc_hr_DallasTXMember_66495ccf-e0b6-495d-a1d4-dd0f3026d309" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_STLouisMoMember_8f71ddc5-8b16-4188-98d1-7eb5debfc0ad" xlink:href="hr-20230930.xsd#hr_STLouisMoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:to="loc_hr_STLouisMoMember_8f71ddc5-8b16-4188-98d1-7eb5debfc0ad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LosAngelesCaliforniaMember_ed2247fe-d6ec-47ef-a077-8108dba20ce5" xlink:href="hr-20230930.xsd#hr_LosAngelesCaliforniaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:to="loc_hr_LosAngelesCaliforniaMember_ed2247fe-d6ec-47ef-a077-8108dba20ce5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AlbanyNYMember_5f3bfa97-72f5-41f5-99b3-51e936ad962a" xlink:href="hr-20230930.xsd#hr_AlbanyNYMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:to="loc_hr_AlbanyNYMember_5f3bfa97-72f5-41f5-99b3-51e936ad962a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HoustonTXMember_92954c96-385a-4f2b-8dea-d737eaf70d5d" xlink:href="hr-20230930.xsd#hr_HoustonTXMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:to="loc_hr_HoustonTXMember_92954c96-385a-4f2b-8dea-d737eaf70d5d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AtlantaGAMember_b1e05486-7d21-482d-ad9c-528ba48225ae" xlink:href="hr-20230930.xsd#hr_AtlantaGAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:to="loc_hr_AtlantaGAMember_b1e05486-7d21-482d-ad9c-528ba48225ae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ChicagoILMember_b968b642-250a-43d0-a024-584a0092d933" xlink:href="hr-20230930.xsd#hr_ChicagoILMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:to="loc_hr_ChicagoILMember_b968b642-250a-43d0-a024-584a0092d933" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_2eedc4dc-c30e-4bf4-941a-b4555e24ce1a" xlink:href="hr-20230930.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable_67235c83-334d-4bf3-b70a-63f53097f893" xlink:to="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_2eedc4dc-c30e-4bf4-941a-b4555e24ce1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_2eedc4dc-c30e-4bf4-941a-b4555e24ce1a_default" xlink:href="hr-20230930.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_2eedc4dc-c30e-4bf4-941a-b4555e24ce1a" xlink:to="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_2eedc4dc-c30e-4bf4-941a-b4555e24ce1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_70b00164-740c-4fe1-a86c-0ba46ae2dd22" xlink:href="hr-20230930.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_2eedc4dc-c30e-4bf4-941a-b4555e24ce1a" xlink:to="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_70b00164-740c-4fe1-a86c-0ba46ae2dd22" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsMember_c78c2a79-d203-4d93-b3d1-d3b52a47ac44" xlink:href="hr-20230930.xsd#hr_RealEstateDispositionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_70b00164-740c-4fe1-a86c-0ba46ae2dd22" xlink:to="loc_hr_RealEstateDispositionsMember_c78c2a79-d203-4d93-b3d1-d3b52a47ac44" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#RealEstateInvestmentsAssetsHeldforSaleDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongLivedAssetsHeldForSaleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertiesClassifiedAsHeldForSale_404d520b-dc14-4c7b-b493-096459b876b2" xlink:href="hr-20230930.xsd#hr_NumberOfPropertiesClassifiedAsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_hr_NumberOfPropertiesClassifiedAsHeldForSale_404d520b-dc14-4c7b-b493-096459b876b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfCorporateEntityClassifiedAsHeldForSale_0581fcc2-800c-4100-b6dd-7e36cc239eff" xlink:href="hr-20230930.xsd#hr_NumberOfCorporateEntityClassifiedAsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_hr_NumberOfCorporateEntityClassifiedAsHeldForSale_0581fcc2-800c-4100-b6dd-7e36cc239eff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale_c1c79372-bdc4-46cb-84e3-c12089e85b01" xlink:href="hr-20230930.xsd#hr_ImpairmentChargeOnRealEstateAssetsHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale_c1c79372-bdc4-46cb-84e3-c12089e85b01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_e13b17cb-1ed3-45a0-9cd2-a06510c0a52f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Land"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_Land_e13b17cb-1ed3-45a0-9cd2-a06510c0a52f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_4b2da176-d0a0-49bb-86f9-bfc01275f720" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_4b2da176-d0a0-49bb-86f9-bfc01275f720" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LeaseIntangibles_2d1da8e1-92d2-4220-a325-43744dc883fb" xlink:href="hr-20230930.xsd#hr_LeaseIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_hr_LeaseIntangibles_2d1da8e1-92d2-4220-a325-43744dc883fb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost_fb87c77a-4585-4a87-ba92-9c5de14d7c50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAtCost_fb87c77a-4585-4a87-ba92-9c5de14d7c50" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_7e4821fe-ad3f-4960-837b-78c8e380c374" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_7e4821fe-ad3f-4960-837b-78c8e380c374" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_16478f55-1399-4dca-b1c8-a8a3b0e52227" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_16478f55-1399-4dca-b1c8-a8a3b0e52227" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_98a77d76-7dd4-47ec-8e06-1e015802c8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_98a77d76-7dd4-47ec-8e06-1e015802c8fe" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_9d7be0ae-ecaa-4b2c-afb8-069d86c1cb48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_9d7be0ae-ecaa-4b2c-afb8-069d86c1cb48" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_fdd5a00d-d80e-4c61-9b5d-43a0e9a465a9" xlink:href="hr-20230930.xsd#hr_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_fdd5a00d-d80e-4c61-9b5d-43a0e9a465a9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_99aee7dd-965d-421c-9508-51d696ab2bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_99aee7dd-965d-421c-9508-51d696ab2bf6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_0b316693-3aad-4cbd-85d3-4ff6c34d634b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_OperatingLeaseLiability_0b316693-3aad-4cbd-85d3-4ff6c34d634b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_6003eb17-4316-46d3-8da1-052f261068f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_6003eb17-4316-46d3-8da1-052f261068f3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_abc9f97a-bc75-4e75-8a73-170fc58e3f27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_abc9f97a-bc75-4e75-8a73-170fc58e3f27" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_7b17bd5c-969f-4e9e-9409-31148444b79c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_7b17bd5c-969f-4e9e-9409-31148444b79c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_55d57601-cdcd-46ae-83cb-ad04a535a598" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_7b17bd5c-969f-4e9e-9409-31148444b79c" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_55d57601-cdcd-46ae-83cb-ad04a535a598" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_55d57601-cdcd-46ae-83cb-ad04a535a598_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_55d57601-cdcd-46ae-83cb-ad04a535a598" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_55d57601-cdcd-46ae-83cb-ad04a535a598_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_da75607e-ee45-42c8-bf65-48d89c22c51b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_55d57601-cdcd-46ae-83cb-ad04a535a598" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_da75607e-ee45-42c8-bf65-48d89c22c51b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_d64f6c5c-7e09-439a-96d7-b248bb453cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_da75607e-ee45-42c8-bf65-48d89c22c51b" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_d64f6c5c-7e09-439a-96d7-b248bb453cb3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesGroundLeasesDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#LeasesGroundLeasesDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/LeasesGroundLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_23d0d253-7372-476a-afb0-f94359e03988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfPropertiesSubjectToGroundLeases_05ad77ef-4a7e-4c3b-be92-4705700d9d09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfPropertiesSubjectToGroundLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_23d0d253-7372-476a-afb0-f94359e03988" xlink:to="loc_us-gaap_NumberOfPropertiesSubjectToGroundLeases_05ad77ef-4a7e-4c3b-be92-4705700d9d09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SquareFeetSubjecttoGroundLeases_a0d5940c-feeb-4cc0-9be5-05028c96b872" xlink:href="hr-20230930.xsd#hr_SquareFeetSubjecttoGroundLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_23d0d253-7372-476a-afb0-f94359e03988" xlink:to="loc_hr_SquareFeetSubjecttoGroundLeases_a0d5940c-feeb-4cc0-9be5-05028c96b872" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_34fd9005-2d86-43f6-89e3-8802eaa61f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_23d0d253-7372-476a-afb0-f94359e03988" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_34fd9005-2d86-43f6-89e3-8802eaa61f7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberofGroundLeasesPrepaid_99788ad4-a7dd-4afe-a56a-86fa114138ee" xlink:href="hr-20230930.xsd#hr_NumberofGroundLeasesPrepaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_23d0d253-7372-476a-afb0-f94359e03988" xlink:to="loc_hr_NumberofGroundLeasesPrepaid_99788ad4-a7dd-4afe-a56a-86fa114138ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AmortizationofPrepaidRent_4a0b85e8-ed27-4168-a797-76f6600be8f7" xlink:href="hr-20230930.xsd#hr_AmortizationofPrepaidRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_23d0d253-7372-476a-afb0-f94359e03988" xlink:to="loc_hr_AmortizationofPrepaidRent_4a0b85e8-ed27-4168-a797-76f6600be8f7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberofGroundLeasesExcludingPrepaidLeases_d303908b-00de-478d-aa13-54352c9ced20" xlink:href="hr-20230930.xsd#hr_NumberofGroundLeasesExcludingPrepaidLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_23d0d253-7372-476a-afb0-f94359e03988" xlink:to="loc_hr_NumberofGroundLeasesExcludingPrepaidLeases_d303908b-00de-478d-aa13-54352c9ced20" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_20138c7c-b548-4d98-a43e-d13d044c4dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_23d0d253-7372-476a-afb0-f94359e03988" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_20138c7c-b548-4d98-a43e-d13d044c4dd0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_981d2f24-1aef-40da-960f-792f6e7f36f0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_20138c7c-b548-4d98-a43e-d13d044c4dd0" xlink:to="loc_srt_RangeAxis_981d2f24-1aef-40da-960f-792f6e7f36f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_981d2f24-1aef-40da-960f-792f6e7f36f0_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_981d2f24-1aef-40da-960f-792f6e7f36f0" xlink:to="loc_srt_RangeMember_981d2f24-1aef-40da-960f-792f6e7f36f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f1b2584e-ef5a-423d-8619-5cc04b1ebde0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_981d2f24-1aef-40da-960f-792f6e7f36f0" xlink:to="loc_srt_RangeMember_f1b2584e-ef5a-423d-8619-5cc04b1ebde0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6a3158d7-034d-4439-bd7a-310446394c84" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f1b2584e-ef5a-423d-8619-5cc04b1ebde0" xlink:to="loc_srt_MinimumMember_6a3158d7-034d-4439-bd7a-310446394c84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_96c60023-74b8-4093-97b9-4b8aca5ed20e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f1b2584e-ef5a-423d-8619-5cc04b1ebde0" xlink:to="loc_srt_MaximumMember_96c60023-74b8-4093-97b9-4b8aca5ed20e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/NotesandBondsPayableDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#NotesandBondsPayableDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/NotesandBondsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a59673dd-8e07-4169-b338-e3ae4d1c6db9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_401bb514-3b4e-44ab-84a8-9dd0565e242a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59673dd-8e07-4169-b338-e3ae4d1c6db9" xlink:to="loc_us-gaap_LongTermDebt_401bb514-3b4e-44ab-84a8-9dd0565e242a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_b0b45a2f-c9b7-4f72-8bf7-beff0ac5bdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59673dd-8e07-4169-b338-e3ae4d1c6db9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_b0b45a2f-c9b7-4f72-8bf7-beff0ac5bdcd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b5139148-eabc-479a-af90-1ed4bee64173" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59673dd-8e07-4169-b338-e3ae4d1c6db9" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b5139148-eabc-479a-af90-1ed4bee64173" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_685f9599-a293-4912-b90a-ce8f2bdb3a68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59673dd-8e07-4169-b338-e3ae4d1c6db9" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_685f9599-a293-4912-b90a-ce8f2bdb3a68" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DebtInstrumentExtensionPeriodForMaturityDate_1bf97b92-ddf7-4b9b-ad77-b4aef98d3bce" xlink:href="hr-20230930.xsd#hr_DebtInstrumentExtensionPeriodForMaturityDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59673dd-8e07-4169-b338-e3ae4d1c6db9" xlink:to="loc_hr_DebtInstrumentExtensionPeriodForMaturityDate_1bf97b92-ddf7-4b9b-ad77-b4aef98d3bce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_b4230ad3-9336-4e72-aaac-d4eb48fe5ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59673dd-8e07-4169-b338-e3ae4d1c6db9" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_b4230ad3-9336-4e72-aaac-d4eb48fe5ccb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9f8af482-3466-4c31-af3e-c5eca95581c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59673dd-8e07-4169-b338-e3ae4d1c6db9" xlink:to="loc_us-gaap_DebtInstrumentTable_9f8af482-3466-4c31-af3e-c5eca95581c1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8bd1c421-32d7-4b65-b9d2-173b357bb014" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9f8af482-3466-4c31-af3e-c5eca95581c1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8bd1c421-32d7-4b65-b9d2-173b357bb014" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8bd1c421-32d7-4b65-b9d2-173b357bb014_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8bd1c421-32d7-4b65-b9d2-173b357bb014" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8bd1c421-32d7-4b65-b9d2-173b357bb014_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6959e4e0-b545-47fc-ac36-ec48d5d5b70b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8bd1c421-32d7-4b65-b9d2-173b357bb014" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6959e4e0-b545-47fc-ac36-ec48d5d5b70b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_969bc05d-a046-449b-b697-3892abeb40ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6959e4e0-b545-47fc-ac36-ec48d5d5b70b" xlink:to="loc_us-gaap_LineOfCreditMember_969bc05d-a046-449b-b697-3892abeb40ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_f00d1473-7c9f-4f18-901c-a3c02f12ede0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MediumTermNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6959e4e0-b545-47fc-ac36-ec48d5d5b70b" xlink:to="loc_us-gaap_MediumTermNotesMember_f00d1473-7c9f-4f18-901c-a3c02f12ede0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_671534b3-1d73-4a14-85b3-803c9f0680d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6959e4e0-b545-47fc-ac36-ec48d5d5b70b" xlink:to="loc_us-gaap_SeniorNotesMember_671534b3-1d73-4a14-85b3-803c9f0680d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_1485c015-e957-4b91-8c01-3470d0e8d5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgagesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6959e4e0-b545-47fc-ac36-ec48d5d5b70b" xlink:to="loc_us-gaap_MortgagesMember_1485c015-e957-4b91-8c01-3470d0e8d5a9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_81d187b2-3db1-40e7-930d-ee1ec139bcd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9f8af482-3466-4c31-af3e-c5eca95581c1" xlink:to="loc_us-gaap_DebtInstrumentAxis_81d187b2-3db1-40e7-930d-ee1ec139bcd8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_81d187b2-3db1-40e7-930d-ee1ec139bcd8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_81d187b2-3db1-40e7-930d-ee1ec139bcd8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_81d187b2-3db1-40e7-930d-ee1ec139bcd8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_81d187b2-3db1-40e7-930d-ee1ec139bcd8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_UnsecuredCreditFacilityOneMember_43922bac-a839-4657-add7-b48c02034d24" xlink:href="hr-20230930.xsd#hr_UnsecuredCreditFacilityOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_UnsecuredCreditFacilityOneMember_43922bac-a839-4657-add7-b48c02034d24" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDueMay2024Member_a62f9bc1-0192-4c97-92fb-baf9bfdada27" xlink:href="hr-20230930.xsd#hr_TermLoanDueMay2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_TermLoanDueMay2024Member_a62f9bc1-0192-4c97-92fb-baf9bfdada27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDueJuly2024Member_5d1094bc-7f26-4042-8bab-332cb37d2984" xlink:href="hr-20230930.xsd#hr_TermLoanDueJuly2024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_TermLoanDueJuly2024Member_5d1094bc-7f26-4042-8bab-332cb37d2984" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2025Member_ea9d0197-f98e-4a64-8efe-204f0271be7c" xlink:href="hr-20230930.xsd#hr_TermLoanDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_TermLoanDue2025Member_ea9d0197-f98e-4a64-8efe-204f0271be7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoandue2026Member_d5499d93-631a-4e9e-a27b-9d592a178d3d" xlink:href="hr-20230930.xsd#hr_TermLoandue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_TermLoandue2026Member_d5499d93-631a-4e9e-a27b-9d592a178d3d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2027Member_941ca346-f5e6-47ef-9321-2961dfe2b978" xlink:href="hr-20230930.xsd#hr_TermLoanDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_TermLoanDue2027Member_941ca346-f5e6-47ef-9321-2961dfe2b978" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2028Member_aecc1501-d387-4093-b099-d9fe03f01ffc" xlink:href="hr-20230930.xsd#hr_TermLoanDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_TermLoanDue2028Member_aecc1501-d387-4093-b099-d9fe03f01ffc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2025Member_91e4224d-7510-4ca1-b145-450cdd632df6" xlink:href="hr-20230930.xsd#hr_SeniorNotesdue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_SeniorNotesdue2025Member_91e4224d-7510-4ca1-b145-450cdd632df6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2026Member_4b1c1a35-97eb-4e03-85c8-e7ae05f66183" xlink:href="hr-20230930.xsd#hr_SeniorNotesDue2026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_SeniorNotesDue2026Member_4b1c1a35-97eb-4e03-85c8-e7ae05f66183" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2027Member_d2db5014-9580-480b-b3c8-ba2af06ea6b3" xlink:href="hr-20230930.xsd#hr_SeniorNotesDue2027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_SeniorNotesDue2027Member_d2db5014-9580-480b-b3c8-ba2af06ea6b3" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2028Member_509e6cb4-66d6-4882-a53a-2fda66466543" xlink:href="hr-20230930.xsd#hr_SeniorNotesdue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_SeniorNotesdue2028Member_509e6cb4-66d6-4882-a53a-2fda66466543" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_f49335b0-3e37-4a3a-b310-59fcd63dceee" xlink:href="hr-20230930.xsd#hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_f49335b0-3e37-4a3a-b310-59fcd63dceee" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2030Member_df7fe3a9-f6b8-4f69-9d69-852baf73e3f6" xlink:href="hr-20230930.xsd#hr_SeniorNotesdue2030Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_SeniorNotesdue2030Member_df7fe3a9-f6b8-4f69-9d69-852baf73e3f6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2031Member_975612cf-920f-44ef-b2cf-4e97a9142351" xlink:href="hr-20230930.xsd#hr_SeniorNotesDue2031Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_SeniorNotesDue2031Member_975612cf-920f-44ef-b2cf-4e97a9142351" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_9a2664f3-f906-4639-b249-eca084a2780e" xlink:href="hr-20230930.xsd#hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_9a2664f3-f906-4639-b249-eca084a2780e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageNotesPayableNetMember_0fb0588e-9302-418f-bd91-77152e84b426" xlink:href="hr-20230930.xsd#hr_MortgageNotesPayableNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_MortgageNotesPayableNetMember_0fb0588e-9302-418f-bd91-77152e84b426" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e36b1edb-ed4d-43a0-bf6a-7df05da5e956" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9f8af482-3466-4c31-af3e-c5eca95581c1" xlink:to="loc_srt_RangeAxis_e36b1edb-ed4d-43a0-bf6a-7df05da5e956" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e36b1edb-ed4d-43a0-bf6a-7df05da5e956_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_e36b1edb-ed4d-43a0-bf6a-7df05da5e956" xlink:to="loc_srt_RangeMember_e36b1edb-ed4d-43a0-bf6a-7df05da5e956_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6fc924c7-871d-4fa5-9c3a-06dad9205c6f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_e36b1edb-ed4d-43a0-bf6a-7df05da5e956" xlink:to="loc_srt_RangeMember_6fc924c7-871d-4fa5-9c3a-06dad9205c6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3010e10f-0a28-414c-8e85-dbaceca6868f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6fc924c7-871d-4fa5-9c3a-06dad9205c6f" xlink:to="loc_srt_MinimumMember_3010e10f-0a28-414c-8e85-dbaceca6868f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a27f4e8a-4971-4261-8137-33a04968fc8e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_6fc924c7-871d-4fa5-9c3a-06dad9205c6f" xlink:to="loc_srt_MaximumMember_a27f4e8a-4971-4261-8137-33a04968fc8e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#NotesandBondsPayableNarrativeDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f4e277de-5f10-4eb9-9140-f20af9efe797" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_3b31b187-ac0e-4b7f-a499-be3617ac3e29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4e277de-5f10-4eb9-9140-f20af9efe797" xlink:to="loc_us-gaap_LongTermDebt_3b31b187-ac0e-4b7f-a499-be3617ac3e29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SquareFeetSubjectToMortgageNotesPayable_75d8450b-b00b-470b-8b43-ac26c09806b8" xlink:href="hr-20230930.xsd#hr_SquareFeetSubjectToMortgageNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4e277de-5f10-4eb9-9140-f20af9efe797" xlink:to="loc_hr_SquareFeetSubjectToMortgageNotesPayable_75d8450b-b00b-470b-8b43-ac26c09806b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PercentageOfInterestBearingInMortgageNotesPayable_94011f6f-9b71-4a13-b1e6-a01749ede0d2" xlink:href="hr-20230930.xsd#hr_PercentageOfInterestBearingInMortgageNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4e277de-5f10-4eb9-9140-f20af9efe797" xlink:to="loc_hr_PercentageOfInterestBearingInMortgageNotesPayable_94011f6f-9b71-4a13-b1e6-a01749ede0d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_92e8a8f6-31b8-4da9-ac6a-b6e23947eeb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4e277de-5f10-4eb9-9140-f20af9efe797" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_92e8a8f6-31b8-4da9-ac6a-b6e23947eeb4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_ef51d069-ace5-40fd-9f40-07f08b0d53c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4e277de-5f10-4eb9-9140-f20af9efe797" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_ef51d069-ace5-40fd-9f40-07f08b0d53c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ExtinguishmentOfDebtEncumberedSquareFootage_c404b85e-08b4-46b2-b98b-80d14781c541" xlink:href="hr-20230930.xsd#hr_ExtinguishmentOfDebtEncumberedSquareFootage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4e277de-5f10-4eb9-9140-f20af9efe797" xlink:to="loc_hr_ExtinguishmentOfDebtEncumberedSquareFootage_c404b85e-08b4-46b2-b98b-80d14781c541" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_236af0c7-f3df-4c92-9ed9-2f07c9b97c70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4e277de-5f10-4eb9-9140-f20af9efe797" xlink:to="loc_us-gaap_DebtInstrumentTable_236af0c7-f3df-4c92-9ed9-2f07c9b97c70" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_7fcc8a89-8a4c-4299-9677-392683c8fbbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_236af0c7-f3df-4c92-9ed9-2f07c9b97c70" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_7fcc8a89-8a4c-4299-9677-392683c8fbbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_7fcc8a89-8a4c-4299-9677-392683c8fbbc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_7fcc8a89-8a4c-4299-9677-392683c8fbbc" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_7fcc8a89-8a4c-4299-9677-392683c8fbbc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_1f5db581-11b0-4463-8614-43f16afa32cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_7fcc8a89-8a4c-4299-9677-392683c8fbbc" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_1f5db581-11b0-4463-8614-43f16afa32cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_a5d4d348-5ac2-478a-9979-9361292744f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgagesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_1f5db581-11b0-4463-8614-43f16afa32cb" xlink:to="loc_us-gaap_MortgagesMember_a5d4d348-5ac2-478a-9979-9361292744f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f58cac1c-c525-49b1-ac04-f1fc1f870d45" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_236af0c7-f3df-4c92-9ed9-2f07c9b97c70" xlink:to="loc_srt_StatementGeographicalAxis_f58cac1c-c525-49b1-ac04-f1fc1f870d45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f58cac1c-c525-49b1-ac04-f1fc1f870d45_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f58cac1c-c525-49b1-ac04-f1fc1f870d45" xlink:to="loc_srt_SegmentGeographicalDomain_f58cac1c-c525-49b1-ac04-f1fc1f870d45_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0756c892-a837-4cec-a01c-72f25759fb7e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f58cac1c-c525-49b1-ac04-f1fc1f870d45" xlink:to="loc_srt_SegmentGeographicalDomain_0756c892-a837-4cec-a01c-72f25759fb7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CO_0acf8514-9aca-49bf-9aca-5b8a62a092ab" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_CO"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0756c892-a837-4cec-a01c-72f25759fb7e" xlink:to="loc_stpr_CO_0acf8514-9aca-49bf-9aca-5b8a62a092ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_GA_07cf4001-e153-463d-832a-9eb7859bf20e" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_GA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_0756c892-a837-4cec-a01c-72f25759fb7e" xlink:to="loc_stpr_GA_07cf4001-e153-463d-832a-9eb7859bf20e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5d9eb488-b6d7-465a-8925-b8f41c1d7665" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_236af0c7-f3df-4c92-9ed9-2f07c9b97c70" xlink:to="loc_us-gaap_DebtInstrumentAxis_5d9eb488-b6d7-465a-8925-b8f41c1d7665" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5d9eb488-b6d7-465a-8925-b8f41c1d7665_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_5d9eb488-b6d7-465a-8925-b8f41c1d7665" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5d9eb488-b6d7-465a-8925-b8f41c1d7665_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fb555237-ef44-4720-80ba-7e4c490dc06f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_5d9eb488-b6d7-465a-8925-b8f41c1d7665" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fb555237-ef44-4720-80ba-7e4c490dc06f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageNotesPayableNetMember_e4e1dbcf-3f32-4dae-96ff-9c1e3cd2d33f" xlink:href="hr-20230930.xsd#hr_MortgageNotesPayableNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fb555237-ef44-4720-80ba-7e4c490dc06f" xlink:to="loc_hr_MortgageNotesPayableNetMember_e4e1dbcf-3f32-4dae-96ff-9c1e3cd2d33f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_bae2084d-1f8c-4876-bc15-2c640c0734cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_236af0c7-f3df-4c92-9ed9-2f07c9b97c70" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_bae2084d-1f8c-4876-bc15-2c640c0734cc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_bae2084d-1f8c-4876-bc15-2c640c0734cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bae2084d-1f8c-4876-bc15-2c640c0734cc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_bae2084d-1f8c-4876-bc15-2c640c0734cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6820a52d-99c3-4bb1-a4b1-70549fe195e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bae2084d-1f8c-4876-bc15-2c640c0734cc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6820a52d-99c3-4bb1-a4b1-70549fe195e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_e61026fe-0419-4269-a615-4cd23b63d21f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgagesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6820a52d-99c3-4bb1-a4b1-70549fe195e7" xlink:to="loc_us-gaap_MortgagesMember_e61026fe-0419-4269-a615-4cd23b63d21f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5d3f541d-9db8-4225-b8a4-2696b47507cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_00082968-d187-44d2-a369-900d5996706d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5d3f541d-9db8-4225-b8a4-2696b47507cf" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_00082968-d187-44d2-a369-900d5996706d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_8159f35e-697c-494b-97da-d486f60fb07e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5d3f541d-9db8-4225-b8a4-2696b47507cf" xlink:to="loc_us-gaap_DerivativeNotionalAmount_8159f35e-697c-494b-97da-d486f60fb07e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_953f365e-814b-4aef-9c02-186e16fb3319" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5d3f541d-9db8-4225-b8a4-2696b47507cf" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_953f365e-814b-4aef-9c02-186e16fb3319" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfSwapTransactions_80e7587c-8cc8-4fd7-8b69-6489665cb516" xlink:href="hr-20230930.xsd#hr_NumberOfSwapTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_5d3f541d-9db8-4225-b8a4-2696b47507cf" xlink:to="loc_hr_NumberOfSwapTransactions_80e7587c-8cc8-4fd7-8b69-6489665cb516" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_629f7f53-6eb8-4100-b0bd-e2fb42bd88cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_5d3f541d-9db8-4225-b8a4-2696b47507cf" xlink:to="loc_us-gaap_DerivativeTable_629f7f53-6eb8-4100-b0bd-e2fb42bd88cc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7869d57c-49c0-4838-b96c-4b103f30c4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_629f7f53-6eb8-4100-b0bd-e2fb42bd88cc" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7869d57c-49c0-4838-b96c-4b103f30c4d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_7869d57c-49c0-4838-b96c-4b103f30c4d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7869d57c-49c0-4838-b96c-4b103f30c4d9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_7869d57c-49c0-4838-b96c-4b103f30c4d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_514cdf0b-4523-4114-8d3c-3d6456469268" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7869d57c-49c0-4838-b96c-4b103f30c4d9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_514cdf0b-4523-4114-8d3c-3d6456469268" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_514cdf0b-4523-4114-8d3c-3d6456469268" xlink:to="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJanuary152024Member_8d3aa9ea-37b5-4e53-98e0-c654d9f723fb" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringJanuary152024Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:to="loc_hr_InterestRateSwapExpiringJanuary152024Member_8d3aa9ea-37b5-4e53-98e0-c654d9f723fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringMay12026Member_6ed65aaf-5c82-439f-8792-37c29f24972d" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringMay12026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:to="loc_hr_InterestRateSwapExpiringMay12026Member_6ed65aaf-5c82-439f-8792-37c29f24972d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJune12026Member_dffd5f60-bf1c-499e-9ab8-ee5c1aa6d238" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringJune12026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:to="loc_hr_InterestRateSwapExpiringJune12026Member_dffd5f60-bf1c-499e-9ab8-ee5c1aa6d238" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringDecember12026Member_512425c6-57e5-44cf-ad3e-e5f42080e97b" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringDecember12026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:to="loc_hr_InterestRateSwapExpiringDecember12026Member_512425c6-57e5-44cf-ad3e-e5f42080e97b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJune12027Member_ab19ef54-e23e-4c85-a076-e4d01b1ab5f9" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringJune12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:to="loc_hr_InterestRateSwapExpiringJune12027Member_ab19ef54-e23e-4c85-a076-e4d01b1ab5f9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringDecember12027Member_792956bf-5202-4db3-8194-318f3f411e18" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringDecember12027Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:to="loc_hr_InterestRateSwapExpiringDecember12027Member_792956bf-5202-4db3-8194-318f3f411e18" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapEffectiveNovember12023Member_a3ead46b-479f-486e-bd18-1f07d3d241df" xlink:href="hr-20230930.xsd#hr_InterestRateSwapEffectiveNovember12023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:to="loc_hr_InterestRateSwapEffectiveNovember12023Member_a3ead46b-479f-486e-bd18-1f07d3d241df" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringMay312026Member_4aebb8d1-3664-45a8-8f5e-c1d23e16f517" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringMay312026Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:to="loc_hr_InterestRateSwapExpiringMay312026Member_4aebb8d1-3664-45a8-8f5e-c1d23e16f517" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_69522ca8-5c6a-4f84-9c5b-9a9d3aed34d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_629f7f53-6eb8-4100-b0bd-e2fb42bd88cc" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_69522ca8-5c6a-4f84-9c5b-9a9d3aed34d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_69522ca8-5c6a-4f84-9c5b-9a9d3aed34d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_69522ca8-5c6a-4f84-9c5b-9a9d3aed34d3" xlink:to="loc_us-gaap_HedgingRelationshipDomain_69522ca8-5c6a-4f84-9c5b-9a9d3aed34d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1e1e904c-fea2-4885-b734-797bb765b822" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_69522ca8-5c6a-4f84-9c5b-9a9d3aed34d3" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1e1e904c-fea2-4885-b734-797bb765b822" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_3192b3dc-ae6c-48ac-b442-1729e6b03e57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1e1e904c-fea2-4885-b734-797bb765b822" xlink:to="loc_us-gaap_CashFlowHedgingMember_3192b3dc-ae6c-48ac-b442-1729e6b03e57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_963ff422-5798-4066-b34a-3d500511c31c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_629f7f53-6eb8-4100-b0bd-e2fb42bd88cc" xlink:to="loc_us-gaap_HedgingDesignationAxis_963ff422-5798-4066-b34a-3d500511c31c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_963ff422-5798-4066-b34a-3d500511c31c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_963ff422-5798-4066-b34a-3d500511c31c" xlink:to="loc_us-gaap_HedgingDesignationDomain_963ff422-5798-4066-b34a-3d500511c31c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0a0d3bbd-5ea8-4d99-8287-c784a0d4effc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_963ff422-5798-4066-b34a-3d500511c31c" xlink:to="loc_us-gaap_HedgingDesignationDomain_0a0d3bbd-5ea8-4d99-8287-c784a0d4effc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8f59247d-33e1-467a-be1a-ad07e13390c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_0a0d3bbd-5ea8-4d99-8287-c784a0d4effc" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8f59247d-33e1-467a-be1a-ad07e13390c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d727c4f8-a0d3-4e23-9380-bd1e95d48953" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_629f7f53-6eb8-4100-b0bd-e2fb42bd88cc" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d727c4f8-a0d3-4e23-9380-bd1e95d48953" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_d727c4f8-a0d3-4e23-9380-bd1e95d48953_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d727c4f8-a0d3-4e23-9380-bd1e95d48953" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_d727c4f8-a0d3-4e23-9380-bd1e95d48953_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4602f617-9793-451b-b806-ef0cea3ddba7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d727c4f8-a0d3-4e23-9380-bd1e95d48953" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4602f617-9793-451b-b806-ef0cea3ddba7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_552e421e-0110-416d-bee5-de70d403ccab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4602f617-9793-451b-b806-ef0cea3ddba7" xlink:to="loc_us-gaap_SubsequentEventMember_552e421e-0110-416d-bee5-de70d403ccab" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_eb88ea24-5465-42d3-a789-b70c0477dc22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_65465ec8-ef40-4042-bdce-4ec9457a30a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_eb88ea24-5465-42d3-a789-b70c0477dc22" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_65465ec8-ef40-4042-bdce-4ec9457a30a7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_725a2d68-8cb4-49dc-952e-1447dd609f25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_eb88ea24-5465-42d3-a789-b70c0477dc22" xlink:to="loc_us-gaap_DerivativeTable_725a2d68-8cb4-49dc-952e-1447dd609f25" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f7720394-b769-4857-b9c5-a0859521bda4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_725a2d68-8cb4-49dc-952e-1447dd609f25" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f7720394-b769-4857-b9c5-a0859521bda4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f7720394-b769-4857-b9c5-a0859521bda4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f7720394-b769-4857-b9c5-a0859521bda4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f7720394-b769-4857-b9c5-a0859521bda4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_80f4a06e-e55a-4d26-a3d6-be10273e47f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f7720394-b769-4857-b9c5-a0859521bda4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_80f4a06e-e55a-4d26-a3d6-be10273e47f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_a44df26d-66ce-4507-a488-c9340fc2184a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_80f4a06e-e55a-4d26-a3d6-be10273e47f6" xlink:to="loc_us-gaap_OtherAssetsMember_a44df26d-66ce-4507-a488-c9340fc2184a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_25bd4b1f-1a2d-4b4d-ad31-f8e9cb5ec44a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_725a2d68-8cb4-49dc-952e-1447dd609f25" xlink:to="loc_us-gaap_HedgingDesignationAxis_25bd4b1f-1a2d-4b4d-ad31-f8e9cb5ec44a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_25bd4b1f-1a2d-4b4d-ad31-f8e9cb5ec44a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_25bd4b1f-1a2d-4b4d-ad31-f8e9cb5ec44a" xlink:to="loc_us-gaap_HedgingDesignationDomain_25bd4b1f-1a2d-4b4d-ad31-f8e9cb5ec44a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c8f08c9d-7757-454e-b212-7f7889a0d7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_25bd4b1f-1a2d-4b4d-ad31-f8e9cb5ec44a" xlink:to="loc_us-gaap_HedgingDesignationDomain_c8f08c9d-7757-454e-b212-7f7889a0d7c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_199a61e2-3973-4db4-a3ee-ec80c92af20c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_c8f08c9d-7757-454e-b212-7f7889a0d7c7" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_199a61e2-3973-4db4-a3ee-ec80c92af20c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c1a172f1-d384-4f7b-aa76-9ab1ee07b7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_725a2d68-8cb4-49dc-952e-1447dd609f25" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c1a172f1-d384-4f7b-aa76-9ab1ee07b7f4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_c1a172f1-d384-4f7b-aa76-9ab1ee07b7f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c1a172f1-d384-4f7b-aa76-9ab1ee07b7f4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_c1a172f1-d384-4f7b-aa76-9ab1ee07b7f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_03b1df0d-f2db-49c9-b79e-f54b55942354" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c1a172f1-d384-4f7b-aa76-9ab1ee07b7f4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_03b1df0d-f2db-49c9-b79e-f54b55942354" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_58f5f79d-c29f-404e-aaff-c497d7960bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_03b1df0d-f2db-49c9-b79e-f54b55942354" xlink:to="loc_us-gaap_InterestRateSwapMember_58f5f79d-c29f-404e-aaff-c497d7960bd5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ceead61b-702d-48cd-a802-09f1b62c29a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_06834169-8861-4a82-b004-ae962af407f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ceead61b-702d-48cd-a802-09f1b62c29a6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_06834169-8861-4a82-b004-ae962af407f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_ffea17c9-e0a6-444e-9eed-f80c3e2468d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_ceead61b-702d-48cd-a802-09f1b62c29a6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_ffea17c9-e0a6-444e-9eed-f80c3e2468d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_412dcf56-913a-425d-acb9-216e6bf9243c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_ceead61b-702d-48cd-a802-09f1b62c29a6" xlink:to="loc_us-gaap_DerivativeTable_412dcf56-913a-425d-acb9-216e6bf9243c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0bfabd6f-27a3-4d1c-a0db-587f0600c2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_412dcf56-913a-425d-acb9-216e6bf9243c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0bfabd6f-27a3-4d1c-a0db-587f0600c2ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0bfabd6f-27a3-4d1c-a0db-587f0600c2ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0bfabd6f-27a3-4d1c-a0db-587f0600c2ec" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0bfabd6f-27a3-4d1c-a0db-587f0600c2ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2003bbf1-2a1a-4153-aa9c-abc1b38be3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0bfabd6f-27a3-4d1c-a0db-587f0600c2ec" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2003bbf1-2a1a-4153-aa9c-abc1b38be3a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_cfa81425-d327-4de4-870b-be253a9d9a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2003bbf1-2a1a-4153-aa9c-abc1b38be3a3" xlink:to="loc_us-gaap_InterestRateContractMember_cfa81425-d327-4de4-870b-be253a9d9a1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_feceb373-5f39-4540-b9b2-80d86ccb478b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryLockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2003bbf1-2a1a-4153-aa9c-abc1b38be3a3" xlink:to="loc_us-gaap_TreasuryLockMember_feceb373-5f39-4540-b9b2-80d86ccb478b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3f308acb-36b0-453b-81ec-42f2a99448de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2003bbf1-2a1a-4153-aa9c-abc1b38be3a3" xlink:to="loc_us-gaap_InterestRateSwapMember_3f308acb-36b0-453b-81ec-42f2a99448de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6b722db8-c443-4663-b997-469f5766fc7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_412dcf56-913a-425d-acb9-216e6bf9243c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6b722db8-c443-4663-b997-469f5766fc7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6b722db8-c443-4663-b997-469f5766fc7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6b722db8-c443-4663-b997-469f5766fc7d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6b722db8-c443-4663-b997-469f5766fc7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cda3fe00-ffb9-43e7-b870-328194bc58e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6b722db8-c443-4663-b997-469f5766fc7d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cda3fe00-ffb9-43e7-b870-328194bc58e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_fe582cc9-e82c-418e-b04d-4ffffb9eedd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cda3fe00-ffb9-43e7-b870-328194bc58e3" xlink:to="loc_us-gaap_InterestExpenseMember_fe582cc9-e82c-418e-b04d-4ffffb9eedd7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_a926b9c1-26e4-4a65-8d67-7e50ec663e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_29834e7b-ce47-484b-b3c2-efa636885352" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a926b9c1-26e4-4a65-8d67-7e50ec663e3d" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_29834e7b-ce47-484b-b3c2-efa636885352" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DerivativeNetAssetPositionAggregateFairValue_7974b21b-47da-4cee-a5ac-9fdf0723df7c" xlink:href="hr-20230930.xsd#hr_DerivativeNetAssetPositionAggregateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_a926b9c1-26e4-4a65-8d67-7e50ec663e3d" xlink:to="loc_hr_DerivativeNetAssetPositionAggregateFairValue_7974b21b-47da-4cee-a5ac-9fdf0723df7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_2751c891-6209-4187-91de-515b4f960fba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_a926b9c1-26e4-4a65-8d67-7e50ec663e3d" xlink:to="loc_us-gaap_DerivativeTable_2751c891-6209-4187-91de-515b4f960fba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2c5f3a89-0e0a-4cbb-8d69-51af1c76202d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_2751c891-6209-4187-91de-515b4f960fba" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2c5f3a89-0e0a-4cbb-8d69-51af1c76202d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2c5f3a89-0e0a-4cbb-8d69-51af1c76202d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2c5f3a89-0e0a-4cbb-8d69-51af1c76202d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2c5f3a89-0e0a-4cbb-8d69-51af1c76202d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d064c5bc-0ebb-4375-b2f7-ce3a690e9533" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2c5f3a89-0e0a-4cbb-8d69-51af1c76202d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d064c5bc-0ebb-4375-b2f7-ce3a690e9533" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ActiveInterestRateSwapsMember_d75ffe34-27ba-4598-a08b-6dad66706a43" xlink:href="hr-20230930.xsd#hr_ActiveInterestRateSwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d064c5bc-0ebb-4375-b2f7-ce3a690e9533" xlink:to="loc_hr_ActiveInterestRateSwapsMember_d75ffe34-27ba-4598-a08b-6dad66706a43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SettledInterestRateSwapsMember_d3a94731-e65e-4e33-a4a2-e9d4f629539a" xlink:href="hr-20230930.xsd#hr_SettledInterestRateSwapsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d064c5bc-0ebb-4375-b2f7-ce3a690e9533" xlink:to="loc_hr_SettledInterestRateSwapsMember_d3a94731-e65e-4e33-a4a2-e9d4f629539a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#CommitmentandContingenciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_db7291e4-3516-4c99-9659-cbd1bd336a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ConstructionActivityTotalFundingDuringthePeriod_cdd98077-43b4-4c14-8a15-dc53e5c0bcd9" xlink:href="hr-20230930.xsd#hr_ConstructionActivityTotalFundingDuringthePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_db7291e4-3516-4c99-9659-cbd1bd336a2a" xlink:to="loc_hr_ConstructionActivityTotalFundingDuringthePeriod_cdd98077-43b4-4c14-8a15-dc53e5c0bcd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureOwnershipPercentage_03ced195-f862-4826-af88-a998a5d2232b" xlink:href="hr-20230930.xsd#hr_JointVentureOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_db7291e4-3516-4c99-9659-cbd1bd336a2a" xlink:to="loc_hr_JointVentureOwnershipPercentage_03ced195-f862-4826-af88-a998a5d2232b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLand_002b098a-4e07-4b4c-a0aa-f76ab2c47096" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireLand"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_db7291e4-3516-4c99-9659-cbd1bd336a2a" xlink:to="loc_us-gaap_PaymentsToAcquireLand_002b098a-4e07-4b4c-a0aa-f76ab2c47096" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_1f95de7f-2130-4a2b-8f4f-54407d29b3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_db7291e4-3516-4c99-9659-cbd1bd336a2a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_1f95de7f-2130-4a2b-8f4f-54407d29b3b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_fbecb712-bdac-4fbd-a1ba-fa025750004e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_db7291e4-3516-4c99-9659-cbd1bd336a2a" xlink:to="loc_us-gaap_OtherCommitmentsTable_fbecb712-bdac-4fbd-a1ba-fa025750004e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_615cf883-6b3c-458c-8680-2fab16938d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_fbecb712-bdac-4fbd-a1ba-fa025750004e" xlink:to="loc_us-gaap_OtherCommitmentsAxis_615cf883-6b3c-458c-8680-2fab16938d4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_615cf883-6b3c-458c-8680-2fab16938d4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OtherCommitmentsAxis_615cf883-6b3c-458c-8680-2fab16938d4c" xlink:to="loc_us-gaap_OtherCommitmentsDomain_615cf883-6b3c-458c-8680-2fab16938d4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_b4ce202b-09c5-44a3-99cf-d7e7d601ef3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OtherCommitmentsAxis_615cf883-6b3c-458c-8680-2fab16938d4c" xlink:to="loc_us-gaap_OtherCommitmentsDomain_b4ce202b-09c5-44a3-99cf-d7e7d601ef3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ActiveDevelopmentPropertiesMember_e8931e60-efb5-4871-b023-c0b903d89798" xlink:href="hr-20230930.xsd#hr_ActiveDevelopmentPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_b4ce202b-09c5-44a3-99cf-d7e7d601ef3f" xlink:to="loc_hr_ActiveDevelopmentPropertiesMember_e8931e60-efb5-4871-b023-c0b903d89798" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RedevelopmentPropertiesMember_cb114273-6b83-451c-b09c-545b4a5bda74" xlink:href="hr-20230930.xsd#hr_RedevelopmentPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_b4ce202b-09c5-44a3-99cf-d7e7d601ef3f" xlink:to="loc_hr_RedevelopmentPropertiesMember_cb114273-6b83-451c-b09c-545b4a5bda74" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember_ef7aa6eb-183d-4572-b356-36800513e5d7" xlink:href="hr-20230930.xsd#hr_CompletedDevelpomentAndRedevelopmentPropertiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsDomain_b4ce202b-09c5-44a3-99cf-d7e7d601ef3f" xlink:to="loc_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember_ef7aa6eb-183d-4572-b356-36800513e5d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_28fac134-f8bb-4738-8c5c-b9198a2a142f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_fbecb712-bdac-4fbd-a1ba-fa025750004e" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_28fac134-f8bb-4738-8c5c-b9198a2a142f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_28fac134-f8bb-4738-8c5c-b9198a2a142f_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_28fac134-f8bb-4738-8c5c-b9198a2a142f" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_28fac134-f8bb-4738-8c5c-b9198a2a142f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_2ca94b33-afed-4ff7-88e2-327615a82341" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_28fac134-f8bb-4738-8c5c-b9198a2a142f" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_2ca94b33-afed-4ff7-88e2-327615a82341" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MedicalOfficeBuildingMember_3b528792-fb05-4788-88db-ae3e2f0b2317" xlink:href="hr-20230930.xsd#hr_MedicalOfficeBuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_2ca94b33-afed-4ff7-88e2-327615a82341" xlink:to="loc_hr_MedicalOfficeBuildingMember_3b528792-fb05-4788-88db-ae3e2f0b2317" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_654280c0-f319-43d9-97e0-03d42bb586df" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_fbecb712-bdac-4fbd-a1ba-fa025750004e" xlink:to="loc_srt_StatementGeographicalAxis_654280c0-f319-43d9-97e0-03d42bb586df" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_654280c0-f319-43d9-97e0-03d42bb586df_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_654280c0-f319-43d9-97e0-03d42bb586df" xlink:to="loc_srt_SegmentGeographicalDomain_654280c0-f319-43d9-97e0-03d42bb586df_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a61c0bfc-3d67-4813-b514-f6dbb61a6c66" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_654280c0-f319-43d9-97e0-03d42bb586df" xlink:to="loc_srt_SegmentGeographicalDomain_a61c0bfc-3d67-4813-b514-f6dbb61a6c66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ScottsdaleArizonaMember_041e18e3-7eba-4301-8d68-a067d93d8e6a" xlink:href="hr-20230930.xsd#hr_ScottsdaleArizonaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_a61c0bfc-3d67-4813-b514-f6dbb61a6c66" xlink:to="loc_hr_ScottsdaleArizonaMember_041e18e3-7eba-4301-8d68-a067d93d8e6a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_ba915ed7-930b-4334-9535-3886ab9b06a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_3921e174-9fe4-4776-aff4-24df8b50c81e" xlink:href="hr-20230930.xsd#hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba915ed7-930b-4334-9535-3886ab9b06a0" xlink:to="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_3921e174-9fe4-4776-aff4-24df8b50c81e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_28cdb0aa-de11-4ef3-8724-8f7ef80be203" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_3921e174-9fe4-4776-aff4-24df8b50c81e" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_28cdb0aa-de11-4ef3-8724-8f7ef80be203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_5d62ceff-07df-449c-ba9d-19d91ccff235" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_3921e174-9fe4-4776-aff4-24df8b50c81e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_5d62ceff-07df-449c-ba9d-19d91ccff235" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_7804fed1-2613-44b2-8b24-df76d4af2ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_3921e174-9fe4-4776-aff4-24df8b50c81e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_7804fed1-2613-44b2-8b24-df76d4af2ea8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_07b5ecd1-4b1f-4d24-b901-76d9303fc762" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_5adeda43-0159-4de3-990d-3991fbfaaa4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba915ed7-930b-4334-9535-3886ab9b06a0" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_5adeda43-0159-4de3-990d-3991fbfaaa4c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_bdf4827c-ff12-4662-8f46-d04281e602bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_5adeda43-0159-4de3-990d-3991fbfaaa4c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_bdf4827c-ff12-4662-8f46-d04281e602bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_bdf4827c-ff12-4662-8f46-d04281e602bb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_bdf4827c-ff12-4662-8f46-d04281e602bb" xlink:to="loc_us-gaap_EquityComponentDomain_bdf4827c-ff12-4662-8f46-d04281e602bb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_edcbbb77-534f-4bc5-9f56-f04d24fd1345" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_bdf4827c-ff12-4662-8f46-d04281e602bb" xlink:to="loc_us-gaap_EquityComponentDomain_edcbbb77-534f-4bc5-9f56-f04d24fd1345" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_91dfb0b7-1fc7-45e2-ac35-5624e4d51b42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_edcbbb77-534f-4bc5-9f56-f04d24fd1345" xlink:to="loc_us-gaap_CommonStockMember_91dfb0b7-1fc7-45e2-ac35-5624e4d51b42" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#StockholdersEquityStockTransactionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityOfferingProgramAvailableForIssuance_e9922026-a2a1-4a0d-b0d7-a2295cebce2c" xlink:href="hr-20230930.xsd#hr_EquityOfferingProgramAvailableForIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_hr_EquityOfferingProgramAvailableForIssuance_e9922026-a2a1-4a0d-b0d7-a2295cebce2c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d2f9adc2-73fb-48dd-b4b8-0a08db6adf79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d2f9adc2-73fb-48dd-b4b8-0a08db6adf79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_e9076662-d12c-40cd-8b08-22ba660b3ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_e9076662-d12c-40cd-8b08-22ba660b3ae4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_f3af0ff9-1831-4155-b0e5-e400e4e7263c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_f3af0ff9-1831-4155-b0e5-e400e4e7263c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_82bac3ce-b057-4a6e-b009-4bc9aea6e501" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_82bac3ce-b057-4a6e-b009-4bc9aea6e501" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_d43fe16e-0660-4a3e-a850-ce55b2c7f2b9" xlink:href="hr-20230930.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_d43fe16e-0660-4a3e-a850-ce55b2c7f2b9" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e23bdfea-65cc-45fa-9fa3-f94d792be59d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e23bdfea-65cc-45fa-9fa3-f94d792be59d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0a61a94b-6803-478e-b842-e52bfe6ac682" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0a61a94b-6803-478e-b842-e52bfe6ac682" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfDirectors_40eda02e-4acc-4e79-a582-218c0e7fbcfc" xlink:href="hr-20230930.xsd#hr_NumberOfDirectors"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_hr_NumberOfDirectors_40eda02e-4acc-4e79-a582-218c0e7fbcfc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_40109285-1a77-4ca4-b107-5fc69391848c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_40109285-1a77-4ca4-b107-5fc69391848c" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PercentageOfRestrictedStockUnits_9cbab4b1-37e8-47d0-8a6f-a29b9702dcc2" xlink:href="hr-20230930.xsd#hr_PercentageOfRestrictedStockUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_hr_PercentageOfRestrictedStockUnits_9cbab4b1-37e8-47d0-8a6f-a29b9702dcc2" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_244109a9-6724-4c11-94ec-ee039919debb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_244109a9-6724-4c11-94ec-ee039919debb" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_5223be96-3e6a-47e6-af8d-620f1095854c" xlink:href="hr-20230930.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_5223be96-3e6a-47e6-af8d-620f1095854c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_e40b9f29-de5a-4aed-aaa0-cdf2f7a56c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_e40b9f29-de5a-4aed-aaa0-cdf2f7a56c3c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4ea0ca2a-5780-40e3-b394-dac755f08046" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4ea0ca2a-5780-40e3-b394-dac755f08046" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_4ea0ca2a-5780-40e3-b394-dac755f08046_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4ea0ca2a-5780-40e3-b394-dac755f08046" xlink:to="loc_us-gaap_EquityComponentDomain_4ea0ca2a-5780-40e3-b394-dac755f08046_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_789de6e6-ac10-46cd-b6a9-9a0827ca670e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4ea0ca2a-5780-40e3-b394-dac755f08046" xlink:to="loc_us-gaap_EquityComponentDomain_789de6e6-ac10-46cd-b6a9-9a0827ca670e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_fa05c5a9-4133-478e-8676-13019af49f54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_789de6e6-ac10-46cd-b6a9-9a0827ca670e" xlink:to="loc_us-gaap_CommonStockMember_fa05c5a9-4133-478e-8676-13019af49f54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f5f6a03a-53d1-4dfd-89a6-fbed23c5eb0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f5f6a03a-53d1-4dfd-89a6-fbed23c5eb0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f5f6a03a-53d1-4dfd-89a6-fbed23c5eb0d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f5f6a03a-53d1-4dfd-89a6-fbed23c5eb0d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_f5f6a03a-53d1-4dfd-89a6-fbed23c5eb0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ec16521b-0a72-444e-9e65-215ba32db12d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f5f6a03a-53d1-4dfd-89a6-fbed23c5eb0d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ec16521b-0a72-444e-9e65-215ba32db12d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_81436a28-23a8-4914-899a-0980f6654cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ec16521b-0a72-444e-9e65-215ba32db12d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_81436a28-23a8-4914-899a-0980f6654cc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_81d4e006-c9c3-474c-a9e5-d6e0b64a805c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_us-gaap_AwardTypeAxis_81d4e006-c9c3-474c-a9e5-d6e0b64a805c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81d4e006-c9c3-474c-a9e5-d6e0b64a805c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_81d4e006-c9c3-474c-a9e5-d6e0b64a805c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_81d4e006-c9c3-474c-a9e5-d6e0b64a805c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22b3e8ec-e233-4a85-88b9-ed5cb3468d29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_81d4e006-c9c3-474c-a9e5-d6e0b64a805c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22b3e8ec-e233-4a85-88b9-ed5cb3468d29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember_e5da0fc9-69a7-421a-a9dd-fa02d5d46f3c" xlink:href="hr-20230930.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22b3e8ec-e233-4a85-88b9-ed5cb3468d29" xlink:to="loc_hr_OperatingPartnershipPerformanceUnitsMember_e5da0fc9-69a7-421a-a9dd-fa02d5d46f3c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonVestedStockAwardMember_793ea54a-f067-41fe-b45e-698aaf1c079b" xlink:href="hr-20230930.xsd#hr_NonVestedStockAwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22b3e8ec-e233-4a85-88b9-ed5cb3468d29" xlink:to="loc_hr_NonVestedStockAwardMember_793ea54a-f067-41fe-b45e-698aaf1c079b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_0fbca455-086c-4a0b-b703-41a06610e75a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22b3e8ec-e233-4a85-88b9-ed5cb3468d29" xlink:to="loc_us-gaap_RestrictedStockMember_0fbca455-086c-4a0b-b703-41a06610e75a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f139ed14-cf11-4c31-a982-bef13326e7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22b3e8ec-e233-4a85-88b9-ed5cb3468d29" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f139ed14-cf11-4c31-a982-bef13326e7c5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_fe3bc9e5-347d-49f3-97ef-10fbd03ff4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_us-gaap_PlanNameAxis_fe3bc9e5-347d-49f3-97ef-10fbd03ff4ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fe3bc9e5-347d-49f3-97ef-10fbd03ff4ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_fe3bc9e5-347d-49f3-97ef-10fbd03ff4ce" xlink:to="loc_us-gaap_PlanNameDomain_fe3bc9e5-347d-49f3-97ef-10fbd03ff4ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_bc36ce78-9bd4-40ae-a7d4-886b0193db88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_fe3bc9e5-347d-49f3-97ef-10fbd03ff4ce" xlink:to="loc_us-gaap_PlanNameDomain_bc36ce78-9bd4-40ae-a7d4-886b0193db88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ExecutiveIncentiveProgramMember_4077f1c4-21c8-41e3-9669-347fa203f01e" xlink:href="hr-20230930.xsd#hr_ExecutiveIncentiveProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_bc36ce78-9bd4-40ae-a7d4-886b0193db88" xlink:to="loc_hr_ExecutiveIncentiveProgramMember_4077f1c4-21c8-41e3-9669-347fa203f01e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LongTermIncentiveProgramDUnitsMember_da8ec19a-f6b4-451e-9556-f43adc4c0254" xlink:href="hr-20230930.xsd#hr_LongTermIncentiveProgramDUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_bc36ce78-9bd4-40ae-a7d4-886b0193db88" xlink:to="loc_hr_LongTermIncentiveProgramDUnitsMember_da8ec19a-f6b4-451e-9556-f43adc4c0254" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIncentivePlanMember_dc5a2320-c493-4819-a474-6f68f1c94233" xlink:href="hr-20230930.xsd#hr_StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_bc36ce78-9bd4-40ae-a7d4-886b0193db88" xlink:to="loc_hr_StockIncentivePlanMember_dc5a2320-c493-4819-a474-6f68f1c94233" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_05e5b04d-6a02-4d31-8f5b-d25c28dcf2f3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_srt_RangeAxis_05e5b04d-6a02-4d31-8f5b-d25c28dcf2f3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_05e5b04d-6a02-4d31-8f5b-d25c28dcf2f3_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_05e5b04d-6a02-4d31-8f5b-d25c28dcf2f3" xlink:to="loc_srt_RangeMember_05e5b04d-6a02-4d31-8f5b-d25c28dcf2f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8b05016c-3710-4289-b361-885566e236a2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_05e5b04d-6a02-4d31-8f5b-d25c28dcf2f3" xlink:to="loc_srt_RangeMember_8b05016c-3710-4289-b361-885566e236a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_98cb2d20-68c7-418b-9443-34e5155f9624" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8b05016c-3710-4289-b361-885566e236a2" xlink:to="loc_srt_MinimumMember_98cb2d20-68c7-418b-9443-34e5155f9624" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7081aca6-a5c7-4e1f-8feb-93cab5bff1e2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8b05016c-3710-4289-b361-885566e236a2" xlink:to="loc_srt_MaximumMember_7081aca6-a5c7-4e1f-8feb-93cab5bff1e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_61f857ec-be0b-4d48-8c78-66a985118efa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_srt_TitleOfIndividualAxis_61f857ec-be0b-4d48-8c78-66a985118efa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_61f857ec-be0b-4d48-8c78-66a985118efa_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_61f857ec-be0b-4d48-8c78-66a985118efa" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_61f857ec-be0b-4d48-8c78-66a985118efa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_df6cf5ff-c80f-418d-8948-72afb2cef048" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_61f857ec-be0b-4d48-8c78-66a985118efa" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_df6cf5ff-c80f-418d-8948-72afb2cef048" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DirectorsMember_48b31ee2-185d-404c-8093-48d228278bb0" xlink:href="hr-20230930.xsd#hr_DirectorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_df6cf5ff-c80f-418d-8948-72afb2cef048" xlink:to="loc_hr_DirectorsMember_48b31ee2-185d-404c-8093-48d228278bb0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NewEmployeeMember_47693e66-6e7e-4a3e-b4f0-dc0b49d44292" xlink:href="hr-20230930.xsd#hr_NewEmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_df6cf5ff-c80f-418d-8948-72afb2cef048" xlink:to="loc_hr_NewEmployeeMember_47693e66-6e7e-4a3e-b4f0-dc0b49d44292" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramAxis_fb2875d9-3b5c-4de7-94ec-46589d2f3f03" xlink:href="hr-20230930.xsd#hr_StockIssuanceProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_hr_StockIssuanceProgramAxis_fb2875d9-3b5c-4de7-94ec-46589d2f3f03" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramDomain_fb2875d9-3b5c-4de7-94ec-46589d2f3f03_default" xlink:href="hr-20230930.xsd#hr_StockIssuanceProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_hr_StockIssuanceProgramAxis_fb2875d9-3b5c-4de7-94ec-46589d2f3f03" xlink:to="loc_hr_StockIssuanceProgramDomain_fb2875d9-3b5c-4de7-94ec-46589d2f3f03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramDomain_f71a0639-9034-430d-a4a6-c2976cb0ed25" xlink:href="hr-20230930.xsd#hr_StockIssuanceProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_hr_StockIssuanceProgramAxis_fb2875d9-3b5c-4de7-94ec-46589d2f3f03" xlink:to="loc_hr_StockIssuanceProgramDomain_f71a0639-9034-430d-a4a6-c2976cb0ed25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PerformanceConditionsMember_7b4e0a2b-faba-4f8a-bf4d-80f2244d6845" xlink:href="hr-20230930.xsd#hr_PerformanceConditionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_StockIssuanceProgramDomain_f71a0639-9034-430d-a4a6-c2976cb0ed25" xlink:to="loc_hr_PerformanceConditionsMember_7b4e0a2b-faba-4f8a-bf4d-80f2244d6845" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MarketCondition1Member_76d897b6-d696-4fed-bd38-06d376debf24" xlink:href="hr-20230930.xsd#hr_MarketCondition1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_PerformanceConditionsMember_7b4e0a2b-faba-4f8a-bf4d-80f2244d6845" xlink:to="loc_hr_MarketCondition1Member_76d897b6-d696-4fed-bd38-06d376debf24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MarketCondition2Member_f5e3ce68-3f69-4323-bb88-f3e954dc3426" xlink:href="hr-20230930.xsd#hr_MarketCondition2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_hr_PerformanceConditionsMember_7b4e0a2b-faba-4f8a-bf4d-80f2244d6845" xlink:to="loc_hr_MarketCondition2Member_f5e3ce68-3f69-4323-bb88-f3e954dc3426" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_27384e57-0550-4d7e-951a-ecdb2d053e17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_us-gaap_GranteeStatusAxis_27384e57-0550-4d7e-951a-ecdb2d053e17" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_27384e57-0550-4d7e-951a-ecdb2d053e17_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_27384e57-0550-4d7e-951a-ecdb2d053e17" xlink:to="loc_us-gaap_GranteeStatusDomain_27384e57-0550-4d7e-951a-ecdb2d053e17_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_3919d36f-7037-4f8e-b075-97ea4ab356cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_27384e57-0550-4d7e-951a-ecdb2d053e17" xlink:to="loc_us-gaap_GranteeStatusDomain_3919d36f-7037-4f8e-b075-97ea4ab356cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_68d01cb2-059a-45fd-9aca-1fae583a3abe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_3919d36f-7037-4f8e-b075-97ea4ab356cb" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_68d01cb2-059a-45fd-9aca-1fae583a3abe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_31f06a15-8e94-4dce-bdc4-b14fac856bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_31f06a15-8e94-4dce-bdc4-b14fac856bd7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_31f06a15-8e94-4dce-bdc4-b14fac856bd7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_31f06a15-8e94-4dce-bdc4-b14fac856bd7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_31f06a15-8e94-4dce-bdc4-b14fac856bd7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_59c42c33-f238-4984-8e74-37c0916cb7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_31f06a15-8e94-4dce-bdc4-b14fac856bd7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_59c42c33-f238-4984-8e74-37c0916cb7a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_bec00e8a-62e9-401c-b828-f899a652332d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_59c42c33-f238-4984-8e74-37c0916cb7a1" xlink:to="loc_us-gaap_SubsequentEventMember_bec00e8a-62e9-401c-b828-f899a652332d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_67fad1a6-8e54-4cd1-81d5-0d72e0398145" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ee06874-b9ee-4e02-9582-38cfc3c891e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_67fad1a6-8e54-4cd1-81d5-0d72e0398145" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ee06874-b9ee-4e02-9582-38cfc3c891e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64fa36f5-0eaa-4d9f-a45c-2a99ecaa8560" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ee06874-b9ee-4e02-9582-38cfc3c891e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64fa36f5-0eaa-4d9f-a45c-2a99ecaa8560" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e9f1f5ef-8724-4ad1-9636-feaca855e550" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ee06874-b9ee-4e02-9582-38cfc3c891e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e9f1f5ef-8724-4ad1-9636-feaca855e550" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_801f787b-a28f-44b7-a31c-86e10c5ebd19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ee06874-b9ee-4e02-9582-38cfc3c891e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_801f787b-a28f-44b7-a31c-86e10c5ebd19" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod_499353b5-e9da-40d6-958a-6483c3c8c910" xlink:href="hr-20230930.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ee06874-b9ee-4e02-9582-38cfc3c891e7" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod_499353b5-e9da-40d6-958a-6483c3c8c910" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_21dcf360-e147-4ede-bbfe-9ae0242ecb0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ee06874-b9ee-4e02-9582-38cfc3c891e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_21dcf360-e147-4ede-bbfe-9ae0242ecb0d" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7c0c98b-eb24-481f-aa25-fadc427a12f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f08c12e7-c0a4-49f0-8d6b-8574a6cfd39c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_67fad1a6-8e54-4cd1-81d5-0d72e0398145" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f08c12e7-c0a4-49f0-8d6b-8574a6cfd39c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1aab2074-7426-4eb4-92ad-ad8ef2efe452" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f08c12e7-c0a4-49f0-8d6b-8574a6cfd39c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1aab2074-7426-4eb4-92ad-ad8ef2efe452" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6a18b396-9076-4d0d-966d-9630af01f7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f08c12e7-c0a4-49f0-8d6b-8574a6cfd39c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6a18b396-9076-4d0d-966d-9630af01f7e6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_ca8b909f-abaf-4ec7-b0ae-ee6f7b8b465d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f08c12e7-c0a4-49f0-8d6b-8574a6cfd39c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_ca8b909f-abaf-4ec7-b0ae-ee6f7b8b465d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue_78eb650d-0949-4427-97a7-d40a88d54cd9" xlink:href="hr-20230930.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f08c12e7-c0a4-49f0-8d6b-8574a6cfd39c" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue_78eb650d-0949-4427-97a7-d40a88d54cd9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3ac69b30-81a6-4b93-92e6-e6f5a1a6a10b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_89dc24d7-9a63-476e-b6dc-432af5ddee64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_67fad1a6-8e54-4cd1-81d5-0d72e0398145" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_89dc24d7-9a63-476e-b6dc-432af5ddee64" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1d50065c-0fb7-4912-a29f-d7f40124ab14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_89dc24d7-9a63-476e-b6dc-432af5ddee64" xlink:to="loc_us-gaap_PlanNameAxis_1d50065c-0fb7-4912-a29f-d7f40124ab14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_1d50065c-0fb7-4912-a29f-d7f40124ab14_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_1d50065c-0fb7-4912-a29f-d7f40124ab14" xlink:to="loc_us-gaap_PlanNameDomain_1d50065c-0fb7-4912-a29f-d7f40124ab14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c087108f-8986-42bd-85b9-dc02765ebe0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_1d50065c-0fb7-4912-a29f-d7f40124ab14" xlink:to="loc_us-gaap_PlanNameDomain_c087108f-8986-42bd-85b9-dc02765ebe0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIncentivePlanMember_3fc97c90-7abd-4a8b-ac2c-725dc3cb7d99" xlink:href="hr-20230930.xsd#hr_StockIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_c087108f-8986-42bd-85b9-dc02765ebe0a" xlink:to="loc_hr_StockIncentivePlanMember_3fc97c90-7abd-4a8b-ac2c-725dc3cb7d99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f92d4a26-ab05-4efb-b433-fae116bcd9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_89dc24d7-9a63-476e-b6dc-432af5ddee64" xlink:to="loc_us-gaap_AwardTypeAxis_f92d4a26-ab05-4efb-b433-fae116bcd9ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f92d4a26-ab05-4efb-b433-fae116bcd9ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f92d4a26-ab05-4efb-b433-fae116bcd9ca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f92d4a26-ab05-4efb-b433-fae116bcd9ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bdc2a3f0-0745-4558-a6ce-9b512c4050fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f92d4a26-ab05-4efb-b433-fae116bcd9ca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bdc2a3f0-0745-4558-a6ce-9b512c4050fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e2719fc9-f711-4a36-b643-9ee88e516eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bdc2a3f0-0745-4558-a6ce-9b512c4050fd" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e2719fc9-f711-4a36-b643-9ee88e516eb0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e89b8a84-f996-4405-8c4b-0c7f0ceb8ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_51b4eb97-b183-4395-8bff-7db79bb0d64c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e89b8a84-f996-4405-8c4b-0c7f0ceb8ec4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_51b4eb97-b183-4395-8bff-7db79bb0d64c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_80f54fe6-2dfe-4ec3-ad5d-eef2c5e43576" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_51b4eb97-b183-4395-8bff-7db79bb0d64c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_80f54fe6-2dfe-4ec3-ad5d-eef2c5e43576" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6ed14b34-a3a7-4763-9b0f-41d15e3119d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_51b4eb97-b183-4395-8bff-7db79bb0d64c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6ed14b34-a3a7-4763-9b0f-41d15e3119d2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_897e830f-73ea-4536-a0dd-8f7ed49f1cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_51b4eb97-b183-4395-8bff-7db79bb0d64c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_897e830f-73ea-4536-a0dd-8f7ed49f1cfe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_1bee252e-98b0-4e52-b7ce-20f9981320bf" xlink:href="hr-20230930.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_51b4eb97-b183-4395-8bff-7db79bb0d64c" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_1bee252e-98b0-4e52-b7ce-20f9981320bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a743e650-759d-4f1a-928b-323201163aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e89b8a84-f996-4405-8c4b-0c7f0ceb8ec4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a743e650-759d-4f1a-928b-323201163aeb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f8c7da9a-ae97-4756-be53-69c9774a3105" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a743e650-759d-4f1a-928b-323201163aeb" xlink:to="loc_us-gaap_AwardTypeAxis_f8c7da9a-ae97-4756-be53-69c9774a3105" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f8c7da9a-ae97-4756-be53-69c9774a3105_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f8c7da9a-ae97-4756-be53-69c9774a3105" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f8c7da9a-ae97-4756-be53-69c9774a3105_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_656f0893-b53c-49aa-bef5-174b59192144" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f8c7da9a-ae97-4756-be53-69c9774a3105" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_656f0893-b53c-49aa-bef5-174b59192144" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_fd0a76ee-d2b9-4be9-a567-1ccc92350771" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_656f0893-b53c-49aa-bef5-174b59192144" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_fd0a76ee-d2b9-4be9-a567-1ccc92350771" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember_403c29d6-d907-47ae-9e86-8f79b57c40f2" xlink:href="hr-20230930.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_656f0893-b53c-49aa-bef5-174b59192144" xlink:to="loc_hr_OperatingPartnershipPerformanceUnitsMember_403c29d6-d907-47ae-9e86-8f79b57c40f2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e2cd9936-fa9b-4ecc-b789-6e78a6095320" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9e2c850e-c471-476e-baf8-5ca2c83f8325" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e2cd9936-fa9b-4ecc-b789-6e78a6095320" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9e2c850e-c471-476e-baf8-5ca2c83f8325" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2f469b2f-153e-498a-ae0b-3844e56059ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9e2c850e-c471-476e-baf8-5ca2c83f8325" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2f469b2f-153e-498a-ae0b-3844e56059ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_39ff47ac-07c3-4789-89c2-ae07e43f06b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9e2c850e-c471-476e-baf8-5ca2c83f8325" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_39ff47ac-07c3-4789-89c2-ae07e43f06b8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1005ce65-d9ad-48ca-8c91-d4148911cded" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9e2c850e-c471-476e-baf8-5ca2c83f8325" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1005ce65-d9ad-48ca-8c91-d4148911cded" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_5a85e15c-b9a8-4012-a84c-6767233e8155" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9e2c850e-c471-476e-baf8-5ca2c83f8325" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_5a85e15c-b9a8-4012-a84c-6767233e8155" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3ef93a4b-24b7-4800-beec-ffa8c3407bac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9e2c850e-c471-476e-baf8-5ca2c83f8325" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3ef93a4b-24b7-4800-beec-ffa8c3407bac" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_14f05550-0483-48e7-baf7-41a0606fb066" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcd463ab-65d6-4355-9e3d-0992dfbd4cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e2cd9936-fa9b-4ecc-b789-6e78a6095320" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcd463ab-65d6-4355-9e3d-0992dfbd4cf0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b9a058b0-896e-46c6-a410-37625428da7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcd463ab-65d6-4355-9e3d-0992dfbd4cf0" xlink:to="loc_us-gaap_AwardTypeAxis_b9a058b0-896e-46c6-a410-37625428da7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9a058b0-896e-46c6-a410-37625428da7f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b9a058b0-896e-46c6-a410-37625428da7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9a058b0-896e-46c6-a410-37625428da7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a24a76c2-1d22-4336-80d0-697e7b2526b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b9a058b0-896e-46c6-a410-37625428da7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a24a76c2-1d22-4336-80d0-697e7b2526b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_6a48fdc3-b529-4a30-8820-91732349b8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a24a76c2-1d22-4336-80d0-697e7b2526b6" xlink:to="loc_us-gaap_EmployeeStockMember_6a48fdc3-b529-4a30-8820-91732349b8b4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#FairValueofFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e3fc6369-6ff8-47b5-befc-fee09d1aa947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_49f27af1-ce51-4cf3-9a72-e035e8af3de3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e3fc6369-6ff8-47b5-befc-fee09d1aa947" xlink:to="loc_us-gaap_DebtInstrumentFairValue_49f27af1-ce51-4cf3-9a72-e035e8af3de3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_207bfd98-1c83-49a6-8369-d08a3a86ae6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_e3fc6369-6ff8-47b5-befc-fee09d1aa947" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_207bfd98-1c83-49a6-8369-d08a3a86ae6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_7d007235-4d74-47c9-8d06-47a3852c6330" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_e3fc6369-6ff8-47b5-befc-fee09d1aa947" xlink:to="loc_us-gaap_DerivativeTable_7d007235-4d74-47c9-8d06-47a3852c6330" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_5eb3d3c1-eb73-4a69-9967-791220f6c094" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_7d007235-4d74-47c9-8d06-47a3852c6330" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_5eb3d3c1-eb73-4a69-9967-791220f6c094" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5eb3d3c1-eb73-4a69-9967-791220f6c094_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_5eb3d3c1-eb73-4a69-9967-791220f6c094" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_5eb3d3c1-eb73-4a69-9967-791220f6c094_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_ceab21f8-5b56-4991-a0b6-bffbec891710" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_5eb3d3c1-eb73-4a69-9967-791220f6c094" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_ceab21f8-5b56-4991-a0b6-bffbec891710" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9b1e4a5d-db63-45fc-8adc-da99d5c5fafa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_ceab21f8-5b56-4991-a0b6-bffbec891710" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9b1e4a5d-db63-45fc-8adc-da99d5c5fafa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_616fc658-e574-4929-b7ff-9d50c055fa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9b1e4a5d-db63-45fc-8adc-da99d5c5fafa" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_616fc658-e574-4929-b7ff-9d50c055fa2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dc4914fa-d3bd-4015-bcb6-312d80e79425" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9b1e4a5d-db63-45fc-8adc-da99d5c5fafa" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dc4914fa-d3bd-4015-bcb6-312d80e79425" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTypeOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockMember" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember_cb4a0af1-2064-4092-8e95-c4a7f39e24d7" xlink:href="hr-20230930.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_hr_OperatingPartnershipPerformanceUnitsMember_cb4a0af1-2064-4092-8e95-c4a7f39e24d7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonVestedStockAwardMember_87996b7a-1254-4dfd-98a8-5a7b00f064ac" xlink:href="hr-20230930.xsd#hr_NonVestedStockAwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_hr_NonVestedStockAwardMember_87996b7a-1254-4dfd-98a8-5a7b00f064ac" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockMember" xlink:type="arc" order="8"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>hr-20230930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:73dbfdf1-2054-4a25-8023-7c5130a0cc11,g:80064ddd-1403-40d2-9d20-e881ce80ef55-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale_351f85d1-4cd3-4604-926a-62a6e4430b83_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale, net</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Held For Sale</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_d73bb378-6ffa-4461-b7cd-b82d691631f4_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete_fd23da1e-254e-4113-a849-5c466b9a9c65_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill adjustment incomplete</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Provisional Information Initial Accounting Goodwill Adjustment Incomplete</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Provisional Information Initial Accounting Goodwill Adjustment Incomplete</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_508d046a-0e3f-4f4f-86d5-1ebd7fef2d7f_totalLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total real estate investments</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Real Estate Investments</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Real Estate Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_27b0fed8-2f13-49b7-9383-39f17a80423f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_2c18b065-5b42-4de3-b562-a90e7e058389_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ReceivablesAndOtherAssets_9877770d-f707-4f88-922a-913423d3809f_terseLabel_en-US" xlink:label="lab_hr_ReceivablesAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables and other assets</link:label>
    <link:label id="lab_hr_ReceivablesAndOtherAssets_label_en-US" xlink:label="lab_hr_ReceivablesAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables And Other Assets</link:label>
    <link:label id="lab_hr_ReceivablesAndOtherAssets_documentation_en-US" xlink:label="lab_hr_ReceivablesAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables And Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReceivablesAndOtherAssets" xlink:href="hr-20230930.xsd#hr_ReceivablesAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ReceivablesAndOtherAssets" xlink:to="lab_hr_ReceivablesAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29f78f55-1625-466e-9a0b-637d836abafc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_763c55d8-0f0f-4578-b2d8-1128c1539ab1_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberofGroundLeasesPrepaid_301fde1b-f5bc-4f79-9b9b-372430f85b00_terseLabel_en-US" xlink:label="lab_hr_NumberofGroundLeasesPrepaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of prepaid ground leases</link:label>
    <link:label id="lab_hr_NumberofGroundLeasesPrepaid_label_en-US" xlink:label="lab_hr_NumberofGroundLeasesPrepaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Ground Leases Prepaid</link:label>
    <link:label id="lab_hr_NumberofGroundLeasesPrepaid_documentation_en-US" xlink:label="lab_hr_NumberofGroundLeasesPrepaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Ground Leases Prepaid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberofGroundLeasesPrepaid" xlink:href="hr-20230930.xsd#hr_NumberofGroundLeasesPrepaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberofGroundLeasesPrepaid" xlink:to="lab_hr_NumberofGroundLeasesPrepaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements_9321a5ce-63b5-4bc3-ac1e-67e370b04e5e_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of forward equity shares (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Equity Forward Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_661c4320-d44f-43f7-b38c-96830e7c5725_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CASH CONSIDERATION</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_e19e5e65-54ca-4151-9341-94d6be39caba_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash consideration</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_3373c312-72cc-471f-b693-bb8692c7a8d5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Values of the Assets Acquired And Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan_2752fae0-5370-4c74-b04b-e4c43c038514_verboseLabel_en-US" xlink:label="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Employee Stock Purchase Plan</link:label>
    <link:label id="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan_documentation_en-US" xlink:label="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental common shares attributable to dilutive effect of employee stock purchase plan.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" xlink:href="hr-20230930.xsd#hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" xlink:to="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ChicagoILMember_8a562de8-4d00-473f-aa0f-45f8eebd8409_terseLabel_en-US" xlink:label="lab_hr_ChicagoILMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chicago, IL</link:label>
    <link:label id="lab_hr_ChicagoILMember_label_en-US" xlink:label="lab_hr_ChicagoILMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chicago, IL [Member]</link:label>
    <link:label id="lab_hr_ChicagoILMember_documentation_en-US" xlink:label="lab_hr_ChicagoILMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chicago, IL</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ChicagoILMember" xlink:href="hr-20230930.xsd#hr_ChicagoILMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ChicagoILMember" xlink:to="lab_hr_ChicagoILMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_2774bc86-8e6f-4988-bf22-74aee4534429_totalLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Acquired</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_4b8a8098-c630-421d-a880-670ae363e609_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures_b9a55a79-5386-42b4-bca1-17d94dd6435d_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in unconsolidated joint ventures</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investments in Unconsolidated Joint Ventures</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investments in Unconsolidated Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_005ca8e7-7190-4d07-a721-93e71c3d0ce7_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_5b6e7f58-fe15-4fea-97d0-f0539757e737_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_d687c0e0-d016-43d7-8cd2-a00d3aa3e97a_terseLabel_en-US" xlink:label="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET REAL ESTATE INVESTMENT</link:label>
    <link:label id="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_label_en-US" xlink:label="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment Net Disposed of During Period</link:label>
    <link:label id="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_documentation_en-US" xlink:label="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate investment net disposed of during the Period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateInvestmentNetDisposedOfDuringPeriod" xlink:href="hr-20230930.xsd#hr_RealEstateInvestmentNetDisposedOfDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateInvestmentNetDisposedOfDuringPeriod" xlink:to="lab_hr_RealEstateInvestmentNetDisposedOfDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_915173ba-738e-4c04-85d7-d9387bdddfe3_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_182a7a13-b8c6-4edb-a47e-58c8fc41cf59_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_62de0eaa-68f7-4666-b3fe-5de6d9bf5456_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested share-based awards, net of withheld shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_0a247f14-51c0-4490-bab9-a8b21dbf92dc_terseLabel_en-US" xlink:label="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 and thereafter</link:label>
    <link:label id="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:href="hr-20230930.xsd#hr_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_hr_FinanceLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_d19e8789-b32c-41c8-ba62-9fc673a00efe_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from redeemable non-controlling interests</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Period Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:to="lab_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests_1625d083-1384-460b-9250-d049efdc8e3c_verboseLabel_en-US" xlink:label="lab_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contributions from redeemable non-controlling interests</link:label>
    <link:label id="lab_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests_label_en-US" xlink:label="lab_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Contributions from Redeemable Noncontrolling Interests</link:label>
    <link:label id="lab_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests_documentation_en-US" xlink:label="lab_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Contributions from Redeemable Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests" xlink:href="hr-20230930.xsd#hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests" xlink:to="lab_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_b9f38130-e0d5-4974-98fd-7f2f6ed38d2e_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $.01 par value per share; 200,000 shares authorized; none issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_326df83d-a736-40b3-a2b4-3df1581962b2_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireNotesReceivable_12212b99-1d0f-43e0-a2d4-50be937068be_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding of mortgages and notes receivable</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireNotesReceivable_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireNotesReceivable" xlink:to="lab_us-gaap_PaymentsToAcquireNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_ff1f71b8-d024-49bc-a157-1dff8af2debf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividendsCommonStock" xlink:to="lab_us-gaap_PaymentsOfDividendsCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_a70ab332-d1cc-49f1-a158-03355acc8a04_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_95a703ec-113d-4fab-81ea-304fdb5b36b2_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings per common share- net income (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_VariableInterestEntityMember_7b2f8423-a208-4027-8122-4a1893775cf8_terseLabel_en-US" xlink:label="lab_hr_VariableInterestEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:label id="lab_hr_VariableInterestEntityMember_label_en-US" xlink:label="lab_hr_VariableInterestEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Member]</link:label>
    <link:label id="lab_hr_VariableInterestEntityMember_documentation_en-US" xlink:label="lab_hr_VariableInterestEntityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_VariableInterestEntityMember" xlink:href="hr-20230930.xsd#hr_VariableInterestEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_VariableInterestEntityMember" xlink:to="lab_hr_VariableInterestEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss_2909a9e0-c3f5-45f7-9df3-c2536b30624e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Financing Receivable, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" xlink:to="lab_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_94148bea-dc82-4de0-9166-15cc36777029_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustments for (gains) losses included in net income (interest expense)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_dae83984-55ce-4722-9edf-992d48509534_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification adjustments for gains included in net income (interest expense)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_0768fa86-41ac-4e2e-a9a7-a49be17544bd_negatedNetLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) Loss, Reclassified from AOCI into income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_TX_8d2224d2-9d6f-42ec-a2ec-13dcbdca1ad6_verboseLabel_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Texas</link:label>
    <link:label id="lab_stpr_TX_30d7100e-6d8b-4452-8b7c-d5b618d169e7_terseLabel_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Texas</link:label>
    <link:label id="lab_stpr_TX_label_en-US" xlink:label="lab_stpr_TX" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">TEXAS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_TX"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_TX" xlink:to="lab_stpr_TX" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_06a15c47-bf54-449d-8d3d-eee97dbd33d2_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding principal repaid</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_37bef70a-eae0-46c1-b50b-d46bc62370d4_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_ffa98a2f-4545-40f7-b939-8f8af399f804_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_485ab6b7-dfdf-41a6-8c1d-92a2e3f86e69_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapExpiringMay312026Member_d94d5df6-c880-4a89-9f1a-4aa842653c1a_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapExpiringMay312026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring May 31, 2026</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringMay312026Member_label_en-US" xlink:label="lab_hr_InterestRateSwapExpiringMay312026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring May 31, 2026 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringMay312026Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapExpiringMay312026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring May 31, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringMay312026Member" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringMay312026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapExpiringMay312026Member" xlink:to="lab_hr_InterestRateSwapExpiringMay312026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_a1d9fef1-d5af-4236-a1f5-8bae2cfb84a3_totalLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_732a4233-4589-4816-bd66-10770ae823f8_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders_20c18c97-ad65-449d-88a5-5dccf3a0c1fc_verboseLabel_en-US" xlink:label="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative net income attributable to common stockholders</link:label>
    <link:label id="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders_label_en-US" xlink:label="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Net Income Attributable to Common Stockholders</link:label>
    <link:label id="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders_documentation_en-US" xlink:label="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative net income attributable to common stockholders.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetIncomeAttributableToCommonStockholders" xlink:href="hr-20230930.xsd#hr_CumulativeNetIncomeAttributableToCommonStockholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_CumulativeNetIncomeAttributableToCommonStockholders" xlink:to="lab_hr_CumulativeNetIncomeAttributableToCommonStockholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_85f17818-eced-48d4-8ca0-65cb2539a228_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings (Loss) per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ExtinguishmentOfDebtEncumberedSquareFootage_5f3eeba6-c13b-4433-b0f7-2d262e9a0b88_terseLabel_en-US" xlink:label="lab_hr_ExtinguishmentOfDebtEncumberedSquareFootage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Encumbered square footage</link:label>
    <link:label id="lab_hr_ExtinguishmentOfDebtEncumberedSquareFootage_label_en-US" xlink:label="lab_hr_ExtinguishmentOfDebtEncumberedSquareFootage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Encumbered Square Footage</link:label>
    <link:label id="lab_hr_ExtinguishmentOfDebtEncumberedSquareFootage_documentation_en-US" xlink:label="lab_hr_ExtinguishmentOfDebtEncumberedSquareFootage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Encumbered Square Footage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ExtinguishmentOfDebtEncumberedSquareFootage" xlink:href="hr-20230930.xsd#hr_ExtinguishmentOfDebtEncumberedSquareFootage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ExtinguishmentOfDebtEncumberedSquareFootage" xlink:to="lab_hr_ExtinguishmentOfDebtEncumberedSquareFootage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquisitionCosts_25eb2867-caf3-44e5-8abb-126685344904_terseLabel_en-US" xlink:label="lab_us-gaap_AcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and pursuit costs</link:label>
    <link:label id="lab_us-gaap_AcquisitionCosts_label_en-US" xlink:label="lab_us-gaap_AcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition Costs, Period Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquisitionCosts" xlink:to="lab_us-gaap_AcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_79948a7f-e744-45d0-b516-437a02f300b8_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f5bd93fc-b670-41af-b8f0-4dfb2b5a0133_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of the activity under the incentive plans</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_e14d89d3-ba91-4a33-8c39-6995414a4617_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_974e73df-a4c6-4fc5-bad6-5688b18d0395_terseLabel_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARRYING VALUE</link:label>
    <link:label id="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reported Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:to="lab_us-gaap_CarryingReportedAmountFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_b75638e9-33bb-449c-b825-66b145b84be8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_e5fb3591-b6a9-4081-b5ea-73a849f54b9a_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingRelationshipDomain_label_en-US" xlink:label="lab_us-gaap_HedgingRelationshipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingRelationshipDomain" xlink:to="lab_us-gaap_HedgingRelationshipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared_4d756f3c-195a-4393-8a57-21d24a491f3e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Owner distributions</link:label>
    <link:label id="lab_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared_label_en-US" xlink:label="lab_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution Made to Limited Liability Company (LLC) Member, Cash Distributions Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" xlink:to="lab_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_2ba8c48a-3669-4cad-b37d-61dd33766a37_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ALLOWANCE FOR CREDIT LOSSES</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_11cebd54-b57c-47b0-b5a5-13c87d27a28c_periodStartLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses, beginning of period</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_480cc857-c7b0-4920-a75a-d1115aab9271_periodEndLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit losses, end of period</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d3a13d46-cc93-474b-8557-315d9a801f25_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7a324944-ee49-4f5f-abd1-fcf3cfc2d3e9_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_18935206-0e4d-4073-95b7-44fc7cd4c789_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SettledInterestRateSwapsMember_6ccb9398-cf37-4024-aeba-b3db6b324eb0_terseLabel_en-US" xlink:label="lab_hr_SettledInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Interest Rate Swaps</link:label>
    <link:label id="lab_hr_SettledInterestRateSwapsMember_label_en-US" xlink:label="lab_hr_SettledInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Interest Rate Swaps [Member]</link:label>
    <link:label id="lab_hr_SettledInterestRateSwapsMember_documentation_en-US" xlink:label="lab_hr_SettledInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled Interest Rate Swaps</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SettledInterestRateSwapsMember" xlink:href="hr-20230930.xsd#hr_SettledInterestRateSwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SettledInterestRateSwapsMember" xlink:to="lab_hr_SettledInterestRateSwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_62959f05-9192-4681-bfd9-9b5770300e84_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AMOUNT</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidCapitalized_e187dfae-b445-423a-8076-bf8f10f238c2_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidCapitalized_label_en-US" xlink:label="lab_us-gaap_InterestPaidCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Capitalized, Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidCapitalized" xlink:to="lab_us-gaap_InterestPaidCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_3ec05c65-b638-4285-bff8-79b8251bb00d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_91539374-fa42-40be-9e8d-80a45e3a0bee_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other information</link:label>
    <link:label id="lab_us-gaap_LeasesOperatingAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesOperatingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Operating [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesOperatingAbstract" xlink:to="lab_us-gaap_LeasesOperatingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_c171164f-4b26-42ef-a3fc-80368ca1107b_terseLabel_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement</link:label>
    <link:label id="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion at Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_180c7872-1970-400c-be86-c06bc7b8b9c9_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and bonds payable</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-Term Debt</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfMediumTermNotes_a410850f-32e9-4e71-8e29-1908b44327ab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfMediumTermNotes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment on term loan</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfMediumTermNotes_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfMediumTermNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Medium-term Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfMediumTermNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfMediumTermNotes" xlink:to="lab_us-gaap_RepaymentsOfMediumTermNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_StraightlineRentLiability_ec44f2a1-4f58-43bb-8ba1-58c6af5801f1_terseLabel_en-US" xlink:label="lab_hr_StraightlineRentLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of straight-line rent on operating leases (lessee)</link:label>
    <link:label id="lab_hr_StraightlineRentLiability_label_en-US" xlink:label="lab_hr_StraightlineRentLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Straight-line Rent Liability</link:label>
    <link:label id="lab_hr_StraightlineRentLiability_documentation_en-US" xlink:label="lab_hr_StraightlineRentLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Straight-line rent liability.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StraightlineRentLiability" xlink:href="hr-20230930.xsd#hr_StraightlineRentLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_StraightlineRentLiability" xlink:to="lab_hr_StraightlineRentLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_e83ffaec-39a9-444a-b276-22b9c1fe0613_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_StraightLineRentReceivable_1371f798-6673-4c98-abc1-6fd22ccac3fc_negatedLabel_en-US" xlink:label="lab_hr_StraightLineRentReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of straight-line rent receivable (lessor)</link:label>
    <link:label id="lab_hr_StraightLineRentReceivable_label_en-US" xlink:label="lab_hr_StraightLineRentReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Straight-line Rent Receivable</link:label>
    <link:label id="lab_hr_StraightLineRentReceivable_documentation_en-US" xlink:label="lab_hr_StraightLineRentReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Straight-line rent receivable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StraightLineRentReceivable" xlink:href="hr-20230930.xsd#hr_StraightLineRentReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_StraightLineRentReceivable" xlink:to="lab_hr_StraightLineRentReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_6cdb9503-a04f-4261-9b34-b27266725274_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_73d15c74-9f51-487b-9018-e7d51ffb0f89_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Real Estate Acquisitions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgagesMember_9fc181ab-ba38-4ec6-b164-05d259c5fc63_terseLabel_en-US" xlink:label="lab_us-gaap_MortgagesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgages</link:label>
    <link:label id="lab_us-gaap_MortgagesMember_label_en-US" xlink:label="lab_us-gaap_MortgagesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgages [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgagesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgagesMember" xlink:to="lab_us-gaap_MortgagesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_498982a7-bb29-4272-84fa-f56abb2703da_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ConsolidationVariableInterestEntityPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Variable Interest Entity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:to="lab_us-gaap_ConsolidationVariableInterestEntityPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_1254694a-bb86-490c-a77f-d9af382e1680_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_8633c162-cae0-40d8-9159-10aa3ae6dee1_terseLabel_en-US" xlink:label="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Entities Not Determined to be VIEs</link:label>
    <link:label id="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_label_en-US" xlink:label="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Entities Not Determined to be VIEs [Member]</link:label>
    <link:label id="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_documentation_en-US" xlink:label="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property Entities Not Determined to be VIEs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PropertyEntitiesNotDeterminedToBeVIEsMember" xlink:href="hr-20230930.xsd#hr_PropertyEntitiesNotDeterminedToBeVIEsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_PropertyEntitiesNotDeterminedToBeVIEsMember" xlink:to="lab_hr_PropertyEntitiesNotDeterminedToBeVIEsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_2760fa27-dac2-4494-acdf-5491d560a7e8_terseLabel_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 and thereafter</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_label_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, after Year Four</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_documentation_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" xlink:href="hr-20230930.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" xlink:to="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_28cd3455-35ae-4ab6-9767-8a0d1728c857_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentChargesAbstract_1f4b11f1-dcdb-481a-a89d-2d4990abff30_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment:</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentChargesAbstract_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentChargesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentChargesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentChargesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentChargesAbstract" xlink:to="lab_us-gaap_AssetImpairmentChargesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_048a4e9d-75b2-4111-99c5-65b17218ed15_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3422a95d-1fcc-44ad-85fa-4b01ef64be07_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average incremental shares of common stock excluded from the computation (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_7a84f3b0-9ece-49de-93de-2e3da75836de_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_43eb8a68-4411-4c54-81a7-b0498414b276_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_8b57853a-d917-45a3-aa08-fafa63a92e02_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ImpairmentOfRealEstateAndCreditLossReserves_ee143e01-4ffe-4075-9634-ff23344b3f51_negatedLabel_en-US" xlink:label="lab_hr_ImpairmentOfRealEstateAndCreditLossReserves" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of real estate properties and credit loss reserves</link:label>
    <link:label id="lab_hr_ImpairmentOfRealEstateAndCreditLossReserves_label_en-US" xlink:label="lab_hr_ImpairmentOfRealEstateAndCreditLossReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Real Estate and Credit Loss Reserves</link:label>
    <link:label id="lab_hr_ImpairmentOfRealEstateAndCreditLossReserves_documentation_en-US" xlink:label="lab_hr_ImpairmentOfRealEstateAndCreditLossReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Real Estate and Credit Loss Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentOfRealEstateAndCreditLossReserves" xlink:href="hr-20230930.xsd#hr_ImpairmentOfRealEstateAndCreditLossReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ImpairmentOfRealEstateAndCreditLossReserves" xlink:to="lab_hr_ImpairmentOfRealEstateAndCreditLossReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_HealthCareRealtyTrustIncorporatedMember_49095c6d-d027-4789-add7-25724b0c3f85_terseLabel_en-US" xlink:label="lab_hr_HealthCareRealtyTrustIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HealthCare Realty Trust Incorporated</link:label>
    <link:label id="lab_hr_HealthCareRealtyTrustIncorporatedMember_label_en-US" xlink:label="lab_hr_HealthCareRealtyTrustIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HealthCare Realty Trust Incorporated [Member]</link:label>
    <link:label id="lab_hr_HealthCareRealtyTrustIncorporatedMember_documentation_en-US" xlink:label="lab_hr_HealthCareRealtyTrustIncorporatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HealthCare Realty Trust Incorporated</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthCareRealtyTrustIncorporatedMember" xlink:href="hr-20230930.xsd#hr_HealthCareRealtyTrustIncorporatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_HealthCareRealtyTrustIncorporatedMember" xlink:to="lab_hr_HealthCareRealtyTrustIncorporatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_a29edc9e-f155-4745-ac05-4bd4c930085d_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_472b2884-2278-4b1e-9a16-9dc8140a9b3c_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for new operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_29e439f3-3340-4c87-8e0e-5b2f5f0d1eb3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_de1f83e6-9fc2-4c7e-bb41-b83103978d6b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TermLoandue2026Member_8bf8eed2-472f-4763-affd-f5563533aaee_terseLabel_en-US" xlink:label="lab_hr_TermLoandue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$150 million Unsecured Term Loan</link:label>
    <link:label id="lab_hr_TermLoandue2026Member_label_en-US" xlink:label="lab_hr_TermLoandue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2026 [Member]</link:label>
    <link:label id="lab_hr_TermLoandue2026Member_documentation_en-US" xlink:label="lab_hr_TermLoandue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2026 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoandue2026Member" xlink:href="hr-20230930.xsd#hr_TermLoandue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TermLoandue2026Member" xlink:to="lab_hr_TermLoandue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities_00cc125b-187d-432b-9585-1bafeb4bd6b6_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_CumulativeDividendsMember_24a6a37a-a6b1-4760-ae33-3e1e0771ee15_terseLabel_en-US" xlink:label="lab_hr_CumulativeDividendsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Dividends</link:label>
    <link:label id="lab_hr_CumulativeDividendsMember_label_en-US" xlink:label="lab_hr_CumulativeDividendsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Dividends [Member]</link:label>
    <link:label id="lab_hr_CumulativeDividendsMember_documentation_en-US" xlink:label="lab_hr_CumulativeDividendsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Dividends [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeDividendsMember" xlink:href="hr-20230930.xsd#hr_CumulativeDividendsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_CumulativeDividendsMember" xlink:to="lab_hr_CumulativeDividendsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_a78628d8-9e0c-40ce-b652-00d776221f78_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_59dbc53b-02f9-4a4f-b675-f6b04b502d62_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:to="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_a59b4ea9-43e7-4356-a47e-b148fa647ec0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets_767978c9-3ed5-42c1-b311-be054de570c2_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease right-of-use assets</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Right-of-Use Assets</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Right-of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_3e171f10-7db5-4b43-a057-0d3baa9077db_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther_9592485c-94d7-4272-8ee0-3d28475cb077_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value Adjustments and Other</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value Adjustments and Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_93dfb166-721e-4908-8ce3-5306e73c4dea_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and bonds payable</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_6806b393-3e8f-44d0-b1ee-82bdfb4d5d38_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted closing price of Legacy HR Common Stock on July 20, 2022 (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale_18e195c5-d04f-4484-b9cc-57d8f0118dea_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities of assets held for sale</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Of Assets Held For Sale</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Of Assets Held For Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_118a1331-2b63-4aee-9737-b6fe77f63981_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_931ad201-a3c8-49ee-b188-ff7d6bbd1454_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PURCHASE PRICE</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_9748e082-4b50-44f9-90a2-29903cbd31d5_totalLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Assumed</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Assumed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_5407bb16-fc21-4195-a1f3-aa74b1639343_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Options, Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_fd53329e-e5d7-4062-8283-16c2f15957b2_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested shares (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_a7a47e56-4b3b-4def-aec5-163e1a0e8b96_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MezzanineLoanMember_3572a7c7-c670-4af4-88c6-b07c65a86bc5_terseLabel_en-US" xlink:label="lab_hr_MezzanineLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine loans</link:label>
    <link:label id="lab_hr_MezzanineLoanMember_label_en-US" xlink:label="lab_hr_MezzanineLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine Loan [Member]</link:label>
    <link:label id="lab_hr_MezzanineLoanMember_documentation_en-US" xlink:label="lab_hr_MezzanineLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mezzanine Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MezzanineLoanMember" xlink:href="hr-20230930.xsd#hr_MezzanineLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MezzanineLoanMember" xlink:to="lab_hr_MezzanineLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_5be2326d-a9fc-407e-9ddf-ba26e5fc3951_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options under the Employee Stock Option Plan</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_dff5d30c-b5c4-44d1-bfdc-c4db100beba5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_a7b54a32-f84e-4348-8491-3a6c94b26fb0_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NotesReceivableCarryingAmount_0497b45f-84e8-4a72-8156-6bd74b23cfd6_terseLabel_en-US" xlink:label="lab_hr_NotesReceivableCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes receivable, carrying amount</link:label>
    <link:label id="lab_hr_NotesReceivableCarryingAmount_label_en-US" xlink:label="lab_hr_NotesReceivableCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Carrying Amount</link:label>
    <link:label id="lab_hr_NotesReceivableCarryingAmount_documentation_en-US" xlink:label="lab_hr_NotesReceivableCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableCarryingAmount" xlink:href="hr-20230930.xsd#hr_NotesReceivableCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NotesReceivableCarryingAmount" xlink:to="lab_hr_NotesReceivableCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_18249603-9aef-4b50-8586-4d21ae7c80bb_totalLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_74216721-5834-4837-8198-e09b295b5cb1_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_70874a24-d97f-483a-9e15-b79c8231afd2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CUMULATIVE MEASUREMENT PERIOD ADJUSTMENTS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:to="lab_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_2cbf2b51-537b-4f58-8710-458c190e73c2_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MAXIMUM EXPOSURE TO LOSS</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:to="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopmentInProcess_d34cee5f-d21d-437f-9722-9beb04589f5a_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_DevelopmentInProcess_label_en-US" xlink:label="lab_us-gaap_DevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development in Process</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopmentInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopmentInProcess" xlink:to="lab_us-gaap_DevelopmentInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_3e9d0e44-69bd-4bcb-bf78-c6410b2b3b96_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_d56579e2-ef57-4d1a-895b-ee43645610d8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5c22f5e7-6a68-4d3e-8a8b-25fd9524f8ae_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress_849e92af-94de-4016-bb56-3ae8f3832838_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Construction in Progress</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Construction in Progress</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation_9dad53d1-20fd-457e-b0ad-426e7a2fb4de_negatedLabel_en-US" xlink:label="lab_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sales of real estate properties</link:label>
    <link:label id="lab_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (Losses) on Sales of Investment Real Estate, Including Discontinued Operation</link:label>
    <link:label id="lab_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation_documentation_en-US" xlink:label="lab_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (Losses) on Sales of Investment Real Estate, Including Discontinued Operation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" xlink:href="hr-20230930.xsd#hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" xlink:to="lab_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_c0c4b6f8-0eac-46b6-be12-fc013c03d69e_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_c0f421be-e7fe-469b-a44c-2d5eafece129_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_d9fd401b-01d0-46d0-9252-0b6bddbbd99a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_HealthcareTrustofAmericaHoldingsLPMember_003fdace-7966-4a04-ae47-632eff2eecc8_terseLabel_en-US" xlink:label="lab_hr_HealthcareTrustofAmericaHoldingsLPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Trust of America Holdings L P</link:label>
    <link:label id="lab_hr_HealthcareTrustofAmericaHoldingsLPMember_label_en-US" xlink:label="lab_hr_HealthcareTrustofAmericaHoldingsLPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Trustof America Holdings L P [Member]</link:label>
    <link:label id="lab_hr_HealthcareTrustofAmericaHoldingsLPMember_documentation_en-US" xlink:label="lab_hr_HealthcareTrustofAmericaHoldingsLPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Trustof America Holdings L P</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustofAmericaHoldingsLPMember" xlink:href="hr-20230930.xsd#hr_HealthcareTrustofAmericaHoldingsLPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_HealthcareTrustofAmericaHoldingsLPMember" xlink:to="lab_hr_HealthcareTrustofAmericaHoldingsLPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateTable_c4b73b9d-f5c6-4a39-b1fe-3bf688089689_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Table]</link:label>
    <link:label id="lab_us-gaap_RealEstateTable_label_en-US" xlink:label="lab_us-gaap_RealEstateTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateTable" xlink:to="lab_us-gaap_RealEstateTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_5ad47bb0-d5cd-4a77-af96-5c0f07d42789_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_d5bab9a0-1ff7-4c0a-88b2-b429fd602ad2_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sales of real estate properties</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains (Losses) on Sales of Investment Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:to="lab_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_4ce505d5-d0ee-4b62-b843-834afe4536aa_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TermLoanDue2027Member_c5478f51-0728-4e26-9c35-018c65a6c12b_terseLabel_en-US" xlink:label="lab_hr_TermLoanDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$200 million Unsecured Term Loan</link:label>
    <link:label id="lab_hr_TermLoanDue2027Member_label_en-US" xlink:label="lab_hr_TermLoanDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2027 [Member]</link:label>
    <link:label id="lab_hr_TermLoanDue2027Member_documentation_en-US" xlink:label="lab_hr_TermLoanDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2027Member" xlink:href="hr-20230930.xsd#hr_TermLoanDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TermLoanDue2027Member" xlink:to="lab_hr_TermLoanDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_bf810627-66c6-4a03-a98b-c743b7fb1b5e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_fa75cbe8-020e-4ff2-be00-fcc45b99f8f3_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfRealEstateNotesReceivable_32851501-ebf5-4d88-bbc9-bfa2df798927_terseLabel_en-US" xlink:label="lab_hr_NumberOfRealEstateNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of real estate notes receivable</link:label>
    <link:label id="lab_hr_NumberOfRealEstateNotesReceivable_label_en-US" xlink:label="lab_hr_NumberOfRealEstateNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Real Estate Notes Receivable</link:label>
    <link:label id="lab_hr_NumberOfRealEstateNotesReceivable_documentation_en-US" xlink:label="lab_hr_NumberOfRealEstateNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Real Estate Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRealEstateNotesReceivable" xlink:href="hr-20230930.xsd#hr_NumberOfRealEstateNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfRealEstateNotesReceivable" xlink:to="lab_hr_NumberOfRealEstateNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_f085a260-a362-4b8b-8e5b-2fd8ffb59a0f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested shares (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares, Restricted Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesRestrictedStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeOperating_a051ade1-7c56-4542-9ede-7126ba6edae6_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InterestIncomeOperating_label_en-US" xlink:label="lab_us-gaap_InterestIncomeOperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Operating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeOperating" xlink:to="lab_us-gaap_InterestIncomeOperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_44bb2603-04a3-4d4b-b0b1-928df4f2275b_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAxis_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_a46c689e-d1a9-49ac-bb6a-43f07ff8c361_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger with HTA</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_48944c7a-bc08-4822-ae96-7904216aa43a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards, beginning of period, Weighted average grant date fair value (in dollar per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_52d23e32-1643-4bfd-9ab3-df0df7089978_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards, ending of period, Weighted average grant date fair value (in dollar per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_3b2a1eb6-3c3f-4da6-9f25-cac2f0c35075_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings on term loans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Medium-term Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfMediumTermNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfMediumTermNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_10930ed0-dc6a-4531-88d8-a4497f8a9a7b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DerivativeFixedInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeFixedInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Fixed Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFixedInterestRate" xlink:to="lab_us-gaap_DerivativeFixedInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_e5075e6d-3720-48cd-9369-800a9c1ca7e1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions to non-controlling interest holders</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_4dac4c9b-80f2-4f4b-b9f6-02488a49d061_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_2ea82a5d-1718-4401-a1c1-c97e76565815_negatedLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_97e583ae-d91d-4299-82f3-63623ee4361d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment Property, Accumulated Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:to="lab_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_02496314-94e7-4caf-be58-1c9d84719d10_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_8d8dc56a-5698-44d2-ae8d-1fe4a102ba89_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease expense</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_69257151-1a1b-4df6-a855-ef9ed8df5b33_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ClosingAdjustmentsDisposedEntity_384bf07b-713b-4053-8f3b-462ce90881e5_negatedTerseLabel_en-US" xlink:label="lab_hr_ClosingAdjustmentsDisposedEntity" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CLOSING ADJUSTMENTS</link:label>
    <link:label id="lab_hr_ClosingAdjustmentsDisposedEntity_label_en-US" xlink:label="lab_hr_ClosingAdjustmentsDisposedEntity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing Adjustments Disposed Entity</link:label>
    <link:label id="lab_hr_ClosingAdjustmentsDisposedEntity_documentation_en-US" xlink:label="lab_hr_ClosingAdjustmentsDisposedEntity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Closing Adjustments Disposed Entity, including closing costs and other adjustments to the sales price.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ClosingAdjustmentsDisposedEntity" xlink:href="hr-20230930.xsd#hr_ClosingAdjustmentsDisposedEntity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ClosingAdjustmentsDisposedEntity" xlink:to="lab_hr_ClosingAdjustmentsDisposedEntity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_296a808b-0126-4b5c-843e-a4e796660769_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_cbfd6f2a-59c6-4608-9147-953682cb78bf_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Non-Controlling Interests</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_773d58ad-c0ae-45f2-b9de-72d679aaadf9_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NonVestedStockAwardMember_0d0a9b8f-f770-441d-8977-23551936acb3_terseLabel_en-US" xlink:label="lab_hr_NonVestedStockAwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-vested Stock Award</link:label>
    <link:label id="lab_hr_NonVestedStockAwardMember_label_en-US" xlink:label="lab_hr_NonVestedStockAwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Vested Stock Award [Member]</link:label>
    <link:label id="lab_hr_NonVestedStockAwardMember_documentation_en-US" xlink:label="lab_hr_NonVestedStockAwardMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non Vested Stock Award</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonVestedStockAwardMember" xlink:href="hr-20230930.xsd#hr_NonVestedStockAwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NonVestedStockAwardMember" xlink:to="lab_hr_NonVestedStockAwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_96e4554b-8cfd-411d-9c39-6ec1243611ed_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfRealEstate_276d521c-2e55-487d-9839-f269bae472db_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfRealEstate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of real estate assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfRealEstate_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfRealEstate" xlink:to="lab_us-gaap_ImpairmentOfRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_CumulativeNetIncomeMember_60b56eaa-3d56-4467-bfd1-db0e4c256c45_terseLabel_en-US" xlink:label="lab_hr_CumulativeNetIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Net Income</link:label>
    <link:label id="lab_hr_CumulativeNetIncomeMember_label_en-US" xlink:label="lab_hr_CumulativeNetIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Net Income [Member]</link:label>
    <link:label id="lab_hr_CumulativeNetIncomeMember_documentation_en-US" xlink:label="lab_hr_CumulativeNetIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Net Income [Member].</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetIncomeMember" xlink:href="hr-20230930.xsd#hr_CumulativeNetIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_CumulativeNetIncomeMember" xlink:to="lab_hr_CumulativeNetIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MiscellaneousMember_f889d971-6c81-4214-8305-08847df6fe38_terseLabel_en-US" xlink:label="lab_hr_MiscellaneousMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Miscellaneous</link:label>
    <link:label id="lab_hr_MiscellaneousMember_label_en-US" xlink:label="lab_hr_MiscellaneousMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Miscellaneous [Member]</link:label>
    <link:label id="lab_hr_MiscellaneousMember_documentation_en-US" xlink:label="lab_hr_MiscellaneousMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Miscellaneous [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MiscellaneousMember" xlink:href="hr-20230930.xsd#hr_MiscellaneousMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MiscellaneousMember" xlink:to="lab_hr_MiscellaneousMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_42b6391f-2835-40d7-bf8f-227698a5d0de_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ffae72dd-0484-40f6-83d3-b5c531a32b63_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_279dbabb-ab4c-414e-b567-cd9148045a3e_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_6254de01-ddf6-46ed-b865-cd81a3808f0c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contracts with Customers (ASC Topic 606)</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireLand_7414d45d-e653-45f3-9166-285a8b6be5de_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLand" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquired a parcel of land</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireLand_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLand" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLand" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireLand"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireLand" xlink:to="lab_us-gaap_PaymentsToAcquireLand" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_be9ac77c-54eb-46ba-8514-50bc252d1ae4_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LongTermIncentiveProgramDUnitsMember_2da39d77-8360-4ae1-924b-125886db4548_terseLabel_en-US" xlink:label="lab_hr_LongTermIncentiveProgramDUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LTIP-D</link:label>
    <link:label id="lab_hr_LongTermIncentiveProgramDUnitsMember_label_en-US" xlink:label="lab_hr_LongTermIncentiveProgramDUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Incentive Program - D Units [Member]</link:label>
    <link:label id="lab_hr_LongTermIncentiveProgramDUnitsMember_documentation_en-US" xlink:label="lab_hr_LongTermIncentiveProgramDUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Incentive Program - D Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LongTermIncentiveProgramDUnitsMember" xlink:href="hr-20230930.xsd#hr_LongTermIncentiveProgramDUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LongTermIncentiveProgramDUnitsMember" xlink:to="lab_hr_LongTermIncentiveProgramDUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LeaseIntangibles_ed4d5d03-db10-4c53-86a1-35d6bf151a28_terseLabel_en-US" xlink:label="lab_hr_LeaseIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease intangibles</link:label>
    <link:label id="lab_hr_LeaseIntangibles_label_en-US" xlink:label="lab_hr_LeaseIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Intangibles</link:label>
    <link:label id="lab_hr_LeaseIntangibles_documentation_en-US" xlink:label="lab_hr_LeaseIntangibles" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LeaseIntangibles" xlink:href="hr-20230930.xsd#hr_LeaseIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LeaseIntangibles" xlink:to="lab_hr_LeaseIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_6a2e3566-e1bf-4472-af20-fcb2f46f8d48_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows outflows related to operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarlyRepaymentOfSeniorDebt_781d1be6-9209-46ff-bf42-61baff430727_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption of notes and bonds payable</link:label>
    <link:label id="lab_us-gaap_EarlyRepaymentOfSeniorDebt_label_en-US" xlink:label="lab_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Early Repayment of Senior Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarlyRepaymentOfSeniorDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:to="lab_us-gaap_EarlyRepaymentOfSeniorDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_1e50e2f0-4215-44e2-bf7b-418471d69ecc_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_f866f9ad-9a96-42dd-875f-6641cfdfcf88_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_d95ee703-ccdb-4965-85d7-e5da71f29efc_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a0ba5a1a-e701-4ad1-ae46-ccf853655991_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet_a42f9b57-fe86-4ac2-b51e-a019d32763b7_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale, net</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Held For Sale, Net</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Held For Sale, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_PerformanceConditionsMember_771e6ac8-75a4-4e79-8443-299ffa724d05_terseLabel_en-US" xlink:label="lab_hr_PerformanceConditionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance conditions</link:label>
    <link:label id="lab_hr_PerformanceConditionsMember_label_en-US" xlink:label="lab_hr_PerformanceConditionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Conditions [Member]</link:label>
    <link:label id="lab_hr_PerformanceConditionsMember_documentation_en-US" xlink:label="lab_hr_PerformanceConditionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Conditions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PerformanceConditionsMember" xlink:href="hr-20230930.xsd#hr_PerformanceConditionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_PerformanceConditionsMember" xlink:to="lab_hr_PerformanceConditionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AlbanyNYMember_f1b9a28c-2ef7-4300-b41a-e99f4062b1a4_terseLabel_en-US" xlink:label="lab_hr_AlbanyNYMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Albany, NY</link:label>
    <link:label id="lab_hr_AlbanyNYMember_label_en-US" xlink:label="lab_hr_AlbanyNYMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Albany, NY [Member]</link:label>
    <link:label id="lab_hr_AlbanyNYMember_documentation_en-US" xlink:label="lab_hr_AlbanyNYMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Albany, NY</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AlbanyNYMember" xlink:href="hr-20230930.xsd#hr_AlbanyNYMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AlbanyNYMember" xlink:to="lab_hr_AlbanyNYMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_0a2ef469-51dc-4164-8174-5e99eff1595c_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use-Assets</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use-Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_HoustonTXMember_161f7676-eb7e-469a-9a1b-5474e9e48e73_terseLabel_en-US" xlink:label="lab_hr_HoustonTXMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Houston, TX</link:label>
    <link:label id="lab_hr_HoustonTXMember_label_en-US" xlink:label="lab_hr_HoustonTXMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Houston, TX [Member]</link:label>
    <link:label id="lab_hr_HoustonTXMember_documentation_en-US" xlink:label="lab_hr_HoustonTXMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Houston, TX</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HoustonTXMember" xlink:href="hr-20230930.xsd#hr_HoustonTXMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_HoustonTXMember" xlink:to="lab_hr_HoustonTXMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_231b296f-ae18-4601-9c56-64cd5674b2a9_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Operating Lease Payments Receivable</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_DallasTXMember_007b844c-6f30-43c6-ada5-f0a89d931dac_terseLabel_en-US" xlink:label="lab_hr_DallasTXMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dallas, TX</link:label>
    <link:label id="lab_hr_DallasTXMember_label_en-US" xlink:label="lab_hr_DallasTXMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dallas, TX [Member]</link:label>
    <link:label id="lab_hr_DallasTXMember_documentation_en-US" xlink:label="lab_hr_DallasTXMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dallas, TX</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DallasTXMember" xlink:href="hr-20230930.xsd#hr_DallasTXMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_DallasTXMember" xlink:to="lab_hr_DallasTXMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesDue2026Member_598e54c9-77d0-41c0-b2e2-a50cd176d91b_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2026</link:label>
    <link:label id="lab_hr_SeniorNotesDue2026Member_label_en-US" xlink:label="lab_hr_SeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2026 [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesDue2026Member_documentation_en-US" xlink:label="lab_hr_SeniorNotesDue2026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2026Member" xlink:href="hr-20230930.xsd#hr_SeniorNotesDue2026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesDue2026Member" xlink:to="lab_hr_SeniorNotesDue2026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_00405443-a4de-4abc-823b-2f9a1c986e5f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Common Stock Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Common Stock Outstanding Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_333a99a7-9f3b-4f1f-ab9f-dfcc6beb252f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_cca66422-b597-467e-ab57-a671e743c166_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_d7223591-821c-475a-a804-363cc2131986_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapExpiringDecember12027Member_e9531c07-6e19-48ce-ba3f-a2845df7b719_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapExpiringDecember12027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring December 1, 2027</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringDecember12027Member_label_en-US" xlink:label="lab_hr_InterestRateSwapExpiringDecember12027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring December 1, 2027 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringDecember12027Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapExpiringDecember12027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring December 1, 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringDecember12027Member" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringDecember12027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapExpiringDecember12027Member" xlink:to="lab_hr_InterestRateSwapExpiringDecember12027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_7fff9d36-29a2-410f-9dcd-ca1d953e6cfa_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_bcd986a8-442e-46c9-93ef-ea320f254ce5_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_0efaafcd-7045-4fbc-b9c1-1edca1315e7e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_86d2cef5-35ae-4173-b7ff-b949db758e1a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock redemptions</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_db19ac8d-4a9e-4ce6-9b6e-e553b116a76f_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities of assets held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_63eab186-53d3-451f-9078-886795c1f854_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities of assets held for sale</link:label>
    <link:label id="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_label_en-US" xlink:label="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:to="lab_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_5d5183fb-90f0-402f-ae1b-82c781ce08a5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of notes and bonds payable</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_3088ced5-3dd5-4443-b4f7-5734a07bfcdb_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentBuildingAndBuildingImprovements_1e47ebfe-284e-444a-9c58-47430bb35ba7_verboseLabel_en-US" xlink:label="lab_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_InvestmentBuildingAndBuildingImprovements_2c1b4e58-e036-41f2-8f25-71a5ca5c1139_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_InvestmentBuildingAndBuildingImprovements_label_en-US" xlink:label="lab_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Building and Building Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:to="lab_us-gaap_InvestmentBuildingAndBuildingImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesdue2025Member_51ef6e7c-7905-48d3-b033-8a3c49661cf9_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2025</link:label>
    <link:label id="lab_hr_SeniorNotesdue2025Member_label_en-US" xlink:label="lab_hr_SeniorNotesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2025 [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesdue2025Member_documentation_en-US" xlink:label="lab_hr_SeniorNotesdue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2025 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2025Member" xlink:href="hr-20230930.xsd#hr_SeniorNotesdue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesdue2025Member" xlink:to="lab_hr_SeniorNotesdue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_5dd212ee-ca7d-456b-a0b5-9c92ed72cc7b_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_fab603d7-ea0c-4e75-b46d-4e7c487ffa02_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MortgageLoanMember_4b3f3469-ddce-445d-bc1e-2e42fe2a0ef2_terseLabel_en-US" xlink:label="lab_hr_MortgageLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage loans</link:label>
    <link:label id="lab_hr_MortgageLoanMember_label_en-US" xlink:label="lab_hr_MortgageLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan [Member]</link:label>
    <link:label id="lab_hr_MortgageLoanMember_documentation_en-US" xlink:label="lab_hr_MortgageLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanMember" xlink:href="hr-20230930.xsd#hr_MortgageLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MortgageLoanMember" xlink:to="lab_hr_MortgageLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_e7f0cffd-87cd-4486-bf16-7d0aec444fc1_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_aba6113e-9491-4e30-8acb-08acb123c1b7_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MarketCondition2Member_56c3f10b-89d2-4ef8-b227-2c113d5983ef_terseLabel_en-US" xlink:label="lab_hr_MarketCondition2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Relative TSR Component</link:label>
    <link:label id="lab_hr_MarketCondition2Member_label_en-US" xlink:label="lab_hr_MarketCondition2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Condition 2 [Member]</link:label>
    <link:label id="lab_hr_MarketCondition2Member_documentation_en-US" xlink:label="lab_hr_MarketCondition2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Condition 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MarketCondition2Member" xlink:href="hr-20230930.xsd#hr_MarketCondition2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MarketCondition2Member" xlink:to="lab_hr_MarketCondition2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapExpiringDecember12026Member_0501f37c-9b97-4147-a8ca-6636ce77b84e_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapExpiringDecember12026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring December 1, 2026</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringDecember12026Member_label_en-US" xlink:label="lab_hr_InterestRateSwapExpiringDecember12026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring December 1, 2026 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringDecember12026Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapExpiringDecember12026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring December 1, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringDecember12026Member" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringDecember12026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapExpiringDecember12026Member" xlink:to="lab_hr_InterestRateSwapExpiringDecember12026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ApproximateSquareFeetProvidedByCompany_c5136b1f-126a-4abd-9afa-9887184094f1_verboseLabel_en-US" xlink:label="lab_hr_ApproximateSquareFeetProvidedByCompany" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate square feet for which Nationwide property management services provided by company</link:label>
    <link:label id="lab_hr_ApproximateSquareFeetProvidedByCompany_label_en-US" xlink:label="lab_hr_ApproximateSquareFeetProvidedByCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate Square Feet Provided by Company</link:label>
    <link:label id="lab_hr_ApproximateSquareFeetProvidedByCompany_documentation_en-US" xlink:label="lab_hr_ApproximateSquareFeetProvidedByCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate square feet for which Nationwide property management services provided by company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ApproximateSquareFeetProvidedByCompany" xlink:href="hr-20230930.xsd#hr_ApproximateSquareFeetProvidedByCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ApproximateSquareFeetProvidedByCompany" xlink:to="lab_hr_ApproximateSquareFeetProvidedByCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_99ff4d17-bc7c-4d37-a24b-1d981e0114d9_verboseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_b3896dd2-41aa-4b0b-883f-8583b8589296_verboseLabel_en-US" xlink:label="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale, net</link:label>
    <link:label id="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_02d6e5b5-507d-4d88-a9c6-e27c186ea40b_totalLabel_en-US" xlink:label="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale, net</link:label>
    <link:label id="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_label_en-US" xlink:label="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-for-sale and Discontinued Operations Net</link:label>
    <link:label id="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_documentation_en-US" xlink:label="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets held for sale and discontinued operations, net.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:href="hr-20230930.xsd#hr_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:to="lab_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_4406f2f2-6e2e-4843-a105-0149a5ce0430_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Non-Controlling Interests:</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_a07e24fc-ac38-4461-934a-ff661a226b8a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_1d9850d5-2d8a-4ff1-8b38-bd28adbec9ef_periodStartLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in unconsolidated joint ventures, beginning of period</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_9debee40-8cc5-41d6-84e4-113c73717ba9_periodEndLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in unconsolidated joint ventures, end of period</link:label>
    <link:label id="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_label_en-US" xlink:label="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:to="lab_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_672ac573-0fd4-4115-bb51-4c0acb25000b_terseLabel_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant date fair value</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_label_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Total Fair Value</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_documentation_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Total Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" xlink:href="hr-20230930.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" xlink:to="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_91ee9bbe-ecbe-4cfc-b572-8e766c509fe8_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable_3cf7fea5-09ce-478c-9dd6-74faf2057587_terseLabel_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from financing receivables</link:label>
    <link:label id="lab_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable_label_en-US" xlink:label="lab_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales-type Lease, Interest Income, Lease Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable" xlink:to="lab_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_8e8cd78d-3f24-41b5-aa27-86a1a0f92594_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable non-controlling interests</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_9166aff8-c9e6-4077-960a-d28de24889f1_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Non-controlling Interests, beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_1e9b5882-054f-4eb5-9dfa-4f0e8f442746_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Non-controlling Interests, ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilities_0f5fbb10-29db-4ccd-8234-5ee3ecb552df_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilities_label_en-US" xlink:label="lab_us-gaap_OtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilities" xlink:to="lab_us-gaap_OtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ReverseRecapitalizationNet_e9f2e12c-f83e-4eba-8efc-564f3982e416_terseLabel_en-US" xlink:label="lab_hr_ReverseRecapitalizationNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of implied Legacy HR Common Stock issued</link:label>
    <link:label id="lab_hr_ReverseRecapitalizationNet_label_en-US" xlink:label="lab_hr_ReverseRecapitalizationNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Net</link:label>
    <link:label id="lab_hr_ReverseRecapitalizationNet_documentation_en-US" xlink:label="lab_hr_ReverseRecapitalizationNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reverse Recapitalization, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReverseRecapitalizationNet" xlink:href="hr-20230930.xsd#hr_ReverseRecapitalizationNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ReverseRecapitalizationNet" xlink:to="lab_hr_ReverseRecapitalizationNet" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_PersonalProperty_963a4aa5-7ec6-415c-81b5-6ecf031aff80_terseLabel_en-US" xlink:label="lab_hr_PersonalProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personal property</link:label>
    <link:label id="lab_hr_PersonalProperty_label_en-US" xlink:label="lab_hr_PersonalProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personal Property</link:label>
    <link:label id="lab_hr_PersonalProperty_documentation_en-US" xlink:label="lab_hr_PersonalProperty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Personal property.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PersonalProperty" xlink:href="hr-20230930.xsd#hr_PersonalProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_PersonalProperty" xlink:to="lab_hr_PersonalProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_f47d124f-fc8c-4d26-8718-1b314405888e_terseLabel_en-US" xlink:label="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross investment amount, total</link:label>
    <link:label id="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_label_en-US" xlink:label="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in Real Estate Properties and Mortgage Notes</link:label>
    <link:label id="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_documentation_en-US" xlink:label="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in real estate properties and mortgage notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InvestmentInRealEstatePropertiesAndMortgageNotes" xlink:href="hr-20230930.xsd#hr_InvestmentInRealEstatePropertiesAndMortgageNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InvestmentInRealEstatePropertiesAndMortgageNotes" xlink:to="lab_hr_InvestmentInRealEstatePropertiesAndMortgageNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_StockIssuanceProgramAxis_44767eb3-ed71-4c30-b1fb-7b5a52ce57fc_terseLabel_en-US" xlink:label="lab_hr_StockIssuanceProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Program [Axis]</link:label>
    <link:label id="lab_hr_StockIssuanceProgramAxis_label_en-US" xlink:label="lab_hr_StockIssuanceProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Program [Axis]</link:label>
    <link:label id="lab_hr_StockIssuanceProgramAxis_documentation_en-US" xlink:label="lab_hr_StockIssuanceProgramAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramAxis" xlink:href="hr-20230930.xsd#hr_StockIssuanceProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_StockIssuanceProgramAxis" xlink:to="lab_hr_StockIssuanceProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_74f61459-c7d3-4968-8d48-50851671e69d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted, Weighted average grant date fair value (in dollar per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_e67f5149-6eed-4232-9828-79fedfff9629_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_OperatingExpensesandCostofGoodsSold_77ee5490-49e3-4d04-9e21-4cc8d3bdd89b_totalLabel_en-US" xlink:label="lab_hr_OperatingExpensesandCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses</link:label>
    <link:label id="lab_hr_OperatingExpensesandCostofGoodsSold_label_en-US" xlink:label="lab_hr_OperatingExpensesandCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses and Cost of Goods Sold</link:label>
    <link:label id="lab_hr_OperatingExpensesandCostofGoodsSold_documentation_en-US" xlink:label="lab_hr_OperatingExpensesandCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses and Cost of Goods Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingExpensesandCostofGoodsSold" xlink:href="hr-20230930.xsd#hr_OperatingExpensesandCostofGoodsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_OperatingExpensesandCostofGoodsSold" xlink:to="lab_hr_OperatingExpensesandCostofGoodsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_18b4cecd-4a2f-48a6-885d-17e3efe88ea9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_5ac48218-c83f-42a1-9b6b-8f8c7f63b0ff_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_7db7e404-683d-434e-ae3f-671f750c48e5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AreaOfLand_69c3bcd4-e1dd-434f-a4b7-b5ff987bc9bc_terseLabel_en-US" xlink:label="lab_us-gaap_AreaOfLand" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area of land</link:label>
    <link:label id="lab_us-gaap_AreaOfLand_label_en-US" xlink:label="lab_us-gaap_AreaOfLand" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area of Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfLand" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AreaOfLand"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AreaOfLand" xlink:to="lab_us-gaap_AreaOfLand" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_04d97f0b-2f0a-47f7-bef2-bf85f55ace5e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt fees</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFeeAmount" xlink:to="lab_us-gaap_DebtInstrumentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_b976580b-93be-408f-9336-2c9119f6b67c_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MediumTermNotesMember_ad21fe45-d6ac-4230-be91-c34d3806fc24_terseLabel_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term notes</link:label>
    <link:label id="lab_us-gaap_MediumTermNotesMember_label_en-US" xlink:label="lab_us-gaap_MediumTermNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medium-term Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MediumTermNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MediumTermNotesMember" xlink:to="lab_us-gaap_MediumTermNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_be771db0-8e23-4bf3-a402-d810fb5dbd91_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5abdb70d-2418-46ac-98af-669fbf0a06f5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_205548ec-d03b-474e-8e0a-a7a6a064d017_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember_14062f10-512b-4004-9d2c-e466ea862da5_terseLabel_en-US" xlink:label="lab_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Completed Develpoment and Redevelopment Properties</link:label>
    <link:label id="lab_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember_label_en-US" xlink:label="lab_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Completed Develpoment and Redevelopment Properties [Member]</link:label>
    <link:label id="lab_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember_documentation_en-US" xlink:label="lab_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Completed Develpoment and Redevelopment Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember" xlink:href="hr-20230930.xsd#hr_CompletedDevelpomentAndRedevelopmentPropertiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember" xlink:to="lab_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_fda830c3-0083-4b1a-ada6-05747b27fd82_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_2e2d2686-76c5-469e-b26d-345557367ccc_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_cd3aacf6-3986-416f-837f-3a4a610554b2_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_dfd2ad58-2231-47cd-947f-2cc5d766298b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_c19b8a00-f9d3-4ea8-8982-ca90ad8620f9_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_CashAcquiredInMerger_12fba736-469c-43a3-98b9-fed9934a2641_terseLabel_en-US" xlink:label="lab_hr_CashAcquiredInMerger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash assumed in Merger, including restricted cash for special dividend payment</link:label>
    <link:label id="lab_hr_CashAcquiredInMerger_label_en-US" xlink:label="lab_hr_CashAcquiredInMerger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired in Merger</link:label>
    <link:label id="lab_hr_CashAcquiredInMerger_documentation_en-US" xlink:label="lab_hr_CashAcquiredInMerger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Acquired in Merger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CashAcquiredInMerger" xlink:href="hr-20230930.xsd#hr_CashAcquiredInMerger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_CashAcquiredInMerger" xlink:to="lab_hr_CashAcquiredInMerger" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_GrossContractualRealEstateNotesReceivableFairValue_a314900a-39de-41ab-a4da-22ac297d2211_terseLabel_en-US" xlink:label="lab_hr_GrossContractualRealEstateNotesReceivableFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross contractual real estate notes receivable at fair value</link:label>
    <link:label id="lab_hr_GrossContractualRealEstateNotesReceivableFairValue_label_en-US" xlink:label="lab_hr_GrossContractualRealEstateNotesReceivableFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Contractual Real Estate Notes Receivable, Fair Value</link:label>
    <link:label id="lab_hr_GrossContractualRealEstateNotesReceivableFairValue_documentation_en-US" xlink:label="lab_hr_GrossContractualRealEstateNotesReceivableFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Contractual Real Estate Notes Receivable, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GrossContractualRealEstateNotesReceivableFairValue" xlink:href="hr-20230930.xsd#hr_GrossContractualRealEstateNotesReceivableFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_GrossContractualRealEstateNotesReceivableFairValue" xlink:to="lab_hr_GrossContractualRealEstateNotesReceivableFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ManagementFeeIncomeMember_6b623c0e-6ff7-4e60-8c7b-b22adcef2ad4_terseLabel_en-US" xlink:label="lab_hr_ManagementFeeIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management fee income</link:label>
    <link:label id="lab_hr_ManagementFeeIncomeMember_label_en-US" xlink:label="lab_hr_ManagementFeeIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Fee Income [Member]</link:label>
    <link:label id="lab_hr_ManagementFeeIncomeMember_documentation_en-US" xlink:label="lab_hr_ManagementFeeIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Management Fee Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ManagementFeeIncomeMember" xlink:href="hr-20230930.xsd#hr_ManagementFeeIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ManagementFeeIncomeMember" xlink:to="lab_hr_ManagementFeeIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapEffectiveNovember12023Member_af01c039-2b9b-41c0-a72f-120874b34e15_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapEffectiveNovember12023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Effective November 1, 2023</link:label>
    <link:label id="lab_hr_InterestRateSwapEffectiveNovember12023Member_label_en-US" xlink:label="lab_hr_InterestRateSwapEffectiveNovember12023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Effective November 1, 2023 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapEffectiveNovember12023Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapEffectiveNovember12023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Effective November 1, 2023</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapEffectiveNovember12023Member" xlink:href="hr-20230930.xsd#hr_InterestRateSwapEffectiveNovember12023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapEffectiveNovember12023Member" xlink:to="lab_hr_InterestRateSwapEffectiveNovember12023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage_a326085d-c3ad-4bbb-828a-d5ee79a21ceb_verboseLabel_en-US" xlink:label="lab_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SQUARE FOOTAGE</link:label>
    <link:label id="lab_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage_label_en-US" xlink:label="lab_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Purchase Price Allocation Square Footage</link:label>
    <link:label id="lab_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage_documentation_en-US" xlink:label="lab_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition Purchase Price Allocation Square Footage.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage" xlink:href="hr-20230930.xsd#hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage" xlink:to="lab_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_27b16a49-824b-4299-a571-6a9e9c49fb07_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_8e543733-b2cc-41d8-8f42-5dbca8e709af_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfSwapTransactions_64fd0dcc-de4d-4107-a186-efb3b829c104_terseLabel_en-US" xlink:label="lab_hr_NumberOfSwapTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of swap transactions</link:label>
    <link:label id="lab_hr_NumberOfSwapTransactions_label_en-US" xlink:label="lab_hr_NumberOfSwapTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Swap Transactions</link:label>
    <link:label id="lab_hr_NumberOfSwapTransactions_documentation_en-US" xlink:label="lab_hr_NumberOfSwapTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Swap Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfSwapTransactions" xlink:href="hr-20230930.xsd#hr_NumberOfSwapTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfSwapTransactions" xlink:to="lab_hr_NumberOfSwapTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_30f62969-ef58-4915-ad9e-dd0a2f091d6b_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional long-lived assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireOtherProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_c268b2e9-98fe-4d55-b1a2-855001628bd6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_a1aa8dc1-4658-4479-92ed-b7a6b4e74320_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_b24e6e8e-82c3-4513-a54c-e617bb0fa49d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities_6eb7be43-383d-4380-ad5b-d1ea2c3cc4c3_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty_1f6c8bd2-8441-4723-a08f-945555e757f5_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REAL ESTATE</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Real Property</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Real Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1d86d4df-1371-4851-9d85-788f967ea6a7_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_57208b28-d7f6-469c-be09-5cbf1ffcff95_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_8fbda144-79ad-44a6-80a0-bdf3784b529d_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilities_7377ded9-c4c6-4efa-a7dc-3294c629981d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MergerRelatedCosts_ed440205-e37e-43cc-89da-507792f2f462_terseLabel_en-US" xlink:label="lab_hr_MergerRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger-related costs</link:label>
    <link:label id="lab_hr_MergerRelatedCosts_label_en-US" xlink:label="lab_hr_MergerRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger Related Costs</link:label>
    <link:label id="lab_hr_MergerRelatedCosts_documentation_en-US" xlink:label="lab_hr_MergerRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MergerRelatedCosts" xlink:href="hr-20230930.xsd#hr_MergerRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MergerRelatedCosts" xlink:to="lab_hr_MergerRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TermLoanDue2028Member_5064b879-eb3a-4fb1-9dd7-9b20d8cd7c35_terseLabel_en-US" xlink:label="lab_hr_TermLoanDue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$300 million Unsecured Term Loan</link:label>
    <link:label id="lab_hr_TermLoanDue2028Member_label_en-US" xlink:label="lab_hr_TermLoanDue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2028 [Member]</link:label>
    <link:label id="lab_hr_TermLoanDue2028Member_documentation_en-US" xlink:label="lab_hr_TermLoanDue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2028Member" xlink:href="hr-20230930.xsd#hr_TermLoanDue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TermLoanDue2028Member" xlink:to="lab_hr_TermLoanDue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_f9e398ac-05ad-4f27-a06f-7415dc962258_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_77bf9bf6-1f8f-4415-8901-83e2aae4f9a1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other amortization</link:label>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_label_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:to="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_1b01e647-11a5-4af7-8d8b-d233a4ca219e_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_9d6e6b11-1938-4760-b53f-1ecf59cbfb4f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distributions from unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Equity Method Investment, Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:to="lab_us-gaap_EquityMethodInvestmentDividendsOrDistributions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_0e7f8edc-e0a7-4d24-8972-9b75ff85d08f_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends to common stockholders and distributions to non-controlling interest holders (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_3a88b95b-3765-4850-8b1d-ffb6f348f304_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends paid per common share, during the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareCashPaid_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Cash Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:to="lab_us-gaap_CommonStockDividendsPerShareCashPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfRealEstateProperties_312d18dd-c5b5-4fee-8373-2b40cc9b1b7f_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfRealEstateProperties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of owned real estate properties</link:label>
    <link:label id="lab_us-gaap_NumberOfRealEstateProperties_label_en-US" xlink:label="lab_us-gaap_NumberOfRealEstateProperties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Real Estate Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfRealEstateProperties" xlink:to="lab_us-gaap_NumberOfRealEstateProperties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_36fa7b34-a8ee-450e-b8b9-4618d321e18c_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_4757fccd-6511-43c2-bd9f-d2f32718e54e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to redemption value of redeemable non-controlling interests</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Accretion to Redemption Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:to="lab_us-gaap_TemporaryEquityAccretionToRedemptionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_41ed32ea-2a5e-400c-b37e-ed3750a85f24_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease cost</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Description [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:to="lab_us-gaap_LesseeFinanceLeaseDescriptionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_33653092-f455-4949-9975-c0e9211ccfa2_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_0692e235-5d90-4c9b-a9f7-85cfcd42495b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_4024d66a-79d3-4f7c-b6c2-9c8e85df811c_verboseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_7f38ec49-1bcd-4e0c-b1ee-bbdac934a394_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ScottsdaleArizonaMember_7b68c148-eb9b-4de6-a77a-4dedd7d24bff_terseLabel_en-US" xlink:label="lab_hr_ScottsdaleArizonaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scottsdale, Arizona</link:label>
    <link:label id="lab_hr_ScottsdaleArizonaMember_label_en-US" xlink:label="lab_hr_ScottsdaleArizonaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scottsdale, Arizona [Member]</link:label>
    <link:label id="lab_hr_ScottsdaleArizonaMember_documentation_en-US" xlink:label="lab_hr_ScottsdaleArizonaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scottsdale, Arizona</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ScottsdaleArizonaMember" xlink:href="hr-20230930.xsd#hr_ScottsdaleArizonaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ScottsdaleArizonaMember" xlink:to="lab_hr_ScottsdaleArizonaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_3b6e4572-3976-4b4f-a408-43cfcc5adb20_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NotesReceivableInterestRate_e3efc0b8-952c-4664-a808-1c612120f322_terseLabel_en-US" xlink:label="lab_hr_NotesReceivableInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INTEREST RATE</link:label>
    <link:label id="lab_hr_NotesReceivableInterestRate_label_en-US" xlink:label="lab_hr_NotesReceivableInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Interest Rate</link:label>
    <link:label id="lab_hr_NotesReceivableInterestRate_documentation_en-US" xlink:label="lab_hr_NotesReceivableInterestRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableInterestRate" xlink:href="hr-20230930.xsd#hr_NotesReceivableInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NotesReceivableInterestRate" xlink:to="lab_hr_NotesReceivableInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_1bedb1b2-71f1-42ba-a4e8-15d4c7da7945_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_1bed3328-bab9-4411-b57b-983c5e2eb96d_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2031</link:label>
    <link:label id="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_label_en-US" xlink:label="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2031, Net of Discount and Issuance Costs [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_documentation_en-US" xlink:label="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2031, Net of Discount and Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" xlink:href="hr-20230930.xsd#hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" xlink:to="lab_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_7cbf889d-f6da-419d-a602-4213a68b5e07_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_53532020-6706-44ac-8e72-aa2247c43194_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_HealthcareTrustOfAmericaIncMember_731f86e5-ac95-4b84-b271-0e53a8820fbd_terseLabel_en-US" xlink:label="lab_hr_HealthcareTrustOfAmericaIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Trust Of America, Inc</link:label>
    <link:label id="lab_hr_HealthcareTrustOfAmericaIncMember_label_en-US" xlink:label="lab_hr_HealthcareTrustOfAmericaIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Trust Of America, Inc [Member]</link:label>
    <link:label id="lab_hr_HealthcareTrustOfAmericaIncMember_documentation_en-US" xlink:label="lab_hr_HealthcareTrustOfAmericaIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Healthcare Trust Of America, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustOfAmericaIncMember" xlink:href="hr-20230930.xsd#hr_HealthcareTrustOfAmericaIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_HealthcareTrustOfAmericaIncMember" xlink:to="lab_hr_HealthcareTrustOfAmericaIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_27d32182-45d7-4339-a436-5bca1a6fa16d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_fe2cc442-050e-4e4d-a0d7-372ee2304945_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_ce24e040-80f7-4012-9810-5e9d78f9d96c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income allocated to participating securities</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:to="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_43893464-6d9b-4ee6-a843-90f32ed0404d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest owned (percent)</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_91cab990-8c66-4a25-ba4d-d27fa1f3546e_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill expected to be tax deductible</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Goodwill, Expected Tax Deductible Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="lab_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_b5df5255-9098-4ae0-af1d-6988904bf6c2_terseLabel_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_label_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Remainder Of Fiscal Year</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_documentation_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Remainder Of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" xlink:href="hr-20230930.xsd#hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" xlink:to="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_180b116c-67da-4268-b0b5-ecbfca9a51c9_verboseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_f073d198-1cac-4b7c-99f7-d24ae7e22fd6_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_386eace5-4c0d-40aa-9878-8e6a919ffa10_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings per common share - net income (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_349db666-4f29-4c72-a9f3-3553ccd0e308_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_PowayCAMember_2bee3958-f4b8-45d0-b19b-9f7bcde2495b_terseLabel_en-US" xlink:label="lab_hr_PowayCAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Poway, CA</link:label>
    <link:label id="lab_hr_PowayCAMember_label_en-US" xlink:label="lab_hr_PowayCAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Poway, CA [Member]</link:label>
    <link:label id="lab_hr_PowayCAMember_documentation_en-US" xlink:label="lab_hr_PowayCAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Poway, CA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PowayCAMember" xlink:href="hr-20230930.xsd#hr_PowayCAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_PowayCAMember" xlink:to="lab_hr_PowayCAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_6b11afe9-9b5e-45d7-9e89-f1c95f0cf312_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_PercentageOfInterestBearingInMortgageNotesPayable_29e4f337-6b89-47af-a486-008ed8ea6204_terseLabel_en-US" xlink:label="lab_hr_PercentageOfInterestBearingInMortgageNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of interest-bearing in mortgage note payable</link:label>
    <link:label id="lab_hr_PercentageOfInterestBearingInMortgageNotesPayable_label_en-US" xlink:label="lab_hr_PercentageOfInterestBearingInMortgageNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Interest-Bearing in Mortgage Notes Payable</link:label>
    <link:label id="lab_hr_PercentageOfInterestBearingInMortgageNotesPayable_documentation_en-US" xlink:label="lab_hr_PercentageOfInterestBearingInMortgageNotesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of Interest-Bearing in Mortgage Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PercentageOfInterestBearingInMortgageNotesPayable" xlink:href="hr-20230930.xsd#hr_PercentageOfInterestBearingInMortgageNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_PercentageOfInterestBearingInMortgageNotesPayable" xlink:to="lab_hr_PercentageOfInterestBearingInMortgageNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets_6af66ae7-172c-4a0e-9927-2036804a07a5_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease intangible assets</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Indefinite Lived Intangible Assets</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Indefinite Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_2dc86e1a-2d1d-4e06-9aab-f17639b436f7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from notes receivable repayments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Collection of Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:to="lab_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ExecutiveIncentiveProgramMember_3b8906a7-aebd-4bed-b155-72c9172260b7_terseLabel_en-US" xlink:label="lab_hr_ExecutiveIncentiveProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Incentive Program</link:label>
    <link:label id="lab_hr_ExecutiveIncentiveProgramMember_label_en-US" xlink:label="lab_hr_ExecutiveIncentiveProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Incentive Program [Member]</link:label>
    <link:label id="lab_hr_ExecutiveIncentiveProgramMember_documentation_en-US" xlink:label="lab_hr_ExecutiveIncentiveProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Incentive Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ExecutiveIncentiveProgramMember" xlink:href="hr-20230930.xsd#hr_ExecutiveIncentiveProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ExecutiveIncentiveProgramMember" xlink:to="lab_hr_ExecutiveIncentiveProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_0f2d7e79-9390-4254-bc18-755f01bd9032_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases_fca0564b-3d85-4138-a1c1-6424be0cf2ad_terseLabel_en-US" xlink:label="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of non-prepaid ground leases</link:label>
    <link:label id="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases_label_en-US" xlink:label="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Ground Leases, Excluding Prepaid Leases</link:label>
    <link:label id="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases_documentation_en-US" xlink:label="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Ground Leases, Excluding Prepaid Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberofGroundLeasesExcludingPrepaidLeases" xlink:href="hr-20230930.xsd#hr_NumberofGroundLeasesExcludingPrepaidLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberofGroundLeasesExcludingPrepaidLeases" xlink:to="lab_hr_NumberofGroundLeasesExcludingPrepaidLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities_3cc4dd60-c796-49fe-9d52-f428c4731b5c_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financing Lease Liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financing Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_f72db330-6108-4cfc-8959-15c7a2750ea9_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseMember_ec7e1e0e-667f-490e-a7c9-ed647b7992e5_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseMember_label_en-US" xlink:label="lab_us-gaap_InterestExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseMember" xlink:to="lab_us-gaap_InterestExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNet_7d09e7dd-cd85-4938-8870-6255242d32d8_totalLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total real estate properties, net</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNet_7ab76410-2f20-4575-9490-0d1245dc03aa_verboseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net real estate investments</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNet_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment Property, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNet" xlink:to="lab_us-gaap_RealEstateInvestmentPropertyNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_9535653f-054f-480f-8648-87236f5a9f2b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash_e82bcbbe-fe2d-4b95-b48e-8b548b04a4aa_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Restricted Cash</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsHeldForSaleLineItems_dc8951a0-01c9-4814-8748-41617d9db00a_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsHeldForSaleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Lived Assets Held-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsHeldForSaleLineItems_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsHeldForSaleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets Held-for-Sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongLivedAssetsHeldForSaleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems" xlink:to="lab_us-gaap_LongLivedAssetsHeldForSaleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LimitedLiabilityCompanyOneMember_8f4823e2-9e33-43f9-a7af-78f9248f8142_terseLabel_en-US" xlink:label="lab_hr_LimitedLiabilityCompanyOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company One</link:label>
    <link:label id="lab_hr_LimitedLiabilityCompanyOneMember_label_en-US" xlink:label="lab_hr_LimitedLiabilityCompanyOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company One [Member]</link:label>
    <link:label id="lab_hr_LimitedLiabilityCompanyOneMember_documentation_en-US" xlink:label="lab_hr_LimitedLiabilityCompanyOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LimitedLiabilityCompanyOneMember" xlink:href="hr-20230930.xsd#hr_LimitedLiabilityCompanyOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LimitedLiabilityCompanyOneMember" xlink:to="lab_hr_LimitedLiabilityCompanyOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_4cdafbf3-0530-440e-9395-fc06b027f1aa_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfCorporateEntityClassifiedAsHeldForSale_c330ad6e-248b-4ef6-82fe-9ac031648128_terseLabel_en-US" xlink:label="lab_hr_NumberOfCorporateEntityClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of corporate entity classified as held for sale</link:label>
    <link:label id="lab_hr_NumberOfCorporateEntityClassifiedAsHeldForSale_label_en-US" xlink:label="lab_hr_NumberOfCorporateEntityClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Corporate Entity Classified as Held for Sale</link:label>
    <link:label id="lab_hr_NumberOfCorporateEntityClassifiedAsHeldForSale_documentation_en-US" xlink:label="lab_hr_NumberOfCorporateEntityClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Corporate Entity Classified as Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfCorporateEntityClassifiedAsHeldForSale" xlink:href="hr-20230930.xsd#hr_NumberOfCorporateEntityClassifiedAsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfCorporateEntityClassifiedAsHeldForSale" xlink:to="lab_hr_NumberOfCorporateEntityClassifiedAsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableMember_690e333e-5843-4187-aa52-8359d86faebe_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable</link:label>
    <link:label id="lab_us-gaap_NotesReceivableMember_label_en-US" xlink:label="lab_us-gaap_NotesReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableMember" xlink:to="lab_us-gaap_NotesReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_UnsecuredCreditFacilityOneMember_b6dcad3d-e11f-4220-b00a-c1ca370c08f2_terseLabel_en-US" xlink:label="lab_hr_UnsecuredCreditFacilityOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$1.5 billion Unsecured Credit Facility</link:label>
    <link:label id="lab_hr_UnsecuredCreditFacilityOneMember_label_en-US" xlink:label="lab_hr_UnsecuredCreditFacilityOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Credit Facility One [Member]</link:label>
    <link:label id="lab_hr_UnsecuredCreditFacilityOneMember_documentation_en-US" xlink:label="lab_hr_UnsecuredCreditFacilityOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Credit Facility One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_UnsecuredCreditFacilityOneMember" xlink:href="hr-20230930.xsd#hr_UnsecuredCreditFacilityOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_UnsecuredCreditFacilityOneMember" xlink:to="lab_hr_UnsecuredCreditFacilityOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_HealthCareRealtyTrustIncMember_c5b19595-95fb-4828-ae25-6bb090566c8a_terseLabel_en-US" xlink:label="lab_hr_HealthCareRealtyTrustIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HealthCare Realty Trust, Inc.</link:label>
    <link:label id="lab_hr_HealthCareRealtyTrustIncMember_label_en-US" xlink:label="lab_hr_HealthCareRealtyTrustIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HealthCare Realty Trust, Inc. [Member]</link:label>
    <link:label id="lab_hr_HealthCareRealtyTrustIncMember_documentation_en-US" xlink:label="lab_hr_HealthCareRealtyTrustIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">HealthCare Realty Trust, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthCareRealtyTrustIncMember" xlink:href="hr-20230930.xsd#hr_HealthCareRealtyTrustIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_HealthCareRealtyTrustIncMember" xlink:to="lab_hr_HealthCareRealtyTrustIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment_931f4278-489a-420a-ba96-da7bf9aeae46_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land held for development</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land Held For Development</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land Held For Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ScheduleOfRealEstateDispositionsTable_329e7800-e698-41e5-bd9d-26eb3b075ca8_terseLabel_en-US" xlink:label="lab_hr_ScheduleOfRealEstateDispositionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Real Estate Dispositions [Table]</link:label>
    <link:label id="lab_hr_ScheduleOfRealEstateDispositionsTable_label_en-US" xlink:label="lab_hr_ScheduleOfRealEstateDispositionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Real Estate Dispositions [Table]</link:label>
    <link:label id="lab_hr_ScheduleOfRealEstateDispositionsTable_documentation_en-US" xlink:label="lab_hr_ScheduleOfRealEstateDispositionsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of real estate dispositions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ScheduleOfRealEstateDispositionsTable" xlink:href="hr-20230930.xsd#hr_ScheduleOfRealEstateDispositionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable" xlink:to="lab_hr_ScheduleOfRealEstateDispositionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_2329abda-81f3-417d-ad2f-3dc4d426ccc1_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_4a7202ac-3936-4d07-bf35-1280bc9a2e85_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_f3f71603-4530-42a2-b25c-2bff22dfb99b_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_e67a0409-56d6-42ac-9181-a7f16668c858_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_c37fe741-3b09-4dac-b953-977479ab35d0_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio_9a84dd01-9646-4c98-a2b6-b5b57c991270_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion ratio</link:label>
    <link:label id="lab_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio_label_en-US" xlink:label="lab_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Consideration Transferred Equity Interests Issuable Conversion Ratio</link:label>
    <link:label id="lab_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio_documentation_en-US" xlink:label="lab_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Consideration Transferred Equity Interests Issuable Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" xlink:href="hr-20230930.xsd#hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" xlink:to="lab_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRevenueExtensibleList_248b8fd5-e943-4426-b6a9-e74c40cc0fd4_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRevenueExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_TypeOfRevenueExtensibleList_label_en-US" xlink:label="lab_us-gaap_TypeOfRevenueExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product and Service [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRevenueExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRevenueExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRevenueExtensibleList" xlink:to="lab_us-gaap_TypeOfRevenueExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet_1f94de05-1c08-47b7-8fa1-7e850fc9c988_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets, net</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets, Net</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssets_4574b963-9f04-4c63-b08c-09d977a4c4fd_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets, net</link:label>
    <link:label id="lab_us-gaap_OtherAssets_label_en-US" xlink:label="lab_us-gaap_OtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssets" xlink:to="lab_us-gaap_OtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_7bafe346-4cf9-446d-9cf8-a592e3565fc6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Implied shares of Legacy HR Common Stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_6c4bb4d3-490f-4c75-9952-d31a5a4b07d1_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_27ea86ac-b481-411f-b8b3-260de0b5266a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate - finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_d823a234-d4ba-4838-aaf8-1d1d5f12326b_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as hedging instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_47133300-a5be-4399-a1e5-6eef0ee1b513_terseLabel_en-US" xlink:label="lab_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited partner's capital, units outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_label_en-US" xlink:label="lab_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Partners' Capital Account, Units Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding" xlink:to="lab_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_77837689-b706-4fc5-8e5e-3abe394d10d2_verboseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_97d94ca8-7429-4a5d-8d6d-6777757d86e4_totalLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total real estate investments</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress_66cf17e3-9537-4db7-b3f8-74e2bac2319a_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Construction in Progress</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Construction in Progress</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_1293c9dd-0dba-4f9d-9854-bf6c2d93ac13_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_f903e941-624a-4b20-bd82-996fd001d93e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average years remaining lease term (excluding renewal options) - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_f99d5088-c590-4655-9269-9b573e5cf184_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfBuildingsOwnedByJointVenture_1509bf84-3d89-4fa5-81f9-ca1b527a5ba0_terseLabel_en-US" xlink:label="lab_hr_NumberOfBuildingsOwnedByJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of buildings owned by joint venture with TIAA</link:label>
    <link:label id="lab_hr_NumberOfBuildingsOwnedByJointVenture_label_en-US" xlink:label="lab_hr_NumberOfBuildingsOwnedByJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Buildings Owned by Joint Venture</link:label>
    <link:label id="lab_hr_NumberOfBuildingsOwnedByJointVenture_documentation_en-US" xlink:label="lab_hr_NumberOfBuildingsOwnedByJointVenture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Buildings Owned by Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfBuildingsOwnedByJointVenture" xlink:href="hr-20230930.xsd#hr_NumberOfBuildingsOwnedByJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfBuildingsOwnedByJointVenture" xlink:to="lab_hr_NumberOfBuildingsOwnedByJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_76ec7520-2c2e-42b1-9bed-00a2f8e5f8ab_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_4f4bdf77-2e87-455b-91f8-3bb9d8671b45_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_9bcb98ef-898a-4c73-8ca6-28654c2424bb_terseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld to pay estimated withholding taxes (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_0bdc8ef0-78d9-40a9-acb4-e300379e8cc0_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual_b6fb02f9-eca5-48b4-9795-7538675921ea_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing receivable, nonaccrual</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, Nonaccrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_DerivativeNetAssetPositionAggregateFairValue_d38cb038-b6cf-4860-bf30-07887494ea38_terseLabel_en-US" xlink:label="lab_hr_DerivativeNetAssetPositionAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives in net asset position</link:label>
    <link:label id="lab_hr_DerivativeNetAssetPositionAggregateFairValue_label_en-US" xlink:label="lab_hr_DerivativeNetAssetPositionAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Net Asset Position Aggregate Fair Value</link:label>
    <link:label id="lab_hr_DerivativeNetAssetPositionAggregateFairValue_documentation_en-US" xlink:label="lab_hr_DerivativeNetAssetPositionAggregateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Net Asset Position Aggregate Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DerivativeNetAssetPositionAggregateFairValue" xlink:href="hr-20230930.xsd#hr_DerivativeNetAssetPositionAggregateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_DerivativeNetAssetPositionAggregateFairValue" xlink:to="lab_hr_DerivativeNetAssetPositionAggregateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MergerConsiderationTransferred_87aeef3b-d59b-4ccf-b8c4-46813bcce344_terseLabel_en-US" xlink:label="lab_hr_MergerConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger consideration transferred</link:label>
    <link:label id="lab_hr_MergerConsiderationTransferred_label_en-US" xlink:label="lab_hr_MergerConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger Consideration Transferred</link:label>
    <link:label id="lab_hr_MergerConsiderationTransferred_documentation_en-US" xlink:label="lab_hr_MergerConsiderationTransferred" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Merger Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MergerConsiderationTransferred" xlink:href="hr-20230930.xsd#hr_MergerConsiderationTransferred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MergerConsiderationTransferred" xlink:to="lab_hr_MergerConsiderationTransferred" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_StockIssuanceProgramDomain_44d6aa1c-dde6-496c-9ffe-f3ee0b8d0a9e_terseLabel_en-US" xlink:label="lab_hr_StockIssuanceProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Program [Domain]</link:label>
    <link:label id="lab_hr_StockIssuanceProgramDomain_label_en-US" xlink:label="lab_hr_StockIssuanceProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuance Program [Domain]</link:label>
    <link:label id="lab_hr_StockIssuanceProgramDomain_documentation_en-US" xlink:label="lab_hr_StockIssuanceProgramDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Stock Issuance Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramDomain" xlink:href="hr-20230930.xsd#hr_StockIssuanceProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_StockIssuanceProgramDomain" xlink:to="lab_hr_StockIssuanceProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateContractMember_86fc89ef-613c-4eec-bef8-ec42f710ceab_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_InterestRateContractMember_label_en-US" xlink:label="lab_us-gaap_InterestRateContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateContractMember" xlink:to="lab_us-gaap_InterestRateContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount_53673e78-cb80-4bc4-bd2d-a2266a3f1a66_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross contractual real estate notes receivable</link:label>
    <link:label id="lab_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount_label_en-US" xlink:label="lab_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquired Real Estate Notes Receivable, Gross Contractual Amount</link:label>
    <link:label id="lab_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount_documentation_en-US" xlink:label="lab_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquired Real Estate Notes Receivable, Gross Contractual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount" xlink:href="hr-20230930.xsd#hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount" xlink:to="lab_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_21686b2f-eec1-4bae-a6ea-93eef4f1834e_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for new finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateDispositionsLineItems_3c475595-2d2f-4e1b-b053-e4a115492e00_terseLabel_en-US" xlink:label="lab_hr_RealEstateDispositionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions [Line Items]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsLineItems_label_en-US" xlink:label="lab_hr_RealEstateDispositionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions [Line Items]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsLineItems_documentation_en-US" xlink:label="lab_hr_RealEstateDispositionsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate dispositions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsLineItems" xlink:href="hr-20230930.xsd#hr_RealEstateDispositionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateDispositionsLineItems" xlink:to="lab_hr_RealEstateDispositionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfDirectors_ccc87f03-05e0-4c3a-9c31-ef8b5b86c988_terseLabel_en-US" xlink:label="lab_hr_NumberOfDirectors" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of directors</link:label>
    <link:label id="lab_hr_NumberOfDirectors_label_en-US" xlink:label="lab_hr_NumberOfDirectors" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Directors</link:label>
    <link:label id="lab_hr_NumberOfDirectors_documentation_en-US" xlink:label="lab_hr_NumberOfDirectors" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Directors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfDirectors" xlink:href="hr-20230930.xsd#hr_NumberOfDirectors"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfDirectors" xlink:to="lab_hr_NumberOfDirectors" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NewEmployeeMember_386af546-478e-4d40-9085-1f751e2add99_terseLabel_en-US" xlink:label="lab_hr_NewEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Employee</link:label>
    <link:label id="lab_hr_NewEmployeeMember_label_en-US" xlink:label="lab_hr_NewEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Employee [Member]</link:label>
    <link:label id="lab_hr_NewEmployeeMember_documentation_en-US" xlink:label="lab_hr_NewEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Employee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NewEmployeeMember" xlink:href="hr-20230930.xsd#hr_NewEmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NewEmployeeMember" xlink:to="lab_hr_NewEmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_4265f39d-6622-4672-86a6-889eb43e4c78_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfRealEstateInvestments_8e4c90fa-4e22-4b6d-a812-a175e42656b5_terseLabel_en-US" xlink:label="lab_hr_NumberOfRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of real estate properties</link:label>
    <link:label id="lab_hr_NumberOfRealEstateInvestments_label_en-US" xlink:label="lab_hr_NumberOfRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Real Estate Investments</link:label>
    <link:label id="lab_hr_NumberOfRealEstateInvestments_documentation_en-US" xlink:label="lab_hr_NumberOfRealEstateInvestments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of real estate investments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRealEstateInvestments" xlink:href="hr-20230930.xsd#hr_NumberOfRealEstateInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfRealEstateInvestments" xlink:to="lab_hr_NumberOfRealEstateInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_74bf7761-651d-4b0a-828d-00150accbaf7_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Issued, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_56f451d0-94dc-4ce9-9d7f-34d094300d78_verboseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_JointVentureOwnershipPercentage_af639817-eb41-45c9-ba7c-fb441273986c_terseLabel_en-US" xlink:label="lab_hr_JointVentureOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture, ownership (in percentage)</link:label>
    <link:label id="lab_hr_JointVentureOwnershipPercentage_label_en-US" xlink:label="lab_hr_JointVentureOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture, Ownership Percentage</link:label>
    <link:label id="lab_hr_JointVentureOwnershipPercentage_documentation_en-US" xlink:label="lab_hr_JointVentureOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureOwnershipPercentage" xlink:href="hr-20230930.xsd#hr_JointVentureOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_JointVentureOwnershipPercentage" xlink:to="lab_hr_JointVentureOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_ee4cd4d3-a352-4a01-b9b4-63d6e97ee783_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_7fb98969-25bf-4e41-9a89-1d1423e51a4e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains arising during the period on interest rate swaps</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_e13a355a-51bd-4944-a3f1-dddc510fb456_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gains arising during the period on interest rate swaps</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_191e5c07-e2cc-434c-84e0-08018e06e16c_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_e48cf5bc-6803-43c6-afcb-5509b9c56eca_terseLabel_en-US" xlink:label="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SQUARE FOOTAGE</link:label>
    <link:label id="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_label_en-US" xlink:label="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area Covered Under Real Estate Investment Sold in Measurement Units</link:label>
    <link:label id="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_documentation_en-US" xlink:label="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Area covered under real estate investment sold in measurement units.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" xlink:href="hr-20230930.xsd#hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" xlink:to="lab_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_033c656f-72df-46f9-ab43-84acf2b17826_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity loss from unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_2489d2f7-903e-486c-8bed-97e0e924d7c2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity loss from unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_c76ae6ec-ab42-4f17-ae45-b9187edc75cd_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity loss recognized during the period</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_70658253-a3ad-4984-b132-f96d7432031c_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_dde025c2-9c25-48ac-8539-d1b0f524d940_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfRecognizedLeaseFinancialReceivables_60926650-6ec7-486b-8456-806fddad7775_terseLabel_en-US" xlink:label="lab_hr_NumberOfRecognizedLeaseFinancialReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of recognized lease financial receivables</link:label>
    <link:label id="lab_hr_NumberOfRecognizedLeaseFinancialReceivables_label_en-US" xlink:label="lab_hr_NumberOfRecognizedLeaseFinancialReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Recognized Lease Financial Receivables</link:label>
    <link:label id="lab_hr_NumberOfRecognizedLeaseFinancialReceivables_documentation_en-US" xlink:label="lab_hr_NumberOfRecognizedLeaseFinancialReceivables" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Recognized Lease Financial Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRecognizedLeaseFinancialReceivables" xlink:href="hr-20230930.xsd#hr_NumberOfRecognizedLeaseFinancialReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfRecognizedLeaseFinancialReceivables" xlink:to="lab_hr_NumberOfRecognizedLeaseFinancialReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfNotesReceivable_8d80ebe6-f13c-4438-9b3b-1caa42e6d87b_terseLabel_en-US" xlink:label="lab_hr_NumberOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of notes receivable</link:label>
    <link:label id="lab_hr_NumberOfNotesReceivable_label_en-US" xlink:label="lab_hr_NumberOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Notes Receivable</link:label>
    <link:label id="lab_hr_NumberOfNotesReceivable_documentation_en-US" xlink:label="lab_hr_NumberOfNotesReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Notes Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfNotesReceivable" xlink:href="hr-20230930.xsd#hr_NumberOfNotesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfNotesReceivable" xlink:to="lab_hr_NumberOfNotesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8d1e49e5-f557-4bd9-9e3b-42a2579d3927_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapExpiringJune12027Member_f65fe079-9b85-4f37-bb90-b4d489ed03d7_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJune12027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring June 1, 2027</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringJune12027Member_label_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJune12027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring June 1, 2027 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringJune12027Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJune12027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring June 1, 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJune12027Member" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringJune12027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapExpiringJune12027Member" xlink:to="lab_hr_InterestRateSwapExpiringJune12027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_891413e9-343b-4b34-9590-63f6ae2ded5c_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flow hedging</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgingMember_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgingMember" xlink:to="lab_us-gaap_CashFlowHedgingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_973e7b8f-fa4e-4e04-b663-540611114e67_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3e799ba2-cc18-480e-bf5a-9e801ddfb5b2_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Decrease) increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_9699d86d-00e9-47e9-a995-4653bb82370f_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_e86632a9-540d-4387-9acc-728bf7037590_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_94d42517-4a06-4b28-bd67-c345a0f0bbd8_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorLeasesPolicyTextBlock_c4f61358-2b1d-40c4-90cd-fd3670bcd6a8_terseLabel_en-US" xlink:label="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Leases - Financing Receivables, Net and Real Estate Notes Receivable and Interest Income</link:label>
    <link:label id="lab_us-gaap_LessorLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LessorLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_b85fa862-22e8-4079-84cf-8dc06ea4587f_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapExpiringJune12026Member_b4f06dd6-3927-4ece-8d22-bb09a5a27953_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJune12026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring June 1, 2026</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringJune12026Member_label_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJune12026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring June 1, 2026 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringJune12026Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJune12026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring June 1, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJune12026Member" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringJune12026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapExpiringJune12026Member" xlink:to="lab_hr_InterestRateSwapExpiringJune12026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_JointVentureCarryingAmount_cc2348c1-6d09-4362-a87a-8ff08e467f1a_terseLabel_en-US" xlink:label="lab_hr_JointVentureCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture, carrying amount</link:label>
    <link:label id="lab_hr_JointVentureCarryingAmount_label_en-US" xlink:label="lab_hr_JointVentureCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture, Carrying Amount</link:label>
    <link:label id="lab_hr_JointVentureCarryingAmount_documentation_en-US" xlink:label="lab_hr_JointVentureCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint Venture, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureCarryingAmount" xlink:href="hr-20230930.xsd#hr_JointVentureCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_JointVentureCarryingAmount" xlink:to="lab_hr_JointVentureCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_d0ae79b6-4824-4933-a9f7-17b1706f66d6_terseLabel_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE</link:label>
    <link:label id="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember_label_en-US" xlink:label="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimate of Fair Value Measurement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="lab_us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AtlantaGAMember_526a1580-eb55-4606-a00e-f8296bc77dae_terseLabel_en-US" xlink:label="lab_hr_AtlantaGAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Atlanta, GA</link:label>
    <link:label id="lab_hr_AtlantaGAMember_label_en-US" xlink:label="lab_hr_AtlantaGAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Atlanta, GA [Member]</link:label>
    <link:label id="lab_hr_AtlantaGAMember_documentation_en-US" xlink:label="lab_hr_AtlantaGAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Atlanta, GA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AtlantaGAMember" xlink:href="hr-20230930.xsd#hr_AtlantaGAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AtlantaGAMember" xlink:to="lab_hr_AtlantaGAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateAcquisitionsMember_af2be381-7cd6-4e5e-946f-da7bd5dde355_terseLabel_en-US" xlink:label="lab_hr_RealEstateAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total real estate acquisitions</link:label>
    <link:label id="lab_hr_RealEstateAcquisitionsMember_label_en-US" xlink:label="lab_hr_RealEstateAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Acquisitions [Member]</link:label>
    <link:label id="lab_hr_RealEstateAcquisitionsMember_documentation_en-US" xlink:label="lab_hr_RealEstateAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate acquisitions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateAcquisitionsMember" xlink:href="hr-20230930.xsd#hr_RealEstateAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateAcquisitionsMember" xlink:to="lab_hr_RealEstateAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_e9bc16c1-75b2-4baf-adc0-5a66866dee9a_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_f4a74181-a0bb-4af4-a503-56680422a6b5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstatePropertiesLineItems_5bc8254b-fa7e-43de-a8af-5cda2a69698c_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstatePropertiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Properties [Line Items]</link:label>
    <link:label id="lab_us-gaap_RealEstatePropertiesLineItems_label_en-US" xlink:label="lab_us-gaap_RealEstatePropertiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Properties [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstatePropertiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstatePropertiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems" xlink:to="lab_us-gaap_RealEstatePropertiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_b9da0a6e-6c8e-4dbf-ac6b-07fa046e6e79_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_FinanceMortgageNotes_f55017e5-dfa9-4440-8d2a-f3de00fd1ad4_negatedTerseLabel_en-US" xlink:label="lab_hr_FinanceMortgageNotes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPANY-FINANCED MORTGAGE NOTES</link:label>
    <link:label id="lab_hr_FinanceMortgageNotes_label_en-US" xlink:label="lab_hr_FinanceMortgageNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Mortgage Notes</link:label>
    <link:label id="lab_hr_FinanceMortgageNotes_documentation_en-US" xlink:label="lab_hr_FinanceMortgageNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Mortgage Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceMortgageNotes" xlink:href="hr-20230930.xsd#hr_FinanceMortgageNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_FinanceMortgageNotes" xlink:to="lab_hr_FinanceMortgageNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_a6d6ceb7-674b-42d1-8b27-9e0a229c5f0f_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_743e557a-82c0-46fd-8d9d-8bfc90e6a83d_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_421373e0-864d-400c-8698-58f38e9c3fb9_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss (income) attributable to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c62d94c3-95b7-45c1-9097-039a2f50f288_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss (income) attributable to non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_55fb403d-ec7c-444e-8d3b-31a4f4b8667b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonemployee</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonemployee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_d4d40bd6-f8c4-4322-b489-ade7c8b3bf10_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_3087d78a-5de3-49d8-b44b-6fcadbb189fa_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SquareFeetSubjectToMortgageNotesPayable_41b2fb21-a8a9-4d14-abc4-9f70fd92af99_terseLabel_en-US" xlink:label="lab_hr_SquareFeetSubjectToMortgageNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Square foot subject to mortgage note payable</link:label>
    <link:label id="lab_hr_SquareFeetSubjectToMortgageNotesPayable_label_en-US" xlink:label="lab_hr_SquareFeetSubjectToMortgageNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Square Feet Subject to Mortgage Notes Payable</link:label>
    <link:label id="lab_hr_SquareFeetSubjectToMortgageNotesPayable_documentation_en-US" xlink:label="lab_hr_SquareFeetSubjectToMortgageNotesPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Square Feet Subject to Mortgage Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SquareFeetSubjectToMortgageNotesPayable" xlink:href="hr-20230930.xsd#hr_SquareFeetSubjectToMortgageNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SquareFeetSubjectToMortgageNotesPayable" xlink:to="lab_hr_SquareFeetSubjectToMortgageNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale_a1621481-f985-42ed-81c1-aad1afa268d5_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities of assets held for sale</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities of Assets Held for Sale</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities of Assets Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e0be7cf3-5395-4654-95b6-e12d5ab90207_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_df9aa392-7897-4fef-8f3a-b5beb1f873f7_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based awards, ending of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_9e22519c-7d8b-4ea1-a5a1-986c6a5c77f2_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and Bonds Payable</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_6baf7f66-7629-459a-8907-64db1664ccf1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_61815ee4-598e-4a0c-9cab-d131189228e5_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable interest entity</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_f41febd0-081e-4bf1-9cfb-07241c6569a0_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_7a43bc7f-3fb4-4e76-986f-5de5d1fadf0f_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_eaa70cb3-506f-442d-ac7f-47a9b323fbce_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (expense)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_489ddc23-a816-477a-8a15-fd80469d8bea_verboseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_10465381-d682-47eb-aa3a-f197a36ab0cf_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_1842f1fc-0e53-49d0-b5b2-08840cfe3ec0_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_STLouisMoMember_2daaf6eb-3a8f-4e32-9a11-aa9662f5810a_terseLabel_en-US" xlink:label="lab_hr_STLouisMoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">St. Louis, MO</link:label>
    <link:label id="lab_hr_STLouisMoMember_label_en-US" xlink:label="lab_hr_STLouisMoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ST Louis Mo [Member]</link:label>
    <link:label id="lab_hr_STLouisMoMember_documentation_en-US" xlink:label="lab_hr_STLouisMoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ST Louis Mo</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_STLouisMoMember" xlink:href="hr-20230930.xsd#hr_STLouisMoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_STLouisMoMember" xlink:to="lab_hr_STLouisMoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_f4e21a29-bef9-43cd-9948-4d9c93f9e2ba_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_24aaff41-0896-4e6a-b317-3d246a979db3_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour_0b209c78-9ee1-4ece-bfce-bb3ccfbb0258_terseLabel_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour_label_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Four</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour_documentation_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour" xlink:href="hr-20230930.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour" xlink:to="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAtCost_6be17cec-a817-4e64-9e9f-fa52eab8d3d1_totalLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAtCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total real estate properties</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyAtCost_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyAtCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment Property, at Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyAtCost" xlink:to="lab_us-gaap_RealEstateInvestmentPropertyAtCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_0a3e96ef-a838-4259-9b4d-9d8066e37a5b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net repayments on unsecured credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RedevelopmentPropertiesMember_75bc14b3-558c-4470-836f-2620a4f98e49_terseLabel_en-US" xlink:label="lab_hr_RedevelopmentPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redevelopment Properties</link:label>
    <link:label id="lab_hr_RedevelopmentPropertiesMember_label_en-US" xlink:label="lab_hr_RedevelopmentPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redevelopment Properties [Member]</link:label>
    <link:label id="lab_hr_RedevelopmentPropertiesMember_documentation_en-US" xlink:label="lab_hr_RedevelopmentPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redevelopment Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RedevelopmentPropertiesMember" xlink:href="hr-20230930.xsd#hr_RedevelopmentPropertiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RedevelopmentPropertiesMember" xlink:to="lab_hr_RedevelopmentPropertiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_acb30da2-b579-4295-b43a-d35f5aef1e6d_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of instruments</link:label>
    <link:label id="lab_us-gaap_NumberOfInterestRateDerivativesHeld_label_en-US" xlink:label="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Interest Rate Derivatives Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:to="lab_us-gaap_NumberOfInterestRateDerivativesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfPropertiesSubjectToGroundLeases_16ffbead-776c-4f91-b5c7-78f92a5cffa5_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfPropertiesSubjectToGroundLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties subject to ground leases</link:label>
    <link:label id="lab_us-gaap_NumberOfPropertiesSubjectToGroundLeases_label_en-US" xlink:label="lab_us-gaap_NumberOfPropertiesSubjectToGroundLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Properties Subject to Ground Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfPropertiesSubjectToGroundLeases" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfPropertiesSubjectToGroundLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfPropertiesSubjectToGroundLeases" xlink:to="lab_us-gaap_NumberOfPropertiesSubjectToGroundLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_633e6929-abbc-4fd8-9b48-eb091e49bf34_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_0f2fb23e-3c3f-43b8-bdd5-6d6523c445d9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_c4be8173-290e-45b8-843e-b6a1af394096_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_89f7def4-27b8-4d15-ae93-989fb910cdb2_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in financing receivable, net</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_0ed8eee4-ffb9-4bc3-b066-d854a51c246f_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapExpiringMay12026Member_11bce0c3-446f-4ab5-b9d9-220a959060ad_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapExpiringMay12026Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring May 1, 2026</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringMay12026Member_label_en-US" xlink:label="lab_hr_InterestRateSwapExpiringMay12026Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring May 1, 2026 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringMay12026Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapExpiringMay12026Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring May 1, 2026</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringMay12026Member" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringMay12026Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapExpiringMay12026Member" xlink:to="lab_hr_InterestRateSwapExpiringMay12026Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesdue2028Member_0bafb31a-7164-43c8-958f-4d65ab1983db_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesdue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2028</link:label>
    <link:label id="lab_hr_SeniorNotesdue2028Member_label_en-US" xlink:label="lab_hr_SeniorNotesdue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2028 [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesdue2028Member_documentation_en-US" xlink:label="lab_hr_SeniorNotesdue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2028 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2028Member" xlink:href="hr-20230930.xsd#hr_SeniorNotesdue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesdue2028Member" xlink:to="lab_hr_SeniorNotesdue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_cea597e2-fdac-4816-8590-6da8653b5b39_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Relationship [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale_1c5febde-b6a7-4c5a-a2b8-dc78643a99fa_terseLabel_en-US" xlink:label="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties classified as held for sale</link:label>
    <link:label id="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale_label_en-US" xlink:label="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Properties Classified as Held for Sale</link:label>
    <link:label id="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale_documentation_en-US" xlink:label="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Properties Classified as Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertiesClassifiedAsHeldForSale" xlink:href="hr-20230930.xsd#hr_NumberOfPropertiesClassifiedAsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfPropertiesClassifiedAsHeldForSale" xlink:to="lab_hr_NumberOfPropertiesClassifiedAsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_66556dfa-cc18-4c37-b8e9-cdd0ca548bdc_terseLabel_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING</link:label>
    <link:label id="lab_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_label_en-US" xlink:label="lab_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract" xlink:to="lab_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_cdbee0de-7c39-49d7-b4bc-62edbb66757a_verboseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_0bdffac4-c834-4d73-b757-cee3e9174739_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_4a8dc46b-ea03-48e1-a164-9580db6e6d81_terseLabel_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock price (in dollar per share)</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_label_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Stock Price</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_documentation_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Stock Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" xlink:href="hr-20230930.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" xlink:to="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_31f2dacb-609f-442a-8c6b-393c8310104a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding and exercisable, beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_00ed0230-1a67-45a9-baad-5790073a6b4e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding and exercisable, end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireFinanceReceivables_22ca76a7-3e11-4d5a-8ad8-757e2f50fff6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in financing receivable</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireFinanceReceivables_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Finance Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireFinanceReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:to="lab_us-gaap_PaymentsToAcquireFinanceReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_01ae656d-64ab-4eca-88bc-f676254fad77_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Company's Allowance For Credit Losses</link:label>
    <link:label id="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:to="lab_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_4cb79356-1f14-4c90-be8a-9852f14f8364_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:to="lab_us-gaap_ExtinguishmentOfDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_34562723-3d79-456b-9106-c040f99e0ab7_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_08fdd1cc-3551-4118-9ad4-1b5d2f7ee696_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_8172d22d-e3a2-4010-af0d-6a8bd18ed799_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_847b61e5-5e9d-4307-be6e-029b43d832bf_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RecapitalizationExchangeRatio_777b1759-edf4-4a73-bd2b-e8a985548518_terseLabel_en-US" xlink:label="lab_hr_RecapitalizationExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exchange ratio</link:label>
    <link:label id="lab_hr_RecapitalizationExchangeRatio_label_en-US" xlink:label="lab_hr_RecapitalizationExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization Exchange Ratio</link:label>
    <link:label id="lab_hr_RecapitalizationExchangeRatio_documentation_en-US" xlink:label="lab_hr_RecapitalizationExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization Exchange Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RecapitalizationExchangeRatio" xlink:href="hr-20230930.xsd#hr_RecapitalizationExchangeRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RecapitalizationExchangeRatio" xlink:to="lab_hr_RecapitalizationExchangeRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_895b5c76-572e-44d7-bd3c-351bf6825465_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_53b84c7c-a06e-42f5-8346-20bf58392176_verboseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS' EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_dbe63468-f2c0-4f64-941e-66f88758cad3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_30262dbe-7b0b-43de-9af9-da16ed4cfd00_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Employee Stock Purchase Plan Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_21a23196-3907-4a30-a8a6-a91844c574cd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_1edfc878-2adb-4187-a481-c0bc86512003_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain)/loss recognized in AOCI on derivative</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_118d577a-49e5-4c8d-97fc-191fc70bd5ae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_55895a6a-074f-404c-ab63-5a4106a1e80e_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of the Activity Under the Incentive Plan and RSU Activity</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_958fdab7-06b5-4aa6-b825-89827eae7718_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_2ecc897e-8b1e-46a8-ab63-0003a5383413_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sales of real estate properties and additional long-lived assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale, Property, Held-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount_35ea1f31-2a4c-41f8-bc28-a5978dab0ce7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FAIR VALUE DISCOUNT AND FEES</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Covered and Not Covered, after Allowance for Credit Loss, Fee, Premium, and Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" xlink:to="lab_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_26e47211-c679-4d0c-9525-457867a07cab_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_ec1de6da-ef5a-49cb-a805-ffea0d527fdc_totalLabel_en-US" xlink:label="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income applicable to common stockholders - basic</link:label>
    <link:label id="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_label_en-US" xlink:label="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) from Continuing Operations Available to Common Stockholders, Basic</link:label>
    <link:label id="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_documentation_en-US" xlink:label="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) from Continuing Operations Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" xlink:href="hr-20230930.xsd#hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" xlink:to="lab_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_26db743b-be9d-4ef7-923a-ffa40a32d3d8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_853db667-11d6-466f-bfe7-c507f1af2243_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementBasisAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Basis [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis" xlink:to="lab_us-gaap_FairValueByMeasurementBasisAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AcquisitionsAndDispositionsTextBlock_69ced902-115b-482a-9a15-ef4a099a85b5_verboseLabel_en-US" xlink:label="lab_hr_AcquisitionsAndDispositionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investments</link:label>
    <link:label id="lab_hr_AcquisitionsAndDispositionsTextBlock_label_en-US" xlink:label="lab_hr_AcquisitionsAndDispositionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and Dispositions [Text Block]</link:label>
    <link:label id="lab_hr_AcquisitionsAndDispositionsTextBlock_documentation_en-US" xlink:label="lab_hr_AcquisitionsAndDispositionsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions and dispositions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AcquisitionsAndDispositionsTextBlock" xlink:href="hr-20230930.xsd#hr_AcquisitionsAndDispositionsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AcquisitionsAndDispositionsTextBlock" xlink:to="lab_hr_AcquisitionsAndDispositionsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_18dea072-830a-4492-98fd-032cd37aaa25_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureItemAmountsDomain_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:to="lab_us-gaap_FairValueDisclosureItemAmountsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_25a87ecc-655c-478b-a2f8-2e03d321aafe_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends declared per common share, during the period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockDividendsPerShareDeclared_label_en-US" xlink:label="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Dividends, Per Share, Declared</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockDividendsPerShareDeclared" xlink:to="lab_us-gaap_CommonStockDividendsPerShareDeclared" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_bbc29748-4e52-46d9-bc98-caff08cc4481_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_a22f5d5e-fb15-4dc8-a22c-f093bff32ae1_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt issuance and assumption costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestIncomeFinancingReceivableNoncash_5a78fddc-7198-4f30-ae21-e2a78e629535_negatedTerseLabel_en-US" xlink:label="lab_hr_InterestIncomeFinancingReceivableNoncash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash interest from financing and notes receivable</link:label>
    <link:label id="lab_hr_InterestIncomeFinancingReceivableNoncash_label_en-US" xlink:label="lab_hr_InterestIncomeFinancingReceivableNoncash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Financing Receivable, Noncash</link:label>
    <link:label id="lab_hr_InterestIncomeFinancingReceivableNoncash_documentation_en-US" xlink:label="lab_hr_InterestIncomeFinancingReceivableNoncash" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income, Financing Receivable, Noncash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestIncomeFinancingReceivableNoncash" xlink:href="hr-20230930.xsd#hr_InterestIncomeFinancingReceivableNoncash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestIncomeFinancingReceivableNoncash" xlink:to="lab_hr_InterestIncomeFinancingReceivableNoncash" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AmortizationofPrepaidRent_da3e8783-aa06-4e38-89cb-a62687bfd754_terseLabel_en-US" xlink:label="lab_hr_AmortizationofPrepaidRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of prepaid rent</link:label>
    <link:label id="lab_hr_AmortizationofPrepaidRent_label_en-US" xlink:label="lab_hr_AmortizationofPrepaidRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Prepaid Rent</link:label>
    <link:label id="lab_hr_AmortizationofPrepaidRent_documentation_en-US" xlink:label="lab_hr_AmortizationofPrepaidRent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Prepaid Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AmortizationofPrepaidRent" xlink:href="hr-20230930.xsd#hr_AmortizationofPrepaidRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AmortizationofPrepaidRent" xlink:to="lab_hr_AmortizationofPrepaidRent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireRealEstate_8453b4ff-6ede-4d55-89b1-6a58f9d11cd1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireRealEstate" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisitions of real estate</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireRealEstate_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireRealEstate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Real Estate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRealEstate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireRealEstate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireRealEstate" xlink:to="lab_us-gaap_PaymentsToAcquireRealEstate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_184cc132-430d-4f3e-8e21-6c392e235246_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRealEstatePropertiesTable_214ef6a6-4522-4382-9929-db4378245df9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Real Estate Properties [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRealEstatePropertiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Real Estate Properties [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRealEstatePropertiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:to="lab_us-gaap_ScheduleOfRealEstatePropertiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_e5259442-b65a-4a75-a9ad-753c4fd5f103_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Operating Lease Payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_87808905-cae9-463b-a8e1-661a605ca556_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value And Carrying Values For Notes And Bonds Payable, Real Estate Notes Receivable, And Notes Receivable</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_1eb31fcb-f782-4f59-9d2b-6431bfe10965_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_OperatingPartnershipPerformanceUnitsMember_dcab9528-709d-4ee2-b572-e12f64e7d1dc_terseLabel_en-US" xlink:label="lab_hr_OperatingPartnershipPerformanceUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Partnership Performance Units</link:label>
    <link:label id="lab_hr_OperatingPartnershipPerformanceUnitsMember_label_en-US" xlink:label="lab_hr_OperatingPartnershipPerformanceUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Partnership Performance Units [Member]</link:label>
    <link:label id="lab_hr_OperatingPartnershipPerformanceUnitsMember_documentation_en-US" xlink:label="lab_hr_OperatingPartnershipPerformanceUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Partnership Performance Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember" xlink:href="hr-20230930.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_OperatingPartnershipPerformanceUnitsMember" xlink:to="lab_hr_OperatingPartnershipPerformanceUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract_45af939b-0095-4992-a965-2d879bce3f3b_verboseLabel_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate properties</link:label>
    <link:label id="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract_label_en-US" xlink:label="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investment Property, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:to="lab_us-gaap_RealEstateInvestmentPropertyNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_f44499ab-855c-4e3e-b6b7-ca4913ab2b53_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Lease Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_AssetDispositionsTableTextBlock_10a506dc-ff65-4758-9bf0-a97b9b55c595_terseLabel_en-US" xlink:label="lab_hr_AssetDispositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Real Estate Dispositions</link:label>
    <link:label id="lab_hr_AssetDispositionsTableTextBlock_label_en-US" xlink:label="lab_hr_AssetDispositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Dispositions [Table Text Block]</link:label>
    <link:label id="lab_hr_AssetDispositionsTableTextBlock_documentation_en-US" xlink:label="lab_hr_AssetDispositionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Dispositions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetDispositionsTableTextBlock" xlink:href="hr-20230930.xsd#hr_AssetDispositionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_AssetDispositionsTableTextBlock" xlink:to="lab_hr_AssetDispositionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ba9df0e9-0fef-4e7c-be40-099a156357ba_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ColoradoSpringsCOMember_4043e47c-0379-46fb-a161-317c4173d6cc_terseLabel_en-US" xlink:label="lab_hr_ColoradoSpringsCOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Colorado Springs, CO</link:label>
    <link:label id="lab_hr_ColoradoSpringsCOMember_label_en-US" xlink:label="lab_hr_ColoradoSpringsCOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Colorado Springs, CO [Member]</link:label>
    <link:label id="lab_hr_ColoradoSpringsCOMember_documentation_en-US" xlink:label="lab_hr_ColoradoSpringsCOMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Colorado Springs, CO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ColoradoSpringsCOMember" xlink:href="hr-20230930.xsd#hr_ColoradoSpringsCOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ColoradoSpringsCOMember" xlink:to="lab_hr_ColoradoSpringsCOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_HoustonTexasMember_7c40fb99-0bfe-4391-924e-866995b0c1e6_terseLabel_en-US" xlink:label="lab_hr_HoustonTexasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Houston, TX</link:label>
    <link:label id="lab_hr_HoustonTexasMember_label_en-US" xlink:label="lab_hr_HoustonTexasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Houston, Texas [Member]</link:label>
    <link:label id="lab_hr_HoustonTexasMember_documentation_en-US" xlink:label="lab_hr_HoustonTexasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Houston, Texas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HoustonTexasMember" xlink:href="hr-20230930.xsd#hr_HoustonTexasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_HoustonTexasMember" xlink:to="lab_hr_HoustonTexasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_PaymentOfSpecialDividendMergerRelated_979b63b3-ffcc-41fb-a9d6-b20527278c0c_negatedTerseLabel_en-US" xlink:label="lab_hr_PaymentOfSpecialDividendMergerRelated" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Special dividend paid in relation to the Merger</link:label>
    <link:label id="lab_hr_PaymentOfSpecialDividendMergerRelated_label_en-US" xlink:label="lab_hr_PaymentOfSpecialDividendMergerRelated" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of Special Dividend, Merger Related</link:label>
    <link:label id="lab_hr_PaymentOfSpecialDividendMergerRelated_documentation_en-US" xlink:label="lab_hr_PaymentOfSpecialDividendMergerRelated" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of Special Dividend, Merger Related</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PaymentOfSpecialDividendMergerRelated" xlink:href="hr-20230930.xsd#hr_PaymentOfSpecialDividendMergerRelated"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_PaymentOfSpecialDividendMergerRelated" xlink:to="lab_hr_PaymentOfSpecialDividendMergerRelated" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets_16487684-4311-4e57-9a5c-b6b77e2c7099_verboseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets, net</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b6e0de6a-2e07-448f-9991-80afb3fee8b5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_04345fc9-60e5-4d5e-90ef-94500240ed40_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests acquired</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Sale of Parent Equity Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_6a9a5cac-068a-4654-952b-4fd80111a5fa_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_7f106515-d0ae-4005-809a-fec22f860f4d_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_947695b3-7938-45c6-9242-b991db82f638_verboseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Invoices accrued for construction, tenant improvements and other capitalized costs</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_11a8899f-c46e-4653-a5ec-abf6dcb5fe04_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_ae8152ae-6c66-4eff-bb24-4b92b869f77f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">(Gain) loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MedicalOfficeBuildingMember_015ac571-67c4-4f17-abd8-a667cdf1a0d6_terseLabel_en-US" xlink:label="lab_hr_MedicalOfficeBuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical office building</link:label>
    <link:label id="lab_hr_MedicalOfficeBuildingMember_label_en-US" xlink:label="lab_hr_MedicalOfficeBuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office Building [Member]</link:label>
    <link:label id="lab_hr_MedicalOfficeBuildingMember_documentation_en-US" xlink:label="lab_hr_MedicalOfficeBuildingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Office Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MedicalOfficeBuildingMember" xlink:href="hr-20230930.xsd#hr_MedicalOfficeBuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MedicalOfficeBuildingMember" xlink:to="lab_hr_MedicalOfficeBuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_8d10c339-bebe-4b14-8088-fb0155e2abfd_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates in the Condensed Consolidated Financial Statements</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_5300e105-8fc8-4965-8d46-4461107b3a35_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis_6144956c-cc60-46d4-b115-85a881ef2043_terseLabel_en-US" xlink:label="lab_hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Acquisitions and Mortgage Note Financing [Axis]</link:label>
    <link:label id="lab_hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis_label_en-US" xlink:label="lab_hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Acquisitions and Mortgage Note Financing [Axis]</link:label>
    <link:label id="lab_hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis_documentation_en-US" xlink:label="lab_hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Acquisitions and Mortgage Note Financing.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis" xlink:href="hr-20230930.xsd#hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis" xlink:to="lab_hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_3738fccc-68ce-49f1-9e15-903831f18333_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment_5242b589-d299-42f6-ba5a-cab29b3cdaf4_verboseLabel_en-US" xlink:label="lab_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property operating</link:label>
    <link:label id="lab_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment_label_en-US" xlink:label="lab_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Costs of Leased and Rented Property or Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment" xlink:to="lab_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateAbstract_984b262e-0d0b-406f-b005-3990235b4071_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Notes Receivable:</link:label>
    <link:label id="lab_us-gaap_RealEstateAbstract_label_en-US" xlink:label="lab_us-gaap_RealEstateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateAbstract" xlink:to="lab_us-gaap_RealEstateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_00ddef12-b007-415b-8b35-57db7aec166d_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_51ed2589-f9b3-4ce5-9d0a-81f449383ba4_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interest</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAdjustmentMember_8ebab278-8f26-4534-ac51-e3b1a43a3de8_terseLabel_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment</link:label>
    <link:label id="lab_srt_RestatementAdjustmentMember_label_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAdjustmentMember" xlink:to="lab_srt_RestatementAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TermLoanDueJuly2024Member_76f3a6ad-1d65-47fc-8398-68e5a29e630e_terseLabel_en-US" xlink:label="lab_hr_TermLoanDueJuly2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$350 million Unsecured Term Loan</link:label>
    <link:label id="lab_hr_TermLoanDueJuly2024Member_label_en-US" xlink:label="lab_hr_TermLoanDueJuly2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due July 2024 [Member]</link:label>
    <link:label id="lab_hr_TermLoanDueJuly2024Member_documentation_en-US" xlink:label="lab_hr_TermLoanDueJuly2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due July 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDueJuly2024Member" xlink:href="hr-20230930.xsd#hr_TermLoanDueJuly2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TermLoanDueJuly2024Member" xlink:to="lab_hr_TermLoanDueJuly2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_a0954094-bd27-463d-b5df-db64c2ffcb67_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LosAngelesCaliforniaMember_091d015f-42bb-4465-9fbf-f7b001fff44d_terseLabel_en-US" xlink:label="lab_hr_LosAngelesCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Los Angeles, CA</link:label>
    <link:label id="lab_hr_LosAngelesCaliforniaMember_label_en-US" xlink:label="lab_hr_LosAngelesCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Los Angeles, California [Member]</link:label>
    <link:label id="lab_hr_LosAngelesCaliforniaMember_documentation_en-US" xlink:label="lab_hr_LosAngelesCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Los Angeles, California [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LosAngelesCaliforniaMember" xlink:href="hr-20230930.xsd#hr_LosAngelesCaliforniaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LosAngelesCaliforniaMember" xlink:to="lab_hr_LosAngelesCaliforniaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_0db8cd5c-c9d2-4f40-bea6-fa8865898200_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units</link:label>
    <link:label id="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_label_en-US" xlink:label="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:to="lab_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_a8eef8fa-d9b0-4996-9d05-9d86a27f152d_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_510fab58-95be-4686-8df3-db41928c3048_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e381aba5-32cc-448a-bc95-1e62590e6f25_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_038b83e1-7f97-4514-b498-065b8843a1c9_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByAssetClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByAssetClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByAssetClassAxis" xlink:to="lab_us-gaap_FairValueByAssetClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_74e1fcce-8ff1-4ad4-bde2-acbd1d890321_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_dbb6f9e9-5348-4a4a-8883-d3ae3cd564ca_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain_a854561e-6208-49c4-8b8b-65165002e63e_terseLabel_en-US" xlink:label="lab_hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Acquisitions and Mortgage Note Financing [Domain]</link:label>
    <link:label id="lab_hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain_label_en-US" xlink:label="lab_hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Acquisitions and Mortgage Note Financing [Domain]</link:label>
    <link:label id="lab_hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain_documentation_en-US" xlink:label="lab_hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Acquisitions and Mortgage Note Financing [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain" xlink:href="hr-20230930.xsd#hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain" xlink:to="lab_hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_21c97917-b984-4275-877e-73f982ac6203_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease expense</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_e79c4cd5-3f33-47cc-ba20-2700e1068f84_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRefundOfTransferTaxesPaid_6ec1391a-ebee-4f6f-9efb-6f533ec394e2_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRefundOfTransferTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refund of transfer taxes paid</link:label>
    <link:label id="lab_hr_BusinessCombinationRefundOfTransferTaxesPaid_label_en-US" xlink:label="lab_hr_BusinessCombinationRefundOfTransferTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Refund of Transfer Taxes Paid</link:label>
    <link:label id="lab_hr_BusinessCombinationRefundOfTransferTaxesPaid_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRefundOfTransferTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Refund of Transfer Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRefundOfTransferTaxesPaid" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRefundOfTransferTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRefundOfTransferTaxesPaid" xlink:to="lab_hr_BusinessCombinationRefundOfTransferTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_d6611744-220c-4e46-856c-21bb0f55b63f_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_93c014d0-525f-446c-9f2f-9e7bd274ede6_terseLabel_en-US" xlink:label="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions and Mortgage Note Repayments [Domain]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_label_en-US" xlink:label="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions and Mortgage Note Repayments [Domain]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_documentation_en-US" xlink:label="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions and Mortgage Note Repayments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" xlink:href="hr-20230930.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" xlink:to="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_77410028-7fc1-405f-8b86-4e804d41f980_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableFairValueDisclosure_f8d30a20-6a6d-4729-8e78-c35de1df0039_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CARRYING VALUE</link:label>
    <link:label id="lab_us-gaap_NotesReceivableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableFairValueDisclosure" xlink:to="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_15e975f2-ed13-4af3-a27d-d5cb8b906551_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested/Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NotesReceivableMaximumLoanCommitment_3ffb1951-5693-4450-8b7b-a21f3bede5eb_terseLabel_en-US" xlink:label="lab_hr_NotesReceivableMaximumLoanCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MAXIMUM LOAN COMMITMENT</link:label>
    <link:label id="lab_hr_NotesReceivableMaximumLoanCommitment_label_en-US" xlink:label="lab_hr_NotesReceivableMaximumLoanCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Maximum Loan Commitment</link:label>
    <link:label id="lab_hr_NotesReceivableMaximumLoanCommitment_documentation_en-US" xlink:label="lab_hr_NotesReceivableMaximumLoanCommitment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Receivable, Maximum Loan Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableMaximumLoanCommitment" xlink:href="hr-20230930.xsd#hr_NotesReceivableMaximumLoanCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NotesReceivableMaximumLoanCommitment" xlink:to="lab_hr_NotesReceivableMaximumLoanCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_c62bb8c3-464e-4cfa-9151-b626f4a5a280_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and bonds payable</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_df401cdd-8f4c-4022-9343-0b8bfd587e15_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes and bonds payable</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_1c4c1fef-8356-4f76-ada0-349d41000679_terseLabel_en-US" xlink:label="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New investments during the period</link:label>
    <link:label id="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_label_en-US" xlink:label="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures in Period</link:label>
    <link:label id="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_documentation_en-US" xlink:label="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" xlink:href="hr-20230930.xsd#hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" xlink:to="lab_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MortgageNote_04fdd66e-4ac2-415b-a019-8f7aa7facddc_terseLabel_en-US" xlink:label="lab_hr_MortgageNote" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage note</link:label>
    <link:label id="lab_hr_MortgageNote_label_en-US" xlink:label="lab_hr_MortgageNote" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Note</link:label>
    <link:label id="lab_hr_MortgageNote_documentation_en-US" xlink:label="lab_hr_MortgageNote" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Note</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageNote" xlink:href="hr-20230930.xsd#hr_MortgageNote"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MortgageNote" xlink:to="lab_hr_MortgageNote" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_5cf045e9-8cc8-4f19-b2c1-0869d2ad7a5c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_bb7cc185-0f1d-476a-8bb3-fe1f5403e159_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive (loss) income attributable to common stockholders</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherFiniteLivedIntangibleAssetsGross_3b6afb67-dacb-406b-85f4-90c8b0b0b75c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease intangibles</link:label>
    <link:label id="lab_us-gaap_OtherFiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_OtherFiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand_961a3778-abbd-4edd-ac72-37178f07d3a9_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Land</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ActiveDevelopmentPropertiesMember_ce84823f-fb4b-4add-94c5-0b5118077a55_terseLabel_en-US" xlink:label="lab_hr_ActiveDevelopmentPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Active Development Properties</link:label>
    <link:label id="lab_hr_ActiveDevelopmentPropertiesMember_label_en-US" xlink:label="lab_hr_ActiveDevelopmentPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Active Development Properties [Member]</link:label>
    <link:label id="lab_hr_ActiveDevelopmentPropertiesMember_documentation_en-US" xlink:label="lab_hr_ActiveDevelopmentPropertiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Active Development Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ActiveDevelopmentPropertiesMember" xlink:href="hr-20230930.xsd#hr_ActiveDevelopmentPropertiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ActiveDevelopmentPropertiesMember" xlink:to="lab_hr_ActiveDevelopmentPropertiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities_945604e6-49ec-47c8-8882-e57c225912b2_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Payable And Accrued Liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Payable And Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_63afba10-5776-4af5-99c4-0eb78895db36_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_56d3b2c9-5cc0-45a7-bd22-7b82e1997e66_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferMortgagePayable_0831c8fa-398c-4be3-8dfa-9ec7ad567bac_terseLabel_en-US" xlink:label="lab_us-gaap_TransferMortgagePayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage note payable assumed in connection with acquisition of real estate, net</link:label>
    <link:label id="lab_us-gaap_TransferMortgagePayable_label_en-US" xlink:label="lab_us-gaap_TransferMortgagePayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer Mortgage Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferMortgagePayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransferMortgagePayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferMortgagePayable" xlink:to="lab_us-gaap_TransferMortgagePayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleLeasebackTransactionNetBookValue_49a67b64-2fa6-4870-98a5-727b8ee5f542_terseLabel_en-US" xlink:label="lab_us-gaap_SaleLeasebackTransactionNetBookValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing receivable, carrying value</link:label>
    <link:label id="lab_us-gaap_SaleLeasebackTransactionNetBookValue_label_en-US" xlink:label="lab_us-gaap_SaleLeasebackTransactionNetBookValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Leaseback Transaction, Net Book Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleLeasebackTransactionNetBookValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleLeasebackTransactionNetBookValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleLeasebackTransactionNetBookValue" xlink:to="lab_us-gaap_SaleLeasebackTransactionNetBookValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_cbc944c2-c0fb-44b3-8de6-7f725a159484_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandAvailableForDevelopment_0a6b70b2-f1cd-4eb1-85f1-d37f9d42d973_terseLabel_en-US" xlink:label="lab_us-gaap_LandAvailableForDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land held for development</link:label>
    <link:label id="lab_us-gaap_LandAvailableForDevelopment_label_en-US" xlink:label="lab_us-gaap_LandAvailableForDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land Available for Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAvailableForDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandAvailableForDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandAvailableForDevelopment" xlink:to="lab_us-gaap_LandAvailableForDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_107307ca-d0f9-4133-b38a-44122b4c6191_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_00d10e66-d2d7-43b1-9d7a-fdbafc510979_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_9fae2894-29fc-4c41-a56e-bc6f9fc4173e_terseLabel_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_label_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Two</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_documentation_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" xlink:href="hr-20230930.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" xlink:to="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_fecb2246-78cb-47f8-a3c5-99d4b7278afa_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_b121d24d-0ec8-4633-9dc2-e1e1e9dcc446_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets, net</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RealEstateLineItems_e9e183cb-fa3e-4685-a9f2-9894cb495038_terseLabel_en-US" xlink:label="lab_us-gaap_RealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Line Items]</link:label>
    <link:label id="lab_us-gaap_RealEstateLineItems_label_en-US" xlink:label="lab_us-gaap_RealEstateLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RealEstateLineItems" xlink:to="lab_us-gaap_RealEstateLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_70f93c08-209c-4391-a9b9-69de7dd5bac2_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits_b2130b93-18e1-4148-a0e1-f85a23463d61_terseLabel_en-US" xlink:label="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of OP Units (in shares)</link:label>
    <link:label id="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits_label_en-US" xlink:label="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of OP Units</link:label>
    <link:label id="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits_documentation_en-US" xlink:label="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of OP Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" xlink:href="hr-20230930.xsd#hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" xlink:to="lab_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_cdefbdea-6330-4041-843b-2d08cd4dbba8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsDomain_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsDomain" xlink:to="lab_us-gaap_OtherCommitmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_9c6069f2-4952-44b5-8632-962b47fb3d28_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock redemptions</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TermLoanDue2025Member_e671fb77-ff3e-41d8-b51d-48f2e60fbd74_terseLabel_en-US" xlink:label="lab_hr_TermLoanDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$300 million Unsecured Term Loan</link:label>
    <link:label id="lab_hr_TermLoanDue2025Member_label_en-US" xlink:label="lab_hr_TermLoanDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2025 [Member]</link:label>
    <link:label id="lab_hr_TermLoanDue2025Member_documentation_en-US" xlink:label="lab_hr_TermLoanDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2025Member" xlink:href="hr-20230930.xsd#hr_TermLoanDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TermLoanDue2025Member" xlink:to="lab_hr_TermLoanDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_baa8cc5c-c62d-473c-8cc6-52eac02eca0c_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_858e279b-d7d8-403b-9847-c4fefa6cffad_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Condensed Balance Sheet</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Condensed Balance Sheet [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:to="lab_srt_ScheduleOfCondensedBalanceSheetTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_750afd14-573c-423d-9e7a-9df9fe91ac8c_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2030</link:label>
    <link:label id="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_label_en-US" xlink:label="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2030, Net of Discount and Issuance Costs [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_documentation_en-US" xlink:label="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2030, Net of Discount and Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" xlink:href="hr-20230930.xsd#hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" xlink:to="lab_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_c4030a63-3f83-40fe-b77c-3b73c8b4d823_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_8d6adc0b-2936-472e-90ea-6f7d8af1766e_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_DirectorsMember_84bb3f99-9382-4f5c-9580-029b6aa215db_terseLabel_en-US" xlink:label="lab_hr_DirectorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors</link:label>
    <link:label id="lab_hr_DirectorsMember_label_en-US" xlink:label="lab_hr_DirectorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors [Member]</link:label>
    <link:label id="lab_hr_DirectorsMember_documentation_en-US" xlink:label="lab_hr_DirectorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Directors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DirectorsMember" xlink:href="hr-20230930.xsd#hr_DirectorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_DirectorsMember" xlink:to="lab_hr_DirectorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue_ca7a83d3-7c8e-4649-ba80-9dd743c15368_terseLabel_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probability adjustment, Weighted average grant date fair value (in dollar per share)</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Probability Adjustment in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Probability Adjustment in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" xlink:href="hr-20230930.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_39cc860a-6f38-4a90-8417-ab153587f1ed_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_9e464f35-39fc-455f-bf0e-8b492f12570e_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for Credit Losses, Interest Income, Income from Real Estate Notes Receivable:</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_StockIncentivePlanMember_015c7b8a-961e-43cc-8e44-4e63b6605831_terseLabel_en-US" xlink:label="lab_hr_StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock incentive plan</link:label>
    <link:label id="lab_hr_StockIncentivePlanMember_label_en-US" xlink:label="lab_hr_StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plan [Member]</link:label>
    <link:label id="lab_hr_StockIncentivePlanMember_documentation_en-US" xlink:label="lab_hr_StockIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Incentive Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIncentivePlanMember" xlink:href="hr-20230930.xsd#hr_StockIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_StockIncentivePlanMember" xlink:to="lab_hr_StockIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_c27c1a54-d9fb-4182-bbe7-d285deea0e89_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_9a98406b-2bc7-4e4d-ac83-c07005d3ce1b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_88dd8962-92a1-4427-b0ec-44d4b89e0e6f_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_a6cbf336-57c4-48ad-aed6-ddc6113639c7_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MarketCondition1Member_00af2247-ab4a-4f5f-a11d-6724530e90d5_terseLabel_en-US" xlink:label="lab_hr_MarketCondition1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Absolute TSR Component</link:label>
    <link:label id="lab_hr_MarketCondition1Member_label_en-US" xlink:label="lab_hr_MarketCondition1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Condition 1 [Member]</link:label>
    <link:label id="lab_hr_MarketCondition1Member_documentation_en-US" xlink:label="lab_hr_MarketCondition1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Condition 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MarketCondition1Member" xlink:href="hr-20230930.xsd#hr_MarketCondition1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MarketCondition1Member" xlink:to="lab_hr_MarketCondition1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CO_818df2d2-6c4f-40d3-8acf-ff77b4b1ab29_verboseLabel_en-US" xlink:label="lab_stpr_CO" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COLORADO</link:label>
    <link:label id="lab_stpr_CO_label_en-US" xlink:label="lab_stpr_CO" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COLORADO</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CO" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_CO"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CO" xlink:to="lab_stpr_CO" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesDue2031Member_2f3efcf8-cfe8-4514-9d49-32ed58aad889_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2031</link:label>
    <link:label id="lab_hr_SeniorNotesDue2031Member_label_en-US" xlink:label="lab_hr_SeniorNotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2031 [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesDue2031Member_documentation_en-US" xlink:label="lab_hr_SeniorNotesDue2031Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2031</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2031Member" xlink:href="hr-20230930.xsd#hr_SeniorNotesDue2031Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesDue2031Member" xlink:to="lab_hr_SeniorNotesDue2031Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_178f8c67-0fa7-490b-b8d4-47b4a04c3fff_terseLabel_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award performance period</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_label_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_documentation_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:href="hr-20230930.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:to="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CumulativeDividends_3a31e721-40e1-4d5e-99ae-d2dc1d5855d5_negatedLabel_en-US" xlink:label="lab_us-gaap_CumulativeDividends" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative dividends</link:label>
    <link:label id="lab_us-gaap_CumulativeDividends_label_en-US" xlink:label="lab_us-gaap_CumulativeDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CumulativeDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CumulativeDividends" xlink:to="lab_us-gaap_CumulativeDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_272733e6-b18a-48da-8b4f-c0fbe0673d75_terseLabel_en-US" xlink:label="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of real estate properties and credit loss reserves</link:label>
    <link:label id="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_label_en-US" xlink:label="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Real Estate, Continuing and Discontinued Operations</link:label>
    <link:label id="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_documentation_en-US" xlink:label="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Real Estate, Continuing and Discontinued Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" xlink:href="hr-20230930.xsd#hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" xlink:to="lab_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA_fed9bedd-5c8d-44c0-894f-cfa00eb40371_terseLabel_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California</link:label>
    <link:label id="lab_stpr_CA_label_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CALIFORNIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA" xlink:to="lab_stpr_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_4160fc27-2699-4bc0-bd64-5198082ee988_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Non-controlling Interests</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate_fd231b79-5621-479d-882f-518d1f33e664_terseLabel_en-US" xlink:label="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extension period for maturity date</link:label>
    <link:label id="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate_label_en-US" xlink:label="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Period for Maturity Date</link:label>
    <link:label id="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate_documentation_en-US" xlink:label="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Extension Period for Maturity Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DebtInstrumentExtensionPeriodForMaturityDate" xlink:href="hr-20230930.xsd#hr_DebtInstrumentExtensionPeriodForMaturityDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_DebtInstrumentExtensionPeriodForMaturityDate" xlink:to="lab_hr_DebtInstrumentExtensionPeriodForMaturityDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_392dabef-3c3e-44fd-8b93-929af018ce58_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_8c67f10b-4458-48f8-85e2-2f319f7c1a61_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_103c4dd8-f73a-488c-ae8d-d6a8d252494f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of the Employee Stock Purchase Plan activity</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_547009f1-0b32-4e31-93d4-fa0175197db6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Buildings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_487b0bec-886b-4fa9-9b75-194c69ecc358_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_21470817-740c-4282-9afb-104214664708_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_9f498a1d-b137-46bd-bd20-fe9869a6cde8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long Lived Assets Held-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets Held-for-Sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable" xlink:to="lab_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_5a24ecc4-c5e8-4813-a39b-c6455c08dc5e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesdue2030Member_98754693-cc5a-447d-b9dc-1b926bfabe2e_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesdue2030Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2030</link:label>
    <link:label id="lab_hr_SeniorNotesdue2030Member_label_en-US" xlink:label="lab_hr_SeniorNotesdue2030Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2030 [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesdue2030Member_documentation_en-US" xlink:label="lab_hr_SeniorNotesdue2030Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2030 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2030Member" xlink:href="hr-20230930.xsd#hr_SeniorNotesdue2030Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesdue2030Member" xlink:to="lab_hr_SeniorNotesdue2030Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SeniorNotesDue2027Member_3a9a8c04-02ad-4a43-a2af-565c8fe9b852_terseLabel_en-US" xlink:label="lab_hr_SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2027</link:label>
    <link:label id="lab_hr_SeniorNotesDue2027Member_label_en-US" xlink:label="lab_hr_SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2027 [Member]</link:label>
    <link:label id="lab_hr_SeniorNotesDue2027Member_documentation_en-US" xlink:label="lab_hr_SeniorNotesDue2027Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes due 2027</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2027Member" xlink:href="hr-20230930.xsd#hr_SeniorNotesDue2027Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SeniorNotesDue2027Member" xlink:to="lab_hr_SeniorNotesDue2027Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_0e4c9a4e-f378-43ec-8605-5fa1d23e6e22_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_d09500ff-a5a8-49e8-b11a-9c347eb56204_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TampaFLMember_1b463da6-508c-4f5f-9639-7a71062ff8ab_terseLabel_en-US" xlink:label="lab_hr_TampaFLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tampa, FL</link:label>
    <link:label id="lab_hr_TampaFLMember_label_en-US" xlink:label="lab_hr_TampaFLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tampa, FL [Member]</link:label>
    <link:label id="lab_hr_TampaFLMember_documentation_en-US" xlink:label="lab_hr_TampaFLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tampa, FL</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TampaFLMember" xlink:href="hr-20230930.xsd#hr_TampaFLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TampaFLMember" xlink:to="lab_hr_TampaFLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_943bafc7-d208-4365-82d2-2fbea9ba08e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices_a8b7a560-b5c2-4af0-8af7-9e25cbaff893_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services</link:label>
    <link:label id="lab_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices_label_en-US" xlink:label="lab_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Fair Value of Legacy HTA Restricted Stock Awards Attributable to Pre-Merger Services</link:label>
    <link:label id="lab_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices_documentation_en-US" xlink:label="lab_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Fair Value of Legacy HTA Restricted Stock Awards Attributable to Pre-Merger Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices" xlink:href="hr-20230930.xsd#hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices" xlink:to="lab_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TermLoanDueMay2024Member_c3aa8b22-b601-40d1-8a9b-d8cd752ae065_terseLabel_en-US" xlink:label="lab_hr_TermLoanDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">$200 million Unsecured Term Loan</link:label>
    <link:label id="lab_hr_TermLoanDueMay2024Member_label_en-US" xlink:label="lab_hr_TermLoanDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due May 2024 [Member]</link:label>
    <link:label id="lab_hr_TermLoanDueMay2024Member_documentation_en-US" xlink:label="lab_hr_TermLoanDueMay2024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan due 2024 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDueMay2024Member" xlink:href="hr-20230930.xsd#hr_TermLoanDueMay2024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TermLoanDueMay2024Member" xlink:to="lab_hr_TermLoanDueMay2024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_216508d5-c44c-435d-ac64-22cad6f7d543_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A Common stock, $.01 par value per share; 1,000,000 shares authorized; 380,860 and 380,590 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryLockMember_c3da454f-7699-4e43-af3e-5a0f35709321_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settled treasury hedges</link:label>
    <link:label id="lab_us-gaap_TreasuryLockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryLockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Lock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryLockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryLockMember" xlink:to="lab_us-gaap_TreasuryLockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_60920f1c-db0b-440f-89e3-c8edbb67f934_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation:</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_879cfcab-9ac8-4970-8ea0-1da1939d44a1_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_GA_3d895fd1-5e54-451b-bb5f-1ccc73b055f4_verboseLabel_en-US" xlink:label="lab_stpr_GA" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GEORGIA</link:label>
    <link:label id="lab_stpr_GA_label_en-US" xlink:label="lab_stpr_GA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GEORGIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_GA" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_GA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_GA" xlink:to="lab_stpr_GA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_afe526a9-9a78-4850-8ed1-79680a4b550d_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_42c324bd-dda3-41e3-8064-d15b785e1d77_terseLabel_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited partners ownership interest (in percent)</link:label>
    <link:label id="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_label_en-US" xlink:label="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Limited Liability Company or Limited Partnership, Members or Limited Partners, Ownership Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:to="lab_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_3b434925-cd73-4541-b7e0-c47635f891f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments made on finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_a292342e-660c-475b-85e1-cd6c3a606487_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Minimum Financing Lease Payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_1c41826c-ace9-4ee3-a0b4-52ca6f3e4fa4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest and other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_b381b118-3145-462a-9505-9be6ed160402_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_FL_d0863988-88cf-4eb8-87c5-856e11143a3e_terseLabel_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Florida</link:label>
    <link:label id="lab_stpr_FL_label_en-US" xlink:label="lab_stpr_FL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FLORIDA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_FL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_FL" xlink:to="lab_stpr_FL" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_2c27b8dd-ec60-4013-8b9d-06d7ce484b2a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_3033fb66-19bd-40ae-a7cd-0bafa365ec61_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_e51b1e72-dc7d-412b-9b3b-9aaaf569af95_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_e0aa0c0b-9b97-4478-a4ab-a27f96f025d3_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET PROCEEDS</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale, Real Estate, Held-for-Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:to="lab_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_9921cc5d-8c40-4ae8-8b5d-5bb5f1eaa983_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LegacyHTAMember_bc61630d-b180-44b1-8e1f-bb7bf5934989_terseLabel_en-US" xlink:label="lab_hr_LegacyHTAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legacy HTA</link:label>
    <link:label id="lab_hr_LegacyHTAMember_label_en-US" xlink:label="lab_hr_LegacyHTAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legacy HTA [Member]</link:label>
    <link:label id="lab_hr_LegacyHTAMember_documentation_en-US" xlink:label="lab_hr_LegacyHTAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legacy HTA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LegacyHTAMember" xlink:href="hr-20230930.xsd#hr_LegacyHTAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LegacyHTAMember" xlink:to="lab_hr_LegacyHTAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_7549f481-b7fe-48c9-86fb-f7293944fac1_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_16a72ced-326a-475d-9ff0-59f267b2cdb2_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EquityOwnershipForConsolidationPercent_14df8c29-a51f-4d15-afac-b7f21820965b_terseLabel_en-US" xlink:label="lab_hr_EquityOwnershipForConsolidationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity ownership for consolidation (percent)</link:label>
    <link:label id="lab_hr_EquityOwnershipForConsolidationPercent_label_en-US" xlink:label="lab_hr_EquityOwnershipForConsolidationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Ownership for Consolidation, Percent</link:label>
    <link:label id="lab_hr_EquityOwnershipForConsolidationPercent_documentation_en-US" xlink:label="lab_hr_EquityOwnershipForConsolidationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Ownership for Consolidation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityOwnershipForConsolidationPercent" xlink:href="hr-20230930.xsd#hr_EquityOwnershipForConsolidationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EquityOwnershipForConsolidationPercent" xlink:to="lab_hr_EquityOwnershipForConsolidationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets_983ba00b-414a-4176-ae97-5b2449aaebfe_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease right-of-use assets</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment,, Financing Lease Right-of-Use Assets</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment,, Financing Lease Right-of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_CommonStockSharesWithheld_6cc2f521-cc8b-4c12-94ed-f8c1514c2e4b_terseLabel_en-US" xlink:label="lab_hr_CommonStockSharesWithheld" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, withheld (in shares)</link:label>
    <link:label id="lab_hr_CommonStockSharesWithheld_label_en-US" xlink:label="lab_hr_CommonStockSharesWithheld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Withheld</link:label>
    <link:label id="lab_hr_CommonStockSharesWithheld_documentation_en-US" xlink:label="lab_hr_CommonStockSharesWithheld" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Withheld</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CommonStockSharesWithheld" xlink:href="hr-20230930.xsd#hr_CommonStockSharesWithheld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_CommonStockSharesWithheld" xlink:to="lab_hr_CommonStockSharesWithheld" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_74f3c9b7-6839-46a0-8086-515e438aaeec_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_3175b64e-34de-4729-85f3-1dc43fd8df79_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstatePropertiesHeldInJointVenturesMember_75a5b7be-99b4-496a-9d12-6d0213d1e069_terseLabel_en-US" xlink:label="lab_hr_RealEstatePropertiesHeldInJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Properties Held in Joint Ventures</link:label>
    <link:label id="lab_hr_RealEstatePropertiesHeldInJointVenturesMember_label_en-US" xlink:label="lab_hr_RealEstatePropertiesHeldInJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Properties Held in Joint Ventures [Member]</link:label>
    <link:label id="lab_hr_RealEstatePropertiesHeldInJointVenturesMember_documentation_en-US" xlink:label="lab_hr_RealEstatePropertiesHeldInJointVenturesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Properties Held in Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstatePropertiesHeldInJointVenturesMember" xlink:href="hr-20230930.xsd#hr_RealEstatePropertiesHeldInJointVenturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstatePropertiesHeldInJointVenturesMember" xlink:to="lab_hr_RealEstatePropertiesHeldInJointVenturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_46229e3c-2062-43a1-83a9-c8b54c48484c_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_54af3346-809f-4a9c-bfbe-9e4d6e4875c1_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessOverviewAbstract_5a3b14dc-6463-4846-9af4-c95406693d31_terseLabel_en-US" xlink:label="lab_hr_BusinessOverviewAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Overview:</link:label>
    <link:label id="lab_hr_BusinessOverviewAbstract_label_en-US" xlink:label="lab_hr_BusinessOverviewAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Overview [Abstract]</link:label>
    <link:label id="lab_hr_BusinessOverviewAbstract_documentation_en-US" xlink:label="lab_hr_BusinessOverviewAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Overview [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessOverviewAbstract" xlink:href="hr-20230930.xsd#hr_BusinessOverviewAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessOverviewAbstract" xlink:to="lab_hr_BusinessOverviewAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_ea5ce172-38b5-46cc-879b-040f427831a4_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_41719a23-8298-417e-a231-2c2ba9be1920_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_60fe7c5f-7984-4156-9341-343a531bd822_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_DispositionSalesPrice_448b6d5f-2d66-4318-bb0c-2169a848e7fd_terseLabel_en-US" xlink:label="lab_hr_DispositionSalesPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SALE PRICE</link:label>
    <link:label id="lab_hr_DispositionSalesPrice_label_en-US" xlink:label="lab_hr_DispositionSalesPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposition Sales Price</link:label>
    <link:label id="lab_hr_DispositionSalesPrice_documentation_en-US" xlink:label="lab_hr_DispositionSalesPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposition Sales Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DispositionSalesPrice" xlink:href="hr-20230930.xsd#hr_DispositionSalesPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_DispositionSalesPrice" xlink:to="lab_hr_DispositionSalesPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_7506af4b-582d-455e-8222-e894ff8dfb73_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EquityOfferingProgramAvailableForIssuance_2106d8cd-6ff9-443f-bce0-4e1b71fbf303_terseLabel_en-US" xlink:label="lab_hr_EquityOfferingProgramAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount remaining available for issuance under the new ATM</link:label>
    <link:label id="lab_hr_EquityOfferingProgramAvailableForIssuance_label_en-US" xlink:label="lab_hr_EquityOfferingProgramAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Offering Program Available for Issuance</link:label>
    <link:label id="lab_hr_EquityOfferingProgramAvailableForIssuance_documentation_en-US" xlink:label="lab_hr_EquityOfferingProgramAvailableForIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Offering Program Available for Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityOfferingProgramAvailableForIssuance" xlink:href="hr-20230930.xsd#hr_EquityOfferingProgramAvailableForIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EquityOfferingProgramAvailableForIssuance" xlink:to="lab_hr_EquityOfferingProgramAvailableForIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_bc55e2d1-f0dc-4d8a-bae7-2ec1fc41f7ca_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_e5625d1f-217a-4545-a27d-acde09d313f4_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_7037ebee-a979-483c-ab75-44b89c6b82b5_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_ea2e96de-2085-41de-a8a9-af68b1def3ef_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire additional interest in an operating property</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_861bdcfa-5b13-4903-85a8-674e09f9fdfa_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_6da65491-1c0c-439b-b7a5-4075a9da29b0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_45e4e05c-c37f-4808-81d6-7aee873cc812_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net identifiable assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a6304ee6-034e-4a5a-9424-c52d3d35a5be_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_c0208c5e-e60f-4d47-a8b2-35e53fc2e5b9_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_4b9050c8-ebe8-4897-9833-ffdc4263cc5b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_c7ca46be-6621-4fd7-87cf-1e422482aae7_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToDevelopRealEstateAssets_ebd60e16-40c9-46c2-b666-f35e2cfabc8e_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Development of real estate</link:label>
    <link:label id="lab_us-gaap_PaymentsToDevelopRealEstateAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Develop Real Estate Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:to="lab_us-gaap_PaymentsToDevelopRealEstateAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_a64b1ee9-6c0a-4ba6-bbe1-a8eb2691e6c2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, before Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_37591d78-3a1a-4d08-8f48-ff5c3fb2b8b1_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_ecd63a24-9095-482c-80f9-f5345218a5d4_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_43433d15-4cf3-4225-810f-6193549470a3_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Joint venture ownership (percent)</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_d859f781-da23-46e8-8d1e-8896415055fb_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_26ae843a-edd4-4ad7-9248-afaaa5d3762d_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_8224656c-082e-4da3-8299-072e9cac913e_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_cd3257c7-b6ce-4946-b172-4148a54adb18_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ground lease, initial term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_a6d59360-5d8f-43b8-91d3-0a040e420fba_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ConstructionActivityTotalFundingDuringthePeriod_6a6d46bf-6554-4eb5-a1d8-4297907f6aaf_terseLabel_en-US" xlink:label="lab_hr_ConstructionActivityTotalFundingDuringthePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction activity and development properties</link:label>
    <link:label id="lab_hr_ConstructionActivityTotalFundingDuringthePeriod_label_en-US" xlink:label="lab_hr_ConstructionActivityTotalFundingDuringthePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Activity, Total Funding During the Period</link:label>
    <link:label id="lab_hr_ConstructionActivityTotalFundingDuringthePeriod_documentation_en-US" xlink:label="lab_hr_ConstructionActivityTotalFundingDuringthePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction Activity, Total Funding During the Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ConstructionActivityTotalFundingDuringthePeriod" xlink:href="hr-20230930.xsd#hr_ConstructionActivityTotalFundingDuringthePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ConstructionActivityTotalFundingDuringthePeriod" xlink:to="lab_hr_ConstructionActivityTotalFundingDuringthePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_860b59f4-867c-4247-b2ad-53962df2c356_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in unconsolidated joint ventures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_95a82705-14bf-4f30-bf32-b21137a5b143_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends to common stockholders and distributions to non-controlling interest holders</link:label>
    <link:label id="lab_us-gaap_DividendsCommonStockCash_label_en-US" xlink:label="lab_us-gaap_DividendsCommonStockCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Common Stock, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCommonStockCash" xlink:to="lab_us-gaap_DividendsCommonStockCash" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_8f1f394b-d6e1-4964-9235-b9da7ef31795_terseLabel_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_label_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Next Twelve Months</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_documentation_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Next Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" xlink:href="hr-20230930.xsd#hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" xlink:to="lab_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_25d8d28c-1482-43f0-ab23-3ee3a867e2c3_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_90cf45bd-bac9-4143-8e04-a2c96f443aca_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_21e4b16c-8df0-4546-a406-0ce40ac733ba_terseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_9003009c-00bc-47ea-849a-0ff891a59682_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_9448e026-896d-43a0-8ba9-464013e6ba63_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EquityMethodInvestmentsRollForward_2617c554-6fa8-42f7-ba2d-e055adc51049_terseLabel_en-US" xlink:label="lab_hr_EquityMethodInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Roll Forward]</link:label>
    <link:label id="lab_hr_EquityMethodInvestmentsRollForward_label_en-US" xlink:label="lab_hr_EquityMethodInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Roll Forward]</link:label>
    <link:label id="lab_hr_EquityMethodInvestmentsRollForward_documentation_en-US" xlink:label="lab_hr_EquityMethodInvestmentsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityMethodInvestmentsRollForward" xlink:href="hr-20230930.xsd#hr_EquityMethodInvestmentsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EquityMethodInvestmentsRollForward" xlink:to="lab_hr_EquityMethodInvestmentsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_d9a0f5e4-e2c7-49a1-8f74-4750cfeb2d97_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swaps</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_4e163b5f-7ad8-4049-99df-18cea3ed5bbf_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_a4b039f8-7847-42a9-8454-a625be903701_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_19b94ac3-61d4-40c1-9ed2-c25bb8648da3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_21e5213a-0882-4dcd-bc3e-4a2521b72518_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average amortization period for the acquired lease intangible assets</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_403bbd0b-ac3e-445a-9cc0-f967334c3141_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_9cabf713-22ec-4488-a3d2-0c7a856f3c51_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_a32b4d49-4d44-4952-9904-18738e431bc2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_b79d8824-042f-4443-81a2-4aa6c74c2ecc_terseLabel_en-US" xlink:label="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions and Mortgage Note Repayments [Axis]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_label_en-US" xlink:label="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions and Mortgage Note Repayments [Axis]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_documentation_en-US" xlink:label="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions and Mortgage Note Repayments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" xlink:href="hr-20230930.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" xlink:to="lab_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_c97275a7-6d8b-4095-ba36-ed2b26ee622f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_2e73b029-0073-4e85-818f-f50c03a26269_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ColumbusOHMember_46750adc-3329-44f2-81a1-89b70906c387_terseLabel_en-US" xlink:label="lab_hr_ColumbusOHMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Columbus, OH</link:label>
    <link:label id="lab_hr_ColumbusOHMember_label_en-US" xlink:label="lab_hr_ColumbusOHMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Columbus, OH [Member]</link:label>
    <link:label id="lab_hr_ColumbusOHMember_documentation_en-US" xlink:label="lab_hr_ColumbusOHMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Columbus, OH</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ColumbusOHMember" xlink:href="hr-20230930.xsd#hr_ColumbusOHMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ColumbusOHMember" xlink:to="lab_hr_ColumbusOHMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_FinanceLeasePrincipalOnlyPayments_1729a141-ec57-4006-83a0-05b92a4fde65_terseLabel_en-US" xlink:label="lab_hr_FinanceLeasePrincipalOnlyPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash flows outflows related to financing leases</link:label>
    <link:label id="lab_hr_FinanceLeasePrincipalOnlyPayments_label_en-US" xlink:label="lab_hr_FinanceLeasePrincipalOnlyPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Only Payments</link:label>
    <link:label id="lab_hr_FinanceLeasePrincipalOnlyPayments_documentation_en-US" xlink:label="lab_hr_FinanceLeasePrincipalOnlyPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Only Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceLeasePrincipalOnlyPayments" xlink:href="hr-20230930.xsd#hr_FinanceLeasePrincipalOnlyPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_FinanceLeasePrincipalOnlyPayments" xlink:to="lab_hr_FinanceLeasePrincipalOnlyPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_bb3698c6-b271-46e7-beb9-d9bed603b156_negatedLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redemption of non-controlling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ParkingIncomeMember_264ad659-0942-4d27-a251-dc9565683d07_terseLabel_en-US" xlink:label="lab_hr_ParkingIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parking income</link:label>
    <link:label id="lab_hr_ParkingIncomeMember_label_en-US" xlink:label="lab_hr_ParkingIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parking Income [Member]</link:label>
    <link:label id="lab_hr_ParkingIncomeMember_documentation_en-US" xlink:label="lab_hr_ParkingIncomeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parking Income [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ParkingIncomeMember" xlink:href="hr-20230930.xsd#hr_ParkingIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ParkingIncomeMember" xlink:to="lab_hr_ParkingIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_7fe58bbc-864c-4eef-aea0-175cdb32887b_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_17cec00d-6dec-4a11-b77b-2a6032b09f00_terseLabel_en-US" xlink:label="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 and thereafter</link:label>
    <link:label id="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_label_en-US" xlink:label="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, after Year Four</link:label>
    <link:label id="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_documentation_en-US" xlink:label="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessor, Operating Lease, Payment to be Received, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" xlink:href="hr-20230930.xsd#hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" xlink:to="lab_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfJointVentures_4f6d3a13-9739-4ad2-bad4-5eef6e311415_terseLabel_en-US" xlink:label="lab_hr_NumberOfJointVentures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of joint ventures</link:label>
    <link:label id="lab_hr_NumberOfJointVentures_label_en-US" xlink:label="lab_hr_NumberOfJointVentures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Joint Ventures</link:label>
    <link:label id="lab_hr_NumberOfJointVentures_documentation_en-US" xlink:label="lab_hr_NumberOfJointVentures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Joint Ventures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfJointVentures" xlink:href="hr-20230930.xsd#hr_NumberOfJointVentures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfJointVentures" xlink:to="lab_hr_NumberOfJointVentures" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_PercentageOfRestrictedStockUnits_87dd00b3-986c-4ca0-8050-7942d1505129_terseLabel_en-US" xlink:label="lab_hr_PercentageOfRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of restricted stock units</link:label>
    <link:label id="lab_hr_PercentageOfRestrictedStockUnits_label_en-US" xlink:label="lab_hr_PercentageOfRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Restricted Stock Units</link:label>
    <link:label id="lab_hr_PercentageOfRestrictedStockUnits_documentation_en-US" xlink:label="lab_hr_PercentageOfRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Restricted Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PercentageOfRestrictedStockUnits" xlink:href="hr-20230930.xsd#hr_PercentageOfRestrictedStockUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_PercentageOfRestrictedStockUnits" xlink:to="lab_hr_PercentageOfRestrictedStockUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_abf4c1dc-1ec5-440e-8cbe-9c05f7f827e3_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_c8f4973a-5196-4cf8-ae23-99e194f2b035_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cash flow hedge gain (loss) to be reclassified to interest expense during the next 12 months</link:label>
    <link:label id="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_label_en-US" xlink:label="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:to="lab_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_562be945-6b7a-47df-b8a1-1561947f9916_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_064ec646-08c9-4858-90c2-086a7756f09a_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_c67f10bf-f583-44ad-b5bf-67fd09439dcb_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate notes receivable</link:label>
    <link:label id="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_label_en-US" xlink:label="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loans on Real Estate, Commercial and Consumer, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:to="lab_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_005415ce-d150-4e52-9b6a-3c654b69a081_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_c491c29e-a98e-4158-bd66-f2dbdd9e9505_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_23def05a-c6e4-4f35-9217-bfce0038dd28_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: comprehensive loss (income) attributable to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_65d50e3b-4ff8-4c0f-b7e3-003974b2f687_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsAxis_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsAxis" xlink:to="lab_us-gaap_OtherCommitmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_47b04d3b-71a2-4703-b50f-1180f4a96723_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REAL ESTATE NOTES RECEIVABLE, GROSS</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:to="lab_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_8685a71b-f20d-4f90-87ae-a746e0cd3feb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MORTGAGE NOTES PAYABLE, NET</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Liabilities Incurred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MortgageLoanRelatedToPropertySales1_798b562b-3087-456e-a76d-4bf3f7bb467c_terseLabel_en-US" xlink:label="lab_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage note receivable taken in connection with sale of real estate</link:label>
    <link:label id="lab_us-gaap_MortgageLoanRelatedToPropertySales1_label_en-US" xlink:label="lab_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Loan Related to Property Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgageLoanRelatedToPropertySales1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:to="lab_us-gaap_MortgageLoanRelatedToPropertySales1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_21b0276a-2b8f-4707-ac3f-3fde864b03b7_netLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GAIN/(IMPAIRMENT)</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements_0df78306-658e-4c5b-a39b-9bb33da701d2_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and improvements</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Buildings and Improvements</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Buildings and Improvements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_6bacf4dc-72a5-4705-963a-b9de8c013b80_terseLabel_en-US" xlink:label="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 and thereafter</link:label>
    <link:label id="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_label_en-US" xlink:label="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:label id="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_documentation_en-US" xlink:label="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:href="hr-20230930.xsd#hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:to="lab_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateNotesReceivableNet_f3f45125-0553-4803-8967-27ec7a49a5f2_terseLabel_en-US" xlink:label="lab_hr_RealEstateNotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in financing receivable, net</link:label>
    <link:label id="lab_hr_RealEstateNotesReceivableNet_label_en-US" xlink:label="lab_hr_RealEstateNotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Notes Receivable, Net</link:label>
    <link:label id="lab_hr_RealEstateNotesReceivableNet_documentation_en-US" xlink:label="lab_hr_RealEstateNotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Notes Receivable, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateNotesReceivableNet" xlink:href="hr-20230930.xsd#hr_RealEstateNotesReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateNotesReceivableNet" xlink:to="lab_hr_RealEstateNotesReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables_2e5b9270-8d91-488e-9ab0-74e1a6943832_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment in financing receivable</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Collection of Finance Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollectionOfFinanceReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:to="lab_us-gaap_ProceedsFromCollectionOfFinanceReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfVariableInterestEntities_bfad6c3f-a706-4e60-b3c9-34f782d073c5_terseLabel_en-US" xlink:label="lab_hr_NumberOfVariableInterestEntities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of variable interest entities</link:label>
    <link:label id="lab_hr_NumberOfVariableInterestEntities_label_en-US" xlink:label="lab_hr_NumberOfVariableInterestEntities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Variable Interest Entities</link:label>
    <link:label id="lab_hr_NumberOfVariableInterestEntities_documentation_en-US" xlink:label="lab_hr_NumberOfVariableInterestEntities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Variable Interest Entities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfVariableInterestEntities" xlink:href="hr-20230930.xsd#hr_NumberOfVariableInterestEntities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfVariableInterestEntities" xlink:to="lab_hr_NumberOfVariableInterestEntities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_ec5406d4-2736-4c36-8c27-05fcc6bf5b35_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NonControllingInterestHoldersMember_9db4a98c-f325-4a36-a5ff-720071c04045_terseLabel_en-US" xlink:label="lab_hr_NonControllingInterestHoldersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Controlling Interest Holders</link:label>
    <link:label id="lab_hr_NonControllingInterestHoldersMember_label_en-US" xlink:label="lab_hr_NonControllingInterestHoldersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Controlling Interest Holders [Member]</link:label>
    <link:label id="lab_hr_NonControllingInterestHoldersMember_documentation_en-US" xlink:label="lab_hr_NonControllingInterestHoldersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Controlling Interest Holders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonControllingInterestHoldersMember" xlink:href="hr-20230930.xsd#hr_NonControllingInterestHoldersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NonControllingInterestHoldersMember" xlink:to="lab_hr_NonControllingInterestHoldersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_9f16034e-ae83-4473-bf18-5ea1f2e817b8_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets, including right-of-use-assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateDispositionsMember_fd56f5be-0ba4-47b4-8919-e59c10b9423c_terseLabel_en-US" xlink:label="lab_hr_RealEstateDispositionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions</link:label>
    <link:label id="lab_hr_RealEstateDispositionsMember_label_en-US" xlink:label="lab_hr_RealEstateDispositionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions [Member]</link:label>
    <link:label id="lab_hr_RealEstateDispositionsMember_documentation_en-US" xlink:label="lab_hr_RealEstateDispositionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Dispositions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsMember" xlink:href="hr-20230930.xsd#hr_RealEstateDispositionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateDispositionsMember" xlink:to="lab_hr_RealEstateDispositionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateOther_25b8790b-47ab-49fa-bba3-4df997cddb3f_terseLabel_en-US" xlink:label="lab_hr_RealEstateOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER (INCLUDING RECEIVABLES)</link:label>
    <link:label id="lab_hr_RealEstateOther_label_en-US" xlink:label="lab_hr_RealEstateOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Other</link:label>
    <link:label id="lab_hr_RealEstateOther_documentation_en-US" xlink:label="lab_hr_RealEstateOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate other.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateOther" xlink:href="hr-20230930.xsd#hr_RealEstateOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateOther" xlink:to="lab_hr_RealEstateOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_6b584905-cb62-4140-98c9-e391bbfff679_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Compensation Cost, Nonvested Awards</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities_afd60a6e-7516-4df2-8455-db4e7dbf940f_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing lease liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Liabilities</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_35333aea-7bc9-4f82-8dbd-16c9d9361380_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod_a4f26f9e-5282-4053-b722-1313e3d9b473_negatedLabel_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Probability adjustment of 2022 &amp; 2023 RSUs (in shares)</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod_label_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options Probability Adjustment In Period</link:label>
    <link:label id="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod_documentation_en-US" xlink:label="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Probability Adjustment In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" xlink:href="hr-20230930.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" xlink:to="lab_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_8ef56f25-0c26-4f5b-a1f4-2540c0957e7f_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale_9c855374-9d4f-48ad-99d0-bc6eaec52c26_terseLabel_en-US" xlink:label="lab_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges on net real estate assets held for sale</link:label>
    <link:label id="lab_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale_label_en-US" xlink:label="lab_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Charge on Real Estate Assets Held for Sale</link:label>
    <link:label id="lab_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale_documentation_en-US" xlink:label="lab_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Charge on Real Estate Assets Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale" xlink:href="hr-20230930.xsd#hr_ImpairmentChargeOnRealEstateAssetsHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale" xlink:to="lab_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_NC_e9ff8017-5df6-406e-a4e5-7c14ae4b593c_terseLabel_en-US" xlink:label="lab_stpr_NC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">North Carolina</link:label>
    <link:label id="lab_stpr_NC_label_en-US" xlink:label="lab_stpr_NC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NORTH CAROLINA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NC" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_NC"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_NC" xlink:to="lab_stpr_NC" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_38070f2d-4c9b-496b-a35c-d6fda400bc5a_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Disaggregation of revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_7115911a-9d40-438f-bde7-d5cca6af3c5c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_SquareFeetSubjecttoGroundLeases_bccc4316-7731-4356-a793-c2e029688a67_terseLabel_en-US" xlink:label="lab_hr_SquareFeetSubjecttoGroundLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Square feet subject to ground leases</link:label>
    <link:label id="lab_hr_SquareFeetSubjecttoGroundLeases_label_en-US" xlink:label="lab_hr_SquareFeetSubjecttoGroundLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Square Feet Subject to Ground Leases</link:label>
    <link:label id="lab_hr_SquareFeetSubjecttoGroundLeases_documentation_en-US" xlink:label="lab_hr_SquareFeetSubjecttoGroundLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Square Feet Subject to Ground Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SquareFeetSubjecttoGroundLeases" xlink:href="hr-20230930.xsd#hr_SquareFeetSubjecttoGroundLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_SquareFeetSubjecttoGroundLeases" xlink:to="lab_hr_SquareFeetSubjecttoGroundLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_TampaFLMiamiFLMember_3938e07a-02dc-4d48-b72f-a05706146834_terseLabel_en-US" xlink:label="lab_hr_TampaFLMiamiFLMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tampa/Miami, FL</link:label>
    <link:label id="lab_hr_TampaFLMiamiFLMember_label_en-US" xlink:label="lab_hr_TampaFLMiamiFLMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tampa FL &amp; Miami FL [Member]</link:label>
    <link:label id="lab_hr_TampaFLMiamiFLMember_documentation_en-US" xlink:label="lab_hr_TampaFLMiamiFLMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tampa FL &amp; Miami FL</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TampaFLMiamiFLMember" xlink:href="hr-20230930.xsd#hr_TampaFLMiamiFLMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_TampaFLMiamiFLMember" xlink:to="lab_hr_TampaFLMiamiFLMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a7a7a293-58f5-4443-b9db-57129f85784e_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other operating</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0c01eedb-3920-4e4d-ac9b-1feb9f4931c7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_bffff3e0-d660-466a-814b-2368531fb8d0_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_f5695eb8-85ba-4520-81f5-980cf7ba5007_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a2841d45-b6df-4a11-b3f9-54bf8ec9b278_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_eff2a7dc-6671-444e-8d52-2bf054f30277_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_f6c58b65-8728-4d9c-997c-5b02f62fa89b_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_8f9d5bcd-48d2-4d6b-bf5c-0f4fdda79198_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Consideration Transferred</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition, Contingent Consideration [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock" xlink:to="lab_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_78d16506-1e82-4f9c-9a34-97ecfe72f7b7_terseLabel_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate investments</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_label_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments [Abstract]</link:label>
    <link:label id="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_documentation_en-US" xlink:label="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract" xlink:to="lab_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_CommonStockFractionalShares_55b04da1-1dc8-4cdb-8b1e-ac6a78e1dd17_terseLabel_en-US" xlink:label="lab_hr_CommonStockFractionalShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, fractional (in shares)</link:label>
    <link:label id="lab_hr_CommonStockFractionalShares_label_en-US" xlink:label="lab_hr_CommonStockFractionalShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Fractional Shares</link:label>
    <link:label id="lab_hr_CommonStockFractionalShares_documentation_en-US" xlink:label="lab_hr_CommonStockFractionalShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Fractional Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CommonStockFractionalShares" xlink:href="hr-20230930.xsd#hr_CommonStockFractionalShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_CommonStockFractionalShares" xlink:to="lab_hr_CommonStockFractionalShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_77967e46-95ed-454b-b192-3f67b66b7b03_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate - operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_83c75cb7-7a90-4d2c-8a9f-334561929779_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_f43481da-df28-4081-97d7-66f5f2db0be0_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average years remaining lease term (excluding renewal options) - finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_617912dc-8fa0-4dd0-9cef-ca48dac358c0_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_22a96498-4b85-42aa-a24d-1c956e5dfe26_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_c644bdc9-3029-415d-ac66-71f90f495582_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_b96d6c24-e2c2-40c2-bc15-a9eb3f5b973e_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_3f4060ac-b2a1-444b-bcc5-4d0cfb807b1a_verboseLabel_en-US" xlink:label="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the beginning and ending common stock outstanding</link:label>
    <link:label id="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_label_en-US" xlink:label="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Beginning and Ending Common Stock Outstanding [Roll Forward]</link:label>
    <link:label id="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_documentation_en-US" xlink:label="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of the beginning and ending common stock outstanding.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" xlink:href="hr-20230930.xsd#hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" xlink:to="lab_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_a8373804-ab3e-4bbb-a809-1e4a69aca7c8_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_9efbc90c-e57f-4200-b470-b1099d8d4d05_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_5b6d1742-1c2b-495b-81da-90ecbe97d7ce_verboseLabel_en-US" xlink:label="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of states that the company owns real estate in, whole units</link:label>
    <link:label id="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_label_en-US" xlink:label="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate Investments Property Owned in Number of States</link:label>
    <link:label id="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_documentation_en-US" xlink:label="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real estate investments property owned in number of states.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" xlink:href="hr-20230930.xsd#hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" xlink:to="lab_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_7b536608-07f2-4eca-86d4-10d44a9a0a2b_terseLabel_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_label_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Three</link:label>
    <link:label id="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_documentation_en-US" xlink:label="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" xlink:href="hr-20230930.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" xlink:to="lab_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1b6846e6-246b-43aa-b1ee-1a13f9d1cefc_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_6a1263da-0b50-441a-90cc-c00b0031df20_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash flows outflows related to financing leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_59aa23fd-487d-432c-915e-c0e27d2da869_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested/Forfeited, Weighted average grant date fair value (in dollar per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OtherPropertyMember_d99dc7a4-7f88-4220-a015-6beeecb16701_terseLabel_en-US" xlink:label="lab_srt_OtherPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parking Garages</link:label>
    <link:label id="lab_srt_OtherPropertyMember_label_en-US" xlink:label="lab_srt_OtherPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Property [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OtherPropertyMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OtherPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OtherPropertyMember" xlink:to="lab_srt_OtherPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_47e8d0c2-ec93-4013-b85a-a94ee864b17e_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_672eb4db-4cf8-43f4-bd20-9a4e0ef61715_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_799b3929-75f0-482c-be74-ff4d146bc5bf_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3d3d0e8e-01ae-4a86-ad90-95042f370a3c_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding - basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount_d3cb759b-625e-4e03-9b6d-2721a5484fc9_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross contractual accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquired Receivables, Gross Contractual Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount" xlink:to="lab_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ActiveInterestRateSwapsMember_5752aaa5-d5b9-4ba6-86fc-cbcd22d25d8e_terseLabel_en-US" xlink:label="lab_hr_ActiveInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Active Interest Rate Swap</link:label>
    <link:label id="lab_hr_ActiveInterestRateSwapsMember_label_en-US" xlink:label="lab_hr_ActiveInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Active Interest Rate Swaps [Member]</link:label>
    <link:label id="lab_hr_ActiveInterestRateSwapsMember_documentation_en-US" xlink:label="lab_hr_ActiveInterestRateSwapsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Active Interest Rate Swaps [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ActiveInterestRateSwapsMember" xlink:href="hr-20230930.xsd#hr_ActiveInterestRateSwapsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ActiveInterestRateSwapsMember" xlink:to="lab_hr_ActiveInterestRateSwapsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_6c28ee31-185c-48f3-8677-19d102814d78_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NatureOfOperationsPolicyTextBlock_25cfdf6d-9982-45be-886b-23ff3af7b62e_terseLabel_en-US" xlink:label="lab_hr_NatureOfOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Overview</link:label>
    <link:label id="lab_hr_NatureOfOperationsPolicyTextBlock_label_en-US" xlink:label="lab_hr_NatureOfOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Policy Text Block]</link:label>
    <link:label id="lab_hr_NatureOfOperationsPolicyTextBlock_documentation_en-US" xlink:label="lab_hr_NatureOfOperationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature Of Operations Policy.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NatureOfOperationsPolicyTextBlock" xlink:href="hr-20230930.xsd#hr_NatureOfOperationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NatureOfOperationsPolicyTextBlock" xlink:to="lab_hr_NatureOfOperationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_FinancingReceivableAllowanceForCreditLossReserves_f544848c-2b27-4085-8985-0ef798969bf3_terseLabel_en-US" xlink:label="lab_hr_FinancingReceivableAllowanceForCreditLossReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit loss reserves</link:label>
    <link:label id="lab_hr_FinancingReceivableAllowanceForCreditLossReserves_label_en-US" xlink:label="lab_hr_FinancingReceivableAllowanceForCreditLossReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Reserves</link:label>
    <link:label id="lab_hr_FinancingReceivableAllowanceForCreditLossReserves_documentation_en-US" xlink:label="lab_hr_FinancingReceivableAllowanceForCreditLossReserves" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss, Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinancingReceivableAllowanceForCreditLossReserves" xlink:href="hr-20230930.xsd#hr_FinancingReceivableAllowanceForCreditLossReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_FinancingReceivableAllowanceForCreditLossReserves" xlink:to="lab_hr_FinancingReceivableAllowanceForCreditLossReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_1dacbfde-11ca-4a21-bd01-d86f940ffed4_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_e72aa7fa-cab6-4727-b406-936eb3ab7ffc_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rental income</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLeaseIncome_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Lease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLeaseIncome" xlink:to="lab_us-gaap_OperatingLeaseLeaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_37103856-4120-4e46-90fc-337c0f7f2a63_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_938d8e4b-c286-432b-988f-1b06331ac4cb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock_d242b760-5bf4-46ec-9aae-5e6e25edfc9b_terseLabel_en-US" xlink:label="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Held for Sale</link:label>
    <link:label id="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock_label_en-US" xlink:label="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Held for Sale [Table Text Block]</link:label>
    <link:label id="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock_documentation_en-US" xlink:label="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Assets and Liabilities Held for Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" xlink:href="hr-20230930.xsd#hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" xlink:to="lab_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_NumberOfPropertyDispositions_7b21b542-afbb-47a5-9d03-bf0ffb996174_terseLabel_en-US" xlink:label="lab_hr_NumberOfPropertyDispositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of property dispositions</link:label>
    <link:label id="lab_hr_NumberOfPropertyDispositions_label_en-US" xlink:label="lab_hr_NumberOfPropertyDispositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Property Dispositions</link:label>
    <link:label id="lab_hr_NumberOfPropertyDispositions_documentation_en-US" xlink:label="lab_hr_NumberOfPropertyDispositions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Property Dispositions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertyDispositions" xlink:href="hr-20230930.xsd#hr_NumberOfPropertyDispositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_NumberOfPropertyDispositions" xlink:to="lab_hr_NumberOfPropertyDispositions" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_e4e5eef8-fe54-4018-a935-618318dff337_totalLabel_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net identifiable assets acquired</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_label_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identifiable Assets Acquired</link:label>
    <link:label id="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_documentation_en-US" xlink:label="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identifiable Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" xlink:to="lab_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_MortgageNotesPayableNetMember_0948e092-3a24-4e98-a010-e357216860c7_terseLabel_en-US" xlink:label="lab_hr_MortgageNotesPayableNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage notes payable</link:label>
    <link:label id="lab_hr_MortgageNotesPayableNetMember_label_en-US" xlink:label="lab_hr_MortgageNotesPayableNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Notes Payable, Net [Member]</link:label>
    <link:label id="lab_hr_MortgageNotesPayableNetMember_documentation_en-US" xlink:label="lab_hr_MortgageNotesPayableNetMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mortgage Notes Payable, Net [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageNotesPayableNetMember" xlink:href="hr-20230930.xsd#hr_MortgageNotesPayableNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_MortgageNotesPayableNetMember" xlink:to="lab_hr_MortgageNotesPayableNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_82a98606-1266-4b2e-840e-16f7b45324b9_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling Interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_InterestRateSwapExpiringJanuary152024Member_5af2143d-1ed1-49c9-acc5-cccf19bc6b92_terseLabel_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJanuary152024Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring January 15, 2024</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringJanuary152024Member_label_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJanuary152024Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring January 15, 2024 [Member]</link:label>
    <link:label id="lab_hr_InterestRateSwapExpiringJanuary152024Member_documentation_en-US" xlink:label="lab_hr_InterestRateSwapExpiringJanuary152024Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap, Expiring January 15, 2024</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJanuary152024Member" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringJanuary152024Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_InterestRateSwapExpiringJanuary152024Member" xlink:to="lab_hr_InterestRateSwapExpiringJanuary152024Member" xlink:type="arc" order="1"/>
    <link:label id="lab_hr_ApproximateSquareFeetInvestedInByCompany_2fec9a84-f2d1-4c44-bd88-4b3a934e5571_terseLabel_en-US" xlink:label="lab_hr_ApproximateSquareFeetInvestedInByCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate square feet invested in by company</link:label>
    <link:label id="lab_hr_ApproximateSquareFeetInvestedInByCompany_label_en-US" xlink:label="lab_hr_ApproximateSquareFeetInvestedInByCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate Square Feet Invested in by Company</link:label>
    <link:label id="lab_hr_ApproximateSquareFeetInvestedInByCompany_documentation_en-US" xlink:label="lab_hr_ApproximateSquareFeetInvestedInByCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approximate Square Feet Invested in by Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ApproximateSquareFeetInvestedInByCompany" xlink:href="hr-20230930.xsd#hr_ApproximateSquareFeetInvestedInByCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_hr_ApproximateSquareFeetInvestedInByCompany" xlink:to="lab_hr_ApproximateSquareFeetInvestedInByCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>hr-20230930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:73dbfdf1-2054-4a25-8023-7c5130a0cc11,g:80064ddd-1403-40d2-9d20-e881ce80ef55-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://healthcarerealty.com/role/CoverPage" xlink:type="simple" xlink:href="hr-20230930.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ac43b10c-f530-4836-af5e-da69b6336b50" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_DocumentType_ac43b10c-f530-4836-af5e-da69b6336b50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_71f84f33-5c68-49a9-8864-595e4fe09967" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_DocumentQuarterlyReport_71f84f33-5c68-49a9-8864-595e4fe09967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_03c4abe0-a086-4ceb-931c-7acf45db9656" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_DocumentPeriodEndDate_03c4abe0-a086-4ceb-931c-7acf45db9656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_2bb3b4ef-52bc-45ba-acc8-8c87676ccf92" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_DocumentTransitionReport_2bb3b4ef-52bc-45ba-acc8-8c87676ccf92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_047a40c0-ce5d-4693-a9fb-c92e76f0bedd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_EntityFileNumber_047a40c0-ce5d-4693-a9fb-c92e76f0bedd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_fb5d46f5-8c04-4d68-8cb5-f3e9393f7112" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_EntityRegistrantName_fb5d46f5-8c04-4d68-8cb5-f3e9393f7112" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_0aff8e76-70ee-4bc2-b916-a630a97f272e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_EntityIncorporationStateCountryCode_0aff8e76-70ee-4bc2-b916-a630a97f272e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_c858657c-336b-4fae-b9ff-7b8ab8393a8b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_EntityTaxIdentificationNumber_c858657c-336b-4fae-b9ff-7b8ab8393a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b9948c80-92ed-4456-ab92-750df9adf70b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_EntityAddressAddressLine1_b9948c80-92ed-4456-ab92-750df9adf70b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_23a22f18-e198-4089-80a9-2aa9a50392d8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_EntityAddressAddressLine2_23a22f18-e198-4089-80a9-2aa9a50392d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_0ec710dc-fbfe-4407-a034-293f42819587" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_EntityAddressCityOrTown_0ec710dc-fbfe-4407-a034-293f42819587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_b2e2b440-30a4-42fb-bca6-b7f49b7d6940" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_EntityAddressStateOrProvince_b2e2b440-30a4-42fb-bca6-b7f49b7d6940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_310bda7c-4bcc-456a-88dc-2526f383ad9a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_EntityAddressPostalZipCode_310bda7c-4bcc-456a-88dc-2526f383ad9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_e8d70bcf-400e-43cf-ba52-498c3dc2a8c2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_CityAreaCode_e8d70bcf-400e-43cf-ba52-498c3dc2a8c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_9c653195-0e34-4e14-a605-f8df75a76748" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_LocalPhoneNumber_9c653195-0e34-4e14-a605-f8df75a76748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_c27c730b-e7cb-45a5-ae93-8be5e759a2c2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_Security12bTitle_c27c730b-e7cb-45a5-ae93-8be5e759a2c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_e36304a9-254d-47d2-b870-109a73f32247" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_TradingSymbol_e36304a9-254d-47d2-b870-109a73f32247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d2479592-0eda-42ec-a049-3fbdb70b4ddf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_SecurityExchangeName_d2479592-0eda-42ec-a049-3fbdb70b4ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_f5c4cf8e-058d-4580-a8f6-ee7e978d1a55" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_EntityCurrentReportingStatus_f5c4cf8e-058d-4580-a8f6-ee7e978d1a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_877bca35-1d6f-4111-9c46-63a7cbdfa763" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_EntityInteractiveDataCurrent_877bca35-1d6f-4111-9c46-63a7cbdfa763" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_5fd9bf94-2e03-49fb-ac55-2d2e0abc22b2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_EntityFilerCategory_5fd9bf94-2e03-49fb-ac55-2d2e0abc22b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_e22cf748-fea6-419a-b2e5-8fe21616469d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_EntitySmallBusiness_e22cf748-fea6-419a-b2e5-8fe21616469d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4ef98927-eaed-4da8-a283-fba026d952a6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_EntityEmergingGrowthCompany_4ef98927-eaed-4da8-a283-fba026d952a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_3a276adb-2fa1-42bf-a25a-a8b612ffcbf5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_EntityShellCompany_3a276adb-2fa1-42bf-a25a-a8b612ffcbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_0728547b-e33c-45c9-8f8c-e981a5f144dd" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_0728547b-e33c-45c9-8f8c-e981a5f144dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_aa0b41ce-dcba-44b9-a80d-496a4eb4a959" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_EntityCentralIndexKey_aa0b41ce-dcba-44b9-a80d-496a4eb4a959" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_6519bed0-6d9e-4107-964b-7e0a9489b854" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_CurrentFiscalYearEndDate_6519bed0-6d9e-4107-964b-7e0a9489b854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_6dcb54c1-39cf-4999-837e-351be1e8128b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_DocumentFiscalYearFocus_6dcb54c1-39cf-4999-837e-351be1e8128b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_95622612-3d49-4674-bc8f-a0a4a717784c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_DocumentFiscalPeriodFocus_95622612-3d49-4674-bc8f-a0a4a717784c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c645189e-d457-426a-a033-4fcad1f390f6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b09d7d87-cde2-4e73-8da6-6a73c5b5fb03" xlink:to="loc_dei_AmendmentFlag_c645189e-d457-426a-a033-4fcad1f390f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="hr-20230930.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_8d78d741-d80a-49c4-89b0-f73a243072e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_0feb4bfe-ced7-4037-b63e-7e1b0de55f2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8d78d741-d80a-49c4-89b0-f73a243072e9" xlink:to="loc_us-gaap_AssetsAbstract_0feb4bfe-ced7-4037-b63e-7e1b0de55f2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_e6036219-3b8d-46d0-9d10-2b9344a4699c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0feb4bfe-ced7-4037-b63e-7e1b0de55f2a" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_e6036219-3b8d-46d0-9d10-2b9344a4699c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_27632fe9-5c93-4a35-b2ec-bd9af0356ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Land"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_e6036219-3b8d-46d0-9d10-2b9344a4699c" xlink:to="loc_us-gaap_Land_27632fe9-5c93-4a35-b2ec-bd9af0356ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_66cafca5-1d7c-4140-b0e8-d89f99cd47c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_e6036219-3b8d-46d0-9d10-2b9344a4699c" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_66cafca5-1d7c-4140-b0e8-d89f99cd47c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross_14d1f4de-9f9f-4ba2-8a34-651a50e4a493" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherFiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_e6036219-3b8d-46d0-9d10-2b9344a4699c" xlink:to="loc_us-gaap_OtherFiniteLivedIntangibleAssetsGross_14d1f4de-9f9f-4ba2-8a34-651a50e4a493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PersonalProperty_d76de92a-7228-44e4-85eb-a31b74fd213e" xlink:href="hr-20230930.xsd#hr_PersonalProperty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_e6036219-3b8d-46d0-9d10-2b9344a4699c" xlink:to="loc_hr_PersonalProperty_d76de92a-7228-44e4-85eb-a31b74fd213e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_2bb7299d-afa1-40cc-bf34-66d70cab8866" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_e6036219-3b8d-46d0-9d10-2b9344a4699c" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss_2bb7299d-afa1-40cc-bf34-66d70cab8866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_1b1330bb-6347-431e-8fa8-5db8d2396ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_e6036219-3b8d-46d0-9d10-2b9344a4699c" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_1b1330bb-6347-431e-8fa8-5db8d2396ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopmentInProcess_2274366a-f3dc-4936-aa30-897282a8ba99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DevelopmentInProcess"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_e6036219-3b8d-46d0-9d10-2b9344a4699c" xlink:to="loc_us-gaap_DevelopmentInProcess_2274366a-f3dc-4936-aa30-897282a8ba99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandAvailableForDevelopment_57ee7192-4538-4cc5-b595-3b1ca2eef05b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LandAvailableForDevelopment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_e6036219-3b8d-46d0-9d10-2b9344a4699c" xlink:to="loc_us-gaap_LandAvailableForDevelopment_57ee7192-4538-4cc5-b595-3b1ca2eef05b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost_29c09619-33e1-4bc5-85e4-7ac39caca4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_e6036219-3b8d-46d0-9d10-2b9344a4699c" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAtCost_29c09619-33e1-4bc5-85e4-7ac39caca4e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_5765b7c6-5851-4ee9-a2f5-25ac2bd10b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateInvestmentPropertyNetAbstract_e6036219-3b8d-46d0-9d10-2b9344a4699c" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_5765b7c6-5851-4ee9-a2f5-25ac2bd10b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_8ebb23b8-b122-46dd-856e-4b8b1a18b9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0feb4bfe-ced7-4037-b63e-7e1b0de55f2a" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_8ebb23b8-b122-46dd-856e-4b8b1a18b9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bea07790-9801-47b4-997b-00b15f40240b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0feb4bfe-ced7-4037-b63e-7e1b0de55f2a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_bea07790-9801-47b4-997b-00b15f40240b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_896ce8e9-1b9f-4d79-bf67-ed17aaaa57b5" xlink:href="hr-20230930.xsd#hr_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0feb4bfe-ced7-4037-b63e-7e1b0de55f2a" xlink:to="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_896ce8e9-1b9f-4d79-bf67-ed17aaaa57b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_06a0e165-89a2-4ca9-8310-536327cb514e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0feb4bfe-ced7-4037-b63e-7e1b0de55f2a" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_06a0e165-89a2-4ca9-8310-536327cb514e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_5fd15650-608a-40a7-b91a-2341b3598532" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0feb4bfe-ced7-4037-b63e-7e1b0de55f2a" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_5fd15650-608a-40a7-b91a-2341b3598532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_252365d3-43f2-41b6-b96a-dbcee4bccfc0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0feb4bfe-ced7-4037-b63e-7e1b0de55f2a" xlink:to="loc_us-gaap_Goodwill_252365d3-43f2-41b6-b96a-dbcee4bccfc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssets_f749fe2b-c0cb-4fa8-bc49-d21f8e8aa521" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0feb4bfe-ced7-4037-b63e-7e1b0de55f2a" xlink:to="loc_us-gaap_OtherAssets_f749fe2b-c0cb-4fa8-bc49-d21f8e8aa521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_fb76ec3d-29c7-4c80-a2f3-019787422540" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_0feb4bfe-ced7-4037-b63e-7e1b0de55f2a" xlink:to="loc_us-gaap_Assets_fb76ec3d-29c7-4c80-a2f3-019787422540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4298e405-7b8d-4dfc-b0b5-8fee6f27f6bc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_8d78d741-d80a-49c4-89b0-f73a243072e9" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4298e405-7b8d-4dfc-b0b5-8fee6f27f6bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_08bb212d-e294-42a9-8617-0318d578140b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4298e405-7b8d-4dfc-b0b5-8fee6f27f6bc" xlink:to="loc_us-gaap_LiabilitiesAbstract_08bb212d-e294-42a9-8617-0318d578140b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_e71dc193-cbf6-44bf-906b-4de098d257f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_08bb212d-e294-42a9-8617-0318d578140b" xlink:to="loc_us-gaap_LongTermDebt_e71dc193-cbf6-44bf-906b-4de098d257f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_c206a0f3-0eba-4c47-96fc-a46d73c26be8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_08bb212d-e294-42a9-8617-0318d578140b" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent_c206a0f3-0eba-4c47-96fc-a46d73c26be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_83bbddb8-1979-47ee-a407-1078d86517ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_08bb212d-e294-42a9-8617-0318d578140b" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_83bbddb8-1979-47ee-a407-1078d86517ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_27d33bcc-51f4-439c-9366-120a78323c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_08bb212d-e294-42a9-8617-0318d578140b" xlink:to="loc_us-gaap_OperatingLeaseLiability_27d33bcc-51f4-439c-9366-120a78323c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_afbad2e0-f373-464d-8a9e-7b9320e967e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_08bb212d-e294-42a9-8617-0318d578140b" xlink:to="loc_us-gaap_FinanceLeaseLiability_afbad2e0-f373-464d-8a9e-7b9320e967e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilities_4712e9ed-9cb2-4935-849f-082c563e5f6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_08bb212d-e294-42a9-8617-0318d578140b" xlink:to="loc_us-gaap_OtherLiabilities_4712e9ed-9cb2-4935-849f-082c563e5f6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_26aaa1d0-ea18-4ac1-a39d-b78e1d4aca76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_08bb212d-e294-42a9-8617-0318d578140b" xlink:to="loc_us-gaap_Liabilities_26aaa1d0-ea18-4ac1-a39d-b78e1d4aca76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_710a9130-4290-4f06-a0c6-9ec1ad24cfe8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4298e405-7b8d-4dfc-b0b5-8fee6f27f6bc" xlink:to="loc_us-gaap_CommitmentsAndContingencies_710a9130-4290-4f06-a0c6-9ec1ad24cfe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_8dc90f29-8aba-40c7-a367-8a8ae80d63a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4298e405-7b8d-4dfc-b0b5-8fee6f27f6bc" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_8dc90f29-8aba-40c7-a367-8a8ae80d63a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_fe0d9202-8c7e-4161-b298-6486599f23a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4298e405-7b8d-4dfc-b0b5-8fee6f27f6bc" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_fe0d9202-8c7e-4161-b298-6486599f23a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_f330aa33-3b54-4d0d-99b2-30fa4e9c8c24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_fe0d9202-8c7e-4161-b298-6486599f23a6" xlink:to="loc_us-gaap_PreferredStockValue_f330aa33-3b54-4d0d-99b2-30fa4e9c8c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fea992a0-ac8f-4a87-a3f5-a725d82363a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_fe0d9202-8c7e-4161-b298-6486599f23a6" xlink:to="loc_us-gaap_CommonStockValue_fea992a0-ac8f-4a87-a3f5-a725d82363a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_de713bc7-b5fd-4e24-b436-d19cf967053d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_fe0d9202-8c7e-4161-b298-6486599f23a6" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_de713bc7-b5fd-4e24-b436-d19cf967053d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_0a6301ec-b4cc-4745-b122-d31b74370135" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_fe0d9202-8c7e-4161-b298-6486599f23a6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax_0a6301ec-b4cc-4745-b122-d31b74370135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetIncomeAttributableToCommonStockholders_cd2a4dfd-5284-4bfd-9e00-5395e83aff2f" xlink:href="hr-20230930.xsd#hr_CumulativeNetIncomeAttributableToCommonStockholders"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_fe0d9202-8c7e-4161-b298-6486599f23a6" xlink:to="loc_hr_CumulativeNetIncomeAttributableToCommonStockholders_cd2a4dfd-5284-4bfd-9e00-5395e83aff2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CumulativeDividends_f2cfe3e1-4af4-488c-accd-516e83e86272" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CumulativeDividends"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_fe0d9202-8c7e-4161-b298-6486599f23a6" xlink:to="loc_us-gaap_CumulativeDividends_f2cfe3e1-4af4-488c-accd-516e83e86272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_daaebe32-0b81-4d86-b6af-0077cbfccc42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_fe0d9202-8c7e-4161-b298-6486599f23a6" xlink:to="loc_us-gaap_StockholdersEquity_daaebe32-0b81-4d86-b6af-0077cbfccc42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_4eb09503-ee81-4997-93c6-b9c6953e0987" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_fe0d9202-8c7e-4161-b298-6486599f23a6" xlink:to="loc_us-gaap_MinorityInterest_4eb09503-ee81-4997-93c6-b9c6953e0987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2d565499-b6d3-4017-8794-1363cd693f44" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_fe0d9202-8c7e-4161-b298-6486599f23a6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2d565499-b6d3-4017-8794-1363cd693f44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8bd4d74b-ed0a-4b9f-8178-e87c5fa4ef16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_4298e405-7b8d-4dfc-b0b5-8fee6f27f6bc" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_8bd4d74b-ed0a-4b9f-8178-e87c5fa4ef16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="hr-20230930.xsd#CondensedConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_522d0346-a565-468e-bafd-430929417977" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_502e314c-7c20-4413-827d-4ed14aa69f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_522d0346-a565-468e-bafd-430929417977" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_502e314c-7c20-4413-827d-4ed14aa69f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_1d87b10b-6a16-4bf6-8cf6-d157606b93e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_522d0346-a565-468e-bafd-430929417977" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_1d87b10b-6a16-4bf6-8cf6-d157606b93e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_02a8dd79-a3e9-4189-8d9e-73e1f64ae8aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_522d0346-a565-468e-bafd-430929417977" xlink:to="loc_us-gaap_PreferredStockSharesIssued_02a8dd79-a3e9-4189-8d9e-73e1f64ae8aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_00202ade-d25e-4c2c-a481-09e31573a110" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_522d0346-a565-468e-bafd-430929417977" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_00202ade-d25e-4c2c-a481-09e31573a110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_54eb2fc5-f3e0-4f8c-86e7-4af773200ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_522d0346-a565-468e-bafd-430929417977" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_54eb2fc5-f3e0-4f8c-86e7-4af773200ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_a25c57a2-b54b-4dde-b389-c26b02989edc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_522d0346-a565-468e-bafd-430929417977" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_a25c57a2-b54b-4dde-b389-c26b02989edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_c54a699f-c65d-41e2-95da-1bdbd5fee060" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_522d0346-a565-468e-bafd-430929417977" xlink:to="loc_us-gaap_CommonStockSharesIssued_c54a699f-c65d-41e2-95da-1bdbd5fee060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a4a8a680-3946-45d1-bbe9-cdc52edf2a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_522d0346-a565-468e-bafd-430929417977" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a4a8a680-3946-45d1-bbe9-cdc52edf2a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="hr-20230930.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_88f572b6-c2a7-425b-8e28-c56721d449b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_2bd20be7-3224-43da-bf85-99ceaa0be504" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_88f572b6-c2a7-425b-8e28-c56721d449b3" xlink:to="loc_us-gaap_RevenuesAbstract_2bd20be7-3224-43da-bf85-99ceaa0be504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_ea6cb1ef-3a10-4d13-9a43-44c7da6955c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_2bd20be7-3224-43da-bf85-99ceaa0be504" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_ea6cb1ef-3a10-4d13-9a43-44c7da6955c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss_91764b4d-7bbc-4977-9560-08cbe145a3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_2bd20be7-3224-43da-bf85-99ceaa0be504" xlink:to="loc_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss_91764b4d-7bbc-4977-9560-08cbe145a3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_26ae9463-5a63-4d3b-b22f-c3b870c128e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_2bd20be7-3224-43da-bf85-99ceaa0be504" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_26ae9463-5a63-4d3b-b22f-c3b870c128e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_773e066c-79f0-4d0f-a2ad-7238455bced8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_2bd20be7-3224-43da-bf85-99ceaa0be504" xlink:to="loc_us-gaap_Revenues_773e066c-79f0-4d0f-a2ad-7238455bced8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_54ab630e-a7e6-48b2-8b1e-b9dbadfb11b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_88f572b6-c2a7-425b-8e28-c56721d449b3" xlink:to="loc_us-gaap_OperatingExpensesAbstract_54ab630e-a7e6-48b2-8b1e-b9dbadfb11b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment_47c8cf2e-0785-4349-9a02-c1fb58dd1f0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_54ab630e-a7e6-48b2-8b1e-b9dbadfb11b2" xlink:to="loc_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment_47c8cf2e-0785-4349-9a02-c1fb58dd1f0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_663bb6db-d192-4463-a891-93aebfb68bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_54ab630e-a7e6-48b2-8b1e-b9dbadfb11b2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_663bb6db-d192-4463-a891-93aebfb68bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquisitionCosts_8d0ec84a-df4d-4c88-97cf-fbdb6a5f54ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AcquisitionCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_54ab630e-a7e6-48b2-8b1e-b9dbadfb11b2" xlink:to="loc_us-gaap_AcquisitionCosts_8d0ec84a-df4d-4c88-97cf-fbdb6a5f54ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MergerRelatedCosts_158a4bba-2b6e-457d-ad23-7e3668bdb17e" xlink:href="hr-20230930.xsd#hr_MergerRelatedCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_54ab630e-a7e6-48b2-8b1e-b9dbadfb11b2" xlink:to="loc_hr_MergerRelatedCosts_158a4bba-2b6e-457d-ad23-7e3668bdb17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_c252a630-5e75-4c1c-9cd9-3a9e59bcc7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_54ab630e-a7e6-48b2-8b1e-b9dbadfb11b2" xlink:to="loc_us-gaap_DepreciationAndAmortization_c252a630-5e75-4c1c-9cd9-3a9e59bcc7ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingExpensesandCostofGoodsSold_b72913db-6e8e-425f-b2e2-36bfacb9f84f" xlink:href="hr-20230930.xsd#hr_OperatingExpensesandCostofGoodsSold"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_54ab630e-a7e6-48b2-8b1e-b9dbadfb11b2" xlink:to="loc_hr_OperatingExpensesandCostofGoodsSold_b72913db-6e8e-425f-b2e2-36bfacb9f84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_df3ebd82-4931-49c7-a4a0-77c1c8bcf62e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_88f572b6-c2a7-425b-8e28-c56721d449b3" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_df3ebd82-4931-49c7-a4a0-77c1c8bcf62e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_49d2b55a-014b-44dd-b014-5b22c2744cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnSalesOfInvestmentRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_df3ebd82-4931-49c7-a4a0-77c1c8bcf62e" xlink:to="loc_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate_49d2b55a-014b-44dd-b014-5b22c2744cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_796e0907-4d96-4c0c-996d-2c95a082d906" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_df3ebd82-4931-49c7-a4a0-77c1c8bcf62e" xlink:to="loc_us-gaap_InterestExpense_796e0907-4d96-4c0c-996d-2c95a082d906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fb1fcefe-f2a0-4539-82ee-8821aa03a046" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_df3ebd82-4931-49c7-a4a0-77c1c8bcf62e" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_fb1fcefe-f2a0-4539-82ee-8821aa03a046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentOfRealEstateAndCreditLossReserves_8854292b-29aa-47ae-9595-77c11844ef63" xlink:href="hr-20230930.xsd#hr_ImpairmentOfRealEstateAndCreditLossReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_df3ebd82-4931-49c7-a4a0-77c1c8bcf62e" xlink:to="loc_hr_ImpairmentOfRealEstateAndCreditLossReserves_8854292b-29aa-47ae-9595-77c11844ef63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_eeb8352a-9dfc-462f-8072-7e258028af35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_df3ebd82-4931-49c7-a4a0-77c1c8bcf62e" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_eeb8352a-9dfc-462f-8072-7e258028af35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_6fecab4f-147f-4882-9222-eca1083dc0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_df3ebd82-4931-49c7-a4a0-77c1c8bcf62e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_6fecab4f-147f-4882-9222-eca1083dc0d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_1ecf53bc-8afa-4706-b5cc-f09453f695b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_df3ebd82-4931-49c7-a4a0-77c1c8bcf62e" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_1ecf53bc-8afa-4706-b5cc-f09453f695b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_117b6691-e26a-442e-843f-91388ffbc069" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_df3ebd82-4931-49c7-a4a0-77c1c8bcf62e" xlink:to="loc_us-gaap_ProfitLoss_117b6691-e26a-442e-843f-91388ffbc069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_22e2499c-df23-423c-9682-fb2720cd6306" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_df3ebd82-4931-49c7-a4a0-77c1c8bcf62e" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_22e2499c-df23-423c-9682-fb2720cd6306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_b7c17686-97aa-4280-9710-c2e7b215d184" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_df3ebd82-4931-49c7-a4a0-77c1c8bcf62e" xlink:to="loc_us-gaap_NetIncomeLoss_b7c17686-97aa-4280-9710-c2e7b215d184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_51a16038-9eb6-4cd4-9ef9-85aaf531598f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_88f572b6-c2a7-425b-8e28-c56721d449b3" xlink:to="loc_us-gaap_EarningsPerShareBasic_51a16038-9eb6-4cd4-9ef9-85aaf531598f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_319984d3-6ec8-4cd6-ae35-ee9b7c6c3c1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_88f572b6-c2a7-425b-8e28-c56721d449b3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_319984d3-6ec8-4cd6-ae35-ee9b7c6c3c1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4600bda4-ad53-4839-b962-9cbac4bceb10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_88f572b6-c2a7-425b-8e28-c56721d449b3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4600bda4-ad53-4839-b962-9cbac4bceb10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2d8e623c-e967-4690-86dc-c076b51f37a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_88f572b6-c2a7-425b-8e28-c56721d449b3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2d8e623c-e967-4690-86dc-c076b51f37a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRevenueExtensibleList_5109a05e-45c8-4d28-8989-b19db7639d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TypeOfRevenueExtensibleList"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_88f572b6-c2a7-425b-8e28-c56721d449b3" xlink:to="loc_us-gaap_TypeOfRevenueExtensibleList_5109a05e-45c8-4d28-8989-b19db7639d6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="hr-20230930.xsd#CondensedConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1e733424-253c-4c59-b390-1e2f4e3ee9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_3640c62a-ae21-4df7-ad43-3272f5d777a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_1e733424-253c-4c59-b390-1e2f4e3ee9d2" xlink:to="loc_us-gaap_StatementTable_3640c62a-ae21-4df7-ad43-3272f5d777a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_cdf6b758-af0b-4da7-a7ef-a814902bfa47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3640c62a-ae21-4df7-ad43-3272f5d777a1" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_cdf6b758-af0b-4da7-a7ef-a814902bfa47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_3c21451b-095a-4c5b-883c-2f453a39c4d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cdf6b758-af0b-4da7-a7ef-a814902bfa47" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_3c21451b-095a-4c5b-883c-2f453a39c4d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_637a1411-5d31-4908-ab03-6023fa4ff536" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_3c21451b-095a-4c5b-883c-2f453a39c4d2" xlink:to="loc_us-gaap_InterestRateSwapMember_637a1411-5d31-4908-ab03-6023fa4ff536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3c85da37-dcf5-43d3-9edc-0f27f804760c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_3640c62a-ae21-4df7-ad43-3272f5d777a1" xlink:to="loc_us-gaap_StatementLineItems_3c85da37-dcf5-43d3-9edc-0f27f804760c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_3d88c5b1-aebb-4e3d-8fbf-72b1b5c1b4f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c85da37-dcf5-43d3-9edc-0f27f804760c" xlink:to="loc_us-gaap_ProfitLoss_3d88c5b1-aebb-4e3d-8fbf-72b1b5c1b4f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_61153cd0-60db-4b78-8f90-a8cd1f04a214" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c85da37-dcf5-43d3-9edc-0f27f804760c" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_61153cd0-60db-4b78-8f90-a8cd1f04a214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_e47a8753-aeff-4166-a6c2-b26a5855613f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_61153cd0-60db-4b78-8f90-a8cd1f04a214" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_e47a8753-aeff-4166-a6c2-b26a5855613f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b70f4b03-0434-43b4-ac2a-a72cabc8768d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_e47a8753-aeff-4166-a6c2-b26a5855613f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_b70f4b03-0434-43b4-ac2a-a72cabc8768d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_1a1584ac-c5b1-4ded-8799-c312571b7538" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract_e47a8753-aeff-4166-a6c2-b26a5855613f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_1a1584ac-c5b1-4ded-8799-c312571b7538" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_651e749f-d1b5-4972-bbe3-a2933372dd5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_61153cd0-60db-4b78-8f90-a8cd1f04a214" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_651e749f-d1b5-4972-bbe3-a2933372dd5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_30ecdcf8-a34c-4315-8664-fa29c0a222d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c85da37-dcf5-43d3-9edc-0f27f804760c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_30ecdcf8-a34c-4315-8664-fa29c0a222d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d31a528d-2088-46a4-995d-45e9b1011262" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c85da37-dcf5-43d3-9edc-0f27f804760c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_d31a528d-2088-46a4-995d-45e9b1011262" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_0511f859-0db0-4e27-9ff2-679933e761d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3c85da37-dcf5-43d3-9edc-0f27f804760c" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_0511f859-0db0-4e27-9ff2-679933e761d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests" xlink:type="simple" xlink:href="hr-20230930.xsd#CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_8b16bf77-3f3f-46c4-8665-09ae4db5ffde" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7a009f35-2df7-4c7b-9b52-165df7160f05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_8b16bf77-3f3f-46c4-8665-09ae4db5ffde" xlink:to="loc_us-gaap_StatementTable_7a009f35-2df7-4c7b-9b52-165df7160f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_5bf8be55-86f8-448c-bd65-6801bb43e8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7a009f35-2df7-4c7b-9b52-165df7160f05" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_5bf8be55-86f8-448c-bd65-6801bb43e8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_d97c93d0-1c49-492c-8403-888604d4f343" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_5bf8be55-86f8-448c-bd65-6801bb43e8e6" xlink:to="loc_us-gaap_EquityComponentDomain_d97c93d0-1c49-492c-8403-888604d4f343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_58d74d97-3d75-4297-837a-105e3ebee5be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d97c93d0-1c49-492c-8403-888604d4f343" xlink:to="loc_us-gaap_ParentMember_58d74d97-3d75-4297-837a-105e3ebee5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f74ffdbd-50ed-4149-a0a7-d9ec7bd66198" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_58d74d97-3d75-4297-837a-105e3ebee5be" xlink:to="loc_us-gaap_CommonStockMember_f74ffdbd-50ed-4149-a0a7-d9ec7bd66198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_29e66c91-cfa4-4e9c-9ba1-0dba8741fcd3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_58d74d97-3d75-4297-837a-105e3ebee5be" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_29e66c91-cfa4-4e9c-9ba1-0dba8741fcd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e7d06fe1-5837-4062-bff7-d6d6f4f3610f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_58d74d97-3d75-4297-837a-105e3ebee5be" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e7d06fe1-5837-4062-bff7-d6d6f4f3610f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeNetIncomeMember_731dd8d0-4cf3-43ad-89f1-b0f47fee9129" xlink:href="hr-20230930.xsd#hr_CumulativeNetIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_58d74d97-3d75-4297-837a-105e3ebee5be" xlink:to="loc_hr_CumulativeNetIncomeMember_731dd8d0-4cf3-43ad-89f1-b0f47fee9129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CumulativeDividendsMember_e95e2ee3-d866-4ce6-99e8-fcd5f79b0be2" xlink:href="hr-20230930.xsd#hr_CumulativeDividendsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ParentMember_58d74d97-3d75-4297-837a-105e3ebee5be" xlink:to="loc_hr_CumulativeDividendsMember_e95e2ee3-d866-4ce6-99e8-fcd5f79b0be2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_0b147a1e-4491-4409-8bde-1d2a4fc79634" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_d97c93d0-1c49-492c-8403-888604d4f343" xlink:to="loc_us-gaap_NoncontrollingInterestMember_0b147a1e-4491-4409-8bde-1d2a4fc79634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_5f4de548-c452-4dbb-94bc-07a1032aac4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7a009f35-2df7-4c7b-9b52-165df7160f05" xlink:to="loc_us-gaap_StatementLineItems_5f4de548-c452-4dbb-94bc-07a1032aac4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5f4de548-c452-4dbb-94bc-07a1032aac4a" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_73f662fa-ff3c-476a-b573-46315d998f60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_73f662fa-ff3c-476a-b573-46315d998f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_bea54fad-a452-41a5-8134-4a9a9b981170" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_bea54fad-a452-41a5-8134-4a9a9b981170" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MergerConsiderationTransferred_803adc0c-1cd8-48d2-8ed5-0cd72d4c87e9" xlink:href="hr-20230930.xsd#hr_MergerConsiderationTransferred"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_hr_MergerConsiderationTransferred_803adc0c-1cd8-48d2-8ed5-0cd72d4c87e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_2da0c6cb-6ee7-4f96-8e2e-b0183b458c60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_2da0c6cb-6ee7-4f96-8e2e-b0183b458c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_5ecb2148-a776-48c6-b383-f95fb5467499" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_5ecb2148-a776-48c6-b383-f95fb5467499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cf06672d-0eed-47ba-be0a-3142d2d726fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_cf06672d-0eed-47ba-be0a-3142d2d726fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_187de80d-e5f7-482f-969b-6e02efaaba39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_187de80d-e5f7-482f-969b-6e02efaaba39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_698a03cc-4ffb-4dca-968e-ec26a3076fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_ProfitLoss_698a03cc-4ffb-4dca-968e-ec26a3076fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_cc6acdd1-6471-4ff7-ae88-cf219d9b0aff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_cc6acdd1-6471-4ff7-ae88-cf219d9b0aff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b9205324-99e7-4524-a5a3-de64180efbf9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_b9205324-99e7-4524-a5a3-de64180efbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCommonStockCash_8f7e750d-51fa-4592-a80f-034df4446b23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DividendsCommonStockCash"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_DividendsCommonStockCash_8f7e750d-51fa-4592-a80f-034df4446b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70e94fa3-527d-4817-a9f9-916afb9270d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_662e46e1-9544-4b50-82e0-ddb398f738d6" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_70e94fa3-527d-4817-a9f9-916afb9270d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_aa0b2aa7-fe99-49a1-a8e0-7122f3432199" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_5f4de548-c452-4dbb-94bc-07a1032aac4a" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_aa0b2aa7-fe99-49a1-a8e0-7122f3432199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6d5f26b8-39de-4745-a933-e76da6b348bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_aa0b2aa7-fe99-49a1-a8e0-7122f3432199" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_6d5f26b8-39de-4745-a933-e76da6b348bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_fd02e9eb-c4b6-44f5-b67a-b557b08feae8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_aa0b2aa7-fe99-49a1-a8e0-7122f3432199" xlink:to="loc_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease_fd02e9eb-c4b6-44f5-b67a-b557b08feae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_8ebb781c-92ed-4d64-9c50-91ae9241d97a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityAccretionToRedemptionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_aa0b2aa7-fe99-49a1-a8e0-7122f3432199" xlink:to="loc_us-gaap_TemporaryEquityAccretionToRedemptionValue_8ebb781c-92ed-4d64-9c50-91ae9241d97a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_93a5ce15-d76b-4288-aa90-f59f8c2c98e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_aa0b2aa7-fe99-49a1-a8e0-7122f3432199" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_93a5ce15-d76b-4288-aa90-f59f8c2c98e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterestsParenthetical" xlink:type="simple" xlink:href="hr-20230930.xsd#CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterestsParenthetical"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterestsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_935c45f1-9c36-4d7a-96af-cea1f6f4aa9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_f140800c-6093-4269-896c-c4f987d36a38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_935c45f1-9c36-4d7a-96af-cea1f6f4aa9c" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_f140800c-6093-4269-896c-c4f987d36a38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="hr-20230930.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_a244fffb-d8a2-496b-adb1-f81a2cecc54e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_599357ec-6b04-4ad8-adcb-3569d28d3cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a244fffb-d8a2-496b-adb1-f81a2cecc54e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_599357ec-6b04-4ad8-adcb-3569d28d3cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1a6a3e35-2fd8-4c90-a7f0-77b5480c01e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_599357ec-6b04-4ad8-adcb-3569d28d3cc7" xlink:to="loc_us-gaap_ProfitLoss_1a6a3e35-2fd8-4c90-a7f0-77b5480c01e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b5dce700-0e97-4ee5-a83c-5f8746e9e767" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_599357ec-6b04-4ad8-adcb-3569d28d3cc7" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b5dce700-0e97-4ee5-a83c-5f8746e9e767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_7c68d89d-99a6-4a0d-abd0-b7e24435a156" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b5dce700-0e97-4ee5-a83c-5f8746e9e767" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_7c68d89d-99a6-4a0d-abd0-b7e24435a156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_b5ea1c3b-3e29-4fb1-9aaa-68f13bbacabd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b5dce700-0e97-4ee5-a83c-5f8746e9e767" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_b5ea1c3b-3e29-4fb1-9aaa-68f13bbacabd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_88446385-e8c6-45cd-88f9-1acfa89b667f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b5dce700-0e97-4ee5-a83c-5f8746e9e767" xlink:to="loc_us-gaap_ShareBasedCompensation_88446385-e8c6-45cd-88f9-1acfa89b667f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StraightLineRentReceivable_6fa2e870-2630-482b-be5a-871470e4f7b3" xlink:href="hr-20230930.xsd#hr_StraightLineRentReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b5dce700-0e97-4ee5-a83c-5f8746e9e767" xlink:to="loc_hr_StraightLineRentReceivable_6fa2e870-2630-482b-be5a-871470e4f7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StraightlineRentLiability_e0b02e44-76a5-4d75-aeed-2b805b36a2c4" xlink:href="hr-20230930.xsd#hr_StraightlineRentLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b5dce700-0e97-4ee5-a83c-5f8746e9e767" xlink:to="loc_hr_StraightlineRentLiability_e0b02e44-76a5-4d75-aeed-2b805b36a2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation_f446b8d3-53b5-4770-99fb-37498de23f6b" xlink:href="hr-20230930.xsd#hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b5dce700-0e97-4ee5-a83c-5f8746e9e767" xlink:to="loc_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation_f446b8d3-53b5-4770-99fb-37498de23f6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9f4ce209-9c43-4028-ab51-bebc020ff854" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b5dce700-0e97-4ee5-a83c-5f8746e9e767" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_9f4ce209-9c43-4028-ab51-bebc020ff854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_980c34ad-30d6-4170-b7db-8b8432dd0cb9" xlink:href="hr-20230930.xsd#hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b5dce700-0e97-4ee5-a83c-5f8746e9e767" xlink:to="loc_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations_980c34ad-30d6-4170-b7db-8b8432dd0cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7bc57d3f-4712-4958-9d0c-4d24cb685437" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b5dce700-0e97-4ee5-a83c-5f8746e9e767" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_7bc57d3f-4712-4958-9d0c-4d24cb685437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_64b371b5-40e3-40f3-ae6e-dd6af88ff6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentDividendsOrDistributions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b5dce700-0e97-4ee5-a83c-5f8746e9e767" xlink:to="loc_us-gaap_EquityMethodInvestmentDividendsOrDistributions_64b371b5-40e3-40f3-ae6e-dd6af88ff6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestIncomeFinancingReceivableNoncash_ced1a338-34c4-4efd-a791-41a213683388" xlink:href="hr-20230930.xsd#hr_InterestIncomeFinancingReceivableNoncash"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b5dce700-0e97-4ee5-a83c-5f8746e9e767" xlink:to="loc_hr_InterestIncomeFinancingReceivableNoncash_ced1a338-34c4-4efd-a791-41a213683388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bdf4d8fd-a25b-4516-9748-fd138940a344" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_b5dce700-0e97-4ee5-a83c-5f8746e9e767" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bdf4d8fd-a25b-4516-9748-fd138940a344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_f576b141-b0a1-4966-850c-ec00cf561109" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bdf4d8fd-a25b-4516-9748-fd138940a344" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssets_f576b141-b0a1-4966-850c-ec00cf561109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ace824c4-6d70-474b-b3fd-6698c8c771b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bdf4d8fd-a25b-4516-9748-fd138940a344" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_ace824c4-6d70-474b-b3fd-6698c8c771b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_648c3517-f5a7-4bd6-8bf3-3fed22c1280e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_bdf4d8fd-a25b-4516-9748-fd138940a344" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_648c3517-f5a7-4bd6-8bf3-3fed22c1280e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d93a3b45-62b8-41c5-853a-ddbd56156974" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_599357ec-6b04-4ad8-adcb-3569d28d3cc7" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_d93a3b45-62b8-41c5-853a-ddbd56156974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7224798f-d3c2-4da2-bf63-dd95be2c08bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a244fffb-d8a2-496b-adb1-f81a2cecc54e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7224798f-d3c2-4da2-bf63-dd95be2c08bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireRealEstate_78523a48-08e0-4578-a002-552130a232de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7224798f-d3c2-4da2-bf63-dd95be2c08bf" xlink:to="loc_us-gaap_PaymentsToAcquireRealEstate_78523a48-08e0-4578-a002-552130a232de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopRealEstateAssets_553eb5f4-90dc-4eda-8a1e-23f1a721843d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToDevelopRealEstateAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7224798f-d3c2-4da2-bf63-dd95be2c08bf" xlink:to="loc_us-gaap_PaymentsToDevelopRealEstateAssets_553eb5f4-90dc-4eda-8a1e-23f1a721843d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_d4eb98f6-9419-405a-bb22-a0581ca4aade" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireOtherProductiveAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7224798f-d3c2-4da2-bf63-dd95be2c08bf" xlink:to="loc_us-gaap_PaymentsToAcquireOtherProductiveAssets_d4eb98f6-9419-405a-bb22-a0581ca4aade" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireNotesReceivable_e7286f33-6210-40e1-8a68-4b44f3832a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireNotesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7224798f-d3c2-4da2-bf63-dd95be2c08bf" xlink:to="loc_us-gaap_PaymentsToAcquireNotesReceivable_e7286f33-6210-40e1-8a68-4b44f3832a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_8d9e0467-a10d-418e-a46c-099960a451de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7224798f-d3c2-4da2-bf63-dd95be2c08bf" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_8d9e0467-a10d-418e-a46c-099960a451de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireFinanceReceivables_eeaa0d61-418f-4393-af1f-61d61506abc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireFinanceReceivables"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7224798f-d3c2-4da2-bf63-dd95be2c08bf" xlink:to="loc_us-gaap_PaymentsToAcquireFinanceReceivables_eeaa0d61-418f-4393-af1f-61d61506abc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_44b09690-91f9-450a-a9e0-ff4f408b6f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromCollectionOfFinanceReceivables"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7224798f-d3c2-4da2-bf63-dd95be2c08bf" xlink:to="loc_us-gaap_ProceedsFromCollectionOfFinanceReceivables_44b09690-91f9-450a-a9e0-ff4f408b6f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests_16d66fc5-6820-4f40-b842-446ad5703070" xlink:href="hr-20230930.xsd#hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7224798f-d3c2-4da2-bf63-dd95be2c08bf" xlink:to="loc_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests_16d66fc5-6820-4f40-b842-446ad5703070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_f2010b93-3cb1-47d2-a804-c4cbd2c85498" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7224798f-d3c2-4da2-bf63-dd95be2c08bf" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_f2010b93-3cb1-47d2-a804-c4cbd2c85498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_298ba410-b087-4559-ab3d-e1addccd8e3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7224798f-d3c2-4da2-bf63-dd95be2c08bf" xlink:to="loc_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable_298ba410-b087-4559-ab3d-e1addccd8e3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CashAcquiredInMerger_4115e339-9dba-4d75-b085-dad4db0abb4b" xlink:href="hr-20230930.xsd#hr_CashAcquiredInMerger"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7224798f-d3c2-4da2-bf63-dd95be2c08bf" xlink:to="loc_hr_CashAcquiredInMerger_4115e339-9dba-4d75-b085-dad4db0abb4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_319c2c8b-a8b0-4442-be9a-10a607b4ea37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_7224798f-d3c2-4da2-bf63-dd95be2c08bf" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_319c2c8b-a8b0-4442-be9a-10a607b4ea37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c5e309f7-01a7-425d-9f45-9726bf32d99d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a244fffb-d8a2-496b-adb1-f81a2cecc54e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c5e309f7-01a7-425d-9f45-9726bf32d99d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_d4e34427-4d5a-4cdf-81ed-bc029987ffb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromRepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c5e309f7-01a7-425d-9f45-9726bf32d99d" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit_d4e34427-4d5a-4cdf-81ed-bc029987ffb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_c6ed4101-ecac-4986-8b59-e7b5ffd4b2cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfMediumTermNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c5e309f7-01a7-425d-9f45-9726bf32d99d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfMediumTermNotes_c6ed4101-ecac-4986-8b59-e7b5ffd4b2cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfMediumTermNotes_d65f56f4-22e1-4c21-8fd3-d0030a144d86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfMediumTermNotes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c5e309f7-01a7-425d-9f45-9726bf32d99d" xlink:to="loc_us-gaap_RepaymentsOfMediumTermNotes_d65f56f4-22e1-4c21-8fd3-d0030a144d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_118bb269-dfaf-47b9-be7c-73552816ab56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c5e309f7-01a7-425d-9f45-9726bf32d99d" xlink:to="loc_us-gaap_RepaymentsOfDebt_118bb269-dfaf-47b9-be7c-73552816ab56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarlyRepaymentOfSeniorDebt_f23e7e4f-8eac-4625-b0b6-799dbe9845f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarlyRepaymentOfSeniorDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c5e309f7-01a7-425d-9f45-9726bf32d99d" xlink:to="loc_us-gaap_EarlyRepaymentOfSeniorDebt_f23e7e4f-8eac-4625-b0b6-799dbe9845f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividendsCommonStock_42963653-8b97-47f9-809c-179427ac986c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c5e309f7-01a7-425d-9f45-9726bf32d99d" xlink:to="loc_us-gaap_PaymentsOfDividendsCommonStock_42963653-8b97-47f9-809c-179427ac986c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PaymentOfSpecialDividendMergerRelated_78b29f3a-e375-4711-b2b7-1b528c0abd36" xlink:href="hr-20230930.xsd#hr_PaymentOfSpecialDividendMergerRelated"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c5e309f7-01a7-425d-9f45-9726bf32d99d" xlink:to="loc_hr_PaymentOfSpecialDividendMergerRelated_78b29f3a-e375-4711-b2b7-1b528c0abd36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_54f074f8-7b6a-49a5-8854-d060eb2a6a06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c5e309f7-01a7-425d-9f45-9726bf32d99d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_54f074f8-7b6a-49a5-8854-d060eb2a6a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_dbd1d478-8b4c-41cc-91e2-8b874fa5173f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c5e309f7-01a7-425d-9f45-9726bf32d99d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_dbd1d478-8b4c-41cc-91e2-8b874fa5173f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_424708ab-13d0-4c9a-bc6a-af48203a693c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c5e309f7-01a7-425d-9f45-9726bf32d99d" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_424708ab-13d0-4c9a-bc6a-af48203a693c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_e4e30c44-db28-429a-a04f-8449f9d0d149" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c5e309f7-01a7-425d-9f45-9726bf32d99d" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_e4e30c44-db28-429a-a04f-8449f9d0d149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_c05d0563-41ff-4daf-a0cf-6d3b745c30a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c5e309f7-01a7-425d-9f45-9726bf32d99d" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_c05d0563-41ff-4daf-a0cf-6d3b745c30a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1df019f7-b6c3-4098-8eed-4fdd070ecd3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_c5e309f7-01a7-425d-9f45-9726bf32d99d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_1df019f7-b6c3-4098-8eed-4fdd070ecd3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6b55293e-d22c-44eb-a4a3-31cac631d37d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a244fffb-d8a2-496b-adb1-f81a2cecc54e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_6b55293e-d22c-44eb-a4a3-31cac631d37d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0ac7e8f2-2a6b-4765-9a9a-e4ddee115d62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a244fffb-d8a2-496b-adb1-f81a2cecc54e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0ac7e8f2-2a6b-4765-9a9a-e4ddee115d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_45ec73da-78bf-4eaa-a6f8-493bff3c896e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a244fffb-d8a2-496b-adb1-f81a2cecc54e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_45ec73da-78bf-4eaa-a6f8-493bff3c896e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_f0ce41cd-6613-4f2f-9db8-fae74ab47c74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_a244fffb-d8a2-496b-adb1-f81a2cecc54e" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_f0ce41cd-6613-4f2f-9db8-fae74ab47c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_b0f43c31-2544-4c12-8467-d7455a327bf5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f0ce41cd-6613-4f2f-9db8-fae74ab47c74" xlink:to="loc_us-gaap_InterestPaidNet_b0f43c31-2544-4c12-8467-d7455a327bf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoanRelatedToPropertySales1_f92987b5-df59-4e19-ac47-d847ef4ce654" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgageLoanRelatedToPropertySales1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f0ce41cd-6613-4f2f-9db8-fae74ab47c74" xlink:to="loc_us-gaap_MortgageLoanRelatedToPropertySales1_f92987b5-df59-4e19-ac47-d847ef4ce654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_64db1410-7bf3-4e00-9795-828f0709a7c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f0ce41cd-6613-4f2f-9db8-fae74ab47c74" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_64db1410-7bf3-4e00-9795-828f0709a7c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferMortgagePayable_eaa2856e-2f6f-42d7-820d-804d7386ddff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TransferMortgagePayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f0ce41cd-6613-4f2f-9db8-fae74ab47c74" xlink:to="loc_us-gaap_TransferMortgagePayable_eaa2856e-2f6f-42d7-820d-804d7386ddff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidCapitalized_74914a28-904c-45e9-b025-d7d9a108140d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidCapitalized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f0ce41cd-6613-4f2f-9db8-fae74ab47c74" xlink:to="loc_us-gaap_InterestPaidCapitalized_74914a28-904c-45e9-b025-d7d9a108140d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="hr-20230930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_60d28f2e-ae82-41c7-96f9-ffc7eb23c5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_7bba959f-9c4f-4eb9-a2fe-a31f589dc66c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_60d28f2e-ae82-41c7-96f9-ffc7eb23c5d8" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_7bba959f-9c4f-4eb9-a2fe-a31f589dc66c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/MergerwithHTA" xlink:type="simple" xlink:href="hr-20230930.xsd#MergerwithHTA"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/MergerwithHTA" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f9e2907a-db01-42ce-8764-f6953b73f5fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_2d44bfe2-bd64-4b71-8230-c12da85b8f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f9e2907a-db01-42ce-8764-f6953b73f5fb" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_2d44bfe2-bd64-4b71-8230-c12da85b8f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestments" xlink:type="simple" xlink:href="hr-20230930.xsd#RealEstateInvestments"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_8afd5422-32f5-4de9-a9b4-f9f2f85fc43c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AcquisitionsAndDispositionsTextBlock_fd93df87-7062-4b09-99c9-d3d53e8e0837" xlink:href="hr-20230930.xsd#hr_AcquisitionsAndDispositionsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_8afd5422-32f5-4de9-a9b4-f9f2f85fc43c" xlink:to="loc_hr_AcquisitionsAndDispositionsTextBlock_fd93df87-7062-4b09-99c9-d3d53e8e0837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/Leases" xlink:type="simple" xlink:href="hr-20230930.xsd#Leases"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6ef13a57-fdb2-4500-955f-f6c882fe3b02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_e068981d-5987-4bff-8cb0-5a06d59b84a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6ef13a57-fdb2-4500-955f-f6c882fe3b02" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_e068981d-5987-4bff-8cb0-5a06d59b84a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_1d48aaa1-5201-4c3b-b50b-75a174cd50ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6ef13a57-fdb2-4500-955f-f6c882fe3b02" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_1d48aaa1-5201-4c3b-b50b-75a174cd50ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/NotesandBondsPayable" xlink:type="simple" xlink:href="hr-20230930.xsd#NotesandBondsPayable"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/NotesandBondsPayable" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d62a0e5b-f8c0-48af-b7bc-ea93483c5555" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_401cd8a3-fcbb-4760-acc3-3cc07c8583c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d62a0e5b-f8c0-48af-b7bc-ea93483c5555" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_401cd8a3-fcbb-4760-acc3-3cc07c8583c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstruments" xlink:type="simple" xlink:href="hr-20230930.xsd#DerivativeFinancialInstruments"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_dcdf5726-c543-4b62-bdb1-9a36860a20b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9d77ce58-04be-47aa-98f2-ba81e153aad5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_dcdf5726-c543-4b62-bdb1-9a36860a20b2" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_9d77ce58-04be-47aa-98f2-ba81e153aad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="hr-20230930.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7a78a6cc-8f6b-4985-8e6f-35ea452dc299" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0d940920-8a37-4b2d-86bf-72f2d9c0086e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_7a78a6cc-8f6b-4985-8e6f-35ea452dc299" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_0d940920-8a37-4b2d-86bf-72f2d9c0086e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquity" xlink:type="simple" xlink:href="hr-20230930.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3e8ea753-5b4c-453a-b2e4-d7ab44ceb4e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0ca68b16-bf93-43ce-81e8-d8f1bb9eff50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3e8ea753-5b4c-453a-b2e4-d7ab44ceb4e7" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_0ca68b16-bf93-43ce-81e8-d8f1bb9eff50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstruments" xlink:type="simple" xlink:href="hr-20230930.xsd#FairValueofFinancialInstruments"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/FairValueofFinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_dcd544bc-a2db-4764-912a-5ccd762c7c58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_d4cf5a5b-7fdc-436a-818a-7e96c77a9875" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_dcd544bc-a2db-4764-912a-5ccd762c7c58" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_d4cf5a5b-7fdc-436a-818a-7e96c77a9875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="hr-20230930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d8a5ea3b-f62f-4780-b3bc-e011a4e327e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NatureOfOperationsPolicyTextBlock_3cc1d9a4-3492-44c3-81cc-ff064e0884da" xlink:href="hr-20230930.xsd#hr_NatureOfOperationsPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d8a5ea3b-f62f-4780-b3bc-e011a4e327e4" xlink:to="loc_hr_NatureOfOperationsPolicyTextBlock_3cc1d9a4-3492-44c3-81cc-ff064e0884da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3a290abd-bc94-4a8c-9ed5-6f2b302c90fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d8a5ea3b-f62f-4780-b3bc-e011a4e327e4" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_3a290abd-bc94-4a8c-9ed5-6f2b302c90fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_4b8adadb-24c7-4234-a3eb-cc09a49a7072" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d8a5ea3b-f62f-4780-b3bc-e011a4e327e4" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_4b8adadb-24c7-4234-a3eb-cc09a49a7072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_b2d626c5-67f3-4b07-b677-378c6f766ac1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationVariableInterestEntityPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d8a5ea3b-f62f-4780-b3bc-e011a4e327e4" xlink:to="loc_us-gaap_ConsolidationVariableInterestEntityPolicy_b2d626c5-67f3-4b07-b677-378c6f766ac1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_5e7a7d98-bfdd-4754-b11c-63e4ba3c9738" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d8a5ea3b-f62f-4780-b3bc-e011a4e327e4" xlink:to="loc_us-gaap_UseOfEstimates_5e7a7d98-bfdd-4754-b11c-63e4ba3c9738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_9ac614be-e036-49c5-a92f-37cc0cfedb1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d8a5ea3b-f62f-4780-b3bc-e011a4e327e4" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_9ac614be-e036-49c5-a92f-37cc0cfedb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_6002c56c-612e-4e53-a390-3abfc2f58686" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d8a5ea3b-f62f-4780-b3bc-e011a4e327e4" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_6002c56c-612e-4e53-a390-3abfc2f58686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_a6a7f539-d8dd-4c08-ad55-12680992116b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d8a5ea3b-f62f-4780-b3bc-e011a4e327e4" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_a6a7f539-d8dd-4c08-ad55-12680992116b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorLeasesPolicyTextBlock_85f73696-c7fb-47eb-ba41-33bdcff5eddf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorLeasesPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d8a5ea3b-f62f-4780-b3bc-e011a4e327e4" xlink:to="loc_us-gaap_LessorLeasesPolicyTextBlock_85f73696-c7fb-47eb-ba41-33bdcff5eddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_02b02636-7157-445e-8b05-149f64d280a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d8a5ea3b-f62f-4780-b3bc-e011a4e327e4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_02b02636-7157-445e-8b05-149f64d280a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="hr-20230930.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_0d5f20b6-7a28-45f6-8291-e1d16249cd79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_dfab404a-40fb-4302-a695-aa5d366b73d0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfCondensedBalanceSheetTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0d5f20b6-7a28-45f6-8291-e1d16249cd79" xlink:to="loc_srt_ScheduleOfCondensedBalanceSheetTableTextBlock_dfab404a-40fb-4302-a695-aa5d366b73d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_3d2850b9-7b99-48ef-902d-6ec10093cb48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0d5f20b6-7a28-45f6-8291-e1d16249cd79" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_3d2850b9-7b99-48ef-902d-6ec10093cb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_fe7cef11-edf7-4af6-80cf-ca67ce8a8223" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0d5f20b6-7a28-45f6-8291-e1d16249cd79" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_fe7cef11-edf7-4af6-80cf-ca67ce8a8223" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_b98733e6-8fba-4252-8eff-79f3d48821a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0d5f20b6-7a28-45f6-8291-e1d16249cd79" xlink:to="loc_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock_b98733e6-8fba-4252-8eff-79f3d48821a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_09523222-f139-4f83-99ea-158eb8a0758c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_0d5f20b6-7a28-45f6-8291-e1d16249cd79" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_09523222-f139-4f83-99ea-158eb8a0758c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/MergerwithHTATables" xlink:type="simple" xlink:href="hr-20230930.xsd#MergerwithHTATables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/MergerwithHTATables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c221f127-4174-4409-aa31-bb4f2e8db08b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_75acebd2-53a2-47b1-816f-24aa8220ad42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c221f127-4174-4409-aa31-bb4f2e8db08b" xlink:to="loc_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock_75acebd2-53a2-47b1-816f-24aa8220ad42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_3ccf82d7-c9da-4dec-9226-e249eb3b8594" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_c221f127-4174-4409-aa31-bb4f2e8db08b" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_3ccf82d7-c9da-4dec-9226-e249eb3b8594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsTables" xlink:type="simple" xlink:href="hr-20230930.xsd#RealEstateInvestmentsTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cc13bf42-eafc-4619-96fe-1ae8269d8e31" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_1d705d1a-e222-4958-9294-b683f3e9e6bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cc13bf42-eafc-4619-96fe-1ae8269d8e31" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_1d705d1a-e222-4958-9294-b683f3e9e6bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_a1cc3521-6ff3-4b6f-9dd3-29dc3d20ce2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cc13bf42-eafc-4619-96fe-1ae8269d8e31" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_a1cc3521-6ff3-4b6f-9dd3-29dc3d20ce2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetDispositionsTableTextBlock_42db976f-708d-457e-bd46-b8cc9375b031" xlink:href="hr-20230930.xsd#hr_AssetDispositionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cc13bf42-eafc-4619-96fe-1ae8269d8e31" xlink:to="loc_hr_AssetDispositionsTableTextBlock_42db976f-708d-457e-bd46-b8cc9375b031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock_8ec5f347-6fe0-4574-ace6-483cf3e1e96e" xlink:href="hr-20230930.xsd#hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cc13bf42-eafc-4619-96fe-1ae8269d8e31" xlink:to="loc_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock_8ec5f347-6fe0-4574-ace6-483cf3e1e96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesTables" xlink:type="simple" xlink:href="hr-20230930.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a9990cc5-2908-4924-a333-2e822cae30f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_1d7e92e2-d85d-48cc-b7d6-c90b925ec3f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a9990cc5-2908-4924-a333-2e822cae30f7" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock_1d7e92e2-d85d-48cc-b7d6-c90b925ec3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a0e6d44c-ac70-4c17-b7d6-1f71de3aeb92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a9990cc5-2908-4924-a333-2e822cae30f7" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a0e6d44c-ac70-4c17-b7d6-1f71de3aeb92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_f2c35d4e-753e-438d-a844-6ece6786c2f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a9990cc5-2908-4924-a333-2e822cae30f7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_f2c35d4e-753e-438d-a844-6ece6786c2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_6f5c289e-1e7f-4e59-9fe5-6f863da8b88d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a9990cc5-2908-4924-a333-2e822cae30f7" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_6f5c289e-1e7f-4e59-9fe5-6f863da8b88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/NotesandBondsPayableTables" xlink:type="simple" xlink:href="hr-20230930.xsd#NotesandBondsPayableTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/NotesandBondsPayableTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_414c641e-e83d-4775-bacf-4939e943654f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_115b65a2-0ff2-4b03-bf07-aece4ede98c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_414c641e-e83d-4775-bacf-4939e943654f" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_115b65a2-0ff2-4b03-bf07-aece4ede98c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables" xlink:type="simple" xlink:href="hr-20230930.xsd#DerivativeFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e6627965-24fa-45fa-9176-5c1628fc848d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_d6f59eb5-8441-43b3-8fad-9ea16b2c0ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e6627965-24fa-45fa-9176-5c1628fc848d" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_d6f59eb5-8441-43b3-8fad-9ea16b2c0ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_c7d21c9f-7634-4009-b987-6ba8618addbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e6627965-24fa-45fa-9176-5c1628fc848d" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock_c7d21c9f-7634-4009-b987-6ba8618addbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="hr-20230930.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_2321adae-f7fd-4fd1-97f4-5badc974f3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_cd35db54-4ab7-487f-a6fa-8c43343b3470" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2321adae-f7fd-4fd1-97f4-5badc974f3e3" xlink:to="loc_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock_cd35db54-4ab7-487f-a6fa-8c43343b3470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a2e7f350-1d9d-4bf6-8ad3-a79731fbbaca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2321adae-f7fd-4fd1-97f4-5badc974f3e3" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a2e7f350-1d9d-4bf6-8ad3-a79731fbbaca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_cc3e17de-32ac-4515-8b4f-e78628eb437c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2321adae-f7fd-4fd1-97f4-5badc974f3e3" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_cc3e17de-32ac-4515-8b4f-e78628eb437c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_87e68b5b-49f6-42f8-91eb-a19b614474ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2321adae-f7fd-4fd1-97f4-5badc974f3e3" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_87e68b5b-49f6-42f8-91eb-a19b614474ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_ea3840b9-2fe6-4171-a6d2-984625da6ec9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2321adae-f7fd-4fd1-97f4-5badc974f3e3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock_ea3840b9-2fe6-4171-a6d2-984625da6ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_077880a4-59f4-4d1a-b048-2f9c247203df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_2321adae-f7fd-4fd1-97f4-5badc974f3e3" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock_077880a4-59f4-4d1a-b048-2f9c247203df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables" xlink:type="simple" xlink:href="hr-20230930.xsd#FairValueofFinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6db258b8-48bf-4834-941a-69877448d760" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_5d552934-374d-405a-a329-65d6f6850ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByBalanceSheetGroupingTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6db258b8-48bf-4834-941a-69877448d760" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTextBlock_5d552934-374d-405a-a329-65d6f6850ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#SummaryofSignificantAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d33bf05f-d0a5-425c-87a9-09c698ef3eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_26294caa-9b7f-4ae9-b444-c9af26df90ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfRealEstatePropertiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d33bf05f-d0a5-425c-87a9-09c698ef3eb0" xlink:to="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_26294caa-9b7f-4ae9-b444-c9af26df90ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_da37fd9d-8d44-4fd3-8405-f947cdadebc1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_26294caa-9b7f-4ae9-b444-c9af26df90ff" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_da37fd9d-8d44-4fd3-8405-f947cdadebc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_fbf4ce4b-bf73-47ca-9d30-b56450f082b9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_da37fd9d-8d44-4fd3-8405-f947cdadebc1" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_fbf4ce4b-bf73-47ca-9d30-b56450f082b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstatePropertiesHeldInJointVenturesMember_bfba883e-9e8e-40c0-be12-0239c07d5ab0" xlink:href="hr-20230930.xsd#hr_RealEstatePropertiesHeldInJointVenturesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_fbf4ce4b-bf73-47ca-9d30-b56450f082b9" xlink:to="loc_hr_RealEstatePropertiesHeldInJointVenturesMember_bfba883e-9e8e-40c0-be12-0239c07d5ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_a6ec16c0-d9d1-408f-8063-33ab0ea83366" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_26294caa-9b7f-4ae9-b444-c9af26df90ff" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_a6ec16c0-d9d1-408f-8063-33ab0ea83366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c7072b9-605c-4740-8ef0-41385f138f03" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_a6ec16c0-d9d1-408f-8063-33ab0ea83366" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c7072b9-605c-4740-8ef0-41385f138f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_b1ea158a-59f6-4eba-8835-137cc8df3ac6" xlink:href="hr-20230930.xsd#hr_PropertyEntitiesNotDeterminedToBeVIEsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c7072b9-605c-4740-8ef0-41385f138f03" xlink:to="loc_hr_PropertyEntitiesNotDeterminedToBeVIEsMember_b1ea158a-59f6-4eba-8835-137cc8df3ac6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_8b06d62a-59ef-464f-a6c0-bcc5495b3258" xlink:href="hr-20230930.xsd#hr_HealthcareTrustofAmericaHoldingsLPMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2c7072b9-605c-4740-8ef0-41385f138f03" xlink:to="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_8b06d62a-59ef-464f-a6c0-bcc5495b3258" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_0e3498dc-0d46-42d7-8aec-4b326b1b2efe" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_26294caa-9b7f-4ae9-b444-c9af26df90ff" xlink:to="loc_srt_OwnershipAxis_0e3498dc-0d46-42d7-8aec-4b326b1b2efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_7cc91184-c53b-450e-9e5d-582c609bf8a6" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_0e3498dc-0d46-42d7-8aec-4b326b1b2efe" xlink:to="loc_srt_OwnershipDomain_7cc91184-c53b-450e-9e5d-582c609bf8a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonControllingInterestHoldersMember_9f0ec48c-8953-4f97-b0b7-21d814cdeed5" xlink:href="hr-20230930.xsd#hr_NonControllingInterestHoldersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_7cc91184-c53b-450e-9e5d-582c609bf8a6" xlink:to="loc_hr_NonControllingInterestHoldersMember_9f0ec48c-8953-4f97-b0b7-21d814cdeed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c4fb46fa-70bc-4ece-99a8-abdd2ee8b10e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_26294caa-9b7f-4ae9-b444-c9af26df90ff" xlink:to="loc_dei_LegalEntityAxis_c4fb46fa-70bc-4ece-99a8-abdd2ee8b10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_b32949aa-a680-486d-9745-a3f2a902b833" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_c4fb46fa-70bc-4ece-99a8-abdd2ee8b10e" xlink:to="loc_dei_EntityDomain_b32949aa-a680-486d-9745-a3f2a902b833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_9344df70-add3-4cf0-b0c3-28b318ef1d6b" xlink:href="hr-20230930.xsd#hr_HealthcareTrustofAmericaHoldingsLPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_b32949aa-a680-486d-9745-a3f2a902b833" xlink:to="loc_hr_HealthcareTrustofAmericaHoldingsLPMember_9344df70-add3-4cf0-b0c3-28b318ef1d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_48a04202-065f-4996-93f3-4bae205d9015" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_26294caa-9b7f-4ae9-b444-c9af26df90ff" xlink:to="loc_srt_ConsolidatedEntitiesAxis_48a04202-065f-4996-93f3-4bae205d9015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_59a16bfa-0632-4ab7-ada2-41cb96276ff4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_48a04202-065f-4996-93f3-4bae205d9015" xlink:to="loc_srt_ConsolidatedEntitiesDomain_59a16bfa-0632-4ab7-ada2-41cb96276ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_VariableInterestEntityMember_610b7a46-3360-41e4-8f9b-1052382d29ef" xlink:href="hr-20230930.xsd#hr_VariableInterestEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_59a16bfa-0632-4ab7-ada2-41cb96276ff4" xlink:to="loc_hr_VariableInterestEntityMember_610b7a46-3360-41e4-8f9b-1052382d29ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_b1f97320-62ce-485d-bc80-0e506b0b0deb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_26294caa-9b7f-4ae9-b444-c9af26df90ff" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_b1f97320-62ce-485d-bc80-0e506b0b0deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_100452d5-ab77-4e19-95a4-29c7038ee57d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b1f97320-62ce-485d-bc80-0e506b0b0deb" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_100452d5-ab77-4e19-95a4-29c7038ee57d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableMember_29f25f1c-8437-40ab-b18f-1ed2e50e71da" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_100452d5-ab77-4e19-95a4-29c7038ee57d" xlink:to="loc_us-gaap_NotesReceivableMember_29f25f1c-8437-40ab-b18f-1ed2e50e71da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstatePropertiesLineItems_de923268-daf0-4a87-86cd-68ad3635838d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstatePropertiesLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRealEstatePropertiesTable_26294caa-9b7f-4ae9-b444-c9af26df90ff" xlink:to="loc_us-gaap_RealEstatePropertiesLineItems_de923268-daf0-4a87-86cd-68ad3635838d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:href="hr-20230930.xsd#hr_BusinessOverviewAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_de923268-daf0-4a87-86cd-68ad3635838d" xlink:to="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_616490ec-70d5-4c26-be63-3868ffe13563" xlink:href="hr-20230930.xsd#hr_InvestmentInRealEstatePropertiesAndMortgageNotes"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:to="loc_hr_InvestmentInRealEstatePropertiesAndMortgageNotes_616490ec-70d5-4c26-be63-3868ffe13563" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRealEstateInvestments_5fe9a722-cdff-48b8-b1e2-7387ad30abe2" xlink:href="hr-20230930.xsd#hr_NumberOfRealEstateInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:to="loc_hr_NumberOfRealEstateInvestments_5fe9a722-cdff-48b8-b1e2-7387ad30abe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_24660275-4b6c-4e42-a9a0-915797924206" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_24660275-4b6c-4e42-a9a0-915797924206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_373b650b-e2f8-4901-b259-36ab64da78d2" xlink:href="hr-20230930.xsd#hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:to="loc_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates_373b650b-e2f8-4901-b259-36ab64da78d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ApproximateSquareFeetInvestedInByCompany_b32a1bc1-aef5-4588-9322-b8cc06d7d393" xlink:href="hr-20230930.xsd#hr_ApproximateSquareFeetInvestedInByCompany"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:to="loc_hr_ApproximateSquareFeetInvestedInByCompany_b32a1bc1-aef5-4588-9322-b8cc06d7d393" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ApproximateSquareFeetProvidedByCompany_ab52a398-3d4a-40fa-96b7-877fa2239e9c" xlink:href="hr-20230930.xsd#hr_ApproximateSquareFeetProvidedByCompany"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:to="loc_hr_ApproximateSquareFeetProvidedByCompany_ab52a398-3d4a-40fa-96b7-877fa2239e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_fac4df48-e541-40af-acf5-8885a83dd16e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_fac4df48-e541-40af-acf5-8885a83dd16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfBuildingsOwnedByJointVenture_570d7f31-285c-45bc-aeb2-441cb1475872" xlink:href="hr-20230930.xsd#hr_NumberOfBuildingsOwnedByJointVenture"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessOverviewAbstract_73c2e197-f377-4376-8b91-2ff508ab7b73" xlink:to="loc_hr_NumberOfBuildingsOwnedByJointVenture_570d7f31-285c-45bc-aeb2-441cb1475872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8edb56-448a-4410-af02-aae18b03eb29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_de923268-daf0-4a87-86cd-68ad3635838d" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8edb56-448a-4410-af02-aae18b03eb29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_d69d2a13-8722-4127-aeb0-7465bd47acaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8edb56-448a-4410-af02-aae18b03eb29" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_d69d2a13-8722-4127-aeb0-7465bd47acaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityOwnershipForConsolidationPercent_7af1710f-fa79-4e32-8a9a-57d2a8f4ea0f" xlink:href="hr-20230930.xsd#hr_EquityOwnershipForConsolidationPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8edb56-448a-4410-af02-aae18b03eb29" xlink:to="loc_hr_EquityOwnershipForConsolidationPercent_7af1710f-fa79-4e32-8a9a-57d2a8f4ea0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_90a10aa8-5441-4fab-85df-2927b3ac4b53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8edb56-448a-4410-af02-aae18b03eb29" xlink:to="loc_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding_90a10aa8-5441-4fab-85df-2927b3ac4b53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_c0728b33-4e12-4248-a91b-3d266104bb23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8edb56-448a-4410-af02-aae18b03eb29" xlink:to="loc_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest_c0728b33-4e12-4248-a91b-3d266104bb23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfVariableInterestEntities_b4b3eb2e-7d05-431c-a27a-4601e5e682e1" xlink:href="hr-20230930.xsd#hr_NumberOfVariableInterestEntities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8edb56-448a-4410-af02-aae18b03eb29" xlink:to="loc_hr_NumberOfVariableInterestEntities_b4b3eb2e-7d05-431c-a27a-4601e5e682e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfNotesReceivable_5522f417-e9db-4aab-acb3-8a3b25bec889" xlink:href="hr-20230930.xsd#hr_NumberOfNotesReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8edb56-448a-4410-af02-aae18b03eb29" xlink:to="loc_hr_NumberOfNotesReceivable_5522f417-e9db-4aab-acb3-8a3b25bec889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfJointVentures_252c5eb4-e52a-4593-b0b1-18ab52d689d5" xlink:href="hr-20230930.xsd#hr_NumberOfJointVentures"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_cc8edb56-448a-4410-af02-aae18b03eb29" xlink:to="loc_hr_NumberOfJointVentures_252c5eb4-e52a-4593-b0b1-18ab52d689d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_4704bc08-035a-43a3-96a5-ddb4076ea6eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_de923268-daf0-4a87-86cd-68ad3635838d" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_4704bc08-035a-43a3-96a5-ddb4076ea6eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_732c2fb5-9b84-4b3f-a63c-eac4a0f020e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract_4704bc08-035a-43a3-96a5-ddb4076ea6eb" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_732c2fb5-9b84-4b3f-a63c-eac4a0f020e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentChargesAbstract_de894449-a310-4b02-be86-4cffeff05903" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetImpairmentChargesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_de923268-daf0-4a87-86cd-68ad3635838d" xlink:to="loc_us-gaap_AssetImpairmentChargesAbstract_de894449-a310-4b02-be86-4cffeff05903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfRealEstate_a9b7dc0a-508a-43fb-9d98-cca6b68f2cbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOfRealEstate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetImpairmentChargesAbstract_de894449-a310-4b02-be86-4cffeff05903" xlink:to="loc_us-gaap_ImpairmentOfRealEstate_a9b7dc0a-508a-43fb-9d98-cca6b68f2cbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateAbstract_e86ae8f8-0b45-4247-9b74-4f0f1e52a5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_de923268-daf0-4a87-86cd-68ad3635838d" xlink:to="loc_us-gaap_RealEstateAbstract_e86ae8f8-0b45-4247-9b74-4f0f1e52a5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateNotesReceivableNet_a940853a-686e-444d-b83f-a8d7e1fa11ee" xlink:href="hr-20230930.xsd#hr_RealEstateNotesReceivableNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateAbstract_e86ae8f8-0b45-4247-9b74-4f0f1e52a5e2" xlink:to="loc_hr_RealEstateNotesReceivableNet_a940853a-686e-444d-b83f-a8d7e1fa11ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f960bd28-2748-4cab-bbee-829d3e22e8cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstatePropertiesLineItems_de923268-daf0-4a87-86cd-68ad3635838d" xlink:to="loc_us-gaap_LeasesAbstract_f960bd28-2748-4cab-bbee-829d3e22e8cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_9ba3c86e-a294-4dfa-9b1c-0ddcb7e4d97d" xlink:href="hr-20230930.xsd#hr_FinancingReceivableAllowanceForCreditLossReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f960bd28-2748-4cab-bbee-829d3e22e8cd" xlink:to="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_9ba3c86e-a294-4dfa-9b1c-0ddcb7e4d97d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRecognizedLeaseFinancialReceivables_6ab68298-9fde-402e-affa-1d80f8671cca" xlink:href="hr-20230930.xsd#hr_NumberOfRecognizedLeaseFinancialReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f960bd28-2748-4cab-bbee-829d3e22e8cd" xlink:to="loc_hr_NumberOfRecognizedLeaseFinancialReceivables_6ab68298-9fde-402e-affa-1d80f8671cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable_c12dc974-ed41-4284-b861-8db007c76390" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f960bd28-2748-4cab-bbee-829d3e22e8cd" xlink:to="loc_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable_c12dc974-ed41-4284-b861-8db007c76390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeOperating_7fc8d938-3144-4b3b-9ce6-35361238a9d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeOperating"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f960bd28-2748-4cab-bbee-829d3e22e8cd" xlink:to="loc_us-gaap_InterestIncomeOperating_7fc8d938-3144-4b3b-9ce6-35361238a9d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfRealEstateNotesReceivable_aa1f0eb5-da94-416d-8eba-d90a78e82916" xlink:href="hr-20230930.xsd#hr_NumberOfRealEstateNotesReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f960bd28-2748-4cab-bbee-829d3e22e8cd" xlink:to="loc_hr_NumberOfRealEstateNotesReceivable_aa1f0eb5-da94-416d-8eba-d90a78e82916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual_b4c1efe2-f9f7-43ea-aace-8576779c23fb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f960bd28-2748-4cab-bbee-829d3e22e8cd" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual_b4c1efe2-f9f7-43ea-aace-8576779c23fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4e744a10-a2c8-4e75-8ebd-547f26c4f3eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fde54fb5-cba5-4b1e-9437-a667d10447bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4e744a10-a2c8-4e75-8ebd-547f26c4f3eb" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fde54fb5-cba5-4b1e-9437-a667d10447bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_33ae5cfc-379a-4075-9966-d0599890123d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fde54fb5-cba5-4b1e-9437-a667d10447bf" xlink:to="loc_srt_ConsolidatedEntitiesAxis_33ae5cfc-379a-4075-9966-d0599890123d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_dc20eef4-c039-41e0-884f-b3b49b15969f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_33ae5cfc-379a-4075-9966-d0599890123d" xlink:to="loc_srt_ConsolidatedEntitiesDomain_dc20eef4-c039-41e0-884f-b3b49b15969f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_657194db-4925-421d-86d1-50c6944d3dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_dc20eef4-c039-41e0-884f-b3b49b15969f" xlink:to="loc_us-gaap_VariableInterestEntityPrimaryBeneficiaryMember_657194db-4925-421d-86d1-50c6944d3dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_2b4705e4-4cce-4aaf-b7e3-c740a5f81d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_fde54fb5-cba5-4b1e-9437-a667d10447bf" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_2b4705e4-4cce-4aaf-b7e3-c740a5f81d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_d0e57ed9-5776-410b-82c1-dbfadd7ad3c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2b4705e4-4cce-4aaf-b7e3-c740a5f81d1c" xlink:to="loc_us-gaap_AssetsAbstract_d0e57ed9-5776-410b-82c1-dbfadd7ad3c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_f4767c66-f954-40c1-af07-98cfdf4c00ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d0e57ed9-5776-410b-82c1-dbfadd7ad3c5" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_f4767c66-f954-40c1-af07-98cfdf4c00ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4b90f386-9eb4-4076-84b0-827b93a23162" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d0e57ed9-5776-410b-82c1-dbfadd7ad3c5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4b90f386-9eb4-4076-84b0-827b93a23162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReceivablesAndOtherAssets_a46bf91f-bc94-461f-864d-8fcee67ac29a" xlink:href="hr-20230930.xsd#hr_ReceivablesAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d0e57ed9-5776-410b-82c1-dbfadd7ad3c5" xlink:to="loc_hr_ReceivablesAndOtherAssets_a46bf91f-bc94-461f-864d-8fcee67ac29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_0a75096a-555a-44b0-b56d-779583a2691a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_d0e57ed9-5776-410b-82c1-dbfadd7ad3c5" xlink:to="loc_us-gaap_Assets_0a75096a-555a-44b0-b56d-779583a2691a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_26c77fc8-9d4b-41e7-b0f8-2b90def1887d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_2b4705e4-4cce-4aaf-b7e3-c740a5f81d1c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_26c77fc8-9d4b-41e7-b0f8-2b90def1887d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities_8b401c28-8881-46df-b977-326fad34a251" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_26c77fc8-9d4b-41e7-b0f8-2b90def1887d" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilities_8b401c28-8881-46df-b977-326fad34a251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_161a1826-8f2e-4707-a387-da4505b768e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_26c77fc8-9d4b-41e7-b0f8-2b90def1887d" xlink:to="loc_us-gaap_StockholdersEquity_161a1826-8f2e-4707-a387-da4505b768e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e7f8e9de-3ad2-4bf4-89b1-11a369a20550" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_26c77fc8-9d4b-41e7-b0f8-2b90def1887d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_e7f8e9de-3ad2-4bf4-89b1-11a369a20550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cadcc56b-33bc-4e53-867d-63fc282b46dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_2fdce399-bae8-4b11-8a22-8c4a669141ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cadcc56b-33bc-4e53-867d-63fc282b46dc" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_2fdce399-bae8-4b11-8a22-8c4a669141ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_8f383e02-b014-4b6f-928c-48684de84542" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_2fdce399-bae8-4b11-8a22-8c4a669141ab" xlink:to="loc_srt_StatementGeographicalAxis_8f383e02-b014-4b6f-928c-48684de84542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_882c9cfb-34ab-4285-a43a-5b1a2bda3874" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_8f383e02-b014-4b6f-928c-48684de84542" xlink:to="loc_srt_SegmentGeographicalDomain_882c9cfb-34ab-4285-a43a-5b1a2bda3874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HoustonTexasMember_0fe41854-aadd-4ed0-90ef-0c6a3404ffbc" xlink:href="hr-20230930.xsd#hr_HoustonTexasMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_882c9cfb-34ab-4285-a43a-5b1a2bda3874" xlink:to="loc_hr_HoustonTexasMember_0fe41854-aadd-4ed0-90ef-0c6a3404ffbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NC_ada46036-81bb-4a8f-a197-2dc1002be52f" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_NC"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_882c9cfb-34ab-4285-a43a-5b1a2bda3874" xlink:to="loc_stpr_NC_ada46036-81bb-4a8f-a197-2dc1002be52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_50579b79-947b-44be-bc0a-724c9646c5ac" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_TX"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_882c9cfb-34ab-4285-a43a-5b1a2bda3874" xlink:to="loc_stpr_TX_50579b79-947b-44be-bc0a-724c9646c5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_11cdcde1-b6a8-4b59-8417-a8dbae1bd293" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_2fdce399-bae8-4b11-8a22-8c4a669141ab" xlink:to="loc_srt_ConsolidatedEntitiesAxis_11cdcde1-b6a8-4b59-8417-a8dbae1bd293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_303bfa46-dd53-497f-9705-d8b71e8a427f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_11cdcde1-b6a8-4b59-8417-a8dbae1bd293" xlink:to="loc_srt_ConsolidatedEntitiesDomain_303bfa46-dd53-497f-9705-d8b71e8a427f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_VariableInterestEntityMember_29b7110e-3615-4611-ab8b-beec2a42db28" xlink:href="hr-20230930.xsd#hr_VariableInterestEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_303bfa46-dd53-497f-9705-d8b71e8a427f" xlink:to="loc_hr_VariableInterestEntityMember_29b7110e-3615-4611-ab8b-beec2a42db28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_fd98e0d6-2912-412a-bef5-2bb493388168" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_303bfa46-dd53-497f-9705-d8b71e8a427f" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_fd98e0d6-2912-412a-bef5-2bb493388168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_20d0edc5-0892-48ba-9afb-4fd0676f0e64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_2fdce399-bae8-4b11-8a22-8c4a669141ab" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_20d0edc5-0892-48ba-9afb-4fd0676f0e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfNotesReceivable_395182ee-dca7-48a3-906a-bf7d405e37e9" xlink:href="hr-20230930.xsd#hr_NumberOfNotesReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_20d0edc5-0892-48ba-9afb-4fd0676f0e64" xlink:to="loc_hr_NumberOfNotesReceivable_395182ee-dca7-48a3-906a-bf7d405e37e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableCarryingAmount_b10df1ac-c189-4f27-ba23-7eea3074cdfa" xlink:href="hr-20230930.xsd#hr_NotesReceivableCarryingAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_20d0edc5-0892-48ba-9afb-4fd0676f0e64" xlink:to="loc_hr_NotesReceivableCarryingAmount_b10df1ac-c189-4f27-ba23-7eea3074cdfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureCarryingAmount_819636b2-ef59-4ade-b612-a585928f4b82" xlink:href="hr-20230930.xsd#hr_JointVentureCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_20d0edc5-0892-48ba-9afb-4fd0676f0e64" xlink:to="loc_hr_JointVentureCarryingAmount_819636b2-ef59-4ade-b612-a585928f4b82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_1f454c99-31bf-4501-a24d-9f92f796838c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_20d0edc5-0892-48ba-9afb-4fd0676f0e64" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_1f454c99-31bf-4501-a24d-9f92f796838c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_9c474a04-7a6c-4bbd-a7ba-c4d4396960fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_20d0edc5-0892-48ba-9afb-4fd0676f0e64" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_9c474a04-7a6c-4bbd-a7ba-c4d4396960fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_44edffc4-11cd-4b5f-b936-bf77eb2361a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_e3e83bff-cefb-4fec-a55c-f4bc92f1283d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_44edffc4-11cd-4b5f-b936-bf77eb2361a1" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_e3e83bff-cefb-4fec-a55c-f4bc92f1283d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_5d02fb48-6ed0-4fee-b30c-905d420e5d20" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_e3e83bff-cefb-4fec-a55c-f4bc92f1283d" xlink:to="loc_srt_StatementGeographicalAxis_5d02fb48-6ed0-4fee-b30c-905d420e5d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_620429bd-02a4-491b-9391-7795bf79fab2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_5d02fb48-6ed0-4fee-b30c-905d420e5d20" xlink:to="loc_srt_SegmentGeographicalDomain_620429bd-02a4-491b-9391-7795bf79fab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PowayCAMember_7ec3c56b-1816-420c-a446-fde5cd68b973" xlink:href="hr-20230930.xsd#hr_PowayCAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_620429bd-02a4-491b-9391-7795bf79fab2" xlink:to="loc_hr_PowayCAMember_7ec3c56b-1816-420c-a446-fde5cd68b973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ColumbusOHMember_20c148b5-8e5f-478c-827d-3a91a687655f" xlink:href="hr-20230930.xsd#hr_ColumbusOHMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_620429bd-02a4-491b-9391-7795bf79fab2" xlink:to="loc_hr_ColumbusOHMember_20c148b5-8e5f-478c-827d-3a91a687655f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_TX_db9b55b0-624a-4afb-9254-8007a80929fa" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_TX"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_620429bd-02a4-491b-9391-7795bf79fab2" xlink:to="loc_stpr_TX_db9b55b0-624a-4afb-9254-8007a80929fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_NC_357ff417-3ce2-4242-bd63-1c28857f3d05" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_NC"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_620429bd-02a4-491b-9391-7795bf79fab2" xlink:to="loc_stpr_NC_357ff417-3ce2-4242-bd63-1c28857f3d05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_FL_bd239a91-93e9-4938-9b58-4553b91cf7ce" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_FL"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_620429bd-02a4-491b-9391-7795bf79fab2" xlink:to="loc_stpr_FL_bd239a91-93e9-4938-9b58-4553b91cf7ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_d930ad4b-b596-4d5d-ad5a-c759f458501d" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_CA"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_620429bd-02a4-491b-9391-7795bf79fab2" xlink:to="loc_stpr_CA_d930ad4b-b596-4d5d-ad5a-c759f458501d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByAssetClassAxis_b59ff2a5-1c81-451b-8f47-75d7917ef18d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByAssetClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_e3e83bff-cefb-4fec-a55c-f4bc92f1283d" xlink:to="loc_us-gaap_FairValueByAssetClassAxis_b59ff2a5-1c81-451b-8f47-75d7917ef18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_90b2e04e-6347-4f4b-8e61-4ec6b94ed5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByAssetClassAxis_b59ff2a5-1c81-451b-8f47-75d7917ef18d" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_90b2e04e-6347-4f4b-8e61-4ec6b94ed5b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MezzanineLoanMember_1ca6222f-b2cb-43b4-ba53-1b0288692792" xlink:href="hr-20230930.xsd#hr_MezzanineLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_90b2e04e-6347-4f4b-8e61-4ec6b94ed5b1" xlink:to="loc_hr_MezzanineLoanMember_1ca6222f-b2cb-43b4-ba53-1b0288692792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageLoanMember_b59cd336-a152-4540-adf6-8eff9a438c44" xlink:href="hr-20230930.xsd#hr_MortgageLoanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_90b2e04e-6347-4f4b-8e61-4ec6b94ed5b1" xlink:to="loc_hr_MortgageLoanMember_b59cd336-a152-4540-adf6-8eff9a438c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_74aa0ddb-11f6-44e8-807f-3db9a5dc7cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_e3e83bff-cefb-4fec-a55c-f4bc92f1283d" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_74aa0ddb-11f6-44e8-807f-3db9a5dc7cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableInterestRate_c4eb31a3-ec30-4d30-83a2-1dc2ab774a19" xlink:href="hr-20230930.xsd#hr_NotesReceivableInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_74aa0ddb-11f6-44e8-807f-3db9a5dc7cf4" xlink:to="loc_hr_NotesReceivableInterestRate_c4eb31a3-ec30-4d30-83a2-1dc2ab774a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleLeasebackTransactionNetBookValue_9b387056-c4ff-4472-a348-ce13ca2fb050" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleLeasebackTransactionNetBookValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_74aa0ddb-11f6-44e8-807f-3db9a5dc7cf4" xlink:to="loc_us-gaap_SaleLeasebackTransactionNetBookValue_9b387056-c4ff-4472-a348-ce13ca2fb050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NotesReceivableMaximumLoanCommitment_59cba514-c8e0-4c57-b949-b2ce513141e6" xlink:href="hr-20230930.xsd#hr_NotesReceivableMaximumLoanCommitment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_74aa0ddb-11f6-44e8-807f-3db9a5dc7cf4" xlink:to="loc_hr_NotesReceivableMaximumLoanCommitment_59cba514-c8e0-4c57-b949-b2ce513141e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_c0d73f24-ec97-4c16-b1cb-42f78dfb677d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_74aa0ddb-11f6-44e8-807f-3db9a5dc7cf4" xlink:to="loc_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss_c0d73f24-ec97-4c16-b1cb-42f78dfb677d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_fe6ec2a4-2dbd-45bd-99ea-aeb5e86e9bfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_74aa0ddb-11f6-44e8-807f-3db9a5dc7cf4" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_fe6ec2a4-2dbd-45bd-99ea-aeb5e86e9bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount_41206fc1-7b5b-45ff-91f4-eb631f1c6de9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_74aa0ddb-11f6-44e8-807f-3db9a5dc7cf4" xlink:to="loc_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount_41206fc1-7b5b-45ff-91f4-eb631f1c6de9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_130b6068-77bc-4407-8ffc-9fabcf0031ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_74aa0ddb-11f6-44e8-807f-3db9a5dc7cf4" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_130b6068-77bc-4407-8ffc-9fabcf0031ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6099a50f-ef06-4b70-8179-958e97d1d92f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_b8937887-9708-431b-b39e-e4f38b05092a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6099a50f-ef06-4b70-8179-958e97d1d92f" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_b8937887-9708-431b-b39e-e4f38b05092a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_b56b02f5-098d-4122-baa5-63234969cd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_b8937887-9708-431b-b39e-e4f38b05092a" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_b56b02f5-098d-4122-baa5-63234969cd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_8e188c8c-f0ee-4395-a43f-a7da3d2442ec" xlink:href="hr-20230930.xsd#hr_FinancingReceivableAllowanceForCreditLossReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_b8937887-9708-431b-b39e-e4f38b05092a" xlink:to="loc_hr_FinancingReceivableAllowanceForCreditLossReserves_8e188c8c-f0ee-4395-a43f-a7da3d2442ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_f08aeed3-1d4d-4f2b-a461-49c139dbbe0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward_b8937887-9708-431b-b39e-e4f38b05092a" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest_f08aeed3-1d4d-4f2b-a461-49c139dbbe0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_48e48711-5654-4127-9582-f074b7d75186" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_458726e6-2eb6-4063-8f9d-f55bd06c70b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_48e48711-5654-4127-9582-f074b7d75186" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_458726e6-2eb6-4063-8f9d-f55bd06c70b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_22624cdd-10af-4b15-9718-9a0264a3e3a8" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_458726e6-2eb6-4063-8f9d-f55bd06c70b1" xlink:to="loc_srt_ProductOrServiceAxis_22624cdd-10af-4b15-9718-9a0264a3e3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8ba99c3f-5539-499e-b408-1c24657d6898" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_22624cdd-10af-4b15-9718-9a0264a3e3a8" xlink:to="loc_srt_ProductsAndServicesDomain_8ba99c3f-5539-499e-b408-1c24657d6898" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ParkingIncomeMember_f87cb718-be38-4535-9e22-815e72b0c602" xlink:href="hr-20230930.xsd#hr_ParkingIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8ba99c3f-5539-499e-b408-1c24657d6898" xlink:to="loc_hr_ParkingIncomeMember_f87cb718-be38-4535-9e22-815e72b0c602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ManagementFeeIncomeMember_6dcfd8a8-7d66-4f72-b454-276d74249aa6" xlink:href="hr-20230930.xsd#hr_ManagementFeeIncomeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8ba99c3f-5539-499e-b408-1c24657d6898" xlink:to="loc_hr_ManagementFeeIncomeMember_6dcfd8a8-7d66-4f72-b454-276d74249aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MiscellaneousMember_299c386d-9c2b-4287-8e30-b384deee132a" xlink:href="hr-20230930.xsd#hr_MiscellaneousMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8ba99c3f-5539-499e-b408-1c24657d6898" xlink:to="loc_hr_MiscellaneousMember_299c386d-9c2b-4287-8e30-b384deee132a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_847439d2-c73e-461b-bd5e-869307cef110" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_458726e6-2eb6-4063-8f9d-f55bd06c70b1" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_847439d2-c73e-461b-bd5e-869307cef110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ddcc0e3-4d68-4e5f-90f2-5327cca139fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_847439d2-c73e-461b-bd5e-869307cef110" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9ddcc0e3-4d68-4e5f-90f2-5327cca139fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/MergerwithHTANarrativeDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#MergerwithHTANarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/MergerwithHTANarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_4f9b0a03-9bf9-4bf6-98b2-5772f38bdcb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b1d2cbea-2a4b-4827-9232-d766212cbdf2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_4f9b0a03-9bf9-4bf6-98b2-5772f38bdcb8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b1d2cbea-2a4b-4827-9232-d766212cbdf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_bcfafd4f-a08c-4204-a537-467a42bd7a63" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b1d2cbea-2a4b-4827-9232-d766212cbdf2" xlink:to="loc_dei_LegalEntityAxis_bcfafd4f-a08c-4204-a537-467a42bd7a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_93dbdf40-3206-40aa-bf7e-13c14f61cfb5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_bcfafd4f-a08c-4204-a537-467a42bd7a63" xlink:to="loc_dei_EntityDomain_93dbdf40-3206-40aa-bf7e-13c14f61cfb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthCareRealtyTrustIncorporatedMember_2e3d0fa9-695b-4b72-8d90-d35867eea784" xlink:href="hr-20230930.xsd#hr_HealthCareRealtyTrustIncorporatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_93dbdf40-3206-40aa-bf7e-13c14f61cfb5" xlink:to="loc_hr_HealthCareRealtyTrustIncorporatedMember_2e3d0fa9-695b-4b72-8d90-d35867eea784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthCareRealtyTrustIncMember_e06a58e2-96a8-4173-a19d-bf0e3c239a81" xlink:href="hr-20230930.xsd#hr_HealthCareRealtyTrustIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_HealthCareRealtyTrustIncorporatedMember_2e3d0fa9-695b-4b72-8d90-d35867eea784" xlink:to="loc_hr_HealthCareRealtyTrustIncMember_e06a58e2-96a8-4173-a19d-bf0e3c239a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustOfAmericaIncMember_4a372377-182b-49d7-a636-186b5c74a5df" xlink:href="hr-20230930.xsd#hr_HealthcareTrustOfAmericaIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_HealthCareRealtyTrustIncorporatedMember_2e3d0fa9-695b-4b72-8d90-d35867eea784" xlink:to="loc_hr_HealthcareTrustOfAmericaIncMember_4a372377-182b-49d7-a636-186b5c74a5df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_76d4dd51-c036-4d87-9f6b-d56f6f96072a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b1d2cbea-2a4b-4827-9232-d766212cbdf2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_76d4dd51-c036-4d87-9f6b-d56f6f96072a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_80d126ab-e018-4cdb-8033-e715432ee919" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_76d4dd51-c036-4d87-9f6b-d56f6f96072a" xlink:to="loc_us-gaap_ClassOfStockDomain_80d126ab-e018-4cdb-8033-e715432ee919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_5e1392c3-a52f-4d10-bd05-9215f475c7c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_80d126ab-e018-4cdb-8033-e715432ee919" xlink:to="loc_us-gaap_CommonClassAMember_5e1392c3-a52f-4d10-bd05-9215f475c7c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_4643fe2f-bd84-462f-a9b7-fc0325ff2d0a" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b1d2cbea-2a4b-4827-9232-d766212cbdf2" xlink:to="loc_srt_RestatementAxis_4643fe2f-bd84-462f-a9b7-fc0325ff2d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_c4b4873e-3d1a-4a7c-a992-d133dd8b714d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_4643fe2f-bd84-462f-a9b7-fc0325ff2d0a" xlink:to="loc_srt_RestatementDomain_c4b4873e-3d1a-4a7c-a992-d133dd8b714d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_b509b523-329e-4926-8729-1b3f1439ee4e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_c4b4873e-3d1a-4a7c-a992-d133dd8b714d" xlink:to="loc_srt_RestatementAdjustmentMember_b509b523-329e-4926-8729-1b3f1439ee4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_b1d2cbea-2a4b-4827-9232-d766212cbdf2" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_feb67831-df9d-4015-a6bc-c9e639cb6123" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_feb67831-df9d-4015-a6bc-c9e639cb6123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio_487017e4-db5d-4187-bc77-0ac0da51daee" xlink:href="hr-20230930.xsd#hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:to="loc_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio_487017e4-db5d-4187-bc77-0ac0da51daee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_efeed96d-e784-4045-acfc-9a8c85f8aa69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_efeed96d-e784-4045-acfc-9a8c85f8aa69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete_eb95197e-dbb5-4bca-8963-f9b602ab6937" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete_eb95197e-dbb5-4bca-8963-f9b602ab6937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c632d64f-9360-4f84-b098-8646e735573b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:to="loc_us-gaap_Goodwill_c632d64f-9360-4f84-b098-8646e735573b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_53be3560-0246-4a0b-89d1-b581f465456c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:to="loc_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_53be3560-0246-4a0b-89d1-b581f465456c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MergerRelatedCosts_e20ab283-9cee-4c79-9958-25ce055ec4f9" xlink:href="hr-20230930.xsd#hr_MergerRelatedCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:to="loc_hr_MergerRelatedCosts_e20ab283-9cee-4c79-9958-25ce055ec4f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRefundOfTransferTaxesPaid_cfd4db17-cacb-46ce-8f03-18de0458ffdd" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRefundOfTransferTaxesPaid"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_880ee0a2-0c4e-4cd3-8367-ebb5ccf38655" xlink:to="loc_hr_BusinessCombinationRefundOfTransferTaxesPaid_cfd4db17-cacb-46ce-8f03-18de0458ffdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/MergerwithHTADetails" xlink:type="simple" xlink:href="hr-20230930.xsd#MergerwithHTADetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/MergerwithHTADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_954b6f2c-6525-493e-ac5c-be93280ee83f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e3a4ed51-df7a-4c8e-991c-796230fab72a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_954b6f2c-6525-493e-ac5c-be93280ee83f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e3a4ed51-df7a-4c8e-991c-796230fab72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_35cd44c2-3e87-4956-bc3b-7466dcab9e0e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e3a4ed51-df7a-4c8e-991c-796230fab72a" xlink:to="loc_dei_LegalEntityAxis_35cd44c2-3e87-4956-bc3b-7466dcab9e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_48dd74ab-a324-4328-aa8f-36bf374ffc1b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_35cd44c2-3e87-4956-bc3b-7466dcab9e0e" xlink:to="loc_dei_EntityDomain_48dd74ab-a324-4328-aa8f-36bf374ffc1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HealthcareTrustOfAmericaIncMember_333558c5-0e47-43aa-a402-4d3e88161b10" xlink:href="hr-20230930.xsd#hr_HealthcareTrustOfAmericaIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_48dd74ab-a324-4328-aa8f-36bf374ffc1b" xlink:to="loc_hr_HealthcareTrustOfAmericaIncMember_333558c5-0e47-43aa-a402-4d3e88161b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_09182d76-8afb-419b-b22b-2891ed7cc6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e3a4ed51-df7a-4c8e-991c-796230fab72a" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_09182d76-8afb-419b-b22b-2891ed7cc6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4292900a-1c48-4fd4-a52c-f21a2727216b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_09182d76-8afb-419b-b22b-2891ed7cc6ab" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4292900a-1c48-4fd4-a52c-f21a2727216b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LegacyHTAMember_79a37470-fcb6-4a1f-a198-2a809ba440ce" xlink:href="hr-20230930.xsd#hr_LegacyHTAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4292900a-1c48-4fd4-a52c-f21a2727216b" xlink:to="loc_hr_LegacyHTAMember_79a37470-fcb6-4a1f-a198-2a809ba440ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b6c7c423-179e-469f-8970-d5bc8bab62ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e3a4ed51-df7a-4c8e-991c-796230fab72a" xlink:to="loc_us-gaap_AwardTypeAxis_b6c7c423-179e-469f-8970-d5bc8bab62ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53a1c9ef-dee2-4bcc-9131-76a8152bbccd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b6c7c423-179e-469f-8970-d5bc8bab62ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53a1c9ef-dee2-4bcc-9131-76a8152bbccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_a7f13bd9-2e44-444e-bab2-34d68a4a627d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_53a1c9ef-dee2-4bcc-9131-76a8152bbccd" xlink:to="loc_us-gaap_RestrictedStockMember_a7f13bd9-2e44-444e-bab2-34d68a4a627d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e3a4ed51-df7a-4c8e-991c-796230fab72a" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_031792e6-110f-4db0-814f-2305531e5767" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_031792e6-110f-4db0-814f-2305531e5767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RecapitalizationExchangeRatio_d766f17c-c206-4016-8eb7-7d78bdb0843b" xlink:href="hr-20230930.xsd#hr_RecapitalizationExchangeRatio"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_hr_RecapitalizationExchangeRatio_d766f17c-c206-4016-8eb7-7d78bdb0843b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_a85cee74-c2a1-46aa-a6e6-3a8675000651" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_a85cee74-c2a1-46aa-a6e6-3a8675000651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_01279fa9-f9bc-4af2-9897-4fcd30fd9681" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_01279fa9-f9bc-4af2-9897-4fcd30fd9681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReverseRecapitalizationNet_469a8cba-7503-40de-9ee5-9c546e497831" xlink:href="hr-20230930.xsd#hr_ReverseRecapitalizationNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_hr_ReverseRecapitalizationNet_469a8cba-7503-40de-9ee5-9c546e497831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices_80c58135-78b0-4ded-857e-46a1d8f92634" xlink:href="hr-20230930.xsd#hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices_80c58135-78b0-4ded-857e-46a1d8f92634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ef14be4d-2cce-438d-800c-edfada40da69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_ef14be4d-2cce-438d-800c-edfada40da69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CommonStockFractionalShares_1a19751f-9fb1-41d8-9219-8cf0d741237d" xlink:href="hr-20230930.xsd#hr_CommonStockFractionalShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_hr_CommonStockFractionalShares_1a19751f-9fb1-41d8-9219-8cf0d741237d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CommonStockSharesWithheld_50a4b523-2c5b-44c9-9b44-1dba628d38d2" xlink:href="hr-20230930.xsd#hr_CommonStockSharesWithheld"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7a8f2c16-530c-4982-969f-b05ac9973fdf" xlink:to="loc_hr_CommonStockSharesWithheld_50a4b523-2c5b-44c9-9b44-1dba628d38d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0ecd38dc-a92f-4824-acc0-6402f38c748d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0cb27e21-15e4-4ef3-831e-5c9d519a4b48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_0ecd38dc-a92f-4824-acc0-6402f38c748d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0cb27e21-15e4-4ef3-831e-5c9d519a4b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_f208801f-c76e-4a80-a8df-c16b782ff4ac" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0cb27e21-15e4-4ef3-831e-5c9d519a4b48" xlink:to="loc_srt_RestatementAxis_f208801f-c76e-4a80-a8df-c16b782ff4ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_24f096a9-ade8-4c1e-a678-5476c78f3c4e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_f208801f-c76e-4a80-a8df-c16b782ff4ac" xlink:to="loc_srt_RestatementDomain_24f096a9-ade8-4c1e-a678-5476c78f3c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_1106226d-4e5f-49a0-a10c-f66074f0f279" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_24f096a9-ade8-4c1e-a678-5476c78f3c4e" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_1106226d-4e5f-49a0-a10c-f66074f0f279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_0cb27e21-15e4-4ef3-831e-5c9d519a4b48" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_dc75db30-e205-4e5b-9db1-86ac7a256ab7" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_dc75db30-e205-4e5b-9db1-86ac7a256ab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_3d2a413a-7c4b-4508-b7b1-42a3caa1e6fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_dc75db30-e205-4e5b-9db1-86ac7a256ab7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand_3d2a413a-7c4b-4508-b7b1-42a3caa1e6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_8402385a-ca20-4e98-9545-45914eb78f09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_dc75db30-e205-4e5b-9db1-86ac7a256ab7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings_8402385a-ca20-4e98-9545-45914eb78f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_cfcebc11-e2bc-4b3f-b45c-81a100251fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_dc75db30-e205-4e5b-9db1-86ac7a256ab7" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_cfcebc11-e2bc-4b3f-b45c-81a100251fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets_092cbec4-effc-4640-bb44-1ccf21c81d8d" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_dc75db30-e205-4e5b-9db1-86ac7a256ab7" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets_092cbec4-effc-4640-bb44-1ccf21c81d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress_c55617d7-a2b8-485a-a3d6-0d5e6539f46e" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_dc75db30-e205-4e5b-9db1-86ac7a256ab7" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress_c55617d7-a2b8-485a-a3d6-0d5e6539f46e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment_c3bf6e39-cd86-4409-a8f4-7de587b3cf90" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract_dc75db30-e205-4e5b-9db1-86ac7a256ab7" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment_c3bf6e39-cd86-4409-a8f4-7de587b3cf90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_b08b783e-1a7f-4581-b995-be2d1186bab2" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments_b08b783e-1a7f-4581-b995-be2d1186bab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale_4a83c468-5f84-4e95-bc27-1c140b1814f2" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale_4a83c468-5f84-4e95-bc27-1c140b1814f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures_b07a3a69-ab50-4c09-ac68-26d68caf78e8" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures_b07a3a69-ab50-4c09-ac68-26d68caf78e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_683e7719-38ed-4d51-9d92-eca27e0cfea4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_683e7719-38ed-4d51-9d92-eca27e0cfea4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_4b3c1fd2-7560-48bb-8df9-f2225ccabe2d" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash_4b3c1fd2-7560-48bb-8df9-f2225ccabe2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_15a21812-e16d-41f2-be51-4ae5ce33ce19" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets_15a21812-e16d-41f2-be51-4ae5ce33ce19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets_2bb5c15d-0380-4263-84d0-32439c03bd68" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets_2bb5c15d-0380-4263-84d0-32439c03bd68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_71972c83-d345-47b8-86af-a181f1ba866d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_0b98a5a3-bf39-4e99-8d6d-7a77d1386e9a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_71972c83-d345-47b8-86af-a181f1ba866d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_7be29eab-2c89-4c86-aca6-859b78f6c8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_7be29eab-2c89-4c86-aca6-859b78f6c8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_65aec9e6-a7ec-4ad2-b697-88c70eceff75" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_7be29eab-2c89-4c86-aca6-859b78f6c8f5" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt_65aec9e6-a7ec-4ad2-b697-88c70eceff75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities_ee8776a9-eab1-44aa-9367-2325c576950b" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_7be29eab-2c89-4c86-aca6-859b78f6c8f5" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities_ee8776a9-eab1-44aa-9367-2325c576950b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale_f688bea6-6fca-4555-920b-2ebab2a26b79" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_7be29eab-2c89-4c86-aca6-859b78f6c8f5" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale_f688bea6-6fca-4555-920b-2ebab2a26b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_d379efb0-d621-43b6-8a4c-82eb12b4e98c" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_7be29eab-2c89-4c86-aca6-859b78f6c8f5" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities_d379efb0-d621-43b6-8a4c-82eb12b4e98c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities_85e69047-e2af-40da-99a1-0cf4e97de86c" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_7be29eab-2c89-4c86-aca6-859b78f6c8f5" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities_85e69047-e2af-40da-99a1-0cf4e97de86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_8414a814-0e42-4e85-b954-3a987a4d4656" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_7be29eab-2c89-4c86-aca6-859b78f6c8f5" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_8414a814-0e42-4e85-b954-3a987a4d4656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_96282f0d-d45e-4757-97df-7b3c476dfeaf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_7be29eab-2c89-4c86-aca6-859b78f6c8f5" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_96282f0d-d45e-4757-97df-7b3c476dfeaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1fb3d958-4ca0-4016-82fa-dc4bcd62593d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_1fb3d958-4ca0-4016-82fa-dc4bcd62593d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_12b34487-22cf-406b-adeb-e2d84c04e9e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_12b34487-22cf-406b-adeb-e2d84c04e9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_180a57c1-4bee-4f7a-8ee0-69e83331a3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_us-gaap_Goodwill_180a57c1-4bee-4f7a-8ee0-69e83331a3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_72973e98-97ba-4545-acf8-056b61963b69" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_72973e98-97ba-4545-acf8-056b61963b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount_06797e6e-510e-45d0-9800-3b9b2df760eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount_06797e6e-510e-45d0-9800-3b9b2df760eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount_5fbdc1a5-65cf-4d81-8fc8-328bf2c6dded" xlink:href="hr-20230930.xsd#hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount_5fbdc1a5-65cf-4d81-8fc8-328bf2c6dded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_GrossContractualRealEstateNotesReceivableFairValue_ede64bd7-f5e7-44c2-ac1a-9197a1c20e1d" xlink:href="hr-20230930.xsd#hr_GrossContractualRealEstateNotesReceivableFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_hr_GrossContractualRealEstateNotesReceivableFairValue_ede64bd7-f5e7-44c2-ac1a-9197a1c20e1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_7e2f99ff-ad2e-4d33-abe3-ffd1d32b2e29" xlink:to="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand_1e3da188-282f-47d5-a809-62be6fb620c6" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand_1e3da188-282f-47d5-a809-62be6fb620c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements_5d41cbb3-642c-4cd0-b917-a3a894e5fabd" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements_5d41cbb3-642c-4cd0-b917-a3a894e5fabd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets_dc7038f2-3b03-4042-b047-4b7d8d32f745" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets_dc7038f2-3b03-4042-b047-4b7d8d32f745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets_23cb7a4b-784b-4141-b972-9e5657cd07d2" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets_23cb7a4b-784b-4141-b972-9e5657cd07d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress_f9bfe047-121e-48f7-88c4-0675937d80f1" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress_f9bfe047-121e-48f7-88c4-0675937d80f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_1e7ac0c5-b69a-4bf7-91cd-0a2484d69667" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments_1e7ac0c5-b69a-4bf7-91cd-0a2484d69667" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet_fc94330b-da6a-48bc-9bfa-e7feb932f2d5" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet_fc94330b-da6a-48bc-9bfa-e7feb932f2d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_f22ff50f-0ee9-42ef-ad3e-1242c62cdd2c" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents_f22ff50f-0ee9-42ef-ad3e-1242c62cdd2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash_b007e5c6-fd4c-4077-8372-617b6bf07faf" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash_b007e5c6-fd4c-4077-8372-617b6bf07faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_59be3172-d4e3-4aac-bcc5-5f11ee012e80" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets_59be3172-d4e3-4aac-bcc5-5f11ee012e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet_e9b22ac3-41bd-40b3-a639-9cdb42f54271" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet_e9b22ac3-41bd-40b3-a639-9cdb42f54271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_760a55b5-96f2-4092-9a4e-9ab2c4f292cc" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired_760a55b5-96f2-4092-9a4e-9ab2c4f292cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities_6140c741-e6ca-4130-9e30-856aaa8c04a4" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities_6140c741-e6ca-4130-9e30-856aaa8c04a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale_7b94ca35-af52-4ec2-87c8-f9f45ea372e8" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale_7b94ca35-af52-4ec2-87c8-f9f45ea372e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities_ab4f035c-b9f7-4dcc-becf-b8582120306f" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities_ab4f035c-b9f7-4dcc-becf-b8582120306f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities_847626a2-4845-49d3-9201-30768b294848" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities_847626a2-4845-49d3-9201-30768b294848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_67d443c9-1acc-4249-87b5-2fbfe13f940b" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities_67d443c9-1acc-4249-87b5-2fbfe13f940b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_2b12310b-640c-480d-9398-1857676aa4d9" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed_2b12310b-640c-480d-9398-1857676aa4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_d0638d38-8858-4626-8065-14849cd280bc" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired_d0638d38-8858-4626-8065-14849cd280bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_d72be496-67f2-4a15-91e1-b11b772cf120" xlink:href="hr-20230930.xsd#hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract_7c636e90-d0df-4295-8291-bd472f5431f5" xlink:to="loc_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill_d72be496-67f2-4a15-91e1-b11b772cf120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#RealEstateInvestmentsRealEstateAcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e9eb065f-d5f5-468e-8b56-d386f89ae0d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_10e07c50-ddb2-4cf3-8c7f-0fed13503a21" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_e9eb065f-d5f5-468e-8b56-d386f89ae0d7" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_10e07c50-ddb2-4cf3-8c7f-0fed13503a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ac414d3b-9c6d-4996-a0e3-3e656fffe352" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_10e07c50-ddb2-4cf3-8c7f-0fed13503a21" xlink:to="loc_srt_StatementGeographicalAxis_ac414d3b-9c6d-4996-a0e3-3e656fffe352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3edfa526-2dac-4b72-8ff1-e9cce5238b6d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ac414d3b-9c6d-4996-a0e3-3e656fffe352" xlink:to="loc_srt_SegmentGeographicalDomain_3edfa526-2dac-4b72-8ff1-e9cce5238b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TampaFLMember_dcc03705-d6ab-4c50-a55a-f5a57cc46336" xlink:href="hr-20230930.xsd#hr_TampaFLMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3edfa526-2dac-4b72-8ff1-e9cce5238b6d" xlink:to="loc_hr_TampaFLMember_dcc03705-d6ab-4c50-a55a-f5a57cc46336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ColoradoSpringsCOMember_4c004897-5901-438c-98b2-86ea0805bff0" xlink:href="hr-20230930.xsd#hr_ColoradoSpringsCOMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3edfa526-2dac-4b72-8ff1-e9cce5238b6d" xlink:to="loc_hr_ColoradoSpringsCOMember_4c004897-5901-438c-98b2-86ea0805bff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_f23c5554-7830-4fcb-a726-7169457cb087" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_10e07c50-ddb2-4cf3-8c7f-0fed13503a21" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_f23c5554-7830-4fcb-a726-7169457cb087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_78e75a8c-b7a5-4d40-9a1c-fbdfa134c484" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_f23c5554-7830-4fcb-a726-7169457cb087" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_78e75a8c-b7a5-4d40-9a1c-fbdfa134c484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MedicalOfficeBuildingMember_751e6f70-7a8e-4060-99ae-b9bb672694bc" xlink:href="hr-20230930.xsd#hr_MedicalOfficeBuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_78e75a8c-b7a5-4d40-9a1c-fbdfa134c484" xlink:to="loc_hr_MedicalOfficeBuildingMember_751e6f70-7a8e-4060-99ae-b9bb672694bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis_2bbccc06-eda4-4fe1-8f91-f161f9e3fc16" xlink:href="hr-20230930.xsd#hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_10e07c50-ddb2-4cf3-8c7f-0fed13503a21" xlink:to="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis_2bbccc06-eda4-4fe1-8f91-f161f9e3fc16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain_13f9f80f-920d-484e-a4ab-35e66feafaf7" xlink:href="hr-20230930.xsd#hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis_2bbccc06-eda4-4fe1-8f91-f161f9e3fc16" xlink:to="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain_13f9f80f-920d-484e-a4ab-35e66feafaf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateAcquisitionsMember_d953f357-f8df-492a-85ce-3dabee544f38" xlink:href="hr-20230930.xsd#hr_RealEstateAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain_13f9f80f-920d-484e-a4ab-35e66feafaf7" xlink:to="loc_hr_RealEstateAcquisitionsMember_d953f357-f8df-492a-85ce-3dabee544f38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_869c4b3b-8829-4816-96b8-6a8edae40f48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_10e07c50-ddb2-4cf3-8c7f-0fed13503a21" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_869c4b3b-8829-4816-96b8-6a8edae40f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1d368502-7f04-45bc-a970-0efca18aac72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_869c4b3b-8829-4816-96b8-6a8edae40f48" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_1d368502-7f04-45bc-a970-0efca18aac72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_663198a4-0a9c-4bc7-80ff-d7a69d3bc6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_869c4b3b-8829-4816-96b8-6a8edae40f48" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred_663198a4-0a9c-4bc7-80ff-d7a69d3bc6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_a3eda5fe-19b3-4815-be51-057426e332ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_869c4b3b-8829-4816-96b8-6a8edae40f48" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_a3eda5fe-19b3-4815-be51-057426e332ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty_d5ede9e0-4907-40cd-829c-076a968ca0b6" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_869c4b3b-8829-4816-96b8-6a8edae40f48" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty_d5ede9e0-4907-40cd-829c-076a968ca0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther_e3b7a7b5-4330-4ef5-9ff9-2aba7fefd6a9" xlink:href="hr-20230930.xsd#hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_869c4b3b-8829-4816-96b8-6a8edae40f48" xlink:to="loc_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther_e3b7a7b5-4330-4ef5-9ff9-2aba7fefd6a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage_032daa73-4460-47d9-bed8-35a24cac59a0" xlink:href="hr-20230930.xsd#hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_869c4b3b-8829-4816-96b8-6a8edae40f48" xlink:to="loc_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage_032daa73-4460-47d9-bed8-35a24cac59a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsNarrativeDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#RealEstateInvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_fbf5d704-14f9-4492-b9ef-6cd1c29e07cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLand_220f2a85-2a8f-4bab-86f3-fdf58c939f29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireLand"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_fbf5d704-14f9-4492-b9ef-6cd1c29e07cd" xlink:to="loc_us-gaap_PaymentsToAcquireLand_220f2a85-2a8f-4bab-86f3-fdf58c939f29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_4c59c4f7-c2ff-403c-bb49-d42c841fa286" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_fbf5d704-14f9-4492-b9ef-6cd1c29e07cd" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_4c59c4f7-c2ff-403c-bb49-d42c841fa286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_150643c6-ba11-43bd-8bc8-87b8a5ff9c34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateTable_41c05517-e313-4818-9a12-d03104aed133" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_150643c6-ba11-43bd-8bc8-87b8a5ff9c34" xlink:to="loc_us-gaap_RealEstateTable_41c05517-e313-4818-9a12-d03104aed133" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d02a53de-44bb-4ab1-8371-fb32c5d89e4c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_41c05517-e313-4818-9a12-d03104aed133" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d02a53de-44bb-4ab1-8371-fb32c5d89e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_4afdaa0b-50cb-41f2-840b-2df838f969cd" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_d02a53de-44bb-4ab1-8371-fb32c5d89e4c" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_4afdaa0b-50cb-41f2-840b-2df838f969cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OtherPropertyMember_82a186c8-e778-4921-a5bf-66a046113810" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OtherPropertyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_4afdaa0b-50cb-41f2-840b-2df838f969cd" xlink:to="loc_srt_OtherPropertyMember_82a186c8-e778-4921-a5bf-66a046113810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_80b8c407-4322-4af6-870d-9b1eca0dd624" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_41c05517-e313-4818-9a12-d03104aed133" xlink:to="loc_srt_StatementGeographicalAxis_80b8c407-4322-4af6-870d-9b1eca0dd624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_628c8203-7549-45ec-8e71-4e552678e328" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_80b8c407-4322-4af6-870d-9b1eca0dd624" xlink:to="loc_srt_SegmentGeographicalDomain_628c8203-7549-45ec-8e71-4e552678e328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LosAngelesCaliforniaMember_0912ace9-a076-4fab-bea6-ec7fe3cf0f15" xlink:href="hr-20230930.xsd#hr_LosAngelesCaliforniaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_628c8203-7549-45ec-8e71-4e552678e328" xlink:to="loc_hr_LosAngelesCaliforniaMember_0912ace9-a076-4fab-bea6-ec7fe3cf0f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_e808e70c-e61d-426c-b689-0a30fc85607b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_41c05517-e313-4818-9a12-d03104aed133" xlink:to="loc_srt_OwnershipAxis_e808e70c-e61d-426c-b689-0a30fc85607b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_cab3c979-773c-468c-9828-218156b5ed14" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_e808e70c-e61d-426c-b689-0a30fc85607b" xlink:to="loc_srt_OwnershipDomain_cab3c979-773c-468c-9828-218156b5ed14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LimitedLiabilityCompanyOneMember_20d5901a-55e4-4f46-98c9-68d78c3e0b0a" xlink:href="hr-20230930.xsd#hr_LimitedLiabilityCompanyOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_cab3c979-773c-468c-9828-218156b5ed14" xlink:to="loc_hr_LimitedLiabilityCompanyOneMember_20d5901a-55e4-4f46-98c9-68d78c3e0b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateLineItems_a42f37d2-aeed-4ba2-b860-e7f6df44ed1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateTable_41c05517-e313-4818-9a12-d03104aed133" xlink:to="loc_us-gaap_RealEstateLineItems_a42f37d2-aeed-4ba2-b860-e7f6df44ed1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityMethodInvestmentsRollForward_13176b4f-6946-42b8-9f95-af08acd3d813" xlink:href="hr-20230930.xsd#hr_EquityMethodInvestmentsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateLineItems_a42f37d2-aeed-4ba2-b860-e7f6df44ed1b" xlink:to="loc_hr_EquityMethodInvestmentsRollForward_13176b4f-6946-42b8-9f95-af08acd3d813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_c4bf9213-1d97-4d77-a1d9-96ae5a0c0464" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_13176b4f-6946-42b8-9f95-af08acd3d813" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_c4bf9213-1d97-4d77-a1d9-96ae5a0c0464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_eac234d2-9b61-47c2-bbe2-51f176392210" xlink:href="hr-20230930.xsd#hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_13176b4f-6946-42b8-9f95-af08acd3d813" xlink:to="loc_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod_eac234d2-9b61-47c2-bbe2-51f176392210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_8abb1337-9617-4391-a23f-9b5bdc1388e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_13176b4f-6946-42b8-9f95-af08acd3d813" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_8abb1337-9617-4391-a23f-9b5bdc1388e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared_ce52f9f1-4acf-419f-b2bd-b9303732ad9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_13176b4f-6946-42b8-9f95-af08acd3d813" xlink:to="loc_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared_ce52f9f1-4acf-419f-b2bd-b9303732ad9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_814b890d-9793-4dbc-801a-6182abf83562" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_EquityMethodInvestmentsRollForward_13176b4f-6946-42b8-9f95-af08acd3d813" xlink:to="loc_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures_814b890d-9793-4dbc-801a-6182abf83562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureOwnershipPercentage_389fe3e5-640a-4dce-b4bb-813913624d9d" xlink:href="hr-20230930.xsd#hr_JointVentureOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RealEstateLineItems_a42f37d2-aeed-4ba2-b860-e7f6df44ed1b" xlink:to="loc_hr_JointVentureOwnershipPercentage_389fe3e5-640a-4dce-b4bb-813913624d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#RealEstateInvestmentsDispositionsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_acdabde0-7b5d-462e-bd23-a1f7f2ec9cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ScheduleOfRealEstateDispositionsTable_67235c83-334d-4bf3-b70a-63f53097f893" xlink:href="hr-20230930.xsd#hr_ScheduleOfRealEstateDispositionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_acdabde0-7b5d-462e-bd23-a1f7f2ec9cd2" xlink:to="loc_hr_ScheduleOfRealEstateDispositionsTable_67235c83-334d-4bf3-b70a-63f53097f893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f4fbfa87-37bf-45ea-8469-a36ae50cac2b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable_67235c83-334d-4bf3-b70a-63f53097f893" xlink:to="loc_srt_StatementGeographicalAxis_f4fbfa87-37bf-45ea-8469-a36ae50cac2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f4fbfa87-37bf-45ea-8469-a36ae50cac2b" xlink:to="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TampaFLMiamiFLMember_1dd452a6-631a-410a-b45e-25b56fa82f6e" xlink:href="hr-20230930.xsd#hr_TampaFLMiamiFLMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:to="loc_hr_TampaFLMiamiFLMember_1dd452a6-631a-410a-b45e-25b56fa82f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DallasTXMember_66495ccf-e0b6-495d-a1d4-dd0f3026d309" xlink:href="hr-20230930.xsd#hr_DallasTXMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:to="loc_hr_DallasTXMember_66495ccf-e0b6-495d-a1d4-dd0f3026d309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_STLouisMoMember_8f71ddc5-8b16-4188-98d1-7eb5debfc0ad" xlink:href="hr-20230930.xsd#hr_STLouisMoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:to="loc_hr_STLouisMoMember_8f71ddc5-8b16-4188-98d1-7eb5debfc0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LosAngelesCaliforniaMember_ed2247fe-d6ec-47ef-a077-8108dba20ce5" xlink:href="hr-20230930.xsd#hr_LosAngelesCaliforniaMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:to="loc_hr_LosAngelesCaliforniaMember_ed2247fe-d6ec-47ef-a077-8108dba20ce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AlbanyNYMember_5f3bfa97-72f5-41f5-99b3-51e936ad962a" xlink:href="hr-20230930.xsd#hr_AlbanyNYMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:to="loc_hr_AlbanyNYMember_5f3bfa97-72f5-41f5-99b3-51e936ad962a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_HoustonTXMember_92954c96-385a-4f2b-8dea-d737eaf70d5d" xlink:href="hr-20230930.xsd#hr_HoustonTXMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:to="loc_hr_HoustonTXMember_92954c96-385a-4f2b-8dea-d737eaf70d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AtlantaGAMember_b1e05486-7d21-482d-ad9c-528ba48225ae" xlink:href="hr-20230930.xsd#hr_AtlantaGAMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:to="loc_hr_AtlantaGAMember_b1e05486-7d21-482d-ad9c-528ba48225ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ChicagoILMember_b968b642-250a-43d0-a024-584a0092d933" xlink:href="hr-20230930.xsd#hr_ChicagoILMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_9e3d8583-6678-4527-b429-316c2206faa9" xlink:to="loc_hr_ChicagoILMember_b968b642-250a-43d0-a024-584a0092d933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_2eedc4dc-c30e-4bf4-941a-b4555e24ce1a" xlink:href="hr-20230930.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable_67235c83-334d-4bf3-b70a-63f53097f893" xlink:to="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_2eedc4dc-c30e-4bf4-941a-b4555e24ce1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_70b00164-740c-4fe1-a86c-0ba46ae2dd22" xlink:href="hr-20230930.xsd#hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis_2eedc4dc-c30e-4bf4-941a-b4555e24ce1a" xlink:to="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_70b00164-740c-4fe1-a86c-0ba46ae2dd22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsMember_c78c2a79-d203-4d93-b3d1-d3b52a47ac44" xlink:href="hr-20230930.xsd#hr_RealEstateDispositionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain_70b00164-740c-4fe1-a86c-0ba46ae2dd22" xlink:to="loc_hr_RealEstateDispositionsMember_c78c2a79-d203-4d93-b3d1-d3b52a47ac44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:href="hr-20230930.xsd#hr_RealEstateDispositionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ScheduleOfRealEstateDispositionsTable_67235c83-334d-4bf3-b70a-63f53097f893" xlink:to="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DispositionSalesPrice_f8d680cc-4b49-4eb0-8492-01c998175741" xlink:href="hr-20230930.xsd#hr_DispositionSalesPrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_DispositionSalesPrice_f8d680cc-4b49-4eb0-8492-01c998175741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ClosingAdjustmentsDisposedEntity_82f9086d-7cbc-4848-807d-eac8fe37d160" xlink:href="hr-20230930.xsd#hr_ClosingAdjustmentsDisposedEntity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_ClosingAdjustmentsDisposedEntity_82f9086d-7cbc-4848-807d-eac8fe37d160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceMortgageNotes_9624466c-c2b9-4615-935c-2377daaed4e9" xlink:href="hr-20230930.xsd#hr_FinanceMortgageNotes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_FinanceMortgageNotes_9624466c-c2b9-4615-935c-2377daaed4e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_f54de941-f746-4723-aff4-f272a6c3af1b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment_f54de941-f746-4723-aff4-f272a6c3af1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_b6adc08d-da2d-422c-af31-aa3ada8f2d6b" xlink:href="hr-20230930.xsd#hr_RealEstateInvestmentNetDisposedOfDuringPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_RealEstateInvestmentNetDisposedOfDuringPeriod_b6adc08d-da2d-422c-af31-aa3ada8f2d6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RealEstateOther_03183315-4e55-4337-838f-88ece716cea1" xlink:href="hr-20230930.xsd#hr_RealEstateOther"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_RealEstateOther_03183315-4e55-4337-838f-88ece716cea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfAssets_6776b336-4653-4bff-a781-1b5b730f1143" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GainLossOnDispositionOfAssets"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_us-gaap_GainLossOnDispositionOfAssets_6776b336-4653-4bff-a781-1b5b730f1143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_72afb055-573f-435d-9221-cec863f61f8e" xlink:href="hr-20230930.xsd#hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits_72afb055-573f-435d-9221-cec863f61f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_84d1f57a-3403-4623-9c7b-99623a89cea7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_84d1f57a-3403-4623-9c7b-99623a89cea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertyDispositions_b114569d-4888-41dc-90b4-3f9b795d228e" xlink:href="hr-20230930.xsd#hr_NumberOfPropertyDispositions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_NumberOfPropertyDispositions_b114569d-4888-41dc-90b4-3f9b795d228e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureOwnershipPercentage_6a222ebd-a97a-48d8-aee0-cf284a3c556b" xlink:href="hr-20230930.xsd#hr_JointVentureOwnershipPercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_JointVentureOwnershipPercentage_6a222ebd-a97a-48d8-aee0-cf284a3c556b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageNote_73692597-4e15-45f8-ba19-573236be131f" xlink:href="hr-20230930.xsd#hr_MortgageNote"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_hr_MortgageNote_73692597-4e15-45f8-ba19-573236be131f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AreaOfLand_abb46edb-c42b-4bff-ae7e-30c6828650ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AreaOfLand"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_RealEstateDispositionsLineItems_a8a2453c-9200-4dc1-bd29-81a417afae8a" xlink:to="loc_us-gaap_AreaOfLand_abb46edb-c42b-4bff-ae7e-30c6828650ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#RealEstateInvestmentsAssetsHeldforSaleDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_95603fd9-c324-4496-a160-8894f12e39e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_7b17bd5c-969f-4e9e-9409-31148444b79c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_95603fd9-c324-4496-a160-8894f12e39e1" xlink:to="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_7b17bd5c-969f-4e9e-9409-31148444b79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_55d57601-cdcd-46ae-83cb-ad04a535a598" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_7b17bd5c-969f-4e9e-9409-31148444b79c" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_55d57601-cdcd-46ae-83cb-ad04a535a598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_da75607e-ee45-42c8-bf65-48d89c22c51b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_55d57601-cdcd-46ae-83cb-ad04a535a598" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_da75607e-ee45-42c8-bf65-48d89c22c51b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_d64f6c5c-7e09-439a-96d7-b248bb453cb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_da75607e-ee45-42c8-bf65-48d89c22c51b" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_d64f6c5c-7e09-439a-96d7-b248bb453cb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongLivedAssetsHeldForSaleLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable_7b17bd5c-969f-4e9e-9409-31148444b79c" xlink:to="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfPropertiesClassifiedAsHeldForSale_404d520b-dc14-4c7b-b493-096459b876b2" xlink:href="hr-20230930.xsd#hr_NumberOfPropertiesClassifiedAsHeldForSale"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_hr_NumberOfPropertiesClassifiedAsHeldForSale_404d520b-dc14-4c7b-b493-096459b876b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfCorporateEntityClassifiedAsHeldForSale_0581fcc2-800c-4100-b6dd-7e36cc239eff" xlink:href="hr-20230930.xsd#hr_NumberOfCorporateEntityClassifiedAsHeldForSale"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_hr_NumberOfCorporateEntityClassifiedAsHeldForSale_0581fcc2-800c-4100-b6dd-7e36cc239eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale_c1c79372-bdc4-46cb-84e3-c12089e85b01" xlink:href="hr-20230930.xsd#hr_ImpairmentChargeOnRealEstateAssetsHeldForSale"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale_c1c79372-bdc4-46cb-84e3-c12089e85b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_e13b17cb-1ed3-45a0-9cd2-a06510c0a52f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Land"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_Land_e13b17cb-1ed3-45a0-9cd2-a06510c0a52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_4b2da176-d0a0-49bb-86f9-bfc01275f720" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentBuildingAndBuildingImprovements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_InvestmentBuildingAndBuildingImprovements_4b2da176-d0a0-49bb-86f9-bfc01275f720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LeaseIntangibles_2d1da8e1-92d2-4220-a325-43744dc883fb" xlink:href="hr-20230930.xsd#hr_LeaseIntangibles"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_hr_LeaseIntangibles_2d1da8e1-92d2-4220-a325-43744dc883fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAtCost_fb87c77a-4585-4a87-ba92-9c5de14d7c50" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyAtCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAtCost_fb87c77a-4585-4a87-ba92-9c5de14d7c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_7e4821fe-ad3f-4960-837b-78c8e380c374" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation_7e4821fe-ad3f-4960-837b-78c8e380c374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RealEstateInvestmentPropertyNet_16478f55-1399-4dca-b1c8-a8a3b0e52227" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RealEstateInvestmentPropertyNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_RealEstateInvestmentPropertyNet_16478f55-1399-4dca-b1c8-a8a3b0e52227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_98a77d76-7dd4-47ec-8e06-1e015802c8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_98a77d76-7dd4-47ec-8e06-1e015802c8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_9d7be0ae-ecaa-4b2c-afb8-069d86c1cb48" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets_9d7be0ae-ecaa-4b2c-afb8-069d86c1cb48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_fdd5a00d-d80e-4c61-9b5d-43a0e9a465a9" xlink:href="hr-20230930.xsd#hr_AssetsHeldForSaleAndDiscontinuedOperationsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet_fdd5a00d-d80e-4c61-9b5d-43a0e9a465a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_99aee7dd-965d-421c-9508-51d696ab2bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities_99aee7dd-965d-421c-9508-51d696ab2bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_0b316693-3aad-4cbd-85d3-4ff6c34d634b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_OperatingLeaseLiability_0b316693-3aad-4cbd-85d3-4ff6c34d634b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_6003eb17-4316-46d3-8da1-052f261068f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities_6003eb17-4316-46d3-8da1-052f261068f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_abc9f97a-bc75-4e75-8a73-170fc58e3f27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongLivedAssetsHeldForSaleLineItems_285d5532-d7df-4341-825c-4a5e2186b450" xlink:to="loc_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation_abc9f97a-bc75-4e75-8a73-170fc58e3f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesLeaseIncomeDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#LeasesLeaseIncomeDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesLeaseIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_4f52f94c-7dee-4e3c-b9fe-8d8acb2449a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLeaseIncome_816d8ea2-e4b9-42f6-96b1-d32b5431f549" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLeaseIncome"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_4f52f94c-7dee-4e3c-b9fe-8d8acb2449a6" xlink:to="loc_us-gaap_OperatingLeaseLeaseIncome_816d8ea2-e4b9-42f6-96b1-d32b5431f549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesLessorAccountingDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#LeasesLessorAccountingDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesLessorAccountingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_715f5df6-fa23-4583-bf59-17f0be2c78ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_be93adb6-a14e-4474-9a5b-d35eb63c9cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_715f5df6-fa23-4583-bf59-17f0be2c78ce" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_be93adb6-a14e-4474-9a5b-d35eb63c9cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_ea437c04-daf9-4b40-bb2b-0f1d2c347a68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_be93adb6-a14e-4474-9a5b-d35eb63c9cb0" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear_ea437c04-daf9-4b40-bb2b-0f1d2c347a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_40687b5e-b01f-464c-ae93-bc1b005f354f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_be93adb6-a14e-4474-9a5b-d35eb63c9cb0" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths_40687b5e-b01f-464c-ae93-bc1b005f354f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_f7749ed3-b296-4490-9ae6-327a557bbcfa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_be93adb6-a14e-4474-9a5b-d35eb63c9cb0" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears_f7749ed3-b296-4490-9ae6-327a557bbcfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_dcaa027d-6663-4b0c-bbd4-09c4fcadd83e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_be93adb6-a14e-4474-9a5b-d35eb63c9cb0" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears_dcaa027d-6663-4b0c-bbd4-09c4fcadd83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_14e5382f-d439-4397-865d-1c8964f536d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_be93adb6-a14e-4474-9a5b-d35eb63c9cb0" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears_14e5382f-d439-4397-865d-1c8964f536d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_0f479af0-5234-43d2-be60-9c323023a696" xlink:href="hr-20230930.xsd#hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_be93adb6-a14e-4474-9a5b-d35eb63c9cb0" xlink:to="loc_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour_0f479af0-5234-43d2-be60-9c323023a696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_29b16451-e525-4529-8124-faa7de9a072f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LessorOperatingLeasePaymentsToBeReceived"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract_be93adb6-a14e-4474-9a5b-d35eb63c9cb0" xlink:to="loc_us-gaap_LessorOperatingLeasePaymentsToBeReceived_29b16451-e525-4529-8124-faa7de9a072f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesGroundLeasesDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#LeasesGroundLeasesDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesGroundLeasesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_87e07fd7-4666-4f5d-a478-0ac119680d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_20138c7c-b548-4d98-a43e-d13d044c4dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_87e07fd7-4666-4f5d-a478-0ac119680d0f" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_20138c7c-b548-4d98-a43e-d13d044c4dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_981d2f24-1aef-40da-960f-792f6e7f36f0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_20138c7c-b548-4d98-a43e-d13d044c4dd0" xlink:to="loc_srt_RangeAxis_981d2f24-1aef-40da-960f-792f6e7f36f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f1b2584e-ef5a-423d-8619-5cc04b1ebde0" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_981d2f24-1aef-40da-960f-792f6e7f36f0" xlink:to="loc_srt_RangeMember_f1b2584e-ef5a-423d-8619-5cc04b1ebde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6a3158d7-034d-4439-bd7a-310446394c84" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f1b2584e-ef5a-423d-8619-5cc04b1ebde0" xlink:to="loc_srt_MinimumMember_6a3158d7-034d-4439-bd7a-310446394c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_96c60023-74b8-4093-97b9-4b8aca5ed20e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f1b2584e-ef5a-423d-8619-5cc04b1ebde0" xlink:to="loc_srt_MaximumMember_96c60023-74b8-4093-97b9-4b8aca5ed20e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_23d0d253-7372-476a-afb0-f94359e03988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_20138c7c-b548-4d98-a43e-d13d044c4dd0" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_23d0d253-7372-476a-afb0-f94359e03988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfPropertiesSubjectToGroundLeases_05ad77ef-4a7e-4c3b-be92-4705700d9d09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfPropertiesSubjectToGroundLeases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_23d0d253-7372-476a-afb0-f94359e03988" xlink:to="loc_us-gaap_NumberOfPropertiesSubjectToGroundLeases_05ad77ef-4a7e-4c3b-be92-4705700d9d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SquareFeetSubjecttoGroundLeases_a0d5940c-feeb-4cc0-9be5-05028c96b872" xlink:href="hr-20230930.xsd#hr_SquareFeetSubjecttoGroundLeases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_23d0d253-7372-476a-afb0-f94359e03988" xlink:to="loc_hr_SquareFeetSubjecttoGroundLeases_a0d5940c-feeb-4cc0-9be5-05028c96b872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_34fd9005-2d86-43f6-89e3-8802eaa61f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_23d0d253-7372-476a-afb0-f94359e03988" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_34fd9005-2d86-43f6-89e3-8802eaa61f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberofGroundLeasesPrepaid_99788ad4-a7dd-4afe-a56a-86fa114138ee" xlink:href="hr-20230930.xsd#hr_NumberofGroundLeasesPrepaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_23d0d253-7372-476a-afb0-f94359e03988" xlink:to="loc_hr_NumberofGroundLeasesPrepaid_99788ad4-a7dd-4afe-a56a-86fa114138ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_AmortizationofPrepaidRent_4a0b85e8-ed27-4168-a797-76f6600be8f7" xlink:href="hr-20230930.xsd#hr_AmortizationofPrepaidRent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_23d0d253-7372-476a-afb0-f94359e03988" xlink:to="loc_hr_AmortizationofPrepaidRent_4a0b85e8-ed27-4168-a797-76f6600be8f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberofGroundLeasesExcludingPrepaidLeases_d303908b-00de-478d-aa13-54352c9ced20" xlink:href="hr-20230930.xsd#hr_NumberofGroundLeasesExcludingPrepaidLeases"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_23d0d253-7372-476a-afb0-f94359e03988" xlink:to="loc_hr_NumberofGroundLeasesExcludingPrepaidLeases_d303908b-00de-478d-aa13-54352c9ced20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#LeasesFutureMinimumLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_dad169aa-7ffc-4cf9-8ba9-18475f537305" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_aecc179b-cedf-4c0d-ad0a-20752724753f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dad169aa-7ffc-4cf9-8ba9-18475f537305" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_aecc179b-cedf-4c0d-ad0a-20752724753f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_60566cae-d2d6-4007-8cfb-acbcfe2da18f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_aecc179b-cedf-4c0d-ad0a-20752724753f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_60566cae-d2d6-4007-8cfb-acbcfe2da18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f087d52c-a3f6-4ac0-9ab0-69153ddc9856" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_aecc179b-cedf-4c0d-ad0a-20752724753f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f087d52c-a3f6-4ac0-9ab0-69153ddc9856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7f607891-3494-4259-948c-c97d37eae59e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_aecc179b-cedf-4c0d-ad0a-20752724753f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_7f607891-3494-4259-948c-c97d37eae59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2405fe12-8fef-4992-8e53-a208d7019f74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_aecc179b-cedf-4c0d-ad0a-20752724753f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2405fe12-8fef-4992-8e53-a208d7019f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5845bd65-002a-455f-a0d4-1d9e2360ae88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_aecc179b-cedf-4c0d-ad0a-20752724753f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_5845bd65-002a-455f-a0d4-1d9e2360ae88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_04b386f7-2e16-49e1-9922-9fcb6c0a580b" xlink:href="hr-20230930.xsd#hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_aecc179b-cedf-4c0d-ad0a-20752724753f" xlink:to="loc_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour_04b386f7-2e16-49e1-9922-9fcb6c0a580b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_78edb52a-9ea5-4030-9760-db500fd0a5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_aecc179b-cedf-4c0d-ad0a-20752724753f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_78edb52a-9ea5-4030-9760-db500fd0a5ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5303aba7-4258-4264-a53b-69d15b8bf303" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_aecc179b-cedf-4c0d-ad0a-20752724753f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5303aba7-4258-4264-a53b-69d15b8bf303" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_45b4b801-6358-4dcb-8e62-5f84c1f75c1c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_aecc179b-cedf-4c0d-ad0a-20752724753f" xlink:to="loc_us-gaap_OperatingLeaseLiability_45b4b801-6358-4dcb-8e62-5f84c1f75c1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_5c963554-c058-4d77-b07d-4adcc84424b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_dad169aa-7ffc-4cf9-8ba9-18475f537305" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_5c963554-c058-4d77-b07d-4adcc84424b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_156df853-9f9e-47af-8e9e-a849ea56559f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_5c963554-c058-4d77-b07d-4adcc84424b8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_156df853-9f9e-47af-8e9e-a849ea56559f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_78d2bdd9-f231-4dbf-92c5-b0eba2071493" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_5c963554-c058-4d77-b07d-4adcc84424b8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_78d2bdd9-f231-4dbf-92c5-b0eba2071493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_bb408264-3c63-479a-812e-548d48924337" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_5c963554-c058-4d77-b07d-4adcc84424b8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_bb408264-3c63-479a-812e-548d48924337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_08b9a9b4-0684-43cf-9487-5a0915535f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_5c963554-c058-4d77-b07d-4adcc84424b8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_08b9a9b4-0684-43cf-9487-5a0915535f1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_3768d50e-811b-4071-805c-68c76dc52378" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_5c963554-c058-4d77-b07d-4adcc84424b8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_3768d50e-811b-4071-805c-68c76dc52378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_8a982540-88bb-4d2e-88b6-86f83dc1a4c8" xlink:href="hr-20230930.xsd#hr_FinanceLeaseLiabilityToBePaidAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_5c963554-c058-4d77-b07d-4adcc84424b8" xlink:to="loc_hr_FinanceLeaseLiabilityToBePaidAfterYearFour_8a982540-88bb-4d2e-88b6-86f83dc1a4c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2d8f51bb-af7e-4506-9ebe-a9ccac04c48c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_5c963554-c058-4d77-b07d-4adcc84424b8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_2d8f51bb-af7e-4506-9ebe-a9ccac04c48c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_ce4619af-cc5d-4ccf-9415-172b6c3a6244" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_5c963554-c058-4d77-b07d-4adcc84424b8" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_ce4619af-cc5d-4ccf-9415-172b6c3a6244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_2597367d-98a8-4d6c-855b-deb64da2b32f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_5c963554-c058-4d77-b07d-4adcc84424b8" xlink:to="loc_us-gaap_FinanceLeaseLiability_2597367d-98a8-4d6c-855b-deb64da2b32f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="simple" xlink:href="hr-20230930.xsd#LeasesFutureMinimumLeasePaymentsDetails_1"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://healthcarerealty.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#LeasesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6117b6e8-2da6-44d6-8581-d8613c66cc15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_68837521-5a8b-44ab-822a-ffc924c7ec7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6117b6e8-2da6-44d6-8581-d8613c66cc15" xlink:to="loc_us-gaap_LeaseCostAbstract_68837521-5a8b-44ab-822a-ffc924c7ec7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_32523869-2302-44d5-995e-ea029066adb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_68837521-5a8b-44ab-822a-ffc924c7ec7b" xlink:to="loc_us-gaap_OperatingLeaseCost_32523869-2302-44d5-995e-ea029066adb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_31a5560f-95c7-45a5-90f3-3f83bd2ff102" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_68837521-5a8b-44ab-822a-ffc924c7ec7b" xlink:to="loc_us-gaap_VariableLeaseCost_31a5560f-95c7-45a5-90f3-3f83bd2ff102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_2911ecf8-b4a2-41ea-9e93-b18d56298eec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeFinanceLeaseDescriptionAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6117b6e8-2da6-44d6-8581-d8613c66cc15" xlink:to="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_2911ecf8-b4a2-41ea-9e93-b18d56298eec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_5451f24d-bee3-44b5-a098-31539c23bd9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_2911ecf8-b4a2-41ea-9e93-b18d56298eec" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_5451f24d-bee3-44b5-a098-31539c23bd9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_0d2e4b0b-13dd-47bf-93ad-ef4896c65463" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_2911ecf8-b4a2-41ea-9e93-b18d56298eec" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_0d2e4b0b-13dd-47bf-93ad-ef4896c65463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_6f123704-08c8-4283-a887-6e5fd53b2167" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeFinanceLeaseDescriptionAbstract_2911ecf8-b4a2-41ea-9e93-b18d56298eec" xlink:to="loc_us-gaap_LeaseCost_6f123704-08c8-4283-a887-6e5fd53b2167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesOperatingAbstract_08ccf64b-d5d5-4500-8a18-e5a2d4c8e5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesOperatingAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6117b6e8-2da6-44d6-8581-d8613c66cc15" xlink:to="loc_us-gaap_LeasesOperatingAbstract_08ccf64b-d5d5-4500-8a18-e5a2d4c8e5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_9ab51ce0-e3ce-46f3-9395-7e8cd0a082d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_08ccf64b-d5d5-4500-8a18-e5a2d4c8e5f9" xlink:to="loc_us-gaap_OperatingLeasePayments_9ab51ce0-e3ce-46f3-9395-7e8cd0a082d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_9d8b28d9-6a13-4131-ace9-442104aa8ca9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_08ccf64b-d5d5-4500-8a18-e5a2d4c8e5f9" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_9d8b28d9-6a13-4131-ace9-442104aa8ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_FinanceLeasePrincipalOnlyPayments_0427426b-c461-4be9-9c9b-22feee7fddb2" xlink:href="hr-20230930.xsd#hr_FinanceLeasePrincipalOnlyPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_08ccf64b-d5d5-4500-8a18-e5a2d4c8e5f9" xlink:to="loc_hr_FinanceLeasePrincipalOnlyPayments_0427426b-c461-4be9-9c9b-22feee7fddb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_a32c554e-96d3-44bd-a160-bdeb04881b98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_08ccf64b-d5d5-4500-8a18-e5a2d4c8e5f9" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_a32c554e-96d3-44bd-a160-bdeb04881b98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9d59e9eb-e1e2-4dd0-b670-69d89c4de630" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_08ccf64b-d5d5-4500-8a18-e5a2d4c8e5f9" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_9d59e9eb-e1e2-4dd0-b670-69d89c4de630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2dce575b-ef8c-4a26-b584-7eb54f0e5eb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_08ccf64b-d5d5-4500-8a18-e5a2d4c8e5f9" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_2dce575b-ef8c-4a26-b584-7eb54f0e5eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_82c5c2c1-bfc9-4a46-975d-dbfcedd7b7ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_08ccf64b-d5d5-4500-8a18-e5a2d4c8e5f9" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_82c5c2c1-bfc9-4a46-975d-dbfcedd7b7ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_7f9147e1-f09c-48d7-b307-1d1992b759ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_08ccf64b-d5d5-4500-8a18-e5a2d4c8e5f9" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_7f9147e1-f09c-48d7-b307-1d1992b759ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_6899c972-38d8-4f6f-b86f-ad0069ed7a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesOperatingAbstract_08ccf64b-d5d5-4500-8a18-e5a2d4c8e5f9" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_6899c972-38d8-4f6f-b86f-ad0069ed7a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/NotesandBondsPayableDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#NotesandBondsPayableDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/NotesandBondsPayableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7bc0ac6d-2fad-4125-89eb-628909582c63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9f8af482-3466-4c31-af3e-c5eca95581c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7bc0ac6d-2fad-4125-89eb-628909582c63" xlink:to="loc_us-gaap_DebtInstrumentTable_9f8af482-3466-4c31-af3e-c5eca95581c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8bd1c421-32d7-4b65-b9d2-173b357bb014" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9f8af482-3466-4c31-af3e-c5eca95581c1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8bd1c421-32d7-4b65-b9d2-173b357bb014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6959e4e0-b545-47fc-ac36-ec48d5d5b70b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8bd1c421-32d7-4b65-b9d2-173b357bb014" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6959e4e0-b545-47fc-ac36-ec48d5d5b70b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_969bc05d-a046-449b-b697-3892abeb40ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6959e4e0-b545-47fc-ac36-ec48d5d5b70b" xlink:to="loc_us-gaap_LineOfCreditMember_969bc05d-a046-449b-b697-3892abeb40ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MediumTermNotesMember_f00d1473-7c9f-4f18-901c-a3c02f12ede0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MediumTermNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6959e4e0-b545-47fc-ac36-ec48d5d5b70b" xlink:to="loc_us-gaap_MediumTermNotesMember_f00d1473-7c9f-4f18-901c-a3c02f12ede0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_671534b3-1d73-4a14-85b3-803c9f0680d7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6959e4e0-b545-47fc-ac36-ec48d5d5b70b" xlink:to="loc_us-gaap_SeniorNotesMember_671534b3-1d73-4a14-85b3-803c9f0680d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_1485c015-e957-4b91-8c01-3470d0e8d5a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgagesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6959e4e0-b545-47fc-ac36-ec48d5d5b70b" xlink:to="loc_us-gaap_MortgagesMember_1485c015-e957-4b91-8c01-3470d0e8d5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_81d187b2-3db1-40e7-930d-ee1ec139bcd8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9f8af482-3466-4c31-af3e-c5eca95581c1" xlink:to="loc_us-gaap_DebtInstrumentAxis_81d187b2-3db1-40e7-930d-ee1ec139bcd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_81d187b2-3db1-40e7-930d-ee1ec139bcd8" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_UnsecuredCreditFacilityOneMember_43922bac-a839-4657-add7-b48c02034d24" xlink:href="hr-20230930.xsd#hr_UnsecuredCreditFacilityOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_UnsecuredCreditFacilityOneMember_43922bac-a839-4657-add7-b48c02034d24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDueMay2024Member_a62f9bc1-0192-4c97-92fb-baf9bfdada27" xlink:href="hr-20230930.xsd#hr_TermLoanDueMay2024Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_TermLoanDueMay2024Member_a62f9bc1-0192-4c97-92fb-baf9bfdada27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDueJuly2024Member_5d1094bc-7f26-4042-8bab-332cb37d2984" xlink:href="hr-20230930.xsd#hr_TermLoanDueJuly2024Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_TermLoanDueJuly2024Member_5d1094bc-7f26-4042-8bab-332cb37d2984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2025Member_ea9d0197-f98e-4a64-8efe-204f0271be7c" xlink:href="hr-20230930.xsd#hr_TermLoanDue2025Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_TermLoanDue2025Member_ea9d0197-f98e-4a64-8efe-204f0271be7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoandue2026Member_d5499d93-631a-4e9e-a27b-9d592a178d3d" xlink:href="hr-20230930.xsd#hr_TermLoandue2026Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_TermLoandue2026Member_d5499d93-631a-4e9e-a27b-9d592a178d3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2027Member_941ca346-f5e6-47ef-9321-2961dfe2b978" xlink:href="hr-20230930.xsd#hr_TermLoanDue2027Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_TermLoanDue2027Member_941ca346-f5e6-47ef-9321-2961dfe2b978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_TermLoanDue2028Member_aecc1501-d387-4093-b099-d9fe03f01ffc" xlink:href="hr-20230930.xsd#hr_TermLoanDue2028Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_TermLoanDue2028Member_aecc1501-d387-4093-b099-d9fe03f01ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2025Member_91e4224d-7510-4ca1-b145-450cdd632df6" xlink:href="hr-20230930.xsd#hr_SeniorNotesdue2025Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_SeniorNotesdue2025Member_91e4224d-7510-4ca1-b145-450cdd632df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2026Member_4b1c1a35-97eb-4e03-85c8-e7ae05f66183" xlink:href="hr-20230930.xsd#hr_SeniorNotesDue2026Member"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_SeniorNotesDue2026Member_4b1c1a35-97eb-4e03-85c8-e7ae05f66183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2027Member_d2db5014-9580-480b-b3c8-ba2af06ea6b3" xlink:href="hr-20230930.xsd#hr_SeniorNotesDue2027Member"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_SeniorNotesDue2027Member_d2db5014-9580-480b-b3c8-ba2af06ea6b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2028Member_509e6cb4-66d6-4882-a53a-2fda66466543" xlink:href="hr-20230930.xsd#hr_SeniorNotesdue2028Member"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_SeniorNotesdue2028Member_509e6cb4-66d6-4882-a53a-2fda66466543" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_f49335b0-3e37-4a3a-b310-59fcd63dceee" xlink:href="hr-20230930.xsd#hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember_f49335b0-3e37-4a3a-b310-59fcd63dceee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesdue2030Member_df7fe3a9-f6b8-4f69-9d69-852baf73e3f6" xlink:href="hr-20230930.xsd#hr_SeniorNotesdue2030Member"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_SeniorNotesdue2030Member_df7fe3a9-f6b8-4f69-9d69-852baf73e3f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2031Member_975612cf-920f-44ef-b2cf-4e97a9142351" xlink:href="hr-20230930.xsd#hr_SeniorNotesDue2031Member"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_SeniorNotesDue2031Member_975612cf-920f-44ef-b2cf-4e97a9142351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_9a2664f3-f906-4639-b249-eca084a2780e" xlink:href="hr-20230930.xsd#hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember_9a2664f3-f906-4639-b249-eca084a2780e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageNotesPayableNetMember_0fb0588e-9302-418f-bd91-77152e84b426" xlink:href="hr-20230930.xsd#hr_MortgageNotesPayableNetMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_8f055fab-5889-4486-9648-68e4f0f9c2c6" xlink:to="loc_hr_MortgageNotesPayableNetMember_0fb0588e-9302-418f-bd91-77152e84b426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_e36b1edb-ed4d-43a0-bf6a-7df05da5e956" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9f8af482-3466-4c31-af3e-c5eca95581c1" xlink:to="loc_srt_RangeAxis_e36b1edb-ed4d-43a0-bf6a-7df05da5e956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6fc924c7-871d-4fa5-9c3a-06dad9205c6f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_e36b1edb-ed4d-43a0-bf6a-7df05da5e956" xlink:to="loc_srt_RangeMember_6fc924c7-871d-4fa5-9c3a-06dad9205c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3010e10f-0a28-414c-8e85-dbaceca6868f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6fc924c7-871d-4fa5-9c3a-06dad9205c6f" xlink:to="loc_srt_MinimumMember_3010e10f-0a28-414c-8e85-dbaceca6868f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a27f4e8a-4971-4261-8137-33a04968fc8e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_6fc924c7-871d-4fa5-9c3a-06dad9205c6f" xlink:to="loc_srt_MaximumMember_a27f4e8a-4971-4261-8137-33a04968fc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_a59673dd-8e07-4169-b338-e3ae4d1c6db9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9f8af482-3466-4c31-af3e-c5eca95581c1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_a59673dd-8e07-4169-b338-e3ae4d1c6db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_401bb514-3b4e-44ab-84a8-9dd0565e242a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59673dd-8e07-4169-b338-e3ae4d1c6db9" xlink:to="loc_us-gaap_LongTermDebt_401bb514-3b4e-44ab-84a8-9dd0565e242a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_b0b45a2f-c9b7-4f72-8bf7-beff0ac5bdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59673dd-8e07-4169-b338-e3ae4d1c6db9" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_b0b45a2f-c9b7-4f72-8bf7-beff0ac5bdcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b5139148-eabc-479a-af90-1ed4bee64173" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59673dd-8e07-4169-b338-e3ae4d1c6db9" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_b5139148-eabc-479a-af90-1ed4bee64173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_685f9599-a293-4912-b90a-ce8f2bdb3a68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59673dd-8e07-4169-b338-e3ae4d1c6db9" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_685f9599-a293-4912-b90a-ce8f2bdb3a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DebtInstrumentExtensionPeriodForMaturityDate_1bf97b92-ddf7-4b9b-ad77-b4aef98d3bce" xlink:href="hr-20230930.xsd#hr_DebtInstrumentExtensionPeriodForMaturityDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59673dd-8e07-4169-b338-e3ae4d1c6db9" xlink:to="loc_hr_DebtInstrumentExtensionPeriodForMaturityDate_1bf97b92-ddf7-4b9b-ad77-b4aef98d3bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_b4230ad3-9336-4e72-aaac-d4eb48fe5ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_a59673dd-8e07-4169-b338-e3ae4d1c6db9" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_b4230ad3-9336-4e72-aaac-d4eb48fe5ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#NotesandBondsPayableNarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ea9a0c31-e08c-42da-a37f-9f43eab5c35a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_236af0c7-f3df-4c92-9ed9-2f07c9b97c70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ea9a0c31-e08c-42da-a37f-9f43eab5c35a" xlink:to="loc_us-gaap_DebtInstrumentTable_236af0c7-f3df-4c92-9ed9-2f07c9b97c70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAxis_7fcc8a89-8a4c-4299-9677-392683c8fbbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_236af0c7-f3df-4c92-9ed9-2f07c9b97c70" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAxis_7fcc8a89-8a4c-4299-9677-392683c8fbbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_1f5db581-11b0-4463-8614-43f16afa32cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAxis_7fcc8a89-8a4c-4299-9677-392683c8fbbc" xlink:to="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_1f5db581-11b0-4463-8614-43f16afa32cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_a5d4d348-5ac2-478a-9979-9361292744f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgagesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ExtinguishmentOfDebtTypeDomain_1f5db581-11b0-4463-8614-43f16afa32cb" xlink:to="loc_us-gaap_MortgagesMember_a5d4d348-5ac2-478a-9979-9361292744f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f58cac1c-c525-49b1-ac04-f1fc1f870d45" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_236af0c7-f3df-4c92-9ed9-2f07c9b97c70" xlink:to="loc_srt_StatementGeographicalAxis_f58cac1c-c525-49b1-ac04-f1fc1f870d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0756c892-a837-4cec-a01c-72f25759fb7e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f58cac1c-c525-49b1-ac04-f1fc1f870d45" xlink:to="loc_srt_SegmentGeographicalDomain_0756c892-a837-4cec-a01c-72f25759fb7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CO_0acf8514-9aca-49bf-9aca-5b8a62a092ab" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_CO"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0756c892-a837-4cec-a01c-72f25759fb7e" xlink:to="loc_stpr_CO_0acf8514-9aca-49bf-9aca-5b8a62a092ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_GA_07cf4001-e153-463d-832a-9eb7859bf20e" xlink:href="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd#stpr_GA"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_0756c892-a837-4cec-a01c-72f25759fb7e" xlink:to="loc_stpr_GA_07cf4001-e153-463d-832a-9eb7859bf20e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5d9eb488-b6d7-465a-8925-b8f41c1d7665" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_236af0c7-f3df-4c92-9ed9-2f07c9b97c70" xlink:to="loc_us-gaap_DebtInstrumentAxis_5d9eb488-b6d7-465a-8925-b8f41c1d7665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fb555237-ef44-4720-80ba-7e4c490dc06f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5d9eb488-b6d7-465a-8925-b8f41c1d7665" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fb555237-ef44-4720-80ba-7e4c490dc06f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MortgageNotesPayableNetMember_e4e1dbcf-3f32-4dae-96ff-9c1e3cd2d33f" xlink:href="hr-20230930.xsd#hr_MortgageNotesPayableNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fb555237-ef44-4720-80ba-7e4c490dc06f" xlink:to="loc_hr_MortgageNotesPayableNetMember_e4e1dbcf-3f32-4dae-96ff-9c1e3cd2d33f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_bae2084d-1f8c-4876-bc15-2c640c0734cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_236af0c7-f3df-4c92-9ed9-2f07c9b97c70" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_bae2084d-1f8c-4876-bc15-2c640c0734cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6820a52d-99c3-4bb1-a4b1-70549fe195e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_bae2084d-1f8c-4876-bc15-2c640c0734cc" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6820a52d-99c3-4bb1-a4b1-70549fe195e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgagesMember_e61026fe-0419-4269-a615-4cd23b63d21f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgagesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6820a52d-99c3-4bb1-a4b1-70549fe195e7" xlink:to="loc_us-gaap_MortgagesMember_e61026fe-0419-4269-a615-4cd23b63d21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f4e277de-5f10-4eb9-9140-f20af9efe797" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_236af0c7-f3df-4c92-9ed9-2f07c9b97c70" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f4e277de-5f10-4eb9-9140-f20af9efe797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_3b31b187-ac0e-4b7f-a499-be3617ac3e29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4e277de-5f10-4eb9-9140-f20af9efe797" xlink:to="loc_us-gaap_LongTermDebt_3b31b187-ac0e-4b7f-a499-be3617ac3e29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SquareFeetSubjectToMortgageNotesPayable_75d8450b-b00b-470b-8b43-ac26c09806b8" xlink:href="hr-20230930.xsd#hr_SquareFeetSubjectToMortgageNotesPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4e277de-5f10-4eb9-9140-f20af9efe797" xlink:to="loc_hr_SquareFeetSubjectToMortgageNotesPayable_75d8450b-b00b-470b-8b43-ac26c09806b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PercentageOfInterestBearingInMortgageNotesPayable_94011f6f-9b71-4a13-b1e6-a01749ede0d2" xlink:href="hr-20230930.xsd#hr_PercentageOfInterestBearingInMortgageNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4e277de-5f10-4eb9-9140-f20af9efe797" xlink:to="loc_hr_PercentageOfInterestBearingInMortgageNotesPayable_94011f6f-9b71-4a13-b1e6-a01749ede0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_92e8a8f6-31b8-4da9-ac6a-b6e23947eeb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4e277de-5f10-4eb9-9140-f20af9efe797" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_92e8a8f6-31b8-4da9-ac6a-b6e23947eeb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_ef51d069-ace5-40fd-9f40-07f08b0d53c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4e277de-5f10-4eb9-9140-f20af9efe797" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_ef51d069-ace5-40fd-9f40-07f08b0d53c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ExtinguishmentOfDebtEncumberedSquareFootage_c404b85e-08b4-46b2-b98b-80d14781c541" xlink:href="hr-20230930.xsd#hr_ExtinguishmentOfDebtEncumberedSquareFootage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f4e277de-5f10-4eb9-9140-f20af9efe797" xlink:to="loc_hr_ExtinguishmentOfDebtEncumberedSquareFootage_c404b85e-08b4-46b2-b98b-80d14781c541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4d7d334e-ccf0-43c9-953b-c5df3c3ffa39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_629f7f53-6eb8-4100-b0bd-e2fb42bd88cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_4d7d334e-ccf0-43c9-953b-c5df3c3ffa39" xlink:to="loc_us-gaap_DerivativeTable_629f7f53-6eb8-4100-b0bd-e2fb42bd88cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_7869d57c-49c0-4838-b96c-4b103f30c4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_629f7f53-6eb8-4100-b0bd-e2fb42bd88cc" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_7869d57c-49c0-4838-b96c-4b103f30c4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_514cdf0b-4523-4114-8d3c-3d6456469268" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_7869d57c-49c0-4838-b96c-4b103f30c4d9" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_514cdf0b-4523-4114-8d3c-3d6456469268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_514cdf0b-4523-4114-8d3c-3d6456469268" xlink:to="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJanuary152024Member_8d3aa9ea-37b5-4e53-98e0-c654d9f723fb" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringJanuary152024Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:to="loc_hr_InterestRateSwapExpiringJanuary152024Member_8d3aa9ea-37b5-4e53-98e0-c654d9f723fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringMay12026Member_6ed65aaf-5c82-439f-8792-37c29f24972d" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringMay12026Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:to="loc_hr_InterestRateSwapExpiringMay12026Member_6ed65aaf-5c82-439f-8792-37c29f24972d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJune12026Member_dffd5f60-bf1c-499e-9ab8-ee5c1aa6d238" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringJune12026Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:to="loc_hr_InterestRateSwapExpiringJune12026Member_dffd5f60-bf1c-499e-9ab8-ee5c1aa6d238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringDecember12026Member_512425c6-57e5-44cf-ad3e-e5f42080e97b" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringDecember12026Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:to="loc_hr_InterestRateSwapExpiringDecember12026Member_512425c6-57e5-44cf-ad3e-e5f42080e97b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringJune12027Member_ab19ef54-e23e-4c85-a076-e4d01b1ab5f9" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringJune12027Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:to="loc_hr_InterestRateSwapExpiringJune12027Member_ab19ef54-e23e-4c85-a076-e4d01b1ab5f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringDecember12027Member_792956bf-5202-4db3-8194-318f3f411e18" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringDecember12027Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:to="loc_hr_InterestRateSwapExpiringDecember12027Member_792956bf-5202-4db3-8194-318f3f411e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapEffectiveNovember12023Member_a3ead46b-479f-486e-bd18-1f07d3d241df" xlink:href="hr-20230930.xsd#hr_InterestRateSwapEffectiveNovember12023Member"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:to="loc_hr_InterestRateSwapEffectiveNovember12023Member_a3ead46b-479f-486e-bd18-1f07d3d241df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_InterestRateSwapExpiringMay312026Member_4aebb8d1-3664-45a8-8f5e-c1d23e16f517" xlink:href="hr-20230930.xsd#hr_InterestRateSwapExpiringMay312026Member"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InterestRateSwapMember_3757bcb9-8f8d-4cf4-bdf1-32671f433485" xlink:to="loc_hr_InterestRateSwapExpiringMay312026Member_4aebb8d1-3664-45a8-8f5e-c1d23e16f517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_69522ca8-5c6a-4f84-9c5b-9a9d3aed34d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_629f7f53-6eb8-4100-b0bd-e2fb42bd88cc" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_69522ca8-5c6a-4f84-9c5b-9a9d3aed34d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingRelationshipDomain_1e1e904c-fea2-4885-b734-797bb765b822" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingRelationshipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_69522ca8-5c6a-4f84-9c5b-9a9d3aed34d3" xlink:to="loc_us-gaap_HedgingRelationshipDomain_1e1e904c-fea2-4885-b734-797bb765b822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgingMember_3192b3dc-ae6c-48ac-b442-1729e6b03e57" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowHedgingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingRelationshipDomain_1e1e904c-fea2-4885-b734-797bb765b822" xlink:to="loc_us-gaap_CashFlowHedgingMember_3192b3dc-ae6c-48ac-b442-1729e6b03e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_963ff422-5798-4066-b34a-3d500511c31c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_629f7f53-6eb8-4100-b0bd-e2fb42bd88cc" xlink:to="loc_us-gaap_HedgingDesignationAxis_963ff422-5798-4066-b34a-3d500511c31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_0a0d3bbd-5ea8-4d99-8287-c784a0d4effc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_963ff422-5798-4066-b34a-3d500511c31c" xlink:to="loc_us-gaap_HedgingDesignationDomain_0a0d3bbd-5ea8-4d99-8287-c784a0d4effc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8f59247d-33e1-467a-be1a-ad07e13390c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_0a0d3bbd-5ea8-4d99-8287-c784a0d4effc" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_8f59247d-33e1-467a-be1a-ad07e13390c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_d727c4f8-a0d3-4e23-9380-bd1e95d48953" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_629f7f53-6eb8-4100-b0bd-e2fb42bd88cc" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_d727c4f8-a0d3-4e23-9380-bd1e95d48953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4602f617-9793-451b-b806-ef0cea3ddba7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_d727c4f8-a0d3-4e23-9380-bd1e95d48953" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4602f617-9793-451b-b806-ef0cea3ddba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_552e421e-0110-416d-bee5-de70d403ccab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4602f617-9793-451b-b806-ef0cea3ddba7" xlink:to="loc_us-gaap_SubsequentEventMember_552e421e-0110-416d-bee5-de70d403ccab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_5d3f541d-9db8-4225-b8a4-2696b47507cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_629f7f53-6eb8-4100-b0bd-e2fb42bd88cc" xlink:to="loc_us-gaap_DerivativeLineItems_5d3f541d-9db8-4225-b8a4-2696b47507cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfInterestRateDerivativesHeld_00082968-d187-44d2-a369-900d5996706d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfInterestRateDerivativesHeld"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5d3f541d-9db8-4225-b8a4-2696b47507cf" xlink:to="loc_us-gaap_NumberOfInterestRateDerivativesHeld_00082968-d187-44d2-a369-900d5996706d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_8159f35e-697c-494b-97da-d486f60fb07e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5d3f541d-9db8-4225-b8a4-2696b47507cf" xlink:to="loc_us-gaap_DerivativeNotionalAmount_8159f35e-697c-494b-97da-d486f60fb07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFixedInterestRate_953f365e-814b-4aef-9c02-186e16fb3319" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFixedInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5d3f541d-9db8-4225-b8a4-2696b47507cf" xlink:to="loc_us-gaap_DerivativeFixedInterestRate_953f365e-814b-4aef-9c02-186e16fb3319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfSwapTransactions_80e7587c-8cc8-4fd7-8b69-6489665cb516" xlink:href="hr-20230930.xsd#hr_NumberOfSwapTransactions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_5d3f541d-9db8-4225-b8a4-2696b47507cf" xlink:to="loc_hr_NumberOfSwapTransactions_80e7587c-8cc8-4fd7-8b69-6489665cb516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f7d18db1-da28-4487-a628-41b5cc5e3a5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_725a2d68-8cb4-49dc-952e-1447dd609f25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f7d18db1-da28-4487-a628-41b5cc5e3a5b" xlink:to="loc_us-gaap_DerivativeTable_725a2d68-8cb4-49dc-952e-1447dd609f25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_f7720394-b769-4857-b9c5-a0859521bda4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_725a2d68-8cb4-49dc-952e-1447dd609f25" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_f7720394-b769-4857-b9c5-a0859521bda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_80f4a06e-e55a-4d26-a3d6-be10273e47f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_f7720394-b769-4857-b9c5-a0859521bda4" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_80f4a06e-e55a-4d26-a3d6-be10273e47f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_a44df26d-66ce-4507-a488-c9340fc2184a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_80f4a06e-e55a-4d26-a3d6-be10273e47f6" xlink:to="loc_us-gaap_OtherAssetsMember_a44df26d-66ce-4507-a488-c9340fc2184a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_25bd4b1f-1a2d-4b4d-ad31-f8e9cb5ec44a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_725a2d68-8cb4-49dc-952e-1447dd609f25" xlink:to="loc_us-gaap_HedgingDesignationAxis_25bd4b1f-1a2d-4b4d-ad31-f8e9cb5ec44a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c8f08c9d-7757-454e-b212-7f7889a0d7c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_25bd4b1f-1a2d-4b4d-ad31-f8e9cb5ec44a" xlink:to="loc_us-gaap_HedgingDesignationDomain_c8f08c9d-7757-454e-b212-7f7889a0d7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_199a61e2-3973-4db4-a3ee-ec80c92af20c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_c8f08c9d-7757-454e-b212-7f7889a0d7c7" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_199a61e2-3973-4db4-a3ee-ec80c92af20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_c1a172f1-d384-4f7b-aa76-9ab1ee07b7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_725a2d68-8cb4-49dc-952e-1447dd609f25" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_c1a172f1-d384-4f7b-aa76-9ab1ee07b7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_03b1df0d-f2db-49c9-b79e-f54b55942354" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_c1a172f1-d384-4f7b-aa76-9ab1ee07b7f4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_03b1df0d-f2db-49c9-b79e-f54b55942354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_58f5f79d-c29f-404e-aaff-c497d7960bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_03b1df0d-f2db-49c9-b79e-f54b55942354" xlink:to="loc_us-gaap_InterestRateSwapMember_58f5f79d-c29f-404e-aaff-c497d7960bd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_eb88ea24-5465-42d3-a789-b70c0477dc22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_725a2d68-8cb4-49dc-952e-1447dd609f25" xlink:to="loc_us-gaap_DerivativeLineItems_eb88ea24-5465-42d3-a789-b70c0477dc22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_65465ec8-ef40-4042-bdce-4ec9457a30a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_eb88ea24-5465-42d3-a789-b70c0477dc22" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeLiability_65465ec8-ef40-4042-bdce-4ec9457a30a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_afebe258-f0a1-4734-923c-e18d4defaf0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_412dcf56-913a-425d-acb9-216e6bf9243c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_afebe258-f0a1-4734-923c-e18d4defaf0a" xlink:to="loc_us-gaap_DerivativeTable_412dcf56-913a-425d-acb9-216e6bf9243c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0bfabd6f-27a3-4d1c-a0db-587f0600c2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_412dcf56-913a-425d-acb9-216e6bf9243c" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0bfabd6f-27a3-4d1c-a0db-587f0600c2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_2003bbf1-2a1a-4153-aa9c-abc1b38be3a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0bfabd6f-27a3-4d1c-a0db-587f0600c2ec" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_2003bbf1-2a1a-4153-aa9c-abc1b38be3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateContractMember_cfa81425-d327-4de4-870b-be253a9d9a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateContractMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2003bbf1-2a1a-4153-aa9c-abc1b38be3a3" xlink:to="loc_us-gaap_InterestRateContractMember_cfa81425-d327-4de4-870b-be253a9d9a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryLockMember_feceb373-5f39-4540-b9b2-80d86ccb478b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryLockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2003bbf1-2a1a-4153-aa9c-abc1b38be3a3" xlink:to="loc_us-gaap_TreasuryLockMember_feceb373-5f39-4540-b9b2-80d86ccb478b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3f308acb-36b0-453b-81ec-42f2a99448de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_2003bbf1-2a1a-4153-aa9c-abc1b38be3a3" xlink:to="loc_us-gaap_InterestRateSwapMember_3f308acb-36b0-453b-81ec-42f2a99448de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6b722db8-c443-4663-b997-469f5766fc7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_412dcf56-913a-425d-acb9-216e6bf9243c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6b722db8-c443-4663-b997-469f5766fc7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_cda3fe00-ffb9-43e7-b870-328194bc58e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6b722db8-c443-4663-b997-469f5766fc7d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_cda3fe00-ffb9-43e7-b870-328194bc58e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseMember_fe582cc9-e82c-418e-b04d-4ffffb9eedd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_cda3fe00-ffb9-43e7-b870-328194bc58e3" xlink:to="loc_us-gaap_InterestExpenseMember_fe582cc9-e82c-418e-b04d-4ffffb9eedd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_ceead61b-702d-48cd-a802-09f1b62c29a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_412dcf56-913a-425d-acb9-216e6bf9243c" xlink:to="loc_us-gaap_DerivativeLineItems_ceead61b-702d-48cd-a802-09f1b62c29a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_06834169-8861-4a82-b004-ae962af407f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ceead61b-702d-48cd-a802-09f1b62c29a6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_06834169-8861-4a82-b004-ae962af407f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_ffea17c9-e0a6-444e-9eed-f80c3e2468d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_ceead61b-702d-48cd-a802-09f1b62c29a6" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax_ffea17c9-e0a6-444e-9eed-f80c3e2468d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_db6261d9-cce1-4029-a911-099df3d9729f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_2751c891-6209-4187-91de-515b4f960fba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_db6261d9-cce1-4029-a911-099df3d9729f" xlink:to="loc_us-gaap_DerivativeTable_2751c891-6209-4187-91de-515b4f960fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_2c5f3a89-0e0a-4cbb-8d69-51af1c76202d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2751c891-6209-4187-91de-515b4f960fba" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_2c5f3a89-0e0a-4cbb-8d69-51af1c76202d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_d064c5bc-0ebb-4375-b2f7-ce3a690e9533" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_2c5f3a89-0e0a-4cbb-8d69-51af1c76202d" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_d064c5bc-0ebb-4375-b2f7-ce3a690e9533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ActiveInterestRateSwapsMember_d75ffe34-27ba-4598-a08b-6dad66706a43" xlink:href="hr-20230930.xsd#hr_ActiveInterestRateSwapsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d064c5bc-0ebb-4375-b2f7-ce3a690e9533" xlink:to="loc_hr_ActiveInterestRateSwapsMember_d75ffe34-27ba-4598-a08b-6dad66706a43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_SettledInterestRateSwapsMember_d3a94731-e65e-4e33-a4a2-e9d4f629539a" xlink:href="hr-20230930.xsd#hr_SettledInterestRateSwapsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_d064c5bc-0ebb-4375-b2f7-ce3a690e9533" xlink:to="loc_hr_SettledInterestRateSwapsMember_d3a94731-e65e-4e33-a4a2-e9d4f629539a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_a926b9c1-26e4-4a65-8d67-7e50ec663e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_2751c891-6209-4187-91de-515b4f960fba" xlink:to="loc_us-gaap_DerivativeLineItems_a926b9c1-26e4-4a65-8d67-7e50ec663e3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_29834e7b-ce47-484b-b3c2-efa636885352" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a926b9c1-26e4-4a65-8d67-7e50ec663e3d" xlink:to="loc_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet_29834e7b-ce47-484b-b3c2-efa636885352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DerivativeNetAssetPositionAggregateFairValue_7974b21b-47da-4cee-a5ac-9fdf0723df7c" xlink:href="hr-20230930.xsd#hr_DerivativeNetAssetPositionAggregateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_a926b9c1-26e4-4a65-8d67-7e50ec663e3d" xlink:to="loc_hr_DerivativeNetAssetPositionAggregateFairValue_7974b21b-47da-4cee-a5ac-9fdf0723df7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#CommitmentandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8f280b09-f5b6-4687-8a17-4fcb17afaaa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_fbecb712-bdac-4fbd-a1ba-fa025750004e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8f280b09-f5b6-4687-8a17-4fcb17afaaa4" xlink:to="loc_us-gaap_OtherCommitmentsTable_fbecb712-bdac-4fbd-a1ba-fa025750004e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsAxis_615cf883-6b3c-458c-8680-2fab16938d4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_fbecb712-bdac-4fbd-a1ba-fa025750004e" xlink:to="loc_us-gaap_OtherCommitmentsAxis_615cf883-6b3c-458c-8680-2fab16938d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsDomain_b4ce202b-09c5-44a3-99cf-d7e7d601ef3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsAxis_615cf883-6b3c-458c-8680-2fab16938d4c" xlink:to="loc_us-gaap_OtherCommitmentsDomain_b4ce202b-09c5-44a3-99cf-d7e7d601ef3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ActiveDevelopmentPropertiesMember_e8931e60-efb5-4871-b023-c0b903d89798" xlink:href="hr-20230930.xsd#hr_ActiveDevelopmentPropertiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_b4ce202b-09c5-44a3-99cf-d7e7d601ef3f" xlink:to="loc_hr_ActiveDevelopmentPropertiesMember_e8931e60-efb5-4871-b023-c0b903d89798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_RedevelopmentPropertiesMember_cb114273-6b83-451c-b09c-545b4a5bda74" xlink:href="hr-20230930.xsd#hr_RedevelopmentPropertiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_b4ce202b-09c5-44a3-99cf-d7e7d601ef3f" xlink:to="loc_hr_RedevelopmentPropertiesMember_cb114273-6b83-451c-b09c-545b4a5bda74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember_ef7aa6eb-183d-4572-b356-36800513e5d7" xlink:href="hr-20230930.xsd#hr_CompletedDevelpomentAndRedevelopmentPropertiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsDomain_b4ce202b-09c5-44a3-99cf-d7e7d601ef3f" xlink:to="loc_hr_CompletedDevelpomentAndRedevelopmentPropertiesMember_ef7aa6eb-183d-4572-b356-36800513e5d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_28fac134-f8bb-4738-8c5c-b9198a2a142f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_fbecb712-bdac-4fbd-a1ba-fa025750004e" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_28fac134-f8bb-4738-8c5c-b9198a2a142f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_2ca94b33-afed-4ff7-88e2-327615a82341" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_28fac134-f8bb-4738-8c5c-b9198a2a142f" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_2ca94b33-afed-4ff7-88e2-327615a82341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MedicalOfficeBuildingMember_3b528792-fb05-4788-88db-ae3e2f0b2317" xlink:href="hr-20230930.xsd#hr_MedicalOfficeBuildingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_2ca94b33-afed-4ff7-88e2-327615a82341" xlink:to="loc_hr_MedicalOfficeBuildingMember_3b528792-fb05-4788-88db-ae3e2f0b2317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_654280c0-f319-43d9-97e0-03d42bb586df" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_fbecb712-bdac-4fbd-a1ba-fa025750004e" xlink:to="loc_srt_StatementGeographicalAxis_654280c0-f319-43d9-97e0-03d42bb586df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_a61c0bfc-3d67-4813-b514-f6dbb61a6c66" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_654280c0-f319-43d9-97e0-03d42bb586df" xlink:to="loc_srt_SegmentGeographicalDomain_a61c0bfc-3d67-4813-b514-f6dbb61a6c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ScottsdaleArizonaMember_041e18e3-7eba-4301-8d68-a067d93d8e6a" xlink:href="hr-20230930.xsd#hr_ScottsdaleArizonaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_a61c0bfc-3d67-4813-b514-f6dbb61a6c66" xlink:to="loc_hr_ScottsdaleArizonaMember_041e18e3-7eba-4301-8d68-a067d93d8e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_db7291e4-3516-4c99-9659-cbd1bd336a2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_fbecb712-bdac-4fbd-a1ba-fa025750004e" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_db7291e4-3516-4c99-9659-cbd1bd336a2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ConstructionActivityTotalFundingDuringthePeriod_cdd98077-43b4-4c14-8a15-dc53e5c0bcd9" xlink:href="hr-20230930.xsd#hr_ConstructionActivityTotalFundingDuringthePeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_db7291e4-3516-4c99-9659-cbd1bd336a2a" xlink:to="loc_hr_ConstructionActivityTotalFundingDuringthePeriod_cdd98077-43b4-4c14-8a15-dc53e5c0bcd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_JointVentureOwnershipPercentage_03ced195-f862-4826-af88-a998a5d2232b" xlink:href="hr-20230930.xsd#hr_JointVentureOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_db7291e4-3516-4c99-9659-cbd1bd336a2a" xlink:to="loc_hr_JointVentureOwnershipPercentage_03ced195-f862-4826-af88-a998a5d2232b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLand_002b098a-4e07-4b4c-a0aa-f76ab2c47096" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireLand"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_db7291e4-3516-4c99-9659-cbd1bd336a2a" xlink:to="loc_us-gaap_PaymentsToAcquireLand_002b098a-4e07-4b4c-a0aa-f76ab2c47096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_1f95de7f-2130-4a2b-8f4f-54407d29b3b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_db7291e4-3516-4c99-9659-cbd1bd336a2a" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_1f95de7f-2130-4a2b-8f4f-54407d29b3b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7d3e62d1-9996-4f46-baed-6dda6a99c2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_5adeda43-0159-4de3-990d-3991fbfaaa4c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7d3e62d1-9996-4f46-baed-6dda6a99c2c9" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_5adeda43-0159-4de3-990d-3991fbfaaa4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_bdf4827c-ff12-4662-8f46-d04281e602bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_5adeda43-0159-4de3-990d-3991fbfaaa4c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_bdf4827c-ff12-4662-8f46-d04281e602bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_edcbbb77-534f-4bc5-9f56-f04d24fd1345" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_bdf4827c-ff12-4662-8f46-d04281e602bb" xlink:to="loc_us-gaap_EquityComponentDomain_edcbbb77-534f-4bc5-9f56-f04d24fd1345" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_91dfb0b7-1fc7-45e2-ac35-5624e4d51b42" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_edcbbb77-534f-4bc5-9f56-f04d24fd1345" xlink:to="loc_us-gaap_CommonStockMember_91dfb0b7-1fc7-45e2-ac35-5624e4d51b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_ba915ed7-930b-4334-9535-3886ab9b06a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_5adeda43-0159-4de3-990d-3991fbfaaa4c" xlink:to="loc_us-gaap_ClassOfStockLineItems_ba915ed7-930b-4334-9535-3886ab9b06a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_3921e174-9fe4-4776-aff4-24df8b50c81e" xlink:href="hr-20230930.xsd#hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_ba915ed7-930b-4334-9535-3886ab9b06a0" xlink:to="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_3921e174-9fe4-4776-aff4-24df8b50c81e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_28cdb0aa-de11-4ef3-8724-8f7ef80be203" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_3921e174-9fe4-4776-aff4-24df8b50c81e" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_28cdb0aa-de11-4ef3-8724-8f7ef80be203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_5d62ceff-07df-449c-ba9d-19d91ccff235" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_3921e174-9fe4-4776-aff4-24df8b50c81e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_5d62ceff-07df-449c-ba9d-19d91ccff235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_7804fed1-2613-44b2-8b24-df76d4af2ea8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_3921e174-9fe4-4776-aff4-24df8b50c81e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_7804fed1-2613-44b2-8b24-df76d4af2ea8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_07b5ecd1-4b1f-4d24-b901-76d9303fc762" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward_3921e174-9fe4-4776-aff4-24df8b50c81e" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_07b5ecd1-4b1f-4d24-b901-76d9303fc762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#StockholdersEquityStockTransactionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a58cc84c-6c44-4669-b002-a630ebef6858" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a58cc84c-6c44-4669-b002-a630ebef6858" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_4ea0ca2a-5780-40e3-b394-dac755f08046" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_4ea0ca2a-5780-40e3-b394-dac755f08046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_789de6e6-ac10-46cd-b6a9-9a0827ca670e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_4ea0ca2a-5780-40e3-b394-dac755f08046" xlink:to="loc_us-gaap_EquityComponentDomain_789de6e6-ac10-46cd-b6a9-9a0827ca670e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_fa05c5a9-4133-478e-8676-13019af49f54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_789de6e6-ac10-46cd-b6a9-9a0827ca670e" xlink:to="loc_us-gaap_CommonStockMember_fa05c5a9-4133-478e-8676-13019af49f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f5f6a03a-53d1-4dfd-89a6-fbed23c5eb0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f5f6a03a-53d1-4dfd-89a6-fbed23c5eb0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ec16521b-0a72-444e-9e65-215ba32db12d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_f5f6a03a-53d1-4dfd-89a6-fbed23c5eb0d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ec16521b-0a72-444e-9e65-215ba32db12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_81436a28-23a8-4914-899a-0980f6654cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ec16521b-0a72-444e-9e65-215ba32db12d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_81436a28-23a8-4914-899a-0980f6654cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_81d4e006-c9c3-474c-a9e5-d6e0b64a805c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_us-gaap_AwardTypeAxis_81d4e006-c9c3-474c-a9e5-d6e0b64a805c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22b3e8ec-e233-4a85-88b9-ed5cb3468d29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_81d4e006-c9c3-474c-a9e5-d6e0b64a805c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22b3e8ec-e233-4a85-88b9-ed5cb3468d29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember_e5da0fc9-69a7-421a-a9dd-fa02d5d46f3c" xlink:href="hr-20230930.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22b3e8ec-e233-4a85-88b9-ed5cb3468d29" xlink:to="loc_hr_OperatingPartnershipPerformanceUnitsMember_e5da0fc9-69a7-421a-a9dd-fa02d5d46f3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonVestedStockAwardMember_793ea54a-f067-41fe-b45e-698aaf1c079b" xlink:href="hr-20230930.xsd#hr_NonVestedStockAwardMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22b3e8ec-e233-4a85-88b9-ed5cb3468d29" xlink:to="loc_hr_NonVestedStockAwardMember_793ea54a-f067-41fe-b45e-698aaf1c079b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_0fbca455-086c-4a0b-b703-41a06610e75a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22b3e8ec-e233-4a85-88b9-ed5cb3468d29" xlink:to="loc_us-gaap_RestrictedStockMember_0fbca455-086c-4a0b-b703-41a06610e75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f139ed14-cf11-4c31-a982-bef13326e7c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22b3e8ec-e233-4a85-88b9-ed5cb3468d29" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f139ed14-cf11-4c31-a982-bef13326e7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_fe3bc9e5-347d-49f3-97ef-10fbd03ff4ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_us-gaap_PlanNameAxis_fe3bc9e5-347d-49f3-97ef-10fbd03ff4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_bc36ce78-9bd4-40ae-a7d4-886b0193db88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_fe3bc9e5-347d-49f3-97ef-10fbd03ff4ce" xlink:to="loc_us-gaap_PlanNameDomain_bc36ce78-9bd4-40ae-a7d4-886b0193db88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ExecutiveIncentiveProgramMember_4077f1c4-21c8-41e3-9669-347fa203f01e" xlink:href="hr-20230930.xsd#hr_ExecutiveIncentiveProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_bc36ce78-9bd4-40ae-a7d4-886b0193db88" xlink:to="loc_hr_ExecutiveIncentiveProgramMember_4077f1c4-21c8-41e3-9669-347fa203f01e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_LongTermIncentiveProgramDUnitsMember_da8ec19a-f6b4-451e-9556-f43adc4c0254" xlink:href="hr-20230930.xsd#hr_LongTermIncentiveProgramDUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_bc36ce78-9bd4-40ae-a7d4-886b0193db88" xlink:to="loc_hr_LongTermIncentiveProgramDUnitsMember_da8ec19a-f6b4-451e-9556-f43adc4c0254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIncentivePlanMember_dc5a2320-c493-4819-a474-6f68f1c94233" xlink:href="hr-20230930.xsd#hr_StockIncentivePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_bc36ce78-9bd4-40ae-a7d4-886b0193db88" xlink:to="loc_hr_StockIncentivePlanMember_dc5a2320-c493-4819-a474-6f68f1c94233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_05e5b04d-6a02-4d31-8f5b-d25c28dcf2f3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_srt_RangeAxis_05e5b04d-6a02-4d31-8f5b-d25c28dcf2f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8b05016c-3710-4289-b361-885566e236a2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_05e5b04d-6a02-4d31-8f5b-d25c28dcf2f3" xlink:to="loc_srt_RangeMember_8b05016c-3710-4289-b361-885566e236a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_98cb2d20-68c7-418b-9443-34e5155f9624" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8b05016c-3710-4289-b361-885566e236a2" xlink:to="loc_srt_MinimumMember_98cb2d20-68c7-418b-9443-34e5155f9624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7081aca6-a5c7-4e1f-8feb-93cab5bff1e2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8b05016c-3710-4289-b361-885566e236a2" xlink:to="loc_srt_MaximumMember_7081aca6-a5c7-4e1f-8feb-93cab5bff1e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_61f857ec-be0b-4d48-8c78-66a985118efa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_srt_TitleOfIndividualAxis_61f857ec-be0b-4d48-8c78-66a985118efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_df6cf5ff-c80f-418d-8948-72afb2cef048" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_61f857ec-be0b-4d48-8c78-66a985118efa" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_df6cf5ff-c80f-418d-8948-72afb2cef048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_DirectorsMember_48b31ee2-185d-404c-8093-48d228278bb0" xlink:href="hr-20230930.xsd#hr_DirectorsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_df6cf5ff-c80f-418d-8948-72afb2cef048" xlink:to="loc_hr_DirectorsMember_48b31ee2-185d-404c-8093-48d228278bb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NewEmployeeMember_47693e66-6e7e-4a3e-b4f0-dc0b49d44292" xlink:href="hr-20230930.xsd#hr_NewEmployeeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_df6cf5ff-c80f-418d-8948-72afb2cef048" xlink:to="loc_hr_NewEmployeeMember_47693e66-6e7e-4a3e-b4f0-dc0b49d44292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramAxis_fb2875d9-3b5c-4de7-94ec-46589d2f3f03" xlink:href="hr-20230930.xsd#hr_StockIssuanceProgramAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_hr_StockIssuanceProgramAxis_fb2875d9-3b5c-4de7-94ec-46589d2f3f03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIssuanceProgramDomain_f71a0639-9034-430d-a4a6-c2976cb0ed25" xlink:href="hr-20230930.xsd#hr_StockIssuanceProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_StockIssuanceProgramAxis_fb2875d9-3b5c-4de7-94ec-46589d2f3f03" xlink:to="loc_hr_StockIssuanceProgramDomain_f71a0639-9034-430d-a4a6-c2976cb0ed25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PerformanceConditionsMember_7b4e0a2b-faba-4f8a-bf4d-80f2244d6845" xlink:href="hr-20230930.xsd#hr_PerformanceConditionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_StockIssuanceProgramDomain_f71a0639-9034-430d-a4a6-c2976cb0ed25" xlink:to="loc_hr_PerformanceConditionsMember_7b4e0a2b-faba-4f8a-bf4d-80f2244d6845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MarketCondition1Member_76d897b6-d696-4fed-bd38-06d376debf24" xlink:href="hr-20230930.xsd#hr_MarketCondition1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_PerformanceConditionsMember_7b4e0a2b-faba-4f8a-bf4d-80f2244d6845" xlink:to="loc_hr_MarketCondition1Member_76d897b6-d696-4fed-bd38-06d376debf24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_MarketCondition2Member_f5e3ce68-3f69-4323-bb88-f3e954dc3426" xlink:href="hr-20230930.xsd#hr_MarketCondition2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_hr_PerformanceConditionsMember_7b4e0a2b-faba-4f8a-bf4d-80f2244d6845" xlink:to="loc_hr_MarketCondition2Member_f5e3ce68-3f69-4323-bb88-f3e954dc3426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_27384e57-0550-4d7e-951a-ecdb2d053e17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_us-gaap_GranteeStatusAxis_27384e57-0550-4d7e-951a-ecdb2d053e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_3919d36f-7037-4f8e-b075-97ea4ab356cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_27384e57-0550-4d7e-951a-ecdb2d053e17" xlink:to="loc_us-gaap_GranteeStatusDomain_3919d36f-7037-4f8e-b075-97ea4ab356cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_68d01cb2-059a-45fd-9aca-1fae583a3abe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_3919d36f-7037-4f8e-b075-97ea4ab356cb" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_68d01cb2-059a-45fd-9aca-1fae583a3abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_31f06a15-8e94-4dce-bdc4-b14fac856bd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_31f06a15-8e94-4dce-bdc4-b14fac856bd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_59c42c33-f238-4984-8e74-37c0916cb7a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_31f06a15-8e94-4dce-bdc4-b14fac856bd7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_59c42c33-f238-4984-8e74-37c0916cb7a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_bec00e8a-62e9-401c-b828-f899a652332d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_59c42c33-f238-4984-8e74-37c0916cb7a1" xlink:to="loc_us-gaap_SubsequentEventMember_bec00e8a-62e9-401c-b828-f899a652332d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_4827a85e-e334-47a7-a7a1-7911946b0c54" xlink:to="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EquityOfferingProgramAvailableForIssuance_e9922026-a2a1-4a0d-b0d7-a2295cebce2c" xlink:href="hr-20230930.xsd#hr_EquityOfferingProgramAvailableForIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_hr_EquityOfferingProgramAvailableForIssuance_e9922026-a2a1-4a0d-b0d7-a2295cebce2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d2f9adc2-73fb-48dd-b4b8-0a08db6adf79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareCashPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_CommonStockDividendsPerShareCashPaid_d2f9adc2-73fb-48dd-b4b8-0a08db6adf79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockDividendsPerShareDeclared_e9076662-d12c-40cd-8b08-22ba660b3ae4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockDividendsPerShareDeclared"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_CommonStockDividendsPerShareDeclared_e9076662-d12c-40cd-8b08-22ba660b3ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_f3af0ff9-1831-4155-b0e5-e400e4e7263c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_f3af0ff9-1831-4155-b0e5-e400e4e7263c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_82bac3ce-b057-4a6e-b009-4bc9aea6e501" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_82bac3ce-b057-4a6e-b009-4bc9aea6e501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_d43fe16e-0660-4a3e-a850-ce55b2c7f2b9" xlink:href="hr-20230930.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue_d43fe16e-0660-4a3e-a850-ce55b2c7f2b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e23bdfea-65cc-45fa-9fa3-f94d792be59d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e23bdfea-65cc-45fa-9fa3-f94d792be59d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0a61a94b-6803-478e-b842-e52bfe6ac682" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_0a61a94b-6803-478e-b842-e52bfe6ac682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NumberOfDirectors_40eda02e-4acc-4e79-a582-218c0e7fbcfc" xlink:href="hr-20230930.xsd#hr_NumberOfDirectors"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_hr_NumberOfDirectors_40eda02e-4acc-4e79-a582-218c0e7fbcfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_40109285-1a77-4ca4-b107-5fc69391848c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_40109285-1a77-4ca4-b107-5fc69391848c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_PercentageOfRestrictedStockUnits_9cbab4b1-37e8-47d0-8a6f-a29b9702dcc2" xlink:href="hr-20230930.xsd#hr_PercentageOfRestrictedStockUnits"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_hr_PercentageOfRestrictedStockUnits_9cbab4b1-37e8-47d0-8a6f-a29b9702dcc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_244109a9-6724-4c11-94ec-ee039919debb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue_244109a9-6724-4c11-94ec-ee039919debb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_5223be96-3e6a-47e6-af8d-620f1095854c" xlink:href="hr-20230930.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod_5223be96-3e6a-47e6-af8d-620f1095854c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_e40b9f29-de5a-4aed-aaa0-cdf2f7a56c3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_51e8e47b-e8d5-492a-a7df-74e21c5ab40b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_e40b9f29-de5a-4aed-aaa0-cdf2f7a56c3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7e4c4a7f-e0a0-481a-bea2-ebd28b0f58e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e16a545a-523e-438f-9ef0-c7013718fd27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7e4c4a7f-e0a0-481a-bea2-ebd28b0f58e3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e16a545a-523e-438f-9ef0-c7013718fd27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_0304742d-a164-49df-9f76-85004e302210" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e16a545a-523e-438f-9ef0-c7013718fd27" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_0304742d-a164-49df-9f76-85004e302210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_c6c9b052-6b51-449d-aa53-836f94e76b5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesRestrictedStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e16a545a-523e-438f-9ef0-c7013718fd27" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesRestrictedStock_c6c9b052-6b51-449d-aa53-836f94e76b5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1848399b-4dc6-4177-9712-4687ec667a04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e16a545a-523e-438f-9ef0-c7013718fd27" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1848399b-4dc6-4177-9712-4687ec667a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements_74ccf92e-017d-423d-bb02-8c215a74703b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e16a545a-523e-438f-9ef0-c7013718fd27" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements_74ccf92e-017d-423d-bb02-8c215a74703b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits_ef261a35-9e10-4997-86a0-52ba97eccb34" xlink:href="hr-20230930.xsd#hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e16a545a-523e-438f-9ef0-c7013718fd27" xlink:to="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits_ef261a35-9e10-4997-86a0-52ba97eccb34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan_583c6ede-1d13-4b65-9f8d-cd79977766e7" xlink:href="hr-20230930.xsd#hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e16a545a-523e-438f-9ef0-c7013718fd27" xlink:to="loc_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan_583c6ede-1d13-4b65-9f8d-cd79977766e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a5b4cdaa-34a0-43a8-b5e3-46acc6bd6816" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_e16a545a-523e-438f-9ef0-c7013718fd27" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_a5b4cdaa-34a0-43a8-b5e3-46acc6bd6816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1ec974db-23b2-460c-875e-87169e467ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7e4c4a7f-e0a0-481a-bea2-ebd28b0f58e3" xlink:to="loc_us-gaap_ProfitLoss_1ec974db-23b2-460c-875e-87169e467ff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_dc06dcc9-3126-4624-acda-ce976d475117" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7e4c4a7f-e0a0-481a-bea2-ebd28b0f58e3" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_dc06dcc9-3126-4624-acda-ce976d475117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9ded2eb1-8cba-419e-8f79-10181acca6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7e4c4a7f-e0a0-481a-bea2-ebd28b0f58e3" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9ded2eb1-8cba-419e-8f79-10181acca6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_d4822a31-af44-4c86-908a-9919072ebafc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7e4c4a7f-e0a0-481a-bea2-ebd28b0f58e3" xlink:to="loc_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther_d4822a31-af44-4c86-908a-9919072ebafc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_faace3bd-7b57-4b4d-8709-81ad29e931ef" xlink:href="hr-20230930.xsd#hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7e4c4a7f-e0a0-481a-bea2-ebd28b0f58e3" xlink:to="loc_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic_faace3bd-7b57-4b4d-8709-81ad29e931ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_28e35c0c-6145-4f4e-9e5b-4bdbcbfc8b96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7e4c4a7f-e0a0-481a-bea2-ebd28b0f58e3" xlink:to="loc_us-gaap_EarningsPerShareBasic_28e35c0c-6145-4f4e-9e5b-4bdbcbfc8b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_56347a5b-04f0-403b-9674-ee13194641c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7e4c4a7f-e0a0-481a-bea2-ebd28b0f58e3" xlink:to="loc_us-gaap_EarningsPerShareDiluted_56347a5b-04f0-403b-9674-ee13194641c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e847a0b7-5681-4858-baaf-a8b1448697b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_89dc24d7-9a63-476e-b6dc-432af5ddee64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e847a0b7-5681-4858-baaf-a8b1448697b4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_89dc24d7-9a63-476e-b6dc-432af5ddee64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_1d50065c-0fb7-4912-a29f-d7f40124ab14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_89dc24d7-9a63-476e-b6dc-432af5ddee64" xlink:to="loc_us-gaap_PlanNameAxis_1d50065c-0fb7-4912-a29f-d7f40124ab14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c087108f-8986-42bd-85b9-dc02765ebe0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_1d50065c-0fb7-4912-a29f-d7f40124ab14" xlink:to="loc_us-gaap_PlanNameDomain_c087108f-8986-42bd-85b9-dc02765ebe0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_StockIncentivePlanMember_3fc97c90-7abd-4a8b-ac2c-725dc3cb7d99" xlink:href="hr-20230930.xsd#hr_StockIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_c087108f-8986-42bd-85b9-dc02765ebe0a" xlink:to="loc_hr_StockIncentivePlanMember_3fc97c90-7abd-4a8b-ac2c-725dc3cb7d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f92d4a26-ab05-4efb-b433-fae116bcd9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_89dc24d7-9a63-476e-b6dc-432af5ddee64" xlink:to="loc_us-gaap_AwardTypeAxis_f92d4a26-ab05-4efb-b433-fae116bcd9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bdc2a3f0-0745-4558-a6ce-9b512c4050fd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f92d4a26-ab05-4efb-b433-fae116bcd9ca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bdc2a3f0-0745-4558-a6ce-9b512c4050fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_e2719fc9-f711-4a36-b643-9ee88e516eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bdc2a3f0-0745-4558-a6ce-9b512c4050fd" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_e2719fc9-f711-4a36-b643-9ee88e516eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_67fad1a6-8e54-4cd1-81d5-0d72e0398145" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_89dc24d7-9a63-476e-b6dc-432af5ddee64" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_67fad1a6-8e54-4cd1-81d5-0d72e0398145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ee06874-b9ee-4e02-9582-38cfc3c891e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_67fad1a6-8e54-4cd1-81d5-0d72e0398145" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ee06874-b9ee-4e02-9582-38cfc3c891e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64fa36f5-0eaa-4d9f-a45c-2a99ecaa8560" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ee06874-b9ee-4e02-9582-38cfc3c891e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_64fa36f5-0eaa-4d9f-a45c-2a99ecaa8560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e9f1f5ef-8724-4ad1-9636-feaca855e550" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ee06874-b9ee-4e02-9582-38cfc3c891e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e9f1f5ef-8724-4ad1-9636-feaca855e550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_801f787b-a28f-44b7-a31c-86e10c5ebd19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ee06874-b9ee-4e02-9582-38cfc3c891e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_801f787b-a28f-44b7-a31c-86e10c5ebd19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod_499353b5-e9da-40d6-958a-6483c3c8c910" xlink:href="hr-20230930.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ee06874-b9ee-4e02-9582-38cfc3c891e7" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod_499353b5-e9da-40d6-958a-6483c3c8c910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_21dcf360-e147-4ede-bbfe-9ae0242ecb0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ee06874-b9ee-4e02-9582-38cfc3c891e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_21dcf360-e147-4ede-bbfe-9ae0242ecb0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7c0c98b-eb24-481f-aa25-fadc427a12f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2ee06874-b9ee-4e02-9582-38cfc3c891e7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f7c0c98b-eb24-481f-aa25-fadc427a12f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f08c12e7-c0a4-49f0-8d6b-8574a6cfd39c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_67fad1a6-8e54-4cd1-81d5-0d72e0398145" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f08c12e7-c0a4-49f0-8d6b-8574a6cfd39c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1aab2074-7426-4eb4-92ad-ad8ef2efe452" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f08c12e7-c0a4-49f0-8d6b-8574a6cfd39c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_1aab2074-7426-4eb4-92ad-ad8ef2efe452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6a18b396-9076-4d0d-966d-9630af01f7e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f08c12e7-c0a4-49f0-8d6b-8574a6cfd39c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6a18b396-9076-4d0d-966d-9630af01f7e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_ca8b909f-abaf-4ec7-b0ae-ee6f7b8b465d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f08c12e7-c0a4-49f0-8d6b-8574a6cfd39c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_ca8b909f-abaf-4ec7-b0ae-ee6f7b8b465d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue_78eb650d-0949-4427-97a7-d40a88d54cd9" xlink:href="hr-20230930.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f08c12e7-c0a4-49f0-8d6b-8574a6cfd39c" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue_78eb650d-0949-4427-97a7-d40a88d54cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3ac69b30-81a6-4b93-92e6-e6f5a1a6a10b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_f08c12e7-c0a4-49f0-8d6b-8574a6cfd39c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3ac69b30-81a6-4b93-92e6-e6f5a1a6a10b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1d69cfa9-76f9-4caa-b756-27094b7d031a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a743e650-759d-4f1a-928b-323201163aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1d69cfa9-76f9-4caa-b756-27094b7d031a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a743e650-759d-4f1a-928b-323201163aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f8c7da9a-ae97-4756-be53-69c9774a3105" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a743e650-759d-4f1a-928b-323201163aeb" xlink:to="loc_us-gaap_AwardTypeAxis_f8c7da9a-ae97-4756-be53-69c9774a3105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_656f0893-b53c-49aa-bef5-174b59192144" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f8c7da9a-ae97-4756-be53-69c9774a3105" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_656f0893-b53c-49aa-bef5-174b59192144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_fd0a76ee-d2b9-4be9-a567-1ccc92350771" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_656f0893-b53c-49aa-bef5-174b59192144" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_fd0a76ee-d2b9-4be9-a567-1ccc92350771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember_403c29d6-d907-47ae-9e86-8f79b57c40f2" xlink:href="hr-20230930.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_656f0893-b53c-49aa-bef5-174b59192144" xlink:to="loc_hr_OperatingPartnershipPerformanceUnitsMember_403c29d6-d907-47ae-9e86-8f79b57c40f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e89b8a84-f996-4405-8c4b-0c7f0ceb8ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a743e650-759d-4f1a-928b-323201163aeb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e89b8a84-f996-4405-8c4b-0c7f0ceb8ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_51b4eb97-b183-4395-8bff-7db79bb0d64c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e89b8a84-f996-4405-8c4b-0c7f0ceb8ec4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_51b4eb97-b183-4395-8bff-7db79bb0d64c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_80f54fe6-2dfe-4ec3-ad5d-eef2c5e43576" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_51b4eb97-b183-4395-8bff-7db79bb0d64c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_80f54fe6-2dfe-4ec3-ad5d-eef2c5e43576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6ed14b34-a3a7-4763-9b0f-41d15e3119d2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_51b4eb97-b183-4395-8bff-7db79bb0d64c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_6ed14b34-a3a7-4763-9b0f-41d15e3119d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_897e830f-73ea-4536-a0dd-8f7ed49f1cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_51b4eb97-b183-4395-8bff-7db79bb0d64c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_897e830f-73ea-4536-a0dd-8f7ed49f1cfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_1bee252e-98b0-4e52-b7ce-20f9981320bf" xlink:href="hr-20230930.xsd#hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_51b4eb97-b183-4395-8bff-7db79bb0d64c" xlink:to="loc_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice_1bee252e-98b0-4e52-b7ce-20f9981320bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_a3a07222-ab52-432c-905a-0bfca7e7d36c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcd463ab-65d6-4355-9e3d-0992dfbd4cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_a3a07222-ab52-432c-905a-0bfca7e7d36c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcd463ab-65d6-4355-9e3d-0992dfbd4cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b9a058b0-896e-46c6-a410-37625428da7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcd463ab-65d6-4355-9e3d-0992dfbd4cf0" xlink:to="loc_us-gaap_AwardTypeAxis_b9a058b0-896e-46c6-a410-37625428da7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a24a76c2-1d22-4336-80d0-697e7b2526b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b9a058b0-896e-46c6-a410-37625428da7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a24a76c2-1d22-4336-80d0-697e7b2526b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_6a48fdc3-b529-4a30-8820-91732349b8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a24a76c2-1d22-4336-80d0-697e7b2526b6" xlink:to="loc_us-gaap_EmployeeStockMember_6a48fdc3-b529-4a30-8820-91732349b8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e2cd9936-fa9b-4ecc-b789-6e78a6095320" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_dcd463ab-65d6-4355-9e3d-0992dfbd4cf0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e2cd9936-fa9b-4ecc-b789-6e78a6095320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9e2c850e-c471-476e-baf8-5ca2c83f8325" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e2cd9936-fa9b-4ecc-b789-6e78a6095320" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9e2c850e-c471-476e-baf8-5ca2c83f8325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2f469b2f-153e-498a-ae0b-3844e56059ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9e2c850e-c471-476e-baf8-5ca2c83f8325" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2f469b2f-153e-498a-ae0b-3844e56059ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_39ff47ac-07c3-4789-89c2-ae07e43f06b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9e2c850e-c471-476e-baf8-5ca2c83f8325" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_39ff47ac-07c3-4789-89c2-ae07e43f06b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1005ce65-d9ad-48ca-8c91-d4148911cded" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9e2c850e-c471-476e-baf8-5ca2c83f8325" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1005ce65-d9ad-48ca-8c91-d4148911cded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_5a85e15c-b9a8-4012-a84c-6767233e8155" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9e2c850e-c471-476e-baf8-5ca2c83f8325" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_5a85e15c-b9a8-4012-a84c-6767233e8155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3ef93a4b-24b7-4800-beec-ffa8c3407bac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9e2c850e-c471-476e-baf8-5ca2c83f8325" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3ef93a4b-24b7-4800-beec-ffa8c3407bac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_14f05550-0483-48e7-baf7-41a0606fb066" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_9e2c850e-c471-476e-baf8-5ca2c83f8325" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_14f05550-0483-48e7-baf7-41a0606fb066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_5290d651-a225-4ac9-8e64-a08fab85fe51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_30f2f028-1311-44d7-9444-f57f3e243b47" xlink:href="hr-20230930.xsd#hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5290d651-a225-4ac9-8e64-a08fab85fe51" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear_30f2f028-1311-44d7-9444-f57f3e243b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_a3d4cd18-bf2c-4a12-8ab7-4128f21a4630" xlink:href="hr-20230930.xsd#hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5290d651-a225-4ac9-8e64-a08fab85fe51" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths_a3d4cd18-bf2c-4a12-8ab7-4128f21a4630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_fc9afe05-9285-40a5-b501-82d2a945fe88" xlink:href="hr-20230930.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5290d651-a225-4ac9-8e64-a08fab85fe51" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo_fc9afe05-9285-40a5-b501-82d2a945fe88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_9f45dbdd-e24c-48a2-83a9-8e5bf8768353" xlink:href="hr-20230930.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5290d651-a225-4ac9-8e64-a08fab85fe51" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree_9f45dbdd-e24c-48a2-83a9-8e5bf8768353" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour_0a6ea448-9ded-4860-8963-9b02f4826ea5" xlink:href="hr-20230930.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5290d651-a225-4ac9-8e64-a08fab85fe51" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour_0a6ea448-9ded-4860-8963-9b02f4826ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_a8b6ee2b-76e2-481d-942e-77d3d335015a" xlink:href="hr-20230930.xsd#hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5290d651-a225-4ac9-8e64-a08fab85fe51" xlink:to="loc_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour_a8b6ee2b-76e2-481d-942e-77d3d335015a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_87ae4bb1-71aa-4f22-8c8b-eb0d380417af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_5290d651-a225-4ac9-8e64-a08fab85fe51" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_87ae4bb1-71aa-4f22-8c8b-eb0d380417af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="hr-20230930.xsd#FairValueofFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5edb1604-2fd3-42bf-95da-654418365f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_7d007235-4d74-47c9-8d06-47a3852c6330" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5edb1604-2fd3-42bf-95da-654418365f8a" xlink:to="loc_us-gaap_DerivativeTable_7d007235-4d74-47c9-8d06-47a3852c6330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementBasisAxis_5eb3d3c1-eb73-4a69-9967-791220f6c094" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementBasisAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7d007235-4d74-47c9-8d06-47a3852c6330" xlink:to="loc_us-gaap_FairValueByMeasurementBasisAxis_5eb3d3c1-eb73-4a69-9967-791220f6c094" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureItemAmountsDomain_ceab21f8-5b56-4991-a0b6-bffbec891710" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosureItemAmountsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementBasisAxis_5eb3d3c1-eb73-4a69-9967-791220f6c094" xlink:to="loc_us-gaap_FairValueDisclosureItemAmountsDomain_ceab21f8-5b56-4991-a0b6-bffbec891710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9b1e4a5d-db63-45fc-8adc-da99d5c5fafa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosureItemAmountsDomain_ceab21f8-5b56-4991-a0b6-bffbec891710" xlink:to="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9b1e4a5d-db63-45fc-8adc-da99d5c5fafa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_616fc658-e574-4929-b7ff-9d50c055fa2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CarryingReportedAmountFairValueDisclosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9b1e4a5d-db63-45fc-8adc-da99d5c5fafa" xlink:to="loc_us-gaap_CarryingReportedAmountFairValueDisclosureMember_616fc658-e574-4929-b7ff-9d50c055fa2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dc4914fa-d3bd-4015-bcb6-312d80e79425" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PortionAtFairValueFairValueDisclosureMember_9b1e4a5d-db63-45fc-8adc-da99d5c5fafa" xlink:to="loc_us-gaap_EstimateOfFairValueFairValueDisclosureMember_dc4914fa-d3bd-4015-bcb6-312d80e79425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_e3fc6369-6ff8-47b5-befc-fee09d1aa947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7d007235-4d74-47c9-8d06-47a3852c6330" xlink:to="loc_us-gaap_DerivativeLineItems_e3fc6369-6ff8-47b5-befc-fee09d1aa947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_49f27af1-ce51-4cf3-9a72-e035e8af3de3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e3fc6369-6ff8-47b5-befc-fee09d1aa947" xlink:to="loc_us-gaap_DebtInstrumentFairValue_49f27af1-ce51-4cf3-9a72-e035e8af3de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_207bfd98-1c83-49a6-8369-d08a3a86ae6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_e3fc6369-6ff8-47b5-befc-fee09d1aa947" xlink:to="loc_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet_207bfd98-1c83-49a6-8369-d08a3a86ae6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_OperatingPartnershipPerformanceUnitsMember" xlink:href="hr-20230930.xsd#hr_OperatingPartnershipPerformanceUnitsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_hr_OperatingPartnershipPerformanceUnitsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_hr_NonVestedStockAwardMember" xlink:href="hr-20230930.xsd#hr_NonVestedStockAwardMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_hr_NonVestedStockAwardMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097275870048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Oct. 27, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35568<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HEALTHCARE REALTY TRUST INCORPORATED<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">MD<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-4738467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3310 West End Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Nashville<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TN<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">37203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">269-8175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A Common Stock, $0.01 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380,874,078<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001360604<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097276767344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNetAbstract', window );"><strong>Real estate properties</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">$ 1,387,821<span></span>
</td>
<td class="nump">$ 1,439,798<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentBuildingAndBuildingImprovements', window );">Buildings and improvements</a></td>
<td class="nump">11,004,195<span></span>
</td>
<td class="nump">11,332,037<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross', window );">Lease intangibles</a></td>
<td class="nump">890,273<span></span>
</td>
<td class="nump">959,998<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_PersonalProperty', window );">Personal property</a></td>
<td class="nump">12,686<span></span>
</td>
<td class="nump">11,907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Investment in financing receivable, net</a></td>
<td class="nump">120,975<span></span>
</td>
<td class="nump">120,236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization', window );">Financing lease right-of-use assets</a></td>
<td class="nump">82,613<span></span>
</td>
<td class="nump">83,824<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DevelopmentInProcess', window );">Construction in progress</a></td>
<td class="nump">85,644<span></span>
</td>
<td class="nump">35,560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LandAvailableForDevelopment', window );">Land held for development</a></td>
<td class="nump">59,871<span></span>
</td>
<td class="nump">74,265<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAtCost', window );">Total real estate properties</a></td>
<td class="nump">13,644,078<span></span>
</td>
<td class="nump">14,057,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation', window );">Less accumulated depreciation and amortization</a></td>
<td class="num">(2,093,952)<span></span>
</td>
<td class="num">(1,645,271)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Total real estate properties, net</a></td>
<td class="nump">11,550,126<span></span>
</td>
<td class="nump">12,412,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">24,668<span></span>
</td>
<td class="nump">60,961<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet', window );">Assets held for sale, net</a></td>
<td class="nump">57,638<span></span>
</td>
<td class="nump">18,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">323,759<span></span>
</td>
<td class="nump">336,983<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in unconsolidated joint ventures</a></td>
<td class="nump">325,453<span></span>
</td>
<td class="nump">327,248<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">250,530<span></span>
</td>
<td class="nump">223,202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssets', window );">Other assets, net</a></td>
<td class="nump">571,554<span></span>
</td>
<td class="nump">469,990<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">13,103,728<span></span>
</td>
<td class="nump">13,849,631<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">5,227,413<span></span>
</td>
<td class="nump">5,351,827<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">204,947<span></span>
</td>
<td class="nump">244,033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities of assets held for sale</a></td>
<td class="nump">3,814<span></span>
</td>
<td class="nump">437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">273,319<span></span>
</td>
<td class="nump">279,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Financing lease liabilities</a></td>
<td class="nump">74,087<span></span>
</td>
<td class="nump">72,939<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">211,365<span></span>
</td>
<td class="nump">218,668<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">5,994,945<span></span>
</td>
<td class="nump">6,167,799<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable non-controlling interests</a></td>
<td class="nump">3,195<span></span>
</td>
<td class="nump">2,014<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $.01 par value per share; 200,000 shares authorized; none issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Class A Common stock, $.01 par value per share; 1,000,000 shares authorized; 380,860 and 380,590 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively</a></td>
<td class="nump">3,809<span></span>
</td>
<td class="nump">3,806<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">9,597,629<span></span>
</td>
<td class="nump">9,587,637<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">17,079<span></span>
</td>
<td class="nump">2,140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_CumulativeNetIncomeAttributableToCommonStockholders', window );">Cumulative net income attributable to common stockholders</a></td>
<td class="nump">1,069,327<span></span>
</td>
<td class="nump">1,307,055<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CumulativeDividends', window );">Cumulative dividends</a></td>
<td class="num">(3,684,144)<span></span>
</td>
<td class="num">(3,329,562)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">7,003,700<span></span>
</td>
<td class="nump">7,571,076<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interest</a></td>
<td class="nump">101,888<span></span>
</td>
<td class="nump">108,742<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">7,105,588<span></span>
</td>
<td class="nump">7,679,818<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 13,103,728<span></span>
</td>
<td class="nump">$ 13,849,631<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets held for sale and discontinued operations, net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AssetsHeldForSaleAndDiscontinuedOperationsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_CumulativeNetIncomeAttributableToCommonStockholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative net income attributable to common stockholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_CumulativeNetIncomeAttributableToCommonStockholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_PersonalProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Personal property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_PersonalProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(1),(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 715<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (j)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480506/715-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CumulativeDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cumulative cash dividends distributed to shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CumulativeDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DevelopmentInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of expenditures for a real estate project that has not yet been completed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DevelopmentInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentBuildingAndBuildingImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate of the carrying amounts as of the balance sheet date of investments in building and building improvements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentBuildingAndBuildingImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LandAvailableForDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of land available for development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LandAvailableForDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherFiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of finite-lived intangible assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherFiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(12)(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of depreciation for real estate property held for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097272862048">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">200,000,000<span></span>
</td>
<td class="nump">200,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">380,860,000<span></span>
</td>
<td class="nump">380,590,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">380,860,000<span></span>
</td>
<td class="nump">380,590,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097275511952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Rental income</a></td>
<td class="nump">$ 333,335<span></span>
</td>
<td class="nump">$ 298,931<span></span>
</td>
<td class="nump">$ 987,109<span></span>
</td>
<td class="nump">$ 578,052<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss', window );">Interest income</a></td>
<td class="nump">4,264<span></span>
</td>
<td class="nump">3,366<span></span>
</td>
<td class="nump">12,711<span></span>
</td>
<td class="nump">7,253<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Other operating</a></td>
<td class="nump">4,661<span></span>
</td>
<td class="nump">4,057<span></span>
</td>
<td class="nump">13,508<span></span>
</td>
<td class="nump">9,270<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">342,260<span></span>
</td>
<td class="nump">306,354<span></span>
</td>
<td class="nump">1,013,328<span></span>
</td>
<td class="nump">594,575<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment', window );">Property operating</a></td>
<td class="nump">131,639<span></span>
</td>
<td class="nump">112,473<span></span>
</td>
<td class="nump">379,074<span></span>
</td>
<td class="nump">226,947<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">13,396<span></span>
</td>
<td class="nump">16,741<span></span>
</td>
<td class="nump">43,796<span></span>
</td>
<td class="nump">38,317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquisitionCosts', window );">Acquisition and pursuit costs</a></td>
<td class="nump">769<span></span>
</td>
<td class="nump">482<span></span>
</td>
<td class="nump">1,725<span></span>
</td>
<td class="nump">3,137<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_MergerRelatedCosts', window );">Merger-related costs</a></td>
<td class="nump">7,450<span></span>
</td>
<td class="nump">79,402<span></span>
</td>
<td class="num">(3,366)<span></span>
</td>
<td class="nump">92,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">182,989<span></span>
</td>
<td class="nump">158,117<span></span>
</td>
<td class="nump">550,661<span></span>
</td>
<td class="nump">267,889<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_OperatingExpensesandCostofGoodsSold', window );">Expenses</a></td>
<td class="nump">336,243<span></span>
</td>
<td class="nump">367,215<span></span>
</td>
<td class="nump">971,890<span></span>
</td>
<td class="nump">628,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate', window );">Gain on sales of real estate properties</a></td>
<td class="nump">48,811<span></span>
</td>
<td class="nump">143,908<span></span>
</td>
<td class="nump">56,974<span></span>
</td>
<td class="nump">197,188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(66,304)<span></span>
</td>
<td class="num">(53,044)<span></span>
</td>
<td class="num">(195,397)<span></span>
</td>
<td class="num">(82,248)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Gain (loss) on extinguishment of debt</a></td>
<td class="nump">62<span></span>
</td>
<td class="num">(1,091)<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="num">(2,520)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ImpairmentOfRealEstateAndCreditLossReserves', window );">Impairment of real estate properties and credit loss reserves</a></td>
<td class="num">(56,873)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(143,510)<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity loss from unconsolidated joint ventures</a></td>
<td class="num">(456)<span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="num">(1,253)<span></span>
</td>
<td class="num">(776)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Interest and other income (expense), net</a></td>
<td class="nump">139<span></span>
</td>
<td class="num">(172)<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
<td class="num">(378)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (expense)</a></td>
<td class="num">(74,621)<span></span>
</td>
<td class="nump">89,477<span></span>
</td>
<td class="num">(281,846)<span></span>
</td>
<td class="nump">111,291<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">(68,604)<span></span>
</td>
<td class="nump">28,616<span></span>
</td>
<td class="num">(240,408)<span></span>
</td>
<td class="nump">76,973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss (income) attributable to non-controlling interests</a></td>
<td class="nump">760<span></span>
</td>
<td class="num">(312)<span></span>
</td>
<td class="nump">2,680<span></span>
</td>
<td class="num">(312)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income attributable to common stockholders</a></td>
<td class="num">$ (67,844)<span></span>
</td>
<td class="nump">$ 28,304<span></span>
</td>
<td class="num">$ (237,728)<span></span>
</td>
<td class="nump">$ 76,661<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share (in dollars per share)</a></td>
<td class="num">$ (0.18)<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="num">$ (0.63)<span></span>
</td>
<td class="nump">$ 0.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share (in dollars per share)</a></td>
<td class="num">$ (0.18)<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="num">$ (0.63)<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">378,925,339<span></span>
</td>
<td class="nump">328,805,255<span></span>
</td>
<td class="nump">378,886,107<span></span>
</td>
<td class="nump">209,806,810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">378,925,339<span></span>
</td>
<td class="nump">332,031,384<span></span>
</td>
<td class="nump">378,886,107<span></span>
</td>
<td class="nump">210,943,990<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfRevenueExtensibleList', window );">Revenue, Product and Service [Extensible List]</a></td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
<td class="text">Service [Member]<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ImpairmentOfRealEstateAndCreditLossReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment of Real Estate and Credit Loss Reserves</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ImpairmentOfRealEstateAndCreditLossReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_MergerRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Merger Related Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_MergerRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_OperatingExpensesandCostofGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Expenses and Cost of Goods Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_OperatingExpensesandCostofGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 932<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(7)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479664/932-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 932<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-10(c)(3)(ii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479664/932-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense incurred and directly related to generating revenue by lessor from operating lease of rented property and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(c))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnSalesOfInvestmentRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(14)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -SubTopic 360<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479638/944-360-45-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -SubTopic 360<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479638/944-360-45-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 360<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479607/944-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnSalesOfInvestmentRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483013/835-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income from financing receivable before allowance for credit loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (a)<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (b)<br> -Subparagraph (1)<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482964/270-10-50-6A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479016/842-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfRevenueExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates type of revenue from product and service. Includes, but is not limited to, revenue from contract with customer and other sources.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfRevenueExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097275799952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (68,604)<span></span>
</td>
<td class="nump">$ 28,616<span></span>
</td>
<td class="num">$ (240,408)<span></span>
</td>
<td class="nump">$ 76,973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Interest rate swaps</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassification adjustments for (gains) losses included in net income (interest expense)</a></td>
<td class="num">(4,168)<span></span>
</td>
<td class="nump">763<span></span>
</td>
<td class="num">(9,874)<span></span>
</td>
<td class="nump">2,672<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gains arising during the period on interest rate swaps</a></td>
<td class="nump">12,016<span></span>
</td>
<td class="nump">6,083<span></span>
</td>
<td class="nump">24,999<span></span>
</td>
<td class="nump">12,905<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income</a></td>
<td class="nump">7,848<span></span>
</td>
<td class="nump">6,846<span></span>
</td>
<td class="nump">15,125<span></span>
</td>
<td class="nump">15,577<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive (loss) income</a></td>
<td class="num">(60,756)<span></span>
</td>
<td class="nump">35,462<span></span>
</td>
<td class="num">(225,283)<span></span>
</td>
<td class="nump">92,550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: comprehensive loss (income) attributable to non-controlling interests</a></td>
<td class="nump">663<span></span>
</td>
<td class="num">(384)<span></span>
</td>
<td class="nump">2,494<span></span>
</td>
<td class="num">(384)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive (loss) income attributable to common stockholders</a></td>
<td class="num">(60,093)<span></span>
</td>
<td class="nump">35,078<span></span>
</td>
<td class="num">(222,789)<span></span>
</td>
<td class="nump">92,166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Interest rate swaps</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gains arising during the period on interest rate swaps</a></td>
<td class="nump">$ 12,016<span></span>
</td>
<td class="nump">$ 6,083<span></span>
</td>
<td class="nump">$ 24,999<span></span>
</td>
<td class="nump">$ 12,905<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097268189584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Total Stockholders&#8217; Equity</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Cumulative Net Income</div></th>
<th class="th"><div>Cumulative Dividends</div></th>
<th class="th"><div>Non-controlling Interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2021</a></td>
<td class="nump">$ 2,185,116<span></span>
</td>
<td class="nump">$ 2,185,116<span></span>
</td>
<td class="nump">$ 1,505<span></span>
</td>
<td class="nump">$ 3,972,917<span></span>
</td>
<td class="num">$ (9,981)<span></span>
</td>
<td class="nump">$ 1,266,158<span></span>
</td>
<td class="num">$ (3,045,483)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="nump">22,855<span></span>
</td>
<td class="nump">22,855<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="nump">22,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_MergerConsiderationTransferred', window );">Merger consideration transferred</a></td>
<td class="nump">5,687,165<span></span>
</td>
<td class="nump">5,576,463<span></span>
</td>
<td class="nump">2,289<span></span>
</td>
<td class="nump">5,574,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,702<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Non-controlling interests acquired</a></td>
<td class="nump">1,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,266<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common stock redemptions</a></td>
<td class="num">(248)<span></span>
</td>
<td class="num">(248)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(248)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">16,772<span></span>
</td>
<td class="nump">16,772<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">16,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Redemption of non-controlling interest</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(97)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="nump">76,973<span></span>
</td>
<td class="nump">76,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,661<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassification adjustments for gains included in net income (interest expense)</a></td>
<td class="nump">2,672<span></span>
</td>
<td class="nump">2,664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gains arising during the period on interest rate swaps</a></td>
<td class="nump">12,905<span></span>
</td>
<td class="nump">12,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends to common stockholders and distributions to non-controlling interest holders</a></td>
<td class="num">(166,451)<span></span>
</td>
<td class="num">(166,009)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(166,009)<span></span>
</td>
<td class="num">(442)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">7,839,026<span></span>
</td>
<td class="nump">7,727,213<span></span>
</td>
<td class="nump">3,806<span></span>
</td>
<td class="nump">9,586,556<span></span>
</td>
<td class="nump">5,524<span></span>
</td>
<td class="nump">1,342,819<span></span>
</td>
<td class="num">(3,211,492)<span></span>
</td>
<td class="nump">111,813<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable Non-controlling Interests, beginning balance at Dec. 31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable Non-controlling Interests, ending balance at Sep. 30, 2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2022</a></td>
<td class="nump">2,177,866<span></span>
</td>
<td class="nump">2,177,866<span></span>
</td>
<td class="nump">1,516<span></span>
</td>
<td class="nump">4,002,525<span></span>
</td>
<td class="num">(1,250)<span></span>
</td>
<td class="nump">1,314,515<span></span>
</td>
<td class="num">(3,139,440)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_MergerConsiderationTransferred', window );">Merger consideration transferred</a></td>
<td class="nump">5,687,165<span></span>
</td>
<td class="nump">5,576,463<span></span>
</td>
<td class="nump">2,289<span></span>
</td>
<td class="nump">5,574,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,702<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Non-controlling interests acquired</a></td>
<td class="nump">1,266<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,266<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common stock redemptions</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(41)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">9,717<span></span>
</td>
<td class="nump">9,717<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">9,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Redemption of non-controlling interest</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(97)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="nump">28,616<span></span>
</td>
<td class="nump">28,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">312<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassification adjustments for gains included in net income (interest expense)</a></td>
<td class="nump">763<span></span>
</td>
<td class="nump">755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">755<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gains arising during the period on interest rate swaps</a></td>
<td class="nump">6,083<span></span>
</td>
<td class="nump">6,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends to common stockholders and distributions to non-controlling interest holders</a></td>
<td class="num">(72,494)<span></span>
</td>
<td class="num">(72,052)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(72,052)<span></span>
</td>
<td class="num">(442)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2022</a></td>
<td class="nump">7,839,026<span></span>
</td>
<td class="nump">7,727,213<span></span>
</td>
<td class="nump">3,806<span></span>
</td>
<td class="nump">9,586,556<span></span>
</td>
<td class="nump">5,524<span></span>
</td>
<td class="nump">1,342,819<span></span>
</td>
<td class="num">(3,211,492)<span></span>
</td>
<td class="nump">111,813<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable Non-controlling Interests, beginning balance at Jun. 30, 2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable Non-controlling Interests, ending balance at Sep. 30, 2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="nump">7,679,818<span></span>
</td>
<td class="nump">7,571,076<span></span>
</td>
<td class="nump">3,806<span></span>
</td>
<td class="nump">9,587,637<span></span>
</td>
<td class="nump">2,140<span></span>
</td>
<td class="nump">1,307,055<span></span>
</td>
<td class="num">(3,329,562)<span></span>
</td>
<td class="nump">108,742<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="nump">112<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common stock redemptions</a></td>
<td class="num">(1,587)<span></span>
</td>
<td class="num">(1,587)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,587)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">11,470<span></span>
</td>
<td class="nump">11,470<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">11,467<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">(240,408)<span></span>
</td>
<td class="num">(237,728)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(237,728)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,680)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassification adjustments for gains included in net income (interest expense)</a></td>
<td class="num">(9,874)<span></span>
</td>
<td class="num">(9,757)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,757)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(117)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gains arising during the period on interest rate swaps</a></td>
<td class="nump">24,999<span></span>
</td>
<td class="nump">24,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends to common stockholders and distributions to non-controlling interest holders</a></td>
<td class="num">(358,942)<span></span>
</td>
<td class="num">(354,582)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(354,582)<span></span>
</td>
<td class="num">(4,360)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2023</a></td>
<td class="nump">7,105,588<span></span>
</td>
<td class="nump">7,003,700<span></span>
</td>
<td class="nump">3,809<span></span>
</td>
<td class="nump">9,597,629<span></span>
</td>
<td class="nump">17,079<span></span>
</td>
<td class="nump">1,069,327<span></span>
</td>
<td class="num">(3,684,144)<span></span>
</td>
<td class="nump">101,888<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable Non-controlling Interests, beginning balance at Dec. 31, 2022</a></td>
<td class="nump">2,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease', window );">Contributions from redeemable non-controlling interests</a></td>
<td class="nump">1,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Adjustments to redemption value of redeemable non-controlling interests</a></td>
<td class="num">(29)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable Non-controlling Interests, ending balance at Sep. 30, 2023</a></td>
<td class="nump">3,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Jun. 30, 2023</a></td>
<td class="nump">7,283,417<span></span>
</td>
<td class="nump">7,179,399<span></span>
</td>
<td class="nump">3,808<span></span>
</td>
<td class="nump">9,595,033<span></span>
</td>
<td class="nump">9,328<span></span>
</td>
<td class="nump">1,137,171<span></span>
</td>
<td class="num">(3,565,941)<span></span>
</td>
<td class="nump">104,018<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock, net of issuance costs</a></td>
<td class="nump">33<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Common stock redemptions</a></td>
<td class="nump">8<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation</a></td>
<td class="nump">2,556<span></span>
</td>
<td class="nump">2,556<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">2,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">(68,604)<span></span>
</td>
<td class="num">(67,844)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(67,844)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(760)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">Reclassification adjustments for gains included in net income (interest expense)</a></td>
<td class="num">(4,168)<span></span>
</td>
<td class="num">(4,118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,118)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gains arising during the period on interest rate swaps</a></td>
<td class="nump">12,016<span></span>
</td>
<td class="nump">11,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DividendsCommonStockCash', window );">Dividends to common stockholders and distributions to non-controlling interest holders</a></td>
<td class="num">(119,670)<span></span>
</td>
<td class="num">(118,203)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(118,203)<span></span>
</td>
<td class="num">(1,467)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Sep. 30, 2023</a></td>
<td class="nump">7,105,588<span></span>
</td>
<td class="nump">$ 7,003,700<span></span>
</td>
<td class="nump">$ 3,809<span></span>
</td>
<td class="nump">$ 9,597,629<span></span>
</td>
<td class="nump">$ 17,079<span></span>
</td>
<td class="nump">$ 1,069,327<span></span>
</td>
<td class="num">$ (3,684,144)<span></span>
</td>
<td class="nump">$ 101,888<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable Non-controlling Interests, beginning balance at Jun. 30, 2023</a></td>
<td class="nump">2,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Redeemable Non-controlling Interests</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease', window );">Contributions from redeemable non-controlling interests</a></td>
<td class="nump">710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityAccretionToRedemptionValue', window );">Adjustments to redemption value of redeemable non-controlling interests</a></td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable Non-controlling Interests, ending balance at Sep. 30, 2023</a></td>
<td class="nump">$ 3,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_MergerConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Merger Consideration Transferred</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_MergerConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStockCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStockCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-23<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-23<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15<br><br>Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16<br><br>Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAccretionToRedemptionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of accretion of temporary equity to its redemption value during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAccretionToRedemptionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in the value of each type or class of stock classified as temporary equity during the period. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097283677344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Dividends to common stockholders and distributions to non-controlling interest holders (in dollars per share)</a></td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.93<span></span>
</td>
<td class="nump">$ 0.93<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097275426080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (240,408)<span></span>
</td>
<td class="nump">$ 76,973<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">550,661<span></span>
</td>
<td class="nump">267,889<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAmortizationOfDeferredCharges', window );">Other amortization</a></td>
<td class="nump">33,822<span></span>
</td>
<td class="nump">11,875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">11,470<span></span>
</td>
<td class="nump">16,772<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_StraightLineRentReceivable', window );">Amortization of straight-line rent receivable (lessor)</a></td>
<td class="num">(29,320)<span></span>
</td>
<td class="num">(12,267)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_StraightlineRentLiability', window );">Amortization of straight-line rent on operating leases (lessee)</a></td>
<td class="nump">4,600<span></span>
</td>
<td class="nump">2,016<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation', window );">Gain on sales of real estate properties</a></td>
<td class="num">(56,974)<span></span>
</td>
<td class="num">(197,188)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">(Gain) loss on extinguishment of debt</a></td>
<td class="num">(62)<span></span>
</td>
<td class="nump">2,520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations', window );">Impairment of real estate properties and credit loss reserves</a></td>
<td class="nump">143,510<span></span>
</td>
<td class="num">(25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity loss from unconsolidated joint ventures</a></td>
<td class="nump">1,253<span></span>
</td>
<td class="nump">776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions', window );">Distributions from unconsolidated joint ventures</a></td>
<td class="nump">4,366<span></span>
</td>
<td class="nump">893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_InterestIncomeFinancingReceivableNoncash', window );">Non-cash interest from financing and notes receivable</a></td>
<td class="num">(1,067)<span></span>
</td>
<td class="num">(1,901)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets, including right-of-use-assets</a></td>
<td class="num">(34,632)<span></span>
</td>
<td class="num">(19,230)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="num">(32,060)<span></span>
</td>
<td class="nump">35,769<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="nump">17,345<span></span>
</td>
<td class="num">(58,213)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">372,504<span></span>
</td>
<td class="nump">126,659<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireRealEstate', window );">Acquisitions of real estate</a></td>
<td class="num">(48,106)<span></span>
</td>
<td class="num">(376,924)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToDevelopRealEstateAssets', window );">Development of real estate</a></td>
<td class="num">(31,318)<span></span>
</td>
<td class="num">(17,572)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherProductiveAssets', window );">Additional long-lived assets</a></td>
<td class="num">(156,871)<span></span>
</td>
<td class="num">(97,797)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireNotesReceivable', window );">Funding of mortgages and notes receivable</a></td>
<td class="num">(14,597)<span></span>
</td>
<td class="num">(3,441)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Investments in unconsolidated joint ventures</a></td>
<td class="num">(3,824)<span></span>
</td>
<td class="num">(99,586)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireFinanceReceivables', window );">Investment in financing receivable</a></td>
<td class="num">(310)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollectionOfFinanceReceivables', window );">Investment in financing receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests', window );">Contributions from redeemable non-controlling interests</a></td>
<td class="nump">710<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyHeldForSale', window );">Proceeds from sales of real estate properties and additional long-lived assets</a></td>
<td class="nump">366,779<span></span>
</td>
<td class="nump">870,806<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable', window );">Proceeds from notes receivable repayments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_CashAcquiredInMerger', window );">Cash assumed in Merger, including restricted cash for special dividend payment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,149,681<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by investing activities</a></td>
<td class="nump">112,463<span></span>
</td>
<td class="nump">1,425,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit', window );">Net repayments on unsecured credit facility</a></td>
<td class="num">(149,000)<span></span>
</td>
<td class="num">(154,400)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfMediumTermNotes', window );">Borrowings on term loans</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">666,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfMediumTermNotes', window );">Repayment on term loan</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(718,500)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of notes and bonds payable</a></td>
<td class="num">(11,988)<span></span>
</td>
<td class="num">(18,880)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarlyRepaymentOfSeniorDebt', window );">Redemption of notes and bonds payable</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,184)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid</a></td>
<td class="num">(354,171)<span></span>
</td>
<td class="num">(165,735)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_PaymentOfSpecialDividendMergerRelated', window );">Special dividend paid in relation to the Merger</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,123,648)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">110<span></span>
</td>
<td class="nump">22,851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Common stock redemptions</a></td>
<td class="num">(1,834)<span></span>
</td>
<td class="num">(894)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Distributions to non-controlling interest holders</a></td>
<td class="num">(3,836)<span></span>
</td>
<td class="num">(442)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Debt issuance and assumption costs</a></td>
<td class="num">(529)<span></span>
</td>
<td class="num">(12,753)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Payments made on finance leases</a></td>
<td class="num">(12)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(521,260)<span></span>
</td>
<td class="num">(1,508,085)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">(Decrease) increase in cash and cash equivalents</a></td>
<td class="num">(36,293)<span></span>
</td>
<td class="nump">44,408<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">60,961<span></span>
</td>
<td class="nump">13,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">24,668<span></span>
</td>
<td class="nump">57,583<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental Cash Flow Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">185,402<span></span>
</td>
<td class="nump">83,382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoanRelatedToPropertySales1', window );">Mortgage note receivable taken in connection with sale of real estate</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Invoices accrued for construction, tenant improvements and other capitalized costs</a></td>
<td class="nump">32,590<span></span>
</td>
<td class="nump">52,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TransferMortgagePayable', window );">Mortgage note payable assumed in connection with acquisition of real estate, net</a></td>
<td class="nump">5,284<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidCapitalized', window );">Capitalized interest</a></td>
<td class="nump">$ 2,077<span></span>
</td>
<td class="nump">$ 848<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_CashAcquiredInMerger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Acquired in Merger</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_CashAcquiredInMerger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gains (Losses) on Sales of Investment Real Estate, Including Discontinued Operation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment of Real Estate, Continuing and Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_InterestIncomeFinancingReceivableNoncash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Income, Financing Receivable, Noncash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_InterestIncomeFinancingReceivableNoncash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_PaymentOfSpecialDividendMergerRelated">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of Special Dividend, Merger Related</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_PaymentOfSpecialDividendMergerRelated</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Contributions from Redeemable Noncontrolling Interests</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_StraightLineRentReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Straight-line rent receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_StraightLineRentReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_StraightlineRentLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Straight-line rent liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_StraightlineRentLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarlyRepaymentOfSeniorDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarlyRepaymentOfSeniorDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentDividendsOrDistributions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 21D<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-21D<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentDividendsOrDistributions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest capitalized, classified as investing activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoanRelatedToPropertySales1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mortgage loan related to property sales in noncash investing and financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoanRelatedToPropertySales1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of other deferred costs recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireFinanceReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of amounts due from customers, clients, lessees, borrowers, or others under the terms of its agreements therewith.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireFinanceReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the acquisition of a piece of land, anything permanently fixed to it, including buildings, structures on it and so forth; includes real estate intended to generate income for the owner; excludes real estate acquired for use by the owner.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToDevelopRealEstateAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments to develop real estate assets is the process of adding improvements on or to a parcel of land. Such improvements may include drainage, utilities, subdividing, access, buildings, and any combination of these elements; and are generally classified as cash flow from investing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToDevelopRealEstateAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollectionOfFinanceReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the collection of receivables arising from the financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollectionOfFinanceReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfMediumTermNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt funding received on a regular basis with maturities ranging from 5-10 years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfMediumTermNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the proceeds from sale of notes receivable, as well as principal collections from a borrowing supported by a written promise to pay an obligation (note receivable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of formerly productive land held for sale, anything permanently fixed to it, including buildings, structures on it, and so forth.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfMediumTermNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to pay off borrowing used to receive debt funding on a regular basis with maturities ranging from 5-10 years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfMediumTermNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TransferMortgagePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value of transfer of mortgage payable in noncash investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TransferMortgagePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097282677376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Business Overview</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Healthcare Realty Trust Incorporated is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September&#160;30, 2023, the Company had gross investments of approximately $13.6&#160;billion in </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">663 wholly-owned real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property.  The Company's 663 re</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">al estate properties are located in 35 states and total approxima</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">tely 39.1&#160;million </span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">square feet. The Company provided leasing and property management services to approximat</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">ely 38.6 million sq</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">uare feet nationwide.   </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In addition, as of September&#160;30, 2023, the Company had a weighted average ownership interest of approxima</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">tely 44%</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> in </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">34 re</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">al estate properties held in joint ventures. See Note 3 below for more details regarding the Company's unconsolidated joint ventures. </span></div><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the Company's Condensed Consolidated Financial Statements, are outside the scope of our independent registered public accounting firm&#8217;s review. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For purposes of this Quarterly Report on Form 10-Q, references to the &#8220;Company&#8221; are to Legacy HR for periods prior to the closing of the Merger and thereafter to Legacy HR and Legacy HTA as the combined company after giving effect to the Merger.  The Merger is described in more detail in Note 2 to these Condensed Consolidated Financial Statements.  The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. However, except as disclosed herein and specific disclosures included as a result of the Merger, management believes there has been no material change in the information disclosed in the Notes to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022. All material intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">This interim financial information should be read in conjunction with the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December&#160;31, 2023 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Principles of Consolidation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s Condensed Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (&#8220;VIEs&#8221;). Accounting Standards Codification (&#8220;ASC&#8221;) Topic 810, Consolidation broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity&#8217;s economic performance or (ii) the equity investment at risk is insufficient to finance that entity&#8217;s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity&#8217;s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE&#8217;s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Condensed Consolidated Financial Statements. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company may change its original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity&#8217;s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than 100% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities&#8217; activities based upon the terms of the respective entities&#8217; ownership agreements. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Healthcare Realty Holdings, L.P., a Delaware limited partnership (the "OP"), is 98.8% owned by the Company.  Holders of operating partnership units (&#8220;OP Units&#8221;) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of September&#160;30, 2023, there were approximately 4.7&#160;million OP Units, or 1.2% of OP units issued and outstanding, held by non-controlling interest holders.  Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates the interests in the OP.  </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of September&#160;30, 2023, the Company had four consolidated VIEs, in addition to the OP, consisting of joint venture investments in which the Company is the primary beneficiary of the VIE based on the combination of operational control and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures.  Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:45.259%"><tr><td style="width:1.0%"></td><td style="width:66.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SEPTEMBER 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net real estate investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">72,756&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,766&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Receivables and other assets</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,594&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total assets</span></div></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">77,116&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities:</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">16,909&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total equity</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">60,207&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total liabilities and equity</span></div></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">77,116&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of September&#160;30, 2023, the Company had three unconsolidated VIEs consisting of two notes receivables and one joint venture.  The Company does not have the power or economic interests to direct the activities of the VIEs on a stand-alone basis, and therefore it was determined that the Company was not the primary beneficiary.  As a result, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method.  See below for additional information regarding the Company's unconsolidated VIEs.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.119%"><tr><td style="width:1.0%"></td><td style="width:21.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands) ORIGINATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SOURCE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING AMOUNT </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM EXPOSURE TO LOSS</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">30,797&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Charlotte, NC </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,743&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">63,579&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">63,579&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Assumed mortgage note receivable in connection with the Merger.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes investments in seven properties.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of September&#160;30, 2023, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities.  See Note 3 below for more details regarding the Company's unconsolidated joint ventures.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Use of Estimates in the Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.</span></div><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Reclassifications </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Certain reclassifications have been made on the Company's prior year Condensed Consolidated Balance Sheet to conform to current year presentation. Previously, the Company's Lease intangibles were included in Building, improvements and lease intangibles and Goodwill was included with Other assets, net. These amounts are now classified as separate line items on the Company's Condensed Consolidated Balance Sheets. </span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:140%">                                            &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Redeemable Non-Controlling Interests</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company accounts for redeemable equity securities in accordance with ASC Topic 480: Accounting for Redeemable Equity Instruments, which requires that equity securities redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders&#8217; equity.  The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Condensed Consolidated Balance Sheets.  Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest&#8217;s share of net income or loss and distributions) or the redemption value.  We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest.  As of September&#160;30, 2023, the Company had redeemable non-controlling interests of $3.2&#160;million.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Asset Impairment</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever the occurrence of an event or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company&#8217;s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its tenants.  During the three and nine months ended September&#160;30, 2023, the Company recognized real estate impairments totaling $56.9&#160;million and $138.3&#160;million, respectively, as a result of completed or planned disposition activity.  </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Investments in Leases - Financing Receivables, Net </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In accordance with ASC Topic 842: Leases, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC Topic 310: Receivables. See below for additional information regarding the Company's financing receivables.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.241%"><tr><td style="width:1.0%"></td><td style="width:26.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.667%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands) ORIGINATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">INTEREST RATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE as of SEPTEMBER 30, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Poway, CA</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5.73%</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">113,634&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">November 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Columbus, OH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6.48%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,341&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">120,975&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Real Estate Notes Receivable</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Real estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower&#8217;s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held-to-maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses.  As of September&#160;30, 2023, real estate notes receivable, net, which are included in Other assets on the Company's Condensed Consolidated Balance Sheets, totaled $155.0&#160;million.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"><tr><td style="width:1.0%"></td><td style="width:15.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.942%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">ORIGINATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">STATED INTEREST RATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM LOAN COMMITMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OUTSTANDING as of <br/>SEPT 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">ALLOWANCE FOR CREDIT LOSSES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE DISCOUNT AND FEES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE as of SEPT 30, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mezzanine loans</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">54,119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">54,119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5,196)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,067)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,856&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mortgage loans </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/30/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/31/2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(353)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">30,797&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">North Carolina</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(257)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,743&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5/17/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2/27/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">65,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">27,651&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(49)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">27,602&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">California</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/30/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/29/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">147,150&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">109,801&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(659)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">109,142&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">201,269&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">163,920&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5,196)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,726)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">154,998&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Allowance for Credit Losses</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Pursuant to ASC Topic 326, Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under ASC Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#8217;s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In its assessment of current expected credit losses for real estate notes receivable, the Company utilizes past payment history of its borrowers, current economic conditions, and forecasted economic conditions through the maturity date of each note to estimate a probability of default and a resulting loss for each real estate note receivable.  During the first quarter of 2023, the Company determined that the risk of credit loss on its mezzanine loans was no longer remote and recorded a credit loss reserve of $5.2&#160;million.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table summarizes the Company's allowance for credit losses on real estate notes receivable:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.672%"><tr><td style="width:1.0%"></td><td style="width:59.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.631%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">TWELVE MONTHS ENDED DECEMBER 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Allowance for credit losses, beginning of period</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Credit loss reserves</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,196&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Allowance for credit losses, end of period</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,196&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Interest Income</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Income from Lease Financing Receivables</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognized the related income from two financing receivables totaling $2.0&#160;million and $6.2&#160;million, respectively, for the three and nine months ended September&#160;30, 2023, and $2.0&#160;million and $5.9&#160;million, respectively for the three and nine months ended September&#160;30, 2022, based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable in any particular period will not equal the cash payments from the lease agreement in that period. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Interest income over the life of the lease.</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Income from Real Estate Notes Receivable</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the three and nine months ended September&#160;30, 2023, the Company recognized interest income of $2.3&#160;million and $6.5&#160;million, respectively, related to real estate notes receivable. The Company recognizes interest income on an accrual basis unless the Company has determined that collectability of contractual amounts is not reasonably assured, at which point the note is placed on non-accrual status and interest income is recognized on a cash basis.  As of January 1, 2023, the Company placed two of its real estate notes receivable with principal balances of $48.9&#160;million on non-accrual status and accordingly did not recognize any interest income for the three and nine month periods ended September&#160;30, 2023. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Revenue from Contracts with Customers (ASC Topic 606)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognizes certain revenue under the core principle of Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of Topic 606. To achieve the core principle, the Company applies the five step model specified in the guidance. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Revenue that is accounted for under Topic 606 is segregated on the Company&#8217;s Condensed Consolidated Statements of Operations in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income. Below is a detail of the amounts by category:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.385%"><tr><td style="width:1.0%"></td><td style="width:33.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>September 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Type of Revenue</span></td><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Parking income</span></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,751&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,428&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7,511&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,100&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Management fee income</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,552&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,426&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,864&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Miscellaneous</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,661&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,057&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">13,508&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,270&#160;</span></td><td style="border-right:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1     Includes the recovery of certain expenses under the financing receivable as outlined in the management agreement.           </span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time, and the Company recognizes revenue monthly based on this principle.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097282645504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Merger with HTA<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Merger with HTA</a></td>
<td class="text">Merger with HTA <div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On July 20, 2022 (the &#8220;Closing Date&#8221;), pursuant to the Agreement and Plan of Merger dated as of February 28, 2022 (the &#8220;Merger Agreement&#8221;), by and among Healthcare Realty Trust Incorporated, a Maryland corporation (now known as HRTI, LLC, a Maryland limited liability company) (&#8220;Legacy HR&#8221;), Healthcare Trust of America, Inc., a Maryland corporation (now known as Healthcare Realty Trust Incorporated) (&#8220;Legacy HTA&#8221;), the OP, and HR Acquisition 2, LLC, a Maryland limited liability company (&#8220;Merger Sub&#8221;), Merger Sub merged with and into Legacy HR, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA (the &#8220;Merger&#8221;).</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On the Closing Date, each outstanding share of Legacy HR common stock, $0.01 par value per share (the &#8220;Legacy HR Common Stock&#8221;), was cancelled and converted into the right to receive one share of Legacy HTA class A common stock at a fixed ratio of 1.00 to 1.00. Per the terms of the Merger Agreement, Legacy HTA declared a special dividend of $4.82 (the &#8220;Special Dividend&#8221;) for each outstanding share of Legacy HTA class A common stock, $0.01 par value per share ( the &#8220;Legacy HTA Common Stock&#8221;), and the OP declared a corresponding distribution to the holders of its partnership units, payable to Legacy HTA stockholders and OP unitholders of record on July 19, 2022. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Immediately following the Merger, Legacy HR converted to a Maryland limited liability company and changed its name to HRTI, LLC and Legacy HTA changed its name to &#8220;Healthcare Realty Trust Incorporated&#8221;. In addition, the equity interests of Legacy HR were contributed by Legacy HTA by means of a contribution and assignment agreement to the OP, and Legacy HR became a wholly-owned subsidiary of the OP.  The Company operates under the </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">name &#8220;Healthcare Realty Trust Incorporated&#8221; and its shares of class A common stock, $0.01 par value per share, trade on the New York Stock Exchange under the ticker symbol &#8220;HR&#8221;.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For accounting purposes, the Merger was treated as a &#8220;reverse acquisition&#8221; in which Legacy HTA was considered the legal acquirer and Legacy HR was considered the accounting acquirer based on various factors, including, but not limited to: (i) the composition of the board of directors of the combined company following the Merger, (ii) the composition of senior management of the combined company following the Merger, and (iii) the premium transferred to the Legacy HTA stockholders. As a result, the historical financial statements of the accounting acquirer, Legacy HR, became the historical financial statements of the Company. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The acquisition was accounted for using the acquisition method of accounting in accordance with ASC 805, Business Combinations, which requires, among other things, the assets acquired and the liabilities assumed and non-controlling interests, if any, to be recognized at their acquisition date fair value. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The implied consideration transferred on the Closing Date is as follows: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.495%"><tr><td style="width:1.0%"></td><td style="width:77.702%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.098%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands, except for per share data</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">228,520,990&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Exchange ratio</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Implied shares of Legacy HR Common Stock issued</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">228,520,990&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjusted closing price of Legacy HR Common Stock on July 20, 2022</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(b)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">24.37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Value of implied Legacy HR Common Stock issued</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,569,057&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:700;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,406&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Consideration transferred</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,576,463&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(a) The number of shares of Legacy HTA Common Stock presented above was based on 228,857,717 total shares of Legacy HTA Common Stock outstanding as of the Closing Date, less 192 Legacy HTA fractional shares that were cancelled in lieu of cash and less 336,535 shares of Legacy HTA restricted stock (net of 215,764 shares of Legacy HTA restricted stock withheld). For accounting purposes, these shares were converted to Legacy HR Common Stock, at an exchange ratio of 1.00 share of Legacy HR Common Stock per share of Legacy HTA Common Stock. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(b) For accounting purposes, the fair value of Legacy HR Common Stock issued to former holders of Legacy HTA Common Stock was based on the per share closing price of Legacy HR Common Stock on July 20, 2022.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(c) Represents the fair value of Legacy HTA restricted shares which fully vested prior to the closing of the Merger or became fully vested as a result of the closing of the Merger and which are attributable to pre-combination services. </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Final Purchase Price Allocation </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the Closing Date: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.553%"><tr><td style="width:1.0%"></td><td style="width:36.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.748%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">&#160;CUMULATIVE MEASUREMENT PERIOD ADJUSTMENTS</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">AMOUNTS RECOGNIZED ON THE CLOSING DATE <br/>(as adjusted)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">ASSETS</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Real estate investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">985,926&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18,359&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,004,285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,960,418&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(119,135)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,841,283&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangible assets</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">831,920&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,839&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">833,759&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,874&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,146&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">13,020&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10,071&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(6,744)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,327&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land held for development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">46,538&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">46,538&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total real estate investments</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,844,747&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(102,535)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,742,212&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets held for sale, net </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">707,442&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(7,946)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">699,496&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">67,892&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">67,892&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">26,034&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,403&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">37,437&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Restricted cash </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,123,647&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,247)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,122,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">198,261&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">16,370&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">214,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(b) (c)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">209,163&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,840)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">205,323&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total assets acquired</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,177,186&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(87,795)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,089,391&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">LIABILITIES</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Notes and bonds payable </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,991,300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,991,300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,227,570&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">17,374&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,244,944&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities of assets held for sale</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28,677&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,939)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">24,738&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">173,948&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10,173&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">184,121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10,720&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(855)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,865&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">203,210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(8,909)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">194,301&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total liabilities assumed</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,635,425&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">13,844&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,649,269&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net identifiable assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,541,761&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(101,639)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,440,122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-controlling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">110,702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">110,702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">145,404&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">101,639&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">247,043&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(a) The weighted average amortization period for the acquired lease intangible assets is approximately 6 years.</span></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(b) Includes $15.9 million of contractual accounts receivable, which approximates fair value.</span></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(c) Includes $78.7 million of gross contractual real estate notes receivable, the fair value of which was $74.8 million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date.</span></div></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The cumulative measurement period adjustments recorded through June 30, 2023 are final and primarily resulted from updated valuations related to the Company&#8217;s real estate assets and liabilities and additional information obtained by the Company related to the properties acquired in the Merger and their respective tenants, and resulted in an increase to goodwill of $101.6&#160;million.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Based on the final purchase price allocation of fair value, approximately $247.0&#160;million has been allocated to goodwill. Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired and liabilities assumed. The recognized goodwill is attributable to expected synergies and benefits arising from the Merger, including anticipated general and administrative cost savings and potential economies of scale benefits in both tenant and vendor relationships following the closing of the Merger.  None of the goodwill recognized is expected to be deductible for tax purposes. During the third quarter of 2023, the Company experienced a sustained decline in the price per share of its common stock, which it identified as an indicator of goodwill impairment.  As a result, the Company performed an interim goodwill evaluation. The fair value of the Company&#8217;s single reporting unit </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">was estimated using a combination of discounted cash flow models and earnings multiples techniques. The quantitative assessment as of September 30, 2023 indicated goodwill was not impaired.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Merger-related Costs</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company incurred Merger-related costs of $7.5 million and $(3.4) million, respectively, during the three and nine months ended September&#160;30, 2023, which were included within Merger-related costs in results of operations. The Merger-related costs primarily consist of legal, consulting, severance, and banking services and for the nine months ended September&#160;30, 2023 including a refund of $17.8&#160;million for transfer taxes paid during the year ended December&#160;31, 2022.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//805/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097282651600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Investments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AcquisitionsAndDispositionsTextBlock', window );">Real Estate Investments</a></td>
<td class="text">Real Estate Investments<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">2023 Acquisition Activity</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%"> </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table details the Company's real estate acquisition activity for the nine months ended September&#160;30, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.941%"><tr><td style="width:1.0%"></td><td style="width:24.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.890%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.836%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.306%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.101%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DATE ACQUIRED</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PURCHASE PRICE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MORTGAGE NOTES PAYABLE, NET</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CASH<br/>CONSIDERATION </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">REAL <br/>ESTATE </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OTHER </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE FOOTAGE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Tampa, FL</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/10/23</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">31,500&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">30,499&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">30,596&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(97)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">115,867&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Colorado Springs, CO</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/28/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,450&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,284)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,024&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,416&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(108)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total real estate acquisitions</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">42,950&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5,284)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">36,523&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">42,012&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(205)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">158,637&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In the third quarter of 2023, the Company acquired a parcel of land previously under a ground lease for $0.8&#160;million and an additional interest in an operating property for $0.6&#160;million.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Unconsolidated Joint Ventures</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's investment in and loss recognized for the three and nine months ended September&#160;30, 2023 and 2022 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.094%"><tr><td style="width:1.0%"></td><td style="width:55.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>September 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures, beginning of period </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,245&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">210,781&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,248&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">161,942&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">New investment during the period </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">117,880&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,824&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">167,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Equity loss recognized during the period </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(456)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(124)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,253)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(776)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Owner distributions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,336)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(785)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(4,366)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(893)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures, end of period </span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">325,453&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,752&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">325,453&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,752&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">In 2023, this was an additional investment in an existing joint venture in which the Company retained a 40% ownership interest. The investment consisted of the Company's sale of a property in Dallas, Texas to the joint venture.  See 2023 Real Estate Asset Dispositions below for additional information.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">2023 Real Estate Asset Dispositions </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table details the Company's dispositions for the nine months ended September&#160;30, 2023:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DATE DISPOSED</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SALE PRICE</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CLOSING ADJUSTMENTS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">COMPANY-FINANCED MORTGAGE NOTES</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NET PROCEEDS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NET REAL ESTATE INVESTMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OTHER (INCLUDING RECEIVABLES) </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">GAIN/(IMPAIRMENT)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE FOOTAGE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Tampa/Miami, FL</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/12/23</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">93,250&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,875)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">87,375&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">87,302&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(888)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">961&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">224,037&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dallas, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">19,210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(141)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">19,069&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">18,986&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">36,691&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">St. Louis, MO</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2/10/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(66)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/23/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">21,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(526)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">20,474&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">20,610&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(188)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">37,165&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">4</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(8,079)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(45,000)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">21,921&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">88,624&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(803)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(20,900)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">147,078&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">5</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/12/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(334)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,966&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,268&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(302)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Albany, NY</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,229)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,771&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,613&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,040)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7,198&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">40,870&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/2/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,320&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(285)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,035&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,567&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,274&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">57,170&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Atlanta, GA</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/22/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">25,142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(66)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">25,076&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">23,226&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(536)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,386&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">55,195&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dallas, TX</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9/15/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">115,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,504)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">113,496&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">64,183&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,094&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">43,219&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">161,264&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9/18/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(24)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,998&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,772)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">52,040&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Chicago, IL</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9/27/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">59,950&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(870)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">59,080&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">74,710&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(380)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(15,250)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">104,912&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total dispositions</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">430,772&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(18,951)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(45,000)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">366,821&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">390,485&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,736&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">18,600&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">922,922&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Includes straight-line rent receivables, leasing commissions and lease inducements.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes two properties, sold in two separate transactions to the same buyer on the same date.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">The Company sold this property to a joint venture in which it retained a 40% interest. Sales price and square footage reflect the total sales price paid by the joint venture and total square footage of the property.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">4</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.81pt">The Company entered into a mortgage note agreement with the buyer for $45&#160;million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">5</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.18pt">The Company sold a land parcel totaling 0.34 acres.</span></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Assets Held for Sale</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company had 17 properties and one corporate entity classified as assets held for sale as of September&#160;30, 2023. The net real estate assets held for sale includes the impact of $15.9&#160;million and $46.4&#160;million, respectively, of impairment charges for the three and nine months ended September&#160;30, 2023.  The Company had one property classified as assets held for sale as of December&#160;31, 2022, which was sold in the first quarter of 2023.  The table below reflects the assets and liabilities classified as held for sale as of September&#160;30, 2023 and December&#160;31, 2022:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"><tr><td style="width:1.0%"></td><td style="width:41.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance Sheet data:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">14,282&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">41,538&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">15,164&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangibles</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12,938&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,986&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">68,758&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18,850&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(13,634)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate assets held for sale, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">55,124&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18,850&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">585&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,929&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets held for sale, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">57,638&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18,893&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,716&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">282&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,020&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,078&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">155&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities of assets held for sale</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,814&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">437&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AcquisitionsAndDispositionsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Acquisitions and dispositions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AcquisitionsAndDispositionsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097282753008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Lessor Accounting</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s properties generally are leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide tenants with fixed rent renewal terms while others have market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company&#8217;s single-tenant net leases generally require the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's leases typically have escalators that are either based on a stated percentage or an index such as the consumer price index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three and nine months ended September&#160;30, 2023 was $333.3 million and $987.1 million, respectively.  Lease income for the Company's operating leases recognized for the three and nine months ended September 30, 2022 was $298.9 million and $578.1 million, respectively.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Future lease payments under the non-cancelable operating leases, excluding any reimbursements and one sale-type lease, as of September&#160;30, 2023 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"><tr><td style="width:1.0%"></td><td style="width:42.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">231,698&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">874,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">770,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">666,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">552,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,918,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,014,062&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Lessee Accounting </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of September&#160;30, 2023, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company&#8217;s ground leases. As of September&#160;30, 2023, the Company had 240 properties totaling 17.4 million square feet that were held under ground leases. Some of the ground lease renewal terms are based on fixed rent renewal terms and others have market rent renewal terms. These ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company&#8217;s ground leases are generally either stated or based on CPI. The Company had 75 prepaid ground leases as of September&#160;30, 2023. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $0.3 million and $0.1&#160;million of the Company&#8217;s rental expense for the three months ended September&#160;30, 2023 and 2022, respectively, and $1.0&#160;million and $0.4&#160;million for the nine months ended September&#160;30, 2023 and 2022, respectively.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s future lease payments (primarily for its 165 non-prepaid ground leases) as of September&#160;30, 2023 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FINANCING</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,288&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,062&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,253&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,630&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">922,019&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">396,397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">982,644&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">405,859&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(709,325)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(331,772)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Lease liabilities</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">273,319&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">74,087&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides details of the Company's total lease expense for the three and nine months ended September&#160;30, 2023 and 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>September 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Operating lease cost</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,312&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,204&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">15,748&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,613&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Variable lease expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,417&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,061&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,788&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,123&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Finance lease cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">387&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">381&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,161&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">884&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">928&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">861&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,913&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total lease expense</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,044&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,507&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">26,467&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12,533&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,281&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,847&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">16,475&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,443&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">524&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">476&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,592&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,262&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new finance lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,874&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">50,463&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">198,261&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">198,261&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">47.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">50.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">58.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">60.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Lessor Accounting</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s properties generally are leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide tenants with fixed rent renewal terms while others have market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company&#8217;s single-tenant net leases generally require the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's leases typically have escalators that are either based on a stated percentage or an index such as the consumer price index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three and nine months ended September&#160;30, 2023 was $333.3 million and $987.1 million, respectively.  Lease income for the Company's operating leases recognized for the three and nine months ended September 30, 2022 was $298.9 million and $578.1 million, respectively.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Future lease payments under the non-cancelable operating leases, excluding any reimbursements and one sale-type lease, as of September&#160;30, 2023 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"><tr><td style="width:1.0%"></td><td style="width:42.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">231,698&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">874,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">770,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">666,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">552,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,918,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,014,062&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Lessee Accounting </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of September&#160;30, 2023, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company&#8217;s ground leases. As of September&#160;30, 2023, the Company had 240 properties totaling 17.4 million square feet that were held under ground leases. Some of the ground lease renewal terms are based on fixed rent renewal terms and others have market rent renewal terms. These ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company&#8217;s ground leases are generally either stated or based on CPI. The Company had 75 prepaid ground leases as of September&#160;30, 2023. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $0.3 million and $0.1&#160;million of the Company&#8217;s rental expense for the three months ended September&#160;30, 2023 and 2022, respectively, and $1.0&#160;million and $0.4&#160;million for the nine months ended September&#160;30, 2023 and 2022, respectively.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s future lease payments (primarily for its 165 non-prepaid ground leases) as of September&#160;30, 2023 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FINANCING</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,288&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,062&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,253&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,630&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">922,019&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">396,397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">982,644&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">405,859&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(709,325)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(331,772)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Lease liabilities</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">273,319&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">74,087&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides details of the Company's total lease expense for the three and nine months ended September&#160;30, 2023 and 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>September 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Operating lease cost</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,312&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,204&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">15,748&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,613&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Variable lease expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,417&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,061&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,788&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,123&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Finance lease cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">387&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">381&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,161&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">884&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">928&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">861&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,913&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total lease expense</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,044&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,507&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">26,467&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12,533&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,281&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,847&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">16,475&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,443&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">524&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">476&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,592&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,262&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new finance lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,874&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">50,463&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">198,261&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">198,261&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">47.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">50.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">58.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">60.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097282550016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes and Bonds Payable<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Notes and Bonds Payable</a></td>
<td class="text">Notes and Bonds Payable<div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below details the Company&#8217;s notes and bonds payable as of September 30, 2023 and December 31, 2022.&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.522%"><tr><td style="width:1.0%"></td><td style="width:39.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.091%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY DATES </span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">BALANCE </span><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:3.73pt;font-weight:700;line-height:120%;position:relative;top:-2.01pt;vertical-align:baseline">1</span><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"> AS OF  </span></div></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EFFECTIVE INTEREST RATE <br/>as of 9/30/2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">9/30/2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">12/31/2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$1.5 billion Unsecured Credit Facility </span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10/25</span></td><td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">236,000&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.24&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$200 million Unsecured Term Loan </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/24</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$350 million Unsecured Term Loan </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/24</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">349,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">349,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$300 million Unsecured Term Loan </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10/25</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">299,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">299,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$150 million Unsecured Term Loan</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/26</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">149,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">149,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$200 million Unsecured Term Loan </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/27</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$300 million Unsecured Term Loan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/28</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">298,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">297,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/25</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">249,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">249,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2026</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/26</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">577,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">571,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2027 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/27</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">482,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">479,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/28</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">297,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2030 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2/30</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">572,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">565,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/30</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2031 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/31</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">295,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">295,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2031 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/31</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">645,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">632,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Mortgage notes payable</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12/23-12/26</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">77,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">84,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.57%-6.88%</span></div></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,227,413&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,351,827&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">On April 26, 2023, the Company exercised its option to extend the maturity date for one year for a fee of approximately $0.4&#160;million.   </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Changes in Mortgage Notes Payable</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On July 28, 2023, the Company assumed a mortgage note payable of $5.6&#160;million in connection with the acquisition of a 42,770 square foot property in Colorado Springs, Colorado.  The note bears interest at a rate of 4.5% per annum and matures on April 1, 2026.</span></div>On August 1, 2023, the Company repaid in full at maturity a mortgage note payable bearing interest at a rate of 3.31% per annum with an outstanding principal of $9.8&#160;million. The mortgage note encumbered a 66,984 square foot property in Marietta, Georgia.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//470/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1C<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097282651600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text">Derivative Financial Instruments<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Risk Management Objective of Using Derivatives</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company&#8217;s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company&#8217;s known or expected cash receipts and its known or expected cash payments principally related to the Company&#8217;s borrowings.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Cash Flow Hedges of Interest Rate Risk</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">life of the agreements without exchange of the underlying notional amount. Such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For derivatives designated, and that qualify, as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income (Loss) ("AOCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings. Amounts reported in AOCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#8217;s variable-rate debt. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of September&#160;30, 2023, the Company had 14 outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.978%"><tr><td style="width:1.0%"></td><td style="width:41.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EXPIRATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">AMOUNT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">WEIGHTED <br/>AVERAGE RATE</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">January 15, 2024</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1.21&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 1, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 1, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,000,000&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.17&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Subsequent Activity</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On October 19, 2023, the Company entered into two swap transactions totaling $100.0&#160;million.  The notional amounts were $50.0&#160;million each with fixed rates of 4.71% and 4.67%. The swap agreements have effective dates of November 1, 2023 and termination dates of June 1, 2027 and December 1, 2027, respectively. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On October 23, 2023, the Company entered into two swap transactions totaling $100.0&#160;million with an aggregate fixed rate of 4.73%. The swap agreements have effective dates of November 1, 2023 and termination dates of May 31, 2026. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Tabular Disclosure of Fair Values of Derivative Instruments on the Balance Sheet</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below presents the fair value of the Company's derivative financial instruments, as well as their classification on the Condensed Consolidated Balance Sheet as of September&#160;30, 2023.</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.394%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.859%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">BALANCE AT SEPTEMBER 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">BALANCE SHEET LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">21,499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">   </span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Tabular Disclosure of the Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below presents the effect of cash flow hedge accounting on AOCI during the three and nine months ended September&#160;30, 2023 and 2022 related to the Company's outstanding interest rate swaps.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"><tr><td style="width:1.0%"></td><td style="width:24.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.940%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECOGNIZED IN <br/>AOCI ON DERIVATIVE<br/>three months ended September 30,</span></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECLASSIFIED FROM <br/>AOCI INTO INCOME<br/>three months ended September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(12,016)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(6,083)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(4,317)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled treasury hedges</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled interest rate swaps</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(12,016)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(6,083)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(4,168)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"><tr><td style="width:1.0%"></td><td style="width:24.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.940%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECOGNIZED IN <br/>AOCI ON DERIVATIVE<br/>nine months ended September 30,</span></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECLASSIFIED FROM <br/>AOCI INTO INCOME<br/>nine months ended September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(24,999)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(12,905)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(10,320)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,226&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled treasury hedges</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled interest rate swaps</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(24,999)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(12,905)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(9,874)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,672&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company estimates that an additional $14.1 million related to active interest rate swaps will be reclassified from AOCI as a decrease to interest expense over the next 12 months, and that an additional $0.6&#160;million related to settled interest rate swaps will be amortized from AOCI as an increase to interest expense over the next 12 months.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Credit-risk-related Contingent Features</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's agreements with each of its derivative counterparties contain a cross-default provision under which the Company could be declared in default of its derivative obligations if&#160;repayment of the underlying&#160;indebtedness is accelerated by the lender due to the Company's&#160;default on the indebtedness.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of September&#160;30, 2023, the fair value of derivatives in a net asset position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was&#160;$21.5&#160;million. As of September&#160;30, 2023, the Company had not posted any collateral related to these agreements and was not in breach of any agreement.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-5C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//815/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097282487744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Legal Proceedings</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company is, from time to time, involved in litigation arising in the ordinary course of business. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company&#8217;s consolidated financial position, results of operations or cash flows.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Development and Redevelopment Activity</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For the nine months ended September 30, 2023, the Company invested $55.3 million and $15.4 million toward active development and redevelopment of properties, respectively, and $9.2&#160;million toward recently completed development and redevelopment projects.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In the second quarter of 2023, the Company entered into a joint venture agreement for the development of a medical office building in Scottsdale, Arizona.  The Company holds a 90% interest in the joint venture and determined the arrangement meets the criteria to be consolidated.  The joint venture acquired an $8.8&#160;million land parcel to be developed with the Company contributing cash of $8.3&#160;million. This is included in the Company's investment toward active development properties for the nine months ended September 30, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480327/954-440-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097282361088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders' Equity<div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Common Stock&#160;&#160;&#160;&#160;</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the nine months ended September&#160;30, 2023 and the twelve months ended December&#160;31, 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.981%"><tr><td style="width:1.0%"></td><td style="width:55.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">TWELVE MONTHS ENDED DECEMBER 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,589,894&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,457,433&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7,397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">229,618,304&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-vested share-based awards, net of withheld shares </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">262,821&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">514,157&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance, end of period</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,860,112&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,589,894&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">At-The-Market Equity Offering Program</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:700;line-height:130%"> </span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company has equity distribution agreements with various sales agents with respect to the at-the-market (&#8220;ATM&#8221;) equity offering program of common stock with an aggregate sales amount of up to $750.0 million.  As of September&#160;30, 2023, $750.0 million remained available for issuance under our current ATM equity offering program.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the nine months ended September&#160;30, 2023, the Company did not sell any shares or enter into any forward sale agreements to sell shares of common stock through its ATM equity offering program.</span></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Common Stock Dividends</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the nine months ended September&#160;30, 2023, the Company declared and paid common stock dividends totaling $0.93 per share.  On October 30, 2023, the Company declared a quarterly common stock dividend in the amount of $0.31 per share payable on November 30, 2023 to stockholders of record on November 14, 2023.</span></div><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Earnings Per Common Share</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company uses the two-class method of computing net earnings per common shares. The Company's non-vested share-based awards are considered participating securities pursuant to the two-class method. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table sets forth the computation of basic and diluted earnings per common share for the three and nine months ended September&#160;30, 2023 and 2022.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED SEPTEMBER 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands, except per share data</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,857,560&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">330,788,997&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,828,004&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">211,740,767&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-vested shares</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,932,221)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,983,742)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,941,897)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,933,957)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,925,339&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">328,805,255&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,886,107&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">209,806,810&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,925,339&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">328,805,255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,886,107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">209,806,810&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dilutive effect of forward equity shares</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dilutive effect of OP Units</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,167,668&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,067,493&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dilutive effect of employee stock purchase plan</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">58,461&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">69,687&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,925,339&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">332,031,384&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,886,107&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">210,943,990&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Net (loss) income</span></td><td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(68,604)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">28,616&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(240,408)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">76,973&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Income allocated to participating securities</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(636)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(610)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,868)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,817)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Loss (income) attributable to non-controlling interest</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(312)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,680&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(312)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(29)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(122)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net (loss) income applicable to common stockholders - basic</span></td><td style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(68,509)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">27,694&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(239,718)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">74,844&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Basic earnings per common share - net income</span></td><td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.63)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">0.36&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Diluted earnings per common share - net income</span></td><td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.63)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">0.35&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The effect of OP units totaling 4,042,993 shares and options under the Company's Employee Stock Purchase Plan (the "ESPP") to purchase the Company's common stock totaling 26,678 shares for the three months ended September&#160;30, </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">2023 were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive due to the loss from continuing operations incurred during that period.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Incentive Plans</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Equity Awards</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the nine months ended September&#160;30, 2023, the Company made the following equity awards:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">During the first quarter of 2023, the Company granted non-vested stock awards to its named executive officers and other members of senior management and employees with a grant date fair value of $5.4&#160;million, which consisted of an aggregate of 270,494 non-vested shares with vesting periods ranging from <span style="-sec-ix-hidden:f-1276">three</span> to eight years.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">&#8226;</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt">During the second quarter of 2023, the Company granted to its 12 independent directors an aggregate of 42,768 shares of non-vested stock awards with a grant date fair value of $0.7&#160;million, and an aggregate of 57,868 LTIP Series D units with a grant date fair value of $1.1&#160;million.  The Company also granted a non-vested stock award to a new employee, which consisted of 508 non-vested shares. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">A summary of the activity under the Company's share-based incentive plans for the three and nine months ended September&#160;30, 2023 and 2022 is included in the table below.</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.847%"><tr><td style="width:1.0%"></td><td style="width:47.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.613%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED SEPTEMBER 30,</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Share-based awards, beginning of period</span></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,932,221&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,941,709&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,795,128&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,562,028&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">71,852&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">313,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">513,876&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(7,434)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(152,314)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(68,481)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(4,130)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(24,363)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,426)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Share-based awards, end of period</span></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,932,221&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,001,997&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,932,221&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,001,997&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">During the nine months ended September&#160;30, 2023 and 2022, the Company withheld 38,632 and</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> 8,745 </span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">shares of common stock, respectively, from participants to pay estimated withholding taxes related to shares that vested. </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Restricted Stock Units</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Prior to 2022, the Company granted long-term incentive awards, comprised of restricted stock, based on backward-looking performance measured at the end of the calendar year. The Company adopted a new incentive compensation structure effective January 2022, comprised of restricted stock and restricted stock units ("RSUs"). The RSUs are granted at the beginning of the year with three-year forward-looking performance targets. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">On January 4, 2023, the Company granted RSUs to members of senior management, with a grant date fair value of $3.7 million, which consisted of an aggregate 165,174 RSUs with a five-year vesting period. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Approximately 43% of the RSUs vest based on two market performance conditions. Relative and absolute total shareholder return ("TSR") awards containing these market performance conditions were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $24.23 for the absolute TSR component and $27.84 for the relative TSR component for the January 2023 grant using the following assumptions:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"><tr><td style="width:1.0%"></td><td style="width:56.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:41.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31, </span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">34.0&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividend assumption</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expected term </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.42&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock price (per share)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$20.21</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The remaining 57% of the RSUs vest based upon certain operating performance conditions.  With respect to the operating performance conditions of the January 4, 2023 grant, the grant date fair value was $20.21 based on the Company's share price on the date of grant. The combined weighted average grant date fair value of the January RSUs was $22.55 per share.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following is a summary of the RSU activity during the three and nine months ended September&#160;30, 2023:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.379%"><tr><td style="width:1.0%"></td><td style="width:35.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.261%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED SEPTEMBER 30, </span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Restricted Stock Units</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Restricted Stock Units</span></td><td colspan="3" style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Non-vested, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">363,250&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">28.57&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">294,932&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">33.04&#160;</span></td><td style="background-color:#ffffff;border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">165,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">22.55&#160;</span></td><td style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Vested/Forfeited</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(17,606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">33.04&#160;</span></td><td style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Probability adjustment of 2022 &amp; 2023 RSUs </span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(47,196)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">20.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(126,446)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">27.40&#160;</span></td><td style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Non-vested, end of period</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">316,054&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">27.77&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">316,054&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">27.77&#160;</span></td><td style="background-color:#ffffff;border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">LTIP Series C Units</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In January 2023, the Company modified its incentive compensation structure to award LTIP Series C units ("LTIP-C units) in the OP to named executive officers in lieu of RSUs. The LTIP-C units were granted with three-year forward-looking performance targets, with a grant date fair value of $7.1&#160;million, which consisted of an aggregate 448,249 LTIP-C units with a five-year vesting period. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Approximately 43% of the LTIP-C units vest based on two market performance conditions. Relative and absolute TSR awards containing these market performance conditions were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $12.24 for the absolute TSR component and $13.98 for the relative TSR component for the January 2023 grant using the following assumption:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"><tr><td style="width:1.0%"></td><td style="width:56.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:41.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31, </span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">34.0&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividend assumption</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expected term </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.42&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock price (per share)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$20.21</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The remaining 57% of the LTIP-C units vest based upon certain operating performance conditions.  With respect to the operating performance conditions of the January 4, 2023 grant, the grant date fair value was $20.21 based on the Company's share price on the date of grant. The combined weighted average grant date fair value of the January LTIP-C units was $15.85 per share.  The Company records amortization expense based on the probability of achieving certain operating performance conditions, which is evaluated throughout the performance period.  </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Employee Stock Purchase Plan</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Legacy HR maintained an ESPP prior to the completion of the Merger. The outstanding options to purchase shares of the common stock of Legacy HR became options to purchase class A common stock of the Company upon completion of the Merger. No new options will be granted under the ESPP. A summary of the activity under the ESPP for the three and nine months ended September&#160;30, 2023 and 2022 is included in the table below.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.847%"><tr><td style="width:1.0%"></td><td style="width:47.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.613%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED SEPTEMBER 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Outstanding and exercisable, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">179,369&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">405,534&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">340,976&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">348,514&#160;</span></td><td style="background-color:#ffffff;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">255,960&#160;</span></td><td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,580)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(4,576)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(7,397)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(17,094)</span></td><td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(4,680)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(37,628)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(28,471)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(83,417)</span></td><td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(132,999)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(140,633)</span></td><td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Outstanding and exercisable, end of period</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">172,109&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">363,330&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">172,109&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">363,330&#160;</span></td><td style="background-color:#ffffff;border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table represents expected amortization of the Company's non-vested shares issued as of September&#160;30, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.321%"><tr><td style="width:1.0%"></td><td style="width:48.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FUTURE AMORTIZATION <br/>of non-vested shares</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-6<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-16<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097283593520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text">Fair Value of Financial Instruments<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following methods and assumptions were used to estimate the fair value of each class of financial instrument for which it is practical to estimate that value.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Cash and cash equivalents</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"> - The carrying amount approximates fair value (level 1 inputs) due to the short term maturity of these investments. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Real estate notes receivabl</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%">e - Real estate notes receivable are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.  Fair value is estimated using cash flow analyses, based on current interest rates for similar types of arrangements.</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"> </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Borrowings under the Unsecured Credit Facility and the Term Loans Due 2024 and 2026</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"> - The carrying amount approximates fair value because the borrowings are based on variable market interest rates.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Senior Notes and Mortgage Notes payable</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"> - The fair value of notes and bonds payable is estimated using cash flow analyses, based on the Company&#8217;s current interest rates for similar types of borrowing arrangements.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt">Interest rate swap agreements</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"> - Interest rate swap agreements are recorded in other liabilities on the Company's Condensed Consolidated Balance Sheets at fair value. Fair value is estimated by utilizing pricing models, level 2 inputs, that consider forward yield curves and discount rates.</span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at September&#160;30, 2023 and December&#160;31, 2022.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.697%"><tr><td style="width:1.0%"></td><td style="width:26.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">September 30, 2023</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Notes and bonds payable </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,227.4&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,941.2&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,351.8&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,149.6&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate notes receivable </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">155.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">151.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">99.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">99.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Level 2 &#8211; model-derived valuations in which significant inputs and significant value drivers are observable in active markets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097275860768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss)</a></td>
<td class="num">$ (67,844)<span></span>
</td>
<td class="nump">$ 28,304<span></span>
</td>
<td class="num">$ (237,728)<span></span>
</td>
<td class="nump">$ 76,661<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097283690048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097276713520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NatureOfOperationsPolicyTextBlock', window );">Business Overview</a></td>
<td class="text"><div style="margin-top:3pt"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Business Overview</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Healthcare Realty Trust Incorporated is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September&#160;30, 2023, the Company had gross investments of approximately $13.6&#160;billion in </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">663 wholly-owned real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property.  The Company's 663 re</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">al estate properties are located in 35 states and total approxima</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">tely 39.1&#160;million </span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">square feet. The Company provided leasing and property management services to approximat</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">ely 38.6 million sq</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">uare feet nationwide.   </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">In addition, as of September&#160;30, 2023, the Company had a weighted average ownership interest of approxima</span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">tely 44%</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"> in </span><span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">34 re</span><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">al estate properties held in joint ventures. See Note 3 below for more details regarding the Company's unconsolidated joint ventures. </span></div>Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the Company's Condensed Consolidated Financial Statements, are outside the scope of our independent registered public accounting firm&#8217;s review.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For purposes of this Quarterly Report on Form 10-Q, references to the &#8220;Company&#8221; are to Legacy HR for periods prior to the closing of the Merger and thereafter to Legacy HR and Legacy HTA as the combined company after giving effect to the Merger.  The Merger is described in more detail in Note 2 to these Condensed Consolidated Financial Statements.  The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. However, except as disclosed herein and specific disclosures included as a result of the Merger, management believes there has been no material change in the information disclosed in the Notes to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022. All material intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">This interim financial information should be read in conjunction with the consolidated financial statements included in the Company&#8217;s Annual Report on Form 10-K for the year ended December&#160;31, 2022. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December&#160;31, 2023 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Principles of Consolidation</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s Condensed Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (&#8220;VIEs&#8221;). Accounting Standards Codification (&#8220;ASC&#8221;) Topic 810, Consolidation broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity&#8217;s economic performance or (ii) the equity investment at risk is insufficient to finance that entity&#8217;s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity&#8217;s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE&#8217;s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Condensed Consolidated Financial Statements. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company may change its original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity&#8217;s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than 100% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities&#8217; activities based upon the terms of the respective entities&#8217; ownership agreements. </span></div>Healthcare Realty Holdings, L.P., a Delaware limited partnership (the "OP"), is 98.8% owned by the Company.  Holders of operating partnership units (&#8220;OP Units&#8221;) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of September&#160;30, 2023, there were approximately 4.7&#160;million OP Units, or 1.2% of OP units issued and outstanding, held by non-controlling interest holders.  Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates the interests in the OP.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationVariableInterestEntityPolicy', window );">Variable Interest Entities</a></td>
<td class="text">As of September&#160;30, 2023, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates in the Condensed Consolidated Financial Statements</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Use of Estimates in the Condensed Consolidated Financial Statements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text">Reclassifications Certain reclassifications have been made on the Company's prior year Condensed Consolidated Balance Sheet to conform to current year presentation. Previously, the Company's Lease intangibles were included in Building, improvements and lease intangibles and Goodwill was included with Other assets, net. These amounts are now classified as separate line items on the Company's Condensed Consolidated Balance Sheets.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Redeemable Non-Controlling Interests</a></td>
<td class="text">Redeemable Non-Controlling InterestsThe Company accounts for redeemable equity securities in accordance with ASC Topic 480: Accounting for Redeemable Equity Instruments, which requires that equity securities redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders&#8217; equity.  The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Condensed Consolidated Balance Sheets.  Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest&#8217;s share of net income or loss and distributions) or the redemption value.  We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Asset Impairment</a></td>
<td class="text">Asset ImpairmentThe Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever the occurrence of an event or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company&#8217;s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its tenants.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorLeasesPolicyTextBlock', window );">Investments in Leases - Financing Receivables, Net and Real Estate Notes Receivable and Interest Income</a></td>
<td class="text">Investments in Leases - Financing Receivables, Net In accordance with ASC Topic 842: Leases, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC Topic 310: Receivables.Real Estate Notes ReceivableReal estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower&#8217;s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held-to-maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses.<div style="margin-top:5pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Allowance for Credit Losses</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Pursuant to ASC Topic 326, Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under ASC Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#8217;s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. </span></div>In its assessment of current expected credit losses for real estate notes receivable, the Company utilizes past payment history of its borrowers, current economic conditions, and forecasted economic conditions through the maturity date of each note to estimate a probability of default and a resulting loss for each real estate note receivable.<div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Interest Income</span></div><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%">Income from Lease Financing Receivables</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognized the related income from two financing receivables totaling $2.0&#160;million and $6.2&#160;million, respectively, for the three and nine months ended September&#160;30, 2023, and $2.0&#160;million and $5.9&#160;million, respectively for the three and nine months ended September&#160;30, 2022, based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable in any particular period will not equal the cash payments from the lease agreement in that period. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Interest income over the life of the lease.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue from Contracts with Customers (ASC Topic 606)</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%">Revenue from Contracts with Customers (ASC Topic 606)</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company recognizes certain revenue under the core principle of Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of Topic 606. To achieve the core principle, the Company applies the five step model specified in the guidance. </span></div>Revenue that is accounted for under Topic 606 is segregated on the Company&#8217;s Condensed Consolidated Statements of Operations in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income.The Company&#8217;s major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time, and the Company recognizes revenue monthly based on this principle.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NatureOfOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nature Of Operations Policy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NatureOfOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationVariableInterestEntityPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2AA<br> -Subparagraph a<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-2AA<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationVariableInterestEntityPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangements entered into by lessor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -SubTopic 30<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-3A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-3A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -SubTopic 30<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483504/205-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097275860608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock', window );">Schedule of Condensed Balance Sheet</a></td>
<td class="text">Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:45.259%"><tr><td style="width:1.0%"></td><td style="width:66.129%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.671%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SEPTEMBER 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net real estate investments</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">72,756&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,766&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Receivables and other assets</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,594&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total assets</span></div></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">77,116&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities:</span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">16,909&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total equity</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">60,207&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total liabilities and equity</span></div></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">77,116&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of Variable Interest Entities</a></td>
<td class="text">As a result, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method.  See below for additional information regarding the Company's unconsolidated VIEs.<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.119%"><tr><td style="width:1.0%"></td><td style="width:21.067%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.858%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.663%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.666%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands) ORIGINATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SOURCE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING AMOUNT </span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM EXPOSURE TO LOSS</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">30,797&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Charlotte, NC </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Note receivable</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,743&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Joint venture</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">63,579&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">63,579&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Assumed mortgage note receivable in connection with the Merger.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes investments in seven properties.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts, Notes, Loans and Financing Receivable</a></td>
<td class="text">See below for additional information regarding the Company's financing receivables.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.241%"><tr><td style="width:1.0%"></td><td style="width:26.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.666%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.667%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands) ORIGINATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">INTEREST RATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE as of SEPTEMBER 30, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 2021</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Poway, CA</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5.73%</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">113,634&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">November 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Columbus, OH</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6.48%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,341&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">120,975&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"><tr><td style="width:1.0%"></td><td style="width:15.157%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.869%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.403%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.942%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.329%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">(dollars in thousands)</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">ORIGINATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">STATED INTEREST RATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MAXIMUM LOAN COMMITMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OUTSTANDING as of <br/>SEPT 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">ALLOWANCE FOR CREDIT LOSSES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE DISCOUNT AND FEES</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE as of SEPT 30, 2023</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mezzanine loans</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/24/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">54,119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">54,119&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5,196)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,067)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,856&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%">Mortgage loans </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6/30/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/31/2023</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">31,150&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(353)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">30,797&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">North Carolina</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12/22/2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(257)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,743&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Florida</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5/17/2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2/27/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">65,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">27,651&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(49)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">27,602&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">California</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/30/2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3/29/2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">45,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">147,150&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">109,801&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(659)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">109,142&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">201,269&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">163,920&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5,196)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,726)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">154,998&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock', window );">Schedule of Company's Allowance For Credit Losses</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table summarizes the Company's allowance for credit losses on real estate notes receivable:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.672%"><tr><td style="width:1.0%"></td><td style="width:59.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.630%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.631%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">TWELVE MONTHS ENDED DECEMBER 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Allowance for credit losses, beginning of period</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Credit loss reserves</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,196&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Allowance for credit losses, end of period</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,196&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of revenue</a></td>
<td class="text">Below is a detail of the amounts by category:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.385%"><tr><td style="width:1.0%"></td><td style="width:33.213%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.321%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>September 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Type of Revenue</span></td><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Parking income</span></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,751&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,428&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7,511&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,100&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Management fee income</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> 1</span></div></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,552&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,426&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,864&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Miscellaneous</span></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">203&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">306&#160;</span></td><td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,661&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,057&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">13,508&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9,270&#160;</span></td><td style="border-right:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table>1     Includes the recovery of certain expenses under the financing receivable as outlined in the management agreement.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfCondensedBalanceSheetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph (a)<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfCondensedBalanceSheetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-11B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-5A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-9<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-4<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097282569792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Merger with HTA (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock', window );">Schedule of Consideration Transferred</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The implied consideration transferred on the Closing Date is as follows: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.495%"><tr><td style="width:1.0%"></td><td style="width:77.702%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.098%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands, except for per share data</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">228,520,990&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Exchange ratio</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1.00&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Implied shares of Legacy HR Common Stock issued</span></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">228,520,990&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjusted closing price of Legacy HR Common Stock on July 20, 2022</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(b)</span></div></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">24.37&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Value of implied Legacy HR Common Stock issued</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,569,057&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:700;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7,406&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Consideration transferred</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,576,463&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(a) The number of shares of Legacy HTA Common Stock presented above was based on 228,857,717 total shares of Legacy HTA Common Stock outstanding as of the Closing Date, less 192 Legacy HTA fractional shares that were cancelled in lieu of cash and less 336,535 shares of Legacy HTA restricted stock (net of 215,764 shares of Legacy HTA restricted stock withheld). For accounting purposes, these shares were converted to Legacy HR Common Stock, at an exchange ratio of 1.00 share of Legacy HR Common Stock per share of Legacy HTA Common Stock. </span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(b) For accounting purposes, the fair value of Legacy HR Common Stock issued to former holders of Legacy HTA Common Stock was based on the per share closing price of Legacy HR Common Stock on July 20, 2022.</span></div>(c) Represents the fair value of Legacy HTA restricted shares which fully vested prior to the closing of the Merger or became fully vested as a result of the closing of the Merger and which are attributable to pre-combination services.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Fair Values of the Assets Acquired And Liabilities Assumed</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the Closing Date: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.553%"><tr><td style="width:1.0%"></td><td style="width:36.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.746%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.748%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">&#160;CUMULATIVE MEASUREMENT PERIOD ADJUSTMENTS</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">AMOUNTS RECOGNIZED ON THE CLOSING DATE <br/>(as adjusted)</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">ASSETS</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Real estate investments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">985,926&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18,359&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,004,285&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Buildings and improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,960,418&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(119,135)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,841,283&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangible assets</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">831,920&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,839&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">833,759&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,874&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,146&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">13,020&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10,071&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(6,744)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,327&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land held for development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">46,538&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">46,538&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total real estate investments</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,844,747&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(102,535)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,742,212&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets held for sale, net </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">707,442&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(7,946)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">699,496&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">67,892&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">67,892&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">26,034&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,403&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">37,437&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Restricted cash </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,123,647&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,247)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,122,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">198,261&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">16,370&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">214,631&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">(b) (c)</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">209,163&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,840)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">205,323&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total assets acquired</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,177,186&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(87,795)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">11,089,391&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">LIABILITIES</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Notes and bonds payable </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,991,300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,991,300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,227,570&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">17,374&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,244,944&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities of assets held for sale</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">28,677&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(3,939)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">24,738&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">173,948&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10,173&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">184,121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing lease liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">10,720&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(855)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,865&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">203,210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(8,909)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">194,301&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total liabilities assumed</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,635,425&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">13,844&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,649,269&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Net identifiable assets acquired</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,541,761&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(101,639)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,440,122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-controlling interest</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">110,702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">110,702&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">145,404&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">101,639&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">247,043&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(a) The weighted average amortization period for the acquired lease intangible assets is approximately 6 years.</span></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(b) Includes $15.9 million of contractual accounts receivable, which approximates fair value.</span></div></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">(c) Includes $78.7 million of gross contractual real estate notes receivable, the fair value of which was $74.8 million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent consideration in asset acquisition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 15<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480123/805-50-15-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Paragraph 1<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097271657184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of Real Estate Acquisitions</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table details the Company's real estate acquisition activity for the nine months ended September&#160;30, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.941%"><tr><td style="width:1.0%"></td><td style="width:24.609%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.890%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.836%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.937%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.306%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.732%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.101%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.001%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DATE ACQUIRED</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">PURCHASE PRICE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MORTGAGE NOTES PAYABLE, NET</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CASH<br/>CONSIDERATION </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">REAL <br/>ESTATE </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OTHER </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE FOOTAGE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Tampa, FL</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/10/23</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">31,500&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">30,499&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">30,596&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(97)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">115,867&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Colorado Springs, CO</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/28/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,450&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,284)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,024&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">11,416&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(108)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Total real estate acquisitions</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">42,950&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(5,284)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">36,523&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">42,012&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(205)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">158,637&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Equity Method Investments</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company's investment in and loss recognized for the three and nine months ended September&#160;30, 2023 and 2022 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.094%"><tr><td style="width:1.0%"></td><td style="width:55.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.766%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.767%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>September 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures, beginning of period </span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,245&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">210,781&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,248&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">161,942&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">New investment during the period </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">117,880&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,824&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">167,479&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Equity loss recognized during the period </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(456)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(124)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,253)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(776)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Owner distributions</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(1,336)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(785)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(4,366)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(893)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Investments in unconsolidated joint ventures, end of period </span></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">325,453&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,752&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">325,453&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">327,752&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">In 2023, this was an additional investment in an existing joint venture in which the Company retained a 40% ownership interest. The investment consisted of the Company's sale of a property in Dallas, Texas to the joint venture.  See 2023 Real Estate Asset Dispositions below for additional information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AssetDispositionsTableTextBlock', window );">Schedule of Real Estate Dispositions</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table details the Company's dispositions for the nine months ended September&#160;30, 2023:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.037%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.698%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.615%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.756%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.074%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.309%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.367%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">DATE DISPOSED</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SALE PRICE</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CLOSING ADJUSTMENTS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">COMPANY-FINANCED MORTGAGE NOTES</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NET PROCEEDS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NET REAL ESTATE INVESTMENT</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OTHER (INCLUDING RECEIVABLES) </span><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">1</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">GAIN/(IMPAIRMENT)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">SQUARE FOOTAGE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Tampa/Miami, FL</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/12/23</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">93,250&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,875)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">87,375&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">87,302&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(888)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">961&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">224,037&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dallas, TX </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">3</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">19,210&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(141)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">19,069&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">18,986&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">36,691&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">St. Louis, MO</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2/10/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">332&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">398&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(66)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,500&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/23/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">21,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(526)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">20,474&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">20,610&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(188)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">37,165&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">4</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">75,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(8,079)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(45,000)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">21,921&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">88,624&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(803)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(20,900)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">147,078&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Los Angeles, CA </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">5</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/12/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,300&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(334)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,966&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,268&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(302)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Albany, NY</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/30/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,229)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,771&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,613&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,040)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7,198&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">40,870&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/2/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,320&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(285)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8,035&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,567&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,274&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">57,170&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Atlanta, GA</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/22/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">25,142&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(66)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">25,076&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">23,226&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(536)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,386&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">55,195&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dallas, TX</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9/15/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">115,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,504)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">113,496&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">64,183&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,094&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">43,219&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">161,264&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Houston, TX</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9/18/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">250&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(24)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">226&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,998&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,772)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">52,040&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Chicago, IL</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">9/27/23</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">59,950&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(870)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">59,080&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">74,710&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(380)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(15,250)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">104,912&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Total dispositions</span></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">430,772&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(18,951)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(45,000)</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">366,821&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">390,485&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,736&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">18,600&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">922,922&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Includes straight-line rent receivables, leasing commissions and lease inducements.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">2</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt">Includes two properties, sold in two separate transactions to the same buyer on the same date.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">3</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt">The Company sold this property to a joint venture in which it retained a 40% interest. Sales price and square footage reflect the total sales price paid by the joint venture and total square footage of the property.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">4</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.81pt">The Company entered into a mortgage note agreement with the buyer for $45&#160;million.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">5</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.18pt">The Company sold a land parcel totaling 0.34 acres.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock', window );">Schedule of Assets and Liabilities Held for Sale</a></td>
<td class="text">The table below reflects the assets and liabilities classified as held for sale as of September&#160;30, 2023 and December&#160;31, 2022:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"><tr><td style="width:1.0%"></td><td style="width:41.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.469%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.471%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%">Dollars in thousands</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">September 30, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance Sheet data:</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">14,282&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,700&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">41,538&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">15,164&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Lease intangibles</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12,938&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,986&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">68,758&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18,850&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accumulated depreciation</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">(13,634)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate assets held for sale, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">55,124&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"></td><td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18,850&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">585&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,929&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">43&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Assets held for sale, net</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">57,638&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">18,893&#160;</span></td><td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accounts payable and accrued liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,716&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">282&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,020&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,078&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">155&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Liabilities of assets held for sale</span></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,814&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">437&#160;</span></td><td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AssetDispositionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Asset Dispositions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AssetDispositionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Assets and Liabilities Held for Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097275868992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock', window );">Schedule of Future Minimum Operating Lease Payments Receivable</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">Future lease payments under the non-cancelable operating leases, excluding any reimbursements and one sale-type lease, as of September&#160;30, 2023 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"><tr><td style="width:1.0%"></td><td style="width:42.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.064%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">231,698&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">874,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">770,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">666,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">552,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,918,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,014,062&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Operating Lease Payments</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s future lease payments (primarily for its 165 non-prepaid ground leases) as of September&#160;30, 2023 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FINANCING</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,288&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,062&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,253&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,630&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">922,019&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">396,397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">982,644&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">405,859&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(709,325)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(331,772)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Lease liabilities</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">273,319&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">74,087&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Minimum Financing Lease Payments</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The Company&#8217;s future lease payments (primarily for its 165 non-prepaid ground leases) as of September&#160;30, 2023 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"><tr><td style="width:1.0%"></td><td style="width:58.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">OPERATING</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FINANCING</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,288&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">513&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,062&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,182&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,253&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,218&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,392&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">14,630&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,294&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">922,019&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">396,397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">982,644&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">405,859&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Discount</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(709,325)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(331,772)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Lease liabilities</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">273,319&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">74,087&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Lease Cost</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides details of the Company's total lease expense for the three and nine months ended September&#160;30, 2023 and 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.863%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.909%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.910%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED <br/>September 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED <br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Operating lease cost</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating lease expense</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,312&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">4,204&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">15,748&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,613&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Variable lease expense</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">2,417&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,061&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6,788&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,123&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Finance lease cost</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Amortization of right-of-use assets</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">387&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">381&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,161&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">884&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest on lease liabilities</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">928&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">861&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,913&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total lease expense</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,044&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">6,507&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">26,467&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">12,533&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Other information</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to operating leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,281&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3,847&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">16,475&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">8,443&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Operating cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">524&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">476&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,592&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">1,262&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Financing cash flows outflows related to financing leases</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new finance lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">9,874&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">50,463&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease liabilities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">198,261&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">198,261&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - operating leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">47.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">50.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average years remaining lease term (excluding renewal options) - finance leases</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">58.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">60.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - operating leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted-average discount rate - finance leases</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097282550016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Notes and Bonds Payable (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below details the Company&#8217;s notes and bonds payable as of September 30, 2023 and December 31, 2022.&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.522%"><tr><td style="width:1.0%"></td><td style="width:39.333%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.091%"></td><td style="width:0.1%"></td></tr><tr style="height:11pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">MATURITY DATES </span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">BALANCE </span><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:3.73pt;font-weight:700;line-height:120%;position:relative;top:-2.01pt;vertical-align:baseline">1</span><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"> AS OF  </span></div></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EFFECTIVE INTEREST RATE <br/>as of 9/30/2023</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">9/30/2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">12/31/2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$1.5 billion Unsecured Credit Facility </span></div></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10/25</span></td><td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">236,000&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">385,000&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.24&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$200 million Unsecured Term Loan </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/24</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,845&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$350 million Unsecured Term Loan </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">2</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/24</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">349,711&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">349,114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$300 million Unsecured Term Loan </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10/25</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">299,952&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">299,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$150 million Unsecured Term Loan</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6/26</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">149,606&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">149,495&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$200 million Unsecured Term Loan </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/27</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">199,362&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$300 million Unsecured Term Loan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/28</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">298,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">297,869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">6.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2025</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5/25</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">249,391&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">249,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2026</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8/26</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">577,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">571,587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.94&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2027 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7/27</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">482,665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">479,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.76&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2028</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1/28</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">297,283&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,852&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2030 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2/30</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">572,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">565,402&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2030</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/30</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">296,385&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.72&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2031 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/31</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">295,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">295,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Senior Notes due 2031 </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3/31</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">645,232&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">632,693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Mortgage notes payable</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">12/23-12/26</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">77,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">84,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:right"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.57%-6.88%</span></div></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">5,227,413&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,351,827&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr></table><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">.</span></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable.</span></div>2On April 26, 2023, the Company exercised its option to extend the maturity date for one year for a fee of approximately $0.4&#160;million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097282452080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">As of September&#160;30, 2023, the Company had 14 outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.978%"><tr><td style="width:1.0%"></td><td style="width:41.810%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.646%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:30.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">EXPIRATION DATE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">AMOUNT</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">WEIGHTED <br/>AVERAGE RATE</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">January 15, 2024</span></td><td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">200,000&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1.21&#160;</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">May 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">100,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.15&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.83&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 1, 2026</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.84&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">June 1, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.13&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">December 1, 2027</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">250,000&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.79&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,000,000&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3.17&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below presents the effect of cash flow hedge accounting on AOCI during the three and nine months ended September&#160;30, 2023 and 2022 related to the Company's outstanding interest rate swaps.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"><tr><td style="width:1.0%"></td><td style="width:24.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.940%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECOGNIZED IN <br/>AOCI ON DERIVATIVE<br/>three months ended September 30,</span></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECLASSIFIED FROM <br/>AOCI INTO INCOME<br/>three months ended September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(12,016)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(6,083)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(4,317)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">614&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled treasury hedges</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled interest rate swaps</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(12,016)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(6,083)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(4,168)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">763&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"><tr><td style="width:1.0%"></td><td style="width:24.206%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.936%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.940%"></td><td style="width:0.1%"></td></tr><tr style="height:26pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECOGNIZED IN <br/>AOCI ON DERIVATIVE<br/>nine months ended September 30,</span></td><td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">(GAIN)/LOSS RECLASSIFIED FROM <br/>AOCI INTO INCOME<br/>nine months ended September 30,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(24,999)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(12,905)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(10,320)</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,226&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled treasury hedges</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Settled interest rate swaps</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">320&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(24,999)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(12,905)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total interest expense</span></td><td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(9,874)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,672&#160;</span></td><td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock', window );">Schedule of Derivative Instruments in Statement of Financial Position, Fair Value</a></td>
<td class="text">The table below presents the fair value of the Company's derivative financial instruments, as well as their classification on the Condensed Consolidated Balance Sheet as of September&#160;30, 2023.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.394%"><tr><td style="width:1.0%"></td><td style="width:57.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.608%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.859%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">BALANCE AT SEPTEMBER 30, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">In thousands</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">BALANCE SHEET LOCATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Derivatives designated as hedging instruments</span></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Interest rate swaps</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Other assets</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">21,499&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097275788320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock', window );">Schedule of Reconciliation of Common Stock Outstanding</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the nine months ended September&#160;30, 2023 and the twelve months ended December&#160;31, 2022:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.981%"><tr><td style="width:1.0%"></td><td style="width:55.370%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.450%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">TWELVE MONTHS ENDED DECEMBER 31, 2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Balance, beginning of period</span></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,589,894&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">150,457,433&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Issuance of common stock</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">7,397&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">229,618,304&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-vested share-based awards, net of withheld shares </span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">262,821&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">514,157&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Balance, end of period</span></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,860,112&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,589,894&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings (Loss) per Share</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table sets forth the computation of basic and diluted earnings per common share for the three and nine months ended September&#160;30, 2023 and 2022.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.744%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.591%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED SEPTEMBER 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in thousands, except per share data</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,857,560&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">330,788,997&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">380,828,004&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">211,740,767&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Non-vested shares</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,932,221)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,983,742)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,941,897)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,933,957)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,925,339&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">328,805,255&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,886,107&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">209,806,810&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Weighted average common shares outstanding - basic</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,925,339&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">328,805,255&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,886,107&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">209,806,810&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dilutive effect of forward equity shares</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dilutive effect of OP Units</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3,167,668&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,067,493&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dilutive effect of employee stock purchase plan</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">58,461&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">69,687&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Weighted average common shares outstanding - diluted</span></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,925,339&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">332,031,384&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">378,886,107&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">210,943,990&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">Net (loss) income</span></td><td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(68,604)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">28,616&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(240,408)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">76,973&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Income allocated to participating securities</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(636)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(610)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,868)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(1,817)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Loss (income) attributable to non-controlling interest</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">760&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(312)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,680&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(312)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(29)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(122)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Net (loss) income applicable to common stockholders - basic</span></td><td style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(68,509)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">27,694&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(239,718)</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">74,844&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Basic earnings per common share - net income</span></td><td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.63)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">0.36&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Diluted earnings per common share - net income</span></td><td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.18)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">0.08&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(0.63)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">0.35&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Summary of the Activity Under the Incentive Plan and RSU Activity</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">A summary of the activity under the Company's share-based incentive plans for the three and nine months ended September&#160;30, 2023 and 2022 is included in the table below.</span></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.847%"><tr><td style="width:1.0%"></td><td style="width:47.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.613%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED SEPTEMBER 30,</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Share-based awards, beginning of period</span></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,932,221&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,941,709&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,795,128&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,562,028&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">71,852&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">313,770&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">513,876&#160;</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(7,434)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(152,314)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(68,481)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(4,130)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(24,363)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(5,426)</span></td><td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Share-based awards, end of period</span></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,932,221&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,001,997&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">1,932,221&#160;</span></td><td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2,001,997&#160;</span></td><td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following is a summary of the RSU activity during the three and nine months ended September&#160;30, 2023:</span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.379%"><tr><td style="width:1.0%"></td><td style="width:35.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.201%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.261%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED SEPTEMBER 30, </span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Restricted Stock Units</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Weighted Average Grant Date Fair Value</span></td><td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Restricted Stock Units</span></td><td colspan="3" style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Non-vested, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">363,250&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">28.57&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">294,932&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">33.04&#160;</span></td><td style="background-color:#ffffff;border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">165,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">22.55&#160;</span></td><td style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Vested/Forfeited</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(17,606)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">33.04&#160;</span></td><td style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Probability adjustment of 2022 &amp; 2023 RSUs </span></td><td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(47,196)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">20.21&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(126,446)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">27.40&#160;</span></td><td style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Non-vested, end of period</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">316,054&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">27.77&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">316,054&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">27.77&#160;</span></td><td style="background-color:#ffffff;border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Stock Options, Valuation Assumptions</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"><tr><td style="width:1.0%"></td><td style="width:56.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:41.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31, </span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">34.0&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividend assumption</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expected term </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.42&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock price (per share)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$20.21</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"><tr><td style="width:1.0%"></td><td style="width:56.346%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:41.454%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED MARCH 31, </span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">34.0&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dividend assumption</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Accrued</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expected term </span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Risk-free rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.42&#160;</span></td><td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Stock price (per share)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$20.21</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock', window );">Summary of Employee Stock Purchase Plan Activity</a></td>
<td class="text">A summary of the activity under the ESPP for the three and nine months ended September&#160;30, 2023 and 2022 is included in the table below.<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.847%"><tr><td style="width:1.0%"></td><td style="width:47.751%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.610%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.613%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">THREE MONTHS ENDED SEPTEMBER 30,</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">NINE MONTHS ENDED SEPTEMBER 30, </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Outstanding and exercisable, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">179,369&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">405,534&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">340,976&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">348,514&#160;</span></td><td style="background-color:#ffffff;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">255,960&#160;</span></td><td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(2,580)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(4,576)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(7,397)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(17,094)</span></td><td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(4,680)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(37,628)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(28,471)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(83,417)</span></td><td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Expired</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(132,999)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">(140,633)</span></td><td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Outstanding and exercisable, end of period</span></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">172,109&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">363,330&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">172,109&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">363,330&#160;</span></td><td style="background-color:#ffffff;border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock', window );">Schedule of Unrecognized Compensation Cost, Nonvested Awards</a></td>
<td class="text"><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The following table represents expected amortization of the Company's non-vested shares issued as of September&#160;30, 2023:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.321%"><tr><td style="width:1.0%"></td><td style="width:48.683%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.117%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FUTURE AMORTIZATION <br/>of non-vested shares</span></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2023</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of employee stock purchase plan activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (i)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097282361088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock', window );">Schedule of Fair Value And Carrying Values For Notes And Bonds Payable, Real Estate Notes Receivable, And Notes Receivable</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%">The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at September&#160;30, 2023 and December&#160;31, 2022.</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.697%"><tr><td style="width:1.0%"></td><td style="width:26.236%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.596%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.716%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">September 30, 2023</span></td><td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">CARRYING VALUE</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%">FAIR VALUE</span></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Notes and bonds payable </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,227.4&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">4,941.2&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,351.8&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">5,149.6&#160;</span></td><td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Real estate notes receivable </span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline">1</span></div></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">155.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">151.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">99.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">99.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%">1</span><span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt">Level 2 &#8211; model-derived valuations in which significant inputs and significant value drivers are observable in active markets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByBalanceSheetGroupingTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByBalanceSheetGroupingTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097267123584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Details)<br> $ in Thousands, shares in Millions, ft&#178; in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>property </div>
<div>financing_receivable </div>
<div>state </div>
<div>variable_interest_entity </div>
<div>note_receivable </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>property </div>
<div>financing_receivable </div>
<div>state </div>
<div>variable_interest_entity </div>
<div>joint_venture </div>
<div>note_receivable </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 01, 2023 </div>
<div>USD ($) </div>
<div>financing_receivable</div>
</th>
<th class="th">
<div>Jun. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessOverviewAbstract', window );"><strong>Business Overview:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_InvestmentInRealEstatePropertiesAndMortgageNotes', window );">Gross investment amount, total</a></td>
<td class="nump">$ 13,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfRealEstateInvestments', window );">Number of real estate properties | property</a></td>
<td class="nump">663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="nump">663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates', window );">Number of states that the company owns real estate in, whole units | state</a></td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ApproximateSquareFeetInvestedInByCompany', window );">Approximate square feet invested in by company | ft&#178;</a></td>
<td class="nump">39.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ApproximateSquareFeetProvidedByCompany', window );">Approximate square feet for which Nationwide property management services provided by company | ft&#178;</a></td>
<td class="nump">38.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfBuildingsOwnedByJointVenture', window );">Number of buildings owned by joint venture with TIAA | property</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Principles of Consolidation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EquityOwnershipForConsolidationPercent', window );">Equity ownership for consolidation (percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfVariableInterestEntities', window );">Number of variable interest entities | variable_interest_entity</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract', window );"><strong>Redeemable Non-Controlling Interests:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests', window );">Redeemable non-controlling interests</a></td>
<td class="nump">$ 3,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 3,195<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 2,014<span></span>
</td>
<td class="nump">$ 2,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetImpairmentChargesAbstract', window );"><strong>Asset Impairment:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfRealEstate', window );">Impairment of real estate assets</a></td>
<td class="nump">56,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateAbstract', window );"><strong>Real Estate Notes Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateNotesReceivableNet', window );">Investment in financing receivable, net</a></td>
<td class="nump">$ 155,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">155,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Allowance for Credit Losses, Interest Income, Income from Real Estate Notes Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinancingReceivableAllowanceForCreditLossReserves', window );">Credit loss reserves</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfRecognizedLeaseFinancialReceivables', window );">Number of recognized lease financial receivables | financing_receivable</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable', window );">Income from financing receivables</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="nump">$ 5,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfRealEstateNotesReceivable', window );">Number of real estate notes receivable | financing_receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual', window );">Financing receivable, nonaccrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=us-gaap_NotesReceivableMember', window );">Notes Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Allowance for Credit Losses, Interest Income, Income from Real Estate Notes Receivable:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeOperating', window );">Interest income</a></td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=hr_VariableInterestEntityMember', window );">Variable Interest Entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Principles of Consolidation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfVariableInterestEntities', window );">Number of variable interest entities | variable_interest_entity</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfNotesReceivable', window );">Number of notes receivable | note_receivable</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfJointVentures', window );">Number of joint ventures | joint_venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_OwnershipAxis=hr_NonControllingInterestHoldersMember', window );">Non-Controlling Interest Holders | Healthcare Trust of America Holdings L P</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Principles of Consolidation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding', window );">Limited partner's capital, units outstanding (in shares) | shares</a></td>
<td class="nump">4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest', window );">Limited partners ownership interest (in percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hr_PropertyEntitiesNotDeterminedToBeVIEsMember', window );">Property Entities Not Determined to be VIEs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Principles of Consolidation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Equity interest owned (percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hr_HealthcareTrustofAmericaHoldingsLPMember', window );">Healthcare Trust of America Holdings L P</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Principles of Consolidation:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Equity interest owned (percent)</a></td>
<td class="nump">98.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hr_RealEstatePropertiesHeldInJointVenturesMember', window );">Real Estate Properties Held in Joint Ventures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessOverviewAbstract', window );"><strong>Business Overview:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Joint venture ownership (percent)</a></td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ApproximateSquareFeetInvestedInByCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Approximate Square Feet Invested in by Company</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ApproximateSquareFeetInvestedInByCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ApproximateSquareFeetProvidedByCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Approximate square feet for which Nationwide property management services provided by company</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ApproximateSquareFeetProvidedByCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessOverviewAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Overview [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessOverviewAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EquityOwnershipForConsolidationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Ownership for Consolidation, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EquityOwnershipForConsolidationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_FinancingReceivableAllowanceForCreditLossReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Allowance for Credit Loss, Reserves</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_FinancingReceivableAllowanceForCreditLossReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_InvestmentInRealEstatePropertiesAndMortgageNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investment in real estate properties and mortgage notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_InvestmentInRealEstatePropertiesAndMortgageNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfBuildingsOwnedByJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Buildings Owned by Joint Venture</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfBuildingsOwnedByJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Notes Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfRealEstateInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfRealEstateInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfRealEstateNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Real Estate Notes Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfRealEstateNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfRecognizedLeaseFinancialReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Recognized Lease Financial Receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfRecognizedLeaseFinancialReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfVariableInterestEntities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Variable Interest Entities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfVariableInterestEntities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Real estate investments property owned in number of states.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateNotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Real Estate Notes Receivable, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateNotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentChargesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentChargesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479328/805-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, of financing receivable on nonaccrual status. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfRealEstate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings in the period to reduce the carrying amount of real property to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfRealEstate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeOperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 39<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480228/946-830-45-39<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(1)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column E)(Footnote 6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-6<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeOperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage investment held by members or limited partners of limited liability company (LLC) or limited partnership (LP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 272<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of limited partner units outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 4.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest income from lease receivable of sales-type lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482964/270-10-50-6A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.27(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_NotesReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_NotesReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=hr_VariableInterestEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=hr_VariableInterestEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=hr_NonControllingInterestHoldersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=hr_NonControllingInterestHoldersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=hr_HealthcareTrustofAmericaHoldingsLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=hr_HealthcareTrustofAmericaHoldingsLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hr_PropertyEntitiesNotDeterminedToBeVIEsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hr_PropertyEntitiesNotDeterminedToBeVIEsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hr_HealthcareTrustofAmericaHoldingsLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hr_HealthcareTrustofAmericaHoldingsLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hr_RealEstatePropertiesHeldInJointVenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=hr_RealEstatePropertiesHeldInJointVenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097276110400">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Consolidated balance sheets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Net real estate investments</a></td>
<td class="nump">$ 11,550,126<span></span>
</td>
<td class="nump">$ 12,412,354<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">24,668<span></span>
</td>
<td class="nump">60,961<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">13,103,728<span></span>
</td>
<td class="nump">13,849,631<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total equity</a></td>
<td class="nump">7,003,700<span></span>
</td>
<td class="nump">7,571,076<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">13,103,728<span></span>
</td>
<td class="nump">$ 13,849,631<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember', window );">Variable interest entity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Net real estate investments</a></td>
<td class="nump">72,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">1,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ReceivablesAndOtherAssets', window );">Receivables and other assets</a></td>
<td class="nump">2,594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">77,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">16,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total equity</a></td>
<td class="nump">60,207<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 77,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ReceivablesAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivables And Other Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ReceivablesAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(10)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097267108992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Variable interest entity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>property </div>
<div>note_receivable</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="nump">663<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=hr_VariableInterestEntityMember', window );">Variable Interest Entity</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfNotesReceivable', window );">Number of notes receivable | note_receivable</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_HoustonTexasMember', window );">Houston, TX | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableCarryingAmount', window );">Notes receivable, carrying amount</a></td>
<td class="nump">$ 30,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">MAXIMUM EXPOSURE TO LOSS</a></td>
<td class="nump">31,150<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NC', window );">North Carolina | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableCarryingAmount', window );">Notes receivable, carrying amount</a></td>
<td class="nump">5,743<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">MAXIMUM EXPOSURE TO LOSS</a></td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_TX', window );">Texas | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_JointVentureCarryingAmount', window );">Joint venture, carrying amount</a></td>
<td class="nump">63,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">MAXIMUM EXPOSURE TO LOSS</a></td>
<td class="nump">$ 63,579<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="nump">7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_JointVentureCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Joint Venture, Carrying Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_JointVentureCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NotesReceivableCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable, Carrying Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NotesReceivableCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfNotesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Notes Receivable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfNotesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph b<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 860<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481420/860-30-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=hr_VariableInterestEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=hr_VariableInterestEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_HoustonTexasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_HoustonTexasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_TX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_TX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097276881520">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleLeasebackTransactionNetBookValue', window );">Financing receivable, carrying value</a></td>
<td class="nump">$ 120,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">201,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">163,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">ALLOWANCE FOR CREDIT LOSSES</a></td>
<td class="num">(5,196)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount', window );">FAIR VALUE DISCOUNT AND FEES</a></td>
<td class="num">(3,726)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">CARRYING VALUE</a></td>
<td class="nump">154,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanMember', window );">Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">147,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">109,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">ALLOWANCE FOR CREDIT LOSSES</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount', window );">FAIR VALUE DISCOUNT AND FEES</a></td>
<td class="num">(659)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">CARRYING VALUE</a></td>
<td class="nump">$ 109,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_PowayCAMember', window );">Poway, CA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">INTEREST RATE</a></td>
<td class="nump">5.73%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleLeasebackTransactionNetBookValue', window );">Financing receivable, carrying value</a></td>
<td class="nump">$ 113,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_ColumbusOHMember', window );">Columbus, OH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">INTEREST RATE</a></td>
<td class="nump">6.48%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleLeasebackTransactionNetBookValue', window );">Financing receivable, carrying value</a></td>
<td class="nump">$ 7,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_TX', window );">Texas | Mezzanine loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">INTEREST RATE</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">$ 54,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">54,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">ALLOWANCE FOR CREDIT LOSSES</a></td>
<td class="num">(5,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount', window );">FAIR VALUE DISCOUNT AND FEES</a></td>
<td class="num">(3,067)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">CARRYING VALUE</a></td>
<td class="nump">$ 45,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_TX', window );">Texas | Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">INTEREST RATE</a></td>
<td class="nump">7.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">$ 31,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">31,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">ALLOWANCE FOR CREDIT LOSSES</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount', window );">FAIR VALUE DISCOUNT AND FEES</a></td>
<td class="num">(353)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">CARRYING VALUE</a></td>
<td class="nump">$ 30,797<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_NC', window );">North Carolina | Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">INTEREST RATE</a></td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">ALLOWANCE FOR CREDIT LOSSES</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount', window );">FAIR VALUE DISCOUNT AND FEES</a></td>
<td class="num">(257)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">CARRYING VALUE</a></td>
<td class="nump">$ 5,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_FL', window );">Florida | Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">INTEREST RATE</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">$ 65,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">27,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">ALLOWANCE FOR CREDIT LOSSES</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount', window );">FAIR VALUE DISCOUNT AND FEES</a></td>
<td class="num">(49)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">CARRYING VALUE</a></td>
<td class="nump">$ 27,602<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_CA', window );">California | Mortgage loans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableInterestRate', window );">INTEREST RATE</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NotesReceivableMaximumLoanCommitment', window );">MAXIMUM LOAN COMMITMENT</a></td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss', window );">REAL ESTATE NOTES RECEIVABLE, GROSS</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">ALLOWANCE FOR CREDIT LOSSES</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount', window );">FAIR VALUE DISCOUNT AND FEES</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">CARRYING VALUE</a></td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NotesReceivableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable, Interest Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NotesReceivableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NotesReceivableMaximumLoanCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notes Receivable, Maximum Loan Commitment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NotesReceivableMaximumLoanCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of allowance for credit loss on financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss and unamortized deferred fee, premium, and discount, of financing receivable covered under loss sharing agreement and financing receivable not covered under loss sharing agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, before allowance for credit loss, of financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-3B<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleLeasebackTransactionNetBookValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net book value of the asset(s) sold in connection with the sale of the property to another party and lease back to the seller.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481266/840-40-55-50<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481266/840-40-55-52<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 51<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481266/840-40-55-51<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479741/842-40-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleLeasebackTransactionNetBookValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=hr_MortgageLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_PowayCAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_PowayCAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_ColumbusOHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_ColumbusOHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_TX">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_TX</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=hr_MezzanineLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=hr_MezzanineLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_NC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_NC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_FL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_FL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097283515296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward', window );"><strong>Financing Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Allowance for credit losses, beginning of period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinancingReceivableAllowanceForCreditLossReserves', window );">Credit loss reserves</a></td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="nump">5,196<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest', window );">Allowance for credit losses, end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,196<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_FinancingReceivableAllowanceForCreditLossReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Allowance for Credit Loss, Reserves</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_FinancingReceivableAllowanceForCreditLossReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of allowance for credit loss on financing receivable. Excludes net investment in lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097272508768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Revenue Recognition (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Type of Revenue</a></td>
<td class="nump">$ 4,661<span></span>
</td>
<td class="nump">$ 4,057<span></span>
</td>
<td class="nump">$ 13,508<span></span>
</td>
<td class="nump">$ 9,270<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=hr_ParkingIncomeMember', window );">Parking income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Type of Revenue</a></td>
<td class="nump">2,751<span></span>
</td>
<td class="nump">2,428<span></span>
</td>
<td class="nump">7,511<span></span>
</td>
<td class="nump">6,100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=hr_ManagementFeeIncomeMember', window );">Management fee income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Type of Revenue</a></td>
<td class="nump">1,552<span></span>
</td>
<td class="nump">1,426<span></span>
</td>
<td class="nump">5,122<span></span>
</td>
<td class="nump">2,864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=hr_MiscellaneousMember', window );">Miscellaneous</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Type of Revenue</a></td>
<td class="nump">$ 358<span></span>
</td>
<td class="nump">$ 203<span></span>
</td>
<td class="nump">$ 875<span></span>
</td>
<td class="nump">$ 306<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=hr_ParkingIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=hr_ParkingIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=hr_ManagementFeeIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=hr_ManagementFeeIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=hr_MiscellaneousMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=hr_MiscellaneousMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097268253248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Merger with HTA - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jul. 20, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 247,043,000<span></span>
</td>
<td class="nump">$ 250,530,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,530,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 223,202,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill expected to be tax deductible</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_MergerRelatedCosts', window );">Merger-related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,450,000<span></span>
</td>
<td class="nump">$ 79,402,000<span></span>
</td>
<td class="num">(3,366,000)<span></span>
</td>
<td class="nump">$ 92,603,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRefundOfTransferTaxesPaid', window );">Refund of transfer taxes paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Revision of Prior Period, Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete', window );">Goodwill adjustment incomplete</a></td>
<td class="nump">$ 101,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=hr_HealthCareRealtyTrustIncorporatedMember', window );">HealthCare Realty Trust Incorporated | Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=hr_HealthCareRealtyTrustIncMember', window );">HealthCare Realty Trust, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=hr_HealthcareTrustOfAmericaIncMember', window );">Healthcare Trust Of America, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio', window );">Conversion ratio</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share, during the period (in dollars per share)</a></td>
<td class="nump">$ 4.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Consideration Transferred Equity Interests Issuable Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Provisional Information Initial Accounting Goodwill Adjustment Incomplete</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRefundOfTransferTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Refund of Transfer Taxes Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRefundOfTransferTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_MergerRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Merger Related Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_MergerRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=hr_HealthCareRealtyTrustIncorporatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=hr_HealthCareRealtyTrustIncorporatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=hr_HealthCareRealtyTrustIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=hr_HealthCareRealtyTrustIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=hr_HealthcareTrustOfAmericaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=hr_HealthcareTrustOfAmericaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097275648736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Merger with HTA (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th">
<div>Jul. 20, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)</a></td>
<td class="nump">228,857,717<span></span>
</td>
<td class="nump">380,860,000<span></span>
</td>
<td class="nump">380,590,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Implied shares of Legacy HR Common Stock issued (in shares)</a></td>
<td class="nump">228,520,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Adjusted closing price of Legacy HR Common Stock on July 20, 2022 (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 24.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ReverseRecapitalizationNet', window );">Value of implied Legacy HR Common Stock issued | $</a></td>
<td class="nump">$ 5,569,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices', window );">Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services | $</a></td>
<td class="nump">7,406<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=hr_LegacyHTAMember', window );">Legacy HTA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred | $</a></td>
<td class="nump">$ 5,576,463<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=hr_HealthcareTrustOfAmericaIncMember', window );">Healthcare Trust Of America, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)</a></td>
<td class="nump">228,520,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RecapitalizationExchangeRatio', window );">Exchange ratio</a></td>
<td class="nump">1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_CommonStockFractionalShares', window );">Common Stock, fractional (in shares)</a></td>
<td class="nump">192<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=hr_HealthcareTrustOfAmericaIncMember', window );">Healthcare Trust Of America, Inc | Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)</a></td>
<td class="nump">336,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_CommonStockSharesWithheld', window );">Common Stock, withheld (in shares)</a></td>
<td class="nump">215,764<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Fair Value of Legacy HTA Restricted Stock Awards Attributable to Pre-Merger Services</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_CommonStockFractionalShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Fractional Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_CommonStockFractionalShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_CommonStockSharesWithheld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Shares Withheld</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_CommonStockSharesWithheld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RecapitalizationExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recapitalization Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RecapitalizationExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ReverseRecapitalizationNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reverse Recapitalization, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ReverseRecapitalizationNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=hr_LegacyHTAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=hr_LegacyHTAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=hr_HealthcareTrustOfAmericaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=hr_HealthcareTrustOfAmericaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097272709888">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Merger with HTA - Schedule of Fair Values of the Assets Acquired And Liabilities Assumed (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jul. 20, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract', window );"><strong>Real estate investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand', window );">Land</a></td>
<td class="nump">$ 1,004,285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings', window );">Buildings and improvements</a></td>
<td class="nump">6,841,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Lease intangible assets</a></td>
<td class="nump">833,759<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets', window );">Financing lease right-of-use assets</a></td>
<td class="nump">13,020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress', window );">Construction in progress</a></td>
<td class="nump">3,327<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment', window );">Land held for development</a></td>
<td class="nump">46,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments', window );">Total real estate investments</a></td>
<td class="nump">8,742,212<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale', window );">Assets held for sale, net</a></td>
<td class="nump">699,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures', window );">Investments in unconsolidated joint ventures</a></td>
<td class="nump">67,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">37,437<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash', window );">Restricted cash</a></td>
<td class="nump">1,122,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="nump">214,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets', window );">Other assets, net</a></td>
<td class="nump">205,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="nump">11,089,391<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">3,991,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,244,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale', window );">Liabilities of assets held for sale</a></td>
<td class="nump">24,738<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">184,121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities', window );">Financing lease liabilities</a></td>
<td class="nump">9,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">194,301<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="nump">5,649,269<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net identifiable assets acquired</a></td>
<td class="nump">5,440,122<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Non-controlling interest</a></td>
<td class="nump">110,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 247,043<span></span>
</td>
<td class="nump">$ 250,530<span></span>
</td>
<td class="nump">$ 223,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Weighted average amortization period for the acquired lease intangible assets</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount', window );">Gross contractual accounts receivable</a></td>
<td class="nump">$ 15,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount', window );">Gross contractual real estate notes receivable</a></td>
<td class="nump">78,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_GrossContractualRealEstateNotesReceivableFairValue', window );">Gross contractual real estate notes receivable at fair value</a></td>
<td class="nump">74,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract', window );"><strong>CUMULATIVE MEASUREMENT PERIOD ADJUSTMENTS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand', window );">Land</a></td>
<td class="nump">18,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements', window );">Buildings and improvements</a></td>
<td class="num">(119,135)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets', window );">Lease intangible assets</a></td>
<td class="nump">1,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets', window );">Financing lease right-of-use assets</a></td>
<td class="nump">3,146<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress', window );">Construction in progress</a></td>
<td class="num">(6,744)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments', window );">Total real estate investments</a></td>
<td class="num">(102,535)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet', window );">Assets held for sale, net</a></td>
<td class="num">(7,946)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">11,403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash', window );">Restricted cash</a></td>
<td class="num">(1,247)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="nump">16,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet', window );">Other assets, net</a></td>
<td class="num">(3,840)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired', window );">Total assets acquired</a></td>
<td class="num">(87,795)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">17,374<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale', window );">Liabilities of assets held for sale</a></td>
<td class="num">(3,939)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">10,173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities', window );">Financing lease liabilities</a></td>
<td class="num">(855)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities', window );">Other liabilities</a></td>
<td class="num">(8,909)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed', window );">Total liabilities assumed</a></td>
<td class="nump">13,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired', window );">Net identifiable assets acquired</a></td>
<td class="num">(101,639)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill', window );">Goodwill</a></td>
<td class="nump">101,639<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract', window );"><strong>Real estate investments</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand', window );">Land</a></td>
<td class="nump">985,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings', window );">Buildings and improvements</a></td>
<td class="nump">6,960,418<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Lease intangible assets</a></td>
<td class="nump">831,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets', window );">Financing lease right-of-use assets</a></td>
<td class="nump">9,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress', window );">Construction in progress</a></td>
<td class="nump">10,071<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment', window );">Land held for development</a></td>
<td class="nump">46,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments', window );">Total real estate investments</a></td>
<td class="nump">8,844,747<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale', window );">Assets held for sale, net</a></td>
<td class="nump">707,442<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures', window );">Investments in unconsolidated joint ventures</a></td>
<td class="nump">67,892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">26,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash', window );">Restricted cash</a></td>
<td class="nump">1,123,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets', window );">Operating lease right-of-use assets</a></td>
<td class="nump">198,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets', window );">Other assets, net</a></td>
<td class="nump">209,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="nump">11,177,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>LIABILITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt', window );">Notes and bonds payable</a></td>
<td class="nump">3,991,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,227,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale', window );">Liabilities of assets held for sale</a></td>
<td class="nump">28,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">173,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities', window );">Financing lease liabilities</a></td>
<td class="nump">10,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">203,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Total liabilities assumed</a></td>
<td class="nump">5,635,425<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net identifiable assets acquired</a></td>
<td class="nump">5,541,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Non-controlling interest</a></td>
<td class="nump">110,702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 145,404<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Acquired Real Estate Notes Receivable, Gross Contractual Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable and Accrued Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Held For Sale, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Construction in Progress</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financing Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment,, Financing Lease Right-of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Assumed</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Of Assets Held For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identifiable Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use-Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Real Estate Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Restricted Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Buildings and Improvements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Indefinite Lived Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Provisional Information, Initial Accounting Incomplete, Land</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Payable And Accrued Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Held For Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Construction in Progress</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Right-of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investments in Unconsolidated Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land Held For Development</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities of Assets Held for Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-Term Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_GrossContractualRealEstateNotesReceivableFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross Contractual Real Estate Notes Receivable, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_GrossContractualRealEstateNotesReceivableFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For receivables acquired in a business combination, excluding certain loans and debt securities acquired in a transfer (as defined), this element represents the gross contractual amounts receivable, by major class of receivable, such as loans, direct finance leases (as defined), and any other class of receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of facility held for productive use including, but not limited to, office, production, storage and distribution facilities, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate acquired, at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479303/805-10-55-37<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482598/350-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482573/350-20-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097271520256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Investments -Real Estate Acquisitions (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jul. 28, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Mar. 10, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis=hr_RealEstateAcquisitionsMember', window );">Total real estate acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">PURCHASE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,950<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">MORTGAGE NOTES PAYABLE, NET</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,284)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">CASH CONSIDERATION</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,523<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty', window );">REAL ESTATE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,012<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther', window );">OTHER</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (205)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,637<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_TampaFLMember', window );">Tampa, FL | Medical office building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">PURCHASE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">MORTGAGE NOTES PAYABLE, NET</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">CASH CONSIDERATION</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty', window );">REAL ESTATE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther', window );">OTHER</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (97)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,867<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_ColoradoSpringsCOMember', window );">Colorado Springs, CO | Medical office building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">PURCHASE PRICE</a></td>
<td class="nump">$ 11,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred', window );">MORTGAGE NOTES PAYABLE, NET</a></td>
<td class="num">(5,284)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">CASH CONSIDERATION</a></td>
<td class="nump">6,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty', window );">REAL ESTATE</a></td>
<td class="nump">11,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther', window );">OTHER</a></td>
<td class="num">$ (108)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="nump">42,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition Purchase Price Allocation Square Footage.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Real Property</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value Adjustments and Other</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479907/805-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479668/805-30-25-5<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 8<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-8<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 7<br> -SubTopic 30<br> -Topic 805<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479637/805-30-30-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis=hr_RealEstateAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis=hr_RealEstateAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_TampaFLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_TampaFLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=hr_MedicalOfficeBuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=hr_MedicalOfficeBuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_ColoradoSpringsCOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_ColoradoSpringsCOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097282378752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Investments - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLand', window );">Payments to acquired a parcel of land</a></td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Payments to acquire additional interest in an operating property</a></td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the acquisition of real estate intended to generate income for the owner; excludes land acquired for use by the owner.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480060/805-50-25-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 805<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480027/805-50-30-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097271576272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in unconsolidated joint ventures, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 327,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity loss recognized during the period</a></td>
<td class="num">$ (456)<span></span>
</td>
<td class="num">$ (124)<span></span>
</td>
<td class="num">(1,253)<span></span>
</td>
<td class="num">$ (776)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in unconsolidated joint ventures, end of period</a></td>
<td class="nump">325,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">325,453<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OtherPropertyMember', window );">Parking Garages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in unconsolidated joint ventures, beginning of period</a></td>
<td class="nump">327,245<span></span>
</td>
<td class="nump">210,781<span></span>
</td>
<td class="nump">327,248<span></span>
</td>
<td class="nump">161,942<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod', window );">New investments during the period</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">117,880<span></span>
</td>
<td class="nump">3,824<span></span>
</td>
<td class="nump">167,479<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Equity loss recognized during the period</a></td>
<td class="num">(456)<span></span>
</td>
<td class="num">(124)<span></span>
</td>
<td class="num">(1,253)<span></span>
</td>
<td class="num">(776)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared', window );">Owner distributions</a></td>
<td class="num">(1,336)<span></span>
</td>
<td class="num">(785)<span></span>
</td>
<td class="num">(4,366)<span></span>
</td>
<td class="num">(893)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures', window );">Investments in unconsolidated joint ventures, end of period</a></td>
<td class="nump">$ 325,453<span></span>
</td>
<td class="nump">$ 327,752<span></span>
</td>
<td class="nump">$ 325,453<span></span>
</td>
<td class="nump">$ 327,752<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OtherPropertyMember', window );">Parking Garages | Los Angeles, CA | Limited Liability Company One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EquityMethodInvestmentsRollForward', window );"><strong>Equity Method Investments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_JointVentureOwnershipPercentage', window );">Joint venture, ownership (in percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EquityMethodInvestmentsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Method Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EquityMethodInvestmentsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures in Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_JointVentureOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Joint Venture, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_JointVentureOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity impact of cash distributions declared to unit-holder of limited liability company (LLC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483014/272-10-45-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity method investee and investment in and advance to affiliate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OtherPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OtherPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_LosAngelesCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_LosAngelesCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=hr_LimitedLiabilityCompanyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=hr_LimitedLiabilityCompanyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097265167232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Investments - Dispositions (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 27, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Sep. 18, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Sep. 15, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Aug. 22, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Aug. 02, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>May 12, 2023 </div>
<div>USD ($) </div>
<div>a </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Mar. 30, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Mar. 23, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Feb. 10, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jan. 30, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jan. 12, 2023 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>disposition_transaction </div>
<div>property</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>property</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">663<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis=hr_RealEstateDispositionsMember', window );">Real Estate Dispositions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 430,772<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18,951)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceMortgageNotes', window );">COMPANY-FINANCED MORTGAGE NOTES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">366,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">390,485<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">OTHER (INCLUDING RECEIVABLES)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,736<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,600<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">922,922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_TampaFLMiamiFLMember', window );">Tampa/Miami, FL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,875)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceMortgageNotes', window );">COMPANY-FINANCED MORTGAGE NOTES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,302<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">OTHER (INCLUDING RECEIVABLES)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(888)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">224,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of owned real estate properties | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfPropertyDispositions', window );">Number of property dispositions | disposition_transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_DallasTXMember', window );">Dallas, TX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 115,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,504)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(141)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceMortgageNotes', window );">COMPANY-FINANCED MORTGAGE NOTES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,496<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">OTHER (INCLUDING RECEIVABLES)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_JointVentureOwnershipPercentage', window );">Joint venture, ownership (in percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_STLouisMoMember', window );">St. Louis, MO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(18)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceMortgageNotes', window );">COMPANY-FINANCED MORTGAGE NOTES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">OTHER (INCLUDING RECEIVABLES)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (66)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_LosAngelesCaliforniaMember', window );">Los Angeles, CA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="nump">$ 21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(334)<span></span>
</td>
<td class="num">(8,079)<span></span>
</td>
<td class="num">(526)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceMortgageNotes', window );">COMPANY-FINANCED MORTGAGE NOTES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(45,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,966<span></span>
</td>
<td class="nump">21,921<span></span>
</td>
<td class="nump">20,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,268<span></span>
</td>
<td class="nump">88,624<span></span>
</td>
<td class="nump">20,610<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">OTHER (INCLUDING RECEIVABLES)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(803)<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (302)<span></span>
</td>
<td class="num">$ (20,900)<span></span>
</td>
<td class="num">$ (188)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">147,078<span></span>
</td>
<td class="nump">37,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_MortgageNote', window );">Mortgage note</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_AlbanyNYMember', window );">Albany, NY</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,229)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceMortgageNotes', window );">COMPANY-FINANCED MORTGAGE NOTES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">OTHER (INCLUDING RECEIVABLES)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,040)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Area of land | a</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_HoustonTXMember', window );">Houston, TX</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(285)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceMortgageNotes', window );">COMPANY-FINANCED MORTGAGE NOTES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,998<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,567<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">OTHER (INCLUDING RECEIVABLES)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,772)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_AtlantaGAMember', window );">Atlanta, GA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(66)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceMortgageNotes', window );">COMPANY-FINANCED MORTGAGE NOTES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">OTHER (INCLUDING RECEIVABLES)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(536)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,195<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=hr_ChicagoILMember', window );">Chicago, IL</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateDispositionsLineItems', window );"><strong>Real Estate Dispositions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DispositionSalesPrice', window );">SALE PRICE</a></td>
<td class="nump">$ 59,950<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ClosingAdjustmentsDisposedEntity', window );">CLOSING ADJUSTMENTS</a></td>
<td class="num">(870)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceMortgageNotes', window );">COMPANY-FINANCED MORTGAGE NOTES</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment', window );">NET PROCEEDS</a></td>
<td class="nump">59,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod', window );">NET REAL ESTATE INVESTMENT</a></td>
<td class="nump">74,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_RealEstateOther', window );">OTHER (INCLUDING RECEIVABLES)</a></td>
<td class="num">(380)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfAssets', window );">GAIN/(IMPAIRMENT)</a></td>
<td class="num">$ (15,250)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits', window );">SQUARE FOOTAGE | ft&#178;</a></td>
<td class="nump">104,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area covered under real estate investment sold in measurement units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ClosingAdjustmentsDisposedEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Closing Adjustments Disposed Entity, including closing costs and other adjustments to the sales price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ClosingAdjustmentsDisposedEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_DispositionSalesPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disposition Sales Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_DispositionSalesPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_FinanceMortgageNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Mortgage Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_FinanceMortgageNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_JointVentureOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Joint Venture, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_JointVentureOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_MortgageNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Mortgage Note</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_MortgageNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfPropertyDispositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Property Dispositions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfPropertyDispositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateDispositionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Real estate dispositions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateDispositionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateInvestmentNetDisposedOfDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Real estate investment net disposed of during the Period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateInvestmentNetDisposedOfDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Real estate other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482130/360-10-45-5<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from the sale of real estate that is held for investment, that is, it is part of an investing activity during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis=hr_RealEstateDispositionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis=hr_RealEstateDispositionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_TampaFLMiamiFLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_TampaFLMiamiFLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_DallasTXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_DallasTXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_STLouisMoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_STLouisMoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_LosAngelesCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_LosAngelesCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_AlbanyNYMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_AlbanyNYMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_HoustonTXMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_HoustonTXMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_AtlantaGAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_AtlantaGAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_ChicagoILMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_ChicagoILMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097268099872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Real Estate Investments - Assets Held for Sale (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>entity </div>
<div>property</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>entity </div>
<div>property</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>property</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsHeldForSaleLineItems', window );"><strong>Long Lived Assets Held-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfPropertiesClassifiedAsHeldForSale', window );">Number of properties classified as held for sale | property</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfCorporateEntityClassifiedAsHeldForSale', window );">Number of corporate entity classified as held for sale | entity</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale', window );">Impairment charges on net real estate assets held for sale</a></td>
<td class="nump">$ 15,900<span></span>
</td>
<td class="nump">$ 46,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">1,387,821<span></span>
</td>
<td class="nump">1,387,821<span></span>
</td>
<td class="nump">$ 1,439,798<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentBuildingAndBuildingImprovements', window );">Building and improvements</a></td>
<td class="nump">11,004,195<span></span>
</td>
<td class="nump">11,004,195<span></span>
</td>
<td class="nump">11,332,037<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAtCost', window );">Total real estate properties</a></td>
<td class="nump">13,644,078<span></span>
</td>
<td class="nump">13,644,078<span></span>
</td>
<td class="nump">14,057,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation', window );">Accumulated depreciation</a></td>
<td class="num">(2,093,952)<span></span>
</td>
<td class="num">(2,093,952)<span></span>
</td>
<td class="num">(1,645,271)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Total real estate properties, net</a></td>
<td class="nump">11,550,126<span></span>
</td>
<td class="nump">11,550,126<span></span>
</td>
<td class="nump">12,412,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">323,759<span></span>
</td>
<td class="nump">323,759<span></span>
</td>
<td class="nump">336,983<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet', window );">Assets held for sale, net</a></td>
<td class="nump">57,638<span></span>
</td>
<td class="nump">57,638<span></span>
</td>
<td class="nump">18,893<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">273,319<span></span>
</td>
<td class="nump">273,319<span></span>
</td>
<td class="nump">279,895<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities of assets held for sale</a></td>
<td class="nump">3,814<span></span>
</td>
<td class="nump">3,814<span></span>
</td>
<td class="nump">437<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongLivedAssetsHeldForSaleLineItems', window );"><strong>Long Lived Assets Held-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">14,282<span></span>
</td>
<td class="nump">14,282<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentBuildingAndBuildingImprovements', window );">Building and improvements</a></td>
<td class="nump">41,538<span></span>
</td>
<td class="nump">41,538<span></span>
</td>
<td class="nump">15,164<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_LeaseIntangibles', window );">Lease intangibles</a></td>
<td class="nump">12,938<span></span>
</td>
<td class="nump">12,938<span></span>
</td>
<td class="nump">1,986<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAtCost', window );">Total real estate properties</a></td>
<td class="nump">68,758<span></span>
</td>
<td class="nump">68,758<span></span>
</td>
<td class="nump">18,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation', window );">Accumulated depreciation</a></td>
<td class="num">(13,634)<span></span>
</td>
<td class="num">(13,634)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RealEstateInvestmentPropertyNet', window );">Total real estate properties, net</a></td>
<td class="nump">55,124<span></span>
</td>
<td class="nump">55,124<span></span>
</td>
<td class="nump">18,850<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">585<span></span>
</td>
<td class="nump">585<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets', window );">Other assets, net</a></td>
<td class="nump">1,929<span></span>
</td>
<td class="nump">1,929<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet', window );">Assets held for sale, net</a></td>
<td class="nump">57,638<span></span>
</td>
<td class="nump">57,638<span></span>
</td>
<td class="nump">18,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,716<span></span>
</td>
<td class="nump">1,716<span></span>
</td>
<td class="nump">282<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">1,020<span></span>
</td>
<td class="nump">1,020<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities', window );">Other liabilities</a></td>
<td class="nump">1,078<span></span>
</td>
<td class="nump">1,078<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation', window );">Liabilities of assets held for sale</a></td>
<td class="nump">$ 3,814<span></span>
</td>
<td class="nump">$ 3,814<span></span>
</td>
<td class="nump">$ 437<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AssetsHeldForSaleAndDiscontinuedOperationsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets held for sale and discontinued operations, net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AssetsHeldForSaleAndDiscontinuedOperationsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ImpairmentChargeOnRealEstateAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment Charge on Real Estate Assets Held for Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ImpairmentChargeOnRealEstateAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_LeaseIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Intangibles</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_LeaseIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfCorporateEntityClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Corporate Entity Classified as Held for Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfCorporateEntityClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfPropertiesClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Properties Classified as Held for Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfPropertiesClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other assets attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as other liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentBuildingAndBuildingImprovements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate of the carrying amounts as of the balance sheet date of investments in building and building improvements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentBuildingAndBuildingImprovements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount classified as liabilities attributable to disposal group held for sale or disposed of.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -SubTopic 20<br> -Topic 205<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5C<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-5B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483475/205-20-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsHeldForSaleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsHeldForSaleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of depreciation for real estate property held for investment purposes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyAtCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyAtCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RealEstateInvestmentPropertyNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RealEstateInvestmentPropertyNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097283327440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLeaseIncome', window );">Rental income</a></td>
<td class="nump">$ 333,335<span></span>
</td>
<td class="nump">$ 298,931<span></span>
</td>
<td class="nump">$ 987,109<span></span>
</td>
<td class="nump">$ 578,052<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLeaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482964/270-10-50-6A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479016/842-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLeaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097283601872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Lessor Accounting (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract', window );"><strong>OPERATING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">$ 231,698<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths', window );">2024</a></td>
<td class="nump">874,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears', window );">2025</a></td>
<td class="nump">770,520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears', window );">2026</a></td>
<td class="nump">666,294<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears', window );">2027</a></td>
<td class="nump">552,111<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour', window );">2028 and thereafter</a></td>
<td class="nump">1,918,689<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived', window );">Total</a></td>
<td class="nump">$ 5,014,062<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessor, Operating Lease, Payment to be Received, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payments to be received by lessor for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479773/842-30-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097275381808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Ground Leases (Details)<br> ft&#178; in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>lease </div>
<div>property</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>ft&#178; </div>
<div>lease </div>
<div>property</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfPropertiesSubjectToGroundLeases', window );">Number of properties subject to ground leases | property</a></td>
<td class="nump">240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_SquareFeetSubjecttoGroundLeases', window );">Square feet subject to ground leases | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberofGroundLeasesPrepaid', window );">Number of prepaid ground leases</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_AmortizationofPrepaidRent', window );">Amortization of prepaid rent | $</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberofGroundLeasesExcludingPrepaidLeases', window );">Number of non-prepaid ground leases</a></td>
<td class="nump">165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Ground lease, initial term</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Ground lease, initial term</a></td>
<td class="text">99 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">99 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_AmortizationofPrepaidRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization of Prepaid Rent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_AmortizationofPrepaidRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberofGroundLeasesExcludingPrepaidLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Ground Leases, Excluding Prepaid Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberofGroundLeasesExcludingPrepaidLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberofGroundLeasesPrepaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Ground Leases Prepaid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberofGroundLeasesPrepaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_SquareFeetSubjecttoGroundLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Square Feet Subject to Ground Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_SquareFeetSubjecttoGroundLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfPropertiesSubjectToGroundLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of separate real estate development properties located on land subject to ground leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfPropertiesSubjectToGroundLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097273336288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Future Minimum Lease Payments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>OPERATING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">$ 3,288<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">14,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">14,253<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">14,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">14,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour', window );">2028 and thereafter</a></td>
<td class="nump">922,019<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">982,644<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Discount</a></td>
<td class="num">(709,325)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities</a></td>
<td class="nump">273,319<span></span>
</td>
<td class="nump">$ 279,895<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>FINANCING</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">2,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">2,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">2,255<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">2,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceLeaseLiabilityToBePaidAfterYearFour', window );">2028 and thereafter</a></td>
<td class="nump">396,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">405,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Discount</a></td>
<td class="num">(331,772)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Lease liabilities</a></td>
<td class="nump">$ 74,087<span></span>
</td>
<td class="nump">$ 72,939<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_FinanceLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_FinanceLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, after Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097271524416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Operating lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">$ 5,312<span></span>
</td>
<td class="nump">$ 4,204<span></span>
</td>
<td class="nump">$ 15,748<span></span>
</td>
<td class="nump">$ 6,613<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease expense</a></td>
<td class="nump">2,417<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="nump">6,788<span></span>
</td>
<td class="nump">3,123<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseDescriptionAbstract', window );"><strong>Finance lease cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">387<span></span>
</td>
<td class="nump">381<span></span>
</td>
<td class="nump">1,161<span></span>
</td>
<td class="nump">884<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">928<span></span>
</td>
<td class="nump">861<span></span>
</td>
<td class="nump">2,770<span></span>
</td>
<td class="nump">1,913<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease expense</a></td>
<td class="nump">9,044<span></span>
</td>
<td class="nump">6,507<span></span>
</td>
<td class="nump">26,467<span></span>
</td>
<td class="nump">12,533<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesOperatingAbstract', window );"><strong>Other information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows outflows related to operating leases</a></td>
<td class="nump">5,281<span></span>
</td>
<td class="nump">3,847<span></span>
</td>
<td class="nump">16,475<span></span>
</td>
<td class="nump">8,443<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows outflows related to financing leases</a></td>
<td class="nump">524<span></span>
</td>
<td class="nump">476<span></span>
</td>
<td class="nump">1,592<span></span>
</td>
<td class="nump">1,262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_FinanceLeasePrincipalOnlyPayments', window );">Financing cash flows outflows related to financing leases</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for new finance lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,874<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">50,463<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new operating lease liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 198,261<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 198,261<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average years remaining lease term (excluding renewal options) - operating leases</a></td>
<td class="text">47 years 6 months<span></span>
</td>
<td class="text">50 years 2 months 12 days<span></span>
</td>
<td class="text">47 years 6 months<span></span>
</td>
<td class="text">50 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average years remaining lease term (excluding renewal options) - finance leases</a></td>
<td class="text">58 years 2 months 12 days<span></span>
</td>
<td class="text">60 years 1 month 6 days<span></span>
</td>
<td class="text">58 years 2 months 12 days<span></span>
</td>
<td class="text">60 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate - operating leases</a></td>
<td class="nump">5.80%<span></span>
</td>
<td class="nump">5.70%<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
<td class="nump">5.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate - finance leases</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_FinanceLeasePrincipalOnlyPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Principal Only Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_FinanceLeasePrincipalOnlyPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesOperatingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesOperatingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseDescriptionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseDescriptionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097272754656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Notes and Bonds Payable (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Apr. 26, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,227,413,000<span></span>
</td>
<td class="nump">$ 5,351,827,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DebtInstrumentExtensionPeriodForMaturityDate', window );">Extension period for maturity date</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Debt fees</a></td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hr_MortgageNotesPayableNetMember', window );">Mortgage notes payable | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.57%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hr_MortgageNotesPayableNetMember', window );">Mortgage notes payable | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.88%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of credit | $1.5 billion Unsecured Credit Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 236,000,000<span></span>
</td>
<td class="nump">385,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.24%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | $200 million Unsecured Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 199,845,000<span></span>
</td>
<td class="nump">199,670,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | $350 million Unsecured Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 349,711,000<span></span>
</td>
<td class="nump">349,114,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 350,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | $300 million Unsecured Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 299,952,000<span></span>
</td>
<td class="nump">299,936,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | $150 million Unsecured Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 149,606,000<span></span>
</td>
<td class="nump">149,495,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | $200 million Unsecured Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 199,467,000<span></span>
</td>
<td class="nump">199,362,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember', window );">Medium-term notes | $300 million Unsecured Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 298,184,000<span></span>
</td>
<td class="nump">297,869,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 249,391,000<span></span>
</td>
<td class="nump">249,115,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.12%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2026</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 577,124,000<span></span>
</td>
<td class="nump">571,587,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.94%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 482,665,000<span></span>
</td>
<td class="nump">479,553,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.76%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 297,283,000<span></span>
</td>
<td class="nump">296,852,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.85%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 572,883,000<span></span>
</td>
<td class="nump">565,402,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2030</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 296,679,000<span></span>
</td>
<td class="nump">296,385,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.72%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 295,706,000<span></span>
</td>
<td class="nump">295,547,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes | Senior Notes due 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 645,232,000<span></span>
</td>
<td class="nump">632,693,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.13%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember', window );">Mortgages | Mortgage notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 77,685,000<span></span>
</td>
<td class="nump">$ 84,247,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_DebtInstrumentExtensionPeriodForMaturityDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Extension Period for Maturity Date</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_DebtInstrumentExtensionPeriodForMaturityDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482949/835-30-55-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_MortgageNotesPayableNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_MortgageNotesPayableNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_UnsecuredCreditFacilityOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_UnsecuredCreditFacilityOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_TermLoanDueMay2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_TermLoanDueMay2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_TermLoanDueJuly2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_TermLoanDueJuly2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_TermLoanDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_TermLoanDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_TermLoandue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_TermLoandue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_TermLoanDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_TermLoanDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_TermLoanDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_TermLoanDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesdue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesdue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesdue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesdue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesdue2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesdue2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097275433424">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Notes and Bonds Payable - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Aug. 01, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 28, 2023 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,227,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,351,827<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hr_MortgageNotesPayableNetMember', window );">Mortgage notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_PercentageOfInterestBearingInMortgageNotesPayable', window );">Percentage of interest-bearing in mortgage note payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=hr_MortgageNotesPayableNetMember', window );">Mortgage notes payable | Mortgages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 77,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 84,247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_CO', window );">COLORADO | Mortgage notes payable | Mortgages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Notes and bonds payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_SquareFeetSubjectToMortgageNotesPayable', window );">Square foot subject to mortgage note payable | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAxis=us-gaap_MortgagesMember', window );">Mortgages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="nump">3.31%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Outstanding principal repaid</a></td>
<td class="nump">$ 9,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAxis=us-gaap_MortgagesMember', window );">Mortgages | GEORGIA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ExtinguishmentOfDebtEncumberedSquareFootage', window );">Encumbered square footage | ft&#178;</a></td>
<td class="nump">66,984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ExtinguishmentOfDebtEncumberedSquareFootage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Extinguishment of Debt, Encumbered Square Footage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ExtinguishmentOfDebtEncumberedSquareFootage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_PercentageOfInterestBearingInMortgageNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of Interest-Bearing in Mortgage Notes Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_PercentageOfInterestBearingInMortgageNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_SquareFeetSubjectToMortgageNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Square Feet Subject to Mortgage Notes Payable</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_SquareFeetSubjectToMortgageNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482925/835-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482900/835-30-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=hr_MortgageNotesPayableNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=hr_MortgageNotesPayableNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_MortgagesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CO">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CO</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAxis=us-gaap_MortgagesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAxis=us-gaap_MortgagesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_GA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_GA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097267473088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Oct. 23, 2023 </div>
<div>USD ($) </div>
<div>transaction</div>
</th>
<th class="th">
<div>Oct. 19, 2023 </div>
<div>USD ($) </div>
<div>transaction</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>derivative</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfInterestRateDerivativesHeld', window );">Number of instruments | derivative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swaps | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.17%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJanuary152024Member', window );">Interest Rate Swap, Expiring January 15, 2024 | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.21%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringMay12026Member', window );">Interest Rate Swap, Expiring May 1, 2026 | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.15%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12026Member', window );">Interest Rate Swap, Expiring June 1, 2026 | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.83%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12026Member', window );">Interest Rate Swap, Expiring December 1, 2026 | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.84%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12027Member', window );">Interest Rate Swap, Expiring June 1, 2027 | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.13%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12027Member', window );">Interest Rate Swap, Expiring June 1, 2027 | Cash flow hedging | Designated as hedging instrument | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.71%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12027Member', window );">Interest Rate Swap, Expiring December 1, 2027 | Cash flow hedging | Designated as hedging instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.79%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12027Member', window );">Interest Rate Swap, Expiring December 1, 2027 | Cash flow hedging | Designated as hedging instrument | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.67%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapEffectiveNovember12023Member', window );">Interest Rate Swap, Effective November 1, 2023 | Cash flow hedging | Designated as hedging instrument | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfSwapTransactions', window );">Number of swap transactions | transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringMay312026Member', window );">Interest Rate Swap, Expiring May 31, 2026 | Cash flow hedging | Designated as hedging instrument | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">AMOUNT</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFixedInterestRate', window );">Weighted average interest rate (percent)</a></td>
<td class="nump">4.73%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfSwapTransactions', window );">Number of swap transactions | transaction</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfSwapTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of Swap Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfSwapTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFixedInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fixed interest rate related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFixedInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfInterestRateDerivativesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of interest rate derivative instruments held by the entity at the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfInterestRateDerivativesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis=us-gaap_CashFlowHedgingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJanuary152024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJanuary152024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringMay12026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringMay12026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringJune12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringDecember12027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapEffectiveNovember12023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapEffectiveNovember12023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringMay312026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_InterestRateSwapExpiringMay312026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097268188768">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other assets | Designated as hedging instrument | Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeLiability', window );">Liability derivatives</a></td>
<td class="nump">$ 21,499<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097271210080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">(Gain)/loss recognized in AOCI on derivative</a></td>
<td class="num">$ (12,016)<span></span>
</td>
<td class="num">$ (6,083)<span></span>
</td>
<td class="num">$ (24,999)<span></span>
</td>
<td class="num">$ (12,905)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">(Gain) Loss, Reclassified from AOCI into income</a></td>
<td class="num">(4,168)<span></span>
</td>
<td class="nump">763<span></span>
</td>
<td class="num">(9,874)<span></span>
</td>
<td class="nump">2,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">(Gain) Loss, Reclassified from AOCI into income</a></td>
<td class="num">(4,168)<span></span>
</td>
<td class="nump">763<span></span>
</td>
<td class="num">(9,874)<span></span>
</td>
<td class="nump">2,672<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">(Gain)/loss recognized in AOCI on derivative</a></td>
<td class="num">(12,016)<span></span>
</td>
<td class="num">(6,083)<span></span>
</td>
<td class="num">(24,999)<span></span>
</td>
<td class="num">(12,905)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember', window );">Interest rate swaps | Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">(Gain) Loss, Reclassified from AOCI into income</a></td>
<td class="num">(4,317)<span></span>
</td>
<td class="nump">614<span></span>
</td>
<td class="num">(10,320)<span></span>
</td>
<td class="nump">2,226<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Settled treasury hedges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">(Gain)/loss recognized in AOCI on derivative</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember', window );">Settled treasury hedges | Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">(Gain) Loss, Reclassified from AOCI into income</a></td>
<td class="nump">107<span></span>
</td>
<td class="nump">107<span></span>
</td>
<td class="nump">126<span></span>
</td>
<td class="nump">320<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Settled interest rate swaps</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">(Gain)/loss recognized in AOCI on derivative</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Settled interest rate swaps | Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax', window );">(Gain) Loss, Reclassified from AOCI into income</a></td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 42<span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
<td class="nump">$ 126<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480627/815-20-45-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_InterestExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_TreasuryLockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097271527376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_DerivativeNetAssetPositionAggregateFairValue', window );">Derivatives in net asset position</a></td>
<td class="nump">$ 21.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_ActiveInterestRateSwapsMember', window );">Active Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest rate cash flow hedge gain (loss) to be reclassified to interest expense during the next 12 months</a></td>
<td class="nump">14.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=hr_SettledInterestRateSwapsMember', window );">Settled Interest Rate Swaps</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet', window );">Interest rate cash flow hedge gain (loss) to be reclassified to interest expense during the next 12 months</a></td>
<td class="num">$ (0.6)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_DerivativeNetAssetPositionAggregateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative Net Asset Position Aggregate Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_DerivativeNetAssetPositionAggregateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480870/815-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_ActiveInterestRateSwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_ActiveInterestRateSwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=hr_SettledInterestRateSwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=hr_SettledInterestRateSwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097271227776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLand', window );">Payments to acquired a parcel of land</a></td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=hr_MedicalOfficeBuildingMember', window );">Medical office building | Scottsdale, Arizona</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_JointVentureOwnershipPercentage', window );">Joint venture, ownership (in percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLand', window );">Payments to acquired a parcel of land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=hr_ActiveDevelopmentPropertiesMember', window );">Active Development Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ConstructionActivityTotalFundingDuringthePeriod', window );">Construction activity and development properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=hr_RedevelopmentPropertiesMember', window );">Redevelopment Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ConstructionActivityTotalFundingDuringthePeriod', window );">Construction activity and development properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsAxis=hr_CompletedDevelpomentAndRedevelopmentPropertiesMember', window );">Completed Develpoment and Redevelopment Properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ConstructionActivityTotalFundingDuringthePeriod', window );">Construction activity and development properties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ConstructionActivityTotalFundingDuringthePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Construction Activity, Total Funding During the Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ConstructionActivityTotalFundingDuringthePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_JointVentureOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Joint Venture, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_JointVentureOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479581/805-30-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the acquisition of real estate intended to generate income for the owner; excludes land acquired for use by the owner.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=hr_MedicalOfficeBuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=hr_MedicalOfficeBuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=hr_ScottsdaleArizonaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=hr_ScottsdaleArizonaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=hr_ActiveDevelopmentPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=hr_ActiveDevelopmentPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=hr_RedevelopmentPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=hr_RedevelopmentPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsAxis=hr_CompletedDevelpomentAndRedevelopmentPropertiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsAxis=hr_CompletedDevelpomentAndRedevelopmentPropertiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097276888384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details) - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward', window );"><strong>Reconciliation of the beginning and ending common stock outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, beginning of period (in shares)</a></td>
<td class="nump">380,590,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, end of period (in shares)</a></td>
<td class="nump">380,860,000<span></span>
</td>
<td class="nump">380,590,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward', window );"><strong>Reconciliation of the beginning and ending common stock outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, beginning of period (in shares)</a></td>
<td class="nump">380,589,894<span></span>
</td>
<td class="nump">150,457,433<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in shares)</a></td>
<td class="nump">7,397<span></span>
</td>
<td class="nump">229,618,304<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Non-vested share-based awards, net of withheld shares (in shares)</a></td>
<td class="nump">262,821<span></span>
</td>
<td class="nump">514,157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance, end of period (in shares)</a></td>
<td class="nump">380,860,112<span></span>
</td>
<td class="nump">380,589,894<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of the beginning and ending common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097264654416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Transactions - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="4">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 30, 2023 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Jan. 04, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jan. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2023 </div>
<div>USD ($) </div>
<div>director </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareCashPaid', window );">Dividends paid per common share, during the period (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="nump">$ 0.93<span></span>
</td>
<td class="nump">$ 0.93<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockDividendsPerShareDeclared', window );">Dividends declared per common share, during the period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hr_ExecutiveIncentiveProgramMember', window );">Executive Incentive Program | Directors | Share-Based Payment Arrangement, Nonemployee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Grant date fair value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hr_StockIncentivePlanMember', window );">Stock incentive plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,852<span></span>
</td>
<td class="nump">313,770<span></span>
</td>
<td class="nump">513,876<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember', window );">Operating Partnership Performance Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_PercentageOfRestrictedStockUnits', window );">Percentage of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod', window );">Award performance period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember', window );">Operating Partnership Performance Units | Performance conditions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_PercentageOfRestrictedStockUnits', window );">Percentage of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember', window );">Operating Partnership Performance Units | Absolute TSR Component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember', window );">Operating Partnership Performance Units | Relative TSR Component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember', window );">Operating Partnership Performance Units | Executive Incentive Program | Share-Based Payment Arrangement, Nonemployee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">448,249<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_NonVestedStockAwardMember', window );">Non-vested Stock Award | Executive Incentive Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue', window );">Grant date fair value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">270,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_NonVestedStockAwardMember', window );">Non-vested Stock Award | Executive Incentive Program | Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue', window );">Grant date fair value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_NonVestedStockAwardMember', window );">Non-vested Stock Award | Executive Incentive Program | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_NonVestedStockAwardMember', window );">Non-vested Stock Award | Executive Incentive Program | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_NonVestedStockAwardMember', window );">Non-vested Stock Award | LTIP-D | Directors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue', window );">Grant date fair value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NumberOfDirectors', window );">Number of directors | director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_NonVestedStockAwardMember', window );">Non-vested Stock Award | LTIP-D | New Employee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock | Stock incentive plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld to pay estimated withholding taxes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,632<span></span>
</td>
<td class="nump">8,745<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_PercentageOfRestrictedStockUnits', window );">Percentage of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Performance conditions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_PercentageOfRestrictedStockUnits', window );">Percentage of restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Absolute TSR Component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Relative TSR Component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Executive Incentive Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue', window );">Grant date fair value | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options under the Employee Stock Option Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted-average incremental shares of common stock excluded from the computation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,678<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options under the Employee Stock Option Plan | Operating Partnership Performance Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Nonvested shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,042,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,042,993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EquityOfferingProgramAvailableForIssuance', window );">Amount remaining available for issuance under the new ATM | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EquityOfferingProgramAvailableForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Offering Program Available for Issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EquityOfferingProgramAvailableForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NumberOfDirectors">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Directors</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NumberOfDirectors</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_PercentageOfRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage Of Restricted Stock Units</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_PercentageOfRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Total Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483014/272-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 272<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482987/272-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-14<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-18<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(2)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareCashPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends paid during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareCashPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockDividendsPerShareDeclared">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate dividends declared during the period for each share of common stock outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockDividendsPerShareDeclared</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average grant-date fair value of options vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hr_ExecutiveIncentiveProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hr_ExecutiveIncentiveProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=hr_DirectorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=hr_DirectorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hr_StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hr_StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_StockIssuanceProgramAxis=hr_PerformanceConditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_StockIssuanceProgramAxis=hr_PerformanceConditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_StockIssuanceProgramAxis=hr_MarketCondition1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_StockIssuanceProgramAxis=hr_MarketCondition1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_StockIssuanceProgramAxis=hr_MarketCondition2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_StockIssuanceProgramAxis=hr_MarketCondition2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hr_NonVestedStockAwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hr_NonVestedStockAwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hr_LongTermIncentiveProgramDUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hr_LongTermIncentiveProgramDUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=hr_NewEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=hr_NewEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097275650832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic', window );">Weighted average common shares outstanding (in shares)</a></td>
<td class="nump">380,857,560<span></span>
</td>
<td class="nump">330,788,997<span></span>
</td>
<td class="nump">380,828,004<span></span>
</td>
<td class="nump">211,740,767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock', window );">Non-vested shares (in shares)</a></td>
<td class="num">(1,932,221)<span></span>
</td>
<td class="num">(1,983,742)<span></span>
</td>
<td class="num">(1,941,897)<span></span>
</td>
<td class="num">(1,933,957)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average common shares outstanding - basic (in shares)</a></td>
<td class="nump">378,925,339<span></span>
</td>
<td class="nump">328,805,255<span></span>
</td>
<td class="nump">378,886,107<span></span>
</td>
<td class="nump">209,806,810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements', window );">Dilutive effect of forward equity shares (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits', window );">Dilutive effect of OP Units (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3,167,668<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,067,493<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan', window );">Dilutive effect of employee stock purchase plan (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">58,461<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">69,687<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average common shares outstanding - diluted (in shares)</a></td>
<td class="nump">378,925,339<span></span>
</td>
<td class="nump">332,031,384<span></span>
</td>
<td class="nump">378,886,107<span></span>
</td>
<td class="nump">210,943,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net (loss) income</a></td>
<td class="num">$ (68,604)<span></span>
</td>
<td class="nump">$ 28,616<span></span>
</td>
<td class="num">$ (240,408)<span></span>
</td>
<td class="nump">$ 76,973<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Income allocated to participating securities</a></td>
<td class="num">(636)<span></span>
</td>
<td class="num">(610)<span></span>
</td>
<td class="num">(1,868)<span></span>
</td>
<td class="num">(1,817)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Loss (income) attributable to non-controlling interest</a></td>
<td class="nump">760<span></span>
</td>
<td class="num">(312)<span></span>
</td>
<td class="nump">2,680<span></span>
</td>
<td class="num">(312)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther', window );">Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units</a></td>
<td class="num">(29)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(122)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic', window );">Net (loss) income applicable to common stockholders - basic</a></td>
<td class="num">$ (68,509)<span></span>
</td>
<td class="nump">$ 27,694<span></span>
</td>
<td class="num">$ (239,718)<span></span>
</td>
<td class="nump">$ 74,844<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic earnings per common share - net income (in dollars per share)</a></td>
<td class="num">$ (0.18)<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="num">$ (0.63)<span></span>
</td>
<td class="nump">$ 0.36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted earnings per common share- net income (in dollars per share)</a></td>
<td class="num">$ (0.18)<span></span>
</td>
<td class="nump">$ 0.08<span></span>
</td>
<td class="num">$ (0.63)<span></span>
</td>
<td class="nump">$ 0.35<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Incremental common shares attributable to dilutive effect of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Incremental Common Shares Attributable to Dilutive Effect of OP Units</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Income (Loss) from Continuing Operations Available to Common Stockholders, Basic</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of dilutive convertible securities excluding adjustments related to ESOP convertible preferred stock, stock options, and restrictive stock units.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shared included in the calculation of diluted EPS as a result of the potentially dilutive effect of equity forward arrangements using the reverse treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 35<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-35<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 33: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4J<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4J<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 4K<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4K<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-2<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 65<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-65<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 66<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-66<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesIssuedBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesIssuedBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesRestrictedStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesRestrictedStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097273205808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of the Activity Under the Incentive Plan and RSU Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Summary of the activity under the incentive plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based awards, beginning of period (in shares)</a></td>
<td class="nump">363,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294,932<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested/Forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,606)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod', window );">Probability adjustment of 2022 &amp; 2023 RSUs (in shares)</a></td>
<td class="num">(47,196)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(126,446)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based awards, ending of period (in shares)</a></td>
<td class="nump">316,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">316,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Share-based awards, beginning of period, Weighted average grant date fair value (in dollar per share)</a></td>
<td class="nump">$ 28.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 33.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, Weighted average grant date fair value (in dollar per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested/Forfeited, Weighted average grant date fair value (in dollar per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.04<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue', window );">Probability adjustment, Weighted average grant date fair value (in dollar per share)</a></td>
<td class="nump">20.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Share-based awards, ending of period, Weighted average grant date fair value (in dollar per share)</a></td>
<td class="nump">$ 27.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=hr_StockIncentivePlanMember', window );">Stock incentive plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Summary of the activity under the incentive plans</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based awards, beginning of period (in shares)</a></td>
<td class="nump">1,932,221<span></span>
</td>
<td class="nump">1,941,709<span></span>
</td>
<td class="nump">1,795,128<span></span>
</td>
<td class="nump">1,562,028<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">71,852<span></span>
</td>
<td class="nump">313,770<span></span>
</td>
<td class="nump">513,876<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested/Forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7,434)<span></span>
</td>
<td class="num">(152,314)<span></span>
</td>
<td class="num">(68,481)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,130)<span></span>
</td>
<td class="num">(24,363)<span></span>
</td>
<td class="num">(5,426)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based awards, ending of period (in shares)</a></td>
<td class="nump">1,932,221<span></span>
</td>
<td class="nump">2,001,997<span></span>
</td>
<td class="nump">1,932,221<span></span>
</td>
<td class="nump">2,001,997<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Probability Adjustment In Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Probability Adjustment in Period, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=hr_StockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=hr_StockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097271562672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jan. 04, 2023</div></th>
<th class="th"><div>Jan. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="nump">4.42%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice', window );">Stock price (in dollar per share)</a></td>
<td class="nump">$ 20.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember', window );">Operating Partnership Performance Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.42%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice', window );">Stock price (in dollar per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.21<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Stock Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=hr_OperatingPartnershipPerformanceUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097272709728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Summary of Activity under Employee Stock Purchase Plan (Details) - Employee stock purchase plan - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Summary of the Employee Stock Purchase Plan activity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding and exercisable, beginning of period (in shares)</a></td>
<td class="nump">179,369<span></span>
</td>
<td class="nump">405,534<span></span>
</td>
<td class="nump">340,976<span></span>
</td>
<td class="nump">348,514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">255,960<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(2,580)<span></span>
</td>
<td class="num">(4,576)<span></span>
</td>
<td class="num">(7,397)<span></span>
</td>
<td class="num">(17,094)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(4,680)<span></span>
</td>
<td class="num">(37,628)<span></span>
</td>
<td class="num">(28,471)<span></span>
</td>
<td class="num">(83,417)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Expired (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(132,999)<span></span>
</td>
<td class="num">(140,633)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding and exercisable, end of period (in shares)</a></td>
<td class="nump">172,109<span></span>
</td>
<td class="nump">363,330<span></span>
</td>
<td class="nump">172,109<span></span>
</td>
<td class="nump">363,330<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097275484080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear', window );">2023</a></td>
<td class="nump">$ 4.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths', window );">2024</a></td>
<td class="nump">13.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo', window );">2025</a></td>
<td class="nump">10.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree', window );">2026</a></td>
<td class="nump">8.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour', window );">2027</a></td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour', window );">2028 and thereafter</a></td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total</a></td>
<td class="nump">$ 39.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, After Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Four</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Three</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Next Twelve Months</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Remainder Of Fiscal Year</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>hr_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140097283153920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value of Financial Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember', window );">CARRYING VALUE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Notes and bonds payable</a></td>
<td class="nump">$ 5,227.4<span></span>
</td>
<td class="nump">$ 5,351.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet', window );">Real estate notes receivable</a></td>
<td class="nump">155.0<span></span>
</td>
<td class="nump">99.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember', window );">FAIR VALUE</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Notes and bonds payable</a></td>
<td class="nump">4,941.2<span></span>
</td>
<td class="nump">5,149.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet', window );">Real estate notes receivable</a></td>
<td class="nump">$ 151.7<span></span>
</td>
<td class="nump">$ 99.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69B<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481568/470-20-55-69C<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1D<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_CarryingReportedAmountFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>hr-20230930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2023"
  xmlns:hr="http://healthcarerealty.com/20230930"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="hr-20230930.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2023-10-27</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeNetIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">hr:CumulativeDividendsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">hr:RealEstatePropertiesHeldInJointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hr:PropertyEntitiesNotDeterminedToBeVIEsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hr:HealthcareTrustofAmericaHoldingsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:NonControllingInterestHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustofAmericaHoldingsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:NonControllingInterestHoldersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustofAmericaHoldingsLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityPrimaryBeneficiaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hr:VariableInterestEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">hr:VariableInterestEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:HoustonTexasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:PowayCAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:ColumbusOHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MezzanineLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:TX</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:NC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:FL</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">hr:MortgageLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:NotesReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2023-01-01</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ParkingIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:ManagementFeeIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:MiscellaneousMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:MiscellaneousMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:MiscellaneousMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">hr:MiscellaneousMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthCareRealtyTrustIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-20</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustOfAmericaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-20</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustOfAmericaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-20</startDate>
            <endDate>2022-07-20</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthCareRealtyTrustIncorporatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-20</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2022-07-20</startDate>
            <endDate>2022-07-20</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2022-07-20</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">hr:LegacyHTAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-20</startDate>
            <endDate>2022-07-20</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustOfAmericaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-20</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">hr:HealthcareTrustOfAmericaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-20</startDate>
            <endDate>2022-07-20</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-20</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-20</startDate>
            <endDate>2022-07-20</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">hr:MedicalOfficeBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:TampaFLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-10</startDate>
            <endDate>2023-03-10</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">hr:MedicalOfficeBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:TampaFLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-10</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">hr:MedicalOfficeBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:ColoradoSpringsCOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-28</startDate>
            <endDate>2023-07-28</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">hr:MedicalOfficeBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:ColoradoSpringsCOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-28</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="hr:RealEstateAcquisitionsAndMortgageNoteFinancingAxis">hr:RealEstateAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="hr:RealEstateAcquisitionsAndMortgageNoteFinancingAxis">hr:RealEstateAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OtherPropertyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">hr:LimitedLiabilityCompanyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:TampaFLMiamiFLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-12</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:TampaFLMiamiFLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-12</startDate>
            <endDate>2023-01-12</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:DallasTXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-01-30</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:DallasTXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-30</startDate>
            <endDate>2023-01-30</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:STLouisMoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-10</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:STLouisMoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-02-10</startDate>
            <endDate>2023-02-10</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-23</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-23</startDate>
            <endDate>2023-03-23</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-30</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-30</startDate>
            <endDate>2023-03-30</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-12</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:LosAngelesCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-12</startDate>
            <endDate>2023-05-12</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AlbanyNYMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AlbanyNYMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-30</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:HoustonTXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-02</instant>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:HoustonTXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-02</startDate>
            <endDate>2023-08-02</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AtlantaGAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-22</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AtlantaGAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-22</startDate>
            <endDate>2023-08-22</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:DallasTXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-15</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:DallasTXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-15</startDate>
            <endDate>2023-09-15</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:HoustonTXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-18</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:HoustonTXMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-18</startDate>
            <endDate>2023-09-18</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:ChicagoILMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-27</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:ChicagoILMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-09-27</startDate>
            <endDate>2023-09-27</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="hr:RealEstateDispositionsAndMortgageNoteRepaymentsAxis">hr:RealEstateDispositionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="hr:RealEstateDispositionsAndMortgageNoteRepaymentsAxis">hr:RealEstateDispositionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:AlbanyNYMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-12</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:UnsecuredCreditFacilityOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:UnsecuredCreditFacilityOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDueMay2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDueMay2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDueJuly2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDueJuly2024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoandue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoandue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:TermLoanDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MediumTermNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesdue2030Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <startDate>2023-04-26</startDate>
            <endDate>2023-04-26</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
        </entity>
        <period>
            <instant>2023-04-26</instant>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CO</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-28</instant>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">hr:MortgageNotesPayableNetMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-07-28</instant>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-01</instant>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-01</startDate>
            <endDate>2023-08-01</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:GA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ExtinguishmentOfDebtAxis">us-gaap:MortgagesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-01</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringJanuary152024Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringMay12026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringJune12026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringDecember12026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringJune12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringDecember12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapEffectiveNovember12023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-19</instant>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringJune12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-19</instant>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringDecember12027Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-19</instant>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:InterestRateSwapExpiringMay312026Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-23</instant>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateContractMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:TreasuryLockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:InterestExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:ActiveInterestRateSwapsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">hr:SettledInterestRateSwapsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">hr:ActiveDevelopmentPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">hr:RedevelopmentPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:OtherCommitmentsAxis">hr:CompletedDevelpomentAndRedevelopmentPropertiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">hr:MedicalOfficeBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">hr:ScottsdaleArizonaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-30</startDate>
            <endDate>2023-10-30</endDate>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hr:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:LongTermIncentiveProgramDUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hr:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hr:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:LongTermIncentiveProgramDUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hr:NewEmployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:NonVestedStockAwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:LongTermIncentiveProgramDUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:StockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:PerformanceConditionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-04</startDate>
            <endDate>2023-01-04</endDate>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">hr:DirectorsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">hr:ExecutiveIncentiveProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:MarketCondition2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">hr:OperatingPartnershipPerformanceUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="hr:StockIssuanceProgramAxis">hr:PerformanceConditionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-01-31</endDate>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-07-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-09-30</endDate>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-30</instant>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:CarryingReportedAmountFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001360604</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="property">
        <measure>hr:property</measure>
    </unit>
    <unit id="state">
        <measure>hr:state</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="variable_interest_entity">
        <measure>hr:variable_interest_entity</measure>
    </unit>
    <unit id="note_receivable">
        <measure>hr:note_receivable</measure>
    </unit>
    <unit id="joint_venture">
        <measure>hr:joint_venture</measure>
    </unit>
    <unit id="financing_receivable">
        <measure>hr:financing_receivable</measure>
    </unit>
    <unit id="disposition_transaction">
        <measure>hr:disposition_transaction</measure>
    </unit>
    <unit id="acre">
        <measure>utr:acre</measure>
    </unit>
    <unit id="entity">
        <measure>hr:entity</measure>
    </unit>
    <unit id="lease">
        <measure>hr:lease</measure>
    </unit>
    <unit id="derivative">
        <measure>hr:derivative</measure>
    </unit>
    <unit id="transaction">
        <measure>hr:transaction</measure>
    </unit>
    <unit id="director">
        <measure>hr:director</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-26">0001360604</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-27">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-28">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-29">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-30">false</dei:AmendmentFlag>
    <us-gaap:TypeOfRevenueExtensibleList contextRef="c-5" id="f-129">http://fasb.org/us-gaap/2023#ServiceMember</us-gaap:TypeOfRevenueExtensibleList>
    <us-gaap:TypeOfRevenueExtensibleList contextRef="c-1" id="f-130">http://fasb.org/us-gaap/2023#ServiceMember</us-gaap:TypeOfRevenueExtensibleList>
    <us-gaap:TypeOfRevenueExtensibleList contextRef="c-6" id="f-131">http://fasb.org/us-gaap/2023#ServiceMember</us-gaap:TypeOfRevenueExtensibleList>
    <us-gaap:TypeOfRevenueExtensibleList contextRef="c-7" id="f-132">http://fasb.org/us-gaap/2023#ServiceMember</us-gaap:TypeOfRevenueExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-269" id="f-1276">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2023-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-35568</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">HEALTHCARE REALTY TRUST INCORPORATED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">MD</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">20-4738467</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">3310 West End Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-10">Suite 700</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">Nashville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">TN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">37203</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">615</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">269-8175</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Class A Common Stock, $0.01 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">HR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-18">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-19">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-20">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-21">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-22">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-23">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-24">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="INF" id="f-25" unitRef="shares">380874078</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Land contextRef="c-3" decimals="-3" id="f-31" unitRef="usd">1387821000</us-gaap:Land>
    <us-gaap:Land contextRef="c-4" decimals="-3" id="f-32" unitRef="usd">1439798000</us-gaap:Land>
    <us-gaap:InvestmentBuildingAndBuildingImprovements contextRef="c-3" decimals="-3" id="f-33" unitRef="usd">11004195000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:InvestmentBuildingAndBuildingImprovements contextRef="c-4" decimals="-3" id="f-34" unitRef="usd">11332037000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:OtherFiniteLivedIntangibleAssetsGross contextRef="c-3" decimals="-3" id="f-35" unitRef="usd">890273000</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
    <us-gaap:OtherFiniteLivedIntangibleAssetsGross contextRef="c-4" decimals="-3" id="f-36" unitRef="usd">959998000</us-gaap:OtherFiniteLivedIntangibleAssetsGross>
    <hr:PersonalProperty contextRef="c-3" decimals="-3" id="f-37" unitRef="usd">12686000</hr:PersonalProperty>
    <hr:PersonalProperty contextRef="c-4" decimals="-3" id="f-38" unitRef="usd">11907000</hr:PersonalProperty>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-3" decimals="-3" id="f-39" unitRef="usd">120975000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss contextRef="c-4" decimals="-3" id="f-40" unitRef="usd">120236000</us-gaap:FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization contextRef="c-3" decimals="-3" id="f-41" unitRef="usd">82613000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization contextRef="c-4" decimals="-3" id="f-42" unitRef="usd">83824000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:DevelopmentInProcess contextRef="c-3" decimals="-3" id="f-43" unitRef="usd">85644000</us-gaap:DevelopmentInProcess>
    <us-gaap:DevelopmentInProcess contextRef="c-4" decimals="-3" id="f-44" unitRef="usd">35560000</us-gaap:DevelopmentInProcess>
    <us-gaap:LandAvailableForDevelopment contextRef="c-3" decimals="-3" id="f-45" unitRef="usd">59871000</us-gaap:LandAvailableForDevelopment>
    <us-gaap:LandAvailableForDevelopment contextRef="c-4" decimals="-3" id="f-46" unitRef="usd">74265000</us-gaap:LandAvailableForDevelopment>
    <us-gaap:RealEstateInvestmentPropertyAtCost contextRef="c-3" decimals="-3" id="f-47" unitRef="usd">13644078000</us-gaap:RealEstateInvestmentPropertyAtCost>
    <us-gaap:RealEstateInvestmentPropertyAtCost contextRef="c-4" decimals="-3" id="f-48" unitRef="usd">14057625000</us-gaap:RealEstateInvestmentPropertyAtCost>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation contextRef="c-3" decimals="-3" id="f-49" unitRef="usd">2093952000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation contextRef="c-4" decimals="-3" id="f-50" unitRef="usd">1645271000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyNet contextRef="c-3" decimals="-3" id="f-51" unitRef="usd">11550126000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:RealEstateInvestmentPropertyNet contextRef="c-4" decimals="-3" id="f-52" unitRef="usd">12412354000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-53" unitRef="usd">24668000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-54" unitRef="usd">60961000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <hr:AssetsHeldForSaleAndDiscontinuedOperationsNet contextRef="c-3" decimals="-3" id="f-55" unitRef="usd">57638000</hr:AssetsHeldForSaleAndDiscontinuedOperationsNet>
    <hr:AssetsHeldForSaleAndDiscontinuedOperationsNet contextRef="c-4" decimals="-3" id="f-56" unitRef="usd">18893000</hr:AssetsHeldForSaleAndDiscontinuedOperationsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-3" id="f-57" unitRef="usd">323759000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-58" unitRef="usd">336983000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-3" decimals="-3" id="f-59" unitRef="usd">325453000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-4" decimals="-3" id="f-60" unitRef="usd">327248000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:Goodwill contextRef="c-3" decimals="-3" id="f-61" unitRef="usd">250530000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-4" decimals="-3" id="f-62" unitRef="usd">223202000</us-gaap:Goodwill>
    <us-gaap:OtherAssets contextRef="c-3" decimals="-3" id="f-63" unitRef="usd">571554000</us-gaap:OtherAssets>
    <us-gaap:OtherAssets contextRef="c-4" decimals="-3" id="f-64" unitRef="usd">469990000</us-gaap:OtherAssets>
    <us-gaap:Assets contextRef="c-3" decimals="-3" id="f-65" unitRef="usd">13103728000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-66" unitRef="usd">13849631000</us-gaap:Assets>
    <us-gaap:LongTermDebt contextRef="c-3" decimals="-3" id="f-67" unitRef="usd">5227413000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-4" decimals="-3" id="f-68" unitRef="usd">5351827000</us-gaap:LongTermDebt>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="c-3" decimals="-3" id="f-69" unitRef="usd">204947000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent contextRef="c-4" decimals="-3" id="f-70" unitRef="usd">244033000</us-gaap:AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-3" decimals="-3" id="f-71" unitRef="usd">3814000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-4" decimals="-3" id="f-72" unitRef="usd">437000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:OperatingLeaseLiability contextRef="c-3" decimals="-3" id="f-73" unitRef="usd">273319000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="c-4" decimals="-3" id="f-74" unitRef="usd">279895000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability contextRef="c-3" decimals="-3" id="f-75" unitRef="usd">74087000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability contextRef="c-4" decimals="-3" id="f-76" unitRef="usd">72939000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OtherLiabilities contextRef="c-3" decimals="-3" id="f-77" unitRef="usd">211365000</us-gaap:OtherLiabilities>
    <us-gaap:OtherLiabilities contextRef="c-4" decimals="-3" id="f-78" unitRef="usd">218668000</us-gaap:OtherLiabilities>
    <us-gaap:Liabilities contextRef="c-3" decimals="-3" id="f-79" unitRef="usd">5994945000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-80" unitRef="usd">6167799000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-81" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-82" unitRef="usd" xsi:nil="true"/>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-3" decimals="-3" id="f-83" unitRef="usd">3195000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-4" decimals="-3" id="f-84" unitRef="usd">2014000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-85"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-86"
      unitRef="usdPerShare">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-87" unitRef="shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-88" unitRef="shares">200000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-89" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-4" decimals="INF" id="f-90" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c-3" decimals="INF" id="f-91" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-4" decimals="INF" id="f-92" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValue contextRef="c-3" decimals="-3" id="f-93" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue contextRef="c-4" decimals="-3" id="f-94" unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-95"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="INF"
      id="f-96"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="INF" id="f-97" unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="INF" id="f-98" unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="-3" id="f-99" unitRef="shares">380860000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="-3" id="f-100" unitRef="shares">380860000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="-3" id="f-101" unitRef="shares">380590000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="-3" id="f-102" unitRef="shares">380590000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-3" id="f-103" unitRef="usd">3809000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-104" unitRef="usd">3806000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-3" decimals="-3" id="f-105" unitRef="usd">9597629000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-4" decimals="-3" id="f-106" unitRef="usd">9587637000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="c-3" decimals="-3" id="f-107" unitRef="usd">-17079000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax contextRef="c-4" decimals="-3" id="f-108" unitRef="usd">-2140000</us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax>
    <hr:CumulativeNetIncomeAttributableToCommonStockholders contextRef="c-3" decimals="-3" id="f-109" unitRef="usd">1069327000</hr:CumulativeNetIncomeAttributableToCommonStockholders>
    <hr:CumulativeNetIncomeAttributableToCommonStockholders contextRef="c-4" decimals="-3" id="f-110" unitRef="usd">1307055000</hr:CumulativeNetIncomeAttributableToCommonStockholders>
    <us-gaap:CumulativeDividends contextRef="c-3" decimals="-3" id="f-111" unitRef="usd">3684144000</us-gaap:CumulativeDividends>
    <us-gaap:CumulativeDividends contextRef="c-4" decimals="-3" id="f-112" unitRef="usd">3329562000</us-gaap:CumulativeDividends>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-113" unitRef="usd">7003700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-114" unitRef="usd">7571076000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest contextRef="c-3" decimals="-3" id="f-115" unitRef="usd">101888000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest contextRef="c-4" decimals="-3" id="f-116" unitRef="usd">108742000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-3" decimals="-3" id="f-117" unitRef="usd">7105588000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-118" unitRef="usd">7679818000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-3" id="f-119" unitRef="usd">13103728000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-120" unitRef="usd">13849631000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-5" decimals="-3" id="f-121" unitRef="usd">333335000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-6" decimals="-3" id="f-122" unitRef="usd">298931000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-1" decimals="-3" id="f-123" unitRef="usd">987109000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-7" decimals="-3" id="f-124" unitRef="usd">578052000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss contextRef="c-5" decimals="-3" id="f-125" unitRef="usd">4264000</us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss>
    <us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss contextRef="c-6" decimals="-3" id="f-126" unitRef="usd">3366000</us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss>
    <us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss contextRef="c-1" decimals="-3" id="f-127" unitRef="usd">12711000</us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss>
    <us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss contextRef="c-7" decimals="-3" id="f-128" unitRef="usd">7253000</us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-133" unitRef="usd">4661000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-134" unitRef="usd">4057000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-135" unitRef="usd">13508000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-3" id="f-136" unitRef="usd">9270000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues contextRef="c-5" decimals="-3" id="f-137" unitRef="usd">342260000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-6" decimals="-3" id="f-138" unitRef="usd">306354000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-1" decimals="-3" id="f-139" unitRef="usd">1013328000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-7" decimals="-3" id="f-140" unitRef="usd">594575000</us-gaap:Revenues>
    <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="c-5" decimals="-3" id="f-141" unitRef="usd">131639000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
    <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="c-6" decimals="-3" id="f-142" unitRef="usd">112473000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
    <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="c-1" decimals="-3" id="f-143" unitRef="usd">379074000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
    <us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment contextRef="c-7" decimals="-3" id="f-144" unitRef="usd">226947000</us-gaap:DirectCostsOfLeasedAndRentedPropertyOrEquipment>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-5" decimals="-3" id="f-145" unitRef="usd">13396000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-6" decimals="-3" id="f-146" unitRef="usd">16741000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-147" unitRef="usd">43796000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-7" decimals="-3" id="f-148" unitRef="usd">38317000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AcquisitionCosts contextRef="c-5" decimals="-3" id="f-149" unitRef="usd">769000</us-gaap:AcquisitionCosts>
    <us-gaap:AcquisitionCosts contextRef="c-6" decimals="-3" id="f-150" unitRef="usd">482000</us-gaap:AcquisitionCosts>
    <us-gaap:AcquisitionCosts contextRef="c-1" decimals="-3" id="f-151" unitRef="usd">1725000</us-gaap:AcquisitionCosts>
    <us-gaap:AcquisitionCosts contextRef="c-7" decimals="-3" id="f-152" unitRef="usd">3137000</us-gaap:AcquisitionCosts>
    <hr:MergerRelatedCosts contextRef="c-5" decimals="-3" id="f-153" unitRef="usd">7450000</hr:MergerRelatedCosts>
    <hr:MergerRelatedCosts contextRef="c-6" decimals="-3" id="f-154" unitRef="usd">79402000</hr:MergerRelatedCosts>
    <hr:MergerRelatedCosts contextRef="c-1" decimals="-3" id="f-155" unitRef="usd">-3366000</hr:MergerRelatedCosts>
    <hr:MergerRelatedCosts contextRef="c-7" decimals="-3" id="f-156" unitRef="usd">92603000</hr:MergerRelatedCosts>
    <us-gaap:DepreciationAndAmortization contextRef="c-5" decimals="-3" id="f-157" unitRef="usd">182989000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-6" decimals="-3" id="f-158" unitRef="usd">158117000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="-3" id="f-159" unitRef="usd">550661000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-7" decimals="-3" id="f-160" unitRef="usd">267889000</us-gaap:DepreciationAndAmortization>
    <hr:OperatingExpensesandCostofGoodsSold contextRef="c-5" decimals="-3" id="f-161" unitRef="usd">336243000</hr:OperatingExpensesandCostofGoodsSold>
    <hr:OperatingExpensesandCostofGoodsSold contextRef="c-6" decimals="-3" id="f-162" unitRef="usd">367215000</hr:OperatingExpensesandCostofGoodsSold>
    <hr:OperatingExpensesandCostofGoodsSold contextRef="c-1" decimals="-3" id="f-163" unitRef="usd">971890000</hr:OperatingExpensesandCostofGoodsSold>
    <hr:OperatingExpensesandCostofGoodsSold contextRef="c-7" decimals="-3" id="f-164" unitRef="usd">628893000</hr:OperatingExpensesandCostofGoodsSold>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate contextRef="c-5" decimals="-3" id="f-165" unitRef="usd">48811000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate contextRef="c-6" decimals="-3" id="f-166" unitRef="usd">143908000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate contextRef="c-1" decimals="-3" id="f-167" unitRef="usd">56974000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:GainsLossesOnSalesOfInvestmentRealEstate contextRef="c-7" decimals="-3" id="f-168" unitRef="usd">197188000</us-gaap:GainsLossesOnSalesOfInvestmentRealEstate>
    <us-gaap:InterestExpense contextRef="c-5" decimals="-3" id="f-169" unitRef="usd">66304000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-6" decimals="-3" id="f-170" unitRef="usd">53044000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-1" decimals="-3" id="f-171" unitRef="usd">195397000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense contextRef="c-7" decimals="-3" id="f-172" unitRef="usd">82248000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-5" decimals="-3" id="f-173" unitRef="usd">62000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-6" decimals="-3" id="f-174" unitRef="usd">-1091000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-1" decimals="-3" id="f-175" unitRef="usd">62000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-7" decimals="-3" id="f-176" unitRef="usd">-2520000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <hr:ImpairmentOfRealEstateAndCreditLossReserves contextRef="c-5" decimals="-3" id="f-177" unitRef="usd">56873000</hr:ImpairmentOfRealEstateAndCreditLossReserves>
    <hr:ImpairmentOfRealEstateAndCreditLossReserves contextRef="c-6" decimals="-3" id="f-178" unitRef="usd">0</hr:ImpairmentOfRealEstateAndCreditLossReserves>
    <hr:ImpairmentOfRealEstateAndCreditLossReserves contextRef="c-1" decimals="-3" id="f-179" unitRef="usd">143510000</hr:ImpairmentOfRealEstateAndCreditLossReserves>
    <hr:ImpairmentOfRealEstateAndCreditLossReserves contextRef="c-7" decimals="-3" id="f-180" unitRef="usd">-25000</hr:ImpairmentOfRealEstateAndCreditLossReserves>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-5" decimals="-3" id="f-181" unitRef="usd">-456000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-6" decimals="-3" id="f-182" unitRef="usd">-124000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-183" unitRef="usd">-1253000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-7" decimals="-3" id="f-184" unitRef="usd">-776000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-5" decimals="-3" id="f-185" unitRef="usd">139000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-6" decimals="-3" id="f-186" unitRef="usd">-172000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-187" unitRef="usd">1278000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-7" decimals="-3" id="f-188" unitRef="usd">-378000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-5" decimals="-3" id="f-189" unitRef="usd">-74621000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-6" decimals="-3" id="f-190" unitRef="usd">89477000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-191" unitRef="usd">-281846000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense contextRef="c-7" decimals="-3" id="f-192" unitRef="usd">111291000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-3" id="f-193" unitRef="usd">-68604000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-6" decimals="-3" id="f-194" unitRef="usd">28616000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-195" unitRef="usd">-240408000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-3" id="f-196" unitRef="usd">76973000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-197" unitRef="usd">-760000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-198" unitRef="usd">312000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-199" unitRef="usd">-2680000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-7" decimals="-3" id="f-200" unitRef="usd">312000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-201" unitRef="usd">-67844000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-202" unitRef="usd">28304000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-203" unitRef="usd">-237728000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-204" unitRef="usd">76661000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-205"
      unitRef="usdPerShare">-0.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-206"
      unitRef="usdPerShare">0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-207"
      unitRef="usdPerShare">-0.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-208"
      unitRef="usdPerShare">0.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-209"
      unitRef="usdPerShare">-0.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-210"
      unitRef="usdPerShare">0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-211"
      unitRef="usdPerShare">-0.63</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-212"
      unitRef="usdPerShare">0.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="-3" id="f-213" unitRef="shares">378925000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="-3" id="f-214" unitRef="shares">328805000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-3" id="f-215" unitRef="shares">378886000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-3" id="f-216" unitRef="shares">209807000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="-3" id="f-217" unitRef="shares">378925000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="-3" id="f-218" unitRef="shares">332031000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-3" id="f-219" unitRef="shares">378886000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-3" id="f-220" unitRef="shares">210944000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-3" id="f-221" unitRef="usd">-68604000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-6" decimals="-3" id="f-222" unitRef="usd">28616000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-223" unitRef="usd">-240408000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-3" id="f-224" unitRef="usd">76973000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-5" decimals="-3" id="f-225" unitRef="usd">4168000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-6" decimals="-3" id="f-226" unitRef="usd">-763000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-1" decimals="-3" id="f-227" unitRef="usd">9874000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-7" decimals="-3" id="f-228" unitRef="usd">-2672000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-8" decimals="-3" id="f-229" unitRef="usd">12016000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-9" decimals="-3" id="f-230" unitRef="usd">6083000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-10" decimals="-3" id="f-231" unitRef="usd">24999000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-11" decimals="-3" id="f-232" unitRef="usd">12905000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-3" id="f-233" unitRef="usd">7848000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-6" decimals="-3" id="f-234" unitRef="usd">6846000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-1" decimals="-3" id="f-235" unitRef="usd">15125000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-7" decimals="-3" id="f-236" unitRef="usd">15577000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-237" unitRef="usd">-60756000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-238" unitRef="usd">35462000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-239" unitRef="usd">-225283000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest contextRef="c-7" decimals="-3" id="f-240" unitRef="usd">92550000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-241" unitRef="usd">-663000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-242" unitRef="usd">384000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-243" unitRef="usd">-2494000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest contextRef="c-7" decimals="-3" id="f-244" unitRef="usd">384000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-3" id="f-245" unitRef="usd">-60093000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-3" id="f-246" unitRef="usd">35078000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-247" unitRef="usd">-222789000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-7" decimals="-3" id="f-248" unitRef="usd">92166000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-12" decimals="-3" id="f-249" unitRef="usd">3808000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-13" decimals="-3" id="f-250" unitRef="usd">9595033000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-14" decimals="-3" id="f-251" unitRef="usd">9328000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-15" decimals="-3" id="f-252" unitRef="usd">1137171000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-16" decimals="-3" id="f-253" unitRef="usd">-3565941000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-17" decimals="-3" id="f-254" unitRef="usd">7179399000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-18" decimals="-3" id="f-255" unitRef="usd">104018000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-19" decimals="-3" id="f-256" unitRef="usd">7283417000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-19" decimals="-3" id="f-257" unitRef="usd">2487000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-20" decimals="-3" id="f-258" unitRef="usd">33000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-21" decimals="-3" id="f-259" unitRef="usd">33000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-5" decimals="-3" id="f-260" unitRef="usd">33000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-20" decimals="-3" id="f-261" unitRef="usd">-8000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-21" decimals="-3" id="f-262" unitRef="usd">-8000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-5" decimals="-3" id="f-263" unitRef="usd">-8000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-22" decimals="-3" id="f-264" unitRef="usd">1000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-20" decimals="-3" id="f-265" unitRef="usd">2555000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-21" decimals="-3" id="f-266" unitRef="usd">2556000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-3" id="f-267" unitRef="usd">2556000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss contextRef="c-23" decimals="-3" id="f-268" unitRef="usd">-67844000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-21" decimals="-3" id="f-269" unitRef="usd">-67844000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-24" decimals="-3" id="f-270" unitRef="usd">-760000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-3" id="f-271" unitRef="usd">-68604000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-25" decimals="-3" id="f-272" unitRef="usd">4118000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-21" decimals="-3" id="f-273" unitRef="usd">4118000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-24" decimals="-3" id="f-274" unitRef="usd">50000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-5" decimals="-3" id="f-275" unitRef="usd">4168000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-25" decimals="-3" id="f-276" unitRef="usd">11869000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-21" decimals="-3" id="f-277" unitRef="usd">11869000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-24" decimals="-3" id="f-278" unitRef="usd">147000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-5" decimals="-3" id="f-279" unitRef="usd">12016000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease contextRef="c-5" decimals="-3" id="f-280" unitRef="usd">710000</us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-5"
      decimals="INF"
      id="f-281"
      unitRef="usdPerShare">0.31</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash contextRef="c-26" decimals="-3" id="f-282" unitRef="usd">118203000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-21" decimals="-3" id="f-283" unitRef="usd">118203000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-24" decimals="-3" id="f-284" unitRef="usd">1467000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-5" decimals="-3" id="f-285" unitRef="usd">119670000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue contextRef="c-5" decimals="-3" id="f-286" unitRef="usd">2000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-27" decimals="-3" id="f-287" unitRef="usd">3809000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-28" decimals="-3" id="f-288" unitRef="usd">9597629000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-29" decimals="-3" id="f-289" unitRef="usd">17079000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-30" decimals="-3" id="f-290" unitRef="usd">1069327000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-31" decimals="-3" id="f-291" unitRef="usd">-3684144000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-32" decimals="-3" id="f-292" unitRef="usd">7003700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-33" decimals="-3" id="f-293" unitRef="usd">101888000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-3" decimals="-3" id="f-294" unitRef="usd">7105588000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-3" decimals="-3" id="f-295" unitRef="usd">3195000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-34" decimals="-3" id="f-296" unitRef="usd">1516000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-35" decimals="-3" id="f-297" unitRef="usd">4002525000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-36" decimals="-3" id="f-298" unitRef="usd">-1250000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-37" decimals="-3" id="f-299" unitRef="usd">1314515000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-38" decimals="-3" id="f-300" unitRef="usd">-3139440000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-39" decimals="-3" id="f-301" unitRef="usd">2177866000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-40" decimals="-3" id="f-302" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-41" decimals="-3" id="f-303" unitRef="usd">2177866000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-41" decimals="-3" id="f-304" unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-42" decimals="-3" id="f-305" unitRef="usd">84000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-43" decimals="-3" id="f-306" unitRef="usd">84000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-6" decimals="-3" id="f-307" unitRef="usd">84000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <hr:MergerConsiderationTransferred contextRef="c-44" decimals="-3" id="f-308" unitRef="usd">2289000</hr:MergerConsiderationTransferred>
    <hr:MergerConsiderationTransferred contextRef="c-42" decimals="-3" id="f-309" unitRef="usd">5574174000</hr:MergerConsiderationTransferred>
    <hr:MergerConsiderationTransferred contextRef="c-43" decimals="-3" id="f-310" unitRef="usd">5576463000</hr:MergerConsiderationTransferred>
    <hr:MergerConsiderationTransferred contextRef="c-45" decimals="-3" id="f-311" unitRef="usd">110702000</hr:MergerConsiderationTransferred>
    <hr:MergerConsiderationTransferred contextRef="c-6" decimals="-3" id="f-312" unitRef="usd">5687165000</hr:MergerConsiderationTransferred>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-45" decimals="-3" id="f-313" unitRef="usd">1266000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-6" decimals="-3" id="f-314" unitRef="usd">1266000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-42" decimals="-3" id="f-315" unitRef="usd">41000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-43" decimals="-3" id="f-316" unitRef="usd">41000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-6" decimals="-3" id="f-317" unitRef="usd">41000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-44" decimals="-3" id="f-318" unitRef="usd">1000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-42" decimals="-3" id="f-319" unitRef="usd">9716000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-43" decimals="-3" id="f-320" unitRef="usd">9717000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-6" decimals="-3" id="f-321" unitRef="usd">9717000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-42" decimals="-3" id="f-322" unitRef="usd">-98000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-43" decimals="-3" id="f-323" unitRef="usd">-98000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-45" decimals="-3" id="f-324" unitRef="usd">97000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-6" decimals="-3" id="f-325" unitRef="usd">-1000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:ProfitLoss contextRef="c-46" decimals="-3" id="f-326" unitRef="usd">28304000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-43" decimals="-3" id="f-327" unitRef="usd">28304000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-45" decimals="-3" id="f-328" unitRef="usd">312000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-6" decimals="-3" id="f-329" unitRef="usd">28616000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-47" decimals="-3" id="f-330" unitRef="usd">-755000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-43" decimals="-3" id="f-331" unitRef="usd">-755000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-45" decimals="-3" id="f-332" unitRef="usd">-8000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-6" decimals="-3" id="f-333" unitRef="usd">-763000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-47" decimals="-3" id="f-334" unitRef="usd">6019000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-43" decimals="-3" id="f-335" unitRef="usd">6019000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-45" decimals="-3" id="f-336" unitRef="usd">64000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-6" decimals="-3" id="f-337" unitRef="usd">6083000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-6"
      decimals="INF"
      id="f-338"
      unitRef="usdPerShare">0.31</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash contextRef="c-48" decimals="-3" id="f-339" unitRef="usd">72052000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-43" decimals="-3" id="f-340" unitRef="usd">72052000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-45" decimals="-3" id="f-341" unitRef="usd">442000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-6" decimals="-3" id="f-342" unitRef="usd">72494000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-49" decimals="-3" id="f-343" unitRef="usd">3806000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-50" decimals="-3" id="f-344" unitRef="usd">9586556000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-51" decimals="-3" id="f-345" unitRef="usd">5524000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-52" decimals="-3" id="f-346" unitRef="usd">1342819000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-53" decimals="-3" id="f-347" unitRef="usd">-3211492000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-54" decimals="-3" id="f-348" unitRef="usd">7727213000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-55" decimals="-3" id="f-349" unitRef="usd">111813000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-56" decimals="-3" id="f-350" unitRef="usd">7839026000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-56" decimals="-3" id="f-351" unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-57" decimals="-3" id="f-352" unitRef="usd">3806000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-58" decimals="-3" id="f-353" unitRef="usd">9587637000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-59" decimals="-3" id="f-354" unitRef="usd">2140000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-60" decimals="-3" id="f-355" unitRef="usd">1307055000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-61" decimals="-3" id="f-356" unitRef="usd">-3329562000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-62" decimals="-3" id="f-357" unitRef="usd">7571076000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-63" decimals="-3" id="f-358" unitRef="usd">108742000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-4" decimals="-3" id="f-359" unitRef="usd">7679818000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-4" decimals="-3" id="f-360" unitRef="usd">2014000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-64" decimals="-3" id="f-361" unitRef="usd">112000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-65" decimals="-3" id="f-362" unitRef="usd">112000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-1" decimals="-3" id="f-363" unitRef="usd">112000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-64" decimals="-3" id="f-364" unitRef="usd">1587000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-65" decimals="-3" id="f-365" unitRef="usd">1587000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-1" decimals="-3" id="f-366" unitRef="usd">1587000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-66" decimals="-3" id="f-367" unitRef="usd">3000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-64" decimals="-3" id="f-368" unitRef="usd">11467000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-65" decimals="-3" id="f-369" unitRef="usd">11470000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-370" unitRef="usd">11470000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:ProfitLoss contextRef="c-67" decimals="-3" id="f-371" unitRef="usd">-237728000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-65" decimals="-3" id="f-372" unitRef="usd">-237728000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-68" decimals="-3" id="f-373" unitRef="usd">-2680000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-374" unitRef="usd">-240408000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-69" decimals="-3" id="f-375" unitRef="usd">9757000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-65" decimals="-3" id="f-376" unitRef="usd">9757000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-68" decimals="-3" id="f-377" unitRef="usd">117000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-1" decimals="-3" id="f-378" unitRef="usd">9874000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-69" decimals="-3" id="f-379" unitRef="usd">24696000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-65" decimals="-3" id="f-380" unitRef="usd">24696000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-68" decimals="-3" id="f-381" unitRef="usd">303000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-1" decimals="-3" id="f-382" unitRef="usd">24999000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease contextRef="c-1" decimals="-3" id="f-383" unitRef="usd">1210000</us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-1"
      decimals="INF"
      id="f-384"
      unitRef="usdPerShare">0.93</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash contextRef="c-70" decimals="-3" id="f-385" unitRef="usd">354582000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-65" decimals="-3" id="f-386" unitRef="usd">354582000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-68" decimals="-3" id="f-387" unitRef="usd">4360000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-1" decimals="-3" id="f-388" unitRef="usd">358942000</us-gaap:DividendsCommonStockCash>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue contextRef="c-1" decimals="-3" id="f-389" unitRef="usd">29000</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-27" decimals="-3" id="f-390" unitRef="usd">3809000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-28" decimals="-3" id="f-391" unitRef="usd">9597629000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-29" decimals="-3" id="f-392" unitRef="usd">17079000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-30" decimals="-3" id="f-393" unitRef="usd">1069327000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-31" decimals="-3" id="f-394" unitRef="usd">-3684144000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-32" decimals="-3" id="f-395" unitRef="usd">7003700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-33" decimals="-3" id="f-396" unitRef="usd">101888000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-3" decimals="-3" id="f-397" unitRef="usd">7105588000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-3" decimals="-3" id="f-398" unitRef="usd">3195000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-71" decimals="-3" id="f-399" unitRef="usd">1505000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-72" decimals="-3" id="f-400" unitRef="usd">3972917000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-73" decimals="-3" id="f-401" unitRef="usd">-9981000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-74" decimals="-3" id="f-402" unitRef="usd">1266158000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-75" decimals="-3" id="f-403" unitRef="usd">-3045483000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-76" decimals="-3" id="f-404" unitRef="usd">2185116000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-77" decimals="-3" id="f-405" unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-78" decimals="-3" id="f-406" unitRef="usd">2185116000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-78" decimals="-3" id="f-407" unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-79" decimals="-3" id="f-408" unitRef="usd">8000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-80" decimals="-3" id="f-409" unitRef="usd">22847000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-81" decimals="-3" id="f-410" unitRef="usd">22855000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-7" decimals="-3" id="f-411" unitRef="usd">22855000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <hr:MergerConsiderationTransferred contextRef="c-79" decimals="-3" id="f-412" unitRef="usd">2289000</hr:MergerConsiderationTransferred>
    <hr:MergerConsiderationTransferred contextRef="c-80" decimals="-3" id="f-413" unitRef="usd">5574174000</hr:MergerConsiderationTransferred>
    <hr:MergerConsiderationTransferred contextRef="c-81" decimals="-3" id="f-414" unitRef="usd">5576463000</hr:MergerConsiderationTransferred>
    <hr:MergerConsiderationTransferred contextRef="c-82" decimals="-3" id="f-415" unitRef="usd">110702000</hr:MergerConsiderationTransferred>
    <hr:MergerConsiderationTransferred contextRef="c-7" decimals="-3" id="f-416" unitRef="usd">5687165000</hr:MergerConsiderationTransferred>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-82" decimals="-3" id="f-417" unitRef="usd">1266000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest contextRef="c-7" decimals="-3" id="f-418" unitRef="usd">1266000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-80" decimals="-3" id="f-419" unitRef="usd">248000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-81" decimals="-3" id="f-420" unitRef="usd">248000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c-7" decimals="-3" id="f-421" unitRef="usd">248000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-79" decimals="-3" id="f-422" unitRef="usd">4000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-80" decimals="-3" id="f-423" unitRef="usd">16768000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-81" decimals="-3" id="f-424" unitRef="usd">16772000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-7" decimals="-3" id="f-425" unitRef="usd">16772000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-80" decimals="-3" id="f-426" unitRef="usd">-98000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-81" decimals="-3" id="f-427" unitRef="usd">-98000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-82" decimals="-3" id="f-428" unitRef="usd">97000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions contextRef="c-7" decimals="-3" id="f-429" unitRef="usd">-1000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:ProfitLoss contextRef="c-83" decimals="-3" id="f-430" unitRef="usd">76661000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-81" decimals="-3" id="f-431" unitRef="usd">76661000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-82" decimals="-3" id="f-432" unitRef="usd">312000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-3" id="f-433" unitRef="usd">76973000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-84" decimals="-3" id="f-434" unitRef="usd">-2664000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-81" decimals="-3" id="f-435" unitRef="usd">-2664000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-82" decimals="-3" id="f-436" unitRef="usd">-8000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-7" decimals="-3" id="f-437" unitRef="usd">-2672000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-84" decimals="-3" id="f-438" unitRef="usd">12841000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-81" decimals="-3" id="f-439" unitRef="usd">12841000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-82" decimals="-3" id="f-440" unitRef="usd">64000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax contextRef="c-7" decimals="-3" id="f-441" unitRef="usd">12905000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-7"
      decimals="INF"
      id="f-442"
      unitRef="usdPerShare">0.93</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:DividendsCommonStockCash contextRef="c-85" decimals="-3" id="f-443" unitRef="usd">166009000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-81" decimals="-3" id="f-444" unitRef="usd">166009000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-82" decimals="-3" id="f-445" unitRef="usd">442000</us-gaap:DividendsCommonStockCash>
    <us-gaap:DividendsCommonStockCash contextRef="c-7" decimals="-3" id="f-446" unitRef="usd">166451000</us-gaap:DividendsCommonStockCash>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-49" decimals="-3" id="f-447" unitRef="usd">3806000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-50" decimals="-3" id="f-448" unitRef="usd">9586556000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-51" decimals="-3" id="f-449" unitRef="usd">5524000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-52" decimals="-3" id="f-450" unitRef="usd">1342819000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-53" decimals="-3" id="f-451" unitRef="usd">-3211492000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-54" decimals="-3" id="f-452" unitRef="usd">7727213000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-55" decimals="-3" id="f-453" unitRef="usd">111813000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-56" decimals="-3" id="f-454" unitRef="usd">7839026000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-56" decimals="-3" id="f-455" unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-456" unitRef="usd">-240408000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-3" id="f-457" unitRef="usd">76973000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-458" unitRef="usd">550661000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-7" decimals="-3" id="f-459" unitRef="usd">267889000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OtherAmortizationOfDeferredCharges contextRef="c-1" decimals="-3" id="f-460" unitRef="usd">33822000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OtherAmortizationOfDeferredCharges contextRef="c-7" decimals="-3" id="f-461" unitRef="usd">11875000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-462" unitRef="usd">11470000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-7" decimals="-3" id="f-463" unitRef="usd">16772000</us-gaap:ShareBasedCompensation>
    <hr:StraightLineRentReceivable contextRef="c-1" decimals="-3" id="f-464" unitRef="usd">29320000</hr:StraightLineRentReceivable>
    <hr:StraightLineRentReceivable contextRef="c-7" decimals="-3" id="f-465" unitRef="usd">12267000</hr:StraightLineRentReceivable>
    <hr:StraightlineRentLiability contextRef="c-1" decimals="-3" id="f-466" unitRef="usd">4600000</hr:StraightlineRentLiability>
    <hr:StraightlineRentLiability contextRef="c-7" decimals="-3" id="f-467" unitRef="usd">2016000</hr:StraightlineRentLiability>
    <hr:GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation contextRef="c-1" decimals="-3" id="f-468" unitRef="usd">56974000</hr:GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation>
    <hr:GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation contextRef="c-7" decimals="-3" id="f-469" unitRef="usd">197188000</hr:GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-1" decimals="-3" id="f-470" unitRef="usd">62000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-7" decimals="-3" id="f-471" unitRef="usd">-2520000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <hr:ImpairmentOfRealEstateContinuingAndDiscontinuedOperations contextRef="c-1" decimals="-3" id="f-472" unitRef="usd">143510000</hr:ImpairmentOfRealEstateContinuingAndDiscontinuedOperations>
    <hr:ImpairmentOfRealEstateContinuingAndDiscontinuedOperations contextRef="c-7" decimals="-3" id="f-473" unitRef="usd">-25000</hr:ImpairmentOfRealEstateContinuingAndDiscontinuedOperations>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-1" decimals="-3" id="f-474" unitRef="usd">-1253000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-7" decimals="-3" id="f-475" unitRef="usd">-776000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions contextRef="c-1" decimals="-3" id="f-476" unitRef="usd">4366000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <us-gaap:EquityMethodInvestmentDividendsOrDistributions contextRef="c-7" decimals="-3" id="f-477" unitRef="usd">893000</us-gaap:EquityMethodInvestmentDividendsOrDistributions>
    <hr:InterestIncomeFinancingReceivableNoncash contextRef="c-1" decimals="-3" id="f-478" unitRef="usd">1067000</hr:InterestIncomeFinancingReceivableNoncash>
    <hr:InterestIncomeFinancingReceivableNoncash contextRef="c-7" decimals="-3" id="f-479" unitRef="usd">1901000</hr:InterestIncomeFinancingReceivableNoncash>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-1" decimals="-3" id="f-480" unitRef="usd">34632000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="c-7" decimals="-3" id="f-481" unitRef="usd">19230000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-1" decimals="-3" id="f-482" unitRef="usd">-32060000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-7" decimals="-3" id="f-483" unitRef="usd">35769000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="c-1" decimals="-3" id="f-484" unitRef="usd">17345000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="c-7" decimals="-3" id="f-485" unitRef="usd">-58213000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-486" unitRef="usd">372504000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-7" decimals="-3" id="f-487" unitRef="usd">126659000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireRealEstate contextRef="c-1" decimals="-3" id="f-488" unitRef="usd">48106000</us-gaap:PaymentsToAcquireRealEstate>
    <us-gaap:PaymentsToAcquireRealEstate contextRef="c-7" decimals="-3" id="f-489" unitRef="usd">376924000</us-gaap:PaymentsToAcquireRealEstate>
    <us-gaap:PaymentsToDevelopRealEstateAssets contextRef="c-1" decimals="-3" id="f-490" unitRef="usd">31318000</us-gaap:PaymentsToDevelopRealEstateAssets>
    <us-gaap:PaymentsToDevelopRealEstateAssets contextRef="c-7" decimals="-3" id="f-491" unitRef="usd">17572000</us-gaap:PaymentsToDevelopRealEstateAssets>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets contextRef="c-1" decimals="-3" id="f-492" unitRef="usd">156871000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:PaymentsToAcquireOtherProductiveAssets contextRef="c-7" decimals="-3" id="f-493" unitRef="usd">97797000</us-gaap:PaymentsToAcquireOtherProductiveAssets>
    <us-gaap:PaymentsToAcquireNotesReceivable contextRef="c-1" decimals="-3" id="f-494" unitRef="usd">14597000</us-gaap:PaymentsToAcquireNotesReceivable>
    <us-gaap:PaymentsToAcquireNotesReceivable contextRef="c-7" decimals="-3" id="f-495" unitRef="usd">3441000</us-gaap:PaymentsToAcquireNotesReceivable>
    <us-gaap:PaymentsToAcquireInterestInJointVenture contextRef="c-1" decimals="-3" id="f-496" unitRef="usd">3824000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:PaymentsToAcquireInterestInJointVenture contextRef="c-7" decimals="-3" id="f-497" unitRef="usd">99586000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <us-gaap:PaymentsToAcquireFinanceReceivables contextRef="c-1" decimals="-3" id="f-498" unitRef="usd">310000</us-gaap:PaymentsToAcquireFinanceReceivables>
    <us-gaap:ProceedsFromCollectionOfFinanceReceivables contextRef="c-7" decimals="-3" id="f-499" unitRef="usd">167000</us-gaap:ProceedsFromCollectionOfFinanceReceivables>
    <hr:ProceedsFromContributionsFromRedeemableNoncontrollingInterests contextRef="c-1" decimals="-3" id="f-500" unitRef="usd">710000</hr:ProceedsFromContributionsFromRedeemableNoncontrollingInterests>
    <hr:ProceedsFromContributionsFromRedeemableNoncontrollingInterests contextRef="c-7" decimals="-3" id="f-501" unitRef="usd">0</hr:ProceedsFromContributionsFromRedeemableNoncontrollingInterests>
    <us-gaap:ProceedsFromSaleOfPropertyHeldForSale contextRef="c-1" decimals="-3" id="f-502" unitRef="usd">366779000</us-gaap:ProceedsFromSaleOfPropertyHeldForSale>
    <us-gaap:ProceedsFromSaleOfPropertyHeldForSale contextRef="c-7" decimals="-3" id="f-503" unitRef="usd">870806000</us-gaap:ProceedsFromSaleOfPropertyHeldForSale>
    <us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable contextRef="c-1" decimals="-3" id="f-504" unitRef="usd">0</us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable>
    <us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable contextRef="c-7" decimals="-3" id="f-505" unitRef="usd">500000</us-gaap:ProceedsFromSaleAndCollectionOfNotesReceivable>
    <hr:CashAcquiredInMerger contextRef="c-1" decimals="-3" id="f-506" unitRef="usd">0</hr:CashAcquiredInMerger>
    <hr:CashAcquiredInMerger contextRef="c-7" decimals="-3" id="f-507" unitRef="usd">1149681000</hr:CashAcquiredInMerger>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-508" unitRef="usd">112463000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-7" decimals="-3" id="f-509" unitRef="usd">1425834000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit contextRef="c-1" decimals="-3" id="f-510" unitRef="usd">-149000000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromRepaymentsOfLinesOfCredit contextRef="c-7" decimals="-3" id="f-511" unitRef="usd">-154400000</us-gaap:ProceedsFromRepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromIssuanceOfMediumTermNotes contextRef="c-1" decimals="-3" id="f-512" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfMediumTermNotes>
    <us-gaap:ProceedsFromIssuanceOfMediumTermNotes contextRef="c-7" decimals="-3" id="f-513" unitRef="usd">666500000</us-gaap:ProceedsFromIssuanceOfMediumTermNotes>
    <us-gaap:RepaymentsOfMediumTermNotes contextRef="c-1" decimals="-3" id="f-514" unitRef="usd">0</us-gaap:RepaymentsOfMediumTermNotes>
    <us-gaap:RepaymentsOfMediumTermNotes contextRef="c-7" decimals="-3" id="f-515" unitRef="usd">718500000</us-gaap:RepaymentsOfMediumTermNotes>
    <us-gaap:RepaymentsOfDebt contextRef="c-1" decimals="-3" id="f-516" unitRef="usd">11988000</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="c-7" decimals="-3" id="f-517" unitRef="usd">18880000</us-gaap:RepaymentsOfDebt>
    <us-gaap:EarlyRepaymentOfSeniorDebt contextRef="c-1" decimals="-3" id="f-518" unitRef="usd">0</us-gaap:EarlyRepaymentOfSeniorDebt>
    <us-gaap:EarlyRepaymentOfSeniorDebt contextRef="c-7" decimals="-3" id="f-519" unitRef="usd">2184000</us-gaap:EarlyRepaymentOfSeniorDebt>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-1" decimals="-3" id="f-520" unitRef="usd">354171000</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock contextRef="c-7" decimals="-3" id="f-521" unitRef="usd">165735000</us-gaap:PaymentsOfDividendsCommonStock>
    <hr:PaymentOfSpecialDividendMergerRelated contextRef="c-1" decimals="-3" id="f-522" unitRef="usd">0</hr:PaymentOfSpecialDividendMergerRelated>
    <hr:PaymentOfSpecialDividendMergerRelated contextRef="c-7" decimals="-3" id="f-523" unitRef="usd">1123648000</hr:PaymentOfSpecialDividendMergerRelated>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-3" id="f-524" unitRef="usd">110000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-7" decimals="-3" id="f-525" unitRef="usd">22851000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-3" id="f-526" unitRef="usd">1834000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-7" decimals="-3" id="f-527" unitRef="usd">894000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsToMinorityShareholders contextRef="c-1" decimals="-3" id="f-528" unitRef="usd">3836000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders contextRef="c-7" decimals="-3" id="f-529" unitRef="usd">442000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="c-1" decimals="-3" id="f-530" unitRef="usd">529000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts contextRef="c-7" decimals="-3" id="f-531" unitRef="usd">12753000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-1" decimals="-3" id="f-532" unitRef="usd">12000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-7" decimals="-3" id="f-533" unitRef="usd">0</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-534" unitRef="usd">-521260000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-7" decimals="-3" id="f-535" unitRef="usd">-1508085000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-536" unitRef="usd">-36293000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-7" decimals="-3" id="f-537" unitRef="usd">44408000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-538" unitRef="usd">60961000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-78" decimals="-3" id="f-539" unitRef="usd">13175000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-540" unitRef="usd">24668000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-56" decimals="-3" id="f-541" unitRef="usd">57583000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-3" id="f-542" unitRef="usd">185402000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-7" decimals="-3" id="f-543" unitRef="usd">83382000</us-gaap:InterestPaidNet>
    <us-gaap:MortgageLoanRelatedToPropertySales1 contextRef="c-1" decimals="-3" id="f-544" unitRef="usd">45000000</us-gaap:MortgageLoanRelatedToPropertySales1>
    <us-gaap:MortgageLoanRelatedToPropertySales1 contextRef="c-7" decimals="-3" id="f-545" unitRef="usd">0</us-gaap:MortgageLoanRelatedToPropertySales1>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-3" id="f-546" unitRef="usd">32590000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-7" decimals="-3" id="f-547" unitRef="usd">52840000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:TransferMortgagePayable contextRef="c-1" decimals="-3" id="f-548" unitRef="usd">5284000</us-gaap:TransferMortgagePayable>
    <us-gaap:TransferMortgagePayable contextRef="c-7" decimals="-3" id="f-549" unitRef="usd">0</us-gaap:TransferMortgagePayable>
    <us-gaap:InterestPaidCapitalized contextRef="c-1" decimals="-3" id="f-550" unitRef="usd">2077000</us-gaap:InterestPaidCapitalized>
    <us-gaap:InterestPaidCapitalized contextRef="c-7" decimals="-3" id="f-551" unitRef="usd">848000</us-gaap:InterestPaidCapitalized>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-552">Summary of Significant Accounting Policies&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Business Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Healthcare Realty Trust Incorporated is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September&#160;30, 2023, the Company had gross investments of approximately $13.6&#160;billion in &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;663 wholly-owned real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property.  The Company's 663 re&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;al estate properties are located in 35 states and total approxima&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;tely 39.1&#160;million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;square feet. The Company provided leasing and property management services to approximat&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;ely 38.6 million sq&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;uare feet nationwide.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;In addition, as of September&#160;30, 2023, the Company had a weighted average ownership interest of approxima&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;tely 44%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt; in &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;34 re&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;al estate properties held in joint ventures. See Note 3 below for more details regarding the Company's unconsolidated joint ventures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the Company's Condensed Consolidated Financial Statements, are outside the scope of our independent registered public accounting firm&#x2019;s review. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For purposes of this Quarterly Report on Form 10-Q, references to the &#x201c;Company&#x201d; are to Legacy HR for periods prior to the closing of the Merger and thereafter to Legacy HR and Legacy HTA as the combined company after giving effect to the Merger.  The Merger is described in more detail in Note 2 to these Condensed Consolidated Financial Statements.  The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. However, except as disclosed herein and specific disclosures included as a result of the Merger, management believes there has been no material change in the information disclosed in the Notes to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022. All material intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;This interim financial information should be read in conjunction with the consolidated financial statements included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2022. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December&#160;31, 2023 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s Condensed Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (&#x201c;VIEs&#x201d;). Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 810, Consolidation broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity&#x2019;s economic performance or (ii) the equity investment at risk is insufficient to finance that entity&#x2019;s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity&#x2019;s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE&#x2019;s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Condensed Consolidated Financial Statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company may change its original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity&#x2019;s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than 100% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities&#x2019; activities based upon the terms of the respective entities&#x2019; ownership agreements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Healthcare Realty Holdings, L.P., a Delaware limited partnership (the "OP"), is 98.8% owned by the Company.  Holders of operating partnership units (&#x201c;OP Units&#x201d;) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of September&#160;30, 2023, there were approximately 4.7&#160;million OP Units, or 1.2% of OP units issued and outstanding, held by non-controlling interest holders.  Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates the interests in the OP.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of September&#160;30, 2023, the Company had four consolidated VIEs, in addition to the OP, consisting of joint venture investments in which the Company is the primary beneficiary of the VIE based on the combination of operational control and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures.  Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:45.259%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.129%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;(dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SEPTEMBER 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Net real estate investments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;72,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Receivables and other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;77,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;16,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;60,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total liabilities and equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;77,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of September&#160;30, 2023, the Company had three unconsolidated VIEs consisting of two notes receivables and one joint venture.  The Company does not have the power or economic interests to direct the activities of the VIEs on a stand-alone basis, and therefore it was determined that the Company was not the primary beneficiary.  As a result, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method.  See below for additional information regarding the Company's unconsolidated VIEs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.119%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.067%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.858%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.246%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.663%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;(dollars in thousands) ORIGINATION DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;LOCATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SOURCE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING AMOUNT &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MAXIMUM EXPOSURE TO LOSS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Houston, TX &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Note receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;30,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Charlotte, NC &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Note receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;63,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;63,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Assumed mortgage note receivable in connection with the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;Includes investments in seven properties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of September&#160;30, 2023, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities.  See Note 3 below for more details regarding the Company's unconsolidated joint ventures.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Use of Estimates in the Condensed Consolidated Financial Statements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Reclassifications &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Certain reclassifications have been made on the Company's prior year Condensed Consolidated Balance Sheet to conform to current year presentation. Previously, the Company's Lease intangibles were included in Building, improvements and lease intangibles and Goodwill was included with Other assets, net. These amounts are now classified as separate line items on the Company's Condensed Consolidated Balance Sheets. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:400;line-height:140%"&gt;                                            &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Redeemable Non-Controlling Interests&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company accounts for redeemable equity securities in accordance with ASC Topic 480: Accounting for Redeemable Equity Instruments, which requires that equity securities redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders&#x2019; equity.  The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Condensed Consolidated Balance Sheets.  Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest&#x2019;s share of net income or loss and distributions) or the redemption value.  We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest.  As of September&#160;30, 2023, the Company had redeemable non-controlling interests of $3.2&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Asset Impairment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever the occurrence of an event or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company&#x2019;s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its tenants.  During the three and nine months ended September&#160;30, 2023, the Company recognized real estate impairments totaling $56.9&#160;million and $138.3&#160;million, respectively, as a result of completed or planned disposition activity.  &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Investments in Leases - Financing Receivables, Net &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;In accordance with ASC Topic 842: Leases, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC Topic 310: Receivables. See below for additional information regarding the Company's financing receivables.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.241%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.667%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;(dollars in thousands) ORIGINATION DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;LOCATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;INTEREST RATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE as of SEPTEMBER 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;May 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Poway, CA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5.73%&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;113,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;November 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Columbus, OH&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6.48%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;120,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Real Estate Notes Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Real estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower&#x2019;s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held-to-maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses.  As of September&#160;30, 2023, real estate notes receivable, net, which are included in Other assets on the Company's Condensed Consolidated Balance Sheets, totaled $155.0&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.869%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.869%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.869%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.403%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.942%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.329%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.329%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.333%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;(dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;ORIGINATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MATURITY&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;STATED INTEREST RATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MAXIMUM LOAN COMMITMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OUTSTANDING as of &lt;br/&gt;SEPT 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;ALLOWANCE FOR CREDIT LOSSES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE DISCOUNT AND FEES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE as of SEPT 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;Mezzanine loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/24/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/24/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;54,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;54,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(5,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(3,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;Mortgage loans &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(353)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;30,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;North Carolina&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/22/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/22/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(257)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5/17/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2/27/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;65,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;27,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;27,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;California&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3/30/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3/29/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;147,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;109,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(659)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;109,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;201,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;163,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(5,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(3,726)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;154,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%"&gt;Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Pursuant to ASC Topic 326, Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under ASC Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#x2019;s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;In its assessment of current expected credit losses for real estate notes receivable, the Company utilizes past payment history of its borrowers, current economic conditions, and forecasted economic conditions through the maturity date of each note to estimate a probability of default and a resulting loss for each real estate note receivable.  During the first quarter of 2023, the Company determined that the risk of credit loss on its mezzanine loans was no longer remote and recorded a credit loss reserve of $5.2&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table summarizes the Company's allowance for credit losses on real estate notes receivable:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.672%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.439%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.631%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED SEPTEMBER 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;TWELVE MONTHS ENDED DECEMBER 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Credit loss reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Allowance for credit losses, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Interest Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%"&gt;Income from Lease Financing Receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company recognized the related income from two financing receivables totaling $2.0&#160;million and $6.2&#160;million, respectively, for the three and nine months ended September&#160;30, 2023, and $2.0&#160;million and $5.9&#160;million, respectively for the three and nine months ended September&#160;30, 2022, based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable in any particular period will not equal the cash payments from the lease agreement in that period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Interest income over the life of the lease.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%"&gt;Income from Real Estate Notes Receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;During the three and nine months ended September&#160;30, 2023, the Company recognized interest income of $2.3&#160;million and $6.5&#160;million, respectively, related to real estate notes receivable. The Company recognizes interest income on an accrual basis unless the Company has determined that collectability of contractual amounts is not reasonably assured, at which point the note is placed on non-accrual status and interest income is recognized on a cash basis.  As of January 1, 2023, the Company placed two of its real estate notes receivable with principal balances of $48.9&#160;million on non-accrual status and accordingly did not recognize any interest income for the three and nine month periods ended September&#160;30, 2023. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Revenue from Contracts with Customers (ASC Topic 606)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company recognizes certain revenue under the core principle of Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of Topic 606. To achieve the core principle, the Company applies the five step model specified in the guidance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Revenue that is accounted for under Topic 606 is segregated on the Company&#x2019;s Condensed Consolidated Statements of Operations in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income. Below is a detail of the amounts by category:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.385%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.213%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.321%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.321%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.321%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Type of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Parking income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Management fee income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Miscellaneous&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;13,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;9,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1     Includes the recovery of certain expenses under the financing receivable as outlined in the management agreement.           &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time, and the Company recognizes revenue monthly based on this principle.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <hr:NatureOfOperationsPolicyTextBlock contextRef="c-1" id="f-553">&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Business Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Healthcare Realty Trust Incorporated is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September&#160;30, 2023, the Company had gross investments of approximately $13.6&#160;billion in &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;663 wholly-owned real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property.  The Company's 663 re&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;al estate properties are located in 35 states and total approxima&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;tely 39.1&#160;million &lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;square feet. The Company provided leasing and property management services to approximat&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;ely 38.6 million sq&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;uare feet nationwide.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;In addition, as of September&#160;30, 2023, the Company had a weighted average ownership interest of approxima&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;tely 44%&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt; in &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;34 re&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;al estate properties held in joint ventures. See Note 3 below for more details regarding the Company's unconsolidated joint ventures. &lt;/span&gt;&lt;/div&gt;Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the Company's Condensed Consolidated Financial Statements, are outside the scope of our independent registered public accounting firm&#x2019;s review.</hr:NatureOfOperationsPolicyTextBlock>
    <hr:InvestmentInRealEstatePropertiesAndMortgageNotes contextRef="c-3" decimals="-8" id="f-554" unitRef="usd">13600000000</hr:InvestmentInRealEstatePropertiesAndMortgageNotes>
    <hr:NumberOfRealEstateInvestments
      contextRef="c-3"
      decimals="INF"
      id="f-555"
      unitRef="property">663</hr:NumberOfRealEstateInvestments>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-3"
      decimals="INF"
      id="f-556"
      unitRef="property">663</us-gaap:NumberOfRealEstateProperties>
    <hr:RealEstateInvestmentsPropertyOwnedInNumberOfStates contextRef="c-3" decimals="INF" id="f-557" unitRef="state">35</hr:RealEstateInvestmentsPropertyOwnedInNumberOfStates>
    <hr:ApproximateSquareFeetInvestedInByCompany contextRef="c-3" decimals="-5" id="f-558" unitRef="sqft">39100000</hr:ApproximateSquareFeetInvestedInByCompany>
    <hr:ApproximateSquareFeetProvidedByCompany contextRef="c-3" decimals="-5" id="f-559" unitRef="sqft">38600000</hr:ApproximateSquareFeetProvidedByCompany>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage contextRef="c-86" decimals="2" id="f-560" unitRef="number">0.44</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <hr:NumberOfBuildingsOwnedByJointVenture
      contextRef="c-3"
      decimals="INF"
      id="f-561"
      unitRef="property">34</hr:NumberOfBuildingsOwnedByJointVenture>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-562">&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For purposes of this Quarterly Report on Form 10-Q, references to the &#x201c;Company&#x201d; are to Legacy HR for periods prior to the closing of the Merger and thereafter to Legacy HR and Legacy HTA as the combined company after giving effect to the Merger.  The Merger is described in more detail in Note 2 to these Condensed Consolidated Financial Statements.  The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. However, except as disclosed herein and specific disclosures included as a result of the Merger, management believes there has been no material change in the information disclosed in the Notes to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December&#160;31, 2022. All material intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;This interim financial information should be read in conjunction with the consolidated financial statements included in the Company&#x2019;s Annual Report on Form 10-K for the year ended December&#160;31, 2022. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December&#160;31, 2023 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-563">&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s Condensed Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (&#x201c;VIEs&#x201d;). Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 810, Consolidation broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity&#x2019;s economic performance or (ii) the equity investment at risk is insufficient to finance that entity&#x2019;s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity&#x2019;s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE&#x2019;s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Condensed Consolidated Financial Statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company may change its original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity&#x2019;s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than 100% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities&#x2019; activities based upon the terms of the respective entities&#x2019; ownership agreements. &lt;/span&gt;&lt;/div&gt;Healthcare Realty Holdings, L.P., a Delaware limited partnership (the "OP"), is 98.8% owned by the Company.  Holders of operating partnership units (&#x201c;OP Units&#x201d;) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of September&#160;30, 2023, there were approximately 4.7&#160;million OP Units, or 1.2% of OP units issued and outstanding, held by non-controlling interest holders.  Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates the interests in the OP.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="c-87"
      decimals="INF"
      id="f-564"
      unitRef="number">1</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <hr:EquityOwnershipForConsolidationPercent contextRef="c-3" decimals="INF" id="f-565" unitRef="number">1</hr:EquityOwnershipForConsolidationPercent>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired contextRef="c-88" decimals="3" id="f-566" unitRef="number">0.988</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding contextRef="c-89" decimals="-5" id="f-567" unitRef="shares">4700000</us-gaap:LimitedPartnersCapitalAccountUnitsOutstanding>
    <us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest contextRef="c-90" decimals="3" id="f-568" unitRef="number">0.012</us-gaap:LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest>
    <hr:NumberOfVariableInterestEntities
      contextRef="c-3"
      decimals="INF"
      id="f-569"
      unitRef="variable_interest_entity">4</hr:NumberOfVariableInterestEntities>
    <srt:ScheduleOfCondensedBalanceSheetTableTextBlock contextRef="c-1" id="f-570">Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:45.259%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.129%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.671%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;(dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SEPTEMBER 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Net real estate investments&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;72,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Receivables and other assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;77,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;16,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;60,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total liabilities and equity&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;77,116&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</srt:ScheduleOfCondensedBalanceSheetTableTextBlock>
    <us-gaap:RealEstateInvestmentPropertyNet contextRef="c-91" decimals="-3" id="f-571" unitRef="usd">72756000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-91" decimals="-3" id="f-572" unitRef="usd">1766000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <hr:ReceivablesAndOtherAssets contextRef="c-91" decimals="-3" id="f-573" unitRef="usd">2594000</hr:ReceivablesAndOtherAssets>
    <us-gaap:Assets contextRef="c-91" decimals="-3" id="f-574" unitRef="usd">77116000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilities contextRef="c-91" decimals="-3" id="f-575" unitRef="usd">16909000</us-gaap:AccountsPayableAndOtherAccruedLiabilities>
    <us-gaap:StockholdersEquity contextRef="c-91" decimals="-3" id="f-576" unitRef="usd">60207000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-91" decimals="-3" id="f-577" unitRef="usd">77116000</us-gaap:LiabilitiesAndStockholdersEquity>
    <hr:NumberOfVariableInterestEntities
      contextRef="c-92"
      decimals="INF"
      id="f-578"
      unitRef="variable_interest_entity">3</hr:NumberOfVariableInterestEntities>
    <hr:NumberOfNotesReceivable
      contextRef="c-92"
      decimals="INF"
      id="f-579"
      unitRef="note_receivable">2</hr:NumberOfNotesReceivable>
    <hr:NumberOfJointVentures
      contextRef="c-93"
      decimals="INF"
      id="f-580"
      unitRef="joint_venture">1</hr:NumberOfJointVentures>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock contextRef="c-1" id="f-581">As a result, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method.  See below for additional information regarding the Company's unconsolidated VIEs.&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.119%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.067%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.858%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.246%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.663%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;(dollars in thousands) ORIGINATION DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;LOCATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SOURCE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING AMOUNT &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MAXIMUM EXPOSURE TO LOSS&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Houston, TX &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Note receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;30,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Charlotte, NC &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Note receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Joint venture&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;63,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;63,579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Assumed mortgage note receivable in connection with the Merger.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;Includes investments in seven properties.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <hr:NumberOfNotesReceivable
      contextRef="c-92"
      decimals="INF"
      id="f-582"
      unitRef="note_receivable">2</hr:NumberOfNotesReceivable>
    <hr:NotesReceivableCarryingAmount contextRef="c-94" decimals="-3" id="f-583" unitRef="usd">30797000</hr:NotesReceivableCarryingAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount contextRef="c-94" decimals="-3" id="f-584" unitRef="usd">31150000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <hr:NotesReceivableCarryingAmount contextRef="c-95" decimals="-3" id="f-585" unitRef="usd">5743000</hr:NotesReceivableCarryingAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount contextRef="c-95" decimals="-3" id="f-586" unitRef="usd">6000000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <hr:JointVentureCarryingAmount contextRef="c-96" decimals="-3" id="f-587" unitRef="usd">63579000</hr:JointVentureCarryingAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount contextRef="c-96" decimals="-3" id="f-588" unitRef="usd">63579000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-96"
      decimals="INF"
      id="f-589"
      unitRef="property">7</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:ConsolidationVariableInterestEntityPolicy contextRef="c-1" id="f-590">As of September&#160;30, 2023, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities.</us-gaap:ConsolidationVariableInterestEntityPolicy>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-591">&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Use of Estimates in the Condensed Consolidated Financial Statements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="c-1" id="f-592">Reclassifications Certain reclassifications have been made on the Company's prior year Condensed Consolidated Balance Sheet to conform to current year presentation. Previously, the Company's Lease intangibles were included in Building, improvements and lease intangibles and Goodwill was included with Other assets, net. These amounts are now classified as separate line items on the Company's Condensed Consolidated Balance Sheets.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy contextRef="c-1" id="f-593">Redeemable Non-Controlling InterestsThe Company accounts for redeemable equity securities in accordance with ASC Topic 480: Accounting for Redeemable Equity Instruments, which requires that equity securities redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders&#x2019; equity.  The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Condensed Consolidated Balance Sheets.  Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest&#x2019;s share of net income or loss and distributions) or the redemption value.  We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest.</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests contextRef="c-3" decimals="-5" id="f-594" unitRef="usd">3200000</us-gaap:TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c-1" id="f-595">Asset ImpairmentThe Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever the occurrence of an event or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company&#x2019;s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its tenants.</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:ImpairmentOfRealEstate contextRef="c-5" decimals="-5" id="f-596" unitRef="usd">56900000</us-gaap:ImpairmentOfRealEstate>
    <us-gaap:ImpairmentOfRealEstate contextRef="c-1" decimals="-5" id="f-597" unitRef="usd">138300000</us-gaap:ImpairmentOfRealEstate>
    <us-gaap:LessorLeasesPolicyTextBlock contextRef="c-1" id="f-598">Investments in Leases - Financing Receivables, Net In accordance with ASC Topic 842: Leases, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC Topic 310: Receivables.Real Estate Notes ReceivableReal estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower&#x2019;s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held-to-maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses.&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%"&gt;Allowance for Credit Losses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Pursuant to ASC Topic 326, Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under ASC Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company&#x2019;s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. &lt;/span&gt;&lt;/div&gt;In its assessment of current expected credit losses for real estate notes receivable, the Company utilizes past payment history of its borrowers, current economic conditions, and forecasted economic conditions through the maturity date of each note to estimate a probability of default and a resulting loss for each real estate note receivable.&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Interest Income&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%"&gt;Income from Lease Financing Receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company recognized the related income from two financing receivables totaling $2.0&#160;million and $6.2&#160;million, respectively, for the three and nine months ended September&#160;30, 2023, and $2.0&#160;million and $5.9&#160;million, respectively for the three and nine months ended September&#160;30, 2022, based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable in any particular period will not equal the cash payments from the lease agreement in that period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Interest income over the life of the lease.&lt;/span&gt;&lt;/div&gt;</us-gaap:LessorLeasesPolicyTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="c-1" id="f-599">See below for additional information regarding the Company's financing receivables.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.241%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.666%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.667%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;(dollars in thousands) ORIGINATION DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;LOCATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;INTEREST RATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE as of SEPTEMBER 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;May 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Poway, CA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5.73%&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;113,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;November 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Columbus, OH&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6.48%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;120,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.869%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.869%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.869%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.403%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.942%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.329%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.329%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.333%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;(dollars in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;ORIGINATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MATURITY&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;STATED INTEREST RATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MAXIMUM LOAN COMMITMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OUTSTANDING as of &lt;br/&gt;SEPT 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;ALLOWANCE FOR CREDIT LOSSES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE DISCOUNT AND FEES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE as of SEPT 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;Mezzanine loans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/24/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/24/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;54,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;54,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(5,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(3,067)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:8.5pt;font-weight:700;line-height:120%"&gt;Mortgage loans &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Texas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6/30/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/31/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;31,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(353)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;30,797&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;North Carolina&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/22/2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12/22/2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(257)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Florida&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5/17/2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2/27/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;65,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;27,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(49)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;27,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;California&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3/30/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3/29/2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;147,150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;109,801&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(659)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;109,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;201,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;163,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(5,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(3,726)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;154,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <hr:NotesReceivableInterestRate
      contextRef="c-97"
      decimals="INF"
      id="f-600"
      unitRef="number">0.0573</hr:NotesReceivableInterestRate>
    <us-gaap:SaleLeasebackTransactionNetBookValue contextRef="c-97" decimals="-3" id="f-601" unitRef="usd">113634000</us-gaap:SaleLeasebackTransactionNetBookValue>
    <hr:NotesReceivableInterestRate
      contextRef="c-98"
      decimals="INF"
      id="f-602"
      unitRef="number">0.0648</hr:NotesReceivableInterestRate>
    <us-gaap:SaleLeasebackTransactionNetBookValue contextRef="c-98" decimals="-3" id="f-603" unitRef="usd">7341000</us-gaap:SaleLeasebackTransactionNetBookValue>
    <us-gaap:SaleLeasebackTransactionNetBookValue contextRef="c-3" decimals="-3" id="f-604" unitRef="usd">120975000</us-gaap:SaleLeasebackTransactionNetBookValue>
    <hr:RealEstateNotesReceivableNet contextRef="c-3" decimals="-5" id="f-605" unitRef="usd">155000000</hr:RealEstateNotesReceivableNet>
    <hr:NotesReceivableInterestRate
      contextRef="c-99"
      decimals="INF"
      id="f-606"
      unitRef="number">0.0800</hr:NotesReceivableInterestRate>
    <hr:NotesReceivableMaximumLoanCommitment contextRef="c-99" decimals="-3" id="f-607" unitRef="usd">54119000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-99" decimals="-3" id="f-608" unitRef="usd">54119000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-99" decimals="-3" id="f-609" unitRef="usd">5196000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount contextRef="c-99" decimals="-3" id="f-610" unitRef="usd">3067000</us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-99" decimals="-3" id="f-611" unitRef="usd">45856000</us-gaap:NotesReceivableFairValueDisclosure>
    <hr:NotesReceivableInterestRate
      contextRef="c-100"
      decimals="INF"
      id="f-612"
      unitRef="number">0.0700</hr:NotesReceivableInterestRate>
    <hr:NotesReceivableMaximumLoanCommitment contextRef="c-100" decimals="-3" id="f-613" unitRef="usd">31150000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-100" decimals="-3" id="f-614" unitRef="usd">31150000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-100" decimals="-3" id="f-615" unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount contextRef="c-100" decimals="-3" id="f-616" unitRef="usd">353000</us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-100" decimals="-3" id="f-617" unitRef="usd">30797000</us-gaap:NotesReceivableFairValueDisclosure>
    <hr:NotesReceivableInterestRate
      contextRef="c-101"
      decimals="INF"
      id="f-618"
      unitRef="number">0.0800</hr:NotesReceivableInterestRate>
    <hr:NotesReceivableMaximumLoanCommitment contextRef="c-101" decimals="-3" id="f-619" unitRef="usd">6000000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-101" decimals="-3" id="f-620" unitRef="usd">6000000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-101" decimals="-3" id="f-621" unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount contextRef="c-101" decimals="-3" id="f-622" unitRef="usd">257000</us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-101" decimals="-3" id="f-623" unitRef="usd">5743000</us-gaap:NotesReceivableFairValueDisclosure>
    <hr:NotesReceivableInterestRate
      contextRef="c-102"
      decimals="INF"
      id="f-624"
      unitRef="number">0.0600</hr:NotesReceivableInterestRate>
    <hr:NotesReceivableMaximumLoanCommitment contextRef="c-102" decimals="-3" id="f-625" unitRef="usd">65000000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-102" decimals="-3" id="f-626" unitRef="usd">27651000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-102" decimals="-3" id="f-627" unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount contextRef="c-102" decimals="-3" id="f-628" unitRef="usd">49000</us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-102" decimals="-3" id="f-629" unitRef="usd">27602000</us-gaap:NotesReceivableFairValueDisclosure>
    <hr:NotesReceivableInterestRate
      contextRef="c-103"
      decimals="INF"
      id="f-630"
      unitRef="number">0.0600</hr:NotesReceivableInterestRate>
    <hr:NotesReceivableMaximumLoanCommitment contextRef="c-103" decimals="-3" id="f-631" unitRef="usd">45000000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-103" decimals="-3" id="f-632" unitRef="usd">45000000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-103" decimals="-3" id="f-633" unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount contextRef="c-103" decimals="-3" id="f-634" unitRef="usd">0</us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-103" decimals="-3" id="f-635" unitRef="usd">45000000</us-gaap:NotesReceivableFairValueDisclosure>
    <hr:NotesReceivableMaximumLoanCommitment contextRef="c-104" decimals="-3" id="f-636" unitRef="usd">147150000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-104" decimals="-3" id="f-637" unitRef="usd">109801000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-104" decimals="-3" id="f-638" unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount contextRef="c-104" decimals="-3" id="f-639" unitRef="usd">659000</us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-104" decimals="-3" id="f-640" unitRef="usd">109142000</us-gaap:NotesReceivableFairValueDisclosure>
    <hr:NotesReceivableMaximumLoanCommitment contextRef="c-3" decimals="-3" id="f-641" unitRef="usd">201269000</hr:NotesReceivableMaximumLoanCommitment>
    <us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss contextRef="c-3" decimals="-3" id="f-642" unitRef="usd">163920000</us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-3" decimals="-3" id="f-643" unitRef="usd">5196000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount contextRef="c-3" decimals="-3" id="f-644" unitRef="usd">3726000</us-gaap:FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-3" decimals="-3" id="f-645" unitRef="usd">154998000</us-gaap:NotesReceivableFairValueDisclosure>
    <hr:FinancingReceivableAllowanceForCreditLossReserves contextRef="c-105" decimals="-5" id="f-646" unitRef="usd">5200000</hr:FinancingReceivableAllowanceForCreditLossReserves>
    <us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock contextRef="c-1" id="f-647">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table summarizes the Company's allowance for credit losses on real estate notes receivable:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:90.672%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.439%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.630%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.631%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED SEPTEMBER 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;TWELVE MONTHS ENDED DECEMBER 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Allowance for credit losses, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Credit loss reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Allowance for credit losses, end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-4" decimals="-3" id="f-648" unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-78" decimals="-3" id="f-649" unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <hr:FinancingReceivableAllowanceForCreditLossReserves contextRef="c-1" decimals="-3" id="f-650" unitRef="usd">5196000</hr:FinancingReceivableAllowanceForCreditLossReserves>
    <hr:FinancingReceivableAllowanceForCreditLossReserves contextRef="c-106" decimals="-3" id="f-651" unitRef="usd">0</hr:FinancingReceivableAllowanceForCreditLossReserves>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-3" decimals="-3" id="f-652" unitRef="usd">5196000</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest contextRef="c-4" decimals="-3" id="f-653" unitRef="usd">0</us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest>
    <hr:NumberOfRecognizedLeaseFinancialReceivables
      contextRef="c-3"
      decimals="INF"
      id="f-654"
      unitRef="financing_receivable">2</hr:NumberOfRecognizedLeaseFinancialReceivables>
    <us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable contextRef="c-5" decimals="-5" id="f-655" unitRef="usd">2000000</us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable>
    <us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable contextRef="c-1" decimals="-5" id="f-656" unitRef="usd">6200000</us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable>
    <us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable contextRef="c-6" decimals="-5" id="f-657" unitRef="usd">2000000</us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable>
    <us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable contextRef="c-7" decimals="-5" id="f-658" unitRef="usd">5900000</us-gaap:SalesTypeLeaseInterestIncomeLeaseReceivable>
    <us-gaap:InterestIncomeOperating contextRef="c-107" decimals="-5" id="f-659" unitRef="usd">2300000</us-gaap:InterestIncomeOperating>
    <us-gaap:InterestIncomeOperating contextRef="c-108" decimals="-5" id="f-660" unitRef="usd">6500000</us-gaap:InterestIncomeOperating>
    <hr:NumberOfRealEstateNotesReceivable
      contextRef="c-109"
      decimals="INF"
      id="f-661"
      unitRef="financing_receivable">2</hr:NumberOfRealEstateNotesReceivable>
    <us-gaap:FinancingReceivableExcludingAccruedInterestNonaccrual contextRef="c-109" decimals="-5" id="f-662" unitRef="usd">48900000</us-gaap:FinancingReceivableExcludingAccruedInterestNonaccrual>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-663">&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Revenue from Contracts with Customers (ASC Topic 606)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company recognizes certain revenue under the core principle of Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of Topic 606. To achieve the core principle, the Company applies the five step model specified in the guidance. &lt;/span&gt;&lt;/div&gt;Revenue that is accounted for under Topic 606 is segregated on the Company&#x2019;s Condensed Consolidated Statements of Operations in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income.The Company&#x2019;s major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time, and the Company recognizes revenue monthly based on this principle.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-664">Below is a detail of the amounts by category:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.385%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:33.213%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.321%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.321%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.321%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.324%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Type of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Parking income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Management fee income&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; 1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,552&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,426&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Miscellaneous&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;306&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,661&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;13,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;9,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;1     Includes the recovery of certain expenses under the financing receivable as outlined in the management agreement.</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-110" decimals="-3" id="f-665" unitRef="usd">2751000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-111" decimals="-3" id="f-666" unitRef="usd">2428000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-112" decimals="-3" id="f-667" unitRef="usd">7511000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-113" decimals="-3" id="f-668" unitRef="usd">6100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-114" decimals="-3" id="f-669" unitRef="usd">1552000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-115" decimals="-3" id="f-670" unitRef="usd">1426000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-116" decimals="-3" id="f-671" unitRef="usd">5122000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-117" decimals="-3" id="f-672" unitRef="usd">2864000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-118" decimals="-3" id="f-673" unitRef="usd">358000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-119" decimals="-3" id="f-674" unitRef="usd">203000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-120" decimals="-3" id="f-675" unitRef="usd">875000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-121" decimals="-3" id="f-676" unitRef="usd">306000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-677" unitRef="usd">4661000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-678" unitRef="usd">4057000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-679" unitRef="usd">13508000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-3" id="f-680" unitRef="usd">9270000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="c-1" id="f-681">Merger with HTA &lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On July 20, 2022 (the &#x201c;Closing Date&#x201d;), pursuant to the Agreement and Plan of Merger dated as of February 28, 2022 (the &#x201c;Merger Agreement&#x201d;), by and among Healthcare Realty Trust Incorporated, a Maryland corporation (now known as HRTI, LLC, a Maryland limited liability company) (&#x201c;Legacy HR&#x201d;), Healthcare Trust of America, Inc., a Maryland corporation (now known as Healthcare Realty Trust Incorporated) (&#x201c;Legacy HTA&#x201d;), the OP, and HR Acquisition 2, LLC, a Maryland limited liability company (&#x201c;Merger Sub&#x201d;), Merger Sub merged with and into Legacy HR, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA (the &#x201c;Merger&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On the Closing Date, each outstanding share of Legacy HR common stock, $0.01 par value per share (the &#x201c;Legacy HR Common Stock&#x201d;), was cancelled and converted into the right to receive one share of Legacy HTA class A common stock at a fixed ratio of 1.00 to 1.00. Per the terms of the Merger Agreement, Legacy HTA declared a special dividend of $4.82 (the &#x201c;Special Dividend&#x201d;) for each outstanding share of Legacy HTA class A common stock, $0.01 par value per share ( the &#x201c;Legacy HTA Common Stock&#x201d;), and the OP declared a corresponding distribution to the holders of its partnership units, payable to Legacy HTA stockholders and OP unitholders of record on July 19, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Immediately following the Merger, Legacy HR converted to a Maryland limited liability company and changed its name to HRTI, LLC and Legacy HTA changed its name to &#x201c;Healthcare Realty Trust Incorporated&#x201d;. In addition, the equity interests of Legacy HR were contributed by Legacy HTA by means of a contribution and assignment agreement to the OP, and Legacy HR became a wholly-owned subsidiary of the OP.  The Company operates under the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;name &#x201c;Healthcare Realty Trust Incorporated&#x201d; and its shares of class A common stock, $0.01 par value per share, trade on the New York Stock Exchange under the ticker symbol &#x201c;HR&#x201d;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For accounting purposes, the Merger was treated as a &#x201c;reverse acquisition&#x201d; in which Legacy HTA was considered the legal acquirer and Legacy HR was considered the accounting acquirer based on various factors, including, but not limited to: (i) the composition of the board of directors of the combined company following the Merger, (ii) the composition of senior management of the combined company following the Merger, and (iii) the premium transferred to the Legacy HTA stockholders. As a result, the historical financial statements of the accounting acquirer, Legacy HR, became the historical financial statements of the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The acquisition was accounted for using the acquisition method of accounting in accordance with ASC 805, Business Combinations, which requires, among other things, the assets acquired and the liabilities assumed and non-controlling interests, if any, to be recognized at their acquisition date fair value. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The implied consideration transferred on the Closing Date is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.495%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.702%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands, except for per share data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;228,520,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Exchange ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Implied shares of Legacy HR Common Stock issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;228,520,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Adjusted closing price of Legacy HR Common Stock on July 20, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;24.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Value of implied Legacy HR Common Stock issued&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,569,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:700;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Consideration transferred&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,576,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(a) The number of shares of Legacy HTA Common Stock presented above was based on 228,857,717 total shares of Legacy HTA Common Stock outstanding as of the Closing Date, less 192 Legacy HTA fractional shares that were cancelled in lieu of cash and less 336,535 shares of Legacy HTA restricted stock (net of 215,764 shares of Legacy HTA restricted stock withheld). For accounting purposes, these shares were converted to Legacy HR Common Stock, at an exchange ratio of 1.00 share of Legacy HR Common Stock per share of Legacy HTA Common Stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(b) For accounting purposes, the fair value of Legacy HR Common Stock issued to former holders of Legacy HTA Common Stock was based on the per share closing price of Legacy HR Common Stock on July 20, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(c) Represents the fair value of Legacy HTA restricted shares which fully vested prior to the closing of the Merger or became fully vested as a result of the closing of the Merger and which are attributable to pre-combination services. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Final Purchase Price Allocation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the Closing Date: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.553%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.360%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;&#160;CUMULATIVE MEASUREMENT PERIOD ADJUSTMENTS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;AMOUNTS RECOGNIZED ON THE CLOSING DATE &lt;br/&gt;(as adjusted)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Real estate investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Land &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;985,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;18,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,004,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,960,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(119,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,841,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Lease intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;831,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;833,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Financing lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;13,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;10,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(6,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Land held for development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;46,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;46,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Total real estate investments&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,844,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(102,535)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,742,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Assets held for sale, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;707,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(7,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;699,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Investments in unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;67,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;67,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;26,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;37,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Restricted cash &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,123,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(1,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,122,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;198,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;16,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;214,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other assets, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(b) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;209,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(3,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;205,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,177,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(87,795)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,089,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Notes and bonds payable &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,991,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,991,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,227,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;17,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,244,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Liabilities of assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;28,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(3,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;24,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;173,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;10,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;184,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Financing lease liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;10,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(855)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;203,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(8,909)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;194,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,635,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;13,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,649,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Net identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,541,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(101,639)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,440,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;110,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;110,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;145,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;101,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;247,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(a) The weighted average amortization period for the acquired lease intangible assets is approximately 6 years.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(b) Includes $15.9 million of contractual accounts receivable, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(c) Includes $78.7 million of gross contractual real estate notes receivable, the fair value of which was $74.8 million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The cumulative measurement period adjustments recorded through June 30, 2023 are final and primarily resulted from updated valuations related to the Company&#x2019;s real estate assets and liabilities and additional information obtained by the Company related to the properties acquired in the Merger and their respective tenants, and resulted in an increase to goodwill of $101.6&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Based on the final purchase price allocation of fair value, approximately $247.0&#160;million has been allocated to goodwill. Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired and liabilities assumed. The recognized goodwill is attributable to expected synergies and benefits arising from the Merger, including anticipated general and administrative cost savings and potential economies of scale benefits in both tenant and vendor relationships following the closing of the Merger.  None of the goodwill recognized is expected to be deductible for tax purposes. During the third quarter of 2023, the Company experienced a sustained decline in the price per share of its common stock, which it identified as an indicator of goodwill impairment.  As a result, the Company performed an interim goodwill evaluation. The fair value of the Company&#x2019;s single reporting unit &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;was estimated using a combination of discounted cash flow models and earnings multiples techniques. The quantitative assessment as of September 30, 2023 indicated goodwill was not impaired.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Merger-related Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company incurred Merger-related costs of $7.5 million and $(3.4) million, respectively, during the three and nine months ended September&#160;30, 2023, which were included within Merger-related costs in results of operations. The Merger-related costs primarily consist of legal, consulting, severance, and banking services and for the nine months ended September&#160;30, 2023 including a refund of $17.8&#160;million for transfer taxes paid during the year ended December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-122"
      decimals="2"
      id="f-682"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <hr:BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio
      contextRef="c-123"
      decimals="INF"
      id="f-683"
      unitRef="shares">1</hr:BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio>
    <hr:BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio
      contextRef="c-123"
      decimals="INF"
      id="f-684"
      unitRef="shares">1.00</hr:BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-124"
      decimals="2"
      id="f-685"
      unitRef="usdPerShare">4.82</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-123"
      decimals="2"
      id="f-686"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-125"
      decimals="2"
      id="f-687"
      unitRef="usdPerShare">0.01</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock contextRef="c-1" id="f-688">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The implied consideration transferred on the Closing Date is as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.495%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.702%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands, except for per share data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;228,520,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Exchange ratio&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Implied shares of Legacy HR Common Stock issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;228,520,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Adjusted closing price of Legacy HR Common Stock on July 20, 2022&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;24.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Value of implied Legacy HR Common Stock issued&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,569,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:700;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Consideration transferred&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,576,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(a) The number of shares of Legacy HTA Common Stock presented above was based on 228,857,717 total shares of Legacy HTA Common Stock outstanding as of the Closing Date, less 192 Legacy HTA fractional shares that were cancelled in lieu of cash and less 336,535 shares of Legacy HTA restricted stock (net of 215,764 shares of Legacy HTA restricted stock withheld). For accounting purposes, these shares were converted to Legacy HR Common Stock, at an exchange ratio of 1.00 share of Legacy HR Common Stock per share of Legacy HTA Common Stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(b) For accounting purposes, the fair value of Legacy HR Common Stock issued to former holders of Legacy HTA Common Stock was based on the per share closing price of Legacy HR Common Stock on July 20, 2022.&lt;/span&gt;&lt;/div&gt;(c) Represents the fair value of Legacy HTA restricted shares which fully vested prior to the closing of the Merger or became fully vested as a result of the closing of the Merger and which are attributable to pre-combination services.</us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-123"
      decimals="INF"
      id="f-689"
      unitRef="shares">228520990</us-gaap:CommonStockSharesOutstanding>
    <hr:RecapitalizationExchangeRatio contextRef="c-123" decimals="2" id="f-690" unitRef="number">1.00</hr:RecapitalizationExchangeRatio>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="c-126"
      decimals="INF"
      id="f-691"
      unitRef="shares">228520990</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-127"
      decimals="2"
      id="f-692"
      unitRef="usdPerShare">24.37</us-gaap:SaleOfStockPricePerShare>
    <hr:ReverseRecapitalizationNet contextRef="c-126" decimals="-3" id="f-693" unitRef="usd">5569057000</hr:ReverseRecapitalizationNet>
    <hr:BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices contextRef="c-126" decimals="-3" id="f-694" unitRef="usd">7406000</hr:BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-128" decimals="-3" id="f-695" unitRef="usd">5576463000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-127"
      decimals="INF"
      id="f-696"
      unitRef="shares">228857717</us-gaap:CommonStockSharesOutstanding>
    <hr:CommonStockFractionalShares
      contextRef="c-124"
      decimals="INF"
      id="f-697"
      unitRef="shares">192</hr:CommonStockFractionalShares>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-129"
      decimals="INF"
      id="f-698"
      unitRef="shares">336535</us-gaap:CommonStockSharesOutstanding>
    <hr:CommonStockSharesWithheld
      contextRef="c-130"
      decimals="INF"
      id="f-699"
      unitRef="shares">215764</hr:CommonStockSharesWithheld>
    <hr:RecapitalizationExchangeRatio contextRef="c-123" decimals="2" id="f-700" unitRef="number">1.00</hr:RecapitalizationExchangeRatio>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="c-1" id="f-701">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the Closing Date: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.553%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:36.360%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.746%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.748%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;&#160;CUMULATIVE MEASUREMENT PERIOD ADJUSTMENTS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;AMOUNTS RECOGNIZED ON THE CLOSING DATE &lt;br/&gt;(as adjusted)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;ASSETS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Real estate investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Land &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;985,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;18,359&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,004,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Buildings and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,960,418&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(119,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,841,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Lease intangible assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;831,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,839&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;833,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Financing lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;13,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;10,071&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(6,744)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Land held for development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;46,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;46,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Total real estate investments&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,844,747&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(102,535)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,742,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Assets held for sale, net &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;707,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(7,946)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;699,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Investments in unconsolidated joint ventures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;67,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;67,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;26,034&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;37,437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Restricted cash &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,123,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(1,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,122,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;198,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;16,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;214,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other assets, net &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;(b) (c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;209,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(3,840)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;205,323&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,177,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(87,795)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;11,089,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;LIABILITIES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Notes and bonds payable &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,991,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,991,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,227,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;17,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,244,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Liabilities of assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;28,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(3,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;24,738&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;173,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;10,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;184,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Financing lease liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;10,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(855)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;203,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(8,909)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;194,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Total liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,635,425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;13,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,649,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Net identifiable assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,541,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(101,639)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,440,122&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;110,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;110,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;145,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;101,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;247,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(a) The weighted average amortization period for the acquired lease intangible assets is approximately 6 years.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(b) Includes $15.9 million of contractual accounts receivable, which approximates fair value.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;(c) Includes $78.7 million of gross contractual real estate notes receivable, the fair value of which was $74.8 million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand contextRef="c-131" decimals="-3" id="f-702" unitRef="usd">985926000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand contextRef="c-126" decimals="-3" id="f-703" unitRef="usd">18359000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand contextRef="c-127" decimals="-3" id="f-704" unitRef="usd">1004285000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings contextRef="c-131" decimals="-3" id="f-705" unitRef="usd">6960418000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements contextRef="c-126" decimals="-3" id="f-706" unitRef="usd">-119135000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings contextRef="c-127" decimals="-3" id="f-707" unitRef="usd">6841283000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets contextRef="c-131" decimals="-3" id="f-708" unitRef="usd">831920000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets contextRef="c-126" decimals="-3" id="f-709" unitRef="usd">1839000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets contextRef="c-127" decimals="-3" id="f-710" unitRef="usd">833759000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets contextRef="c-131" decimals="-3" id="f-711" unitRef="usd">9874000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets contextRef="c-126" decimals="-3" id="f-712" unitRef="usd">3146000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets contextRef="c-127" decimals="-3" id="f-713" unitRef="usd">13020000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress contextRef="c-131" decimals="-3" id="f-714" unitRef="usd">10071000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress contextRef="c-126" decimals="-3" id="f-715" unitRef="usd">-6744000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress contextRef="c-127" decimals="-3" id="f-716" unitRef="usd">3327000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment contextRef="c-131" decimals="-3" id="f-717" unitRef="usd">46538000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment contextRef="c-127" decimals="-3" id="f-718" unitRef="usd">46538000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments contextRef="c-131" decimals="-3" id="f-719" unitRef="usd">8844747000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments contextRef="c-126" decimals="-3" id="f-720" unitRef="usd">-102535000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments contextRef="c-127" decimals="-3" id="f-721" unitRef="usd">8742212000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale contextRef="c-131" decimals="-3" id="f-722" unitRef="usd">707442000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet contextRef="c-126" decimals="-3" id="f-723" unitRef="usd">-7946000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale contextRef="c-127" decimals="-3" id="f-724" unitRef="usd">699496000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures contextRef="c-131" decimals="-3" id="f-725" unitRef="usd">67892000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures contextRef="c-127" decimals="-3" id="f-726" unitRef="usd">67892000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents contextRef="c-131" decimals="-3" id="f-727" unitRef="usd">26034000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents contextRef="c-126" decimals="-3" id="f-728" unitRef="usd">11403000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents contextRef="c-127" decimals="-3" id="f-729" unitRef="usd">37437000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash contextRef="c-131" decimals="-3" id="f-730" unitRef="usd">1123647000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash contextRef="c-126" decimals="-3" id="f-731" unitRef="usd">-1247000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash contextRef="c-127" decimals="-3" id="f-732" unitRef="usd">1122400000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets contextRef="c-131" decimals="-3" id="f-733" unitRef="usd">198261000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets contextRef="c-126" decimals="-3" id="f-734" unitRef="usd">16370000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets contextRef="c-127" decimals="-3" id="f-735" unitRef="usd">214631000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets contextRef="c-131" decimals="-3" id="f-736" unitRef="usd">209163000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet contextRef="c-126" decimals="-3" id="f-737" unitRef="usd">-3840000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets contextRef="c-127" decimals="-3" id="f-738" unitRef="usd">205323000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="c-131" decimals="-3" id="f-739" unitRef="usd">11177186000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired contextRef="c-126" decimals="-3" id="f-740" unitRef="usd">-87795000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets contextRef="c-127" decimals="-3" id="f-741" unitRef="usd">11089391000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt contextRef="c-131" decimals="-3" id="f-742" unitRef="usd">3991300000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt contextRef="c-127" decimals="-3" id="f-743" unitRef="usd">3991300000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities contextRef="c-131" decimals="-3" id="f-744" unitRef="usd">1227570000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities contextRef="c-126" decimals="-3" id="f-745" unitRef="usd">17374000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities contextRef="c-127" decimals="-3" id="f-746" unitRef="usd">1244944000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale contextRef="c-131" decimals="-3" id="f-747" unitRef="usd">28677000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale contextRef="c-126" decimals="-3" id="f-748" unitRef="usd">-3939000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale contextRef="c-127" decimals="-3" id="f-749" unitRef="usd">24738000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities contextRef="c-131" decimals="-3" id="f-750" unitRef="usd">173948000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities contextRef="c-126" decimals="-3" id="f-751" unitRef="usd">10173000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities contextRef="c-127" decimals="-3" id="f-752" unitRef="usd">184121000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities contextRef="c-131" decimals="-3" id="f-753" unitRef="usd">10720000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities contextRef="c-126" decimals="-3" id="f-754" unitRef="usd">-855000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities contextRef="c-127" decimals="-3" id="f-755" unitRef="usd">9865000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities contextRef="c-131" decimals="-3" id="f-756" unitRef="usd">203210000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities contextRef="c-126" decimals="-3" id="f-757" unitRef="usd">-8909000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities contextRef="c-127" decimals="-3" id="f-758" unitRef="usd">194301000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities contextRef="c-131" decimals="-3" id="f-759" unitRef="usd">5635425000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed contextRef="c-126" decimals="-3" id="f-760" unitRef="usd">13844000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities contextRef="c-127" decimals="-3" id="f-761" unitRef="usd">5649269000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="c-131" decimals="-3" id="f-762" unitRef="usd">5541761000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired contextRef="c-126" decimals="-3" id="f-763" unitRef="usd">-101639000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet contextRef="c-127" decimals="-3" id="f-764" unitRef="usd">5440122000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue contextRef="c-131" decimals="-3" id="f-765" unitRef="usd">110702000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue contextRef="c-127" decimals="-3" id="f-766" unitRef="usd">110702000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:Goodwill contextRef="c-131" decimals="-3" id="f-767" unitRef="usd">145404000</us-gaap:Goodwill>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill contextRef="c-126" decimals="-3" id="f-768" unitRef="usd">101639000</hr:BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill>
    <us-gaap:Goodwill contextRef="c-127" decimals="-3" id="f-769" unitRef="usd">247043000</us-gaap:Goodwill>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="c-127" id="f-770">P6Y</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <us-gaap:BusinessCombinationAcquiredReceivablesGrossContractualAmount contextRef="c-127" decimals="-5" id="f-771" unitRef="usd">15900000</us-gaap:BusinessCombinationAcquiredReceivablesGrossContractualAmount>
    <hr:BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount contextRef="c-127" decimals="-5" id="f-772" unitRef="usd">78700000</hr:BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount>
    <hr:GrossContractualRealEstateNotesReceivableFairValue contextRef="c-127" decimals="-5" id="f-773" unitRef="usd">74800000</hr:GrossContractualRealEstateNotesReceivableFairValue>
    <hr:BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete contextRef="c-132" decimals="-5" id="f-774" unitRef="usd">101600000</hr:BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete>
    <us-gaap:Goodwill contextRef="c-127" decimals="-5" id="f-775" unitRef="usd">247000000</us-gaap:Goodwill>
    <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount contextRef="c-127" decimals="INF" id="f-776" unitRef="usd">0</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
    <hr:MergerRelatedCosts contextRef="c-5" decimals="-5" id="f-777" unitRef="usd">7500000</hr:MergerRelatedCosts>
    <hr:MergerRelatedCosts contextRef="c-1" decimals="-5" id="f-778" unitRef="usd">-3400000</hr:MergerRelatedCosts>
    <hr:BusinessCombinationRefundOfTransferTaxesPaid contextRef="c-1" decimals="-5" id="f-779" unitRef="usd">17800000</hr:BusinessCombinationRefundOfTransferTaxesPaid>
    <hr:AcquisitionsAndDispositionsTextBlock contextRef="c-1" id="f-780">Real Estate Investments&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;2023 Acquisition Activity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:130%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table details the Company's real estate acquisition activity for the nine months ended September&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.941%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.609%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.890%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.836%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.937%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.306%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.732%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.001%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;DATE ACQUIRED&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;PURCHASE PRICE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MORTGAGE NOTES PAYABLE, NET&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CASH&lt;br/&gt;CONSIDERATION &lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;REAL &lt;br/&gt;ESTATE &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OTHER &lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SQUARE FOOTAGE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Tampa, FL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/10/23&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;31,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;30,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;30,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;115,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Colorado Springs, CO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/28/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;11,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(5,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;11,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;42,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Total real estate acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;42,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(5,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;36,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;42,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;158,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;In the third quarter of 2023, the Company acquired a parcel of land previously under a ground lease for $0.8&#160;million and an additional interest in an operating property for $0.6&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Unconsolidated Joint Ventures&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company's investment in and loss recognized for the three and nine months ended September&#160;30, 2023 and 2022 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.094%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.435%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.766%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.766%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.766%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Investments in unconsolidated joint ventures, beginning of period &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;210,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;161,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;New investment during the period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;117,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;167,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Equity loss recognized during the period &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(776)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Owner distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(1,336)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(785)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(4,366)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Investments in unconsolidated joint ventures, end of period &lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;325,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;325,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;In 2023, this was an additional investment in an existing joint venture in which the Company retained a 40% ownership interest. The investment consisted of the Company's sale of a property in Dallas, Texas to the joint venture.  See 2023 Real Estate Asset Dispositions below for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;2023 Real Estate Asset Dispositions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table details the Company's dispositions for the nine months ended September&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.037%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.698%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.615%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.756%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.074%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.309%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;DATE DISPOSED&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SALE PRICE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CLOSING ADJUSTMENTS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;COMPANY-FINANCED MORTGAGE NOTES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;NET PROCEEDS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;NET REAL ESTATE INVESTMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OTHER (INCLUDING RECEIVABLES) &lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;GAIN/(IMPAIRMENT)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SQUARE FOOTAGE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Tampa/Miami, FL&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/12/23&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;93,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(5,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;87,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;87,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(888)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;224,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dallas, TX &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/30/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;19,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(141)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;19,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;18,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;36,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;St. Louis, MO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2/10/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Los Angeles, CA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/23/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;21,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(526)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;20,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;20,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;37,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Los Angeles, CA &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/30/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(8,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(45,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;21,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;88,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(803)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(20,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;147,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Los Angeles, CA &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/12/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Albany, NY&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6/30/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;40,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Houston, TX&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8/2/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;57,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Atlanta, GA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8/22/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;25,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;25,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;23,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(536)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;55,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dallas, TX&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;9/15/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;115,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;113,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;64,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;43,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;161,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Houston, TX&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;9/18/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;52,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Chicago, IL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;9/27/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;59,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(870)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;59,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;74,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(380)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(15,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;104,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total dispositions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;430,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(18,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(45,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;366,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;390,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;18,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;922,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Includes straight-line rent receivables, leasing commissions and lease inducements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;Includes two properties, sold in two separate transactions to the same buyer on the same date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt"&gt;The Company sold this property to a joint venture in which it retained a 40% interest. Sales price and square footage reflect the total sales price paid by the joint venture and total square footage of the property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.81pt"&gt;The Company entered into a mortgage note agreement with the buyer for $45&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.18pt"&gt;The Company sold a land parcel totaling 0.34 acres.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Assets Held for Sale&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company had 17 properties and one corporate entity classified as assets held for sale as of September&#160;30, 2023. The net real estate assets held for sale includes the impact of $15.9&#160;million and $46.4&#160;million, respectively, of impairment charges for the three and nine months ended September&#160;30, 2023.  The Company had one property classified as assets held for sale as of December&#160;31, 2022, which was sold in the first quarter of 2023.  The table below reflects the assets and liabilities classified as held for sale as of September&#160;30, 2023 and December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.087%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.879%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.469%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.471%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Balance Sheet data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;14,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;41,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;15,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Lease intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;68,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;18,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(13,634)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Real estate assets held for sale, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;55,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;18,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Assets held for sale, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;57,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;18,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Liabilities of assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</hr:AcquisitionsAndDispositionsTextBlock>
    <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="c-1" id="f-781">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table details the Company's real estate acquisition activity for the nine months ended September&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.941%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.609%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.890%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.836%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.937%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.588%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.306%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.732%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.101%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.001%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;DATE ACQUIRED&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;PURCHASE PRICE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MORTGAGE NOTES PAYABLE, NET&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CASH&lt;br/&gt;CONSIDERATION &lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;REAL &lt;br/&gt;ESTATE &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OTHER &lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SQUARE FOOTAGE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Tampa, FL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/10/23&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;31,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;30,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;30,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(97)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;115,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Colorado Springs, CO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/28/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;11,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(5,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;11,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(108)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;42,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Total real estate acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;42,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(5,284)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;36,523&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;42,012&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(205)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;158,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-133" decimals="-3" id="f-782" unitRef="usd">31500000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="c-133" decimals="-3" id="f-783" unitRef="usd">0</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-133" decimals="-3" id="f-784" unitRef="usd">30499000</us-gaap:PaymentsToAcquireBusinessesGross>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty contextRef="c-134" decimals="-3" id="f-785" unitRef="usd">30596000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther contextRef="c-134" decimals="-3" id="f-786" unitRef="usd">-97000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther>
    <hr:BusinessAcquisitionPurchasePriceAllocationSquareFootage contextRef="c-134" decimals="0" id="f-787" unitRef="sqft">115867</hr:BusinessAcquisitionPurchasePriceAllocationSquareFootage>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-135" decimals="-3" id="f-788" unitRef="usd">11450000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="c-135" decimals="-3" id="f-789" unitRef="usd">5284000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-135" decimals="-3" id="f-790" unitRef="usd">6024000</us-gaap:PaymentsToAcquireBusinessesGross>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty contextRef="c-136" decimals="-3" id="f-791" unitRef="usd">11416000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther contextRef="c-136" decimals="-3" id="f-792" unitRef="usd">-108000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther>
    <hr:BusinessAcquisitionPurchasePriceAllocationSquareFootage contextRef="c-136" decimals="0" id="f-793" unitRef="sqft">42770</hr:BusinessAcquisitionPurchasePriceAllocationSquareFootage>
    <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="c-137" decimals="-3" id="f-794" unitRef="usd">42950000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred contextRef="c-137" decimals="-3" id="f-795" unitRef="usd">5284000</us-gaap:BusinessCombinationConsiderationTransferredLiabilitiesIncurred>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-137" decimals="-3" id="f-796" unitRef="usd">36523000</us-gaap:PaymentsToAcquireBusinessesGross>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty contextRef="c-138" decimals="-3" id="f-797" unitRef="usd">42012000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty>
    <hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther contextRef="c-138" decimals="-3" id="f-798" unitRef="usd">-205000</hr:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther>
    <hr:BusinessAcquisitionPurchasePriceAllocationSquareFootage contextRef="c-138" decimals="0" id="f-799" unitRef="sqft">158637</hr:BusinessAcquisitionPurchasePriceAllocationSquareFootage>
    <us-gaap:PaymentsToAcquireLand contextRef="c-5" decimals="-5" id="f-800" unitRef="usd">800000</us-gaap:PaymentsToAcquireLand>
    <us-gaap:PaymentsToAcquireProductiveAssets contextRef="c-5" decimals="-5" id="f-801" unitRef="usd">600000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:EquityMethodInvestmentsTextBlock contextRef="c-1" id="f-802">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company's investment in and loss recognized for the three and nine months ended September&#160;30, 2023 and 2022 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.094%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.435%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.766%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.766%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.766%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.767%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Investments in unconsolidated joint ventures, beginning of period &lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;210,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;161,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;New investment during the period &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;117,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;167,479&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Equity loss recognized during the period &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(456)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(124)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,253)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(776)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Owner distributions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(1,336)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(785)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(4,366)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(893)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Investments in unconsolidated joint ventures, end of period &lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;325,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;325,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;327,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;In 2023, this was an additional investment in an existing joint venture in which the Company retained a 40% ownership interest. The investment consisted of the Company's sale of a property in Dallas, Texas to the joint venture.  See 2023 Real Estate Asset Dispositions below for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-139" decimals="-3" id="f-803" unitRef="usd">327245000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-140" decimals="-3" id="f-804" unitRef="usd">210781000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-141" decimals="-3" id="f-805" unitRef="usd">327248000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-142" decimals="-3" id="f-806" unitRef="usd">161942000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod contextRef="c-143" decimals="-3" id="f-807" unitRef="usd">0</hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod>
    <hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod contextRef="c-144" decimals="-3" id="f-808" unitRef="usd">117880000</hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod>
    <hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod contextRef="c-145" decimals="-3" id="f-809" unitRef="usd">3824000</hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod>
    <hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod contextRef="c-146" decimals="-3" id="f-810" unitRef="usd">167479000</hr:InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-143" decimals="-3" id="f-811" unitRef="usd">-456000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-144" decimals="-3" id="f-812" unitRef="usd">-124000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-145" decimals="-3" id="f-813" unitRef="usd">-1253000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments contextRef="c-146" decimals="-3" id="f-814" unitRef="usd">-776000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared contextRef="c-143" decimals="-3" id="f-815" unitRef="usd">1336000</us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared>
    <us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared contextRef="c-144" decimals="-3" id="f-816" unitRef="usd">785000</us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared>
    <us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared contextRef="c-145" decimals="-3" id="f-817" unitRef="usd">4366000</us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared>
    <us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared contextRef="c-146" decimals="-3" id="f-818" unitRef="usd">893000</us-gaap:DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-147" decimals="-3" id="f-819" unitRef="usd">325453000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-148" decimals="-3" id="f-820" unitRef="usd">327752000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-147" decimals="-3" id="f-821" unitRef="usd">325453000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures contextRef="c-148" decimals="-3" id="f-822" unitRef="usd">327752000</us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures>
    <hr:JointVentureOwnershipPercentage contextRef="c-149" decimals="2" id="f-823" unitRef="number">0.40</hr:JointVentureOwnershipPercentage>
    <hr:AssetDispositionsTableTextBlock contextRef="c-1" id="f-824">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table details the Company's dispositions for the nine months ended September&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.037%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.698%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.615%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.756%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.074%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.309%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.838%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.367%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:6.397%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;DATE DISPOSED&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SALE PRICE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CLOSING ADJUSTMENTS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;COMPANY-FINANCED MORTGAGE NOTES&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;NET PROCEEDS&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;NET REAL ESTATE INVESTMENT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OTHER (INCLUDING RECEIVABLES) &lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;GAIN/(IMPAIRMENT)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;SQUARE FOOTAGE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Tampa/Miami, FL&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/12/23&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;93,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(5,875)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;87,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;87,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(888)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;224,037&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dallas, TX &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;3&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/30/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;19,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(141)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;19,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;18,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;36,691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;St. Louis, MO&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2/10/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;398&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Los Angeles, CA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/23/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;21,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(526)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;20,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;20,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(188)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;37,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Los Angeles, CA &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;4&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/30/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;75,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(8,079)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(45,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;21,921&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;88,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(803)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(20,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;147,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Los Angeles, CA &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/12/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Albany, NY&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6/30/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,229)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,040)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7,198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;40,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Houston, TX&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8/2/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(285)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8,035&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;57,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Atlanta, GA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8/22/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;25,142&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(66)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;25,076&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;23,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(536)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;55,195&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dallas, TX&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;9/15/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;115,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,504)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;113,496&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;64,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6,094&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;43,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;161,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Houston, TX&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;9/18/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;52,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Chicago, IL&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;9/27/23&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;59,950&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(870)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;59,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;74,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(380)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(15,250)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;104,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Total dispositions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;430,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(18,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(45,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;366,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;390,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;18,600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;922,922&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Includes straight-line rent receivables, leasing commissions and lease inducements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;Includes two properties, sold in two separate transactions to the same buyer on the same date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.17pt"&gt;The Company sold this property to a joint venture in which it retained a 40% interest. Sales price and square footage reflect the total sales price paid by the joint venture and total square footage of the property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;4&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:13.81pt"&gt;The Company entered into a mortgage note agreement with the buyer for $45&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.18pt"&gt;The Company sold a land parcel totaling 0.34 acres.&lt;/span&gt;&lt;/div&gt;</hr:AssetDispositionsTableTextBlock>
    <hr:DispositionSalesPrice contextRef="c-150" decimals="-3" id="f-825" unitRef="usd">93250000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-150" decimals="-3" id="f-826" unitRef="usd">5875000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes contextRef="c-150" decimals="-3" id="f-827" unitRef="usd">0</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-151" decimals="-3" id="f-828" unitRef="usd">87375000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-150" decimals="-3" id="f-829" unitRef="usd">87302000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-150" decimals="-3" id="f-830" unitRef="usd">-888000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-151" decimals="-3" id="f-831" unitRef="usd">961000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-150" decimals="0" id="f-832" unitRef="sqft">224037</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-152" decimals="-3" id="f-833" unitRef="usd">19210000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-152" decimals="-3" id="f-834" unitRef="usd">141000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes contextRef="c-152" decimals="-3" id="f-835" unitRef="usd">0</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-153" decimals="-3" id="f-836" unitRef="usd">19069000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-152" decimals="-3" id="f-837" unitRef="usd">18986000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-152" decimals="-3" id="f-838" unitRef="usd">43000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-153" decimals="-3" id="f-839" unitRef="usd">40000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-152" decimals="0" id="f-840" unitRef="sqft">36691</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-154" decimals="-3" id="f-841" unitRef="usd">350000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-154" decimals="-3" id="f-842" unitRef="usd">18000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes contextRef="c-154" decimals="-3" id="f-843" unitRef="usd">0</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-155" decimals="-3" id="f-844" unitRef="usd">332000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-154" decimals="-3" id="f-845" unitRef="usd">398000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-154" decimals="-3" id="f-846" unitRef="usd">0</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-155" decimals="-3" id="f-847" unitRef="usd">-66000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-154" decimals="0" id="f-848" unitRef="sqft">6500</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-156" decimals="-3" id="f-849" unitRef="usd">21000000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-156" decimals="-3" id="f-850" unitRef="usd">526000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes contextRef="c-156" decimals="-3" id="f-851" unitRef="usd">0</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-157" decimals="-3" id="f-852" unitRef="usd">20474000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-156" decimals="-3" id="f-853" unitRef="usd">20610000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-156" decimals="-3" id="f-854" unitRef="usd">52000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-157" decimals="-3" id="f-855" unitRef="usd">-188000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-156" decimals="0" id="f-856" unitRef="sqft">37165</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-158" decimals="-3" id="f-857" unitRef="usd">75000000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-158" decimals="-3" id="f-858" unitRef="usd">8079000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes contextRef="c-158" decimals="-3" id="f-859" unitRef="usd">45000000</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-159" decimals="-3" id="f-860" unitRef="usd">21921000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-158" decimals="-3" id="f-861" unitRef="usd">88624000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-158" decimals="-3" id="f-862" unitRef="usd">-803000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-159" decimals="-3" id="f-863" unitRef="usd">-20900000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-158" decimals="0" id="f-864" unitRef="sqft">147078</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-160" decimals="-3" id="f-865" unitRef="usd">3300000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-160" decimals="-3" id="f-866" unitRef="usd">334000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes contextRef="c-160" decimals="-3" id="f-867" unitRef="usd">0</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-161" decimals="-3" id="f-868" unitRef="usd">2966000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-160" decimals="-3" id="f-869" unitRef="usd">3268000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-160" decimals="-3" id="f-870" unitRef="usd">0</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-161" decimals="-3" id="f-871" unitRef="usd">-302000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-160" decimals="0" id="f-872" unitRef="sqft">0</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-162" decimals="-3" id="f-873" unitRef="usd">10000000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-162" decimals="-3" id="f-874" unitRef="usd">1229000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes contextRef="c-162" decimals="-3" id="f-875" unitRef="usd">0</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-163" decimals="-3" id="f-876" unitRef="usd">8771000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-162" decimals="-3" id="f-877" unitRef="usd">2613000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-162" decimals="-3" id="f-878" unitRef="usd">-1040000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-163" decimals="-3" id="f-879" unitRef="usd">7198000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-162" decimals="0" id="f-880" unitRef="sqft">40870</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-164" decimals="-3" id="f-881" unitRef="usd">8320000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-164" decimals="-3" id="f-882" unitRef="usd">285000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes contextRef="c-164" decimals="-3" id="f-883" unitRef="usd">0</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-165" decimals="-3" id="f-884" unitRef="usd">8035000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-164" decimals="-3" id="f-885" unitRef="usd">4567000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-164" decimals="-3" id="f-886" unitRef="usd">194000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-165" decimals="-3" id="f-887" unitRef="usd">3274000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-164" decimals="0" id="f-888" unitRef="sqft">57170</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-166" decimals="-3" id="f-889" unitRef="usd">25142000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-166" decimals="-3" id="f-890" unitRef="usd">66000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes contextRef="c-166" decimals="-3" id="f-891" unitRef="usd">0</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-167" decimals="-3" id="f-892" unitRef="usd">25076000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-166" decimals="-3" id="f-893" unitRef="usd">23226000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-166" decimals="-3" id="f-894" unitRef="usd">-536000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-167" decimals="-3" id="f-895" unitRef="usd">2386000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-166" decimals="0" id="f-896" unitRef="sqft">55195</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-168" decimals="-3" id="f-897" unitRef="usd">115000000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-168" decimals="-3" id="f-898" unitRef="usd">1504000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes contextRef="c-168" decimals="-3" id="f-899" unitRef="usd">0</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-169" decimals="-3" id="f-900" unitRef="usd">113496000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-168" decimals="-3" id="f-901" unitRef="usd">64183000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-168" decimals="-3" id="f-902" unitRef="usd">6094000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-169" decimals="-3" id="f-903" unitRef="usd">43219000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-168" decimals="0" id="f-904" unitRef="sqft">161264</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-170" decimals="-3" id="f-905" unitRef="usd">250000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-170" decimals="-3" id="f-906" unitRef="usd">24000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes contextRef="c-170" decimals="-3" id="f-907" unitRef="usd">0</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-171" decimals="-3" id="f-908" unitRef="usd">226000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-170" decimals="-3" id="f-909" unitRef="usd">1998000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-170" decimals="-3" id="f-910" unitRef="usd">0</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-171" decimals="-3" id="f-911" unitRef="usd">-1772000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-170" decimals="0" id="f-912" unitRef="sqft">52040</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-172" decimals="-3" id="f-913" unitRef="usd">59950000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-172" decimals="-3" id="f-914" unitRef="usd">870000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes contextRef="c-172" decimals="-3" id="f-915" unitRef="usd">0</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-173" decimals="-3" id="f-916" unitRef="usd">59080000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-172" decimals="-3" id="f-917" unitRef="usd">74710000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-172" decimals="-3" id="f-918" unitRef="usd">-380000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-173" decimals="-3" id="f-919" unitRef="usd">-15250000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-172" decimals="0" id="f-920" unitRef="sqft">104912</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <hr:DispositionSalesPrice contextRef="c-174" decimals="-3" id="f-921" unitRef="usd">430772000</hr:DispositionSalesPrice>
    <hr:ClosingAdjustmentsDisposedEntity contextRef="c-174" decimals="-3" id="f-922" unitRef="usd">18951000</hr:ClosingAdjustmentsDisposedEntity>
    <hr:FinanceMortgageNotes contextRef="c-174" decimals="-3" id="f-923" unitRef="usd">45000000</hr:FinanceMortgageNotes>
    <us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment contextRef="c-175" decimals="-3" id="f-924" unitRef="usd">366821000</us-gaap:ProceedsFromSaleOfRealEstateHeldforinvestment>
    <hr:RealEstateInvestmentNetDisposedOfDuringPeriod contextRef="c-174" decimals="-3" id="f-925" unitRef="usd">390485000</hr:RealEstateInvestmentNetDisposedOfDuringPeriod>
    <hr:RealEstateOther contextRef="c-174" decimals="-3" id="f-926" unitRef="usd">2736000</hr:RealEstateOther>
    <us-gaap:GainLossOnDispositionOfAssets contextRef="c-175" decimals="-3" id="f-927" unitRef="usd">18600000</us-gaap:GainLossOnDispositionOfAssets>
    <hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits contextRef="c-174" decimals="0" id="f-928" unitRef="sqft">922922</hr:AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="c-150"
      decimals="INF"
      id="f-929"
      unitRef="property">2</us-gaap:NumberOfRealEstateProperties>
    <hr:NumberOfPropertyDispositions
      contextRef="c-150"
      decimals="INF"
      id="f-930"
      unitRef="disposition_transaction">2</hr:NumberOfPropertyDispositions>
    <hr:JointVentureOwnershipPercentage contextRef="c-153" decimals="2" id="f-931" unitRef="number">0.40</hr:JointVentureOwnershipPercentage>
    <hr:MortgageNote contextRef="c-158" decimals="-6" id="f-932" unitRef="usd">45000000</hr:MortgageNote>
    <us-gaap:AreaOfLand contextRef="c-176" decimals="2" id="f-933" unitRef="acre">0.34</us-gaap:AreaOfLand>
    <hr:NumberOfPropertiesClassifiedAsHeldForSale
      contextRef="c-3"
      decimals="INF"
      id="f-934"
      unitRef="property">17</hr:NumberOfPropertiesClassifiedAsHeldForSale>
    <hr:NumberOfCorporateEntityClassifiedAsHeldForSale contextRef="c-3" decimals="INF" id="f-935" unitRef="entity">1</hr:NumberOfCorporateEntityClassifiedAsHeldForSale>
    <hr:ImpairmentChargeOnRealEstateAssetsHeldForSale contextRef="c-5" decimals="-5" id="f-936" unitRef="usd">15900000</hr:ImpairmentChargeOnRealEstateAssetsHeldForSale>
    <hr:ImpairmentChargeOnRealEstateAssetsHeldForSale contextRef="c-1" decimals="-5" id="f-937" unitRef="usd">46400000</hr:ImpairmentChargeOnRealEstateAssetsHeldForSale>
    <hr:NumberOfPropertiesClassifiedAsHeldForSale
      contextRef="c-4"
      decimals="INF"
      id="f-938"
      unitRef="property">1</hr:NumberOfPropertiesClassifiedAsHeldForSale>
    <hr:ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock contextRef="c-1" id="f-939">The table below reflects the assets and liabilities classified as held for sale as of September&#160;30, 2023 and December&#160;31, 2022:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.073%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.087%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.879%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.469%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.494%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.471%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:120%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Balance Sheet data:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;14,282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,700&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;41,538&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;15,164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Lease intangibles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;68,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;18,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;(13,634)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Real estate assets held for sale, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;55,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;18,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other assets, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Assets held for sale, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;57,638&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;18,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;282&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Liabilities of assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;437&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</hr:ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock>
    <us-gaap:Land contextRef="c-177" decimals="-3" id="f-940" unitRef="usd">14282000</us-gaap:Land>
    <us-gaap:Land contextRef="c-178" decimals="-3" id="f-941" unitRef="usd">1700000</us-gaap:Land>
    <us-gaap:InvestmentBuildingAndBuildingImprovements contextRef="c-177" decimals="-3" id="f-942" unitRef="usd">41538000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <us-gaap:InvestmentBuildingAndBuildingImprovements contextRef="c-178" decimals="-3" id="f-943" unitRef="usd">15164000</us-gaap:InvestmentBuildingAndBuildingImprovements>
    <hr:LeaseIntangibles contextRef="c-177" decimals="-3" id="f-944" unitRef="usd">12938000</hr:LeaseIntangibles>
    <hr:LeaseIntangibles contextRef="c-178" decimals="-3" id="f-945" unitRef="usd">1986000</hr:LeaseIntangibles>
    <us-gaap:RealEstateInvestmentPropertyAtCost contextRef="c-177" decimals="-3" id="f-946" unitRef="usd">68758000</us-gaap:RealEstateInvestmentPropertyAtCost>
    <us-gaap:RealEstateInvestmentPropertyAtCost contextRef="c-178" decimals="-3" id="f-947" unitRef="usd">18850000</us-gaap:RealEstateInvestmentPropertyAtCost>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation contextRef="c-177" decimals="-3" id="f-948" unitRef="usd">13634000</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation contextRef="c-178" decimals="-3" id="f-949" unitRef="usd">0</us-gaap:RealEstateInvestmentPropertyAccumulatedDepreciation>
    <us-gaap:RealEstateInvestmentPropertyNet contextRef="c-177" decimals="-3" id="f-950" unitRef="usd">55124000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:RealEstateInvestmentPropertyNet contextRef="c-178" decimals="-3" id="f-951" unitRef="usd">18850000</us-gaap:RealEstateInvestmentPropertyNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-177" decimals="-3" id="f-952" unitRef="usd">585000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-178" decimals="-3" id="f-953" unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets contextRef="c-177" decimals="-3" id="f-954" unitRef="usd">1929000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets contextRef="c-178" decimals="-3" id="f-955" unitRef="usd">43000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherAssets>
    <hr:AssetsHeldForSaleAndDiscontinuedOperationsNet contextRef="c-177" decimals="-3" id="f-956" unitRef="usd">57638000</hr:AssetsHeldForSaleAndDiscontinuedOperationsNet>
    <hr:AssetsHeldForSaleAndDiscontinuedOperationsNet contextRef="c-178" decimals="-3" id="f-957" unitRef="usd">18893000</hr:AssetsHeldForSaleAndDiscontinuedOperationsNet>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities contextRef="c-177" decimals="-3" id="f-958" unitRef="usd">1716000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities contextRef="c-178" decimals="-3" id="f-959" unitRef="usd">282000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities>
    <us-gaap:OperatingLeaseLiability contextRef="c-177" decimals="-3" id="f-960" unitRef="usd">1020000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability contextRef="c-178" decimals="-3" id="f-961" unitRef="usd">0</us-gaap:OperatingLeaseLiability>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities contextRef="c-177" decimals="-3" id="f-962" unitRef="usd">1078000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities contextRef="c-178" decimals="-3" id="f-963" unitRef="usd">155000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherLiabilities>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-177" decimals="-3" id="f-964" unitRef="usd">3814000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation contextRef="c-178" decimals="-3" id="f-965" unitRef="usd">437000</us-gaap:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation>
    <us-gaap:LesseeFinanceLeasesTextBlock contextRef="c-1" id="f-966">Leases&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Lessor Accounting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s properties generally are leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide tenants with fixed rent renewal terms while others have market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company&#x2019;s single-tenant net leases generally require the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company's leases typically have escalators that are either based on a stated percentage or an index such as the consumer price index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three and nine months ended September&#160;30, 2023 was $333.3 million and $987.1 million, respectively.  Lease income for the Company's operating leases recognized for the three and nine months ended September 30, 2022 was $298.9 million and $578.1 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Future lease payments under the non-cancelable operating leases, excluding any reimbursements and one sale-type lease, as of September&#160;30, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.573%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.063%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.064%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;231,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;874,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;770,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;666,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;552,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,918,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,014,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Lessee Accounting &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of September&#160;30, 2023, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company&#x2019;s ground leases. As of September&#160;30, 2023, the Company had 240 properties totaling 17.4 million square feet that were held under ground leases. Some of the ground lease renewal terms are based on fixed rent renewal terms and others have market rent renewal terms. These ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company&#x2019;s ground leases are generally either stated or based on CPI. The Company had 75 prepaid ground leases as of September&#160;30, 2023. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $0.3 million and $0.1&#160;million of the Company&#x2019;s rental expense for the three months ended September&#160;30, 2023 and 2022, respectively, and $1.0&#160;million and $0.4&#160;million for the nine months ended September&#160;30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s future lease payments (primarily for its 165 non-prepaid ground leases) as of September&#160;30, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FINANCING&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;922,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;396,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;982,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;405,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(709,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(331,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;273,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;74,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides details of the Company's total lease expense for the three and nine months ended September&#160;30, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.863%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;15,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Variable lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;26,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating cash flows outflows related to operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;16,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating cash flows outflows related to financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Financing cash flows outflows related to financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;50,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;198,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;198,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average years remaining lease term (excluding renewal options) - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;47.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;50.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average years remaining lease term (excluding renewal options) - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;58.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;60.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-967">Leases&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Lessor Accounting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s properties generally are leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide tenants with fixed rent renewal terms while others have market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company&#x2019;s single-tenant net leases generally require the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company's leases typically have escalators that are either based on a stated percentage or an index such as the consumer price index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three and nine months ended September&#160;30, 2023 was $333.3 million and $987.1 million, respectively.  Lease income for the Company's operating leases recognized for the three and nine months ended September 30, 2022 was $298.9 million and $578.1 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Future lease payments under the non-cancelable operating leases, excluding any reimbursements and one sale-type lease, as of September&#160;30, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.573%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.063%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.064%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;231,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;874,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;770,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;666,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;552,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,918,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,014,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Lessee Accounting &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of September&#160;30, 2023, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company&#x2019;s ground leases. As of September&#160;30, 2023, the Company had 240 properties totaling 17.4 million square feet that were held under ground leases. Some of the ground lease renewal terms are based on fixed rent renewal terms and others have market rent renewal terms. These ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company&#x2019;s ground leases are generally either stated or based on CPI. The Company had 75 prepaid ground leases as of September&#160;30, 2023. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $0.3 million and $0.1&#160;million of the Company&#x2019;s rental expense for the three months ended September&#160;30, 2023 and 2022, respectively, and $1.0&#160;million and $0.4&#160;million for the nine months ended September&#160;30, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s future lease payments (primarily for its 165 non-prepaid ground leases) as of September&#160;30, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FINANCING&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;922,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;396,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;982,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;405,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(709,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(331,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;273,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;74,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides details of the Company's total lease expense for the three and nine months ended September&#160;30, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.863%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;15,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Variable lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;26,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating cash flows outflows related to operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;16,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating cash flows outflows related to financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Financing cash flows outflows related to financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;50,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;198,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;198,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average years remaining lease term (excluding renewal options) - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;47.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;50.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average years remaining lease term (excluding renewal options) - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;58.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;60.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-5" decimals="-5" id="f-968" unitRef="usd">333300000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-1" decimals="-5" id="f-969" unitRef="usd">987100000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-6" decimals="-5" id="f-970" unitRef="usd">298900000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:OperatingLeaseLeaseIncome contextRef="c-7" decimals="-5" id="f-971" unitRef="usd">578100000</us-gaap:OperatingLeaseLeaseIncome>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock contextRef="c-1" id="f-972">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Future lease payments under the non-cancelable operating leases, excluding any reimbursements and one sale-type lease, as of September&#160;30, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.461%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:42.573%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.063%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:27.064%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;231,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;874,750&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;770,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;666,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;552,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,918,689&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,014,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear contextRef="c-3" decimals="-3" id="f-973" unitRef="usd">231698000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths contextRef="c-3" decimals="-3" id="f-974" unitRef="usd">874750000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears contextRef="c-3" decimals="-3" id="f-975" unitRef="usd">770520000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedTwoYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears contextRef="c-3" decimals="-3" id="f-976" unitRef="usd">666294000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedThreeYears>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears contextRef="c-3" decimals="-3" id="f-977" unitRef="usd">552111000</us-gaap:LessorOperatingLeasePaymentsToBeReceivedFourYears>
    <hr:LessorOperatingLeasePaymenttobeReceivedafterYearFour contextRef="c-3" decimals="-3" id="f-978" unitRef="usd">1918689000</hr:LessorOperatingLeasePaymenttobeReceivedafterYearFour>
    <us-gaap:LessorOperatingLeasePaymentsToBeReceived contextRef="c-3" decimals="-3" id="f-979" unitRef="usd">5014062000</us-gaap:LessorOperatingLeasePaymentsToBeReceived>
    <us-gaap:NumberOfPropertiesSubjectToGroundLeases
      contextRef="c-3"
      decimals="INF"
      id="f-980"
      unitRef="property">240</us-gaap:NumberOfPropertiesSubjectToGroundLeases>
    <hr:SquareFeetSubjecttoGroundLeases contextRef="c-1" decimals="-5" id="f-981" unitRef="sqft">17400000</hr:SquareFeetSubjecttoGroundLeases>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-179" id="f-982">P40Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract contextRef="c-180" id="f-983">P99Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <hr:NumberofGroundLeasesPrepaid contextRef="c-1" decimals="INF" id="f-984" unitRef="lease">75</hr:NumberofGroundLeasesPrepaid>
    <hr:AmortizationofPrepaidRent contextRef="c-5" decimals="-5" id="f-985" unitRef="usd">300000</hr:AmortizationofPrepaidRent>
    <hr:AmortizationofPrepaidRent contextRef="c-6" decimals="-5" id="f-986" unitRef="usd">100000</hr:AmortizationofPrepaidRent>
    <hr:AmortizationofPrepaidRent contextRef="c-1" decimals="-5" id="f-987" unitRef="usd">1000000</hr:AmortizationofPrepaidRent>
    <hr:AmortizationofPrepaidRent contextRef="c-7" decimals="-5" id="f-988" unitRef="usd">400000</hr:AmortizationofPrepaidRent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-989">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s future lease payments (primarily for its 165 non-prepaid ground leases) as of September&#160;30, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FINANCING&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;922,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;396,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;982,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;405,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(709,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(331,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;273,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;74,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-990">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s future lease payments (primarily for its 165 non-prepaid ground leases) as of September&#160;30, 2023 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:48.165%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;OPERATING&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FINANCING&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,288&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;513&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,392&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;14,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;922,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;396,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;982,644&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;405,859&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(709,325)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(331,772)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;273,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;74,087&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <hr:NumberofGroundLeasesExcludingPrepaidLeases contextRef="c-3" decimals="INF" id="f-991" unitRef="lease">165</hr:NumberofGroundLeasesExcludingPrepaidLeases>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-3" decimals="-3" id="f-992" unitRef="usd">3288000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-3" decimals="-3" id="f-993" unitRef="usd">513000</us-gaap:FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-3" decimals="-3" id="f-994" unitRef="usd">14062000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-3" decimals="-3" id="f-995" unitRef="usd">2182000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-3" decimals="-3" id="f-996" unitRef="usd">14253000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo contextRef="c-3" decimals="-3" id="f-997" unitRef="usd">2218000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-3" decimals="-3" id="f-998" unitRef="usd">14392000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree contextRef="c-3" decimals="-3" id="f-999" unitRef="usd">2255000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-3" decimals="-3" id="f-1000" unitRef="usd">14630000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour contextRef="c-3" decimals="-3" id="f-1001" unitRef="usd">2294000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <hr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour contextRef="c-3" decimals="-3" id="f-1002" unitRef="usd">922019000</hr:LesseeOperatingLeaseLiabilityToBePaidAfterYearFour>
    <hr:FinanceLeaseLiabilityToBePaidAfterYearFour contextRef="c-3" decimals="-3" id="f-1003" unitRef="usd">396397000</hr:FinanceLeaseLiabilityToBePaidAfterYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-3" decimals="-3" id="f-1004" unitRef="usd">982644000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue contextRef="c-3" decimals="-3" id="f-1005" unitRef="usd">405859000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-3" decimals="-3" id="f-1006" unitRef="usd">709325000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount contextRef="c-3" decimals="-3" id="f-1007" unitRef="usd">331772000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-3" decimals="-3" id="f-1008" unitRef="usd">273319000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability contextRef="c-3" decimals="-3" id="f-1009" unitRef="usd">74087000</us-gaap:FinanceLeaseLiability>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-1010">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides details of the Company's total lease expense for the three and nine months ended September&#160;30, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.863%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.909%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.910%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED &lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;4,204&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;15,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Variable lease expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;2,417&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Finance lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;387&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;381&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;861&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total lease expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;6,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;26,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;12,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Other information&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating cash flows outflows related to operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;16,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;8,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Operating cash flows outflows related to financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;524&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;476&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;1,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Financing cash flows outflows related to financing leases&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;9,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;50,463&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Right-of-use assets obtained in exchange for new operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;198,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;198,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:8pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average years remaining lease term (excluding renewal options) - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;47.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;50.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average years remaining lease term (excluding renewal options) - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;58.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;60.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate - finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-5" decimals="-3" id="f-1011" unitRef="usd">5312000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-6" decimals="-3" id="f-1012" unitRef="usd">4204000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-3" id="f-1013" unitRef="usd">15748000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-7" decimals="-3" id="f-1014" unitRef="usd">6613000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-5" decimals="-3" id="f-1015" unitRef="usd">2417000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-6" decimals="-3" id="f-1016" unitRef="usd">1061000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-1" decimals="-3" id="f-1017" unitRef="usd">6788000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-7" decimals="-3" id="f-1018" unitRef="usd">3123000</us-gaap:VariableLeaseCost>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-5" decimals="-3" id="f-1019" unitRef="usd">387000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-6" decimals="-3" id="f-1020" unitRef="usd">381000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-1" decimals="-3" id="f-1021" unitRef="usd">1161000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-7" decimals="-3" id="f-1022" unitRef="usd">884000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-5" decimals="-3" id="f-1023" unitRef="usd">928000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-6" decimals="-3" id="f-1024" unitRef="usd">861000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-1" decimals="-3" id="f-1025" unitRef="usd">2770000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-7" decimals="-3" id="f-1026" unitRef="usd">1913000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:LeaseCost contextRef="c-5" decimals="-3" id="f-1027" unitRef="usd">9044000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-6" decimals="-3" id="f-1028" unitRef="usd">6507000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-1" decimals="-3" id="f-1029" unitRef="usd">26467000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-7" decimals="-3" id="f-1030" unitRef="usd">12533000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments contextRef="c-5" decimals="-3" id="f-1031" unitRef="usd">5281000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-6" decimals="-3" id="f-1032" unitRef="usd">3847000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-3" id="f-1033" unitRef="usd">16475000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-7" decimals="-3" id="f-1034" unitRef="usd">8443000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-5" decimals="-3" id="f-1035" unitRef="usd">524000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-6" decimals="-3" id="f-1036" unitRef="usd">476000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-1" decimals="-3" id="f-1037" unitRef="usd">1592000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-7" decimals="-3" id="f-1038" unitRef="usd">1262000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <hr:FinanceLeasePrincipalOnlyPayments contextRef="c-5" decimals="-3" id="f-1039" unitRef="usd">7000</hr:FinanceLeasePrincipalOnlyPayments>
    <hr:FinanceLeasePrincipalOnlyPayments contextRef="c-6" decimals="-3" id="f-1040" unitRef="usd">3000</hr:FinanceLeasePrincipalOnlyPayments>
    <hr:FinanceLeasePrincipalOnlyPayments contextRef="c-1" decimals="-3" id="f-1041" unitRef="usd">12000</hr:FinanceLeasePrincipalOnlyPayments>
    <hr:FinanceLeasePrincipalOnlyPayments contextRef="c-7" decimals="-3" id="f-1042" unitRef="usd">3000</hr:FinanceLeasePrincipalOnlyPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-5" decimals="-3" id="f-1043" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-6" decimals="-3" id="f-1044" unitRef="usd">9874000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-1" decimals="-3" id="f-1045" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-7" decimals="-3" id="f-1046" unitRef="usd">50463000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-5" decimals="-3" id="f-1047" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-6" decimals="-3" id="f-1048" unitRef="usd">198261000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-1049" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-7" decimals="-3" id="f-1050" unitRef="usd">198261000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-3" id="f-1051">P47Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-56" id="f-1052">P50Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-3" id="f-1053">P58Y2M12D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-56" id="f-1054">P60Y1M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-3" decimals="3" id="f-1055" unitRef="number">0.058</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-56" decimals="3" id="f-1056" unitRef="number">0.057</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-3" decimals="3" id="f-1057" unitRef="number">0.050</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-56" decimals="3" id="f-1058" unitRef="number">0.050</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-1059">Notes and Bonds Payable&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below details the Company&#x2019;s notes and bonds payable as of September 30, 2023 and December 31, 2022.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.522%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:39.333%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.091%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MATURITY DATES &lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;BALANCE &lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:3.73pt;font-weight:700;line-height:120%;position:relative;top:-2.01pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt; AS OF  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;EFFECTIVE INTEREST RATE &lt;br/&gt;as of 9/30/2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;9/30/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;12/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$1.5 billion Unsecured Credit Facility &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10/25&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;236,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$200 million Unsecured Term Loan &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$350 million Unsecured Term Loan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;349,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;349,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$300 million Unsecured Term Loan &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10/25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;299,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;299,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$150 million Unsecured Term Loan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6/26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;149,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;149,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$200 million Unsecured Term Loan &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$300 million Unsecured Term Loan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;298,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;297,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;249,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;249,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8/26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;577,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;571,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2027 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;482,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;479,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;297,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2030 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2/30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;572,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;565,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2031 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;295,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;295,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2031 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;645,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;632,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Mortgage notes payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12/23-12/26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;77,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;84,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.57%-6.88%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,227,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,351,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:14.26pt"&gt;On April 26, 2023, the Company exercised its option to extend the maturity date for one year for a fee of approximately $0.4&#160;million.   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Changes in Mortgage Notes Payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On July 28, 2023, the Company assumed a mortgage note payable of $5.6&#160;million in connection with the acquisition of a 42,770 square foot property in Colorado Springs, Colorado.  The note bears interest at a rate of 4.5% per annum and matures on April 1, 2026.&lt;/span&gt;&lt;/div&gt;On August 1, 2023, the Company repaid in full at maturity a mortgage note payable bearing interest at a rate of 3.31% per annum with an outstanding principal of $9.8&#160;million. The mortgage note encumbered a 66,984 square foot property in Marietta, Georgia.</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock contextRef="c-1" id="f-1060">&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below details the Company&#x2019;s notes and bonds payable as of September 30, 2023 and December 31, 2022.&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.522%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:39.333%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.692%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.091%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:11pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;MATURITY DATES &lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;BALANCE &lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:3.73pt;font-weight:700;line-height:120%;position:relative;top:-2.01pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt; AS OF  &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;EFFECTIVE INTEREST RATE &lt;br/&gt;as of 9/30/2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;9/30/2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;12/31/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$1.5 billion Unsecured Credit Facility &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10/25&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;236,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;385,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.24&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$200 million Unsecured Term Loan &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$350 million Unsecured Term Loan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;2&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/24&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;349,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;349,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$300 million Unsecured Term Loan &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10/25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;299,952&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;299,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$150 million Unsecured Term Loan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6/26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;149,606&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;149,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$200 million Unsecured Term Loan &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;199,362&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$300 million Unsecured Term Loan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;298,184&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;297,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;6.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5/25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;249,391&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;249,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8/26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;577,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;571,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.94&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2027 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7/27&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;482,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;479,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1/28&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;297,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2030 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2/30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;572,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;565,402&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2030&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/30&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;296,385&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2031 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;295,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;295,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Senior Notes due 2031 &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3/31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;645,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;632,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Mortgage notes payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;12/23-12/26&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;77,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;84,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.57%-6.88%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;5,227,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,351,827&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable.&lt;/span&gt;&lt;/div&gt;2On April 26, 2023, the Company exercised its option to extend the maturity date for one year for a fee of approximately $0.4&#160;million.</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-181" decimals="INF" id="f-1061" unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LongTermDebt contextRef="c-181" decimals="-3" id="f-1062" unitRef="usd">236000000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-182" decimals="-3" id="f-1063" unitRef="usd">385000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-181"
      decimals="4"
      id="f-1064"
      unitRef="number">0.0624</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-183" decimals="INF" id="f-1065" unitRef="usd">200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt contextRef="c-183" decimals="-3" id="f-1066" unitRef="usd">199845000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-184" decimals="-3" id="f-1067" unitRef="usd">199670000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-183"
      decimals="4"
      id="f-1068"
      unitRef="number">0.0630</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-185" decimals="INF" id="f-1069" unitRef="usd">350000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt contextRef="c-185" decimals="-3" id="f-1070" unitRef="usd">349711000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-186" decimals="-3" id="f-1071" unitRef="usd">349114000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-185"
      decimals="4"
      id="f-1072"
      unitRef="number">0.0630</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-187" decimals="INF" id="f-1073" unitRef="usd">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt contextRef="c-187" decimals="-3" id="f-1074" unitRef="usd">299952000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-188" decimals="-3" id="f-1075" unitRef="usd">299936000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-187"
      decimals="4"
      id="f-1076"
      unitRef="number">0.0630</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-189" decimals="INF" id="f-1077" unitRef="usd">150000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt contextRef="c-189" decimals="-3" id="f-1078" unitRef="usd">149606000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-190" decimals="-3" id="f-1079" unitRef="usd">149495000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-189"
      decimals="4"
      id="f-1080"
      unitRef="number">0.0630</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-191" decimals="INF" id="f-1081" unitRef="usd">200000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt contextRef="c-191" decimals="-3" id="f-1082" unitRef="usd">199467000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-192" decimals="-3" id="f-1083" unitRef="usd">199362000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-191"
      decimals="4"
      id="f-1084"
      unitRef="number">0.0630</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-193" decimals="INF" id="f-1085" unitRef="usd">300000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LongTermDebt contextRef="c-193" decimals="-3" id="f-1086" unitRef="usd">298184000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-194" decimals="-3" id="f-1087" unitRef="usd">297869000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-193"
      decimals="4"
      id="f-1088"
      unitRef="number">0.0630</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-195" decimals="-3" id="f-1089" unitRef="usd">249391000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-196" decimals="-3" id="f-1090" unitRef="usd">249115000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-195"
      decimals="4"
      id="f-1091"
      unitRef="number">0.0412</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-197" decimals="-3" id="f-1092" unitRef="usd">577124000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-198" decimals="-3" id="f-1093" unitRef="usd">571587000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-197"
      decimals="4"
      id="f-1094"
      unitRef="number">0.0494</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-199" decimals="-3" id="f-1095" unitRef="usd">482665000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-200" decimals="-3" id="f-1096" unitRef="usd">479553000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-199"
      decimals="4"
      id="f-1097"
      unitRef="number">0.0476</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-201" decimals="-3" id="f-1098" unitRef="usd">297283000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-202" decimals="-3" id="f-1099" unitRef="usd">296852000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-201"
      decimals="4"
      id="f-1100"
      unitRef="number">0.0385</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-203" decimals="-3" id="f-1101" unitRef="usd">572883000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-204" decimals="-3" id="f-1102" unitRef="usd">565402000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-203"
      decimals="4"
      id="f-1103"
      unitRef="number">0.0530</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-205" decimals="-3" id="f-1104" unitRef="usd">296679000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-206" decimals="-3" id="f-1105" unitRef="usd">296385000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-205"
      decimals="4"
      id="f-1106"
      unitRef="number">0.0272</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-207" decimals="-3" id="f-1107" unitRef="usd">295706000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-208" decimals="-3" id="f-1108" unitRef="usd">295547000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-207"
      decimals="4"
      id="f-1109"
      unitRef="number">0.0225</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-209" decimals="-3" id="f-1110" unitRef="usd">645232000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-210" decimals="-3" id="f-1111" unitRef="usd">632693000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-209"
      decimals="4"
      id="f-1112"
      unitRef="number">0.0513</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-211" decimals="-3" id="f-1113" unitRef="usd">77685000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-212" decimals="-3" id="f-1114" unitRef="usd">84247000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-213"
      decimals="4"
      id="f-1115"
      unitRef="number">0.0357</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-214"
      decimals="4"
      id="f-1116"
      unitRef="number">0.0688</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:LongTermDebt contextRef="c-3" decimals="-3" id="f-1117" unitRef="usd">5227413000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-4" decimals="-3" id="f-1118" unitRef="usd">5351827000</us-gaap:LongTermDebt>
    <hr:DebtInstrumentExtensionPeriodForMaturityDate contextRef="c-215" id="f-1119">P1Y</hr:DebtInstrumentExtensionPeriodForMaturityDate>
    <us-gaap:DebtInstrumentFeeAmount contextRef="c-216" decimals="-5" id="f-1120" unitRef="usd">400000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:LongTermDebt contextRef="c-217" decimals="-5" id="f-1121" unitRef="usd">5600000</us-gaap:LongTermDebt>
    <hr:SquareFeetSubjectToMortgageNotesPayable contextRef="c-217" decimals="0" id="f-1122" unitRef="sqft">42770</hr:SquareFeetSubjectToMortgageNotesPayable>
    <hr:PercentageOfInterestBearingInMortgageNotesPayable
      contextRef="c-218"
      decimals="3"
      id="f-1123"
      unitRef="number">0.045</hr:PercentageOfInterestBearingInMortgageNotesPayable>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="c-219"
      decimals="4"
      id="f-1124"
      unitRef="number">0.0331</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:ExtinguishmentOfDebtAmount contextRef="c-220" decimals="-5" id="f-1125" unitRef="usd">9800000</us-gaap:ExtinguishmentOfDebtAmount>
    <hr:ExtinguishmentOfDebtEncumberedSquareFootage contextRef="c-221" decimals="0" id="f-1126" unitRef="sqft">66984</hr:ExtinguishmentOfDebtEncumberedSquareFootage>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="c-1" id="f-1127">Derivative Financial Instruments&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Risk Management Objective of Using Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company&#x2019;s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company&#x2019;s known or expected cash receipts and its known or expected cash payments principally related to the Company&#x2019;s borrowings.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Cash Flow Hedges of Interest Rate Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company&#x2019;s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;life of the agreements without exchange of the underlying notional amount. Such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For derivatives designated, and that qualify, as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income (Loss) ("AOCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings. Amounts reported in AOCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company&#x2019;s variable-rate debt. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of September&#160;30, 2023, the Company had 14 outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.978%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.810%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.646%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;EXPIRATION DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;AMOUNT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;WEIGHTED &lt;br/&gt;AVERAGE RATE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;January 15, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;May 1, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;June 1, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;December 1, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;June 1, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;December 1, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.75pt;font-style:italic;font-weight:400;line-height:130%"&gt;Subsequent Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On October 19, 2023, the Company entered into two swap transactions totaling $100.0&#160;million.  The notional amounts were $50.0&#160;million each with fixed rates of 4.71% and 4.67%. The swap agreements have effective dates of November 1, 2023 and termination dates of June 1, 2027 and December 1, 2027, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On October 23, 2023, the Company entered into two swap transactions totaling $100.0&#160;million with an aggregate fixed rate of 4.73%. The swap agreements have effective dates of November 1, 2023 and termination dates of May 31, 2026. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Tabular Disclosure of Fair Values of Derivative Instruments on the Balance Sheet&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below presents the fair value of the Company's derivative financial instruments, as well as their classification on the Condensed Consolidated Balance Sheet as of September&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.394%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.608%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.859%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;BALANCE AT SEPTEMBER 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;BALANCE SHEET LOCATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;21,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;   &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Tabular Disclosure of the Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below presents the effect of cash flow hedge accounting on AOCI during the three and nine months ended September&#160;30, 2023 and 2022 related to the Company's outstanding interest rate swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.206%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.940%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:26pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECOGNIZED IN &lt;br/&gt;AOCI ON DERIVATIVE&lt;br/&gt;three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECLASSIFIED FROM &lt;br/&gt;AOCI INTO INCOME&lt;br/&gt;three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(12,016)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(6,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(4,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled treasury hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(12,016)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(6,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(4,168)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.206%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.940%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:26pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECOGNIZED IN &lt;br/&gt;AOCI ON DERIVATIVE&lt;br/&gt;nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECLASSIFIED FROM &lt;br/&gt;AOCI INTO INCOME&lt;br/&gt;nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(24,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(12,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(10,320)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled treasury hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(24,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(12,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(9,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company estimates that an additional $14.1 million related to active interest rate swaps will be reclassified from AOCI as a decrease to interest expense over the next 12 months, and that an additional $0.6&#160;million related to settled interest rate swaps will be amortized from AOCI as an increase to interest expense over the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Credit-risk-related Contingent Features&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company's agreements with each of its derivative counterparties contain a cross-default provision under which the Company could be declared in default of its derivative obligations if&#160;repayment of the underlying&#160;indebtedness is accelerated by the lender due to the Company's&#160;default on the indebtedness.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of September&#160;30, 2023, the fair value of derivatives in a net asset position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was&#160;$21.5&#160;million. As of September&#160;30, 2023, the Company had not posted any collateral related to these agreements and was not in breach of any agreement.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-1128">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;As of September&#160;30, 2023, the Company had 14 outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.978%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.810%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.646%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;EXPIRATION DATE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;AMOUNT&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;WEIGHTED &lt;br/&gt;AVERAGE RATE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;January 15, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;200,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;May 1, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;100,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;June 1, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;December 1, 2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;June 1, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;December 1, 2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;250,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below presents the effect of cash flow hedge accounting on AOCI during the three and nine months ended September&#160;30, 2023 and 2022 related to the Company's outstanding interest rate swaps.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.206%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.940%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:26pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECOGNIZED IN &lt;br/&gt;AOCI ON DERIVATIVE&lt;br/&gt;three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECLASSIFIED FROM &lt;br/&gt;AOCI INTO INCOME&lt;br/&gt;three months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(12,016)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(6,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(4,317)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled treasury hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(12,016)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(6,083)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(4,168)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;763&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.694%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.206%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.940%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:26pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECOGNIZED IN &lt;br/&gt;AOCI ON DERIVATIVE&lt;br/&gt;nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;(GAIN)/LOSS RECLASSIFIED FROM &lt;br/&gt;AOCI INTO INCOME&lt;br/&gt;nine months ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(24,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(12,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(10,320)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,226&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled treasury hedges&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Settled interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;320&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(24,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(12,905)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(9,874)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:NumberOfInterestRateDerivativesHeld
      contextRef="c-3"
      decimals="INF"
      id="f-1129"
      unitRef="derivative">14</us-gaap:NumberOfInterestRateDerivativesHeld>
    <us-gaap:DerivativeNotionalAmount contextRef="c-222" decimals="-3" id="f-1130" unitRef="usd">200000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="c-222"
      decimals="4"
      id="f-1131"
      unitRef="number">0.0121</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount contextRef="c-223" decimals="-3" id="f-1132" unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="c-223"
      decimals="4"
      id="f-1133"
      unitRef="number">0.0215</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount contextRef="c-224" decimals="-3" id="f-1134" unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="c-224"
      decimals="4"
      id="f-1135"
      unitRef="number">0.0383</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount contextRef="c-225" decimals="-3" id="f-1136" unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="c-225"
      decimals="4"
      id="f-1137"
      unitRef="number">0.0384</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount contextRef="c-226" decimals="-3" id="f-1138" unitRef="usd">150000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="c-226"
      decimals="4"
      id="f-1139"
      unitRef="number">0.0413</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount contextRef="c-227" decimals="-3" id="f-1140" unitRef="usd">250000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="c-227"
      decimals="4"
      id="f-1141"
      unitRef="number">0.0379</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeNotionalAmount contextRef="c-228" decimals="-3" id="f-1142" unitRef="usd">1000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="c-228"
      decimals="4"
      id="f-1143"
      unitRef="number">0.0317</us-gaap:DerivativeFixedInterestRate>
    <hr:NumberOfSwapTransactions
      contextRef="c-229"
      decimals="INF"
      id="f-1144"
      unitRef="transaction">2</hr:NumberOfSwapTransactions>
    <us-gaap:DerivativeNotionalAmount contextRef="c-229" decimals="-5" id="f-1145" unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-230" decimals="-5" id="f-1146" unitRef="usd">50000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-231" decimals="-5" id="f-1147" unitRef="usd">50000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="c-230"
      decimals="4"
      id="f-1148"
      unitRef="number">0.0471</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="c-231"
      decimals="4"
      id="f-1149"
      unitRef="number">0.0467</us-gaap:DerivativeFixedInterestRate>
    <hr:NumberOfSwapTransactions
      contextRef="c-232"
      decimals="INF"
      id="f-1150"
      unitRef="transaction">2</hr:NumberOfSwapTransactions>
    <us-gaap:DerivativeNotionalAmount contextRef="c-232" decimals="-5" id="f-1151" unitRef="usd">100000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeFixedInterestRate
      contextRef="c-232"
      decimals="4"
      id="f-1152"
      unitRef="number">0.0473</us-gaap:DerivativeFixedInterestRate>
    <us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock contextRef="c-1" id="f-1153">The table below presents the fair value of the Company's derivative financial instruments, as well as their classification on the Condensed Consolidated Balance Sheet as of September&#160;30, 2023.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.394%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.608%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.859%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;BALANCE AT SEPTEMBER 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;In thousands&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;BALANCE SHEET LOCATION&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Derivatives designated as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Interest rate swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;21,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeLiability contextRef="c-233" decimals="-3" id="f-1154" unitRef="usd">21499000</us-gaap:DerivativeFairValueOfDerivativeLiability>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-234" decimals="-3" id="f-1155" unitRef="usd">12016000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-235" decimals="-3" id="f-1156" unitRef="usd">6083000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-236" decimals="-3" id="f-1157" unitRef="usd">4317000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-237" decimals="-3" id="f-1158" unitRef="usd">-614000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-238" decimals="-3" id="f-1159" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-239" decimals="-3" id="f-1160" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-240" decimals="-3" id="f-1161" unitRef="usd">-107000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-241" decimals="-3" id="f-1162" unitRef="usd">-107000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-8" decimals="-3" id="f-1163" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-9" decimals="-3" id="f-1164" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-242" decimals="-3" id="f-1165" unitRef="usd">-42000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-243" decimals="-3" id="f-1166" unitRef="usd">-42000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-5" decimals="-3" id="f-1167" unitRef="usd">12016000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-6" decimals="-3" id="f-1168" unitRef="usd">6083000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-244" decimals="-3" id="f-1169" unitRef="usd">4168000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-245" decimals="-3" id="f-1170" unitRef="usd">-763000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-246" decimals="-3" id="f-1171" unitRef="usd">24999000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-247" decimals="-3" id="f-1172" unitRef="usd">12905000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-248" decimals="-3" id="f-1173" unitRef="usd">10320000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-249" decimals="-3" id="f-1174" unitRef="usd">-2226000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-250" decimals="-3" id="f-1175" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-251" decimals="-3" id="f-1176" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-252" decimals="-3" id="f-1177" unitRef="usd">-126000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-253" decimals="-3" id="f-1178" unitRef="usd">-320000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-10" decimals="-3" id="f-1179" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-11" decimals="-3" id="f-1180" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-254" decimals="-3" id="f-1181" unitRef="usd">-320000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-255" decimals="-3" id="f-1182" unitRef="usd">-126000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-1" decimals="-3" id="f-1183" unitRef="usd">24999000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax contextRef="c-7" decimals="-3" id="f-1184" unitRef="usd">12905000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-256" decimals="-3" id="f-1185" unitRef="usd">9874000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax contextRef="c-257" decimals="-3" id="f-1186" unitRef="usd">-2672000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet contextRef="c-258" decimals="-5" id="f-1187" unitRef="usd">14100000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet contextRef="c-259" decimals="-5" id="f-1188" unitRef="usd">-600000</us-gaap:InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet>
    <hr:DerivativeNetAssetPositionAggregateFairValue contextRef="c-3" decimals="-5" id="f-1189" unitRef="usd">21500000</hr:DerivativeNetAssetPositionAggregateFairValue>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-1190">Commitments and Contingencies&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company is, from time to time, involved in litigation arising in the ordinary course of business. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company&#x2019;s consolidated financial position, results of operations or cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Development and Redevelopment Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;For the nine months ended September 30, 2023, the Company invested $55.3 million and $15.4 million toward active development and redevelopment of properties, respectively, and $9.2&#160;million toward recently completed development and redevelopment projects.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;In the second quarter of 2023, the Company entered into a joint venture agreement for the development of a medical office building in Scottsdale, Arizona.  The Company holds a 90% interest in the joint venture and determined the arrangement meets the criteria to be consolidated.  The joint venture acquired an $8.8&#160;million land parcel to be developed with the Company contributing cash of $8.3&#160;million. This is included in the Company's investment toward active development properties for the nine months ended September 30, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <hr:ConstructionActivityTotalFundingDuringthePeriod contextRef="c-260" decimals="-5" id="f-1191" unitRef="usd">55300000</hr:ConstructionActivityTotalFundingDuringthePeriod>
    <hr:ConstructionActivityTotalFundingDuringthePeriod contextRef="c-261" decimals="-5" id="f-1192" unitRef="usd">15400000</hr:ConstructionActivityTotalFundingDuringthePeriod>
    <hr:ConstructionActivityTotalFundingDuringthePeriod contextRef="c-262" decimals="-5" id="f-1193" unitRef="usd">9200000</hr:ConstructionActivityTotalFundingDuringthePeriod>
    <hr:JointVentureOwnershipPercentage
      contextRef="c-263"
      decimals="2"
      id="f-1194"
      unitRef="number">0.90</hr:JointVentureOwnershipPercentage>
    <us-gaap:PaymentsToAcquireLand contextRef="c-263" decimals="-5" id="f-1195" unitRef="usd">8800000</us-gaap:PaymentsToAcquireLand>
    <us-gaap:PaymentsToAcquireBusinessesGross contextRef="c-263" decimals="-5" id="f-1196" unitRef="usd">8300000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c-1" id="f-1197">Stockholders' Equity&lt;div style="margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Common Stock&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the nine months ended September&#160;30, 2023 and the twelve months ended December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.981%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.370%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.880%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.450%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED SEPTEMBER 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;TWELVE MONTHS ENDED DECEMBER 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,589,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,457,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Issuance of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;229,618,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Non-vested share-based awards, net of withheld shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;262,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;514,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,860,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,589,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;At-The-Market Equity Offering Program&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-style:italic;font-weight:700;line-height:130%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company has equity distribution agreements with various sales agents with respect to the at-the-market (&#x201c;ATM&#x201d;) equity offering program of common stock with an aggregate sales amount of up to $750.0 million.  As of September&#160;30, 2023, $750.0 million remained available for issuance under our current ATM equity offering program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;During the nine months ended September&#160;30, 2023, the Company did not sell any shares or enter into any forward sale agreements to sell shares of common stock through its ATM equity offering program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:7pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Common Stock Dividends&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;During the nine months ended September&#160;30, 2023, the Company declared and paid common stock dividends totaling $0.93 per share.  On October 30, 2023, the Company declared a quarterly common stock dividend in the amount of $0.31 per share payable on November 30, 2023 to stockholders of record on November 14, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Earnings Per Common Share&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The Company uses the two-class method of computing net earnings per common shares. The Company's non-vested share-based awards are considered participating securities pursuant to the two-class method. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table sets forth the computation of basic and diluted earnings per common share for the three and nine months ended September&#160;30, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.744%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.744%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED SEPTEMBER 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED SEPTEMBER 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands, except per share data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,857,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;330,788,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,828,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;211,740,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Non-vested shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,932,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,983,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,941,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,933,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted average common shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,925,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;328,805,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,886,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;209,806,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,925,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;328,805,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,886,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;209,806,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dilutive effect of forward equity shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dilutive effect of OP Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,167,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,067,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dilutive effect of employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;58,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;69,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted average common shares outstanding - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,925,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;332,031,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,886,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;210,943,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(68,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;28,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(240,408)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;76,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Income allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(636)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(610)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,868)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,817)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Loss (income) attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(312)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(312)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Net (loss) income applicable to common stockholders - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(68,509)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;27,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(239,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;74,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Basic earnings per common share - net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.63)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;0.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Diluted earnings per common share - net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.63)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;0.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The effect of OP units totaling 4,042,993 shares and options under the Company's Employee Stock Purchase Plan (the "ESPP") to purchase the Company's common stock totaling 26,678 shares for the three months ended September&#160;30, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;2023 were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive due to the loss from continuing operations incurred during that period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Equity Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;During the nine months ended September&#160;30, 2023, the Company made the following equity awards:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt"&gt;During the first quarter of 2023, the Company granted non-vested stock awards to its named executive officers and other members of senior management and employees with a grant date fair value of $5.4&#160;million, which consisted of an aggregate of 270,494 non-vested shares with vesting periods ranging from &lt;span style="-sec-ix-hidden:f-1276"&gt;three&lt;/span&gt; to eight years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%;padding-left:12.55pt"&gt;During the second quarter of 2023, the Company granted to its 12 independent directors an aggregate of 42,768 shares of non-vested stock awards with a grant date fair value of $0.7&#160;million, and an aggregate of 57,868 LTIP Series D units with a grant date fair value of $1.1&#160;million.  The Company also granted a non-vested stock award to a new employee, which consisted of 508 non-vested shares. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;A summary of the activity under the Company's share-based incentive plans for the three and nine months ended September&#160;30, 2023 and 2022 is included in the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.847%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.751%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.763%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.763%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.610%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.613%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED SEPTEMBER 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED SEPTEMBER 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Share-based awards, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,932,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,941,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,795,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,562,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;71,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;313,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;513,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(7,434)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(152,314)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(68,481)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(4,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(24,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(5,426)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Share-based awards, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,932,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,001,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,932,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,001,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;During the nine months ended September&#160;30, 2023 and 2022, the Company withheld 38,632 and&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt; 8,745 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;shares of common stock, respectively, from participants to pay estimated withholding taxes related to shares that vested. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Prior to 2022, the Company granted long-term incentive awards, comprised of restricted stock, based on backward-looking performance measured at the end of the calendar year. The Company adopted a new incentive compensation structure effective January 2022, comprised of restricted stock and restricted stock units ("RSUs"). The RSUs are granted at the beginning of the year with three-year forward-looking performance targets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;On January 4, 2023, the Company granted RSUs to members of senior management, with a grant date fair value of $3.7 million, which consisted of an aggregate 165,174 RSUs with a five-year vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Approximately 43% of the RSUs vest based on two market performance conditions. Relative and absolute total shareholder return ("TSR") awards containing these market performance conditions were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $24.23 for the absolute TSR component and $27.84 for the relative TSR component for the January 2023 grant using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.454%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED MARCH 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dividend assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Expected term &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Stock price (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$20.21&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The remaining 57% of the RSUs vest based upon certain operating performance conditions.  With respect to the operating performance conditions of the January 4, 2023 grant, the grant date fair value was $20.21 based on the Company's share price on the date of grant. The combined weighted average grant date fair value of the January RSUs was $22.55 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following is a summary of the RSU activity during the three and nine months ended September&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.379%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.201%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.432%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.028%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.261%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED SEPTEMBER 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED SEPTEMBER 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Non-vested, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;363,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;28.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;294,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;33.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;165,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;22.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Vested/Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(17,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;33.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Probability adjustment of 2022 &amp;amp; 2023 RSUs &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(47,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;20.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(126,446)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;27.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Non-vested, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;316,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;27.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;316,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;27.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;LTIP Series C Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;In January 2023, the Company modified its incentive compensation structure to award LTIP Series C units ("LTIP-C units) in the OP to named executive officers in lieu of RSUs. The LTIP-C units were granted with three-year forward-looking performance targets, with a grant date fair value of $7.1&#160;million, which consisted of an aggregate 448,249 LTIP-C units with a five-year vesting period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Approximately 43% of the LTIP-C units vest based on two market performance conditions. Relative and absolute TSR awards containing these market performance conditions were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $12.24 for the absolute TSR component and $13.98 for the relative TSR component for the January 2023 grant using the following assumption:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.454%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED MARCH 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dividend assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Expected term &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Stock price (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$20.21&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The remaining 57% of the LTIP-C units vest based upon certain operating performance conditions.  With respect to the operating performance conditions of the January 4, 2023 grant, the grant date fair value was $20.21 based on the Company's share price on the date of grant. The combined weighted average grant date fair value of the January LTIP-C units was $15.85 per share.  The Company records amortization expense based on the probability of achieving certain operating performance conditions, which is evaluated throughout the performance period.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Gotham Medium',sans-serif;font-size:7.75pt;font-style:italic;font-weight:700;line-height:130%"&gt;Employee Stock Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;Legacy HR maintained an ESPP prior to the completion of the Merger. The outstanding options to purchase shares of the common stock of Legacy HR became options to purchase class A common stock of the Company upon completion of the Merger. No new options will be granted under the ESPP. A summary of the activity under the ESPP for the three and nine months ended September&#160;30, 2023 and 2022 is included in the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.847%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.751%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.763%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.763%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.610%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.613%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED SEPTEMBER 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED SEPTEMBER 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Outstanding and exercisable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;179,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;405,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;340,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;348,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;255,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(2,580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(4,576)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(7,397)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(17,094)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(4,680)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(37,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(28,471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(83,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(132,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(140,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Outstanding and exercisable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;172,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;363,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;172,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;363,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table represents expected amortization of the Company's non-vested shares issued as of September&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.321%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.683%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.117%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FUTURE AMORTIZATION &lt;br/&gt;of non-vested shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock contextRef="c-1" id="f-1198">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the nine months ended September&#160;30, 2023 and the twelve months ended December&#160;31, 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:77.981%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.370%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.880%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.450%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED SEPTEMBER 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;TWELVE MONTHS ENDED DECEMBER 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Balance, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,589,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;150,457,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Issuance of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;7,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;229,618,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Non-vested share-based awards, net of withheld shares &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;262,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;514,157&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Balance, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,860,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,589,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-57"
      decimals="INF"
      id="f-1199"
      unitRef="shares">380589894</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-71"
      decimals="INF"
      id="f-1200"
      unitRef="shares">150457433</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-66"
      decimals="INF"
      id="f-1201"
      unitRef="shares">7397</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c-264"
      decimals="INF"
      id="f-1202"
      unitRef="shares">229618304</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-66"
      decimals="INF"
      id="f-1203"
      unitRef="shares">262821</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="c-264"
      decimals="INF"
      id="f-1204"
      unitRef="shares">514157</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-27"
      decimals="INF"
      id="f-1205"
      unitRef="shares">380860112</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c-57"
      decimals="INF"
      id="f-1206"
      unitRef="shares">380589894</us-gaap:CommonStockSharesOutstanding>
    <hr:EquityOfferingProgramAvailableForIssuance contextRef="c-27" decimals="INF" id="f-1207" unitRef="usd">750000000</hr:EquityOfferingProgramAvailableForIssuance>
    <hr:EquityOfferingProgramAvailableForIssuance contextRef="c-27" decimals="INF" id="f-1208" unitRef="usd">750000000</hr:EquityOfferingProgramAvailableForIssuance>
    <us-gaap:CommonStockDividendsPerShareCashPaid
      contextRef="c-1"
      decimals="INF"
      id="f-1209"
      unitRef="usdPerShare">0.93</us-gaap:CommonStockDividendsPerShareCashPaid>
    <us-gaap:CommonStockDividendsPerShareDeclared
      contextRef="c-265"
      decimals="INF"
      id="f-1210"
      unitRef="usdPerShare">0.31</us-gaap:CommonStockDividendsPerShareDeclared>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-1211">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table sets forth the computation of basic and diluted earnings per common share for the three and nine months ended September&#160;30, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.744%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.744%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.591%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED SEPTEMBER 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED SEPTEMBER 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in thousands, except per share data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,857,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;330,788,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;380,828,004&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;211,740,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Non-vested shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,932,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,983,742)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,941,897)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,933,957)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted average common shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,925,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;328,805,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,886,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;209,806,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Weighted average common shares outstanding - basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,925,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;328,805,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,886,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;209,806,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dilutive effect of forward equity shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dilutive effect of OP Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3,167,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,067,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dilutive effect of employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;58,461&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;69,687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Weighted average common shares outstanding - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,925,339&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;332,031,384&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;378,886,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;210,943,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;Net (loss) income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(68,604)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;28,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(240,408)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;76,973&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Income allocated to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(636)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(610)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,868)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(1,817)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Loss (income) attributable to non-controlling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(312)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(312)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(122)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Net (loss) income applicable to common stockholders - basic&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(68,509)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;27,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(239,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;74,844&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Basic earnings per common share - net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.63)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;0.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Diluted earnings per common share - net income&lt;/span&gt;&lt;/td&gt;&lt;td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.18)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;0.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(0.63)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;0.35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic contextRef="c-5" decimals="0" id="f-1212" unitRef="shares">380857560</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic contextRef="c-6" decimals="0" id="f-1213" unitRef="shares">330788997</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic contextRef="c-1" decimals="0" id="f-1214" unitRef="shares">380828004</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesIssuedBasic contextRef="c-7" decimals="0" id="f-1215" unitRef="shares">211740767</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock contextRef="c-5" decimals="0" id="f-1216" unitRef="shares">1932221</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock contextRef="c-6" decimals="0" id="f-1217" unitRef="shares">1983742</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock contextRef="c-1" decimals="0" id="f-1218" unitRef="shares">1941897</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesRestrictedStock contextRef="c-7" decimals="0" id="f-1219" unitRef="shares">1933957</us-gaap:WeightedAverageNumberOfSharesRestrictedStock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-1220" unitRef="shares">378925339</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-1221" unitRef="shares">328805255</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-1222" unitRef="shares">378886107</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="0" id="f-1223" unitRef="shares">209806810</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-1224" unitRef="shares">378925339</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-1225" unitRef="shares">328805255</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-1226" unitRef="shares">378886107</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="0" id="f-1227" unitRef="shares">209806810</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements contextRef="c-5" decimals="0" id="f-1228" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements>
    <us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements contextRef="c-6" decimals="0" id="f-1229" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements>
    <us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements contextRef="c-1" decimals="0" id="f-1230" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements>
    <us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements contextRef="c-7" decimals="0" id="f-1231" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToEquityForwardAgreements>
    <hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits contextRef="c-5" decimals="0" id="f-1232" unitRef="shares">0</hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits>
    <hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits contextRef="c-6" decimals="0" id="f-1233" unitRef="shares">3167668</hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits>
    <hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits contextRef="c-1" decimals="0" id="f-1234" unitRef="shares">0</hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits>
    <hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits contextRef="c-7" decimals="0" id="f-1235" unitRef="shares">1067493</hr:IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits>
    <hr:IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan contextRef="c-5" decimals="0" id="f-1236" unitRef="shares">0</hr:IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan>
    <hr:IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan contextRef="c-6" decimals="0" id="f-1237" unitRef="shares">58461</hr:IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan>
    <hr:IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan contextRef="c-1" decimals="0" id="f-1238" unitRef="shares">0</hr:IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan>
    <hr:IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan contextRef="c-7" decimals="0" id="f-1239" unitRef="shares">69687</hr:IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-1240" unitRef="shares">378925339</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="0" id="f-1241" unitRef="shares">332031384</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-1242" unitRef="shares">378886107</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="0" id="f-1243" unitRef="shares">210943990</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ProfitLoss contextRef="c-5" decimals="-3" id="f-1244" unitRef="usd">-68604000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-6" decimals="-3" id="f-1245" unitRef="usd">28616000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-1" decimals="-3" id="f-1246" unitRef="usd">-240408000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss contextRef="c-7" decimals="-3" id="f-1247" unitRef="usd">76973000</us-gaap:ProfitLoss>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic contextRef="c-5" decimals="-3" id="f-1248" unitRef="usd">636000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic contextRef="c-6" decimals="-3" id="f-1249" unitRef="usd">610000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic contextRef="c-1" decimals="-3" id="f-1250" unitRef="usd">1868000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic contextRef="c-7" decimals="-3" id="f-1251" unitRef="usd">1817000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-1252" unitRef="usd">-760000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-1253" unitRef="usd">312000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-1254" unitRef="usd">-2680000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest contextRef="c-7" decimals="-3" id="f-1255" unitRef="usd">312000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther contextRef="c-5" decimals="-3" id="f-1256" unitRef="usd">-29000</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
    <us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther contextRef="c-6" decimals="-3" id="f-1257" unitRef="usd">0</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
    <us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther contextRef="c-1" decimals="-3" id="f-1258" unitRef="usd">-122000</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
    <us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther contextRef="c-7" decimals="-3" id="f-1259" unitRef="usd">0</us-gaap:DilutiveSecuritiesEffectOnBasicEarningsPerShareOther>
    <hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic contextRef="c-5" decimals="-3" id="f-1260" unitRef="usd">-68509000</hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic>
    <hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic contextRef="c-6" decimals="-3" id="f-1261" unitRef="usd">27694000</hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic>
    <hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic contextRef="c-1" decimals="-3" id="f-1262" unitRef="usd">-239718000</hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic>
    <hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic contextRef="c-7" decimals="-3" id="f-1263" unitRef="usd">74844000</hr:NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-1264"
      unitRef="usdPerShare">-0.18</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-1265"
      unitRef="usdPerShare">0.08</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-1266"
      unitRef="usdPerShare">-0.63</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-1267"
      unitRef="usdPerShare">0.36</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-1268"
      unitRef="usdPerShare">-0.18</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-1269"
      unitRef="usdPerShare">0.08</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-1270"
      unitRef="usdPerShare">-0.63</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-1271"
      unitRef="usdPerShare">0.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="c-266"
      decimals="INF"
      id="f-1272"
      unitRef="shares">4042993</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-267"
      decimals="INF"
      id="f-1273"
      unitRef="shares">26678</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue contextRef="c-268" decimals="-5" id="f-1274" unitRef="usd">5400000</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-268"
      decimals="INF"
      id="f-1275"
      unitRef="shares">270494</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-270" id="f-1277">P8Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <hr:NumberOfDirectors
      contextRef="c-271"
      decimals="INF"
      id="f-1278"
      unitRef="director">12</hr:NumberOfDirectors>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-272"
      decimals="INF"
      id="f-1279"
      unitRef="shares">42768</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue contextRef="c-272" decimals="-5" id="f-1280" unitRef="usd">700000</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-273"
      decimals="INF"
      id="f-1281"
      unitRef="shares">57868</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue contextRef="c-273" decimals="-5" id="f-1282" unitRef="usd">1100000</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-274"
      decimals="INF"
      id="f-1283"
      unitRef="shares">508</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="c-1" id="f-1284">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;A summary of the activity under the Company's share-based incentive plans for the three and nine months ended September&#160;30, 2023 and 2022 is included in the table below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.847%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.751%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.763%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.763%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.610%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.613%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED SEPTEMBER 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED SEPTEMBER 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Share-based awards, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,932,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,941,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,795,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,562,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;71,852&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;313,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;513,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(7,434)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(152,314)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(68,481)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(4,130)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(24,363)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(5,426)&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Share-based awards, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,932,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,001,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;1,932,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2,001,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following is a summary of the RSU activity during the three and nine months ended September&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.379%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:35.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.201%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.432%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.028%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.261%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED SEPTEMBER 30, &lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED SEPTEMBER 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Non-vested, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;363,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;28.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;294,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;33.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;165,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;22.55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Vested/Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(17,606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;33.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Probability adjustment of 2022 &amp;amp; 2023 RSUs &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(47,196)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;20.21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(126,446)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;27.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Non-vested, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;316,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;27.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.25pt solid #000000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;316,054&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;27.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.25pt solid #000;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-275"
      decimals="INF"
      id="f-1285"
      unitRef="shares">1932221</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-276"
      decimals="INF"
      id="f-1286"
      unitRef="shares">1941709</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-277"
      decimals="INF"
      id="f-1287"
      unitRef="shares">1795128</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-278"
      decimals="INF"
      id="f-1288"
      unitRef="shares">1562028</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-279"
      decimals="INF"
      id="f-1289"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-280"
      decimals="INF"
      id="f-1290"
      unitRef="shares">71852</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-281"
      decimals="INF"
      id="f-1291"
      unitRef="shares">313770</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-282"
      decimals="INF"
      id="f-1292"
      unitRef="shares">513876</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-279"
      decimals="INF"
      id="f-1293"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-280"
      decimals="INF"
      id="f-1294"
      unitRef="shares">7434</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-281"
      decimals="INF"
      id="f-1295"
      unitRef="shares">152314</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-282"
      decimals="INF"
      id="f-1296"
      unitRef="shares">68481</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-279"
      decimals="INF"
      id="f-1297"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-280"
      decimals="INF"
      id="f-1298"
      unitRef="shares">4130</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-281"
      decimals="INF"
      id="f-1299"
      unitRef="shares">24363</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-282"
      decimals="INF"
      id="f-1300"
      unitRef="shares">5426</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-283"
      decimals="INF"
      id="f-1301"
      unitRef="shares">1932221</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-284"
      decimals="INF"
      id="f-1302"
      unitRef="shares">2001997</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-283"
      decimals="INF"
      id="f-1303"
      unitRef="shares">1932221</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-284"
      decimals="INF"
      id="f-1304"
      unitRef="shares">2001997</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="c-285"
      decimals="INF"
      id="f-1305"
      unitRef="shares">38632</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="c-286"
      decimals="INF"
      id="f-1306"
      unitRef="shares">8745</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-1" id="f-1307">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue contextRef="c-287" decimals="-5" id="f-1308" unitRef="usd">3700000</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-287"
      decimals="INF"
      id="f-1309"
      unitRef="shares">165174</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-288" id="f-1310">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <hr:PercentageOfRestrictedStockUnits
      contextRef="c-288"
      decimals="2"
      id="f-1311"
      unitRef="number">0.43</hr:PercentageOfRestrictedStockUnits>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="c-289"
      decimals="2"
      id="f-1312"
      unitRef="usdPerShare">24.23</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="c-290"
      decimals="2"
      id="f-1313"
      unitRef="usdPerShare">27.84</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="c-1" id="f-1314">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.454%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED MARCH 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dividend assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Expected term &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Stock price (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$20.21&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.932%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.346%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:41.454%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED MARCH 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;34.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Dividend assumption&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Accrued&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Expected term &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Risk-free rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="2" style="border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Stock price (per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #929292;border-left:0.5pt solid #929292;border-right:0.5pt solid #929292;border-top:0.5pt solid #929292;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$20.21&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-288"
      decimals="3"
      id="f-1315"
      unitRef="number">0.340</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-288" id="f-1316">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-288"
      decimals="4"
      id="f-1317"
      unitRef="number">0.0442</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice
      contextRef="c-288"
      decimals="2"
      id="f-1318"
      unitRef="usdPerShare">20.21</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice>
    <hr:PercentageOfRestrictedStockUnits
      contextRef="c-291"
      decimals="2"
      id="f-1319"
      unitRef="number">0.57</hr:PercentageOfRestrictedStockUnits>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="c-291"
      decimals="2"
      id="f-1320"
      unitRef="usdPerShare">20.21</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="c-288"
      decimals="2"
      id="f-1321"
      unitRef="usdPerShare">22.55</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-292"
      decimals="INF"
      id="f-1322"
      unitRef="shares">363250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-292"
      decimals="2"
      id="f-1323"
      unitRef="usdPerShare">28.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-293"
      decimals="INF"
      id="f-1324"
      unitRef="shares">294932</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-293"
      decimals="2"
      id="f-1325"
      unitRef="usdPerShare">33.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-294"
      decimals="INF"
      id="f-1326"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-294"
      decimals="2"
      id="f-1327"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-295"
      decimals="INF"
      id="f-1328"
      unitRef="shares">165174</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-295"
      decimals="2"
      id="f-1329"
      unitRef="usdPerShare">22.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-294"
      decimals="INF"
      id="f-1330"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-294"
      decimals="2"
      id="f-1331"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-295"
      decimals="INF"
      id="f-1332"
      unitRef="shares">17606</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-295"
      decimals="2"
      id="f-1333"
      unitRef="usdPerShare">33.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod
      contextRef="c-294"
      decimals="INF"
      id="f-1334"
      unitRef="shares">47196</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-294"
      decimals="2"
      id="f-1335"
      unitRef="usdPerShare">20.21</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod
      contextRef="c-295"
      decimals="INF"
      id="f-1336"
      unitRef="shares">126446</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-295"
      decimals="2"
      id="f-1337"
      unitRef="usdPerShare">27.40</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-296"
      decimals="INF"
      id="f-1338"
      unitRef="shares">316054</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-296"
      decimals="2"
      id="f-1339"
      unitRef="usdPerShare">27.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-296"
      decimals="INF"
      id="f-1340"
      unitRef="shares">316054</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-296"
      decimals="2"
      id="f-1341"
      unitRef="usdPerShare">27.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod contextRef="c-297" id="f-1342">P3Y</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="c-298" decimals="-5" id="f-1343" unitRef="usd">7100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-299"
      decimals="INF"
      id="f-1344"
      unitRef="shares">448249</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-299" id="f-1345">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <hr:PercentageOfRestrictedStockUnits
      contextRef="c-297"
      decimals="2"
      id="f-1346"
      unitRef="number">0.43</hr:PercentageOfRestrictedStockUnits>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="c-300"
      decimals="2"
      id="f-1347"
      unitRef="usdPerShare">12.24</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="c-301"
      decimals="2"
      id="f-1348"
      unitRef="usdPerShare">13.98</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-297"
      decimals="3"
      id="f-1349"
      unitRef="number">0.340</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-297" id="f-1350">P3Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-297"
      decimals="4"
      id="f-1351"
      unitRef="number">0.0442</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice
      contextRef="c-297"
      decimals="2"
      id="f-1352"
      unitRef="usdPerShare">20.21</hr:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice>
    <hr:PercentageOfRestrictedStockUnits
      contextRef="c-302"
      decimals="2"
      id="f-1353"
      unitRef="number">0.57</hr:PercentageOfRestrictedStockUnits>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="c-302"
      decimals="2"
      id="f-1354"
      unitRef="usdPerShare">20.21</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
      contextRef="c-297"
      decimals="2"
      id="f-1355"
      unitRef="usdPerShare">15.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock contextRef="c-1" id="f-1356">A summary of the activity under the ESPP for the three and nine months ended September&#160;30, 2023 and 2022 is included in the table below.&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.847%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.751%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.763%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.763%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.610%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.613%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;THREE MONTHS ENDED SEPTEMBER 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;border-right:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;NINE MONTHS ENDED SEPTEMBER 30, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-right:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Outstanding and exercisable, beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;179,369&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;405,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;340,976&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;348,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.5pt solid #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;255,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(2,580)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(4,576)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(7,397)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(17,094)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(4,680)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(37,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(28,471)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(83,417)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(132,999)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;(140,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Outstanding and exercisable, end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;172,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;363,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-left:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;172,109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;363,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-right:0.5pt solid #000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-303"
      decimals="INF"
      id="f-1357"
      unitRef="shares">179369</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-304"
      decimals="INF"
      id="f-1358"
      unitRef="shares">405534</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-305"
      decimals="INF"
      id="f-1359"
      unitRef="shares">340976</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-306"
      decimals="INF"
      id="f-1360"
      unitRef="shares">348514</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-307"
      decimals="INF"
      id="f-1361"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-308"
      decimals="INF"
      id="f-1362"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-309"
      decimals="INF"
      id="f-1363"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-310"
      decimals="INF"
      id="f-1364"
      unitRef="shares">255960</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-307"
      decimals="INF"
      id="f-1365"
      unitRef="shares">2580</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-308"
      decimals="INF"
      id="f-1366"
      unitRef="shares">4576</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-309"
      decimals="INF"
      id="f-1367"
      unitRef="shares">7397</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-310"
      decimals="INF"
      id="f-1368"
      unitRef="shares">17094</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-307"
      decimals="INF"
      id="f-1369"
      unitRef="shares">4680</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-308"
      decimals="INF"
      id="f-1370"
      unitRef="shares">37628</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-309"
      decimals="INF"
      id="f-1371"
      unitRef="shares">28471</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="c-310"
      decimals="INF"
      id="f-1372"
      unitRef="shares">83417</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="c-307"
      decimals="INF"
      id="f-1373"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="c-308"
      decimals="INF"
      id="f-1374"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="c-309"
      decimals="INF"
      id="f-1375"
      unitRef="shares">132999</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="c-310"
      decimals="INF"
      id="f-1376"
      unitRef="shares">140633</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-311"
      decimals="INF"
      id="f-1377"
      unitRef="shares">172109</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-312"
      decimals="INF"
      id="f-1378"
      unitRef="shares">363330</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-311"
      decimals="INF"
      id="f-1379"
      unitRef="shares">172109</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-312"
      decimals="INF"
      id="f-1380"
      unitRef="shares">363330</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock contextRef="c-1" id="f-1381">&lt;div style="margin-bottom:3pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following table represents expected amortization of the Company's non-vested shares issued as of September&#160;30, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:35.321%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.683%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.117%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FUTURE AMORTIZATION &lt;br/&gt;of non-vested shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;10.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#2c2c2c;font-family:'Univers Next Pro Medium',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.25pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock>
    <hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear contextRef="c-3" decimals="-5" id="f-1382" unitRef="usd">4100000</hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear>
    <hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths contextRef="c-3" decimals="-5" id="f-1383" unitRef="usd">13300000</hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths>
    <hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo contextRef="c-3" decimals="-5" id="f-1384" unitRef="usd">10800000</hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo>
    <hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree contextRef="c-3" decimals="-5" id="f-1385" unitRef="usd">8000000.0</hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree>
    <hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour contextRef="c-3" decimals="-5" id="f-1386" unitRef="usd">2400000</hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour>
    <hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour contextRef="c-3" decimals="-5" id="f-1387" unitRef="usd">500000</hr:EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-3" decimals="-5" id="f-1388" unitRef="usd">39100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-1389">Fair Value of Financial Instruments&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The following methods and assumptions were used to estimate the fair value of each class of financial instrument for which it is practical to estimate that value.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt"&gt;Cash and cash equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"&gt; - The carrying amount approximates fair value (level 1 inputs) due to the short term maturity of these investments. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt"&gt;Real estate notes receivabl&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"&gt;e - Real estate notes receivable are recorded in other assets on the Company's Condensed Consolidated Balance Sheets.  Fair value is estimated using cash flow analyses, based on current interest rates for similar types of arrangements.&lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt"&gt;Borrowings under the Unsecured Credit Facility and the Term Loans Due 2024 and 2026&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"&gt; - The carrying amount approximates fair value because the borrowings are based on variable market interest rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt"&gt;Senior Notes and Mortgage Notes payable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"&gt; - The fair value of notes and bonds payable is estimated using cash flow analyses, based on the Company&#x2019;s current interest rates for similar types of borrowing arrangements.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%;padding-left:14.32pt"&gt;Interest rate swap agreements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:120%"&gt; - Interest rate swap agreements are recorded in other liabilities on the Company's Condensed Consolidated Balance Sheets at fair value. Fair value is estimated by utilizing pricing models, level 2 inputs, that consider forward yield curves and discount rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at September&#160;30, 2023 and December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.697%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.716%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.716%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.540%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Notes and bonds payable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,227.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,941.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,351.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,149.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Real estate notes receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;155.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;151.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;99.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;99.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Level 2 &#x2013; model-derived valuations in which significant inputs and significant value drivers are observable in active markets.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueByBalanceSheetGroupingTextBlock contextRef="c-1" id="f-1390">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Century',serif;font-size:9pt;font-weight:400;line-height:140%"&gt;The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at September&#160;30, 2023 and December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:86.697%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.236%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.716%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.596%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.716%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.540%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:0.25pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;September 30, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="6" style="background-color:#000000;border-left:1pt solid #ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Gotham Medium',sans-serif;font-size:5.75pt;font-weight:700;line-height:120%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-style:italic;font-weight:400;line-height:100%"&gt;Dollars in millions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;CARRYING VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#2c2c2c;font-family:'Gotham Medium',sans-serif;font-size:6pt;font-weight:700;line-height:120%"&gt;FAIR VALUE&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Notes and bonds payable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,227.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;4,941.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,351.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;5,149.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;Real estate notes receivable &lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:4.87pt;font-weight:400;line-height:100%;position:relative;top:-2.62pt;vertical-align:baseline"&gt;1&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;155.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;151.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="border-left:0.25pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;99.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Univers Next Pro Light',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%"&gt;99.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-left:0.25pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%"&gt;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Gotham Book',sans-serif;font-size:6.25pt;font-weight:400;line-height:140%;padding-left:15.77pt"&gt;Level 2 &#x2013; model-derived valuations in which significant inputs and significant value drivers are observable in active markets.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueByBalanceSheetGroupingTextBlock>
    <us-gaap:DebtInstrumentFairValue contextRef="c-313" decimals="-5" id="f-1391" unitRef="usd">5227400000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="c-314" decimals="-5" id="f-1392" unitRef="usd">4941200000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="c-315" decimals="-5" id="f-1393" unitRef="usd">5351800000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue contextRef="c-316" decimals="-5" id="f-1394" unitRef="usd">5149600000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet contextRef="c-313" decimals="-5" id="f-1395" unitRef="usd">155000000.0</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet contextRef="c-314" decimals="-5" id="f-1396" unitRef="usd">151700000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet contextRef="c-315" decimals="-5" id="f-1397" unitRef="usd">99600000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
    <us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet contextRef="c-316" decimals="-5" id="f-1398" unitRef="usd">99600000</us-gaap:MortgageLoansOnRealEstateCommercialAndConsumerNet>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-5" id="f-1399">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-5" id="f-1400">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-5" id="f-1401">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-5" id="f-1402">false</ecd:Rule10b51ArrTrmntdFlag>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>74
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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ME=S0?2@HSU8IU=<X.8)K.6'%,LXF;! N;!"N9(/4UZK\@)&^8,.X=CPZH_-
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M =EK#.#WK83.>KHQ'Z^/_UEA\S]02P,$%     @ 4S1C5V\%VA[T @  .PH
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M3/%T!\H&X/VEE.:Y8\\/]7DQ^@-02P,$%     @ 4S1C5VMQ(*C'!P  IR,
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MI,RF)''$'&Y0S?VH/A]BNM:7+U%QR,XV$YQ8101F2"(1,\?V*S>PY7[8WM@
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MV*CE=2?,1X$O60*1)[(PH7R5>.S63>ZG;IF8Y1MP(&<]B*N; C$O<ID HQ)
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M^PS:O2_T5,]T<9M)*OM^%CS%7?_*.%XWI(42DKJ09T-W)[OJ*X11&GU16+4
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M1(K12>_TA J"L)ZNQF"'&,2(JX6GT7C4JX$,SU_3=]T^H (!5%YD6HJ!/=H
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M9BW3Y/#EJEK(AE[3_'2]W6Y$.=S]YQ26_?!H)H =0\ZV#]L0?MXO T;ZB\W
M:B>&=V,?JM!5(ACW6N'G(+&%*2YKK<#_-&X''!Q7LH9O\8("CSQ9>X8KPJI"
MFRAN):<0B #KU-6UD6M[RL+W=17<.AEU%;>M]CO/$UHM9])]5PJ(>[=;31X
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M:\'1M=,"O*=DOG^@ ]K_,3C[#U!+ P04    " !3-&-7I_\6.[8(  #Z*0
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MH,?\$Q4HO89I$K&6#[F5YJFC6/X6FTW,6J9Q[H&!M,L,-.M5N)=1ROIOECK
M&@Z&"MH@$<-Y@7?%3E4K__S30;<S_&!?UYG(IEDT9,J'>CX'88AF<W5R:SH-
M[HNGQG0UK+V6  !@(CK!@G7,D/%6)B=X9E\&FZV$4:(BZ;RP=2QG)D'R@H1
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M7E8[)TG2)4( 27)-\) SKPMME*.PK#AF%]%6Y92_"<>5=2[6DJ<::%UTX2-
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M) SZ(5_RAF-BQ?\JW140N>AV1886RK DC$D6$JA3#T@TW4U<\1\W4Z3N'TU
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M*[5SATQ2# 6)R2TU]V.Q=QHW1HG1(0(KJ:6]V^?EAK 7K-DZ+P5@]S'QM./
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M%4E!F@\CB@,.<(7*LED>,,=42%V>'X-Z7\(?YZ5KD'[,;#8[B.'#V(<K-(!
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M1G(<#[UJ2*%O.;''[2:D\D'9230<NJ%_H!OHQ48N5JUK;8@"'W9#RX'18.W
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M;>M2/RZEP%C,![#/E6O[P@QV7\@O_@U02P,$%     @ 4S1C5^:;>2*?!0
M<A   !D   !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL[5C;;N,V$/V5@=MN
M$X"Q)>J>30SDV@W0.$&2[CX4?: MVB96$E62CI-^?8>4[-B)UMTN]JGHBT52
MG#,S/&<HTD=+J3[K.><&GLJBTL>]N3'UX6"@)W->,MV7-:_PS52JDAGLJME
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MV5D'_+]4.*O[C@UP?&B-_@%02P,$%     @ 4S1C5[WH(&CG!   =PP  !D
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M0JNQUQHZ0X2WN@TR-ZTOAGP(-7>J 9=N^==NW;KOF&K  T 'H6 >S(SBF"=
MKQEW8RZ 7M=Q>.3C6Q@]0S+@X/#$<[GK.@>F'7N8[-JV[P")D6U['D\"M+_#
MN+>K(_8B&.4&W/,2YL&H6 3<#0(S'L<A=P2NFP#J1<AC1_PW5)P1XI!K,#6?
M(_D@. )B=)^9LO2S4O;F)UQA]]<7?W<(^G3)KLM,;]9ZW DC'H9Q-^)P@1$_
M\7:M5T6=5P^ N0U'];))%X@WK$;XZ"0$,?=#I^N&"%9Q]'T[M[YU6WL'* C$
M52_VM_?.$8 #() (=H%PU\]-$,E**%#L9]8/8QX*_P!-['[HA#3F G2^B&DP
M"GD2(>;:^1)A(I6D6U>LEHW.TJQ&7"!24NFRR71&R R]$-@+'6$0&(>Q_76
M0HIAK&_5'S"I=9/=+&W0@<@2* <-Z@9WEH1FI5;P7\,,P?J> WB[V*]U>S3[
M![(XI+&:%I-GKY=(@2E7M_#H86M[Z6.3I>3CTH"A[R8'W7'U'=?=])YOJ*SK
M/$O7RA^STRH/[(!OMSX0B=EZH S,05OO)3QR[-;[//9]L ]-?SG"OC4TMCE0
M,;#+Q4#$MA]ZMN^%%K5[ _9WB OV45W845VXG^ILQ;).>$942= UO@8U6.H
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MNUMCX.<&?HH["Y2BO*":A@,I-B#M:N/-#M)44VL#CG';E;&6YBTS=CH<9]T
M,8,QFW,V8Q'E&DZC2*RX9GP.(Q&SB*&"/^ SE8Q.8@3&-4I4&M"LT4_P]@(U
M9;%Z!V_,.[A;B)6B?*H&KC88;20WRO&<97C\.CRX/(:6=P2^Y[?@?GP!;]^\
M@Z4T-)0F$!<:_Y$8(5M;(/_W[YK<BP+X10'\-&"K)F"1T]5S3I=93E\^FI5P
MI3%17ZORR-RVJ]W:S72BEC3"H6-VBT*Y1B?\_3<2>'\V@&X5H%M-WL-/JV2"
MTC9-;#A.S?:@,1CL5.-SK6S'OA>%JTH@"]%)0]C-NPZ#H#5PUQ6XV@6N=B.N
MNF)6A6_TM&?].@7.SF&:WCD Z*  '?QDT^TN4%!N ]/HQHV180]V^NU7=[M;
M .HV GHO[/G$C^#NP2"HJ^D1?!(:1I*EY\P9<C1G##/C*HR- ?>L;Z](IW<8
M4O0. +I?@.XWD^('*AQ!1*5\L@<W3>P17@4X<QEL,:'E=?O=:C80KY02KQ'+
M]>G#U?7]-5P^C&[&][>7<'<#'V_&XTH5\';8V"*DX]5@V)(S\D(]I%[ .95&
MM3A]+5HV!]VSQ:24*'(@C2*'$"E2JA1Y0:;V(2?9U:5.MUTC3*14)M(L3;]$
MSO:N-'I>'3=+T2&-\A#>X2-5KT;)0T@1*;6(! >B9*/([8N[E"S2K%D?A/EV
MA;7Y;EW)G^1C=Y<,K4ZW7\.&4FU(HR[\&B%[.R=V$X92/,@+ZO$:WY%YC.T"
M_2@E[M8%Q5[VKJF<,ZX@QIFQ\8Z[QEAF]Z=LHL4RO;-,A#8WH'2X,'=.E':!
M>3\3YFC))_8:5-QBP_\ 4$L#!!0    ( %,T8U=!)H($B0@   9-   9
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M-"",@7Z?<:ZV"Q.@OB1%?P!02P,$%     @ 4S1C5]XL8SC4 P  (Q0  !D
M  !X;"]W;W)K<VAE971S+W-H965T,S0N>&ULM9AM;]LV$,>_"J$60PMLD40]
MV,YL TFDH@46P(C;[<6P%XQ\EHE(I$O2=OOM2SU8L61%2!;FC252=S_R>-3?
MXDT/7#S(#8!"/_*,R9FU46I[:=LRV4!.Y 7? M-/UESD1.FF2&VY%4!6I5.>
MV=AQ0CLGE%GS:=FW$/,IWZF,,E@()'=Y3L3/:\CX86:YUK'CCJ8;5738\^F6
MI+ $]6V[$+IE-Y05S8%)RAD2L)Y95^YE['J%0VGQ-X6#/+E'12CWG#\4C2^K
MF>44,X(,$E4@B+[LX0:RK"#I>7ROH58S9N%X>G^D?RJ#U\'<$PDW//N'KM1F
M9HTMM((UV67JCA\^0QU04/ 2GLGR%QUJ6\="R4XJGM?.>@8Y9=65_*@7XL1!
M<_H=<.V NP[^$PY>[> ]=P2_=O"?.T)0.Y2AVU7LY<)%1)'Y5/ #$H6UIA4W
MY>J7WGJ]*"LVRE()_91J/S5?5AL$\35:TI31-4T(4^@J2?B.*<I2M. 932A(
M] >Z@SVP'>AKPK5MF>D/$2A",_E1/_^VC-"']Q_1>T09^KKA.TG82DYMI2=:
M#&<G]:2NJTGA)R;EH5O.U$:BF*U@U>,?#?M/!OQMO4#-*N'C*EWC0> 2MA?(
M<WY'V,%>SWQNGN^.^\)YW>CQ_QZ]M1A>LV6\DN<]P8NH)&DJ("7E!M [Y[@O
M_OU+FZ(O"G+Y7U_6*Z[?SRTD\5)N20(S2VN>!+$':_[;.S=T_NQ;<I.PR"0L
M-@1K)<=ODN,/T>=??V[A)"5]6:@ 80DH_D?V<S\,W:F]/UW='B,G&+6-HG,C
MUPN<<=LJ/K>:X)'3&+7"#)HP@\$P%T0\%.)$6<+SWB@'_5^ZUTS"(I.PV!"L
ME82P24+X1D(0FDR.25AD$A8;@K62,VJ2,WJM$%2 X.3%Q*.@*P0]1C[NO.+1
MN9$&=4CQN5'H.D_HP+B)<CP8Y2UA^G-6?[@JM 88D(-!S$MWG$E89!(6&X*U
M<C%I<C%Y(SF8F$R.25AD$A8;@K62XSJ/'_K.:P6A)IR^HFX0X(XB]%GY..Q(
M0H]5X.(.*^ZQPN/0[Q<%]^10XP[+ I6)/GL2!OH,TAOIH/]+MYQ16F24%INB
MM3.!'S.!WT@4:K"I%)FD149IL2E:.T6/QSEW\$#R+&'PSK[AO6#<U85S(^QX
M75DX-QJ/@JXJ] SGA!U1L$^*'CF(M*PV2536+:K#;-/;5+2NRCI.I__:O;QQ
M>_JCH@)6%ED>\57Y[):(E#*),ECKH9R+D=8O456DJH;BV[+D<L^5XGEYNP&R
M E$8Z.=KSM6Q40S0U 7GOP!02P,$%     @ 4S1C5U^(<0_W!0  T2\  !D
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MNRE6B4<K%:.?@S,,),T#I?F@M "4%D+1NFIJ*X#V.Y0 ;= :("C- Z7YH+0
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M+]I=^\RS->V^?194N\M;?+79_0:SQR3G*"4+Z<KJ3V6N8=7^\>I$T*+<OOQ
MA:!9>;@D."9,=9#7%Y2*YQ/EH-G%/_\?4$L#!!0    ( %,T8U<+J(X=S@0
M ,@:   9    >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;,V9:V_;-A2&_PJA
M%4,"9-'-\B6S#236BF1HL2!.V@_%/C R;6F11)>DX@38C]^AI,BF+#,SP X+
MX%BB>5X>/CXB]5KC#65//"9$H)<LS?G$BH587]@VCV*287Y.UR2'3Y:495C
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M&\1D;U"3!R7,,AJFG^3R>Y\+!I\F$">FGPE;$0:#BAA=WU^BDY (G*3\%'U
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MKZ6:2XI6+HY#KTW.:7CI/^,U^=D5%6YW5=&Z78"_P$?*P369HUP1,KY6/;C
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MX?C ^7B[6B^N=X,WM^!Z-K__[_2?N_\1CP9XX1,#O-T ;]\!_FZ O^^ \6[
M>-\!P6Y L.^ <#<@W'? 9#=@TAXP>6) M!L0[3M#O!L0[SO '7U[Y$9[#WEX
ML/=^M-UO#[?;?KR#^*DAWQYPM_V(^\%30[X]Y.[=8WYT__2]>^XGT_7T^-5R
M\=59;H_?>-LO[A;0W?C-4WXVWZ[UL_5R\[>SS;CU\?MZ>N6(U7JZKATY_U*O
MUIN%O%XYATXR6]TL5K/MBEPYOR3U>CJ[6OWJ_,V9S9WSSXO;U71^L7IUM-[<
MB"UU]'$W874_H??$A+&C%_/UYY4CYA?UA3G^:'/C'^Z!]^T>O/&LX%E]\]+Q
M)B\<;^3YSN]GB?/+WWYU/JW__=_<2?0?/3?P= _/C?;WDGV\8']/V+V3V\O-
M_?7V]](]O-$ +[-[Q>W\I>./]O=RNZ>G?SEN^^9-;:!\#EP.NX'%'I[G[^^5
M=B^M/VR>, -NGWKF 9D.?$#T'E[G$?GF.1=-;OSO>CF=KZ;W/]5OEIL3E.7Z
MK[[(V&,%/7D'GH"-+/$?TM"_F\G?(PV-_/MOM3G2D>OZ>O4_/7?@S3T[[F>W
MYVN_K6ZF'^O7!YL3LE6]_%(?'&]N?3CJS2<22TA,D%A*8AF)Y20F2:P@L9+$
M%(EI$JL@S B4\4.@C&WZ<75[_:%>.HM/SN+KO+[8O#K:!$Q]'S"[W)K5*^=?
MMG1\8YUB:+B06$)B@L12$LM(+"<Q26(%B94DIDA,DUAUCP5WV/9]E2_'8>B_
M.OK2DQG!0V8$ULQXZB2D+QJLTM!H(+&$Q 2)I226D5A.8I+$"A(K24R1F":Q
M"L*,# D?,B3\.2]D0C)02"PA,4%B*8EE)):3F"2Q@L1*$E,DIDFL@C C4"8/
M@3*QGI2<G2CAO'LO3T5?:EC'#DT-$DM(3)!82F(9B>4D)DFL(+&2Q!2):1*K
M[K'PT2N4L3^:3+S^%RG10QY$UCPX56_/9)4Y)TGQ^]FY%M7Y65\P6)&AP4!B
M"8D)$DM)+".QG,0DB14D5I*8(C%-8E74>>OBT(WBP.T/AO@A&&)[,+S5[TZJ
M?QRFLCJI3D7BZ+?OS[.33#C5VW/1&Q)6<&A(D%A"8H+$4A++2"PG,4EB!8F5
M)*9(3)-8%7=#8AR,1J/^D'!'3>UD9/_%B#C?O)QX>RI$TIL)]N%#0P'5$E03
MJ):B6H9J.:I)5"M0K40UA6H:U:J=]C@@_#",O"?.(MQ'O33WV8!X+TZ4(\[.
M3\Z%(ZL_Q/T+C=ZXL&*#XX+4$E03J):B6H9J.:I)5"M0K40UA6H:U:J=9L1%
M/!I'P1-QX35QX5GCXNUY+MX[O\CJ5/V>;-^8>"].A?SCY(T29[_V)H;5&YP8
MI):@FD"U%-4R5,M13:):@6HEJBE4TZA6[;3'B>%-_/")O&B*GJZU]G6<G<CJ
MZ!>IWYW(]]N3BOZ,0&N=J):@FD"U%-4R5,M13:):@6HEJBE4TZA6[;3'O^-P
MH_#)-RF:\J9K[8(=G_WG[R?OA9.^?7N^?0/S7[;2_!N[-3@L2"U!-8%J*:IE
MJ):CFD2U M5*5%.HIE&MVFF/3RABS]O\\T1:-+5-U][;/)]>WTR/]&QZ/7OA
MI*HW(]"^)JHEJ"90+46U#-5R5).H5J!:B6H*U32J591F)DE3WG1_4GO31>N;
MJ):@FD"U%-4R5,M13:):@6HEJBE4TZA649J9+TV7T_V1,J=]\. 00>N<J"90
M+46U#-5R5).H5J!:B6H*U;3;[6+&OA<T[U/LT@&:U$R'IMGI(M5.NS(X)M!R
M)ZH)5$M1+4.U'-4DJA6H5J*:0C7M]C0S@V@2M&,"FM2,B:;GZ>)%3[LX.#+0
MJB>J"51+42U#M1S5)*H5J%:BFD(U[79[FIVS"FA"<Y.NIO#I_5CATSY\:#:@
M6H)J M525,M0+4<UB6H%JI6HIE!->]V*9C3Q.Z<3U*1F/C1]3X_L>]JQP6F!
M]CU13:!:BFH9JN6H)E&M0+42U12J::_;T-RDQ<AKIP4TJ9D67I,6<-W3[@T.
M#+3NB6H"U5)4RU M1S6):@6JE:BF4$U[W8+F811%[;R YC3SHJE[>D#=TVX,
MS@BT[HEJ M525,M0+4<UB6H%JI6HIE!->]V"9ARZ[8CX&1MU>DW9T[/6R(:5
M/>W6X*@@M035!*JEJ):A6HYJ$M4*5"M13:&:WFG&YSV\\<B?M-,"FM5,BZ;L
MZ=G+GLC&OO8Y!J<(6@=%-8%J*:IEJ):CFD2U M5*5%.HIG>:D2+M /D9'4^O
MZ7AZUH[7HP#YEA"/KYRP38XG+J30&R1H[Q/5$E03J):B6H9J.:I)5"M0K40U
MA6IZIUF#Y&>4.;VFS.G9RYS)].IJNGKAG/^]-QG0,B>J):@F4"U%M0S5<E23
MJ%:@6HEJ"M4TJE649H9(T_GT[LMB^"=./+0%BFH)J@E42U$M0[4<U22J%:A6
MHII"-8UJ%:69^=*413U[6=3^B1/[X,$A@O9"=YJQMX!K[("XBP>T\8EJ&:KE
MJ"91K4"U$M54WS,I]MS6$TFCDU:49EY.L6E]^O;6YYZ?);$K0P, U1*_6Y\[
MW 3 N+7^T4E35,M0+4<UB6H%JI6HIGJ?2./6;T$U.F=%:>;R;TJ=OKW4^1V?
M$;&+@Z, ;7;ZW6Y<^S0 G3!%M0S5<E23J%:@6HEJZODGD48GK"C-S "OR0![
M5?.Y#W[8AP]>\&@ST^]VVUS7'\=A>]6CG4M4RU M1S6):@6JE:BF^IY)\2B,
MVRL?W3N3TLR5_^ABZO;2Y;"/=-BQP3G 7D3=[SQZX=B-_'8,L-='9R^0SEXA
MG;U$.GN-=/8BZ>Q5TKM/)#>*H[ = ^P%T']&L=)OBI6^M8HU_+,:=F]P$I!:
MXG?K:>$H[KP90,Z9HEJ&:CFJ250K4*U$-=7S/!K[[10@9ZPHS4R!IC#IVPN3
M>WT"PVX,7OEH(7*GF1=2]-RXO?31IB.J9:B6HYI$M0+52E13?4^DSCL Z':6
ME&8N_:;JZ-NKCH,^66&W!D< 6F7TNV4P-W2]L//C'RTIHEJ&:CFJ250K4*U$
M-=7S3/+#,.[\,@#==9+2S!AHBHJ^O:A8+&;SM?.EGJ]OE_6+N\]-+%>?9S?.
M+[.Y<U,O/V[^9GI9]Y\8H#5&5$M03:!:BFH9JN6H)E&M0+42U=1.BQ__ N'E
MN)T<:#N1TLSD:-J)OGU'RK/U2T<M;F>K%XY^VQL/: L1U1)4$ZB6HEJ&:CFJ
M250K4*U$-85J&M4J2C-SI&DA^O=M)[SE[*,%151+4$V@6HIJ&:KEJ"91K4"U
M$M44JFE4JRC-R)=QTW8<V]N.]I:S??#0$$&U!-4$JJ6HEJ%:CFH2U0I4*W?:
MXW<M_?;.]0J=4J-:16EF-C15R/$S5<C]FM!V97!(H/5'5!.HEJ):AFHYJDE4
M*U"M''>[C8=NU X)=+]*5*LHS0R)IBLYMG<EOZ,O;1<'!P9:GT0U@6HIJF6H
MEJ.:1+4"U<IQMQ;9.:= =ZM$M8K2S+AH"I;CYPN6MFJU??C@;$ KE:@F4"U%
MM0S5<E23J%:@6CGN=B5]WVNG [I/):I5E&:F0].['%L;70/KUW9L<%:06H)J
M M525,M0+4<UB6H%JI4[S<B*N//"@YQ2HUI%:696-.W,L;V=.;BC;?<&QP7:
MU$0U@6HIJF6HEJ.:1+4"U<IQ=WO(SLL.=#]*5*LHS0R+IL\YMO<Y]ZIRVXW!
M 8'V.%%-H%J*:AFJY:@F4:U M7*G/?YMQV$8MB,"W6D2U2I*,R.BZ7J.G[G"
M^)#*M]T:'!5HN1/5!*JEJ):A6HYJ$M4*5"MWFO&)P*"]/9A"Y]2H5E&:F15-
MNW-L;W>JQ<HYF5_65_7JA7-ZTIL0:+\3U1)4$ZB6HEJ&:CFJ250K4*U$-85J
M&M4J2C.3I.EWCG]2OW.,]CM1+4$U@6HIJF6HEJ.:1+4"U4I44ZBF4:VB-"-?
M@J;?&?Q(O],^>&B(H%J":@+54E3+4"T/>EJ/?OOD7O8<->EN$5ST'.:YG<-*
M]!XH5-.H5E&:N9R;2F: 5#+MRN!UC58R44V@6HIJ&:KE04]1T??'[77=<U0T
MFL3M==US6."%[66-[B*):AK5*DHSE[77+&N\1&D7!R]QM$2):@+54E3+4"T/
MGJT6RIY##L=]/[B?I4KTMBM4TZA649JYNIO.8_!CG4?[\,%+&>T\HII M135
M,E3+@VX3T(O;OXZ3?4=M+[#07LP]AXW&DW%[0:/[/J*:1K6*TLP%W=04 VNU
M:6!-T8X-7MZDEJ":0+44U3)4RW>:4=[SPJB]O+M'15'HC=O+NWN8-PK;5UDI
MT7N@4$VC6D5IYO)NFH4!W"RT>X-7.-HL1#6!:BFJ9:B6!\_V[63/(9O7VGY[
M=7>/"KSVTD9W:T0UC6H5I9E+N^D!!D /T&X,7LYH#Q#5!*JEJ):A6A[TM./\
MD==>T3U'>:.X^^JZYS@WBMJK&MU_$=4TJE649J[JIKH7@-4]NS5X=:/5/503
MJ):B6H9J>= MM'5^6'</<<>3T21J+^WN<?[$#8/VVD;W1T0UC6H5I9EKNZG:
M!?:JG5XLUY?3R]J9+]9U[WI&BW:HEJ":0+44U3)4RU%-[C1C]_*^M\S1!AVJ
M*533J%91FAD038,NL%^G^>3JPW3^UPNG^D=O.J U.51+4$V@6HIJ&:KEJ"91
MK4"U$M44JFE4JRC-")&PJ<F%][T=O(8;H@TZ5$M03:!:BFH9JN6H)E&M0+42
MU12J:52K*,W,EZ:W%]I[>_8:KGWPX!!!ZWJH)E M1;5LISU^F;"MNK9>)N3H
MI!+5"E0K44VAFD:UBM+,=&CJ?^$S];_]6KUV97!,H)4_5!.HEJ):%O8T\%S/
MB]LQ@6Z(B&H%JI6HIE!-HUI%:69,-#W"T-XC_(Z6L%T<'!EHM1#5!*JEJ):%
MW?Y>YZP"W2,1U0I4*U%-H9I&M8K2S+AH6HJAM2;U;.W8/GQP-I!:@FH"U5)4
MRW::T1&<3-QV/)!S2E0K4*U$-85J&M4J2C/CH6DYAO:6X[ 2LQT;'!9HQ1'5
M!*JEJ):%W2ZA%[I^.RS031%1K4"U$M44JFE4JRC-#(NF-QG:>Y.#*]%V;W!>
MH!U*5!.HEJ):%G:OV7SHCMJ7;L_1226J%:A6HII"-8UJ%:69@=%4,D-[)7.O
MHK7=&!P2:!43U02JI:B6[31C*Q"WO1-YCLXI4:U M1+5%*II5*LHS<R(IMH9
M/G.-["&U;;LU."O0FB>J"51+42W;:8]/*,:C:-(YH4#[FZA6H%J):@K5-*I5
ME&:&15/S#)^I>2[KJ;/XY%Q-YQ>;J)CV9@1:]D2U!-4$JJ6HEJ%:OM-<]_$O
M3UYV]CU")RU0K40UA6H:U2I*,S)BTK0X)_;-#O/%[6J]F+]PSO_>%P_VT4/C
M =425!.HEJ):AFHYJDE4*U"M1#6%:AK5*DHS4Z3I:D[NVUYX%WR"UCA1+4$U
M@6HIJF6HEJ.:1+4"U4I44ZBF4:VB-#-?O"9?[&U/>Q?</GAPB'B=]_:\H/5J
M/4&G%*B6]MR!R/=:]R!#Y\Q13:):@6HEJBE4TZA649JYYIOJYN29ZN9^#6^[
M,GCQ=VN'A^W-QQ)T2H%J:>\=B(+VXD<W;D0UB6H%JI6HIE!-HUI%:>;B;XJ8
M$VN3ZWMZVW9Q<!",.^NH<PY 3BA0+7W^YF?HA#FJ250K4*U$-85J&M4J2C,S
MH&E;3IYO6]K*V/;A@Q=\3T^PO;M_@DXI4"WMN0/1R._\Y$=W?$0UB6H%JI6H
MIE!-HUI%:>:J;VJ3$WMM<EC'VHX-SH!N]\^-V[6>!)U3H%K:<P_&03AIAP"Z
M3R2J250K4*U$-85J&M4J2C-#H*E"3NQ5R,'=:;LW. >>W1LQ02<4J);VW'PW
M'K<S -U-$M4DJA6H5J*:0C6-:A6EF1G05!TG]JKC7G5HNS%XW7=W/3QT)Q.O
MO?;1[B*JI3UWP??:ESW)T#ES5).H5J!:B6H*U32J591F+OZFNCBQ5Q<']9SM
MUN 0B#L_/0.O\P&@!)U4H%K:=Q<F;KMRG*&3YJ@F4:U M1+5%*II5*LHS4B!
MJ"DG1O9RXLGZ:CI?3U\XV4G?NK>/'KKN42U!-8%J*:IEJ):CFD2U M5*5%.H
MIE&MHC0S19IR8O23RHD16DY$M035!*JEJ):A6HYJ$M4*5"M13:&:1K6*TLQ\
M:<J)T8^4$^V#!X<(N@,EJHFHKSCICEOOGJ3HI!FJY:@F4:U M1+5%*II5*LH
MS4R'IL88(35&NS(X)M!=)U%-1#T-Q?95GE-TR@S5<E23J%:@6HEJ"M4TJE64
M9H9$4W>,K%6J[ZD[VL7!@4%J":J)G6;Y;6R*3IBA6HYJ$M4*5"M13:&:1K6*
MTLRX:)J1T8\U(^W#!V<#NO,DJHFHI[49C":=TPET2TE4RU%-HEJ!:B6J*533
MJ%91FID/38<R(CN4=FQP6J#[3J*:B+KM2,_OM+Q3=-(,U7)4DZA6H%J):@K5
M-*I5E&:F15.VC."RI=T;'!CH'I2H)J)ND_(P\#MY@>XMB6HYJDE4*U"M1#6%
M:AK5*DHS\Z(I9D9 ,=-N#,X(=.])5!-1MW'I^5$G(] ])5$M1S6):@6JE:BF
M4$VC6D5I9D8T_<T([&_:K<%9@>Y!B6HBZBEF!FX<M,,"W5P2U7)4DZA6H%J)
M:@K5-*I5E&:$1=S4/&-[S?/T\^SC]'+QPI&J+Q[LHX?& ZHEJ"90+46U#-5R
M5).H5J!:B6H*U32J591FIDA3\XQ_4LTS1FN>J):@FD"U%-4R5,M13:):@6HE
MJBE4TZA649J9+UZ3+S]2\XR[Y<<@CMO[1I[:YQB<#FA_$]525,M0+4<UB6H%
MJI6HIE!-HUI%:68Z-#7/&*EYQCWEQ\ZU8$[M<PU.";2^B6HIJF6HEJ.:1+4"
MU4I44ZBF4:VB-#,EFIYG;"V&?4_/<R=:VH^G]DD'QP6I"51+42U#M1S5)*H5
MJ%:BFD(UC6H5I9EQT?0\XQ_K><;=]F,0CZ)./J %3E03J):B6H9J.:I)5"M0
MK40UA6H:U2I*,_.AZ7G&9,\S[K8?)^.)VTD+M,"):@+54E3+4"U'-8EJ!:J5
MJ*903:-:16EF6C0]SQCN><8][4>_>W:!]C=13:!:BFH9JN6H)E&M0+42U12J
M:52K*,W,BZ;G&0,]S[AOR\R@<\&L4_M<@U,";7"B6HIJ&:KEJ"91K4"U$M44
MJFE4JRC-3(FFZ1F#3<^XVW]T1^/8]=II@78X44V@6HIJ&:KEJ"91K4"U$M44
MJFE4JRCM/BV.5I_K>IU,U]/C5]?U\K(^K:^N5L['Q>U\PV^K6P]_ZBSK3YLT
M<7\[\0Z.-B.;PX]?W4PO:SU=7L[F*^>J_K09.GJYO0S)<G;Y^>&;]>)F2SH?
M%NOUXOKNR\_U]*)>;@_8_/VGQ6+][9OM!%\7RS_O;M[Q_P-02P,$%     @
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MNDR*NDG4$\4K6P477.F::H>%[JL@#$"O+SE7NXEQT';JY ]02P,$%     @
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M:&5E=#0U+GAM;+58;8_:.!#^*U9N=6HE2EYYVP+20G*]2MUJ5=2[#Z?[8,@
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M5G01D7C4+-9E)=9EH-D]1[]_6R>Y<;(_>+K1*U\4#XI?Z130!KV]"A4:$L:
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M."D4WABP355Q\S1#J=LI&[']PJW8E,XO1%E:\PTNT=W5-X:BJ&<I1(7*"JW
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ME055O:#\_9<T+;[_4#5PGV:_K]_.Q7\!4$L#!!0    ( %,T8U<'!4=0F 4
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MZS5!54W0.4W/%3A'KS[ENX=V,=\Y&H3'549]QVD2KBEJG?!*_L)N_=MLEJ[
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M7!4*+0I2H4]SD(06XK.BZ(&B =8'8*V!-TCDA(.8V%*)T*'861?P0QNP]T[
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M1 /!!I0;.<D[-8UZP=%%P:JMV "]HJJ104IX)MB PE'HQ0/%!I@7^Y$[D&R
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M5Y>C*.X614?Q+#^>%USIPSYO;O1U#(0)T.,KKOV4'7/B5Q>\X1]02P,$%
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M+?Y3UF=KEW\</SSSUM3=(9\-?S*:O0%02P$"% ,4    " !3-&-7!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( %,T8U=&%X*U[@   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( %,T8U>97)PC$ 8  )PG   3
M          "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M4S1C5R]Y#!W[!0  TA\  !@              ("!#0@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( %,T8U>&MZ(UQ@<  +@@   8
M          " @3X.  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4
M    " !3-&-7;P7:'O0"   ["@  &               @($Z%@  >&PO=V]R
M:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%     @ 4S1C5VMQ(*C'!P  IR,
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M965T."YX;6Q02P$"% ,4    " !3-&-7 CQGO*(:  "J30  &
M    @('40@  >&PO=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @
M4S1C5^J/(9W1#@  HB8  !D              ("!K%T  'AL+W=O<FMS:&5E
M=',O<VAE970Q,"YX;6Q02P$"% ,4    " !3-&-7$^#%;X,*   ]&   &0
M            @(&T;   >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4
M Q0    ( %,T8U>G_Q8[M@@  /HI   9              " @6YW  !X;"]W
M;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#%     @ 4S1C5UBLQPH1!0
M-PL  !D              ("!6X   'AL+W=O<FMS:&5E=',O<VAE970Q,RYX
M;6Q02P$"% ,4    " !3-&-7 ([G]L4)   ?&P  &0              @(&C
MA0  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM;%!+ 0(4 Q0    ( %,T8U?F
M)&WD$00  '()   9              " @9^/  !X;"]W;W)K<VAE971S+W-H
M965T,34N>&UL4$L! A0#%     @ 4S1C5VK075E #@  3BP  !D
M     ("!YY,  'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %,T8U<!R!U];@<  /81   9              "
M@6F_  !X;"]W;W)K<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ 4S1C
M5ZGL&\P/"   JQ(  !D              ("!#L<  'AL+W=O<FMS:&5E=',O
M<VAE970R,BYX;6Q02P$"% ,4    " !3-&-79$9&Y/T)   M%P  &0
M        @(%4SP  >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0
M   ( %,T8U?FFWDBGP4  '(0   9              " @8C9  !X;"]W;W)K
M<VAE971S+W-H965T,C0N>&UL4$L! A0#%     @ 4S1C5TOB=JQ,!   = D
M !D              ("!7M\  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q0
M2P$"% ,4    " !3-&-7O>@@:.<$  !W#   &0              @('AXP
M>&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( %,T8U?\5#RR
MKP@  "T9   9              " @?_H  !X;"]W;W)K<VAE971S+W-H965T
M,C<N>&UL4$L! A0#%     @ 4S1C5TM_^<8Z P  +0<  !D
M ("!Y?$  'AL+W=O<FMS:&5E=',O<VAE970R."YX;6Q02P$"% ,4    " !3
M-&-76QT]W H-  !QF0  &0              @(%6]0  >&PO=V]R:W-H965T
M<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( %,T8U=\8HB2X@,  #<1   9
M          " @9<" 0!X;"]W;W)K<VAE971S+W-H965T,S N>&UL4$L! A0#
M%     @ 4S1C5X3P\'FD P  T0X  !D              ("!L 8! 'AL+W=O
M<FMS:&5E=',O<VAE970S,2YX;6Q02P$"% ,4    " !3-&-702:"!(D(   &
M30  &0              @(&+"@$ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM
M;%!+ 0(4 Q0    ( %,T8U>.L[3$_P(  # )   9              " @4L3
M 0!X;"]W;W)K<VAE971S+W-H965T,S,N>&UL4$L! A0#%     @ 4S1C5]XL
M8SC4 P  (Q0  !D              ("!@18! 'AL+W=O<FMS:&5E=',O<VAE
M970S-"YX;6Q02P$"% ,4    " !3-&-77XAQ#_<%  #1+P  &0
M    @(&,&@$ >&PO=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    (
M %,T8U<+J(X=S@0  ,@:   9              " @;H@ 0!X;"]W;W)K<VAE
M971S+W-H965T,S8N>&UL4$L! A0#%     @ 4S1C5T$;AV!>"P  2UT  !D
M             ("!OR4! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"
M% ,4    " !3-&-7P)UV1A0%   E(   &0              @(%4,0$ >&PO
M=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4 Q0    ( %,T8U<:\01_?@(
M (8%   9              " @9\V 0!X;"]W;W)K<VAE971S+W-H965T,SDN
M>&UL4$L! A0#%     @ 4S1C5S"9GRVT!   0A@  !D              ("!
M5#D! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " !3-&-7
MF?1T0PL7  !4FP$ &0              @($_/@$ >&PO=V]R:W-H965T<R]S
M:&5E=#0Q+GAM;%!+ 0(4 Q0    ( %,T8U<4E2CA)P8  $0>   9
M      " @8%5 0!X;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%
M  @ 4S1C5UZ^=T*/ @  M0<  !D              ("!WUL! 'AL+W=O<FMS
M:&5E=',O<VAE970T,RYX;6Q02P$"% ,4    " !3-&-7H8V3%W8"  "E!@
M&0              @(&E7@$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+
M 0(4 Q0    ( %,T8U=FDPI$' 0  .(6   9              " @5)A 0!X
M;"]W;W)K<VAE971S+W-H965T-#4N>&UL4$L! A0#%     @ 4S1C5S6/9IW&
M P  MA(  !D              ("!I64! 'AL+W=O<FMS:&5E=',O<VAE970T
M-BYX;6Q02P$"% ,4    " !3-&-7\=4'K4$%  "\&0  &0
M@(&B:0$ >&PO=V]R:W-H965T<R]S:&5E=#0W+GAM;%!+ 0(4 Q0    ( %,T
M8U=M>+:!C@D  (]B   9              " @1IO 0!X;"]W;W)K<VAE971S
M+W-H965T-#@N>&UL4$L! A0#%     @ 4S1C5W5DX06V!   12$  !D
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M=#4S+GAM;%!+ 0(4 Q0    ( %,T8U?/1Q-+3@0  .D8   9
M  " @<^/ 0!X;"]W;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @
M4S1C5]KG*L5: P  , P  !D              ("!5)0! 'AL+W=O<FMS:&5E
M=',O<VAE970U-2YX;6Q02P$"% ,4    " !3-&-77D9]BHT1  #E#@$ &0
M            @('EEP$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4
M Q0    ( %,T8U<'!4=0F 4  '46   9              " @:FI 0!X;"]W
M;W)K<VAE971S+W-H965T-3<N>&UL4$L! A0#%     @ 4S1C5Y5.3N';!0
M6R$  !D              ("!>*\! 'AL+W=O<FMS:&5E=',O<VAE970U."YX
M;6Q02P$"% ,4    " !3-&-7&0OH::P#   P#P  &0              @(&*
MM0$ >&PO=V]R:W-H965T<R]S:&5E=#4Y+GAM;%!+ 0(4 Q0    ( %,T8U?B
M'Q0!C@,  !0-   9              " @6VY 0!X;"]W;W)K<VAE971S+W-H
M965T-C N>&UL4$L! A0#%     @ 4S1C5\Z?G=6( @  Q@8  !D
M     ("!,KT! 'AL+W=O<FMS:&5E=',O<VAE970V,2YX;6Q02P$"% ,4
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( %,T8U=W2W&%!@(  /$D   :
M          "  5S, 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( %,T8U?_)Z=UXP$  &PD   3              "  9K. 0!;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@    !& $8 (1,  *[0 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>316</ContextCount>
  <ElementCount>442</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>115</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>18</UnitCount>
  <MyReports>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests</Role>
      <ShortName>Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterestsParenthetical</Role>
      <ShortName>Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Merger with HTA</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/MergerwithHTA</Role>
      <ShortName>Merger with HTA</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Real Estate Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestments</Role>
      <ShortName>Real Estate Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Notes and Bonds Payable</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://healthcarerealty.com/role/NotesandBondsPayable</Role>
      <ShortName>Notes and Bonds Payable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Derivative Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/DerivativeFinancialInstruments</Role>
      <ShortName>Derivative Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Fair Value of Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/FairValueofFinancialInstruments</Role>
      <ShortName>Fair Value of Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - Merger with HTA (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/MergerwithHTATables</Role>
      <ShortName>Merger with HTA (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/MergerwithHTA</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - Real Estate Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestmentsTables</Role>
      <ShortName>Real Estate Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/RealEstateInvestments</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/Leases</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - Notes and Bonds Payable (Tables)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://healthcarerealty.com/role/NotesandBondsPayableTables</Role>
      <ShortName>Notes and Bonds Payable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/NotesandBondsPayable</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - Derivative Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables</Role>
      <ShortName>Derivative Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/DerivativeFinancialInstruments</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/StockholdersEquity</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - Fair Value of Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables</Role>
      <ShortName>Fair Value of Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/FairValueofFinancialInstruments</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - Summary of Significant Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - Summary of Significant Accounting Policies - Consolidated balance sheets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Consolidated balance sheets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - Summary of Significant Accounting Policies - Variable interest entity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Variable interest entity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Revenue Recognition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - Merger with HTA - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/MergerwithHTANarrativeDetails</Role>
      <ShortName>Merger with HTA - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - Merger with HTA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/MergerwithHTADetails</Role>
      <ShortName>Merger with HTA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/MergerwithHTATables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - Merger with HTA - Schedule of Fair Values of the Assets Acquired And Liabilities Assumed (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails</Role>
      <ShortName>Merger with HTA - Schedule of Fair Values of the Assets Acquired And Liabilities Assumed (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - Real Estate Investments -Real Estate Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails</Role>
      <ShortName>Real Estate Investments -Real Estate Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - Real Estate Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestmentsNarrativeDetails</Role>
      <ShortName>Real Estate Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails</Role>
      <ShortName>Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - Real Estate Investments - Dispositions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails</Role>
      <ShortName>Real Estate Investments - Dispositions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - Real Estate Investments - Assets Held for Sale (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails</Role>
      <ShortName>Real Estate Investments - Assets Held for Sale (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - Leases - Lease Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/LeasesLeaseIncomeDetails</Role>
      <ShortName>Leases - Lease Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - Leases - Lessor Accounting (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/LeasesLessorAccountingDetails</Role>
      <ShortName>Leases - Lessor Accounting (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - Leases - Ground Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/LeasesGroundLeasesDetails</Role>
      <ShortName>Leases - Ground Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - Leases - Future Minimum Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails</Role>
      <ShortName>Leases - Future Minimum Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954498 - Disclosure - Leases - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/LeasesLeaseCostDetails</Role>
      <ShortName>Leases - Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954499 - Disclosure - Notes and Bonds Payable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://healthcarerealty.com/role/NotesandBondsPayableDetails</Role>
      <ShortName>Notes and Bonds Payable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/NotesandBondsPayableTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954500 - Disclosure - Notes and Bonds Payable - Narrative (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails</Role>
      <ShortName>Notes and Bonds Payable - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954501 - Disclosure - Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails</Role>
      <ShortName>Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954502 - Disclosure - Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails</Role>
      <ShortName>Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954503 - Disclosure - Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails</Role>
      <ShortName>Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954504 - Disclosure - Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails</Role>
      <ShortName>Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954505 - Disclosure - Commitment and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails</Role>
      <ShortName>Commitment and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954506 - Disclosure - Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails</Role>
      <ShortName>Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954507 - Disclosure - Stockholders' Equity - Stock Transactions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Stock Transactions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954508 - Disclosure - Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails</Role>
      <ShortName>Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954509 - Disclosure - Stockholders' Equity - Summary of the Activity Under the Incentive Plan and RSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails</Role>
      <ShortName>Stockholders' Equity - Summary of the Activity Under the Incentive Plan and RSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954510 - Disclosure - Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails</Role>
      <ShortName>Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954511 - Disclosure - Stockholders' Equity - Summary of Activity under Employee Stock Purchase Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails</Role>
      <ShortName>Stockholders' Equity - Summary of Activity under Employee Stock Purchase Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954512 - Disclosure - Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails</Role>
      <ShortName>Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="hr-20230930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954513 - Disclosure - Fair Value of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails</Role>
      <ShortName>Fair Value of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables</ParentRole>
      <Position>62</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="hr-20230930.htm">hr-20230930.htm</File>
    <File>hr-20230930.xsd</File>
    <File>hr-20230930_cal.xml</File>
    <File>hr-20230930_def.xml</File>
    <File>hr-20230930_lab.xml</File>
    <File>hr-20230930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2023</BaseTaxonomy>
    <BaseTaxonomy items="1054">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/ecd/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>80
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "hr-20230930.htm": {
   "nsprefix": "hr",
   "nsuri": "http://healthcarerealty.com/20230930",
   "dts": {
    "inline": {
     "local": [
      "hr-20230930.htm"
     ]
    },
    "schema": {
     "local": [
      "hr-20230930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/ecd/2023/ecd-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "hr-20230930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "hr-20230930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "hr-20230930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hr-20230930_pre.xml"
     ]
    }
   },
   "keyStandard": 310,
   "keyCustom": 132,
   "axisStandard": 30,
   "axisCustom": 3,
   "memberStandard": 40,
   "memberCustom": 73,
   "hidden": {
    "total": 10,
    "http://xbrl.sec.gov/dei/2023": 5,
    "http://fasb.org/us-gaap/2023": 5
   },
   "contextCount": 316,
   "entityCount": 1,
   "segmentCount": 115,
   "elementCount": 792,
   "unitCount": 18,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 1054,
    "http://xbrl.sec.gov/ecd/2023": 4,
    "http://xbrl.sec.gov/dei/2023": 30,
    "http://fasb.org/srt/2023": 1
   },
   "report": {
    "R1": {
     "role": "http://healthcarerealty.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
     "longName": "0000002 - Statement - Condensed Consolidated Balance Sheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:Land",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:OtherFiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
     "longName": "0000003 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
     "longName": "0000004 - Statement - Condensed Consolidated Statements of Operations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OperatingLeaseLeaseIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
     "longName": "0000005 - Statement - Condensed Consolidated Statements of Comprehensive Income",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests",
     "longName": "0000006 - Statement - Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests",
     "shortName": "Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-78",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-78",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterestsParenthetical",
     "longName": "0000007 - Statement - Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests (Parenthetical)",
     "shortName": "Condensed Consolidated Statements of Equity and Redeemable Non-Controlling Interests (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R8": {
     "role": "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows",
     "longName": "0000008 - Statement - Condensed Consolidated Statements of Cash Flows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProfitLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "0000009 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://healthcarerealty.com/role/MergerwithHTA",
     "longName": "0000010 - Disclosure - Merger with HTA",
     "shortName": "Merger with HTA",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://healthcarerealty.com/role/RealEstateInvestments",
     "longName": "0000011 - Disclosure - Real Estate Investments",
     "shortName": "Real Estate Investments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "hr:AcquisitionsAndDispositionsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "hr:AcquisitionsAndDispositionsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://healthcarerealty.com/role/Leases",
     "longName": "0000012 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://healthcarerealty.com/role/NotesandBondsPayable",
     "longName": "0000013 - Disclosure - Notes and Bonds Payable",
     "shortName": "Notes and Bonds Payable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://healthcarerealty.com/role/DerivativeFinancialInstruments",
     "longName": "0000014 - Disclosure - Derivative Financial Instruments",
     "shortName": "Derivative Financial Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://healthcarerealty.com/role/CommitmentsandContingencies",
     "longName": "0000015 - Disclosure - Commitments and Contingencies",
     "shortName": "Commitments and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://healthcarerealty.com/role/StockholdersEquity",
     "longName": "0000016 - Disclosure - Stockholders' Equity",
     "shortName": "Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://healthcarerealty.com/role/FairValueofFinancialInstruments",
     "longName": "0000017 - Disclosure - Fair Value of Financial Instruments",
     "shortName": "Fair Value of Financial Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R19": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "hr:NatureOfOperationsPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "hr:NatureOfOperationsPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables",
     "longName": "9954472 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "srt:ScheduleOfCondensedBalanceSheetTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://healthcarerealty.com/role/MergerwithHTATables",
     "longName": "9954473 - Disclosure - Merger with HTA (Tables)",
     "shortName": "Merger with HTA (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://healthcarerealty.com/role/RealEstateInvestmentsTables",
     "longName": "9954474 - Disclosure - Real Estate Investments (Tables)",
     "shortName": "Real Estate Investments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://healthcarerealty.com/role/LeasesTables",
     "longName": "9954475 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://healthcarerealty.com/role/NotesandBondsPayableTables",
     "longName": "9954476 - Disclosure - Notes and Bonds Payable (Tables)",
     "shortName": "Notes and Bonds Payable (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables",
     "longName": "9954477 - Disclosure - Derivative Financial Instruments (Tables)",
     "shortName": "Derivative Financial Instruments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://healthcarerealty.com/role/StockholdersEquityTables",
     "longName": "9954478 - Disclosure - Stockholders' Equity (Tables)",
     "shortName": "Stockholders' Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables",
     "longName": "9954479 - Disclosure - Fair Value of Financial Instruments (Tables)",
     "shortName": "Fair Value of Financial Instruments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails",
     "longName": "9954480 - Disclosure - Summary of Significant Accounting Policies (Details)",
     "shortName": "Summary of Significant Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "hr:InvestmentInRealEstatePropertiesAndMortgageNotes",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-8",
      "ancestors": [
       "span",
       "div",
       "hr:NatureOfOperationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ImpairmentOfRealEstate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R30": {
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails",
     "longName": "9954481 - Disclosure - Summary of Significant Accounting Policies - Consolidated balance sheets (Details)",
     "shortName": "Summary of Significant Accounting Policies - Consolidated balance sheets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:RealEstateInvestmentPropertyNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-91",
      "name": "us-gaap:RealEstateInvestmentPropertyNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R31": {
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails",
     "longName": "9954482 - Disclosure - Summary of Significant Accounting Policies - Variable interest entity (Details)",
     "shortName": "Summary of Significant Accounting Policies - Variable interest entity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:NumberOfRealEstateProperties",
      "unitRef": "property",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "hr:NatureOfOperationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-94",
      "name": "hr:NotesReceivableCarryingAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R32": {
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails",
     "longName": "9954483 - Disclosure - Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:SaleLeasebackTransactionNetBookValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:SaleLeasebackTransactionNetBookValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails",
     "longName": "9954484 - Disclosure - Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R34": {
     "role": "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails",
     "longName": "9954485 - Disclosure - Summary of Significant Accounting Policies - Revenue Recognition (Details)",
     "shortName": "Summary of Significant Accounting Policies - Revenue Recognition (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-110",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R35": {
     "role": "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
     "longName": "9954486 - Disclosure - Merger with HTA - Narrative (Details)",
     "shortName": "Merger with HTA - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-127",
      "name": "us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R36": {
     "role": "http://healthcarerealty.com/role/MergerwithHTADetails",
     "longName": "9954487 - Disclosure - Merger with HTA (Details)",
     "shortName": "Merger with HTA (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-127",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-127",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:AssetAcquisitionContingentConsiderationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails",
     "longName": "9954488 - Disclosure - Merger with HTA - Schedule of Fair Values of the Assets Acquired And Liabilities Assumed (Details)",
     "shortName": "Merger with HTA - Schedule of Fair Values of the Assets Acquired And Liabilities Assumed (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-127",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-127",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails",
     "longName": "9954489 - Disclosure - Real Estate Investments -Real Estate Acquisitions (Details)",
     "shortName": "Real Estate Investments -Real Estate Acquisitions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-137",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-137",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://healthcarerealty.com/role/RealEstateInvestmentsNarrativeDetails",
     "longName": "9954490 - Disclosure - Real Estate Investments - Narrative (Details)",
     "shortName": "Real Estate Investments - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:PaymentsToAcquireLand",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:PaymentsToAcquireProductiveAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails",
     "longName": "9954491 - Disclosure - Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details)",
     "shortName": "Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-139",
      "name": "us-gaap:InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails",
     "longName": "9954492 - Disclosure - Real Estate Investments - Dispositions (Details)",
     "shortName": "Real Estate Investments - Dispositions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:NumberOfRealEstateProperties",
      "unitRef": "property",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "hr:NatureOfOperationsPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-174",
      "name": "hr:DispositionSalesPrice",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "hr:AssetDispositionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R42": {
     "role": "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails",
     "longName": "9954493 - Disclosure - Real Estate Investments - Assets Held for Sale (Details)",
     "shortName": "Real Estate Investments - Assets Held for Sale (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "hr:NumberOfPropertiesClassifiedAsHeldForSale",
      "unitRef": "property",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "hr:NumberOfPropertiesClassifiedAsHeldForSale",
      "unitRef": "property",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://healthcarerealty.com/role/LeasesLeaseIncomeDetails",
     "longName": "9954494 - Disclosure - Leases - Lease Income (Details)",
     "shortName": "Leases - Lease Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OperatingLeaseLeaseIncome",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R44": {
     "role": "http://healthcarerealty.com/role/LeasesLessorAccountingDetails",
     "longName": "9954495 - Disclosure - Leases - Lessor Accounting (Details)",
     "shortName": "Leases - Lessor Accounting (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://healthcarerealty.com/role/LeasesGroundLeasesDetails",
     "longName": "9954496 - Disclosure - Leases - Ground Leases (Details)",
     "shortName": "Leases - Ground Leases (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:NumberOfPropertiesSubjectToGroundLeases",
      "unitRef": "property",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "hr:SquareFeetSubjecttoGroundLeases",
      "unitRef": "sqft",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails",
     "longName": "9954497 - Disclosure - Leases - Future Minimum Lease Payments (Details)",
     "shortName": "Leases - Future Minimum Lease Payments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://healthcarerealty.com/role/LeasesLeaseCostDetails",
     "longName": "9954498 - Disclosure - Leases - Lease Cost (Details)",
     "shortName": "Leases - Lease Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
     "longName": "9954499 - Disclosure - Notes and Bonds Payable (Details)",
     "shortName": "Notes and Bonds Payable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LongTermDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-215",
      "name": "hr:DebtInstrumentExtensionPeriodForMaturityDate",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails",
     "longName": "9954500 - Disclosure - Notes and Bonds Payable - Narrative (Details)",
     "shortName": "Notes and Bonds Payable - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LongTermDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-218",
      "name": "hr:PercentageOfInterestBearingInMortgageNotesPayable",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
     "longName": "9954501 - Disclosure - Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details)",
     "shortName": "Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:NumberOfInterestRateDerivativesHeld",
      "unitRef": "derivative",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:NumberOfInterestRateDerivativesHeld",
      "unitRef": "derivative",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails",
     "longName": "9954502 - Disclosure - Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details)",
     "shortName": "Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-233",
      "name": "us-gaap:DerivativeFairValueOfDerivativeLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-233",
      "name": "us-gaap:DerivativeFairValueOfDerivativeLiability",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails",
     "longName": "9954503 - Disclosure - Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details)",
     "shortName": "Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
     "longName": "9954504 - Disclosure - Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details)",
     "shortName": "Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "hr:DerivativeNetAssetPositionAggregateFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "hr:DerivativeNetAssetPositionAggregateFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails",
     "longName": "9954505 - Disclosure - Commitment and Contingencies - Narrative (Details)",
     "shortName": "Commitment and Contingencies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:PaymentsToAcquireLand",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-263",
      "name": "hr:JointVentureOwnershipPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails",
     "longName": "9954506 - Disclosure - Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details)",
     "shortName": "Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "us-gaap:CommonStockSharesIssued",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-71",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R56": {
     "role": "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
     "longName": "9954507 - Disclosure - Stockholders' Equity - Stock Transactions - Narrative (Details)",
     "shortName": "Stockholders' Equity - Stock Transactions - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:CommonStockDividendsPerShareCashPaid",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails",
     "longName": "9954508 - Disclosure - Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details)",
     "shortName": "Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:WeightedAverageNumberOfSharesIssuedBasic",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:WeightedAverageNumberOfSharesIssuedBasic",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails",
     "longName": "9954509 - Disclosure - Stockholders' Equity - Summary of the Activity Under the Incentive Plan and RSU Activity (Details)",
     "shortName": "Stockholders' Equity - Summary of the Activity Under the Incentive Plan and RSU Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-292",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-292",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
     "longName": "9954510 - Disclosure - Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details)",
     "shortName": "Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-288",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-288",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails",
     "longName": "9954511 - Disclosure - Stockholders' Equity - Summary of Activity under Employee Stock Purchase Plan (Details)",
     "shortName": "Stockholders' Equity - Summary of Activity under Employee Stock Purchase Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-303",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-303",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails",
     "longName": "9954512 - Disclosure - Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details)",
     "shortName": "Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "hr:EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails",
     "longName": "9954513 - Disclosure - Fair Value of Financial Instruments (Details)",
     "shortName": "Fair Value of Financial Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-313",
      "name": "us-gaap:DebtInstrumentFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-313",
      "name": "us-gaap:DebtInstrumentFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueByBalanceSheetGroupingTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hr-20230930.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedAfterYearFour",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028 and thereafter",
        "label": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, after Year Four",
        "documentation": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, After Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class [Domain]",
        "label": "Asset Class [Domain]",
        "documentation": "Class of asset."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r220",
      "r310",
      "r311",
      "r577",
      "r578",
      "r579",
      "r638",
      "r640",
      "r643",
      "r651",
      "r659",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r676",
      "r696",
      "r715",
      "r864",
      "r922"
     ]
    },
    "us-gaap_NotesReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesReceivableMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes Receivable",
        "label": "Notes Receivable [Member]",
        "documentation": "An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date(s) within one year of the balance sheet date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "hr_TermLoanDue2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "TermLoanDue2027Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "$200 million Unsecured Term Loan",
        "label": "Term Loan due 2027 [Member]",
        "documentation": "Term Loan due 2027"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassifications",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r820"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "us-gaap_RealEstatePropertiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RealEstatePropertiesLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Properties [Line Items]",
        "label": "Real Estate Properties [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r61"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Minimum Operating Lease Payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "us-gaap_TemporaryEquityAccretionToRedemptionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityAccretionToRedemptionValue",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Adjustments to redemption value of redeemable non-controlling interests",
        "label": "Temporary Equity, Accretion to Redemption Value",
        "documentation": "Value of accretion of temporary equity to its redemption value during the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of right-of-use assets",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r489",
      "r709"
     ]
    },
    "hr_NotesReceivableInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NotesReceivableInterestRate",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "INTEREST RATE",
        "label": "Notes Receivable, Interest Rate",
        "documentation": "Notes Receivable, Interest Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Lessor, Operating Lease, Payment to be Received, Year One",
        "documentation": "Amount of lease payment to be received by lessor for operating lease in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r499"
     ]
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity interest owned (percent)",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "hr_RecapitalizationExchangeRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "RecapitalizationExchangeRatio",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange ratio",
        "label": "Recapitalization Exchange Ratio",
        "documentation": "Recapitalization Exchange Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLeaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLeaseIncome",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/LeasesLeaseIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rental income",
        "label": "Operating Lease, Lease Income",
        "documentation": "Amount of operating lease income from lease payments and variable lease payments paid and payable to lessor. Includes, but is not limited to, variable lease payments not included in measurement of lease receivable."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r497",
      "r500"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LessorOperatingLeasePaymentsToBeReceived",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Lessor, Operating Lease, Payment to be Received",
        "documentation": "Amount of lease payments to be received by lessor for operating lease."
       }
      }
     },
     "auth_ref": [
      "r499"
     ]
    },
    "hr_InvestmentInRealEstatePropertiesAndMortgageNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "InvestmentInRealEstatePropertiesAndMortgageNotes",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross investment amount, total",
        "label": "Investment in Real Estate Properties and Mortgage Notes",
        "documentation": "Investment in real estate properties and mortgage notes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill expected to be tax deductible",
        "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount",
        "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes."
       }
      }
     },
     "auth_ref": [
      "r86"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation:",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedFourYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedFourYears",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Four",
        "documentation": "Amount of lease payment to be received by lessor for operating lease in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r499"
     ]
    },
    "us-gaap_TemporaryEquityIssuePeriodIncreaseOrDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityIssuePeriodIncreaseOrDecrease",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contributions from redeemable non-controlling interests",
        "label": "Temporary Equity, Carrying Amount, Period Increase (Decrease)",
        "documentation": "Change in the value of each type or class of stock classified as temporary equity during the period. The redemption requirement does not constitute an unconditional obligation that will be settled in a variable number of shares constituting a monetary value predominantly indexed to (a) a fixed monetary amount known at inception, (b) an amount inversely correlated with the residual value of the entity, or (c) an amount determined by reference to something other than the fair value of issuer's stock. Does not include mandatorily redeemable stock. The exception is if redemption is required upon liquidation or termination of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r65"
     ]
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAxis",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Axis]",
        "label": "Business Acquisition [Axis]",
        "documentation": "Information by business combination or series of individually immaterial business combinations."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r80",
      "r437",
      "r703",
      "r704"
     ]
    },
    "hr_ClosingAdjustmentsDisposedEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ClosingAdjustmentsDisposedEntity",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "CLOSING ADJUSTMENTS",
        "label": "Closing Adjustments Disposed Entity",
        "documentation": "Closing Adjustments Disposed Entity, including closing costs and other adjustments to the sales price."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionAcquireeDomain",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition, Acquiree [Domain]",
        "label": "Business Acquisition, Acquiree [Domain]",
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree."
       }
      }
     },
     "auth_ref": [
      "r437",
      "r703",
      "r704"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r299"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedThreeYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedThreeYears",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Three",
        "documentation": "Amount of lease payment to be received by lessor for operating lease in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r499"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedTwoYears": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedTwoYears",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessor, Operating Lease, Payment to be Received, Year Two",
        "documentation": "Amount of lease payment to be received by lessor for operating lease in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r499"
     ]
    },
    "hr_ApproximateSquareFeetProvidedByCompany": {
     "xbrltype": "areaItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ApproximateSquareFeetProvidedByCompany",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Approximate square feet for which Nationwide property management services provided by company",
        "label": "Approximate Square Feet Provided by Company",
        "documentation": "Approximate square feet for which Nationwide property management services provided by company"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r80",
      "r437"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023",
        "label": "Lessor, Operating Lease, Payment to be Received, Remainder of Fiscal Year",
        "documentation": "Amount of lease payment to be received by lessor for operating lease in remainder of current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r906"
     ]
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessAcquisitionLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Acquisition [Line Items]",
        "label": "Business Acquisition [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r437"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LessorOperatingLeasePaymentsToBeReceivedMaturityTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Minimum Operating Lease Payments Receivable",
        "label": "Lessor, Operating Lease, Payment to be Received, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of maturity of undiscounted cash flows to be received by lessor on annual basis for operating lease."
       }
      }
     },
     "auth_ref": [
      "r906"
     ]
    },
    "us-gaap_NumberOfRealEstateProperties": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfRealEstateProperties",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of owned real estate properties",
        "label": "Number of Real Estate Properties",
        "documentation": "The number of real estate properties owned as of the balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteBuildingsAndImprovements",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Buildings and improvements",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Buildings and Improvements",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Buildings and Improvements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnDispositionOfAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainLossOnDispositionOfAssets",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "GAIN/(IMPAIRMENT)",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r830",
      "r851",
      "r853"
     ]
    },
    "hr_PercentageOfInterestBearingInMortgageNotesPayable": {
     "xbrltype": "percentItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "PercentageOfInterestBearingInMortgageNotesPayable",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of interest-bearing in mortgage note payable",
        "label": "Percentage of Interest-Bearing in Mortgage Notes Payable",
        "documentation": "Percentage of Interest-Bearing in Mortgage Notes Payable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares withheld to pay estimated withholding taxes (in shares)",
        "label": "Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net identifiable assets acquired",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identifiable Assets Acquired",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Net Identifiable Assets Acquired"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted, Weighted average grant date fair value (in dollar per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Discount",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "hr_FinanceMortgageNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "FinanceMortgageNotes",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "COMPANY-FINANCED MORTGAGE NOTES",
        "label": "Finance Mortgage Notes",
        "documentation": "Finance Mortgage Notes"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberOfPropertyDispositions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NumberOfPropertyDispositions",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of property dispositions",
        "label": "Number of Property Dispositions",
        "documentation": "Number of Property Dispositions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contracts with Customers (ASC Topic 606)",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r207",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r673"
     ]
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing lease liabilities",
        "verboseLabel": "Lease liabilities",
        "label": "Finance Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r482",
      "r496"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "hr_ActiveInterestRateSwapsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ActiveInterestRateSwapsMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Active Interest Rate Swap",
        "label": "Active Interest Rate Swaps [Member]",
        "documentation": "Active Interest Rate Swaps [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NonControllingInterestHoldersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NonControllingInterestHoldersMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Controlling Interest Holders",
        "label": "Non-Controlling Interest Holders [Member]",
        "documentation": "Non-Controlling Interest Holders"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Share-based awards, beginning of period (in shares)",
        "periodEndLabel": "Share-based awards, ending of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r416",
      "r417"
     ]
    },
    "hr_RealEstateDispositionsAndMortgageNoteRepaymentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "RealEstateDispositionsAndMortgageNoteRepaymentsAxis",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Dispositions and Mortgage Note Repayments [Axis]",
        "label": "Real Estate Dispositions and Mortgage Note Repayments [Axis]",
        "documentation": "Real Estate Dispositions and Mortgage Note Repayments [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate, Type of Property [Axis]",
        "label": "Real Estate, Type of Property [Axis]",
        "documentation": "Information by type of real estate property."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r220",
      "r659",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669"
     ]
    },
    "hr_RealEstateAcquisitionsAndMortgageNoteFinancingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "RealEstateAcquisitionsAndMortgageNoteFinancingAxis",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Acquisitions and Mortgage Note Financing [Axis]",
        "label": "Real Estate Acquisitions and Mortgage Note Financing [Axis]",
        "documentation": "Real Estate Acquisitions and Mortgage Note Financing."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Share-based awards, beginning of period, Weighted average grant date fair value (in dollar per share)",
        "periodEndLabel": "Share-based awards, ending of period, Weighted average grant date fair value (in dollar per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r416",
      "r417"
     ]
    },
    "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate [Domain]",
        "label": "Real Estate [Domain]",
        "documentation": "Land and any structures permanently fixed to it."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669"
     ]
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total real estate investments",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "hr_IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "IncrementalCommonSharesAttributableToDilutiveEffectOfEmployeeStockPurchasePlan",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Dilutive effect of employee stock purchase plan (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Employee Stock Purchase Plan",
        "documentation": "Incremental common shares attributable to dilutive effect of employee stock purchase plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Vested/Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "hr_ImpairmentChargeOnRealEstateAssetsHeldForSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ImpairmentChargeOnRealEstateAssetsHeldForSale",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment charges on net real estate assets held for sale",
        "label": "Impairment Charge on Real Estate Assets Held for Sale",
        "documentation": "Impairment Charge on Real Estate Assets Held for Sale"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r229",
      "r230",
      "r231",
      "r260",
      "r280",
      "r281",
      "r284",
      "r288",
      "r293",
      "r294",
      "r318",
      "r335",
      "r337",
      "r338",
      "r339",
      "r342",
      "r343",
      "r374",
      "r375",
      "r378",
      "r381",
      "r388",
      "r468",
      "r559",
      "r560",
      "r561",
      "r562",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r592",
      "r612",
      "r632",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r803",
      "r832",
      "r840"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Allowance for Credit Losses, Interest Income, Income from Real Estate Notes Receivable:",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits": {
     "xbrltype": "areaItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "AreaCoveredUnderRealEstateInvestmentSoldInMeasurementUnits",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SQUARE FOOTAGE",
        "label": "Area Covered Under Real Estate Investment Sold in Measurement Units",
        "documentation": "Area covered under real estate investment sold in measurement units."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r763"
     ]
    },
    "hr_SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "SeniorNotesDue2030NetOfDiscountAndIssuanceCostsMember",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes due 2030",
        "label": "Senior Notes due 2030, Net of Discount and Issuance Costs [Member]",
        "documentation": "Senior Notes due 2030, Net of Discount and Issuance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RealEstateInvestmentPropertyNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RealEstateInvestmentPropertyNetAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Real estate properties",
        "label": "Real Estate Investment Property, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Two",
        "documentation": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Two"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested/Forfeited, Weighted average grant date fair value (in dollar per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "hr_InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "InvestmentsInAndAdvanceToAffiliatesSubsidiariesAssociatesAndJointVenturesInPeriod",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New investments during the period",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures in Period",
        "documentation": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures in Period"
       }
      }
     },
     "auth_ref": []
    },
    "hr_MedicalOfficeBuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "MedicalOfficeBuildingMember",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medical office building",
        "label": "Medical Office Building [Member]",
        "documentation": "Medical Office Building [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total undiscounted lease payments",
        "label": "Finance Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "hr_ParkingIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ParkingIncomeMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Parking income",
        "label": "Parking Income [Member]",
        "documentation": "Parking Income [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_RealEstateInvestmentNetDisposedOfDuringPeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "RealEstateInvestmentNetDisposedOfDuringPeriod",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NET REAL ESTATE INVESTMENT",
        "label": "Real Estate Investment Net Disposed of During Period",
        "documentation": "Real estate investment net disposed of during the Period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NotesReceivableCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NotesReceivableCarryingAmount",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes receivable, carrying amount",
        "label": "Notes Receivable, Carrying Amount",
        "documentation": "Notes Receivable, Carrying Amount"
       }
      }
     },
     "auth_ref": []
    },
    "hr_IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "IncrementalCommonSharesAttributableToDilutiveEffectOfOPUnits",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dilutive effect of OP Units (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of OP Units",
        "documentation": "Incremental Common Shares Attributable to Dilutive Effect of OP Units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfPropertiesSubjectToGroundLeases": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfPropertiesSubjectToGroundLeases",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of properties subject to ground leases",
        "label": "Number of Properties Subject to Ground Leases",
        "documentation": "Number of separate real estate development properties located on land subject to ground leases."
       }
      }
     },
     "auth_ref": [
      "r902"
     ]
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Axis]",
        "label": "Investment, Name [Axis]",
        "documentation": "Information by name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r316",
      "r317"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseRightOfUseAssets",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing lease right-of-use assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Right-of-Use Assets",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Right-of-Use Assets"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r730"
     ]
    },
    "hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedStockPrice",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock price (in dollar per share)",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Stock Price",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Stock Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberOfSwapTransactions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NumberOfSwapTransactions",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of swap transactions",
        "label": "Number of Swap Transactions",
        "documentation": "Number of Swap Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commitments and contingencies",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r135",
      "r526",
      "r591"
     ]
    },
    "hr_RealEstateAcquisitionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "RealEstateAcquisitionsMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total real estate acquisitions",
        "label": "Real Estate Acquisitions [Member]",
        "documentation": "Real estate acquisitions."
       }
      }
     },
     "auth_ref": []
    },
    "hr_RealEstateDispositionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "RealEstateDispositionsMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Dispositions",
        "label": "Real Estate Dispositions [Member]",
        "documentation": "Real Estate Dispositions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_SeniorNotesDue2031Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "SeniorNotesDue2031Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes due 2031",
        "label": "Senior Notes due 2031 [Member]",
        "documentation": "Senior Notes due 2031"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "hr_STLouisMoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "STLouisMoMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "St. Louis, MO",
        "label": "ST Louis Mo [Member]",
        "documentation": "ST Louis Mo"
       }
      }
     },
     "auth_ref": []
    },
    "hr_CumulativeNetIncomeAttributableToCommonStockholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "CumulativeNetIncomeAttributableToCommonStockholders",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cumulative net income attributable to common stockholders",
        "label": "Cumulative Net Income Attributable to Common Stockholders",
        "documentation": "Cumulative net income attributable to common stockholders."
       }
      }
     },
     "auth_ref": []
    },
    "hr_ReceivablesAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ReceivablesAndOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivables and other assets",
        "label": "Receivables And Other Assets",
        "documentation": "Receivables And Other Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MinorityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterest",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interest",
        "label": "Equity, Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r187",
      "r260",
      "r318",
      "r335",
      "r337",
      "r338",
      "r339",
      "r342",
      "r343",
      "r468",
      "r529",
      "r593"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Expired (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period",
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements."
       }
      }
     },
     "auth_ref": [
      "r415"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesOfAssetsHeldForSale",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities of assets held for sale",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities of Assets Held for Sale",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities of Assets Held for Sale"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HedgingDesignationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingDesignationAxis",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Axis]",
        "label": "Hedging Designation [Axis]",
        "documentation": "Information by designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r450"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "hr_AssetsHeldForSaleAndDiscontinuedOperationsNet",
       "weight": 1.0,
       "order": 2.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "verboseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r481"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r414"
     ]
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioPreviouslyReportedMember",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Previously Reported",
        "label": "Previously Reported [Member]",
        "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r262",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r276",
      "r290",
      "r436",
      "r461",
      "r462",
      "r463",
      "r479",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r809",
      "r811",
      "r812",
      "r813",
      "r839",
      "r845",
      "r846",
      "r899",
      "r908",
      "r909"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Probability adjustment, Weighted average grant date fair value (in dollar per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Probability Adjustment in Period, Weighted Average Grant Date Fair Value",
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Probability Adjustment in Period, Weighted Average Grant Date Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "hr_LesseeOperatingLeaseLiabilityToBePaidAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "LesseeOperatingLeaseLiabilityToBePaidAfterYearFour",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028 and thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Four",
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, after Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other assets, net",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets"
       }
      }
     },
     "auth_ref": []
    },
    "hr_RedevelopmentPropertiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "RedevelopmentPropertiesMember",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redevelopment Properties",
        "label": "Redevelopment Properties [Member]",
        "documentation": "Redevelopment Properties"
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Goodwill"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023",
        "label": "Finance Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r210",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r310",
      "r311",
      "r577",
      "r578",
      "r579",
      "r638",
      "r640",
      "r643",
      "r651",
      "r661",
      "r662",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r676",
      "r696",
      "r715",
      "r864",
      "r922"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Future Minimum Financing Lease Payments",
        "label": "Finance Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r905"
     ]
    },
    "hr_SquareFeetSubjectToMortgageNotesPayable": {
     "xbrltype": "areaItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "SquareFeetSubjectToMortgageNotesPayable",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Square foot subject to mortgage note payable",
        "label": "Square Feet Subject to Mortgage Notes Payable",
        "documentation": "Square Feet Subject to Mortgage Notes Payable"
       }
      }
     },
     "auth_ref": []
    },
    "hr_InterestRateSwapExpiringJune12027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "InterestRateSwapExpiringJune12027Member",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Swap, Expiring June 1, 2027",
        "label": "Interest Rate Swap, Expiring June 1, 2027 [Member]",
        "documentation": "Interest Rate Swap, Expiring June 1, 2027"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable non-controlling interests",
        "periodStartLabel": "Redeemable Non-controlling Interests, beginning balance",
        "periodEndLabel": "Redeemable Non-controlling Interests, ending balance",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests",
        "documentation": "Carrying amount, attributable to parent and noncontrolling interests, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r34",
      "r260",
      "r318",
      "r468"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding and exercisable, beginning of period (in shares)",
        "periodEndLabel": "Outstanding and exercisable, end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r408",
      "r409"
     ]
    },
    "hr_LimitedLiabilityCompanyOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "LimitedLiabilityCompanyOneMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Limited Liability Company One",
        "label": "Limited Liability Company One [Member]",
        "documentation": "Limited Liability Company One"
       }
      }
     },
     "auth_ref": []
    },
    "hr_RealEstateDispositionsAndMortgageNoteRepaymentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "RealEstateDispositionsAndMortgageNoteRepaymentsDomain",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Dispositions and Mortgage Note Repayments [Domain]",
        "label": "Real Estate Dispositions and Mortgage Note Repayments [Domain]",
        "documentation": "Real Estate Dispositions and Mortgage Note Repayments [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_HealthCareRealtyTrustIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "HealthCareRealtyTrustIncMember",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "HealthCare Realty Trust, Inc.",
        "label": "HealthCare Realty Trust, Inc. [Member]",
        "documentation": "HealthCare Realty Trust, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "hr_StraightLineRentReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "StraightLineRentReceivable",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Amortization of straight-line rent receivable (lessor)",
        "label": "Straight-line Rent Receivable",
        "documentation": "Straight-line rent receivable."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Expenses",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterestsAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable Non-Controlling Interests:",
        "label": "Temporary Equity, Carrying Amount, Including Portion Attributable to Noncontrolling Interests [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows outflows related to financing leases",
        "label": "Finance Lease, Interest Payment on Liability",
        "documentation": "Amount of interest paid on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r485",
      "r492"
     ]
    },
    "hr_ManagementFeeIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ManagementFeeIncomeMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Management fee income",
        "label": "Management Fee Income [Member]",
        "documentation": "Management Fee Income [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_UnsecuredCreditFacilityOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "UnsecuredCreditFacilityOneMember",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "$1.5 billion Unsecured Credit Facility",
        "label": "Unsecured Credit Facility One [Member]",
        "documentation": "Unsecured Credit Facility One"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "hr_BusinessAcquisitionPurchasePriceAllocationSquareFootage": {
     "xbrltype": "areaItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessAcquisitionPurchasePriceAllocationSquareFootage",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "SQUARE FOOTAGE",
        "label": "Business Acquisition Purchase Price Allocation Square Footage",
        "documentation": "Business Acquisition Purchase Price Allocation Square Footage."
       }
      }
     },
     "auth_ref": []
    },
    "hr_OperatingExpensesandCostofGoodsSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "OperatingExpensesandCostofGoodsSold",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Expenses",
        "label": "Operating Expenses and Cost of Goods Sold",
        "documentation": "Operating Expenses and Cost of Goods Sold"
       }
      }
     },
     "auth_ref": []
    },
    "hr_DirectorsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "DirectorsMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Directors",
        "label": "Directors [Member]",
        "documentation": "Directors"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromCollectionOfFinanceReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromCollectionOfFinanceReceivables",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment in financing receivable",
        "label": "Proceeds from Collection of Finance Receivables",
        "documentation": "The cash inflow associated with the collection of receivables arising from the financing of goods and services."
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "hr_BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationAcquiredRealEstateNotesReceivableGrossContractualAmount",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross contractual real estate notes receivable",
        "label": "Business Combination, Acquired Real Estate Notes Receivable, Gross Contractual Amount",
        "documentation": "Business Combination, Acquired Real Estate Notes Receivable, Gross Contractual Amount"
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing lease liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financing Lease Liabilities",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Financing Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteLand",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Land",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Land"
       }
      }
     },
     "auth_ref": []
    },
    "hr_PropertyEntitiesNotDeterminedToBeVIEsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "PropertyEntitiesNotDeterminedToBeVIEsMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property Entities Not Determined to be VIEs",
        "label": "Property Entities Not Determined to be VIEs [Member]",
        "documentation": "Property Entities Not Determined to be VIEs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (loss) income applicable to common stockholders - basic",
        "label": "Net Income (Loss) from Continuing Operations Available to Common Stockholders, Basic",
        "documentation": "Net Income (Loss) from Continuing Operations Available to Common Stockholders, Basic"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets acquired",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Acquired",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Acquired"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OPERATING",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_JointVentureCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "JointVentureCarryingAmount",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Joint venture, carrying amount",
        "label": "Joint Venture, Carrying Amount",
        "documentation": "Joint Venture, Carrying Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseInterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest on lease liabilities",
        "label": "Finance Lease, Interest Expense",
        "documentation": "Amount of interest expense on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r483",
      "r489",
      "r709"
     ]
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberOfRecognizedLeaseFinancialReceivables": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NumberOfRecognizedLeaseFinancialReceivables",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of recognized lease financial receivables",
        "label": "Number of Recognized Lease Financial Receivables",
        "documentation": "Number of Recognized Lease Financial Receivables"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430"
     ]
    },
    "us-gaap_ProceedsFromRepaymentsOfLinesOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromRepaymentsOfLinesOfCredit",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net repayments on unsecured credit facility",
        "label": "Proceeds from (Repayments of) Lines of Credit",
        "documentation": "The net cash inflow or cash outflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with either short term or long term maturity that is collateralized (backed by pledge, mortgage or other lien in the entity's assets)."
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingGoodwillAdjustmentIncomplete",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill adjustment incomplete",
        "label": "Business Combination Provisional Information Initial Accounting Goodwill Adjustment Incomplete",
        "documentation": "Business Combination Provisional Information Initial Accounting Goodwill Adjustment Incomplete"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430"
     ]
    },
    "hr_DispositionSalesPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "DispositionSalesPrice",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SALE PRICE",
        "label": "Disposition Sales Price",
        "documentation": "Disposition Sales Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r792"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r790"
     ]
    },
    "hr_HoustonTXMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "HoustonTXMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Houston, TX",
        "label": "Houston, TX [Member]",
        "documentation": "Houston, TX"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r788"
     ]
    },
    "hr_AmortizationofPrepaidRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "AmortizationofPrepaidRent",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of prepaid rent",
        "label": "Amortization of Prepaid Rent",
        "documentation": "Amortization of Prepaid Rent"
       }
      }
     },
     "auth_ref": []
    },
    "hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardPerformancePeriod",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award performance period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period",
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Performance Period"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseRightOfUseAssets",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Right-Of-Use Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r788"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_ScottsdaleArizonaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ScottsdaleArizonaMember",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Scottsdale, Arizona",
        "label": "Scottsdale, Arizona [Member]",
        "documentation": "Scottsdale, Arizona"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r728"
     ]
    },
    "hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearThree",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Three",
        "documentation": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Three"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r789"
     ]
    },
    "hr_BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuableConversionRatio",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion ratio",
        "label": "Business Combination Consideration Transferred Equity Interests Issuable Conversion Ratio",
        "documentation": "Business Combination Consideration Transferred Equity Interests Issuable Conversion Ratio"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "us-gaap_NumberOfInterestRateDerivativesHeld": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfInterestRateDerivativesHeld",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of instruments",
        "label": "Number of Interest Rate Derivatives Held",
        "documentation": "Number of interest rate derivative instruments held by the entity at the reporting date."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r108"
     ]
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAccountsPayableAndAccruedLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable and Accrued Liabilities",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Accounts Payable and Accrued Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other liabilities",
        "label": "Other Liabilities",
        "documentation": "Amount of liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r134",
      "r520",
      "r586",
      "r587",
      "r726",
      "r924"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r788"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r329",
      "r330",
      "r660",
      "r855"
     ]
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValueAdjustmentsandOther",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OTHER",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value Adjustments and Other",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value Adjustments and Other"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "hr_ProceedsFromContributionsFromRedeemableNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ProceedsFromContributionsFromRedeemableNoncontrollingInterests",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Contributions from redeemable non-controlling interests",
        "label": "Proceeds from Contributions from Redeemable Noncontrolling Interests",
        "documentation": "Proceeds from Contributions from Redeemable Noncontrolling Interests"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Combination and Asset Acquisition [Abstract]",
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsHeldForSale",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets held for sale, net",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Held For Sale",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Held For Sale"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r789"
     ]
    },
    "hr_SquareFeetSubjecttoGroundLeases": {
     "xbrltype": "areaItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "SquareFeetSubjecttoGroundLeases",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Square feet subject to ground leases",
        "label": "Square Feet Subject to Ground Leases",
        "documentation": "Square Feet Subject to Ground Leases"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsProbabilityAdjustmentInPeriod",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Probability adjustment of 2022 &amp; 2023 RSUs (in shares)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options Probability Adjustment In Period",
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Probability Adjustment In Period"
       }
      }
     },
     "auth_ref": []
    },
    "hr_LessorOperatingLeasePaymenttobeReceivedafterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "LessorOperatingLeasePaymenttobeReceivedafterYearFour",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails": {
       "parentTag": "us-gaap_LessorOperatingLeasePaymentsToBeReceived",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028 and thereafter",
        "label": "Lessor, Operating Lease, Payment to be Received, after Year Four",
        "documentation": "Lessor, Operating Lease, Payment to be Received, after Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTATables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Values of the Assets Acquired And Liabilities Assumed",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "hr_ApproximateSquareFeetInvestedInByCompany": {
     "xbrltype": "areaItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ApproximateSquareFeetInvestedInByCompany",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Approximate square feet invested in by company",
        "label": "Approximate Square Feet Invested in by Company",
        "documentation": "Approximate Square Feet Invested in by Company"
       }
      }
     },
     "auth_ref": []
    },
    "hr_MarketCondition2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "MarketCondition2Member",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Relative TSR Component",
        "label": "Market Condition 2 [Member]",
        "documentation": "Market Condition 2"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NatureOfOperationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NatureOfOperationsPolicyTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Overview",
        "label": "Nature of Operations [Policy Text Block]",
        "documentation": "Nature Of Operations Policy."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r791"
     ]
    },
    "hr_ConstructionActivityTotalFundingDuringthePeriod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ConstructionActivityTotalFundingDuringthePeriod",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction activity and development properties",
        "label": "Construction Activity, Total Funding During the Period",
        "documentation": "Construction Activity, Total Funding During the Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive (loss) income attributable to common stockholders",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r238",
      "r240",
      "r249",
      "r517",
      "r538"
     ]
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLandHeldForDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land held for development",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land Held For Development",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land Held For Development"
       }
      }
     },
     "auth_ref": []
    },
    "hr_DerivativeNetAssetPositionAggregateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "DerivativeNetAssetPositionAggregateFairValue",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives in net asset position",
        "label": "Derivative Net Asset Position Aggregate Fair Value",
        "documentation": "Derivative Net Asset Position Aggregate Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberOfBuildingsOwnedByJointVenture": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NumberOfBuildingsOwnedByJointVenture",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of buildings owned by joint venture with TIAA",
        "label": "Number of Buildings Owned by Joint Venture",
        "documentation": "Number of Buildings Owned by Joint Venture"
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteIndefiniteLivedIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease intangible assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Indefinite Lived Intangible Assets",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Indefinite Lived Intangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "hr_ScheduleOfRealEstateDispositionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ScheduleOfRealEstateDispositionsTable",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Real Estate Dispositions [Table]",
        "label": "Schedule of Real Estate Dispositions [Table]",
        "documentation": "Schedule of real estate dispositions."
       }
      }
     },
     "auth_ref": []
    },
    "hr_InterestRateSwapExpiringJune12026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "InterestRateSwapExpiringJune12026Member",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Swap, Expiring June 1, 2026",
        "label": "Interest Rate Swap, Expiring June 1, 2026 [Member]",
        "documentation": "Interest Rate Swap, Expiring June 1, 2026"
       }
      }
     },
     "auth_ref": []
    },
    "hr_CompletedDevelpomentAndRedevelopmentPropertiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "CompletedDevelpomentAndRedevelopmentPropertiesMember",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Completed Develpoment and Redevelopment Properties",
        "label": "Completed Develpoment and Redevelopment Properties [Member]",
        "documentation": "Completed Develpoment and Redevelopment Properties"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestNonaccrual": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancingReceivableExcludingAccruedInterestNonaccrual",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing receivable, nonaccrual",
        "label": "Financing Receivable, Excluding Accrued Interest, Nonaccrual",
        "documentation": "Amortized cost excluding accrued interest, of financing receivable on nonaccrual status. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r323"
     ]
    },
    "us-gaap_DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DistributionMadeToLimitedLiabilityCompanyLLCMemberCashDistributionsDeclared",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Owner distributions",
        "label": "Distribution Made to Limited Liability Company (LLC) Member, Cash Distributions Declared",
        "documentation": "Amount of equity impact of cash distributions declared to unit-holder of limited liability company (LLC)."
       }
      }
     },
     "auth_ref": [
      "r171",
      "r292"
     ]
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentConstructionInProgress",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in progress",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Construction in Progress",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Construction in Progress"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberofGroundLeasesExcludingPrepaidLeases": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NumberofGroundLeasesExcludingPrepaidLeases",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of non-prepaid ground leases",
        "label": "Number of Ground Leases, Excluding Prepaid Leases",
        "documentation": "Number of Ground Leases, Excluding Prepaid Leases"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r793"
     ]
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "hr_AcquisitionsAndDispositionsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "AcquisitionsAndDispositionsTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Real Estate Investments",
        "label": "Acquisitions and Dispositions [Text Block]",
        "documentation": "Acquisitions and dispositions."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r794"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r727"
     ]
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "hr_SeniorNotesdue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "SeniorNotesdue2028Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes due 2028",
        "label": "Senior Notes due 2028 [Member]",
        "documentation": "Senior Notes due 2028 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r728"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "hr_FinanceLeasePrincipalOnlyPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "FinanceLeasePrincipalOnlyPayments",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing cash flows outflows related to financing leases",
        "label": "Finance Lease, Principal Only Payments",
        "documentation": "Finance Lease, Principal Only Payments"
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesOfAssetsHeldForSale",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities of assets held for sale",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Of Assets Held For Sale",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Of Assets Held For Sale"
       }
      }
     },
     "auth_ref": []
    },
    "hr_InterestRateSwapExpiringJanuary152024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "InterestRateSwapExpiringJanuary152024Member",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Swap, Expiring January 15, 2024",
        "label": "Interest Rate Swap, Expiring January 15, 2024 [Member]",
        "documentation": "Interest Rate Swap, Expiring January 15, 2024"
       }
      }
     },
     "auth_ref": []
    },
    "hr_ImpairmentOfRealEstateAndCreditLossReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ImpairmentOfRealEstateAndCreditLossReserves",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Impairment of real estate properties and credit loss reserves",
        "label": "Impairment of Real Estate and Credit Loss Reserves",
        "documentation": "Impairment of Real Estate and Credit Loss Reserves"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r728"
     ]
    },
    "hr_NumberOfRealEstateInvestments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NumberOfRealEstateInvestments",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of real estate properties",
        "label": "Number of Real Estate Investments",
        "documentation": "Number of real estate investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stockholders' Equity",
        "label": "Equity [Text Block]",
        "documentation": "The entire disclosure for equity."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r259",
      "r373",
      "r375",
      "r377",
      "r378",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r387",
      "r389",
      "r460",
      "r635",
      "r636",
      "r658"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockValue",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, $.01 par value per share; 200,000 shares authorized; none issued and outstanding",
        "label": "Preferred Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r527",
      "r710"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r795"
     ]
    },
    "hr_RealEstateOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "RealEstateOther",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OTHER (INCLUDING RECEIVABLES)",
        "label": "Real Estate Other",
        "documentation": "Real estate other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r228",
      "r260",
      "r295",
      "r303",
      "r307",
      "r318",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r442",
      "r446",
      "r468",
      "r525",
      "r603",
      "r710",
      "r726",
      "r859",
      "r860",
      "r911"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r729"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r728"
     ]
    },
    "hr_NotesReceivableMaximumLoanCommitment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NotesReceivableMaximumLoanCommitment",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MAXIMUM LOAN COMMITMENT",
        "label": "Notes Receivable, Maximum Loan Commitment",
        "documentation": "Notes Receivable, Maximum Loan Commitment"
       }
      }
     },
     "auth_ref": []
    },
    "hr_StockIssuanceProgramDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "StockIssuanceProgramDomain",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Issuance Program [Domain]",
        "label": "Stock Issuance Program [Domain]",
        "documentation": "[Domain] for Stock Issuance Program [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromSaleOfRealEstateHeldforinvestment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfRealEstateHeldforinvestment",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "NET PROCEEDS",
        "label": "Proceeds from Sale, Real Estate, Held-for-Investment",
        "documentation": "Cash received from the sale of real estate that is held for investment, that is, it is part of an investing activity during the period."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationAxis",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Axis]",
        "label": "Balance Sheet Location [Axis]",
        "documentation": "Information by location on balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": []
    },
    "hr_NewEmployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NewEmployeeMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Employee",
        "label": "New Employee [Member]",
        "documentation": "New Employee"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r771"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Earnings (Loss) per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "hr_EquityOfferingProgramAvailableForIssuance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "EquityOfferingProgramAvailableForIssuance",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount remaining available for issuance under the new ATM",
        "label": "Equity Offering Program Available for Issuance",
        "documentation": "Equity Offering Program Available for Issuance"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (loss) income attributable to common stockholders",
        "terseLabel": "Net income (loss)",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r160",
      "r190",
      "r224",
      "r236",
      "r239",
      "r243",
      "r260",
      "r265",
      "r267",
      "r268",
      "r270",
      "r271",
      "r275",
      "r276",
      "r282",
      "r295",
      "r302",
      "r306",
      "r308",
      "r318",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r464",
      "r468",
      "r534",
      "r611",
      "r630",
      "r631",
      "r686",
      "r724",
      "r859"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Implied shares of Legacy HR Common Stock issued (in shares)",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r142",
      "r171"
     ]
    },
    "hr_ChicagoILMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ChicagoILMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chicago, IL",
        "label": "Chicago, IL [Member]",
        "documentation": "Chicago, IL"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-vested share-based awards, net of withheld shares (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r141",
      "r142",
      "r171"
     ]
    },
    "hr_InterestRateSwapExpiringMay312026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "InterestRateSwapExpiringMay312026Member",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Swap, Expiring May 31, 2026",
        "label": "Interest Rate Swap, Expiring May 31, 2026 [Member]",
        "documentation": "Interest Rate Swap, Expiring May 31, 2026"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r141",
      "r142",
      "r171",
      "r413"
     ]
    },
    "hr_MezzanineLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "MezzanineLoanMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mezzanine loans",
        "label": "Mezzanine Loan [Member]",
        "documentation": "Mezzanine Loan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental Cash Flow Information",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HedgingDesignationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingDesignationDomain",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Domain]",
        "label": "Hedging Designation [Domain]",
        "documentation": "Designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r732",
      "r743",
      "r753",
      "r778"
     ]
    },
    "us-gaap_InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeFinancingReceivableBeforeAllowanceForCreditLoss",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Interest Income, Financing Receivable, before Allowance for Credit Loss",
        "documentation": "Amount of interest income from financing receivable before allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r209"
     ]
    },
    "us-gaap_RealEstateInvestmentPropertyAccumulatedDepreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RealEstateInvestmentPropertyAccumulatedDepreciation",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less accumulated depreciation and amortization",
        "negatedTerseLabel": "Accumulated depreciation",
        "label": "Real Estate Investment Property, Accumulated Depreciation",
        "documentation": "The cumulative amount of depreciation for real estate property held for investment purposes."
       }
      }
     },
     "auth_ref": [
      "r521"
     ]
    },
    "us-gaap_EquityMethodInvestmentDividendsOrDistributions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentDividendsOrDistributions",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distributions from unconsolidated joint ventures",
        "label": "Proceeds from Equity Method Investment, Distribution",
        "documentation": "Amount of distribution received from equity method investee for return on investment, classified as operating activities. Excludes distribution for return of investment, classified as investing activities."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r12",
      "r148",
      "r531"
     ]
    },
    "hr_RealEstateDispositionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "RealEstateDispositionsLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Dispositions [Line Items]",
        "label": "Real Estate Dispositions [Line Items]",
        "documentation": "Real estate dispositions."
       }
      }
     },
     "auth_ref": []
    },
    "hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedRemainderOfFiscalYear",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023",
        "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Remainder Of Fiscal Year",
        "documentation": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Remainder Of Fiscal Year"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "us-gaap_MortgageLoansOnRealEstateCommercialAndConsumerNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MortgageLoansOnRealEstateCommercialAndConsumerNet",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real estate notes receivable",
        "label": "Mortgage Loans on Real Estate, Commercial and Consumer, Net",
        "documentation": "The balance represents the amount of loans that are secured by real estate mortgages, offset by the reserve to cover probable credit losses on the loan portfolio."
       }
      }
     },
     "auth_ref": [
      "r522"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireBusinessesGross",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CASH CONSIDERATION",
        "verboseLabel": "Cash consideration",
        "label": "Payments to Acquire Businesses, Gross",
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r439"
     ]
    },
    "us-gaap_TransferMortgagePayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TransferMortgagePayable",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortgage note payable assumed in connection with acquisition of real estate, net",
        "label": "Transfer Mortgage Payable",
        "documentation": "The fair value of transfer of mortgage payable in noncash investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r50",
      "r51"
     ]
    },
    "us-gaap_DividendsCommonStockCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DividendsCommonStockCash",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends to common stockholders and distributions to non-controlling interest holders",
        "label": "Dividends, Common Stock, Cash",
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group, Held-for-sale, Not Discontinued Operations",
        "label": "Disposal Group, Held-for-Sale, Not Discontinued Operations [Member]",
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r21",
      "r223"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r742",
      "r750",
      "r760",
      "r777",
      "r785",
      "r789",
      "r797"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r764"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r732",
      "r743",
      "r753",
      "r778"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r774"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options under the Employee Stock Option Plan",
        "label": "Employee Stock Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Domain]",
        "label": "Title of Individual [Domain]",
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals."
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberOfVariableInterestEntities": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NumberOfVariableInterestEntities",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of variable interest entities",
        "label": "Number of Variable Interest Entities",
        "documentation": "Number of Variable Interest Entities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r866",
      "r867",
      "r868",
      "r869",
      "r870",
      "r871",
      "r872",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r772"
     ]
    },
    "us-gaap_DevelopmentInProcess": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DevelopmentInProcess",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in progress",
        "label": "Development in Process",
        "documentation": "The current amount of expenditures for a real estate project that has not yet been completed."
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r773"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Common stock redemptions",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FINANCING",
        "label": "Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Disaggregation of revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r864"
     ]
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToMinorityShareholders",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Distributions to non-controlling interest holders",
        "label": "Payments to Noncontrolling Interests",
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r44"
     ]
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of the Activity Under the Incentive Plan and RSU Activity",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "documentation": "Tabular disclosure of share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r74"
     ]
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Real Estate Acquisitions",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]",
        "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r80"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r399",
      "r695",
      "r696",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701"
     ]
    },
    "us-gaap_RealEstateInvestmentPropertyAtCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RealEstateInvestmentPropertyAtCost",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyNet",
       "weight": 1.0,
       "order": 1.0
      },
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total real estate properties",
        "label": "Real Estate Investment Property, at Cost",
        "documentation": "Amount of real estate investment property which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments."
       }
      }
     },
     "auth_ref": [
      "r523"
     ]
    },
    "us-gaap_RealEstateInvestmentPropertyNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RealEstateInvestmentPropertyNet",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "hr_AssetsHeldForSaleAndDiscontinuedOperationsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total real estate properties, net",
        "verboseLabel": "Net real estate investments",
        "label": "Real Estate Investment Property, Net",
        "documentation": "Amount of real estate investment property, net of accumulated depreciation, which may include the following: (1) land available-for-sale; (2) land available-for-development; (3) investments in building and building improvements; (4) tenant allowances; (5) developments in-process; (6) rental properties; and (7) other real estate investments."
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "(Gain)/loss recognized in AOCI on derivative",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r234",
      "r448",
      "r449",
      "r452"
     ]
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndOtherAccruedLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other liabilities",
        "label": "Accounts Payable and Other Accrued Liabilities",
        "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r584"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r77",
      "r403"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gains arising during the period on interest rate swaps",
        "verboseLabel": "Gains arising during the period on interest rate swaps",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r233",
      "r234"
     ]
    },
    "us-gaap_FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancingReceivableCoveredAndNotCoveredAfterAllowanceForCreditLossFeePremiumAndDiscount",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "FAIR VALUE DISCOUNT AND FEES",
        "label": "Financing Receivable, Covered and Not Covered, after Allowance for Credit Loss, Fee, Premium, and Discount",
        "documentation": "Amount, after allowance for credit loss and unamortized deferred fee, premium, and discount, of financing receivable covered under loss sharing agreement and financing receivable not covered under loss sharing agreement."
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Reclassification adjustments for (gains) losses included in net income (interest expense)",
        "negatedTerseLabel": "Reclassification adjustments for gains included in net income (interest expense)",
        "negatedNetLabel": "(Gain) Loss, Reclassified from AOCI into income",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax",
        "documentation": "Amount, after tax, of reclassification of gain (loss) from accumulated other comprehensive income (AOCI) for derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r235"
     ]
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjusted closing price of Legacy HR Common Stock on July 20, 2022 (in dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for new operating lease liabilities",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r493",
      "r709"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "us-gaap_HedgingRelationshipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingRelationshipDomain",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Domain]",
        "label": "Hedging Relationship [Domain]",
        "documentation": "Nature or intent of a hedge."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Land",
        "documentation": "Amount of real estate acquired, at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_NoncontrollingInterestMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestMember",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling Interests",
        "label": "Noncontrolling Interest [Member]",
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r389",
      "r836",
      "r837",
      "r838",
      "r927"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate swaps",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Stockholders' equity",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease intangible assets",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r476",
      "r505"
     ]
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationDisclosureTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTA"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Merger with HTA",
        "label": "Business Combination Disclosure [Text Block]",
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r438"
     ]
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r88",
      "r102",
      "r221",
      "r222",
      "r242",
      "r262",
      "r263",
      "r264",
      "r266",
      "r274",
      "r319",
      "r322",
      "r389",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r462",
      "r469",
      "r471",
      "r475",
      "r503",
      "r548",
      "r549",
      "r563",
      "r593",
      "r609",
      "r633",
      "r634",
      "r657",
      "r725",
      "r834",
      "r844",
      "r901",
      "r927"
     ]
    },
    "us-gaap_ParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ParentMember",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Stockholders\u2019 Equity",
        "label": "Parent [Member]",
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r476",
      "r505"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "us-gaap_CashFlowHedgingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowHedgingMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flow hedging",
        "label": "Cash Flow Hedging [Member]",
        "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "us-gaap_FairValueByMeasurementBasisAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementBasisAxis",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Basis [Axis]",
        "label": "Measurement Basis [Axis]",
        "documentation": "Information by measurement basis."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r125",
      "r358",
      "r690",
      "r691"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "us-gaap_ProceedsFromSaleOfPropertyHeldForSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleOfPropertyHeldForSale",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sales of real estate properties and additional long-lived assets",
        "label": "Proceeds from Sale, Property, Held-for-Sale",
        "documentation": "The cash inflow from the sale of formerly productive land held for sale, anything permanently fixed to it, including buildings, structures on it, and so forth."
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "us-gaap_InterestPaidCapitalized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidCapitalized",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized interest",
        "label": "Interest Paid, Capitalized, Investing Activities",
        "documentation": "Amount of cash paid for interest capitalized, classified as investing activity."
       }
      }
     },
     "auth_ref": [
      "r681",
      "r831"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "us-gaap_DilutiveSecuritiesEffectOnBasicEarningsPerShareOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DilutiveSecuritiesEffectOnBasicEarningsPerShareOther",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": "hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to loss attributable to non-controlling interest for legally outstanding restricted units",
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities",
        "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of dilutive convertible securities excluding adjustments related to ESOP convertible preferred stock, stock options, and restrictive stock units."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate - operating leases",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r709"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockByClassTable",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class [Table]",
        "label": "Schedule of Stock by Class [Table]",
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r67",
      "r68",
      "r69",
      "r70",
      "r71",
      "r72",
      "r169",
      "r170",
      "r171",
      "r229",
      "r230",
      "r231",
      "r293",
      "r374",
      "r375",
      "r376",
      "r378",
      "r381",
      "r386",
      "r388",
      "r559",
      "r560",
      "r561",
      "r562",
      "r694",
      "r803",
      "r832"
     ]
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentsTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Equity Method Investments",
        "label": "Equity Method Investments [Table Text Block]",
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information."
       }
      }
     },
     "auth_ref": [
      "r314"
     ]
    },
    "us-gaap_ClassOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Line Items]",
        "label": "Class of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r230",
      "r231",
      "r293",
      "r374",
      "r375",
      "r376",
      "r378",
      "r381",
      "r386",
      "r388",
      "r559",
      "r560",
      "r561",
      "r562",
      "r694",
      "r803",
      "r832"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average discount rate - finance leases",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for finance lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r495",
      "r709"
     ]
    },
    "us-gaap_DirectCostsOfLeasedAndRentedPropertyOrEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DirectCostsOfLeasedAndRentedPropertyOrEquipment",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "hr_OperatingExpensesandCostofGoodsSold",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Property operating",
        "label": "Direct Costs of Leased and Rented Property or Equipment",
        "documentation": "Amount of expense incurred and directly related to generating revenue by lessor from operating lease of rented property and equipment."
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interests acquired",
        "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest",
        "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r73",
      "r178"
     ]
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable Non-controlling Interests",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total undiscounted lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r770"
     ]
    },
    "us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in unconsolidated joint ventures",
        "periodStartLabel": "Investments in unconsolidated joint ventures, beginning of period",
        "periodEndLabel": "Investments in unconsolidated joint ventures, end of period",
        "label": "Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures",
        "documentation": "Amount of investment in equity method investee and investment in and advance to affiliate."
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "(Decrease) increase in cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r158"
     ]
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DesignatedAsHedgingInstrumentMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Designated as hedging instrument",
        "label": "Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r158",
      "r256"
     ]
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value",
        "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "us-gaap_PaymentsToDevelopRealEstateAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToDevelopRealEstateAssets",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Development of real estate",
        "label": "Payments to Develop Real Estate Assets",
        "documentation": "Payments to develop real estate assets is the process of adding improvements on or to a parcel of land. Such improvements may include drainage, utilities, subdividing, access, buildings, and any combination of these elements; and are generally classified as cash flow from investing activities."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing lease right-of-use assets",
        "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization",
        "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r804"
     ]
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Class A",
        "label": "Common Class A [Member]",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other liabilities",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r208",
      "r229",
      "r230",
      "r231",
      "r260",
      "r280",
      "r281",
      "r284",
      "r288",
      "r293",
      "r294",
      "r318",
      "r335",
      "r337",
      "r338",
      "r339",
      "r342",
      "r343",
      "r374",
      "r375",
      "r378",
      "r381",
      "r388",
      "r468",
      "r559",
      "r560",
      "r561",
      "r562",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r592",
      "r612",
      "r632",
      "r652",
      "r653",
      "r654",
      "r655",
      "r656",
      "r803",
      "r832",
      "r840"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted earnings per common share (in dollars per share)",
        "verboseLabel": "Diluted earnings per common share- net income (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r267",
      "r268",
      "r270",
      "r271",
      "r273",
      "r280",
      "r284",
      "r287",
      "r288",
      "r290",
      "r463",
      "r464",
      "r518",
      "r539",
      "r684"
     ]
    },
    "us-gaap_ProceedsFromSaleAndCollectionOfNotesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromSaleAndCollectionOfNotesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from notes receivable repayments",
        "label": "Proceeds from Sale and Collection of Notes Receivable",
        "documentation": "The cash inflow associated with the proceeds from sale of notes receivable, as well as principal collections from a borrowing supported by a written promise to pay an obligation (note receivable)."
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "srt_OtherPropertyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OtherPropertyMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Parking Garages",
        "label": "Other Property [Member]",
        "documentation": "Property classified as other."
       }
      }
     },
     "auth_ref": [
      "r677",
      "r678",
      "r930",
      "r931"
     ]
    },
    "us-gaap_RestrictedStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockMember",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock",
        "verboseLabel": "Restricted stock",
        "label": "Restricted Stock [Member]",
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "srt_ScheduleOfCondensedBalanceSheetTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfCondensedBalanceSheetTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Condensed Balance Sheet",
        "label": "Condensed Balance Sheet [Table Text Block]",
        "documentation": "Tabular disclosure of condensed balance sheet, including, but not limited to, balance sheets of consolidated entities and consolidation eliminations."
       }
      }
     },
     "auth_ref": [
      "r816",
      "r835"
     ]
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Joint venture ownership (percent)",
        "label": "Equity Method Investment, Ownership Percentage",
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting."
       }
      }
     },
     "auth_ref": [
      "r315"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock, net of issuance costs",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r141",
      "r142",
      "r171",
      "r565",
      "r632",
      "r653",
      "r725"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfRevenueExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TypeOfRevenueExtensibleList",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue, Product and Service [Extensible List]",
        "label": "Revenue, Product and Service [Extensible Enumeration]",
        "documentation": "Indicates type of revenue from product and service. Includes, but is not limited to, revenue from contract with customer and other sources."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows outflows related to operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r486",
      "r492"
     ]
    },
    "us-gaap_InterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest Expense",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r191",
      "r244",
      "r298",
      "r477",
      "r617",
      "r724",
      "r925"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other income (expense)",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r682"
     ]
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Redemption of non-controlling interest",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests)."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r171",
      "r178"
     ]
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeasePrincipalPayments",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments made on finance leases",
        "label": "Finance Lease, Principal Payments",
        "documentation": "Amount of cash outflow for principal payment on finance lease."
       }
      }
     },
     "auth_ref": [
      "r484",
      "r492"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Cash and cash equivalents",
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r225",
      "r679"
     ]
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Common stock redemptions",
        "label": "Stock Repurchased and Retired During Period, Value",
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital)."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r141",
      "r142",
      "r171"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r141",
      "r142",
      "r171",
      "r559",
      "r632",
      "r653"
     ]
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other income (expense)",
        "label": "Nonoperating Income (Expense)",
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "us-gaap_LongLivedAssetsHeldForSaleLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongLivedAssetsHeldForSaleLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long Lived Assets Held-for-sale [Line Items]",
        "label": "Long-Lived Assets Held-for-Sale [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for new finance lease liabilities",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r493",
      "r709"
     ]
    },
    "us-gaap_AssetImpairmentChargesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetImpairmentChargesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Impairment:",
        "label": "Asset Impairment Charges [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_ReverseRecapitalizationNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ReverseRecapitalizationNet",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Value of implied Legacy HR Common Stock issued",
        "label": "Reverse Recapitalization, Net",
        "documentation": "Reverse Recapitalization, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsTable",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Table]",
        "label": "Other Commitments [Table]",
        "documentation": "Disclosure of information about obligations resulting from other commitments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic earnings per common share (in dollars per share)",
        "verboseLabel": "Basic earnings per common share - net income (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r267",
      "r268",
      "r270",
      "r271",
      "r273",
      "r278",
      "r280",
      "r284",
      "r287",
      "r288",
      "r290",
      "r463",
      "r464",
      "r518",
      "r539",
      "r684"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Net proceeds from issuance of common stock",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "hr_ColumbusOHMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ColumbusOHMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Columbus, OH",
        "label": "Columbus, OH [Member]",
        "documentation": "Columbus, OH"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r731",
      "r801"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r433",
      "r434",
      "r565",
      "r836",
      "r837",
      "r838",
      "r898",
      "r927"
     ]
    },
    "hr_LongTermIncentiveProgramDUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "LongTermIncentiveProgramDUnitsMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LTIP-D",
        "label": "Long-term Incentive Program - D Units [Member]",
        "documentation": "Long-term Incentive Program - D Units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDebtTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Debt",
        "label": "Schedule of Debt [Table Text Block]",
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests",
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r35",
      "r221",
      "r241",
      "r242",
      "r243",
      "r262",
      "r263",
      "r264",
      "r266",
      "r274",
      "r276",
      "r292",
      "r319",
      "r322",
      "r389",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r462",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r503",
      "r547",
      "r548",
      "r549",
      "r565",
      "r632"
     ]
    },
    "hr_RealEstateAcquisitionsAndMortgageNoteFinancingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "RealEstateAcquisitionsAndMortgageNoteFinancingDomain",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Acquisitions and Mortgage Note Financing [Domain]",
        "label": "Real Estate Acquisitions and Mortgage Note Financing [Domain]",
        "documentation": "Real Estate Acquisitions and Mortgage Note Financing [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_SeniorNotesdue2030Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "SeniorNotesdue2030Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes due 2030",
        "label": "Senior Notes due 2030 [Member]",
        "documentation": "Senior Notes due 2030 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfMediumTermNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfMediumTermNotes",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Borrowings on term loans",
        "label": "Proceeds from Issuance of Medium-term Notes",
        "documentation": "The cash inflow from a debt funding received on a regular basis with maturities ranging from 5-10 years."
       }
      }
     },
     "auth_ref": [
      "r43"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r253"
     ]
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit",
        "label": "Line of Credit [Member]",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessOverviewAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessOverviewAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Overview:",
        "label": "Business Overview [Abstract]",
        "documentation": "Business Overview [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and other income (expense), net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "FINANCING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r253"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average years remaining lease term (excluding renewal options) - finance leases",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r494",
      "r709"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "INVESTING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r158",
      "r159",
      "r160"
     ]
    },
    "hr_NumberOfNotesReceivable": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NumberOfNotesReceivable",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of notes receivable",
        "label": "Number of Notes Receivable",
        "documentation": "Number of Notes Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests",
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r221",
      "r241",
      "r242",
      "r243",
      "r262",
      "r263",
      "r264",
      "r266",
      "r274",
      "r276",
      "r292",
      "r319",
      "r322",
      "r389",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r462",
      "r469",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r503",
      "r547",
      "r548",
      "r549",
      "r565",
      "r632"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "OPERATING ACTIVITIES",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r796"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r17",
      "r38",
      "r454",
      "r457",
      "r503",
      "r547",
      "r548",
      "r823",
      "r824",
      "r825",
      "r836",
      "r837",
      "r838"
     ]
    },
    "hr_SeniorNotesDue2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "SeniorNotesDue2027Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes due 2027",
        "label": "Senior Notes due 2027 [Member]",
        "documentation": "Senior Notes due 2027"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Cash and Cash Equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r735",
      "r746",
      "r756",
      "r781"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDividendsCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Dividends paid",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity."
       }
      }
     },
     "auth_ref": [
      "r45"
     ]
    },
    "hr_SeniorNotesdue2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "SeniorNotesdue2025Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes due 2025",
        "label": "Senior Notes due 2025 [Member]",
        "documentation": "Senior Notes due 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_MortgageNote": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "MortgageNote",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortgage note",
        "label": "Mortgage Note",
        "documentation": "Mortgage Note"
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total real estate investments",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Real Estate Investments",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Real Estate Investments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units (RSUs)",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsDomain",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Domain]",
        "label": "Other Commitments [Domain]",
        "documentation": "Other future obligation."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "us-gaap_MediumTermNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MediumTermNotesMember",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Medium-term notes",
        "label": "Medium-term Notes [Member]",
        "documentation": "Debt instruments with maturities ranging from five to ten years."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GranteeStatusAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GranteeStatusAxis",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grantee Status [Axis]",
        "label": "Grantee Status [Axis]",
        "documentation": "Information by status of recipient to whom award is granted."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430"
     ]
    },
    "us-gaap_OtherCommitmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsAxis",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Axis]",
        "label": "Other Commitments [Axis]",
        "documentation": "Information by type of other commitment."
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Payable And Accrued Liabilities",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Accounts Payable And Accrued Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberOfJointVentures": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NumberOfJointVentures",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of joint ventures",
        "label": "Number of Joint Ventures",
        "documentation": "Number of Joint Ventures"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Face amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r132",
      "r345",
      "r478",
      "r690",
      "r691"
     ]
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayments of notes and bonds payable",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "us-gaap_GranteeStatusDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GranteeStatusDomain",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grantee Status [Domain]",
        "label": "Grantee Status [Domain]",
        "documentation": "Status of recipient to whom award is granted."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "us-gaap_DebtInstrumentFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFairValue",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notes and bonds payable",
        "label": "Debt Instrument, Fair Value Disclosure",
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r467",
      "r690",
      "r691"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average common shares outstanding - diluted (in shares)",
        "totalLabel": "Weighted average common shares outstanding - diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r279",
      "r288"
     ]
    },
    "hr_JointVentureOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "JointVentureOwnershipPercentage",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Joint venture, ownership (in percentage)",
        "label": "Joint Venture, Ownership Percentage",
        "documentation": "Joint Venture, Ownership Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherCommitmentsLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Commitments [Line Items]",
        "label": "Other Commitments [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r797"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "hr_OperatingExpensesandCostofGoodsSold",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r60"
     ]
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsInUnconsolidatedJointVentures",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in unconsolidated joint ventures",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investments in Unconsolidated Joint Ventures",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Investments in Unconsolidated Joint Ventures"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleLeasebackTransactionNetBookValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleLeasebackTransactionNetBookValue",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing receivable, carrying value",
        "label": "Sale Leaseback Transaction, Net Book Value",
        "documentation": "The net book value of the asset(s) sold in connection with the sale of the property to another party and lease back to the seller."
       }
      }
     },
     "auth_ref": [
      "r192",
      "r193",
      "r194",
      "r907"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r799"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average common shares outstanding - basic (in shares)",
        "totalLabel": "Weighted average common shares outstanding - basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r278",
      "r288"
     ]
    },
    "us-gaap_RepaymentsOfMediumTermNotes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RepaymentsOfMediumTermNotes",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayment on term loan",
        "label": "Repayments of Medium-term Notes",
        "documentation": "The cash outflow to pay off borrowing used to receive debt funding on a regular basis with maturities ranging from 5-10 years."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r765"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r798"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesRestrictedStock": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesRestrictedStock",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Non-vested shares (in shares)",
        "label": "Weighted Average Number of Shares, Restricted Stock",
        "documentation": "Number of shares of restricted stock determined by relating the portion of time within a reporting period that restricted shares have been outstanding to the total time in that period. Restricted shares are subject to sales, contractual, regulatory or other restrictions that prevent or inhibit the holder from freely disposing of them before the restriction ends."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "hr_TermLoanDue2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "TermLoanDue2025Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "$300 million Unsecured Term Loan",
        "label": "Term Loan due 2025 [Member]",
        "documentation": "Term Loan due 2025"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Invoices accrued for construction, tenant improvements and other capitalized costs",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r50",
      "r51"
     ]
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOperatingLeaseRightOfUseAssets",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use-Assets",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Operating Lease Right-of-Use-Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedPaymentArrangementNonemployeeMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Payment Arrangement, Nonemployee",
        "label": "Share-Based Payment Arrangement, Nonemployee [Member]",
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires."
       }
      }
     },
     "auth_ref": [
      "r402",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentFeeAmount",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt fees",
        "label": "Debt Instrument, Fee Amount",
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r31"
     ]
    },
    "hr_GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "GainsLossesonSalesofInvestmentRealEstateIncludingDiscontinuedOperation",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Gain on sales of real estate properties",
        "label": "Gains (Losses) on Sales of Investment Real Estate, Including Discontinued Operation",
        "documentation": "Gains (Losses) on Sales of Investment Real Estate, Including Discontinued Operation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r706"
     ]
    },
    "hr_ActiveDevelopmentPropertiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ActiveDevelopmentPropertiesMember",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Active Development Properties",
        "label": "Active Development Properties [Member]",
        "documentation": "Active Development Properties"
       }
      }
     },
     "auth_ref": []
    },
    "hr_ImpairmentOfRealEstateContinuingAndDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ImpairmentOfRealEstateContinuingAndDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of real estate properties and credit loss reserves",
        "label": "Impairment of Real Estate, Continuing and Discontinued Operations",
        "documentation": "Impairment of Real Estate, Continuing and Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByAssetClassAxis",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Class [Axis]",
        "label": "Asset Class [Axis]",
        "documentation": "Information by class of asset."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r126"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r800"
     ]
    },
    "hr_HealthCareRealtyTrustIncorporatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "HealthCareRealtyTrustIncorporatedMember",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "HealthCare Realty Trust Incorporated",
        "label": "HealthCare Realty Trust Incorporated [Member]",
        "documentation": "HealthCare Realty Trust Incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "hr_TermLoanDueJuly2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "TermLoanDueJuly2024Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "$350 million Unsecured Term Loan",
        "label": "Term Loan due July 2024 [Member]",
        "documentation": "Term Loan due July 2024"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r731",
      "r801"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r742",
      "r750",
      "r760",
      "r777",
      "r785",
      "r789",
      "r797"
     ]
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseTermOfContract",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ground lease, initial term",
        "label": "Lessee, Operating Lease, Term of Contract",
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r903"
     ]
    },
    "hr_TermLoandue2026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "TermLoandue2026Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "$150 million Unsecured Term Loan",
        "label": "Term Loan due 2026 [Member]",
        "documentation": "Term Loan due 2026 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r731",
      "r801"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average years remaining lease term (excluding renewal options) - operating leases",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r494",
      "r709"
     ]
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedConstructionInProgress",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in progress",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Construction in Progress",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Construction in Progress"
       }
      }
     },
     "auth_ref": []
    },
    "hr_SettledInterestRateSwapsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "SettledInterestRateSwapsMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Settled Interest Rate Swaps",
        "label": "Settled Interest Rate Swaps [Member]",
        "documentation": "Settled Interest Rate Swaps"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r139",
      "r140",
      "r185",
      "r186",
      "r261",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r351",
      "r356",
      "r357",
      "r358",
      "r359",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r478",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r833"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r487"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r728"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r69",
      "r72",
      "r129",
      "r130",
      "r132",
      "r136",
      "r169",
      "r170",
      "r261",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r351",
      "r356",
      "r357",
      "r358",
      "r359",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r369",
      "r478",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r833"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r261",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r351",
      "r356",
      "r357",
      "r358",
      "r359",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r369",
      "r478",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r833"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average incremental shares of common stock excluded from the computation (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r289"
     ]
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfDebtIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Debt issuance and assumption costs",
        "label": "Payments of Debt Issuance Costs",
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r487"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "hr_AssetsHeldForSaleAndDiscontinuedOperationsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets, net",
        "label": "Disposal Group, Including Discontinued Operation, Other Assets",
        "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r137",
      "r138",
      "r164"
     ]
    },
    "us-gaap_PaymentsToAcquireNotesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireNotesReceivable",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Funding of mortgages and notes receivable",
        "label": "Payments to Acquire Notes Receivable",
        "documentation": "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "us-gaap_LesseeFinanceLeaseDescriptionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeFinanceLeaseDescriptionAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease cost",
        "label": "Lessee, Finance Lease, Description [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireOtherProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireOtherProductiveAssets",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Additional long-lived assets",
        "label": "Payments to Acquire Other Productive Assets",
        "documentation": "Amount of cash outflow for the purchase of or improvements to tangible or intangible assets, used to produce goods or deliver services, classified as other."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_InterestRateSwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRateSwapMember",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Interest Rate Swaps",
        "terseLabel": "Settled interest rate swaps",
        "label": "Interest Rate Swap [Member]",
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period."
       }
      }
     },
     "auth_ref": [
      "r674",
      "r720",
      "r721"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable and accrued liabilities",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_PaymentsToAcquireFinanceReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireFinanceReceivables",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Investment in financing receivable",
        "label": "Payments to Acquire Finance Receivables",
        "documentation": "The cash outflow for the purchase of amounts due from customers, clients, lessees, borrowers, or others under the terms of its agreements therewith."
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "ASSETS",
        "terseLabel": "Assets:",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireRealEstate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireRealEstate",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Acquisitions of real estate",
        "label": "Payments to Acquire Real Estate",
        "documentation": "The cash outflow from the acquisition of a piece of land, anything permanently fixed to it, including buildings, structures on it and so forth; includes real estate intended to generate income for the owner; excludes real estate acquired for use by the owner."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireInterestInJointVenture": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireInterestInJointVenture",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Investments in unconsolidated joint ventures",
        "label": "Payments to Acquire Interest in Joint Venture",
        "documentation": "The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group."
       }
      }
     },
     "auth_ref": [
      "r42"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment in financing receivable, net",
        "label": "Financing Receivable, Excluding Accrued Interest, after Allowance for Credit Loss",
        "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of financing receivable. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r263",
      "r264",
      "r292",
      "r511",
      "r558",
      "r576",
      "r583",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r592",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r610",
      "r614",
      "r615",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r632",
      "r716"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForCreditLossesOnFinancingReceivablesTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Company's Allowance For Credit Losses",
        "label": "Financing Receivable, Allowance for Credit Loss [Table Text Block]",
        "documentation": "Tabular disclosure of allowance for credit loss on financing receivable."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r848"
     ]
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossesRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancingReceivableAllowanceForCreditLossesRollForward",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing Receivable, Allowance for Credit Loss [Roll Forward]",
        "label": "Financing Receivable, Allowance for Credit Loss [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationOtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Disposal Group, Including Discontinued Operation, Other Liabilities",
        "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r137",
      "r138",
      "r164"
     ]
    },
    "us-gaap_PaymentsToAcquireLand": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireLand",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CommitmentandContingenciesNarrativeDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to acquired a parcel of land",
        "label": "Payments to Acquire Land",
        "documentation": "The cash outflow from the acquisition of real estate intended to generate income for the owner; excludes land acquired for use by the owner."
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "MORTGAGE NOTES PAYABLE, NET",
        "label": "Business Combination, Consideration Transferred, Liabilities Incurred",
        "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r2",
      "r85",
      "r440"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r326",
      "r513",
      "r688",
      "r710",
      "r849",
      "r850"
     ]
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment, Name [Domain]",
        "label": "Investment, Name [Domain]",
        "documentation": "Name of investment including named security. Excludes entity that is consolidated."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r316",
      "r317"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "hr_CashAcquiredInMerger": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "CashAcquiredInMerger",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash assumed in Merger, including restricted cash for special dividend payment",
        "label": "Cash Acquired in Merger",
        "documentation": "Cash Acquired in Merger"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r374"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r737",
      "r748",
      "r758",
      "r783"
     ]
    },
    "hr_TermLoanDue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "TermLoanDue2028Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "$300 million Unsecured Term Loan",
        "label": "Term Loan due 2028 [Member]",
        "documentation": "Term Loan due 2028"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherFiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherFiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease intangibles",
        "label": "Other Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before accumulated amortization of finite-lived intangible assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "hr_InterestRateSwapExpiringMay12026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "InterestRateSwapExpiringMay12026Member",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Swap, Expiring May 1, 2026",
        "label": "Interest Rate Swap, Expiring May 1, 2026 [Member]",
        "documentation": "Interest Rate Swap, Expiring May 1, 2026"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockDividendsPerShareCashPaid": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockDividendsPerShareCashPaid",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterestsParenthetical",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Dividends to common stockholders and distributions to non-controlling interest holders (in dollars per share)",
        "terseLabel": "Dividends paid per common share, during the period (in dollars per share)",
        "label": "Common Stock, Dividends, Per Share, Cash Paid",
        "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsHeldForSaleNet",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets held for sale, net",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Held For Sale, Net",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Assets Held For Sale, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r592"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r592",
      "r609",
      "r927",
      "r928"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r580",
      "r582",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r604",
      "r605",
      "r606",
      "r607",
      "r620",
      "r621",
      "r622",
      "r623",
      "r626",
      "r627",
      "r628",
      "r629",
      "r644",
      "r645",
      "r646",
      "r647",
      "r713",
      "r715"
     ]
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestmentsAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real estate investments",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments [Abstract]",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Real Estate Investments"
       }
      }
     },
     "auth_ref": []
    },
    "hr_StraightlineRentLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "StraightlineRentLiability",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of straight-line rent on operating leases (lessee)",
        "label": "Straight-line Rent Liability",
        "documentation": "Straight-line rent liability."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders' equity",
        "terseLabel": "Total equity",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r144",
      "r145",
      "r162",
      "r593",
      "r609",
      "r633",
      "r634",
      "r710",
      "r726",
      "r834",
      "r844",
      "r901",
      "r927"
     ]
    },
    "srt_RestatementAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementAdjustmentMember",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revision of Prior Period, Adjustment",
        "label": "Revision of Prior Period, Adjustment [Member]",
        "documentation": "Cumulative increase (decrease) for adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r263",
      "r264",
      "r273",
      "r274",
      "r290",
      "r462",
      "r463",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r813",
      "r814"
     ]
    },
    "hr_DallasTXMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "DallasTXMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dallas, TX",
        "label": "Dallas, TX [Member]",
        "documentation": "Dallas, TX"
       }
      }
     },
     "auth_ref": []
    },
    "hr_ExecutiveIncentiveProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ExecutiveIncentiveProgramMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Incentive Program",
        "label": "Executive Incentive Program [Member]",
        "documentation": "Executive Incentive Program [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Preferred stock, par value (in dollars per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r374"
     ]
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes and bonds payable",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-Term Debt",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Long-Term Debt"
       }
      }
     },
     "auth_ref": []
    },
    "hr_InterestRateSwapExpiringDecember12026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "InterestRateSwapExpiringDecember12026Member",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Swap, Expiring December 1, 2026",
        "label": "Interest Rate Swap, Expiring December 1, 2026 [Member]",
        "documentation": "Interest Rate Swap, Expiring December 1, 2026"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeNotionalAmount",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AMOUNT",
        "label": "Derivative, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payment on derivative."
       }
      }
     },
     "auth_ref": [
      "r896",
      "r897"
     ]
    },
    "hr_RealEstatePropertiesHeldInJointVenturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "RealEstatePropertiesHeldInJointVenturesMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Properties Held in Joint Ventures",
        "label": "Real Estate Properties Held in Joint Ventures [Member]",
        "documentation": "Real Estate Properties Held in Joint Ventures"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Relationship [Axis]",
        "label": "Hedging Relationship [Axis]",
        "documentation": "Information by type of hedging relationship."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r112",
      "r117"
     ]
    },
    "hr_HoustonTexasMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "HoustonTexasMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Houston, TX",
        "label": "Houston, Texas [Member]",
        "documentation": "Houston, Texas [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_MergerRelatedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "MergerRelatedCosts",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "hr_OperatingExpensesandCostofGoodsSold",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Merger-related costs",
        "label": "Merger Related Costs",
        "documentation": "Merger Related Costs"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r736",
      "r747",
      "r757",
      "r782"
     ]
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentNetIdentifiableAssetsAcquired",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities assumed",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Assumed",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Liabilities Assumed"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockDividendsPerShareDeclared": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockDividendsPerShareDeclared",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends declared per common share, during the period (in dollars per share)",
        "label": "Common Stock, Dividends, Per Share, Declared",
        "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding."
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "hr_MortgageLoanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "MortgageLoanMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortgage loans",
        "label": "Mortgage Loan [Member]",
        "documentation": "Mortgage Loan"
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets, net",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets, Net",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Assets, Net"
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancingLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing lease liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Liabilities",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financing Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "hr_MarketCondition1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "MarketCondition1Member",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Absolute TSR Component",
        "label": "Market Condition 1 [Member]",
        "documentation": "Market Condition 1"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r765"
     ]
    },
    "hr_TampaFLMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "TampaFLMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tampa, FL",
        "label": "Tampa, FL [Member]",
        "documentation": "Tampa, FL"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r765"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Lease Cost",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r904"
     ]
    },
    "hr_VariableInterestEntityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "VariableInterestEntityMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity",
        "label": "Variable Interest Entity [Member]",
        "documentation": "Variable Interest Entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r739",
      "r750",
      "r760",
      "r785"
     ]
    },
    "hr_InterestIncomeFinancingReceivableNoncash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "InterestIncomeFinancingReceivableNoncash",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Non-cash interest from financing and notes receivable",
        "label": "Interest Income, Financing Receivable, Noncash",
        "documentation": "Interest Income, Financing Receivable, Noncash"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "hr_LegacyHTAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "LegacyHTAMember",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legacy HTA",
        "label": "Legacy HTA [Member]",
        "documentation": "Legacy HTA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r738",
      "r749",
      "r759",
      "r784"
     ]
    },
    "us-gaap_RealEstateAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RealEstateAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate Notes Receivable:",
        "label": "Real Estate [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberOfDirectors": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NumberOfDirectors",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of directors",
        "label": "Number Of Directors",
        "documentation": "Number Of Directors"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430"
     ]
    },
    "hr_ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ScheduleOfAssetsAndLiabilitiesHeldForSaleTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Assets and Liabilities Held for Sale",
        "label": "Schedule of Assets and Liabilities Held for Sale [Table Text Block]",
        "documentation": "Schedule of Assets and Liabilities Held for Sale"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r263",
      "r264",
      "r292",
      "r511",
      "r558",
      "r576",
      "r583",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r592",
      "r594",
      "r595",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r604",
      "r605",
      "r606",
      "r607",
      "r608",
      "r610",
      "r614",
      "r615",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r632",
      "r716"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r54"
     ]
    },
    "hr_LeaseIntangibles": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "LeaseIntangibles",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease intangibles",
        "label": "Lease Intangibles",
        "documentation": "Lease Intangibles"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CumulativeDividends": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CumulativeDividends",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Cumulative dividends",
        "label": "Cumulative Dividends",
        "documentation": "Amount of cumulative cash dividends distributed to shareholders."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_GainsLossesOnSalesOfInvestmentRealEstate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainsLossesOnSalesOfInvestmentRealEstate",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain on sales of real estate properties",
        "label": "Gains (Losses) on Sales of Investment Real Estate",
        "documentation": "The net gain (loss) resulting from sales and other disposals of real estate owned for investment purposes."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r197",
      "r199",
      "r826",
      "r827",
      "r830",
      "r919",
      "r926"
     ]
    },
    "hr_CumulativeDividendsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "CumulativeDividendsMember",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative Dividends",
        "label": "Cumulative Dividends [Member]",
        "documentation": "Cumulative Dividends [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r735",
      "r746",
      "r756",
      "r781"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeFinanceLeasesTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Finance Leases [Text Block]",
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "us-gaap_MortgageLoanRelatedToPropertySales1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MortgageLoanRelatedToPropertySales1",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortgage note receivable taken in connection with sale of real estate",
        "label": "Mortgage Loan Related to Property Sales",
        "documentation": "Mortgage loan related to property sales in noncash investing and financing activities."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r50",
      "r51"
     ]
    },
    "hr_MergerConsiderationTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "MergerConsiderationTransferred",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Merger consideration transferred",
        "label": "Merger Consideration Transferred",
        "documentation": "Merger Consideration Transferred"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r115",
      "r117",
      "r119",
      "r580",
      "r582",
      "r596",
      "r597",
      "r598",
      "r599",
      "r600",
      "r601",
      "r602",
      "r604",
      "r605",
      "r606",
      "r607",
      "r620",
      "r621",
      "r622",
      "r623",
      "r626",
      "r627",
      "r628",
      "r629",
      "r644",
      "r645",
      "r646",
      "r647",
      "r680",
      "r713",
      "r715"
     ]
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentFinancingLeaseRightOfUseAssets",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRealEstateInvestments",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing lease right-of-use assets",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment,, Financing Lease Right-of-Use Assets",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment,, Financing Lease Right-of-Use Assets"
       }
      }
     },
     "auth_ref": []
    },
    "hr_RealEstateInvestmentsPropertyOwnedInNumberOfStates": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "RealEstateInvestmentsPropertyOwnedInNumberOfStates",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Number of states that the company owns real estate in, whole units",
        "label": "Real Estate Investments Property Owned in Number of States",
        "documentation": "Real estate investments property owned in number of states."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "hr_NumberOfRealEstateNotesReceivable": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NumberOfRealEstateNotesReceivable",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of real estate notes receivable",
        "label": "Number of Real Estate Notes Receivable",
        "documentation": "Number of Real Estate Notes Receivable"
       }
      }
     },
     "auth_ref": []
    },
    "hr_EquityOwnershipForConsolidationPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "EquityOwnershipForConsolidationPercent",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity ownership for consolidation (percent)",
        "label": "Equity Ownership for Consolidation, Percent",
        "documentation": "Equity Ownership for Consolidation, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NotesReceivableFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NotesReceivableFairValueDisclosure",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CARRYING VALUE",
        "label": "Notes Receivable, Fair Value Disclosure",
        "documentation": "Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date."
       }
      }
     },
     "auth_ref": [
      "r900"
     ]
    },
    "us-gaap_InterestIncomeOperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeOperating",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income",
        "label": "Interest Income, Operating",
        "documentation": "Amount of operating interest income, including, but not limited to, amortization and accretion of premiums and discounts on securities."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r613",
      "r649",
      "r650",
      "r723",
      "r724",
      "r929"
     ]
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentOtherLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentLiabilitiesAssumed",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Other Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosureItemAmountsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosureItemAmountsDomain",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement [Domain]",
        "label": "Fair Value Measurement [Domain]",
        "documentation": "Measurement basis, for example, but not limited to, reported value, fair value, portion at fair value, portion at other than fair value."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r690",
      "r691"
     ]
    },
    "hr_ExtinguishmentOfDebtEncumberedSquareFootage": {
     "xbrltype": "areaItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ExtinguishmentOfDebtEncumberedSquareFootage",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Encumbered square footage",
        "label": "Extinguishment of Debt, Encumbered Square Footage",
        "documentation": "Extinguishment of Debt, Encumbered Square Footage"
       }
      }
     },
     "auth_ref": []
    },
    "hr_PerformanceConditionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "PerformanceConditionsMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance conditions",
        "label": "Performance Conditions [Member]",
        "documentation": "Performance Conditions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssets",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other assets, net",
        "label": "Other Assets",
        "documentation": "Amount of assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r227",
      "r524",
      "r726"
     ]
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r327",
      "r328",
      "r616"
     ]
    },
    "us-gaap_CarryingReportedAmountFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CarryingReportedAmountFairValueDisclosureMember",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CARRYING VALUE",
        "label": "Reported Value Measurement [Member]",
        "documentation": "Measured as reported on the statement of financial position (balance sheet)."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r128"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r328",
      "r616"
     ]
    },
    "us-gaap_PortionAtFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PortionAtFairValueFairValueDisclosureMember",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Portion at Fair Value Measurement",
        "label": "Portion at Fair Value Measurement [Member]",
        "documentation": "Measured at fair value for financial reporting purposes."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "hr_AssetDispositionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "AssetDispositionsTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Real Estate Dispositions",
        "label": "Asset Dispositions [Table Text Block]",
        "documentation": "Asset Dispositions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EstimateOfFairValueFairValueDisclosureMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EstimateOfFairValueFairValueDisclosureMember",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "FAIR VALUE",
        "label": "Estimate of Fair Value Measurement [Member]",
        "documentation": "Measured as an estimate of fair value."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r467",
      "r690",
      "r691"
     ]
    },
    "hr_FinancingReceivableAllowanceForCreditLossReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "FinancingReceivableAllowanceForCreditLossReserves",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit loss reserves",
        "label": "Financing Receivable, Allowance for Credit Loss, Reserves",
        "documentation": "Financing Receivable, Allowance for Credit Loss, Reserves"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r476",
      "r505"
     ]
    },
    "hr_DebtInstrumentExtensionPeriodForMaturityDate": {
     "xbrltype": "durationItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "DebtInstrumentExtensionPeriodForMaturityDate",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Extension period for maturity date",
        "label": "Debt Instrument, Extension Period for Maturity Date",
        "documentation": "Debt Instrument, Extension Period for Maturity Date"
       }
      }
     },
     "auth_ref": []
    },
    "hr_NumberofGroundLeasesPrepaid": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NumberofGroundLeasesPrepaid",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of prepaid ground leases",
        "label": "Number of Ground Leases Prepaid",
        "documentation": "Number of Ground Leases Prepaid"
       }
      }
     },
     "auth_ref": []
    },
    "hr_CumulativeNetIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "CumulativeNetIncomeMember",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cumulative Net Income",
        "label": "Cumulative Net Income [Member]",
        "documentation": "Cumulative Net Income [Member]."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable and accrued liabilities",
        "label": "Accounts Payable and Accrued Liabilities",
        "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations."
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentRestrictedCash",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentAssetsAcquired",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Restricted Cash",
        "documentation": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Restricted Cash"
       }
      }
     },
     "auth_ref": []
    },
    "hr_HealthcareTrustofAmericaHoldingsLPMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "HealthcareTrustofAmericaHoldingsLPMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Healthcare Trust of America Holdings L P",
        "label": "Healthcare Trustof America Holdings L P [Member]",
        "documentation": "Healthcare Trustof America Holdings L P"
       }
      }
     },
     "auth_ref": []
    },
    "hr_SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "SeniorNotesDue2031NetOfDiscountAndIssuanceCostsMember",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes due 2031",
        "label": "Senior Notes due 2031, Net of Discount and Issuance Costs [Member]",
        "documentation": "Senior Notes due 2031, Net of Discount and Issuance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive (loss) income",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r177",
      "r238",
      "r240",
      "r247",
      "r515",
      "r536"
     ]
    },
    "hr_OperatingPartnershipPerformanceUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "OperatingPartnershipPerformanceUnitsMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Partnership Performance Units",
        "label": "Operating Partnership Performance Units [Member]",
        "documentation": "Operating Partnership Performance Units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityEntityMaximumLossExposureAmount",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MAXIMUM EXPOSURE TO LOSS",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount",
        "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE)."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r100"
     ]
    },
    "hr_NumberOfCorporateEntityClassifiedAsHeldForSale": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NumberOfCorporateEntityClassifiedAsHeldForSale",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of corporate entity classified as held for sale",
        "label": "Number of Corporate Entity Classified as Held for Sale",
        "documentation": "Number of Corporate Entity Classified as Held for Sale"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryLockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryLockMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Settled treasury hedges",
        "label": "Treasury Lock [Member]",
        "documentation": "Customized agreement that fixes the yield or price on a specified treasury security for a specific period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfLongLivedAssetsHeldForSaleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfLongLivedAssetsHeldForSaleTable",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long Lived Assets Held-for-sale [Table]",
        "label": "Long-Lived Assets Held-for-Sale [Table]",
        "documentation": "Description and amounts of long lived assets held for sale. Disclosure may include the description of the facts and circumstances leading to the expected disposal, manner and timing of disposal, the carrying value of the assets held for sale, the gain (loss) recognized in the income statement and the income statement caption that includes that gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r21"
     ]
    },
    "hr_AlbanyNYMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "AlbanyNYMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Albany, NY",
        "label": "Albany, NY [Member]",
        "documentation": "Albany, NY"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit facility",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "hr_MiscellaneousMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "MiscellaneousMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Miscellaneous",
        "label": "Miscellaneous [Member]",
        "documentation": "Miscellaneous [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net identifiable assets acquired",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r83"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: comprehensive loss (income) attributable to non-controlling interests",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r9",
      "r89",
      "r104",
      "r238",
      "r240",
      "r248",
      "r516",
      "r537"
     ]
    },
    "us-gaap_BusinessCombinationAcquiredReceivablesGrossContractualAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAcquiredReceivablesGrossContractualAmount",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross contractual accounts receivable",
        "label": "Business Combination, Acquired Receivables, Gross Contractual Amount",
        "documentation": "For receivables acquired in a business combination, excluding certain loans and debt securities acquired in a transfer (as defined), this element represents the gross contractual amounts receivable, by major class of receivable, such as loans, direct finance leases (as defined), and any other class of receivables."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "hr_PersonalProperty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "PersonalProperty",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Personal property",
        "label": "Personal Property",
        "documentation": "Personal property."
       }
      }
     },
     "auth_ref": []
    },
    "hr_GrossContractualRealEstateNotesReceivableFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "GrossContractualRealEstateNotesReceivableFairValue",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross contractual real estate notes receivable at fair value",
        "label": "Gross Contractual Real Estate Notes Receivable, Fair Value",
        "documentation": "Gross Contractual Real Estate Notes Receivable, Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "hr_PaymentOfSpecialDividendMergerRelated": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "PaymentOfSpecialDividendMergerRelated",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Special dividend paid in relation to the Merger",
        "label": "Payment of Special Dividend, Merger Related",
        "documentation": "Payment of Special Dividend, Merger Related"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Revenues",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r245",
      "r260",
      "r296",
      "r297",
      "r301",
      "r304",
      "r305",
      "r309",
      "r310",
      "r312",
      "r318",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r468",
      "r519",
      "r859"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 2.0
      },
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "verboseLabel": "Lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r482"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r740",
      "r751",
      "r761",
      "r786"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r739",
      "r750",
      "r760",
      "r777",
      "r785"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Discount",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r496"
     ]
    },
    "stpr_TX": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2023",
     "localname": "TX",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Texas",
        "terseLabel": "Texas",
        "label": "TEXAS"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r788"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r739",
      "r750",
      "r760",
      "r785"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r739",
      "r750",
      "r760",
      "r785"
     ]
    },
    "us-gaap_RevenuesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenuesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Revenues",
        "label": "Revenues [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r740",
      "r751",
      "r761",
      "r786"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Class A Common stock, $.01 par value per share; 1,000,000 shares authorized; 380,860 and 380,590 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r528",
      "r710"
     ]
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r739",
      "r750",
      "r760",
      "r785"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r739",
      "r750",
      "r760",
      "r785"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r142",
      "r592"
     ]
    },
    "us-gaap_LessorOperatingLeasePaymentsFiscalYearMaturityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LessorOperatingLeasePaymentsFiscalYearMaturityAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLessorAccountingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "OPERATING",
        "label": "Lessor, Operating Lease, Payment to be Received, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheetsParenthetical",
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common stock, outstanding (in shares)",
        "terseLabel": "Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)",
        "periodStartLabel": "Balance, beginning of period (in shares)",
        "periodEndLabel": "Balance, end of period (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r142",
      "r592",
      "r609",
      "r927",
      "r928"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r741",
      "r752",
      "r762",
      "r787"
     ]
    },
    "us-gaap_ExtinguishmentOfDebtAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ExtinguishmentOfDebtAxis",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Extinguishment of Debt [Axis]",
        "label": "Extinguishment of Debt [Axis]",
        "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r788"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r733",
      "r744",
      "r754",
      "r779"
     ]
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ExtinguishmentOfDebtAmount",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding principal repaid",
        "label": "Extinguishment of Debt, Amount",
        "documentation": "Gross amount of debt extinguished."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ExtinguishmentOfDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ExtinguishmentOfDebtTypeDomain",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Extinguishment of Debt, Type [Domain]",
        "label": "Extinguishment of Debt, Type [Domain]",
        "documentation": "Type of debt extinguished."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "us-gaap_ConsolidationVariableInterestEntityPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationVariableInterestEntityPolicy",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entities",
        "label": "Consolidation, Variable Interest Entity, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for consolidation to describe the significant judgments and assumptions made in determining whether a variable interest held by the entity requires the variable interest entity to be consolidated and (or) disclose information about its involvement with the variable interest entity; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; and the significant factors considered and judgments made in determining that the power to direct the activities that significantly impact the economic performance of the variable interest entity are shared (as defined)."
       }
      }
     },
     "auth_ref": [
      "r92",
      "r95",
      "r98"
     ]
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireProductiveAssets",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments to acquire additional interest in an operating property",
        "label": "Payments to Acquire Productive Assets",
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r893",
      "r894",
      "r895"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r788"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r788"
     ]
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redeemable Non-Controlling Interests",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r198"
     ]
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationConsiderationTransferred1",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consideration transferred",
        "verboseLabel": "PURCHASE PRICE",
        "label": "Business Combination, Consideration Transferred",
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r2",
      "r15"
     ]
    },
    "us-gaap_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      },
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": "hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic",
       "weight": 1.0,
       "order": 1.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (loss) income",
        "terseLabel": "Net (loss) income",
        "verboseLabel": "Net (loss) income",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r224",
      "r236",
      "r239",
      "r252",
      "r260",
      "r265",
      "r275",
      "r276",
      "r295",
      "r302",
      "r306",
      "r308",
      "r318",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r441",
      "r444",
      "r445",
      "r464",
      "r468",
      "r519",
      "r532",
      "r564",
      "r611",
      "r630",
      "r631",
      "r686",
      "r707",
      "r708",
      "r725",
      "r825",
      "r859"
     ]
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Operating Lease Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 3.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain (loss) on extinguishment of debt",
        "negatedTerseLabel": "(Gain) loss on extinguishment of debt",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r62",
      "r63"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofEquityandRedeemableNonControllingInterests",
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r713",
      "r714",
      "r715",
      "r717",
      "r718",
      "r719",
      "r722",
      "r836",
      "r837",
      "r898",
      "r923",
      "r927"
     ]
    },
    "us-gaap_ScheduleOfRealEstatePropertiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfRealEstatePropertiesTable",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Real Estate Properties [Table]",
        "label": "Schedule of Real Estate Properties [Table]",
        "documentation": "Schedule detailing quantitative information concerning real estate properties and units within those properties by ownership of the property."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MortgagesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MortgagesMember",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortgages",
        "label": "Mortgages [Member]",
        "documentation": "A loan to finance the purchase of real estate where the lender has a lien on the property as collateral for the loan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset Impairment",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r165"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "hr_OperatingExpensesandCostofGoodsSold",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r615"
     ]
    },
    "us-gaap_ImpairmentOfRealEstate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOfRealEstate",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of real estate assets",
        "label": "Impairment of Real Estate",
        "documentation": "The charge against earnings in the period to reduce the carrying amount of real property to fair value."
       }
      }
     },
     "auth_ref": [
      "r830",
      "r852"
     ]
    },
    "stpr_NC": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2023",
     "localname": "NC",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "North Carolina",
        "label": "NORTH CAROLINA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesIssuedBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesIssuedBasic",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average common shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Issued, Basic",
        "documentation": "This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic)."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r53"
     ]
    },
    "us-gaap_AreaOfLand": {
     "xbrltype": "areaItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AreaOfLand",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Area of land",
        "label": "Area of Land",
        "documentation": "Area of land held."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ASSETS",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": "hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Net loss (income) attributable to non-controlling interests",
        "negatedTerseLabel": "Loss (income) attributable to non-controlling interest",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r179",
      "r236",
      "r239",
      "r275",
      "r276",
      "r533",
      "r825"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "LIABILITIES",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Weighted average common shares outstanding",
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "stpr_CA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2023",
     "localname": "CA",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "California",
        "label": "CALIFORNIA"
       }
      }
     },
     "auth_ref": []
    },
    "stpr_CO": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2023",
     "localname": "CO",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "COLORADO",
        "label": "COLORADO"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "stpr_FL": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2023",
     "localname": "FL",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Florida",
        "label": "FLORIDA"
       }
      }
     },
     "auth_ref": []
    },
    "stpr_GA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2023",
     "localname": "GA",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "GEORGIA",
        "label": "GEORGIA"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Axis]",
        "label": "Title of Individual [Axis]",
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals."
       }
      }
     },
     "auth_ref": [
      "r842",
      "r910"
     ]
    },
    "us-gaap_SalesTypeLeaseInterestIncomeLeaseReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesTypeLeaseInterestIncomeLeaseReceivable",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income from financing receivables",
        "label": "Sales-type Lease, Interest Income, Lease Receivable",
        "documentation": "Amount of interest income from lease receivable of sales-type lease."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r501"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average amortization period for the acquired lease intangible assets",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r512"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notes and Bonds Payable",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r258",
      "r344",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r360",
      "r367",
      "r368",
      "r370"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant date fair value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings."
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets acquired",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "documentation": "Amount of assets acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued liabilities",
        "label": "Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities",
        "documentation": "Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r137",
      "r138",
      "r164"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LessorLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LessorLeasesPolicyTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investments in Leases - Financing Receivables, Net and Real Estate Notes Receivable and Interest Income",
        "label": "Lessor, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangements entered into by lessor."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r205",
      "r206",
      "r498"
     ]
    },
    "us-gaap_OtherAmortizationOfDeferredCharges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAmortizationOfDeferredCharges",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other amortization",
        "label": "Amortization of Other Deferred Charges",
        "documentation": "Amount of amortization of other deferred costs recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r151"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "hr_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Grant date fair value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Total Fair Value",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Total Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities assumed",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "documentation": "Amount of liabilities assumed at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate cash flow hedge gain (loss) to be reclassified to interest expense during the next 12 months",
        "label": "Interest Rate Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months, Net",
        "documentation": "The estimated net amount of unrealized gains or losses on interest rate cash flow hedges as of the balance sheet date expected to be reclassified to earnings within the next twelve months."
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "us-gaap_AcquisitionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AcquisitionCosts",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "hr_OperatingExpensesandCostofGoodsSold",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition and pursuit costs",
        "label": "Acquisition Costs, Period Cost",
        "documentation": "The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r182"
     ]
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other assets, including right-of-use-assets",
        "label": "Increase (Decrease) in Other Operating Assets",
        "documentation": "Amount of increase (decrease) in operating assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "hr_AtlantaGAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "AtlantaGAMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Atlanta, GA",
        "label": "Atlanta, GA [Member]",
        "documentation": "Atlanta, GA"
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationRefundOfTransferTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRefundOfTransferTaxesPaid",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Refund of transfer taxes paid",
        "label": "Business Combination, Refund of Transfer Taxes Paid",
        "documentation": "Business Combination, Refund of Transfer Taxes Paid"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Employee Stock Purchase Plan Activity",
        "label": "Schedule of Share-Based Compensation, Employee Stock Purchase Plan, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of employee stock purchase plan activity."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest paid",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r254",
      "r255"
     ]
    },
    "us-gaap_LeaseCostAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease cost",
        "label": "Lease, Cost [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r728"
     ]
    },
    "us-gaap_LimitedPartnersCapitalAccountUnitsOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LimitedPartnersCapitalAccountUnitsOutstanding",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Limited partner's capital, units outstanding (in shares)",
        "label": "Limited Partners' Capital Account, Units Outstanding",
        "documentation": "The number of limited partner units outstanding."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealEstateInvestments",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Buildings and improvements",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Buildings",
        "documentation": "Amount of facility held for productive use including, but not limited to, office, production, storage and distribution facilities, acquired at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r83"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock Options, Valuation Assumptions",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Nonvested shares (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares",
        "documentation": "Number of non-vested options outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Legal Entity [Axis]",
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Unrecognized Compensation Cost, Nonvested Awards",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityDomain",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity [Domain]",
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease expense",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r488",
      "r709"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average grant date fair value (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average grant-date fair value of options vested."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeFixedInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFixedInterestRate",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average interest rate (percent)",
        "label": "Derivative, Fixed Interest Rate",
        "documentation": "Fixed interest rate related to the interest rate derivative."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease expense",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r490",
      "r709"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r728"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease expense",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r491",
      "r709"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFairValueOfDerivativeLiability",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability derivatives",
        "label": "Derivative Liability, Subject to Master Netting Arrangement, before Offset",
        "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r114",
      "r147",
      "r232",
      "r680"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToEquityForwardAgreements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncrementalCommonSharesAttributableToEquityForwardAgreements",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dilutive effect of forward equity shares (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Equity Forward Agreements",
        "documentation": "Additional shared included in the calculation of diluted EPS as a result of the potentially dilutive effect of equity forward arrangements using the reverse treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r683"
     ]
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetAcquisitionContingentConsiderationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetAcquisitionContingentConsiderationTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTATables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Consideration Transferred",
        "label": "Asset Acquisition, Contingent Consideration [Table Text Block]",
        "documentation": "Tabular disclosure of contingent consideration in asset acquisition."
       }
      }
     },
     "auth_ref": [
      "r892"
     ]
    },
    "us-gaap_OtherAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other Assets [Member]",
        "documentation": "Primary financial statement caption encompassing other assets."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r122"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other operating",
        "terseLabel": "Type of Revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r296",
      "r297",
      "r301",
      "r304",
      "r305",
      "r309",
      "r310",
      "r312",
      "r398",
      "r399",
      "r511"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityScheduleofStockOptionsValuationAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BalanceSheetLocationDomain",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Location [Domain]",
        "label": "Balance Sheet Location [Domain]",
        "documentation": "Location in the balance sheet (statement of financial position)."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r116"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Variable Interest Entities",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r94",
      "r97",
      "r99",
      "r101"
     ]
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-controlling interest",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective interest rate",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r130",
      "r372",
      "r478"
     ]
    },
    "us-gaap_FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REAL ESTATE NOTES RECEIVABLE, GROSS",
        "label": "Financing Receivable, Excluding Accrued Interest, before Allowance for Credit Loss",
        "documentation": "Amortized cost excluding accrued interest, before allowance for credit loss, of financing receivable. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r324",
      "r325",
      "r847"
     ]
    },
    "us-gaap_RealEstateTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RealEstateTable",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate [Table]",
        "label": "Real Estate [Table]",
        "documentation": "Disclosure of information about real estate investment companies including, but not limited to, real estate investment trusts, real estate owned, retail land sales, and time share transactions."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r734",
      "r745",
      "r755",
      "r780"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r260",
      "r318",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r443",
      "r446",
      "r447",
      "r468",
      "r590",
      "r685",
      "r726",
      "r859",
      "r911",
      "r912"
     ]
    },
    "us-gaap_EarlyRepaymentOfSeniorDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarlyRepaymentOfSeniorDebt",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Redemption of notes and bonds payable",
        "label": "Early Repayment of Senior Debt",
        "documentation": "The cash outflow for the extinguishment of long-term borrowing, with the highest claim on the assets of the entity in case of bankruptcy or liquidation, before its maturity."
       }
      }
     },
     "auth_ref": [
      "r46"
     ]
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Interest Entity [Line Items]",
        "label": "Variable Interest Entity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r443",
      "r446",
      "r447",
      "r507",
      "r508",
      "r509"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Financial Instruments",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts."
       }
      }
     },
     "auth_ref": [
      "r180",
      "r451",
      "r459"
     ]
    },
    "us-gaap_RealEstateLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RealEstateLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real Estate [Line Items]",
        "label": "Real Estate [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Variable Interest Entities [Table]",
        "label": "Schedule of Variable Interest Entities [Table]",
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r94",
      "r97",
      "r99",
      "r101",
      "r442",
      "r443",
      "r446",
      "r447",
      "r507",
      "r508",
      "r509"
     ]
    },
    "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      },
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Liabilities of assets held for sale",
        "totalLabel": "Liabilities of assets held for sale",
        "label": "Disposal Group, Including Discontinued Operation, Liabilities",
        "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r137",
      "r138",
      "r164",
      "r223",
      "r224"
     ]
    },
    "us-gaap_VariableInterestEntityPrimaryBeneficiaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableInterestEntityPrimaryBeneficiaryMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable interest entity",
        "label": "Variable Interest Entity, Primary Beneficiary [Member]",
        "documentation": "Variable Interest Entities (VIE) in which the entity has a controlling financial interest (as defined) and of which it is therefore the primary beneficiary. A controlling financial interest is determined based on both: (a) the entity's power to direct activities of the VIE that most significantly impact the VIE's economic performance and (b) the entity's obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE. VIEs of which the entity is the primary beneficiary are included in the consolidated financial statements of the entity."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r442",
      "r443",
      "r446",
      "r447"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails": {
       "parentTag": "hr_NetIncomeLossfromContinuingOperationsAvailabletoCommonStockholdersBasic",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityComputationofBasicandDilutedEarningsLossPerCommonShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Income allocated to participating securities",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic",
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method."
       }
      }
     },
     "auth_ref": [
      "r283",
      "r285",
      "r286"
     ]
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 5.0
      },
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofOperations",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity loss from unconsolidated joint ventures",
        "negatedTerseLabel": "Equity loss from unconsolidated joint ventures",
        "verboseLabel": "Equity loss recognized during the period",
        "label": "Income (Loss) from Equity Method Investments",
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss)."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r148",
      "r189",
      "r300",
      "r313",
      "r531"
     ]
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Employee stock purchase plan",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Liabilities",
        "label": "Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentsAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "CUMULATIVE MEASUREMENT PERIOD ADJUSTMENTS",
        "label": "Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates in the Condensed Consolidated Financial Statements",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r56",
      "r57",
      "r58",
      "r200",
      "r201",
      "r202",
      "r203"
     ]
    },
    "us-gaap_InterestExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestExpenseMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest expense",
        "label": "Interest Expense [Member]",
        "documentation": "Primary financial statement caption encompassing interest expense."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_InterestRateContractMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestRateContractMember",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate swaps",
        "label": "Interest Rate Contract [Member]",
        "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate."
       }
      }
     },
     "auth_ref": [
      "r674",
      "r680",
      "r702"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r261",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r351",
      "r356",
      "r357",
      "r358",
      "r359",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r478",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r833"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r775"
     ]
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest",
     "crdr": "credit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofCompanysAllowanceForCreditLossesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "ALLOWANCE FOR CREDIT LOSSES",
        "periodStartLabel": "Allowance for credit losses, beginning of period",
        "periodEndLabel": "Allowance for credit losses, end of period",
        "label": "Financing Receivable, Allowance for Credit Loss, Excluding Accrued Interest",
        "documentation": "Amount excluding accrued interest, of allowance for credit loss on financing receivable. Excludes net investment in lease."
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "us-gaap_DerivativeLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLineItems",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails",
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Line Items]",
        "label": "Derivative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r459"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r188",
      "r530",
      "r710",
      "r834",
      "r844",
      "r901"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "LIABILITIES AND STOCKHOLDERS' EQUITY",
        "terseLabel": "Liabilities:",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeTable",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsDerivativeInstrumentsDesignatedasCashFlowHedgesDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsEffectofCashFlowHedgingonAOCIDetails",
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsFairValueofDerivativeInstrumentsontheBalanceSheetDetails",
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative [Table]",
        "label": "Derivative [Table]",
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r105",
      "r106",
      "r108",
      "r110",
      "r113",
      "r117",
      "r120",
      "r121",
      "r123",
      "r459"
     ]
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeniorNotesMember",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior notes",
        "label": "Senior Notes [Member]",
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other comprehensive income",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r25",
      "r237",
      "r240",
      "r246",
      "r469",
      "r470",
      "r475",
      "r514",
      "r535",
      "r823",
      "r824"
     ]
    },
    "hr_CommonStockSharesWithheld": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "CommonStockSharesWithheld",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock, withheld (in shares)",
        "label": "Common Stock, Shares Withheld",
        "documentation": "Common Stock, Shares Withheld"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Notes and bonds payable",
        "terseLabel": "Notes and bonds payable",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r186",
      "r357",
      "r371",
      "r690",
      "r691",
      "r921"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupClassificationAxis",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Classification [Axis]",
        "label": "Disposal Group Classification [Axis]",
        "documentation": "Information by disposal group classification."
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2023",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r776"
     ]
    },
    "hr_SeniorNotesDue2026Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "SeniorNotesDue2026Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes due 2026",
        "label": "Senior Notes due 2026 [Member]",
        "documentation": "Senior Notes due 2026"
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRestrictedCash",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails": {
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash",
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Restricted Cash"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://healthcarerealty.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisposalGroupClassificationDomain",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disposal Group Classification [Domain]",
        "label": "Disposal Group Classification [Domain]",
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations."
       }
      }
     },
     "auth_ref": []
    },
    "hr_PercentageOfRestrictedStockUnits": {
     "xbrltype": "percentItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "PercentageOfRestrictedStockUnits",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of restricted stock units",
        "label": "Percentage Of Restricted Stock Units",
        "documentation": "Percentage Of Restricted Stock Units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LeasesOperatingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesOperatingAbstract",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other information",
        "label": "Leases, Operating [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_TermLoanDueMay2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "TermLoanDueMay2024Member",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "$200 million Unsecured Term Loan",
        "label": "Term Loan due May 2024 [Member]",
        "documentation": "Term Loan due 2024 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidatedEntitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesDomain",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Domain]",
        "label": "Consolidated Entities [Domain]",
        "documentation": "Entity or group of entities consolidated into reporting entity."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r261",
      "r442",
      "r443",
      "r446",
      "r447",
      "r504",
      "r670",
      "r817",
      "r818",
      "r819",
      "r858",
      "r861",
      "r862"
     ]
    },
    "srt_OwnershipAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipAxis",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership [Axis]",
        "label": "Ownership [Axis]",
        "documentation": "Information by name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity [Abstract]",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "EmployeeServiceShareBasedCompensationNonVestedAwardsCompensationCostNotYetRecognizedYearFour",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Four",
        "documentation": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "hr_InterestRateSwapExpiringDecember12027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "InterestRateSwapExpiringDecember12027Member",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Swap, Expiring December 1, 2027",
        "label": "Interest Rate Swap, Expiring December 1, 2027 [Member]",
        "documentation": "Interest Rate Swap, Expiring December 1, 2027"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ConsolidatedEntitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ConsolidatedEntitiesAxis",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesConsolidatedbalancesheetsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesVariableinterestentityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Entities [Axis]",
        "label": "Consolidated Entities [Axis]",
        "documentation": "Information by consolidated entity or group of entities."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r261",
      "r442",
      "r443",
      "r446",
      "r447",
      "r504",
      "r670",
      "r817",
      "r818",
      "r819",
      "r858",
      "r861",
      "r862"
     ]
    },
    "hr_FinanceLeaseLiabilityToBePaidAfterYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "FinanceLeaseLiabilityToBePaidAfterYearFour",
     "crdr": "credit",
     "calculation": {
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/LeasesFutureMinimumLeasePaymentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028 and thereafter",
        "label": "Finance Lease, Liability, to be Paid, after Year Four",
        "documentation": "Finance Lease, Liability, to be Paid, after Year Four"
       }
      }
     },
     "auth_ref": []
    },
    "hr_PowayCAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "PowayCAMember",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesScheduleofNotesReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Poway, CA",
        "label": "Poway, CA [Member]",
        "documentation": "Poway, CA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Land": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Land",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 1.0
      },
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Land",
        "terseLabel": "Land",
        "label": "Land",
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale."
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "hr_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedRealProperty",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "REAL ESTATE",
        "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Real Property",
        "documentation": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Real Property"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r511",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r675",
      "r695",
      "r711",
      "r810",
      "r856",
      "r857",
      "r864",
      "r922"
     ]
    },
    "hr_StockIssuanceProgramAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "StockIssuanceProgramAxis",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Issuance Program [Axis]",
        "label": "Stock Issuance Program [Axis]",
        "documentation": "Stock Issuance Program [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_OwnershipDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "OwnershipDomain",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails",
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ownership [Domain]",
        "label": "Ownership [Domain]",
        "documentation": "Name of entity in which ownership interest is disclosed. Excludes equity method investee and named security investment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r332",
      "r333",
      "r334",
      "r400",
      "r401",
      "r427",
      "r428",
      "r429",
      "r506",
      "r510",
      "r546",
      "r581",
      "r582",
      "r637",
      "r639",
      "r641",
      "r642",
      "r648",
      "r671",
      "r672",
      "r687",
      "r694",
      "r705",
      "r712",
      "r715",
      "r854",
      "r863",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918"
     ]
    },
    "us-gaap_InvestmentBuildingAndBuildingImprovements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentBuildingAndBuildingImprovements",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 2.0
      },
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Buildings and improvements",
        "terseLabel": "Building and improvements",
        "label": "Investment Building and Building Improvements",
        "documentation": "Aggregate of the carrying amounts as of the balance sheet date of investments in building and building improvements."
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "hr_NonVestedStockAwardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NonVestedStockAwardMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-vested Stock Award",
        "label": "Non Vested Stock Award [Member]",
        "documentation": "Non Vested Stock Award"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueByBalanceSheetGroupingTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByBalanceSheetGroupingTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value And Carrying Values For Notes And Bonds Payable, Real Estate Notes Receivable, And Notes Receivable",
        "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]",
        "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r127"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesRevenueRecognitionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r309",
      "r511",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r675",
      "r695",
      "r711",
      "r810",
      "r856",
      "r857",
      "r864",
      "r922"
     ]
    },
    "hr_LosAngelesCaliforniaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "LosAngelesCaliforniaMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails",
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Los Angeles, CA",
        "label": "Los Angeles, California [Member]",
        "documentation": "Los Angeles, California [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r332",
      "r333",
      "r334",
      "r401",
      "r510",
      "r546",
      "r581",
      "r582",
      "r637",
      "r639",
      "r641",
      "r642",
      "r648",
      "r671",
      "r672",
      "r687",
      "r694",
      "r705",
      "r712",
      "r863",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r332",
      "r333",
      "r334",
      "r400",
      "r401",
      "r427",
      "r428",
      "r429",
      "r506",
      "r510",
      "r546",
      "r581",
      "r582",
      "r637",
      "r639",
      "r641",
      "r642",
      "r648",
      "r671",
      "r672",
      "r687",
      "r694",
      "r705",
      "r712",
      "r715",
      "r854",
      "r863",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryofActivityunderEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Summary of the Employee Stock Purchase Plan activity",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accumulated other comprehensive income",
        "label": "Accumulated Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax",
        "documentation": "Amount, after tax, of accumulated other comprehensive (income) loss for defined benefit plan, that has not been recognized in net periodic benefit cost (credit)."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r38",
      "r865"
     ]
    },
    "hr_NumberOfPropertiesClassifiedAsHeldForSale": {
     "xbrltype": "integerItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "NumberOfPropertiesClassifiedAsHeldForSale",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of properties classified as held for sale",
        "label": "Number of Properties Classified as Held for Sale",
        "documentation": "Number of Properties Classified as Held for Sale"
       }
      }
     },
     "auth_ref": []
    },
    "hr_EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsCompensationCostNotYetRecognizedNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails": {
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityAmortizationofCompensationforNonvestedSharesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Next Twelve Months",
        "documentation": "Employee Service Share-based Compensation, Non Vested Awards, Compensation Cost Not yet Recognized, Next Twelve Months"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r257"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://healthcarerealty.com/role/LeasesGroundLeasesDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r331",
      "r332",
      "r333",
      "r334",
      "r401",
      "r510",
      "r546",
      "r581",
      "r582",
      "r637",
      "r639",
      "r641",
      "r642",
      "r648",
      "r671",
      "r672",
      "r687",
      "r694",
      "r705",
      "r712",
      "r863",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918"
     ]
    },
    "hr_AssetsHeldForSaleAndDiscontinuedOperationsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "AssetsHeldForSaleAndDiscontinuedOperationsNet",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      },
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets",
      "http://healthcarerealty.com/role/RealEstateInvestmentsAssetsHeldforSaleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Assets held for sale, net",
        "totalLabel": "Assets held for sale, net",
        "label": "Assets Held-for-sale and Discontinued Operations Net",
        "documentation": "Assets held for sale and discontinued operations, net."
       }
      }
     },
     "auth_ref": []
    },
    "hr_CommonStockFractionalShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "CommonStockFractionalShares",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock, fractional (in shares)",
        "label": "Common Stock, Fractional Shares",
        "documentation": "Common Stock, Fractional Shares"
       }
      }
     },
     "auth_ref": []
    },
    "srt_RestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementAxis",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revision of Prior Period [Axis]",
        "label": "Revision of Prior Period [Axis]",
        "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r290",
      "r320",
      "r321",
      "r436",
      "r461",
      "r462",
      "r463",
      "r464",
      "r479",
      "r502",
      "r503",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557"
     ]
    },
    "srt_RestatementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementDomain",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails",
      "http://healthcarerealty.com/role/MergerwithHTAScheduleofFairValuesoftheAssetsAcquiredAndLiabilitiesAssumedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revision of Prior Period [Domain]",
        "label": "Revision of Prior Period [Domain]",
        "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r290",
      "r320",
      "r321",
      "r436",
      "r461",
      "r462",
      "r463",
      "r464",
      "r479",
      "r502",
      "r503",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557"
     ]
    },
    "us-gaap_LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Limited partners ownership interest (in percent)",
        "label": "Limited Liability Company or Limited Partnership, Members or Limited Partners, Ownership Interest",
        "documentation": "Percentage investment held by members or limited partners of limited liability company (LLC) or limited partnership (LP)."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "hr_TampaFLMiamiFLMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "TampaFLMiamiFLMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsDispositionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tampa/Miami, FL",
        "label": "Tampa FL &amp; Miami FL [Member]",
        "documentation": "Tampa FL &amp; Miami FL"
       }
      }
     },
     "auth_ref": []
    },
    "hr_ColoradoSpringsCOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ColoradoSpringsCOMember",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsRealEstateAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Colorado Springs, CO",
        "label": "Colorado Springs, CO [Member]",
        "documentation": "Colorado Springs, CO [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Summary of the activity under the incentive plans",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "hr_BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "BusinessCombinationFairValueOfLegacyHTARestrictedStockAwardsAttributableToPreMergerServices",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services",
        "label": "Business Combination Fair Value of Legacy HTA Restricted Stock Awards Attributable to Pre-Merger Services",
        "documentation": "Business Combination Fair Value of Legacy HTA Restricted Stock Awards Attributable to Pre-Merger Services"
       }
      }
     },
     "auth_ref": []
    },
    "hr_ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "ReconciliationOfBeginningAndEndingCommonStockOutstandingRollForward",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityReconciliationofBeginningandEndingCommonStockOutstandingDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Reconciliation of the beginning and ending common stock outstanding",
        "label": "Reconciliation of Beginning and Ending Common Stock Outstanding [Roll Forward]",
        "documentation": "Reconciliation of the beginning and ending common stock outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "hr_InterestRateSwapEffectiveNovember12023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "InterestRateSwapEffectiveNovember12023Member",
     "presentation": [
      "http://healthcarerealty.com/role/DerivativeFinancialInstrumentsCashFlowHedgesofInterestRateRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest Rate Swap, Effective November 1, 2023",
        "label": "Interest Rate Swap, Effective November 1, 2023 [Member]",
        "documentation": "Interest Rate Swap, Effective November 1, 2023"
       }
      }
     },
     "auth_ref": []
    },
    "hr_HealthcareTrustOfAmericaIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "HealthcareTrustOfAmericaIncMember",
     "presentation": [
      "http://healthcarerealty.com/role/MergerwithHTADetails",
      "http://healthcarerealty.com/role/MergerwithHTANarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Healthcare Trust Of America, Inc",
        "label": "Healthcare Trust Of America, Inc [Member]",
        "documentation": "Healthcare Trust Of America, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "hr_StockIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "StockIncentivePlanMember",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityStockTransactionsNarrativeDetails",
      "http://healthcarerealty.com/role/StockholdersEquitySummaryoftheActivityUndertheIncentivePlanandRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock incentive plan",
        "label": "Stock Incentive Plan [Member]",
        "documentation": "Stock Incentive Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/FairValueofFinancialInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair Value of Financial Instruments",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r465"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r32"
     ]
    },
    "hr_RealEstateNotesReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "RealEstateNotesReceivableNet",
     "crdr": "debit",
     "presentation": [
      "http://healthcarerealty.com/role/SummaryofSignificantAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investment in financing receivable, net",
        "label": "Real Estate Notes Receivable, Net",
        "documentation": "Real Estate Notes Receivable, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfCommonStockOutstandingRollForwardTableTextBlock",
     "presentation": [
      "http://healthcarerealty.com/role/StockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation of Common Stock Outstanding",
        "label": "Schedule of Common Stock Outstanding Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in common stock outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LandAvailableForDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LandAvailableForDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_RealEstateInvestmentPropertyAtCost",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://healthcarerealty.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land held for development",
        "label": "Land Available for Development",
        "documentation": "Carrying amount of land available for development."
       }
      }
     },
     "auth_ref": [
      "r920"
     ]
    },
    "hr_MortgageNotesPayableNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "MortgageNotesPayableNetMember",
     "presentation": [
      "http://healthcarerealty.com/role/NotesandBondsPayableDetails",
      "http://healthcarerealty.com/role/NotesandBondsPayableNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mortgage notes payable",
        "label": "Mortgage Notes Payable, Net [Member]",
        "documentation": "Mortgage Notes Payable, Net [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "hr_EquityMethodInvestmentsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://healthcarerealty.com/20230930",
     "localname": "EquityMethodInvestmentsRollForward",
     "presentation": [
      "http://healthcarerealty.com/role/RealEstateInvestmentsUnconsolidatedJointVentureAcquisitionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Method Investments [Roll Forward]",
        "label": "Equity Method Investments [Roll Forward]",
        "documentation": "Equity Method Investments"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "7",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "8",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-10"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(i-k)",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-14"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "21D",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-21D"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "205",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(2)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(c)(2)",
   "SubTopic": "20",
   "Topic": "860",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(27)",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.22)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.27(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-13"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "272",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "310",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-5"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-2"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481303/470-50-40-4"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481244/470-50-50-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(CFRR 211.02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "37",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "25",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-5"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-15"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-16"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-21"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-24"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2AA",
   "Subparagraph": "a",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-2AA"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "b",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-4"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-5A"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-6"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-9"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4I"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a),(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "182",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480401/815-10-55-182"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "25",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480238/815-25-50-1"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480870/815-30-50-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-11"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-12"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-1A"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-2"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482925/835-30-45-3"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "835",
   "SubTopic": "30",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482949/835-30-55-8"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15(1),(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.15)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480848/942-470-50-3"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483475/205-20-45-11"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5B"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//470/tableOfContent"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 4.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-5"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//805/tableOfContent"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-23"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//815/tableOfContent"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "932",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-10(c)(3)(ii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479664/932-10-S99-1"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "932",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-10(c)(7)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479664/932-10-S99-1"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r186": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r187": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r188": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r189": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r190": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r191": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r192": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481266/840-40-55-50"
  },
  "r193": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "51",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481266/840-40-55-51"
  },
  "r194": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481266/840-40-55-52"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "SubTopic": "360",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479638/944-360-45-3"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "SubTopic": "360",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479638/944-360-45-4"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "360",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479607/944-360-50-1"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "SubTopic": "30",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-14"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(a)",
   "SubTopic": "30",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-3A"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(b)",
   "SubTopic": "30",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-3A"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(b)",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-5C"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(210.5-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-2"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "65",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-65"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "66",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-66"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482964/270-10-50-6A"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481664/323-10-45-1"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-16"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-3B"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-5"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1C"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1F"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1I"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-4"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-6"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480627/815-20-45-3"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482736/825-10-45-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483013/835-20-50-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482900/835-30-50-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-4"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-5"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479016/842-30-45-3"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-12"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-5"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-5"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481435/852-10-45-14"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481420/860-30-50-1A"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-3"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(10)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-3"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)(1)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "35",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-35"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69E"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69F"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4J"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481175/810-10-55-4K"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column B)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "39",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480228/946-830-45-39"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii",
   "Section": "6"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r804": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r808": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r809": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r810": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r811": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r812": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r813": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r814": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r815": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(c))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r816": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r817": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(i)",
   "Publisher": "SEC"
  },
  "r818": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "01",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r819": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "13",
   "Subsection": "02",
   "Paragraph": "(a)",
   "Subparagraph": "(4)(iv)",
   "Publisher": "SEC"
  },
  "r820": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r826": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r827": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r828": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r829": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r830": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r831": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482130/360-10-45-5"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-2"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(j)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "15",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480123/805-50-15-3"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480060/805-50-25-1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-1"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "805",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480027/805-50-30-2"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479773/842-30-50-12"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479741/842-40-50-2"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(14)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column E)(Footnote 6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>81
<FILENAME>0001360604-23-000096-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001360604-23-000096-xbrl.zip
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M\ &'HV5BN\ACMN]M]G9W-GMGPYU2$*T=[91^ESVC0/=/@]E Y4F098U"L(Z
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MTF@HWX8S41Y/Z2*3Y8,P& G_^P>Y*WW>_V\A#G:R^C8&,Q8=CP/(H*W@I $
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M DHD;!GFV99(6>G(+^&T])YHDM"-71RED2!" (YP.PFAY#P6XD @5X )FP2
M9.7#XT=01A M[MOQ69,C0I;:T0QE%YFB6AVY:^P4NGD_K&.HN][Y3OA*ZZCZ
M;N&KPR^60%:5S1.+7M&>5<!5E\@>"N<>BJ*3C1\]A(@:*?=OH\? .UDP7*?A
M>4H1EZ_V$+I$"8$O_&/HDD]FLKI(#"QG-G$#U'=^RS]5<&^R\DC9;&KY=UL]
MRFE"7X#S.@):6MHE"G^4.I(LC%$H/$.>/IR$"A'T[:HVQGN*R$F9/>'U*6:,
M5N_;'0=V59R029/DZ',Y=(/)MTM1&Y.((_PB_"L(?R8\,A5(VP/R*S9T;A"=
M$T!/PC<"GIT,6V@ :4.\^O%-L(>8+'H$F:<O0TR#UV"_AE.'^4SX(*='G$,4
M"0/7(T8P\CQR":3'1.3?WR<N6,;$('[$Z07DR:EQ'*76L0IA[R0C)+61Y^SK
MJ10G=C-\3;,*'?(MT79PZ3C$-J:Z3U:2Y]$TL4CX0!Y*T"1$$R+YHR&4=X59
M?@8AHWAI,\(+6EPPK#:Y.=W.1U% OB-\4.;V_$@P3BYZ_ _9$=Q$KR=WPGK2
MAT'F4$170I>+HEBP),%!;U%'$#8<$+_K&!W:X)<5-<OO+GQ0E#_76U$J2R+O
M&-7DO4L5K5@KD*F_0WYW_I.Z74,WAY%5:6)V!1FS!]Y(T1#^^20,R1N3)$0P
M!&C+U*GBL5J]?^%H#TN 32A-,RD;OH_K@,4#^,H.]9MAR@B@S(D>'[EQ3-0_
M]H@^#P,?J,1[$S"AF#>!QCZ134^0+E",DBS%)1MG]HSQ7#3P;N+A1-5KDI[F
MCTT\-(L0WK<?A _PHY$F?2JJTDFOC8<NS2@;0T;904R?9!-38P9''SN;DE/9
M-EV(46$8QO^48;ELCLN9'4U62@_I*299>KZ07I''FIVN7D'VG$5L+*V,^",W
M3AC;2/$<P:F4!"&9VBK3>CJ)&R<L[X,;)^]J+Q8M%V(<(,$CNA$+R+:)Y4(+
M%JC>#B%BL?93@8"BO?:+:$1,'O*6,/,N"$!'9-MO(D1IR.,P8=DG^/PI#%[B
M8?9U1Q#N,::+<_# ]9.^VF"__.\?3$4A^]RP1/JU_#F[;.6"]'LQNV#C K,'
M09 FO7;#6K,K77_.,I.5Q[:2!:#FHTZ=U906IHP<W5Q*T:_ R%$[7:/\7'Y5
M[LBR5;[IU+'TW8Z9WWVJVM',\NV\:B!+K$?-RF?G<8.L61O9I1PN/"?R]"D(
MW]:<7-"+J*2UTXMFAQB*W.I]7R^W-^?]-16PQV+#]9=1Q5'#RCZNUUE=:WMD
MU&T>-^7*36;\@4TPM6.:9K4FF-&1M?*M&DWJ6'*^/%\F%JMRJV8?8^ >G*<O
MD\B%:I*M_2L497L#BZ9"[GZ3&]E\;5F4*"Y3+_E7ZB2?)V#83ASJ\1+'Y?JX
MP<EH:I:#8X-W@E!0K[,V=N8.UAWXT6,^8H;Y 3VEFT1)_(J0(FW&M:ZQ2Q#2
M=WG0-%IX<<FK@2Y\_ +1L1 _NQ$UZWSDVR[RP&V""GFX&#H(.RAT(@%*_%QG
MZ8@PS8D29/4#^K@^#+4I#E4]T*=O/G"[RXZF51S8*J_.J7*38BIL*Q<^1=H'
M=:>=E^H6#,6CYM$0>]Y4N'\@$H&&KI,^+CDBPQ\[;$>&%:7352MV2V2SHU=0
MT:(0ONR6_UBS(TOEQW"A)XW$_9)]_!+@Q-R69XZ^>DT%'#T<;_@>IAUS&[Z/
M$ST,/[!)F4]U9@LJN=U>(V[+@8P\)71;6XW3A@A]>F9_8\?!(YR]TUQ$(^FF
M*U(#Z&[>AW*R;A)?:<X/\5\FOIO(>5K\%;669+_2(C:6[8Z(//]SZ^KZZYKL
M9EI61BMF[NDC;B8Q]9V(H%A4#?YDU':"N)T^D% X$17D6=)44>BMGFI*HFEH
MHF1,6S]F:YUB8A[(C\C^29S*B>^T4W@/Z'^?#P)](5JWIH.\FL(:<#]?UR<$
M,^"O&KM[TOO\))MQD#C:9R&&O-AGO#+;9F8U4P-8FMV"'J/ F\2KMQS:WB;.
MI*K-V]L5NJ%+0#S .)SEZ38YYQC!M,[DIF$XT_M/N/T88O2SC0:$7LZ0]X+>
MHM:G3=..NM#Z816])<OBXCYKKM+EG)WA+U\)$?HH#L(WX3H@CFS^+A'Y^&W3
M;?LH^WS#AVY\X2\3[XUH$:I)%'$A]$53TFW"7(BXW?VG$-.:.9K'=4L@ C+I
M!PZ?8*H8/35%5$Q]Q8_A!!%8*6;R4.$#J*<T\RN]8?JT-.7KHPCA 7@R(C+N
M2<C3^Q>RXK*&E<)\L[X/?O B_"1_^;"D;W</5Z+P_?OYPO6>.W)AS9Z+'EV/
MJ+<LW/ 1\OWI4K_C)V2_D?MG:YQ;5K(>LM\^]7"0"&OKY%U3GM;&*PMYZ.=:
MB? M\$!P1&37M["@"R*Z7^#*;--C%,8^#J.A.]ZZL+F'=6X['Q>0>7,[6Q!L
M^-N=T+=_G[AI;%8I /;I9E,"N9\\SIX]^TR ^#*Y/XWP0D"($.H44V+RQ?1W
M:N2X_H3VB8JHF11-PF?W&3Y(,FP2HA->AD3IO+4)&,C3H\ECY#HN$#$!ZPS\
M:R@Y6V1'$*Y&(R)N".H(0PW(TX*7K" DN51<7!=HK:2L(Q=\*$'1")=#6QG3
MCL?DYG0U4RJ?S[:<6_E[M^8@QO2IL$L?>@Q1!"=V)]2GD'M<D.$XBJ-YD-T)
M+^1#BH70?9S$29GQ"*,D Q7-O@%ZH9B((J(2$CDSE3A4%F'AYE9<V-:=\(AM
MV,N[Z$ON[ A]B"R2%4Z\6%SW"& *NBAB*X^(#B0VR *CW%U>/4RI]+=;^#5#
M/A'4X<0F@A@3 J0=+=R( B0YK2 8!CU'5S(%Z>R>;)$$TX\TR#E%.:A@X2FE
MUL$@K66>412%!OR:+(?L;KY):?)MD!UKP!:)"0>&^K3J>>65Y/)10):$H1.?
M2V!/:!G9M ()GC,&2PO#WLC38O1*3/P!#J$Z:81\ JB.\+#NJ7 ?V7)$G! G
M#?E2&BQ.@ G/$R*+IF:QG;:]L!/S.-K2]D*$TR.'-A^!=6QH!3"W4F):_H2;
M:5>'&;ME',&@5H?Y!W,'7$2E$Y,<1^(\Y4!I64P,O51OHVQC(=3413A!>B+'
MY[*R$^*>XVYR*V%APFVTT18\?^[%*>$0JEAD/KAL2'S5 +25-W<J1QMM)G7Y
M*4^L>9HX+^Y3[BWPQ//L1'+N5.$1$V'=$9(Y-ZX][9, ;)(<,$8P!@A6L4ZP
MD^L'<&(Y?[Y(R#3I*^SZB6N<MA6>6T+"+'. IN!,=XR3,TW("'E*(3&[;H3C
M8>!0836#CTLK"HA+09: $SW8GWU[/SWE/"=;G';R-25=% JZMMNIDSXC?Z_'
M+.\% $,$!UU947][3Y:9"O;^_3D 969[)"2?5F$2'DKLTR ]NTHL(XJ?*,)Q
ME%&I,Q7-F28'L4FNF8RF):DAMH,G(JSA8EKZZ88+6 :C6A@@-Q5A:\H=V! U
MF7R9UL1.9[D)22D\R-JOH'9@K*,(W$*D!2'2*--F*>S/E^I%0FJES*3-/#N.
MR3]A=C],'@8B3_EK43D2(4?U:'9M82W+).!7S+";6YHZX1(2(YN;^!&T:DER
M*#!(NL@F=E9R@DJ=6#W;9 KU/P'[$:7G0Z($^8G&(JAZ^#J5:O<S:9KT7TV>
M1Y&>R$QB9GG>RML!DX,)5&P#3B9$K?O)TFD5]Q,A%^)QXL0X7)31*1.1S9%7
M6&;'_!\AL?$6K^P(EQ1Q4 +^%^13]U.CWJ<L+C>N@6=.U?S<;)MYV_[^\GQJ
MVR$G&%,M23;N))M/(3<3]\YT^O5B=YE$>!":3<JVIV8IQ5)(.29X)+9A(O+6
M0((8,*D!'-!'8/(!%0OK-)R;V9%SR'M/%:8/SQAAB CT:.,<VA!(3-VEF2T-
M*R5,1X_H%UZR:G O/CIYU-SNHK1Y$SS+P8\Q).G OVW/_8EG:)^_;.[NS:2T
M +4.U7\AJ&V/+&$*N]SPH2Q%8 )I2!0N8Z(!(%;E,"D2^LX,$M2\2>@NIN(
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MW6C__O[RX;X:Z[F(Y[%+H^B]GE1T@G,IUGVE<N8W'TT<=YTD+[;P74FNFTO
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MQI@\]AE[;]P8W97)=AGE($LTEFQ*//N7*6MT;[1J"5H+CJQBV!P]?-4I62=
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M)RNB5#0,S\7HGF1A,4T6JM3J=47)Y(;68:E"EM@F"QG.+D3+LCA=')8NRC;
M2Z8+A6H1JX[6&SRDNC$D.&.3C0-7<IWH,<E#RMX#FO.ST#6.;P:[\(7:ZL'X
MOX+=&'-CJUQ9RHED:[Y+)42B@:UE:OLDPK!!)"=$)WOHXYWI1"=*5A?EHIT^
MBF",TTH%M+(EOZ(26NE26M&-@IV1#D$KN\ZH7K\$EE/)%\M!WT\J/QGVJ2[M
M>@T/9?QS14]^";!N@Y Z.KE&NA?D.8/H<4DT]%5%7GCX)Q?-3*0WUTU1T.%)
M%[5NP:,,3E9UBZR\:<1U$YC5ZBF*+BIK KU<9C$JL[:8DS63E":U>I8BZKK$
MGLS:X7BVR_CI['<<16=+^;]@9T)2&Z#^HX#FD P]J@A&VG-XGA[>\B/;,@W.
M?*RURCU0_\?3FPZMKG<W W?%LT(L.Y-G+1WN .U0+%U06T(QF*A9-?1R/#IR
M*,3QNQM1NW*\=GB.WR/2=BQAMF7K)^MN'@?VSV'@D?VOV#VEG(8UO CRW?TV
MI 3RT#'&PK)?I_%"R2K']ZZR"IB3?_/(_S#V;V&B[]*0IF0PF!+!*?\X*/_0
MD=K"/&! U%41#7,UC9)+?D[_#/5^*)/J31H8EKNLY3D5'&J0W\O=<_[ UG;+
M&P8M:'Q& I^1<$0S$M0"?%#]C 2MU=M_1H*>M&WG4Q*:-R5AZ>;B$I=/3]@T
M/>'R]XE+]@#C!NZP@_&(8O,Z\-OG<^>55ROGE0P-5B@T3Z%9PPC6C5,0!?QJ
MDUU"+7 R,5(@B$55RJY*QBGT#CTWP>R8!I6P1><F*$K'T(V-7^\Z-4#OR*9>
M^E.-CF94,>% TI0*UEK%4\U*X%K-4[N58,OHJ(I9Q5,/-.6BB<W;S^DA5S)(
M 0ZZCJHS?9\L%.Q#Y-$-WB+7:5\EFSU'8U &Q[5=VYZ,)AXUY6"/M%HDV>U\
M;(9^<I7V,X/*D<T]S)H(A?,$!G"^2W<*3?JO"K>Y;-(^Z38OW&>7V,U.D;:#
M[&_R(8A3YKV?.X9/0SOT\\03.*I-7R^E7:ZZ,<>PRQEJCQ"%2T[I=FR>S,R4
M+\A#O@W9-L)?)CX6,E>73T[98<='>,HD*^\?,\WK@41P'*14 ::HB^::/OQU
M=R?GK'*ZK**RR"HZ5/6(NJ6+DLI>,W_.+J?++AJ3["(#NZ@*URR<5=AAE2T-
ML&IB%6@=)\JJ(<J&S-F%LPL[F:%Y^]W7Q#@J>"]Z5Q<M;95Q^"0QSC,UJ)@M
MZ:0U<0J,(2/JA5AD11O7<G;A[%(ANVSI#5\3NT"?04D3)9F[+YQ9V&&6+1WS
M:V(6F$<$_9-$3=ZGUV(3V:7H25R#V86-K9;)+@]X!!G"X5O"*^<H#*& (\GR
MW(5S"D^'U0W:^\)D@6VF^-VA3Q2[S:&NHFA"SV6#P4+C Y%./R0?NMD%=G#T
M#:!H?HGRF?=5J5+J*%OFEU E#62)G0LZ2>J6#I'Z._(F^!J_T&^B=;(".F'R
MMEB<"SC@..!.!'"%Y.Z6>00[RUV+RUW.!4WA@CP'G#LP05?B3- H)CCBD6#'
M=R5'5H.N/);(R/E<-$0(L8-'8Y#I/ 3"%5?Y(9#WTD;N\'@2VD,48:?O.W<X
M=L,UULDZHT1N]0J>SW'4<I[@@.. :RK@]@N(5".%%2Z%.4\TA"?R]KC>DR54
MSA)-8HEC<>GNH?U4^Q$(ELY#PGY$^\@=MTM72"=NJ<+M._^91#%MQ_80S-JL
M0(>5*S_MK4*A3(%\/@?C._S[Q(W<&-_C\-FU<2(A[K =//GT*1N%A=;J%:SZ
MX,*BXC/ZZLF@6)Y05X<\(5TO./::TPFWLSC@..":"K@RC_^9$^G=1*07; 7/
MZ80S&".N,^/\97#^:AI_\7/P!EUY+$$3Z*,)\Q*/.TC"520'' =<(P!7J$.'
MLM(K;<.)!EG=P(VA+7)A2\IL];J&:&I\5C=G"/89(N^I]QX,87&&.#Q>5[K<
MY<#K"NH,J=4SNA+'&W-3I7=G1T,F[&B*78FS8R/T4[F.8QR,Z_ :[[#MH2AR
M!V0IE ?0+/Y%QR\^(==?G.$(!>=N.I["33L&"/@5XF#XX^*\-4Y?G#$YX YL
M8&P)<-.I,VN& 8/*.D?1\*L7O'S#SA/^E7 ^?+@L(OHP%W.'J<&&TNIIHKRF
M%157;YR+.."8!=R>?BLKXD?EXJ=^9[<R8EC%M];JZ=Q#KM%#9H7Q=<KX7<[X
MC5"?1^%6_TJ]9A2Z$5FKX-!:"SI;>DR30@3"2E/7&69["]$+&D<"]YXY_W'
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M8[4#&J<%!O7G4?C5OU*W&85N1-8J.+1:@X[$'M/$$8&PTM1WAI'D0O2"QI'
MW6?.?QQP=:9HENT]?\%$6>'25)D%06*Q:Q5LK\[I@C,4!USM@*O5D2Y7$ID2
MET3UT$79/O4VNEA%O=SJJ1(O"#PLWLOVKDL6!PH5!Y9E<;)HC'X]"D_[G%Q!
MN^9#5S%A$ 8CVF8LG2'N+\T0SYQNGDC-68\#C@.. XX#C@.. XX#C@..0<"5
MZ" N3:*B3=B3*F;B*(881?@FO,#)3X6]/VC<+BIR#67,%15X.NYS#;[,A?OL
M.MAW(B$.%D9)I?/V!.0[@N-&<PX/N7"3CR-D=WWXXWMT1(B UKR_2T]7UU^7
M"2KI[$Q;U$W7G3T+(@Y053^E%6E&*UJK)W6LU? 1'(T*$=P].Y:G:#A.UN8R
MD0.. XX#[I@!5RA]S)#>-V"F2F9.\8">*6RLZ*V>JFNB;JY.FN$)877E!9>&
MW2[';@W8W7(H61IVC59/$]4N+WUE)JVW--2:P+BF:&F<<1MAK1Q+:Z6YIG#@
M3<]F% G/T-,-!CCS T5N G/ <<!QP'' <<!QP'' << U$W!E>GY+)XI]VPXQ
M//,AN)O:T)M&BIA0R+*:*UJEH[?%7WD,0@>'[3@8GTD=A4!3B +/=80,-R7Z
M,XH-?];Z,S^PXTY&N9%LK$7R%^0AW\8"BH5[/([QZ!&'@BJ)@B(IZ@8(%]G^
M6IHO P@K)%\0'.MI_H]E;'DO]C[<7HNPM[+2E7/-]+'T##E-&J!MH A,;H.0
M9HO'R4DT>,8/P77@SWG&5ZEC7#0.9$FMGBJ:4L%$\H+LNZLVX-QRLMRR)<1=
M$[?(T-M MPRQNT:=<H[A'%,CQVRII:Z)8Y163S9$R>#LPMF%)791M^0_U,0N
M-+53ZEJBJA0<[<<YAG-,M0$*]?^Q]ZW-B2-9HG]%P9V)K8J0*23THFJ"",IV
M=3'797MMNG?G?ID0*#&: HF6A%WN7W_/R=0+)(&$>0B<O;$UMD&IS/,^)\^C
M;%OF(_&.@JZ,9BBBI)1O/L79AK/-?A6-7$M%HS:Z8):UVJ+>JEA'P#F&<\Q^
M.:9=2X[1P#1K2:)A9"<&<'[A_')$?JDEN^BH8*26*JJ<83C#G!+#K-RT7IJ>
M]PK@Z,W<A1-LPSN5I]-T,#M7E#IJ_1@GO->-7AGA %[6V)2;VL*7YMWU\Z\>
MY:LE4XHK+%\V.6/H!H$[V^UUO;;ILEYF_8LP;9XV_J5ZL3"/^!0/U[.B&=OT
M@%@2?-%GAPW';9_7<4>CQ6PQ-0-BT3/2IFSLM.G.;/0O_7"$$O9BRX2"3AH*
MEPP&T4%Q=#$[[#F?,BZ#.:M##MP@9-VTS4ZS[_0O]._,(CFK0]^NE'CT-Y9X
MG.(I$]2>(0H?DH*=<MBLDASXYMS ?<!EB]S *S(*4P,EFAHHE3'BWY\[^OZ\
M47U#XN^1XC<=O(E66V]Q00\:NN&L\@Y8I8YW:7 LC-9T=%GLY$S XNS"V>58
M&1MZ)M)9IXP-I473:3N&M%VV!N<7SB^[52]*+=6+3-L]:IHHJ6^Y2>/LPMEE
MQ^HETV6J7NJEC7992U%%Q<@VP.0JAO/,$52,5DL5HS2ZLB@9JBA)%2=,<7;A
M[+)'=CE"T>S8_D6LB[^(Y^9QBAJW0^!\POFD-GQ2QW)9I:5QM<+9Y0399=\9
M@.M5C%Y?%7,N72AQ'@>]F'7'2Y,?1,$A ?[1CKXP<L^^VV0ESBE394ZGG5A7
M"P^9A X]H8V);LD+_<3/(WJCT:T8W.(=I]Z(2Z-,"?1F7%:T"; 5E2P:2L6;
M,HYMWIB- XX#[E0!5TDPE\D(VK5@EEI,,*L5,WXXMCF;',D6/0:72)Q+3HY+
MSL5K_4&\)^(A%_@V>/HFY9# @R7'Q/.(Q=W436[JQ/O,@'B9AN$@ 6%E>2!C
MB%,V*K8WX^)@3[[K[A'<;G154=454=*S784XDNLJ\SG@.. XX([NLNY>'BM,
M'FNBHF63NCB2]XKD@O*+W2-9;70EJ27JK>QT.H[B(_C4N\>PAFRL&;HH:=R5
M/ATE=RZN]&J=<CQ84#!'?R[LLW>FN5'$ <<!QP'' <<!QP%7)V<JNK[*3R3L
M.R./F#[YYKFS1["I[\;WID><($KJW2Y15]+#$D-NB=?!VSH*"1B<!$Y-?IZ+
M,W:9RL!-380_\[1;KF4/4:-<*LGU@<P7WF@"0M7J.=8#"3  D$D:R9.:F,VJ
M9!.7]SE9]>SPR1F! XX#[B0 5TWTEDECW5KTRBTN>CDCG 0CE$E4W9X/),X'
M)\,'Y^*Q/4Y,CUP,D5JQ?G).')_>")^WQ[;+0LF>]9^%'\R($_@#-VG<CSW[
M^T[8K9]"F0+Y,@7C!_+GPO;M@#P2[]D>$28>'LC(?7+H*H620FYT>0KC@:.\
M&]S/_9-!M3"@C -H-5'7>#'NZ6@5#C@.. ZXH^>ZUE:F*TRFZSR9DG/827#8
M!H>Y=@RF<@8[.08[%U?\(;XOQ;Y%3D%>ZWD[YEPH'\65+>CV_,-V7"^5BG)%
MDH25A%KSND#)6J/;X9XG9P@.. ZX=P*XMWF>NQ?!.A?!1[@JWY ,_ 9\&H#/
M;*\]?CMX*-=U]QR*D_DX@YZ,QCH71Q,G2]OK)TMSNN ,Q0'' 5='Q6QD9B$N
M*V38T]@.;ER_<D_ =JO1U351T[A6YKQP&KRPX0;S#;P@<5ZH93EI&J59K,F-
M;EOBMU>UNN5\ Q.V*1-V=-X@ZW04TF[=Q,"='^<R<C0U?=\>PU8H_9O)53T2
ML3 %<B8^^I'3A44L^(%.7&%^I? ANJX4R"^\LR<?_S'T/G6YO\DYDP/N2'9%
M9B9V04#S+IA@>[C9W",38%W8=I\R-2JP2].??)NZ+]^)]41^,VT'_[@J*WIC
MX/V!^:NRMJ/#2S6-I[9SEN* .S7 [>7Z\WBR2.6RJ![>[_XI(XM\C<^P.[H/
M73N)H%.)P%.#3TC)GH4KCH3L"Z9G^Y@';-%*<@&X0)C3G'<!&"OVMCTS((+_
M8LY][F]S]N. JY6__49%]I6 PB([4V?8)A#'M_+['<Y0''"G!KA=7A(?6Q)U
MN"2JB:^]9[K(H%YI-;H\Q')L3[M6TD"1J#3HM/@PF=-1KWO*C+;LYR/XVU?V
MLVT1Q_*%P,6>6'%'XXD[M1!%IF,)ENT'GCU<T-Q^_&)1O:X0/?7A;^N8])YX
MM-!]+;/V;[^M<BOKN$P;S\7[CM9";L52^IC+6@F7R8UNJ]G)II5@4$'P\>FD
ML(2B@3,(ERP<<!QP''"G!KAJ]8OJ>NLP5C(IQ8-ZIK*91]O3:6*KE1VXS4L:
MC]7(>6?853AVCX#=#?Y\,7:S"%0;73 2.?+JTEIZ9YRI,<Y4U&RTC2.WAN;(
M!M=ZZ'K@75X$[OQSJRG#U@7?G=J6$ %BAT7)\@C_+]?K_D$L>S$K#5$]%Z)?
MS:GIC(A@!L(CF0=D-@17M-T2!;DERP40KG+\7 +;!1 R]%41'/D$]K=='/E-
MO'2XLU81E,J&?MR/J5!--$D-:Q2P_[[KT=!DP$(WYG!*!F[^;+;*<E5O=-NB
MT:HX=:TB^VXK>CFWO%=N4<M,S3H\MV O&U$U-%%5.<=PCJD5QY09=G1XCNDT
MNJJHRA4O2SFW<&[9+[=LB#D<AUM ZW4EL:W(HB%E(U"<8SC'[/:LE2(]:J9_
M34&IPY%X1T)/1I8D4>F4#P!RMN%LLU]%LR&=^DC,(C>ZNJC+.C!,Q1X=G&,X
MQ^R78S9<Y1Z)8_#B%Y2+P?F%\TN]^$6K);\HJ&&,=D=LR3Q4QCGFE#AF0&9S
MUS.]5\8NEZ;GO0(\>C-WX03;,,]* [6Q_8M8%W\1S\UC'#6^I*T?V]!;W4_T
MK%&"+?P3[6!F>D^V0W?0F0<A1727*WH+GAFZ0>#./FN Z]Q52ER77Q(G6'BO
M0$<K)-391$ *$M!@0@1SA+.$30>Q+3AN0'Q1"-PG@J4%PHL=3&C]\BU^@+G3
M^,NEZU PFP&QA&^V8SHCVYP*CP'\@74=2[<:8T_05U <ZU]\H><X"WCB@0#-
M!5@5_0U(19!:%_^7-BS#1UZ)Z0G$P46NR(C>,#-2:$OLFED43 ^VSRJJGSQ8
M;F[B8F-\W"?".-Z8'V^L68B3$"ZZ#(";NSZ=2_;9(U,S ,[]\F);P23BNM13
M(0I;R2/F$$"S"(H?626^<B2STZ<.E:(OX]G5"FQ0X93I?W%-E"3VV)#UL3E2
M.Y*E*Z;:,H;CL=621J:D6:8R:OT;BYC"AR9>DOKQ1"Z&'C%_7IA8"?/9G+Z8
MKW[CT_)N8:OAP;0V['45OVL1<@2X_\,\X.L8YD"_@ JA;  2G#2$B8?*Y_]L
MQHL$GL8 )2RR[R4J+F#6?WPR*\C0C;2R!1K>F'Q$9>QW8DZ#R0AD5;2IP\AV
MH>+K=GCD!SSRJS#P%GX@8$6:AZ8%*(LW\\5:L\G8G+Q$.0/HR\(^E]:R(DNI
M+R1"TY\(6#_GUV/3WT*U> N?"#_@ZQ-?N*;:,4[ "M4CR\)JT](GU)/"/J61
M1JVN\ ^XWF>< VJ/2@@H9EKZS$1P%["\]798[V>KOSLFF+_Y!$P-PQ5[%/8Y
M-><^^1S]\,6R_?G4?/UL.W1U^M"791F&FUOM8H-2E7T<ZAM#;4J:@>(]S#,,
M7QQJHR:5_"M&,OM,5YNJ5OQQJRD5?K9N6:D%RW;VLJQ>_&AZV=T6-#)H'R>K
M\N[^^J$WZ-_^)O0N!_T_^H/^]6-A6Z#L"5MXOKPDWDP*:F2V-HL]IJ7%JB2V
MEEPRO9*6K&2.?CYY(!>LBV5>+_F*'"2/"#JD5= \IO]51[/:U,O)\MO^[;7P
MX^YV\/U1N+Z]NKZB-LM2(NT2VDM2> G\KX%3KB>\#V[02L$(55@%VC^) \G;
M8'4'T;>]6?[QB*H/V&+\8\&DJFI28F<QQ[Q3[Z6\H%3(<9\1QX.=M%+N1-F^
ML=N/7% U8"NE)2JM; ?04LD/!XVS<Y(_19*OQ6P15=]NML@!B/U<M%@O-3,C
M< 6/ &I'-GAVJ4D9V#H$?AMA:&#NN5CE9PG#5\&=$PQ[.4\"(N79#FSB?]ZM
MX;Z-67XRL+\B<X"W'0XO<2S!G.$]TU_T#^?=%_5-"G6E[#0%1?AY2NA-G6/U
M4L"L+'B,1E=56WRT6-UTR5Z0W0%S2M-%PZB8A\WU2"J&0^]-N0#;0H!1T*4)
M^&Y\1<;$\XAU.3&])U+9;M):C6Z[+1HR;P1?*^FU!TQC*T))-/0CM"(\%]%%
M&]%=#$V\&<.<$.+X7(!5$6 4@%\1?I<I\%4F99F2LJ*WN-"JD]#:$79I,RU1
M/\9LDG,15&G-@7?U?N"9^/$%?A5<=R= _YW8S_1J]L.4^+[K90*"YT7H;PO-
M,DJ?>)\?0U#>P L> ) /,1PK$SI.".R(;3DKQGCSH@-WIMHM8E7:]1D\Q8,B
M]AT)+_P@#BE.B8G#>ZD4(^3,I=ANA=@TI/4;VQS:4SMXK4SJ6J.KB%J+6V*U
ML,1VBEHZ(JXE5:S3X9(LP2@.%4!9Y0-H:<ZD1\RI0&BV/=Z/S'&CQ#]OB;4C
MNXL.CKNA<]I=YQ$!ZH[[SC-A5U*84'M-X1I7XES9/JYM.PMBW3%EL84S@N%]
MO%?,MJKA-MKA;;0C$0'.].GHHF24SZ+@8C"%?$3;1P$SH% :PC9AVPO;G\RH
M+3<&; \#+@3+!M%23'#G7"\!$Z/$PR"'A'6<3<0[(-=N ' )7%:35;J$5IN:
M$U/@5EM)//=G<]/V(MF4;[+1)(R11RP[8'+-(_"ZYW.WY79CRB4 OALG.ON2
MZ6DLJ7:L7+U=^<Y+QXL"I2VJ$O=/CVW#K0C MY%!%M-M$'O9FTUNG6U&*VMG
MP*38V'-G@-91NNKO/ZX-DO"9UEJ"X.,"KFKZ=C)Q\!N EX'[!PDFKI6X+M5%
M&PXE$66U8KXK%VP',NQ*(CV+5[71U74><WO#P,/T+,/- HW+LY)N9SX-QZ-<
M[KPER%>69_0BH:T=@?+?-=(WI'1417H6KWJC:^2,YCRV/(O*S6D;CK6%!6_[
MYKF(U5N<"(ME'?$H6"I:PQ9"6-@!#C%MCI3*+-F;;%U7I'H(-I-W>+$1M0-C
M%L.W"*!)^@%V#]MB.)9NH(78VGL20HR+\Q2F.[JYV!N6\6Y"[+0..P#M7*3:
MY<1TG@CML)(J4?-]$K (WS2\/*]EN1K%G%YG\(:E'A2>8MCR#B%,*>S"'5\L
M?'+!/CYO,WR7US\@03S,>+HB['_[#@7S742_/0K/JG+$P$(01=3:_)+HZ.IB
MSYC&0I".*+</FW9Z;K*M-QJQ[EQS\Y5F4=.RW-'(6Y EO<$%VS8!TQ6ZCX!]
MSV"-99P,TC<)H"OS@0P23P8#F:=?UR7:<"#$MP'QJJAKM2_BK;\49!;>NQ%W
M!S3CWD+@>#>DBVWE"*6>9X?RG=YZ'P+Y:J.K&KD3?(YHWIW19._;L@UN2HC"
M-X^9.)/9"QMD)8 <NPW?AP#_^OJ[3RS@F=@1BF%>F5LTL 5T651;]9Q%RFEF
M6UMRCS2C8WF?)FIJ#:=QAG(X>F4(W3:-,>XG:%G+=ES[5@+]VS^N'_?:B'B/
M;89K'Y;OC?Y<V&Q<R&K95%6E>@CY6$];=(-.!8^:YB -7 IMCR0IF)4%HM'H
M*H8HM;+)&\=M,LJ)8]M&G#LDC@Y:6)K8R9GV?D3J.)<;S"OR3*;N/*=:X;PC
M,?L1A2$T$VK?[HJE@Y=IDMB6#ELO^+Z17%JD[0K)$HVRJ3E]BNISCU9?P=6#
M?2*P0%Y-7>?I8@KT8PD\&>"-5AR-(\).K07ZM]N2-M9-J9IHZ(=-*WK?J*YJ
MD^T&U>U&MZ.+>H?W*MH&P=\6#LUH M,+NQ8]F4]A;>C!4F%/C\ZKBC0Z677[
M;EP=O U31/7 %/Z^<5Q5EKT5QRH8W**B\"S8K0K>DXHTS(1]Q^52>Y5C20KX
M/Q&D?S"(5B9UO+$2C0K1%"[-#BW-=H1I'4RSCJ@:Y<.J7*KE2344:DFA$K?)
M=B#+6 $+231V7NU?Q\ P&$^OK,N5.&QI1(A%*](OW>F4C-AD@7+(Q$*CG&*R
MFJ5,UE<>86.3E<)TCUB$S&CVN(/UE?@-P M*J:C,\LP-KMV44"X3=@K,^(>'
M&,A88I> .%+2.<2NMEJ-KLZ;!M5#?.T P6G#:VS_(M;%7\1S\Q O-0#)ABS)
M7[BDVQ;G$;:8D-O0_);5S;S;RX!=&FDI)L'>J'?C>P;EU^]D:GUS/?QC12=$
M;6&5C(;C.(Y0+?&NL5W!F-L=MMN-KJ&W1",GE8>+OZW$W^I% /PX#[TI+MFV
ME&P]QTK[+VN#Q^O5O7)$=?^N,5Y1NFW">!:S6 9SC+$4YR+%,'D>+;#%#"PQ
MVQ%^$.^)>$M=' BV?AKA'0&MAP&N$_PYSER="E;8(4H(91T7=9N]6(1X&%ZS
M^@Z#=Q59IG%95BM95@JE)6PR+#<1):4C:L819DR?1A^U<Z\OM.EE!J\OW(]]
M65 KUH^ OG6MF-K")FR2+"I:Q1:(O+[PV#2S77WA+FB&MG139%4TVC6L2N45
MA@=1 ]_ZM[W;2UYAN!_O!I5L$H@1J"CPR6CAD7BLQ]@<T;EYO.)PU_V=TL[]
M0XR$NS%.7H7_N:3PKRHUI1:F>7;$5H[3SZL0ZTDP9=NE[(=@L'Y'542E7@1S
M+O&CKZ[GN2^P52I= ^+-A*D+"_)(T!9![[[O+S!%YV[,;(L!@)/&0"O$AR29
MQX=J%1]Z Z)+2+=VHZMIFLACX&] <JQKED08EV E)5A:5;]!;O$[NMK89UOB
MMX2XPK%'DI$KKHZ8[%Z3Z/;I"4R:\,52'S"_:^@Z5MPI^;SEYR[3[M,,ML4P
M6%72,/HL=@X\M_I]X[2"T-P*IW@=:(B&P07E20M*B\SFE);>JZ#<Y6@ZTYN^
MQHQU-WXDCNUZ6>Y:;V<:W,ZLI\@LB]X2PK.#T]$EX[#%L^<BM.*Q?R"@;.N\
MI=,^JB=!X4<0O'1G,]=Y#-S1SZHT+&-S,541)=Z<ISXB:L<HQJL)317U-A]I
MO@UF'[-9J#9-8O7(E(Z0%P)7""8D3&H];TFVHQ++6/DRV$9DSB#X@' E5@5K
M2^:W$3439=LAN80P:]/\5;DM:LIAXQ#G(LXP666^5%1DA]=$Z#R.J)Z!#8&B
MX9+L39>K2RH[2\C82(P7A9_"Y>E;;"\57$19--3ZY=J?C,"Z3(DDVN2"A;K.
M//=C'R[C-Q?4[GSAC2:F_T:ZQKN W(QB[C0>V6E<A^0L'O5&U^C4.8!%7R&W
M*4!7113]W7; J P^7\@R_4YMQ-:5[:<Z]("+6-241YBX4PM(B\NSZ@W$?MB.
MZ]G!Z^/$]$@(Q\JRS* ]$-N';8SWOA%<N@=B/H*S..PTNHI2J][Y-;G$K,DV
M3L;:Q(N@Q".F[82P;)W=KH[<L^^AMJ>K"H!JY%!=NOEMTMJM1A<8F4OANDGA
M7/15T[%MO(.015VMU1S9DQ%*$2:$F6D13!]F#6B),,5YOUPBE99(87/2&P3;
MO6<[(WMN3B/HYM$MSBXYK%EQ=OC;H43:@+[2]T7M=GT;,YYC\XF%S]K^)'VS
M>>.)?=;$%K03^!:!?_MV FT%C31)E+4MZQQY]XEC$$[9VM@]$HZ*$6.U98@M
MHWP>"F]!<286[(<K,O)0;7_$GF_T)U0(5#N@DTU_('\N[&>@F[/O9KD7H8^,
MB_]_G4#Q(6ZJ1WN'.=;R'U+?O(>3N,#I##41LOI1>[[K7Z.)Z3R1!S,@U^,Q
M&55.EFWCI!E-E#N']0#/CG1V:$W7G&!T#.F*2BN;YG-L$_UDI.YED7@5S$ 8
MDB?;<6PV;W!.T7G>4K<*ZRA[9)W*G& TNEI+[&A'2")YUT2@&W6B FSDUA8E
M/6L]'UL>GE'(8JW$Q.3O0EFY*Y=S%Q#9C\?YMUT<^42\ZRIBHETC*:&T&EU9
M$36MHM5TH!@-9Y+WRB2J5B<ND1I=51=5HX9]=*FN_11@R3;\KV4_=_\!_ZQ$
MIW09$#1W?3KGZ#,K1'HF7UYL*YA$R$D]-72#P)U];B6/F$/8^2(H?F1UTR&M
M=?\Q]#YU8_"L;F^G3QW*59+Q[%KA[F:F!X[210A#+<?077/*]+\3+[')GLC%
M$#SFGQ?F."#>9W/Z8K[ZC4_++X:WAGO4VO#:552MA>T10/@/\X"O8T@ %G<]
M6H3'DI&$B8?BYO_88T/6Q^9([4B6KIAJRQB.QU9+&IF29IG*J/5O;&DVH"-T
MP*+#*7 LZF@64VF&#C:BG?Y#.7E%@ !\IN;<)Y^C'[Y$*56V0P]*'_JR_,:<
M[%8* _9Q2!V&VI0T Y$1FNOABT/::5(\K4@U]IFN-E6M^.-64RK\;-VR4@N6
M[>QE6;WXT?2R^?%][>#Q_1#WD2Q>T_%SCS< [.W'\:T>%_/YE.!=O3D5J*/U
M;>J^"'V'*6]@XL+XDY9 T1S]?/+<A6-=+$N9[9M)CPAF8E>!U)C^5QU2:E/?
M""HJ2F_[M]?"C[O;P?='X?KVZOJ*RIA',@_(;$@\H=T2EV"UFT;;%>B];,QG
M'_2FE0*AW)+;%5J<G\2!Y"I(/YDH=31:-;<12#4*WIG#>+!X9"E_<9_N8BTC
MKQO2^"**N0>"N265KY84S.HS5%%I95/[ROM_!PV2<)(_=Y+?<%G[5I+'6:QM
ML6W4C^+/18W]<+W@"1Q[VH O/:,U,'\2AV:[N([#ADX*+W8PH<.L5V99E[C$
M.0]F/W-NWJ# (EJY<4TG[(0R<*.1RSBBU)<J<[C2Z"IJ[L220]P2<T*MSU%V
MJ'8J$^K:O'M%K6_>_<GHF;[S[-HC;/$Z&GD+8M%1N8!4/_ 6%)2B$!#'= +!
MGN'41\)*A_!2&_9 X+OFW [@%'_A>*J\BD;.R_4YR@Z5SB7#^_6O.7$L.UB
M.=EW1@O/(];717#K!O\BU+RLK'DPM5,6U0[7/)Q:=YB=NB=JU;&"1324DQ]E
M T[9\?V<L+MX>KC[JIMCXLQJ=N^\XNV(@D,RT]S?PL_KHK,GQL^U.,H.M<_
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MEHE#!T-Z"E4VE0J)@G13&JPF=+%OLDAZ%&Y+%!T@"B-'?0H1/?A_'I8B8GJ
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MMGWGC,$9HQ:,<8QF\@HV>1-UF;,+9Y<:&UM["!FI8$>IBMCI&#6SHVA(XE.
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MN3N@#:>O(DM% Y(-)AYA62 T4V0&9YKX:.(#&3^2>4"0RMA*T7V=6!TXVO&
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M'=/ (S#4;4K'VNVF++5W7^.E-MMRZ1JO<UY6*;5LR539PGZ/6I()9HY^/GG
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M).Z9D/K^(*2[><H53AN_(\3+XV*8O"/YFS##'\/VG&&[*E>( 22R#^+?(UY
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M;G1UHYGMRY.FER=\U1+5>+ K@=!M"0YM ITF'Q21";W@"HR@7LP=PFSU_(6
MJAA>2<&F#;!1FMF>"1%L1-I/$D\+B -2?!7F'IG:,T"A!X0GD%]S,@+6"EQD
MBBG\+/B+(>S10=,9O@#_('1PA740A67=$2$69EI'W[^<NCY>HUS! X4<^2G
MQ^._+PO]8N;2JC#7)=CYH&. L59XJE.*H5#WCA:S!9L^*,Q H2X\@LY#I'3-
MV)V@,$'+!X'NN8NGB?#/A4.$=DL4Y);<%DP/" ^@/Z6(F7N 6(H(C_B+*2KW
ML>?.A,7<,O$7I$[*:[CNE/X),)5")PT2ZU_\)>1$.47.<@=1VED4A%Q '24P
M"6)/27"' 2AL6'WXND0L*R\%),]1#)(D80F6H1_](-X33HQDU :,!0="TD*(
M!<0!>O(9+<8'A0<!>[8S\JB% J]X"FU4)*!J3-B6JPBNDNYB9#(GSF+B0%9F
M5(6ZB\VB$40ANZZP22W(_RM@QQ)<AF9&NO.%-YH@TH!^1P1EA#L*"6F<$JOB
MBH6Y6YNEFD>30H5*/9IF4<U>I%7@@,*0$"<Z'F.#B$:;0O1^H&B0J3YE?@01
M^34"<HN$X JH7# C<I0/_@6'K"9&NF/EV.PQTV58FZ4.-*F?X,69!PE'H;4?
M!)X]7%!YBR=AHA^^Y+\ZP+R1A!@2AXQM?)EG4_%-!5+"XB*R+!@7^!%JB9$]
MI[!Y@N>\4*R9%B@8VP\\)C%'K@]JQ7R&1]@[YJ ]J((18*N..PO[*E)4)1L
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MQ>G[<QHB)C[R,F<()RBM#X,7T2TC4HISO[%KY\_C0]-PQ+YZDJ_NB$.]."[
M^ ;GT/)-$82)>,[4'A$4S<]G$Z0:.+XY):.5OO5RQ*IR+7V3[$7)EJHGBQ)/
M'.+_[5"3WZR1O7@[D)!_RU J^==[D#TXWD*+V?YJ>[X:HH!YDWSJ$<5675]$
M>O=U!!CB+P/Q!=W=0YKA%D2_")Z.SAE*<FY(EH_+<,]P?W3<[PZOYL Z9LBG
MEYXRK#.L']>K.6%K94.4&RU)53E=+#@MBHD#$X=C._F5!N-%!23!X#DY95@
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M^FEK:X4W^S/Z0_01O=*UAL[K#%"ZO#6\B>V,B&6Z,VO4)%'SPR$JI6A\S@H
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MX8(UF6\.Z(O_!G0.I2>Z69# NIF\N:F,DW,C,!D+[N'!Y9B2.@>M]!/6[EM
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M5=QV]BQ>J7NH,?>P)*=@1[^U@YP"#>=&R :G"04[H-3)*;@:).SH7788$H0
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MH;/S/LB.@#IQ%DW0F8#56B$LDO0-O@-?7DQ]5/'X?-<:6O8<6..BEQ)Q:;Q
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M$Z-.<.";UCD"[=TDZ,(8MZEY!D/GHTN><49[W&D'TR*S"*9ZQP")P[YY*=D
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MH5/.$K.S)Z9'K("2(]L+LY(P)72CC.F'"<9IX1$/,(Y%3JN_A"F34=F/Z=_
M?V[> B;]@HG0(O^Y/?A&?Q(^_QH]SHD8-P\8ESC1HW?'>L&HOB1Z^!O63N'7
M%W-\:K'$J2P%,'%O T1%@ KQU/YAVE,4$/"HHLA.T>0ID=<:+4WAF\FT.[+,
MG-I5W'(.R]1W+1/0\F;2!$(S>B ]K;6CF%E0YN8L7#)<N"[-(A]\RX),@320
M4\E:X+(7.XU>3UD=V4$ADV=-I[2L(3H =X-LUC"7%?XP#E(#J)C$!9A6FL+%
M&2?G_L1U%J\36BEX"+&1M%I-DS7(O8VI!O$YM?7)7RX!(U'M9Y"%:H_6.3R*
M%@]00.K!P[9J$]AA4N=G:ZNR[<[3DM[1O; .^PG>+-5/,K!PVDBI4( ]40!;
MT(^]&>D-?2>[-&-%A2@)/$AP3Q(BRDI=F9*]Z"&JR@$4N0]?-XTB H\4D5(J
M^I<4 3Y_! E_,])U?JPGPE*9CZ5MX1(QQP:T0_SKL,E/RYNMD<_7,5T\C/8(
M4(U$$HW+KZ$<Q_VJA6=Y84:1<T,;#9 WRY\XHU#]SH/D;PR96M$2D;417*FJ
M7BMQ^P=6N&V)OQ+$!&;; \I0"&AI^=">F_1!G@7VU*8)U?.%B\9VZ;%MOF&3
ME)+"%G$N@OL7T[.'[=GHWL9LZ:P$-E%(I!_6A[F;"6P>UCR U0W3^P.V+C/8
M7G#!0=U$L.1L3B\SUK!.,:BU*):[AFDK>WI#-<E(@^U\DP^V]$53TF2MJ8M&
M^2EI0E.3Y3.ZK6)D7WK0;<6C)-"IJX"5.?S^"D[I;'2S+M"'#)</^A@5244;
MT_\5-W=*S-QMST;[_;FS+?\N,Q9<D%3"BD[AF@Z:65]#2NY*9"R2TE?P"&';
MNO<[CE4I/W:X2^GAT'M4RZX7^+?. FZ/![/6SR'8CICK.#)],T=>Y[JXK6-D
M&T!JEO1Y<5FLB215QKY$)[YS7NZ%9R"G'X?^F_Y"(X.6:[Y:ZUNA>'W'H=#/
M2;$<F?ZEW^E(+YPA)/L\YU)RFTJ 7]90G"VJZ+*36]:B8_QFJ""B>#L@>)<V
M/^B-@V/7(.&%Q@P*'[L*8GA,KVB<HK)9.,=/<CL1WR7@.WC[FJYS1GTR?)DR
M2!X>'!$4<J@,1)WC3Y'\>^W*0#L1WQ7L1"%PF@P*02VH# KM)5A*>.Q(HO@$
MULM1B-D3)$IWCS;R?HM+A]IH"9PAB9R8DO6=-2B"J<,2N'Z <W0PUS7*=5T"
MK9C,7CT^UYDB.-@U.A@2.H6$+'!ZBL?,%$&%7#_ ,3J8ZT:@_B7.2*GQV#$G
MZ'1>T045?^0/-Y&;()/@4,>*50&4X7C%R@'VVY>(/.Q'-9TS1(63I.18S9/7
M!+ :DNH<N,/10\=[ZYS.*YRH9,U+J"MZF&*JSA$\'%IBH)AT7>4$?K^ "5-,
MIT3/ 0[EX>C!(G+> ,6D<KI0\,REP*EDM>/IHQ=:'LC3<\Z#&\+EVN<6:"QW
MQ$?F\_FO_$2X+!?]C#>_Y^2!RP=XX"SR<>8.M'*  \TBH9?L_ZH'^+],+9RY
M^ZI5YKZRT^)8>CH60N&LCVAHVGA9M!Q6'5_](7*ICM0CC@C&(G!S&E:BTINT
M_:#1 RW!<X)^ &%?^?:R;'Q=AL;V3VMT\U_+=5+%1V^TZ,@[\3/3F_5RIXX&
M :-V$& J(H=3=2Q\2'SM\'$]$-CN6AT- L*>$& .U@$.5N^)  1]YE,=Z%--
MW'R"$K&@0SG0&_>>*/D+"8K(=&7-W*E2N9]C0RIA+0,GJ!JGJEFS)YE#52>'
MZICZ06;ZH6:^U-'U@X(9?#SH!SFE;Q;SIJKRIJRW^=3YL+ O#C84FR_<X<3T
M+#*?FC/F89W&P^J$/*&YL$\A1YZ (85TJLITZH7X7#GQD$?+:HV6HG.R6IO)
M"$R!5.""E:- 6 S\4IRR$A6(T6BI!J?JYU: >JVE%F&K1E9L<=I4K[!)Z.$C
M&&16;G'F^-DK6ZP\_&#!A21RO"1PDE[#$1Y,.1T]X:P\<+&2BS/'SUXY:^7A
M!XLN!)XS9(DS#%9TP8HNCA!RK=!=#UKYXMB@J>-YOQ)[!JZZM1V_>T9"R@@T
M5[+Q_5N.*$$!0:MG0X24B45KVX0;1"ZL W[:U*GP<F/;_PKXR*<NI9BZE&$S
MKG-J2A>PBAM=Y(W',%2>,+*4 DIU$Y3E81';DP$6!?4DP4*F0\\$K85TJ' $
M':H";F6>D_ED5@I3HE<#RR*HU*I3HCA64>4,C65 5)0!\4@]<&).I\[0Q!BZ
M[V0.EKKB](?#/-UU>?ACMAS$:HVB(5HH'NV("0/G*<Z"_I(#8>U;BJ#HX/E*
M25>#]7>KBLD[/,=*F(QGC2FUBZRO8SV<L;(14-!8*CQF#.HIV<1,"U2%@1VN
MS_$Q(% ,"&?4\S&:+P@OFPJJ.G_S4KQ A"3Y)8C&_DK,6.X,^H,XE11A[SI3
M.EK8QNEPEN=?L3]81>"S:_F!-TX5Q%K^4M>9Q1CP&-(_50&(N&-B(U'JY0V6
MPUJL&!)86^]Z2'7>4-P>K"]J\^5&2^14G0E]O9R_<H1>*2;T)W?GSL;G:8]P
M$C9F#J./@^?1N1T?.LU[:KV:T^G'6GJINVS;3H'#(F8ENTA1'O=JFQ1F=,_H
M=FES(GW/GUANJE3A(4<R5Y3MDT]SS+H?6W=4;L39K=6N<H.)?0$?JC2QQUDH
M8AT\Z#/F<(D>4N5ROV_+JI-[41=4G9-(]R/F?#Z%EPN=K*A8!TNQ)LYTA(#-
M:+=\E-SW,NA73>IR5GI!H26?29IVJ>[CQ%W?C(U=Y^T.[F#/%D"7WMQR37R&
MU_YAVE/$I>^$M80Q4.X7D%=YFI*H\/F]S2/E_9>5Z\_DI0YK+<$;/Z64"+ ?
MTSC5J&?]%;,[5R-'I>Y?3BE1(DB49'":D#\=@!D>)C"GV Z>4DRD1DN3.5W>
MS_"<OK;NU!D0)\BJJ-\+%UX:JXBLOB*R?LQG$G!!QX?4WA K#%$2,%)K;6?(
M#9E9/BMP/>\JF*V[@2@LO34:)68>:FQ&M]?3OF-- %2YT>*;!?QX5HYU<4#<
M!X?J!@[WA9^"\$NI!F1EK R@AVE*H6Q-J2)4U62Q(-.45P/$?7"HE:0I-81?
M2A5>O<^:Z[='8!NE"]HHA<VPV%;ILO7N,;=*(:12=;#.-DO7#L7J-TO; &BP
M[1*#:)VV2UO JO%LPW3M4*Q^P[0-@ +=,BFUW#)]HH5 \-^1_:,5O6%W\0:$
M'K;^"1]&[_-FNJ_V[.;%\7WG[5:E1U0Y67IGS?R%^P$\W&"?L8MY,C)O,-F8
M!$G+CHCO^":M6"K8[18C*#'./G8?-GE+&?IB>M;HSGF;6S./'LVW7=><O=(Q
M#%\^5E]Y,C_PHS9.%.W-Z1E^UYG]L#Q P_I\]\*=<36QT9(Y7A8Y(V4\5M3Z
MWYR-B!,\&)8.F"$^$ S?W)Q]_,,CT1P(0C,)2#0)@N H"/(+?K?1Z3\]-7ZE
M;9&BOZ[?(YZ_? #AM1V$;\]\>Y3,E_\YG"Y&UNB!IDR\S1<^Y4=OO"F#[3=G
M,<M96QHG,S8@5CE52_HS$8VQ%@XIXD]<("20PI]XQ )BCTC?FOL6LCF09HGG
MR%*BES(U##(]Z'NO254(=$T$29@[GHU?N'6MJ8DD^/QNC_Q)I,)B5X5"R*\N
M,5] .8 "RKQD4S6$TMOZYXO[J;7^PE5==:P=.6W BQ4P&:^7T&0)O;EEF?%_
M)^[*)+Y:-R^N97Z_,<>^Y=Z:TW?SPVM\6G\P/#5\256"QV[R:BMQ3T## 2U?
M )V+B4HX)WD723$92"IB&<I[UVYOT.F308\,?N^0NU[WOM/M=^[QIW[OZ^-]
M>P"_/#QVV]V[Q_97TA_ !]\ZW4&?HTJJF1\L.[&Q(>Z1FA$,[48,5"+\R1JU
M_>7'4J,FEE;D18F\6R[8VU#G$LQ3HZH/U.9P,0V6!) (1\P$-<6):->+-307
MH14)3?>[B:;*MV\B!4]&"UH;@]^A=Z&/&BYSXL"H14EQ&#=;N"X\;@0V ?X$
MJ/'QJ;8SRLLZ:5W.L2[:'G\4ANJ.?$)MB59ZQUL;3>5P>P61%/8H!-XA6= N
M9TM:C9<0#%<GU!/:J2I.@.[["#L6 ;=AMQE':>#BCA!Y,T<!IL?.=.J\X]VL
M8-$F7?1M 9L3>O!! $-:6B$;WF;FW]X(^A$I@_6#HKK<B1SCH>OK%\2FHN""
M8SP:VZ[GD[\6I@L&%55.DA^OX)&C$L(>!H''';JH 3M0N^!. 9W,$:@T\"BI
MA#GCL3W$/29UG;'@DKQ1WGOX&,^:V>#NO9DS,_#VZ=>BD:D>>;?]"3&#9Y.1
MZ<.;FK9+?IC3!366?RN2+8RQW'B^L!++%XX.XG9M0[YL;D,"07R<>;Z[P \]
M6E0ZF)BS<(/R6T"WQ]D35:$#=.@?8!%_XAKR^<]JS'^6&RVEF95<#%B9PF\<
M>9_8PPDNW[,IIX!4 #/S]=6U7I&*\'OA#86>9R=7'0F]B(+%]QS8.5WC.3FE
M&F@-SL'^@V(./T+A".R>1W 1^#NUFVM""UI]>&/_O)G ?M^:W=('JHT6W;V$
M0HZR\<^UW?XF<;7$))B]J4G_^3-X_8!@PAK%\'UOP;2_.R"UUBQ&)JW1HCJ#
M?%BFZVW&)PJX;4S?[M*WP ,'%%TNA1LJUDQY'=DN^'R.FY!83<B06*R/6$X6
M"B[V4@6'MC=(R@SR<6Y19I+HZ=[!"D83SU;!&(V6+'):2J?4Y<S(<:;A+-?&
MK5/Q+&V<3@\1LH:;+6T<>@H'8TXZ5\SI C@"6FIW7O)U\/@$3K9K _#NPPAN
MR2B3SA]E(BBW9M:8[A!E34(&,94,JW66>MG,D&A4V/ WZWWIQZ;Z8X6A*M<&
MJBEHE "-*6?42?>JN1&QW>86"<G^+MYPZG@+UPKC_-N6ZV6M=P!/^#(%?L7>
M7TY&B^!#? ,+5CO'8("[L.H2.VH3;_$&C_] (*'/@.3^@7OCM$,)2O@;>H""
MP9TP]#''T,=&L!U5:N[M.OTV_" 2FP:-@AB6/0ON1\.9+Q;LW/,ZCDI0LT8O
M7#^7 T).S;EGW48_?([RV^P9)0Z]Z'/B=IM'<M0)#?X<QH,-HZG+&H:$P\2X
M\,%AM+A)H\4;AX7!WV0,W@B9?^:;V7_;=EM!:&JJ=$:W587L/Q]TVWQOFS.I
M,;-@4%T5#)K#[Z^N P)TLRZX\>07874R/*;_V]8X"27-<C=!&. O756$]RP<
M2%1B@<2MHQ('OS]W.N1;KSOXO4\ZW?O./>EWG@:=;U\ZSP0$.[._9$$ZI58I
M;YRR%^M"54-B=A^[VVA)UHA9;O;MMG67=?:3WGTK/8]BWT+>O(WJMJUWWWYC
M:BXFHZ7+L=JS6I#(V+=7M?A9+%<LHG;6&DN<=5? ?LS)#0(K'+B?X _.Z/'F
M.(SD'MI N0#!+GR0.8;53[4AW4CZ*AX\47"JC2&)G"AF10#RM-RIK*51-BP9
M\F[P?.5LD:=2Y,D"IZ5T<*PU\IA"W 7+72F7-8:EAK#4#(6#G\\+E@QY-WA0
M=[;(PS-&3E%%CM\3>7EZIIVD9=K95-2&!RM7/%RDL, 9M3F,V=&]/BYJ^W:O
M9V,+2H",SM<2,CE4M,$W6IK Z4HR%80-.SDMIK(R?.J/*0''D$F<IK$I<R?
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MG,CM!E@'A>C90!/3)?['/)CW:JY26+WFR3  PLH$IR3!^>*X+C6R7FRN[!^
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MGPD3(0 ^ .&04W#]R 3ASCT.)),:3@^>Q^DL"F8+' *,-<2:<&*5,/$8L88
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M(H/<T92' DX+=3?CU?$#7AV/W6<]ZOF,8$%SP"YCQR5L)?QU^MV\[S-=/_U
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M<+,53:20/;L,O-*G(.CC O&R6OC-#07\"@IF-"!(_F5Q)U//*BE),,-=N%+
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M40:.<7L*6NE(:&F;?R*)ME\Z#EG*6BR5/*N(I_!DA%"!T9&#!@SK>GW2]5[
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MA+M)HCC?92,$6^WAM$,2DNFPTO)7?J73P[U)="6%B 30E ?8<PC_,2P@!L,
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M6LLTU'K+ILUL&0VU98&! HL]AF?!4[V)*M0N$ZJ7=GTI X>\F72$:## -/D
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M+9BQ[T$<U'8;;3P_FK54P[(/J&'+MLY=FLY3KOB_U-GE$?<I;ABZVC+KQ]
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MX:8TY +L8@' JKHHNPBZ5I.+L*U%N&53"3.Y5N@G#)4'3UB,9G5T,0$'1-2
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M(9;E,FZPCJN6Y>XU,IB.O%@VNWCT&QBC0GP;O'B7$J/M OX"_OR+WK*+N;C
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MWB.XW2)\CD5 =\W6+ XZUN)*6.WS $=]8#ZN ?:\CPA*,H'E[R6T2"P<*5X
M&R-KN3X#/H_5N%B="[\@,\R I,YVP*G+IM#;;/SPLGBIV$_X+BZNE3/BNQ)6
M!MLZ#)P>!CPGE1;/L"6(^O86#\$\+U$6^I,_1\KW;!D?<1F_TC)BHPB0F5:*
M_MI0%9^1),0J#.S146'U$,I1KMXV5R]?LTN^JSYMLJOT0JO4K#6(7U"^?'#8
MQ BL%N>)*5W'HYK2((FC&%@C1> OOL?E.,1S]TX5\VC*QAWB)2.DP.)3U5%Y
MFEXTRP0SZ.Y683<N7P79H7+[AX"\0V53=JB4'2KWV*%2BL^%XO,F".,G5$SH
M?("K-W8F6),3998.>1UCZF4R9^],B=09M5I;U5KQ2,#OP?AS0^J4 ^._QU8!
M'=XJX%O>*@ 5NS OO@91!)=A3["C[(!PE81HBE0*!ZATN;"#8?U[P9,/;^Q3
MTSI.G(CW/,!'_Z*;S=P'X1W-Z)6!$KD_BQT6J.W*"VAFC##U506$A>+Q?IQA
MCWGB=R<2/^MV\688A@=\YPY<'J88,H]S'+5UP*<,L,T=,G3,6^85;A8F7&_H
M^$\L2@TQC*GTD'&' 6^9Q&,=$9A@UW[VI'EJA'WJ]9 S,W6"X_S@(3^$@A^*
M[=VX(P^W,S!&0.3!6QX84VYQB^EIW 5D8!_#/'W\B\)P=/LGUP?CTH4Y/2 K
M\@7 ?4=CXNOKXL/'L'.)**,@1,,G=EP/OW]RPG[*!KE_,S<DWNENP42.=;=V
M_IV@:4]CI38RB=\K$NY? =C6RC-MH07;<P^;D(;YN&0[P2HBDV)-)' L%O(/
ML5<$"!Z<$1-SPLM6SDO%)A28,L5OPD<4PG5Q'+K=A#>.(#X4'4'[Q3Y^(KP(
MG)\QI7D8IEPYT[(^\FK# &]S^__S;KV!TK+?K7V7;E01YV([K,JJT*U2EMXU
MT%S(;5BVOR6.'\.^H5Z?N(WA"R_]?.5&/6 .:OGF=,%%56Z<\ ?H\GLW^E&9
MI+M76L7]XF+D#'PF+D5'?-PAC#N5XL!9(]PR)-R1GZ;<:>K^XU(#T6Y,A!D5
MK1N0PC>.#Y](XR<1R<.GQ'.06WTW#DA[PM/%BX$W^Z*)&_?N'6\2P1!CUAOZ
M[K\3U'(X2GRDX'\8JJ9LK(9#QC6FCT^%>>%^FU%C_YY=^G\7EKX_M_0%$J+X
M <'ABUY:A8U(Q8OVQTAI^SZ>0]SS70RT_(3DUFL7_YL=,] Q 9_)%>B2PD1T
MFHBQ8->6VW[@9KV;$]=K'-ECVYP6;$XZT0D\SC-@1_98_W7ZJ$R24G-]DA(-
M-1<.R\99-B!U(!&1\>HHV\EJ'F0'VS)V>^XXQQQ8<.?ET&4#I4,1>MPU=X.!
MV\-C%#3TZ;=<VXG?5&4(EBK#2E!NXJ%!.1CPYEX^BZ)E[\IW)$J3G-[CG-[O
MT09.>D-^?."B\!H !6B3WB=HJ.FF<Z'7W[-?Z5:]WA>?$MB&?%<^8!B4TJ=A
M7EQB*.T>>35ZR[14.L<3!Q#O\0;R/VL?BQ?35_K'7W^EJ\5\&.]C3+3E9X.]
MX)EAQ+4[*:I\3?F#0J74?<W-2#5K4;]F#6 )J+,U-0RD-7#B!4,E4O*Q+GYU
MB24A(9RM+RX$]P1 JJO\.O!-\&_PC-'R^D\: .;$H)^P)YP2NR/TA;L.J WL
M$8WJB_-FR,":%8>PW4QRIW0M:$0NJ?F#00N <>4B3Z OE'1'W%Q,V:"XG#MN
MAUA6X%SFZHL"M>BK"<FC("<5UOD^)=YF@<%_)5'L#B;[%$K )<248%S (C+L
M CB95=BS[.>F5.@5J3#(J)"Q4'G!,)@2#(-?EW#$K^ 99X;) !@.W@;60QCC
MM8'R,G3Q704SGCNTPI6GB:96";H:M#U8GY(1T O!.! X-EWXS7-_(-O'P?P-
MB_=D::)4\ F6\\;KW 2]9L[;*7O>5=_:]X_*];5RH=P]?NG<*]>WG^[N;]J/
MUW>WFT^K<0KNCZXI7\&9]+C%PE DEXW$'<ZI447;6] &Y&?#?U$;/ ?>,]_.
M6/KTQ!4#J).(.S:T4TCK."&(E2 )>9RUF\ %H(%X.\J"ZX1BR'D1007\CII_
MHTN#P@#V9\Q0?!1>QG6HBVU2(SX8YPF[J,;%70KV59!X?2X!G-PS<?J8Q)4J
MRK3QZNS6GG+P\QV='HRI(KN(U#B&\!SN<,&0*7 QP"Z:RW>]/)[;U?%<:_?'
M<U6$4RL33O)03Q[J'8TV:H/#CW$US#R)@_ 855'A=",-\@;4D+SHCHC&Z^!&
MNW[1!E1Y3LLSBV+T.(:D"'J@8@8)VG0HW-W4UAQP$I ODT01UVS?P+Y4KM74
MX432*4BU(M&$Y[G,8MY*6$H5]FV/9C!GEBY\<:IHU8+>RF*"J*$&"0:J4PW&
M]3&%VL@O[;.H%[K=W8;;5+*]4?/3POHP(Q[LPP3#Z7B[IK3S\S)^$4\U!><Z
M!JU/X0-\4B\)0^ Y>-0//WCQ\R G/RD-N4-0^"J_H<_8",SY46XD>!'>/2F0
M7$TMAU=07TUM!9AB9D"L-AFV8OOKQBD8R09(I>]^R)[<**9@S8-#,8.!(L[0
M"O$B9('OW+ 4)O5!CLZ,[9Q?8R20#HOI<!.3]#RXE4[:(JZB^'6]8#1"L1<'
MO1]T> VL% TF"AN-O6#"P$QW?O*'B=/BH.L)HSE2QLZ$5%XR%C8OBD=Q=( G
M;O@Q>ZNZ63?X/6:B(#7G_UUIJ/OM5 ^VFU:K;=2JWM"UIEE?^O/&7=IMS:HM
MO_45C[5K]O8?V]1L>S>/;2[_>8-6]26+ '?14KA$U3>/Q'3NK^^N7M<+^]CF
M]'CWV/ZJW'Z_^:-SK]Q]4AZ^M.\[#\JW[_>77]H/G3.;;?OOG?OVYX[R[?[Z
M$O[=OK["XP,NO<]KIDO6=9R$O2&=WC@1G:"A'ALGH/!Z:*'Y?H F8E\!V<T#
M,^,P> J=49F>]R=$G9OV/ZYOOM_,TT=8NQ,PQC',7Z!7'F=?39O->XU7!<#(
M"+CWV 7IX[\ZX-&$$T57+I3T;U.?<>HWZIRZ8>7N*H9:1(IM(Z(8%<&AR_!
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MA4(^75H7%:9 S2:0& =5D<:6*DN&@@S\\1E9QM2TT&@B:X:N&9*E#+XL^'.
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M)<IN@D#)P@F(&ZVW%Z]@?+TIO<>_*GNG@.J[4Q$\+";*_B0.#?6?'3P_A%&
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M5]@PBX<7,,4"GU2/=LS'+3?=M3BVOZW*O?0[B5_Z;5C-LQ90@W5%.N@>QH]
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M6B^*A))T J,95O2\=)..O%F85&L>=-FX"]28_+P3K!='ZZ6'!?7L[!U.EQ<
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M$+DUR$65(+3Z+A.JCZBR$FE[T[HC,VF71^U$B&\E##R(_(<^>+MNJ'QC\+S
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M4,>0V?,'F !]J#*V"7!W,0X[^B58'H=.V-H_((^H% ^VZI!2K#:6T35+>-C
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MRZ^;T3W!S<'WC,_,,)I)]L:5WL^<6/3GB3*(VV8)?BGN87D3W.Y=WQ)MNE%
M!R=K;_M7??3K/OC1I "=1^_,KY]^0P6-WT\GN-0/R][?<]0SZKTE2A:++OM
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M4=F]F$[$0O D.>J-!1PV>YALMDT6X9-?VM7>#6K(KX,2$RO,E5_^F)]/EGK
MTY+B,F/ENV;HRR=^T LR,LC 27:E\*4 3[R/* UEM#$N<I%K'^[L!?19TN9X
MJND@*>53O(0T+6UB5_E2L[*I7*.A&WTQ<TU&/PH<">CLDNA\YCIE1ZNW^=H"
MUK%J#W?G8]:6_5/7)AZ/)G?&M#K-9OE3@'?^"MH2G,D+DY/#%365?3,G46K!
M*)P:TL3D$X3X,)IH)=$0R!V2X7>W!#L4XY-5,J[-E>8)=%;1&RZXU^%:5!;:
M MDNY8\WL.IQ-,>M?7Q<K3:=JN2XI,DARP@2M_UL!$%4.)N2H"0H+17-U/*P
M50[5"9)E377D4^7*+IJH>\RV:H7]&PP0Y+T8K7F=L9"#MU8 <6#+H5!$B"5.
M%]7M(C5)^?#PI.6QZY,M7GD\*[FVFE;=J]26<0?5EE?D3K7,]QHBTP@&V5_R
M@VTFEI9*00+Q@+="Z-J%6]9 .3>SI*;D.SB)705KEC&WF!;; .RH]\)&<$_3
MAZ&**K>@Q^%Z.$Y&[0.@/!IJ<*TDFI8,=",IL5!<2B:LROA/KAZ1]41$V="E
MX6EXLHOXZUH;B\I$B_2.=\WD%4Q@=(6(T^?F9_C[FU]N]D$&GBGKB7)9$UG.
M'7%;5(0)$Z--6?BX^?!VAQ<>_SRNLJ::SL5<MQ[DWVZ*K'X>3<>3)K^X@E$_
M^K\UL]H5B[2QG@U4)\T+1,!-5<L27EK,HAB5="H(KA[&'R\S8=NWG1$-.A%P
M91?U)@.P7?<H".EL*O$%$LG(DR'60RS72EP'%CCDK8H!;?!([[WTW,S)PZ1:
M\6+V'I YD[>!4O&<ZL'KCW\P=8 B5JGS "EV-6_GD'"S<(Q9I*82@: W7/Q7
ME8BR/&KJ0K9^*_?P%!3ZR.%1-_K<17B5HZS:),"'&1U_F[6[G^\.+E.(I468
M=4H0F9TIZ7F&<)8LDS$!;)/]N/E%QSWJ.4@'36<"K&AB)>CWWL(%[BW%#/S:
M,C;*'*3.GA@:2D'8B*-TWA(?4N( -C#ZV 8[AOBGB^;+3_CHV2S%+VXGZ(H7
MGMOF>JA,*T; %"@S%',&;X-CB[UULX[OOO6X6^K!XF\JRJ[B2KR$!S<0)QUR
MTVN+=K[5B3@C%?$B<^\H#U8\=D)R"CI<LXMVIL)=1%9W$]W:SW)"RI0-)3XE
M47*JT,6B49!2\82A1\>2?AB:]!P<V<-4L8>_NHL<*VZHQ6RX+9D :7&\TG)8
M6D\EZHI0K7 W<4X3)TIKK>"!4Y4<95OU)]]@ *][_[EMM-5D73$N<1VF.>NW
M0571MUV/Y/AN;AU-;5#] 6*N[/P^@DXYSW3 K8QJP9'K:.;[Y$LUR1B<YD;G
MO%6T^8DI_Q&7^)BZWT6Z=??XE06JOL[W(\W0G?-2$R%T.94%26QVH?3VX\+R
MQ!ULKLOYV!N.ZQK74D!37WH=!#R\]OW1W_U@"C]_;9/C7P[\>$;@P-!5%YP2
MS=$BE58E$B(:-!04U>C!TU2]>L]:,.>VO]>5?@?!XC? 6ECC7\&/IR-([X<?
M(4Y'([1'?_;C_OBW81-*KN2,W=?32<FM&\;^H-]6T;H[JH5QO,6X.HJ6Z&I,
M3Q-D48DZZPAY"GKO(#JCL_$Q2J7B";V\4%H6 '/$*2\)=]%080'44BKVM\7G
M#;$@SXS.NZB[ QH_2%6[Z6"?N<JLM-5M^Y*7E"9F,V&0. H+#$NUJ_*O!'+\
M((+3T/-2S^)#E;36WGNB9L5W3>/@!Z5PPO@24. ==S'>^-ZCMC?>30J5^AZO
M]B'>WF2G\2 -5>@\R%A62>\S"08$B08IIK)EB3UL(';HW-\ J4I=NSNUN7"]
M-Y <4<9H])-H()9'1A+Z8RF5SIYQJQ/&7>O8/6'-FYHZ7UFY;C_I=N"%KFKD
MN CC*^67LC3:1*U)=DJ6K !6"NX:XFS,*<M(<1FMK/P-D)ZH=MV>&EM;L>QP
M<7=@W;STX\L7PU3^4U)2OOA!6WUYLBC6V>[T/1G0LQ96$U>*)Y?"G[BE!HI2
M,,$)SP73M>O8;07L63.CON@KYF2TR40W-7H0YOO))8QFH^]YJ4-V#)? 6*HU
M:/S*:IF(S1% &Q^YVUP%:>WCGZ52J\FK@WHU<Q34&T6=]D2I4LJWD"@HG8@Q
M3EEDDG:LMLORC!5Z@/ JAM[<%-28]S_IM]SZ-&GB/R]GD5^S1,*;H7(=32F4
M0UR2H1QQEPBP; G'900ESZRM?C:R+;;S,NHZT4@7):MG/M7X@__:5N%;K$RS
MTBEW1M&S05(6N2V-6!FN4@FEX= 3%USC-!'2<[55G8A=UH=MP3U!"9M.]/MP
M<>E$.1VP:'G\/::99Y:C.9(Y3AZ#-JL7UI#DI:(J&&VAMI.XC.),>7&@N#MI
M"/CXL'M@L@67@ B?.)$A2V)=::W"O-#.<ZI4[=*(FS"=*3FJJJ(#<_/V(G==
MKZW996Y.H&3IY1"#5PB3 7'EG-9K;1*C4IK070&L1Z$=JPA6E_9)%UHXA5)8
M:X. A/"@8HY$&.>+HZR(<UJ31)5SUE'&Q5:6[[,-BZRHYVU"(W>1]_&BXK9!
M]:V%1NZDJ>W"X_81\_%(D"*G +CM12I<V5TIFLT2%T\1)&Z$RFFWU<YR8LK?
M)S2R ]WO(MT.7)'5F^:'4;]<)_X,0Q1V[..7BY@_99B3I;FCXZ5#!4O$ZL2(
MHE$[*9-(2\4=NKFL6X?P9"(N=])K<S2EG-K%_&*H_?E089:/TNVM_.,O/>J5
M_ [C/]9]/$T44E2$6H?^C@V>.)]#*9I'M=&9@JY==[VC^_A'.M4*I]#]![0)
MHS<XR-*(CVI?"L0EB4Z",/",F@'75.D6;7YW$5[=TC,/D-SO@=@+C*;,?"21
M65QR,S<D>"Z( ?""&AE3WJ*=R&.O.!_55A-DW72-NX45'X"RS&FA R>0%8+R
M"4C0C!.OK'+<9AGLPUOS9>VN?_[9J+:2"#LX]5P]X'E.B?^C?S6]*DV,?OGC
MNBE!D'/0+$LEHW-$L)!+@0=&/)>)N.QX-DY;88\3'[8!Z'D0Z'BZZN"L=+DS
MQFW*2\]%::2GDABO2ZF7D(@W*)(HDQ1HC6NZ78VJ76*,'\%S7G2I)OD.;ONW
M/=/C.4402-[@P98S/4:LYYS8*+W6CDE6/53ON9V@'\"0+K1P"B?HGPK9RT/^
M"LW%R%]?HJ,W: ^+;!960.G$2UGIL*0SP4TVEKH*5B:PN%1N%>:WJ5/$.@"G
M?H:^DZ:;VA*O?'[Z:<:DNY#F!T';@*IXAKX6R!-T=ZBCJ*8K*1^/ I9'%W&A
M%-*'TF%/$2^%)RHPST,JD0<UB@L<6?6/]6HXIN9W$&[E^D%-J78S_ Q_^$7)
M.+1D)+-*$N]3(A(2)8Y")C1J+R25.8>'SLJ*2D%+SSWNJ78E63>U!%6S%-#D
M>M1[][+GDY>:"DTL"Z&TQ,K$,V<(3Y%1R@,H_MB=UJ).5WG<;$:6K^[,QMEK
MGK/:]I%4S06UO/[S/WJ**N."<<1)$TJD,) 0J2>&HY^II8[*/^;];Z6HS_]X
M]HK:45(5#W<>O2]E+*:8@)&@?3'QE"-6,E.:SZ/1QT+B;JN& 6<:1;*O!5Q%
MWD?@P"(5>0M4WUH4R4Z:VBZ28!\Q'S&4B(J02[6@E$HQ76?0\#-4D62#86"]
MY.9;B2+I0/>[2/>(!;8X;DB,42!",U52M1CQP082 ")'4"GPS1T@GD6!K9T4
ML&6!K5VDUT%J\VIL[YK)VD"4G)P%FC3ACI7:8MPCUJP(#T$Z(:QE^J&ZN[FJ
M>03DLV;,<52S=H%XHABAA3G5/(Q$Z#A,:.-[CQHIM)L4*@4++5*JVE>^&*:W
MC1_>>?7MU8"1WM.4 F&LM".2:,]:BI06*3BO4C1QN_J9>Z2[;<)6+]YD,=T^
MXG3N10E!,"\(1$&)+/TD2^HJ80D7YV!0(&R+$*+U+WB"/-\NE+T^Z&1O:7:P
MUWWR.#[P8P@^_O/S",?M8Q'V.YC\W#3_G!4/< '];ZHTB3)G'+;AQ MI200F
MHN<YT.I)6=O@.C.B=*:2VAU8[M?(6L1$^.'+YNJJWU8FZ2E7\D.8)!$W7R*C
M,B0XB?X^CZ"80 <?-O?"V^9-9\:!+N3;04#3Z_[0#R/NT;<X?_DC#J:EZOT\
MZWBQR/T,N1G!B\&@^;V4W7K=C%Z.(/4G)8BF%VDR(G.)BY\S. RF26"Q' !F
M8U,.VM0OP5@'^IGQ[BD5VT$\U(IAK :Z;G"]#+KU-0DZFXE(A?\X!YYX" JL
M!A>J!TT=#/K;X62'RNP@#FO% %XV7Q!:0I&AZ!;?9(2[>F2O 3Z,X*H_O<*_
M>-4?MU+OH3-+=8Z,F*!*!S T!!S+..>"%BRSJ--2+'\''*TQE&^'N4=7?,5V
M(FNJI-Y4<BWX!FU4;(\)&C35EAA3&B1):HC-.1*7?8B94H19.RE_,ZHS95EE
M=710FO[V6O">0%IIH%163)/9-2$(L"(@NR.TP980B5<JDBQ#=#PS;K?+Q=\K
M,'4GJ,<*5#V. WH$=9UV!*M*%%UH=*=UB<_!D0 )@N)\H2I)3D$EOM6!Q_.-
M8.U0\UM%M.ZB@:.%,VX#ZEN+:-U)45O%->XCY:-10',JN4,'@A9_0CH6B!..
MM04<0S9E0ZT2V_X,(EKK:WX7X=8]U/R MO?7ER_F=X8&HHA*X^9I66F3C8/R
M4FI2BM_$I&UPYF'TUO+IY;U'GDJ<W4X2;BJ(IVX:],MF,+T*T_'[ORTB!6AD
MT@9%+)26;:;TK.8F$>$=\]H:K=3F1F8/G_K,E760D#J(9$6+,R@52C<8Z8DL
M>5..*XGV*#7>4L?=4G;Z,XYDW4=I^TBJ9A3C/.)9*)-SB<<2$3C.:\E)2%J0
M4C#4XL]$HH^5XGQFL>%[*VI'254\WFY?__IM+R0N'$Y>! P.H0M+D#B62*5$
M<"QF$Q\[G-Y*4:_?/GM%[2BIBB>_[>M?ON@EW&5\*<T9E,.=,JE$?%*>1*-<
MELHJRAX[P-A*42]?/'M%[2BI#HXT'^EEAN_/W"N<VZ5BLL)!V2P-,2H9QTPI
MLMI9E[C3ZZG9_;% 78UT<??=6;_%+<;UO<_F87TV=Z'.T?IL[J'WY]1GT]'
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M**,?!GM6#")>PG-B$1>[,.&1X.'#Q%[W1/XC1'_=G_A!_]]M*,@O?\1+/[R
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M$=Y9XV626CWL M_Q0O\ X7>:GQH-*MZO=BSRGM/<\DP325(!D489@E,UDQ(
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M;T>Q9A JAQ295T2KLN4FRXC-T1+!;<@\ZE3JF^YQO+,GGC/@UM/IIVY0[T-
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MU"0G&=$7-VB7"?1"-#-!ATQ-7@JT[MYR.;GZ;.?#[@/4?WJW/+?#VE""2[D
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MB3@Y W"B6$;Q"L<YVWP)51W6.7#MR=55\6;B=MZ@10%OF_'X-4IPC>!ZUH?
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MXKV/)$D(TF9 %ZMZI.AJ*,^;#C7EW,$%S'U8L\-DEZW/TG(BI-8EM(?ASB2
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M,Q@6\;' LHRD\!I#[;+LR8<3SD*R3M%?*5P<37]>RK#!7#BD+G3ANI?JE5M
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MFAD==>"--% P)%JD1JW/9RL=>XSTCYVTGX+UD!OM;YU/)UY=.<:+=39"$*Z
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M9#]1KJ%T48!NK<%^]\?UETC _N__^O]02P,$%     @ 4S1C5]?%O+X6=@$
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M_7-1_O(Z2\BR1/VH7*#S"?4OV#P&U:^@ZT'?_=/W@OWT'_\"0 5'GLWY+1=
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M>BTYJ$4'7QKA+9X>F2-FB=<,.AZ5U<P!V>:T'BT8^X@VAT[%^8+=+!]Y7D4
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M$7/DDAOY A)2!I@(S#EE&#FQY@GR5M-3VV#5XIV!JVMMTMQ&Z^@"=@(& Z]
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M?;Q8/:WFDDJ^\D^\CD@^7U:IWE0H\GW6NJ1<%\V<>4[BXB2.(&%A4)\"8Q+
M@"6)\(G\J]!/(MI#@.EQQ$:)=KPF:>FA5M?F(FQ+%>U-49]Q.KKM'!C[@6FG
M!;HJ)E+'ZIUO@=Y.?C &Z-J[TH'!'VF'VOO+MU/W\@00.[>O?=H<:RM[@KZM
M;>TIK?1,RI<\<K::\QNQ?:/Z'2G2Y'S!ZIO5]Z4 ZYKA.!!NA%T,I5G+I,W)
M$,0)<6 8)-0+_)AXGM:-Z!/EF)HKLU%#';.O,P14<<AE)H52(\.\?CU'2,^
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M 8HR=-.P)N@08ZEY6/BVXS,PH5L(XUT'ZE::JF*PE:[J-U:K@P\X%&\=>GM
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MC25VZ.IE5'(XHNHV-QQ[O!\UW'(54I<L.2NK/OR^2)?%[=WOM1GK\\0)DC"
M-/2Q) @L?Q("PRA6URQ=2AV'F1#$P=ZF1A,;8>L"5Z6XX&<IL.EIZV&4]5C#
M&G:#NVX.P#; C6\M7"SQQN&^1F4/+;6W.43O)7,GY0>I1;;@C1/H_8K?9W^D
M674UXT;\ECWQ"V7'Y"_7Y-OYTU+W!J9INU.CD%I^L'9GLE490;_60?DWE1:@
M5@-(/<Z.V=RGPW_<7SPD\@,3T#"@&SF-^Z+7RX%LW-EHSN2^,+0=R[W;Z)L9
MF!2\6"?I/*>2,$FRG,5NX,=^A* @R(/(H1S&'#.Y7R(HX#Z1O^!F^7_W]C,U
M JOR!Z8+D>5/)>*F*7_WHZEG\5C :.BCTE+"=OK>+XV4%BV<(SA82\.[OY>1
MD^T>5'4WI>[AQ_MQP.<L+R.G-DEMNI,W)6[DNB$2$%$OE#LD+B!127"QXX<X
M(:[K1-2$%PSZGAI7U*(#L@1*YMUT3V;<83(*>GPR$+8#<\Q16 ?84_5 RA(+
MF?0\*C/U@&2;K?HT87Q4WL2!761/-%V4:[:RG1X6REETQ52Z:)&65P>*@B^+
MLO!)SMGY8GWU,N6%_-OJB;/K;/%PS_,G50)IYF(GB7#D03=6^;T=)X&4XQ F
M3DB3B&(:)UK!8 /*.#5&_)0M>5%6-J+9@A7@F;PHK;0/F0<;R\-\.9$1&IA7
M&Q5!2\<SL-$2M-4$E9Z@4;0<U):JH-;U#"AMH5*W+.7V]D.M'8DPA2$?*8;A
M;8?>)!IBZ$'IC*,8K..Q(C"&1JX5NS%X5WV/=I[KZB(WXB-GZ>I)-5RN23."
M7 <'CH"^QV.(>.1"S+U8KNT.I@CY7B0;,L]9<*!++1H8/QO!6F(@3>REFKOS
MC!AZ.0X!K7NV<QINHR7RK:54'M1*3EAB5DIJ\TCG*!S6#G2Z>QKY..>HRKN'
M.<=?,8^T7>8D?7A<RK_R6]GV.A_+C"<("8^XZMX6AD@EW,54_C/ 24CDKQQ7
MN+I!MEV=3,V /W]26[9_KD\-BEIPJ"0'>4T;V=K[-R_]4>#GN5P-.-<\)#Z(
M^E%+W0J6 Q/'W2O8E)2;W%$6,-(/MK6!U5AQMKN?VKP1]T]V(FV/H=$=9-OY
MYFCQM<=D;X?6'GVVGWU5I2W^R)>/&:N"HJI2;IL*,-@7@O $^K'**(H0@=2+
M0NAY-$Y<P9W0]4U\P\<ZG!I[WB6/G*WD#DI=XJE2;U?"@Y;T9J;64<SU["V;
M2 [,G9W @2_WY?9TD%(ON@!9,L..=C>J+::K_+9!IOU>;ZOLNJ:P30*8F>M'
MKHAB#,,P\B%*Y$^$)BX,!?.\)"&)+Y)F)Z=MF.WVTV/[]O:V6;X6OS+)LMS<
M)-L#N;9-UA/&-S/*-G+:@,G8+#L-KK>SRS:?F5W#K!N/HY;9GE?'-LVZI=]C
MFQUX^$U/P,KXE]:O9V'":!PX/B2..O3W0A?&U$?*L/,D WN!%VG=F!I8SJF9
M@E4<T7PCX)L<C.R,YJCG8*>,T8]Y%E:-^O741OU-CL1.&?T?^UA,_RMXJY.Q
MKK$9Y71LI_,?\82L"\&!3LDZN^N9V+)V5-R(1LBR]Z*L1%.\>VG]:^-IB'SF
M!DF$8"P"%R(<41@[+H8\8H$K!'6$7G*D4X28VC+?]OC<<C('EX4J\@7:FACF
MJ>PS-'I.H*$!'WK_UL)ZS=QM#<Y4GLG6+P9U&)T"IJU<D7U$&#<9Y D@[61[
M/*6M?C3Y,<N7#^2!-TE.8I&XV"444J)NA_(DA-0-$70"Y@5Q$H@D-/)O;[4_
M-7);BV?&8-NHZ9'3"5@,S#MKR0:(.^[0VA)!;+<^ZMSO4&U[6G<]UK,*N*2"
M;)ZRTMKZ@^2E?=5<)*^21Y:%QU]F*,8Q]D@$*?5BB+S(@Q@) D40$OFKR/&9
M4?4[[9ZG-LL;63<)CDIIM3>OYM#K$<(@@ Y,%:]D/@,=T+Z<@4IR\*7^WT$L
M%&, ;=4$U^YWW&K@IG#LU $W;J!O&.-7OECQ8N9Z 0IC=8A.<0A1["201)&
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M#AK9RVO\<C[4XBO[OJ7 &3A_4@G7]$\=3= ^?O@X$- #\XQEC(U.'GL@UNL
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M(DV-*=I)\X^G.J>[J<[!%Z4;*)4S=!I;&& ]<AIWV 9FLY.3T^N-V'CYY'=
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MQKDQET95SRN//)("?-/B5KG^7*TFI"AU^G^=]S\^[?_L%)C1E&-@)Z:HYT4
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M:O ?GX/_T(*_T9JX(>BQ^/74F;5\X'S%9L=I^JSB[,A'V"<GZ&WIC=J5:N>
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MWJC=ZZ;,%&JFQ5P,X!O>Y;M#;NJ=PQ!H:I^OQ :5W(XV^V;@C-KV#SQZM@,
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M,5^AJ;$A#*<[&)O>/(Z%WF7E8UZ2]6]%OGM\NR9EF<FLKF]954L/PS@*/1Q
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MQKZ'+,T:.+0,TOM#)36\??\)?%3_>48%'_)\N\E-BRL,0]F_VCM%<>(EVA+
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M"_+0N']#FF(O)@DD@BIBHX)#ZD<15/LGK#910>Q1(V(;'FII)+87%^SE!8W
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MJ8>]*(Y9:AK_W#_2THCU("VHQ065O#H.DOW-F!,&T!UD4W>83<REO7#9<^D
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M=,;9-[1K%S:C,]G$6B58Z704MG%07%<G[E[7* \J[:] K7^G3$0)*@3 5D$
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MW.5!C#B#B D,,4\D#!'W, H]CZMMK!6##0^Z/.XZR P>E=!0\1.KQ;;C)P/
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MO69=KO97E48Z5XQ1G>TC#8.K1$3'TDV;NS@.M&_2'4?JYCS?T5.VKBD,J_)
M:80E)S2!7DS5;I^0&%(<1!"G.$@$$4EB%O[<V<O<S/C.0["5LK> D 6B=LZ7
MP3A-Y40QAFBP]^,H!(Z]&*_[>!=OQ%$U3WD5CC\\D-^XR)D0O/RD1-/%<7?U
M<U_:U9P#P1A.$P$Q]05$,<'U3M!3*I,HQ"'RK8+"C'J=FV'8"@WT,%;UR$N]
M4R@$60*UC2=KT2YCKC=WA/-,6W+UP#)??8-+76X5D+(4:\MP8;-A,K,NSL$?
MV=J\QET+=[&MM_UR4178AC(OH)L"VX- <L6%;-3GM&S(-C"\X4.V>MD^T7)
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M,W+7*\/,1[T_>] MZ1X^YPV#OXYK]C%BS \#B$*/Z[.Q@%B?C6,6IH$(PBA
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M.IX?/*RIL_.&/Y"EOG!]^"[$^I<BWSPK"?8S$"?8PZD7049$"E$<:M8>H<Z
ML4]B+V(DBJS.@*8=S]H\[F.N+U<<7)&BJ/+EJE^5X%->:((^G36G_OHAUV&F
MRF36%T_M74O]4/M:ZK+F]GOUV\&YRMT#:V9:QQBND>WI?G0N=)V;1FQ0R0VV
M@H]J/&U!<Y_FW-WM>^4[&X'1D?AL]KZ=02R+M>9[YQNVUBE!#Z+XD3&Q2]01
M-/0EHU"J RM$,DIAR@,*8Q3Z5 K?2V.C1)W.7N9FZAI!JT"/1E++T--N4+LM
MCS.HQO:0#T')V)08H=!E-U0#+9NA_FMO+[K;GL0X&*FWM01F#]L3'U1E:>Y$
M(9O$*0O*@R.OSFT6U[6.M(QY\52M@(VL%WW)_$9 =4]B!QB-/'V'PV/%== !
MPB"6@V/M3<9OT*%,F]F@ZS'K*)_=H>B.%.N5FC??L^?6J/VZRM;E%_%$1;'@
MC- T"C!,O(HJ30201DD A1_(&(F$^YI@U"CLQ[S7V4W[G1>A)?JK[[P2WCC<
MQ0+_;I,P&JIC&PHS0,'OM>3F[ <V7[9I9-$X"$\4:G3NIVL3=60/U,DP)(NF
MIHI+LM>N%:@TX.5A/JC]A<">A&5;:.NK6%_2<ET0MEZ@B,@T3"GTO#2"*$T#
M2-2Y"P8<)REE(I0A-6.LL>S99HY,R%SSIF:?G8?(%'8S!]$(4(YLT(^S_[0J
M\VE^X-^W@CMT"UE"Y<@K9-KKI$XA2R@.?4*VKP^]6"1EE8=T<"DE$5)&B%"(
M*P(%$0I(8YI 1E#JAX0&-+*\/#S:S]QVEFT/>'T/J&6VO0,\#JGI/=_90(U^
MEU?=W&D91[Z>ZT3"V17<\5XFOF;K5/7M55KWX_9I)KKJ[2NFJ->?KN^1R(LY
M@U*J/0E*(@Q3*CVU14EH2I6%B%(C%W%_5W,V".U%M:V!>5I%#\R]ATN'X(UL
M)"I)#^GSC&V%+7#F62GN )PJ-^4-D&XR4LR .)V7TO/^9-DI9GJT<U0,WQBV
MGU([LRM2?E<;-<TBPS^\_%H*?K.JMW#JO'G)UMF/F@5U>P:A).72$RGTI)!J
MJY4P2 7RH"8J]:,XC!)*[(Y^]D+,[Q1X\_6WZX?'FZ^_@,NKQYO?;AYO;"LX
M#A@*LRW:N/".;)CUP4]+#[;BZ_B!G[0&(%O]#'9*@+T6HQP4AX/H:.,W0(!)
M]X3# 3K<+I[1DO5.\BI?Y@7A^<.SYI4KKVX;[R[R4"B0,FU>J"L8QI)"XL<^
M#/V$(3\)><Q,[RU.=#&WG>-63-#(J4Y,M\8;GE,P]NX0'8 SL@$ZAHO]Q<(I
M@(QW@@Z FF@'. PPF\U@#Q8G-X&GWIMJ\]<C=VO3U_>DM9W[>[XIU_E*;1O)
M]@)+&3)/TE3MXZ@4$(6I#], "8CC.$TCZC%?&$61'FU];M:MD? "//X?XSE[
M!+->>W8>$B.;LCT(6CQ[(W8$$&/[=1XP$YDN6X!LC-9I $[:JR.O3&6J3DO;
MLE(=#UD;J"9_Y58^/ N6D>66UO2+*+Z)XEXL-2W!(DU2&H<TA%(R!I&OMV4I
MCR$-O"A(@@0SC]DQ@QGU:_2I3L^@T(@,>",SJ%A LA4HM-@ZQ7>=5U3)M3+&
M\]QL+'IMH3MH)^57T*[3+;);D2\:"$$CM6,HC:VH<T@G,JPNH+4QME8XG;2_
M9JU,99*M=&I9:;OWK WWATV9K4197N5/-%M5W]&]8/FW5?9?ZM2N.EIG,M,N
MR\J1639<&9RL^#:;2A_D-4FJX%648OW<PH\13F*,U,[4]S77= )3$K'J6C<1
M 4N\-#6NB322D/-S0]8AM*22[@*LA#F'UECCV+M,S&!L1EY8MAJ"EHHZZVRK
M)&AK"6KQMPP_O$IF:&D*&E4O0#W6]>/O/LS&2]@,AGNB1>\]A]UFL1QY1$XN
MKV/U.]6"/#)NK25\[)Z&5H@HLA]*F!]BSS&ODX'^+OBW5V[Z?7&=_25B+#PN
M8J(KW"00(2QAFJ8^Q!Z1-)1"8&I5;>L,6>;FJMJKTJJ?4)>A:[1IWW7M]3&Y
M]G(^CF8WD!.-SLC+^)@#,Z#NQ=F0.BN-,5R2B:MGG W9VP(;YS<Y,'!#Z9RO
MUDI_]="W%K-SH8/M/BGE'XAF^+DCFFWX6BT(ZY?M4PL/A2B2+(6Q)W21CDC
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M:0!UI?EW&3JS[>ED@S'R:J,ET_<&:@!: NH"LCM'2?U(G4+YZI?M-UP2SCM
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MIM$TD=.UH*#4DEZ K)(2_)2IWU1B_VR9K78"8+,MM0/01EX!&K0>:K1J(2]
M+:;#K+%N'%SE@YWH9=I,KVY5W^1P]3P^S"Q49>#V5>!VF1_*,+%E7FX*L9"8
MAYZ^=XE)S"%*@A1BD6#(PH@+GTNENE6:5G^7<]MZ7EW>W__CYNLOX+?+S[]>
MVYD% X#-+(1;V$8V%H?5!=LU:,!>8G=VPQP=1R;$H,-)K8DY (>&Q>+-83:F
M,E<?=(%/74!,K,JZRLR>$^/#R_Z1NWK3<_D'*;A.0EV_W*S*=5'MJLN*LD57
MH[E]KK9,OXER+?C-JJ[PL? CD2:1#*#@?@@1D2$D0<(ACQC%-/7B*/(7*_%-
M;;P,<_6G$MUHZJ;UU&TK,&(4127?OW_*"RFR]3D;H\F&W\R.SFI(I['&E3ZP
M4@BTE7[%2T-?0/NY1G-0J7X!:N5!2_N&#*LJ0]8 < %J"#15UETWX8.U@9]Z
MV!PM$Y.)/>EB,_5@'"Y9D_=O[?,]6%2_D#^SITU5"T3OX[.*#G412DG]-/)A
M%*=JO4*1I\[>"56+EB]#*KB(!#5T\9KT-[=M]9?+_W/SY=<OX//MY5=P=?OE
MR\WCE^NOC\;.0B.,>SVSKI&;?&?=2%S7ZMG+[!9&8Q>K:S@G\JB>#ZN-\]0&
MI).^4J-&IG*-VFC4\H1:O3;L]*%O]70=IH^"KA<L#BC%3!G;& F(F"0P]94!
MIG$02T0B$MAZ.]O-S\_%67_6^E: YBN^XXBPV\"_0I!+Y/F,<X@E8A!Y00#3
M$(704R<LR2.<"#^R\08-Q6^:,LFNT3,[H@S%9.2EIXJ.J,K":<'<;>V/J>MH
M^_VJZ4FWR,>4.MS&'GW&>JMYL_HA:G[]\F:E>2GX#Z)$?,POI<R6&5'?\,.&
MEAG/2%'G@N:L^JUZ]G_FV6K]FWIUHQW*.S\*0\R70D(<1C%$,HDAX<2#(4JY
MOBWRXL3(XSN&<+.S$>(/==S=*0GXIM!!ZNI88<5Y.,HX]NY]WW5T1K96+=VT
M/Z)BYZG5TQ4G]@I>@+:*%V"O9$V66.D)MHH:N#;&'U?CS?B[CN]$._=W&V>;
M#?]H W'R=."^QZF.$J-AU3IWC->']?+=COE8>$AR'L?J:$)8 )$?44@\/U6;
M[8201!*U\6:&*V^[W;DMFKL0I55N6D;L$*G>M6VH_B,O2Z^BLX:I;FS^AT(P
MD>4V@\+&S!Y3^*2%?/7P5,;MF(0MNW3TS^<$?-74G4WES(A)#T5"F1/&L-K7
M*\-" ^9##\<I#PA/2&1D74YW,3=#TP0MU32RAG5:.P T.[Z?!\O(]N<U(@[+
MB_9K[S1XZU4'[Q"W=4S!XR%;1Y\</*>?"_%=K,KLA[A9L?Q)?!7K6_E(_EQ0
MFC#FXPAZTM=A6C&!F-(02N'+"'FA\"-U:,_79&D\N4_U937+=SV.^DWO104_
MZ1*#NER3%OE-J4'6"OK\GB\5]I;,N%UC8&P?7" [OJ%H@5J+"7[ZK+&] $K>
M*IV3_*D.4@<(WY'"R3V)!5SN+,O)GJ8V,7TJ'[$UO:\,9.;05^2?LE6V%E5V
MU(W:&*Z^93O*N5\*]4TL0AH32>,$<L(H1%Y,(8XD@JG',/74_Q*[O851KW/;
M;M1TCME.5$O38H:TF9%QCM_(YJ:.)JH%;E(P]R+OLC$KJ1VR?MB Y(H(Q*C/
M:;E!;&!X0Q=B];(+!I&[(O^1E>H'LKQ9R;QXJGY[HR3(R++AZ<Y6WRHC^+P4
M2BZRXHLT]DF8)!@22M7^2' ."4L"&"9^@J67\)"87FJXDFEVYDO)= [_Q;"!
MZ?7DO ?<(UN[XSP9+:U 2ZT+T"@&]IJ!O6H7X'W&[1Q.D]''[UWY3D89QS/I
M4,Y"W(8J95A'[TBC<A8RW10KYS5MO59>,EVH^Z/X(9;YL_[Z5?_/NAB[*!L'
M%A,8X2"44%)$=2$=#E/$(JAK9_K82Q(2&47OF'0VM]6M%ABT) 9[D8W-9S_&
MO>N94^1&7J@Z0>OW'MJC9[RJ.$5QHN5BV"=H8_F-43EITOM;F,I6&^O2,L+F
M[[QK/1Z3:D*+%$6QAT0,42J8YC_%NC1/ $64L""(4C^@9_$ACBC[_&R_RR)I
M[_$Q##DES6:(W^4T=7:9EC<5WBXM*[R]^T?S+@5^7'\\?^U:/V=_1.]5^,=F
M&">I 60DT%^Q') -TB-5!K(2P6[GQ$6VN%:RK%\N.5<3MFS^]5D)[R_BD$A*
M? ]&21+KE/T(IKH>D"=H@G$:<1H:L=QU]C*WW4@M*&A$O-C^ +2PX'9E&!;6
M#6SW?L$97".O[(.1,K::1D@<N?HI!?O;M_S'OZOWZUL?]</^LJ>[U4F,E)%B
M6W-B]K"[B1\LHIB'-& IC!CS((I( BD/ IA0' CU720B/GOB!W^IB?_X1W[^
MQ _.F/A6<+WGQ.]"RLG$#T:9^,'[3_S 9N(' R?^]F9X2RR^#6IM-A<+#X<^
MPY+ ,,4,(BI"B+G.Q!4L(3R*$TJL0D5.]#.WR?\JZ'WOB*@W8#K?1(WK2K"*
MF.6/;/T=D'TQ+1UL56C23U'11EZ E;"D S\U&&;1) X@'ME@["H+[&"^Z\G6
MM8X6Z0'!47S(J5XFC0CI4?4P!J3O\8&\8:0I+Z7LP3^K+D@U.[Z*]8<\_V=%
M4K9 *5$&(T8PD$0=('#BP123"":!VDD($<D(&3E);3J=FV79UT,L6@06C!3%
MB_[E#RVS)6>7"?1FIL,UH"/;$2TNV,D+6@+74:]:YIK'T"&WE05$KGBI3+J<
MEE/* H0W?% V[PXS1O4<$Z\J)[_<;1F:-^*K^'/]^(=8_A!?\M7Z>[E@E*4(
ML0 R3U*($-6['!'#1"9!1/PH17;5ZVP%F)N14I\@LC-"UI";&:0Q@1S9.#6B
M;TO@[:2_T''W5%3UE"[ /P0IW#A'SH7,D;&R[GY2PS44G$,C-KB=@;Q(9,4O
M?Y!L69&^YD7KSGSAD9@F'@V@])F.E:6^#N;W(0\3F7(4\#2QJJ7;T=?<S)06
M%7P72PYD7@"^%]22]:<#73,SY0BSD2U2!==.S JSCP:8V7,$]:/ABC*HHZ=I
M&83Z57Y#*&3PRL"SV(:6XE\;U=#U#_6/)EC+]Y+02QB!W),I1'X80AIBHG8[
M?A!0Q&(_]:T.7\=ZF9N%V L)Q ]KPW <2,.CU+GPC'UVVB-3"3A"=G$G!*[.
M1D?[F/8PU*7FF]-/Y\,#BSA6&80/VME8D>?2<EVH,]7"\[COB3B&/. )1*':
M&:0\(5!R2B2+?"\UHP;KZ6=N<[Y)?]W)"7[?2FH8^]J'JYD!<(#6R"9@"%#V
M]1*[87!5$O%$+]-6/>Q6]4UAPY['K8->KY^>E_F+$ ^B^)$Q<9QX^VN^JGFS
M*X[MLOTG73[\:[[^AUCO8U/T^?3QCWR12B("G"(8I))!Q) /210+2%DLU6^0
MGX3",+YU1#'G9HK4=QH91QR..7S=)FL^@S*RQ=MJ"1HUFRH*]$VUA0N@=-U6
M2*BUO7A=CD$KK,F0P(M8MR(/&X^.<7S R.-N'%0ZD_&?*'YT%M^!3;#H!,-S
M,BYTS+ZG"@&= +]6M.<4O0UT#6@JG;H8W<>*_+9F1*R+U'T5?U1_*A=2,!H$
M*(8)U@0AB<20A$R'>W)$DR#!1!(K7X%1MW-;O;54E0L_EZ^HB,XHKV0&OZ&'
MP3FH8[L<*O!JB4$M<L/;NJ]1J2F::\$=^B&L@'+EF##K=%I/A140;UP7=F_;
M&2C!N#H0E9EZ\K'@53GW3)1W1<XN>?ZLK.2G)?EF8G*,&IJ=I:D%UA$,O)H5
MC=A5JHJ67?"*Z+A1P<SHF$':;6N<HSFZ2\,*2/"[EM^!M\,*IXY 5=5.8UP8
MW]L4L]8G,256BFXMB-U+PW8V=75NLORER#?/-RNVW.@/0-?%S#5O@S):M\^B
MJ+97%0M2G6BSH'[@\P!QZ E-LQJ'(4PY"Z#PU?_43PPAH]#V\\28FSVJ";Y(
M0^1E';\Z<"S,MCWC(SRRC=HJ "H---%,HP-H*P%V6EPTU1MK1=QMB\X#TM$V
M:: 0DVZ;S@/J<!MU9FO#K..](,OK*AS]<[82-VOQ5"Y$*GP<JO.=)*%0I@]'
MD*0R@"E.$:,HC;P0VYB^(WW,S:YI$4$M(_A=2PDJ,2WOA8Z!:6:[SH1H9,-D
MC8ZUR>G0WY$].=;#I,:B0\5#2]#UZ$#.:4U??2NKD]K^VTP\F8;,PPJME$$4
MIKZ:Z#2%<<I%PGE$";,*NS_:R]RF>DV:GDM0>QV&S_;CF)K-][.1&GG&#P')
MGA.Z"P17;-!'^YB6![I+S3<,T)T/#R@KQXKJ$IDL:Q[[VBG39OM^S#]FRXTF
M7+J64K#UK;R]^W65Z2-0X(<>34/H8^%#Y",,B:=^DC@B0:B.1#PV"@P[4XZY
M&9"MF$!4<NI9<GL'*E'M'<#GCE'O_>U4R(_NO]FI 9KJ%[4B;YCK=\-S_69X
MIAD2B\)NTPS-9#7<QAPBNT)MYP/;49/MC,:G*[]V/@*O*JTY:.Z,P@7[.M+E
MQ_R)9*L%XT)2+@B,P]"#R$,^Q"BD,. >9AQQ2HG5&?5X-W-;>FI_3TM,\'LM
MJ.76]02H9GO7\Z$:>:T8@-*PH@,G07!99>!M)].7%3BIZ-$Z J>?MK_Z>]25
MARIK4]?YN5^O+I_6IO=]Q]^>VZRNI 0M,<&]6&^*%;A\TGQ>YI=Z)\#JO\D[
M'Z>1I_10B*SNZ;I1&'0Y=Z+)R6[DNE5J7\/U/#EL\=XF/G[*BWOQK#Z&[Z04
MM[+90^@S[B)EL1=K[S)*HT!G6$<0QV$ TSB@*)$TY %>K,0WLA;<;"GO[]3H
MPT[K#[O=]8C^EG8442&X>'K6FW7+TD,&<)LM\8X@G,8V;(6M\A;WXNI3Q?88
MHB5VM_:;H^-H'V#0X:1[ G, #O<'%F]:^[H>1?'T.2>KCQNAP^N;I#P1)[ZD
M20*EU)=9/L>01KJV(I:!B#UUB$B,&!Q.=3"WS<1_#ST//&7+I8Y!_G6EEJB-
MIK;5L@,MO+$/Y#B<O?ZFLT$:>R>Q!0+PC0!:1/L"",>A,?;[G W11 Z=MU Y
M\<YTJG_2[7+\K:G\*9TRMQPEW<\-I=YLF<?:\7*[69=KLM+Q 0M*"&8L8I#%
M@2X9&S)=&3J&42 (\P+!B&=$Q&?6W=S,74,QV5[HMS'#H"6V+2=G)^+=-M ]
MCB-;Q',A'$#6:8+,&:R=G<U/3-]IHNI;'D^CM^R]*9?\/Q_S.Y'KG))/JT?Q
MY_K#4I\*#-TI)UZ?FTU08F[*RO\$'G-P=WU[D+GU*<_7FK[3W+%R"K=^SXH#
MR$:>_J9H@=^U]* 2WU%@= \X@SPNI]J<S.72HU3;Y]+WJ-T$+XOUXH%]%WRS
MK(Y4*ZX&4? /9*ESE1Z^"[%^K&YJ=I\OCK (DI1"GJAC$?)""E.,$LB0%)+$
M3$K"36R#=<]SLQA;X6N?02,^:.0'E0)FQL)^#+I-R*C(CFQ83@"I[$AU#^S4
MF@S&J<M#HQIM>6?4?^TMC7U_D]B?P3!LK=+P!JS=-0]BE>7%5[6RE-5I*?2J
M4O=5O/-FM;Y<\6V:I<YZW5863"*/2.XC&.F##@I"#E.1$)ARF4J1^H1AH]/.
M4 %F9[DJ)4"E17-,#SUC1\:P,>CU 8V.[,B6ZRBH-7.P6B"V:E2I8[M4X$H3
M>U?2L!$P=C6-/A(3N:(&CX@3C]59*)[T: UK=2J/UUDZMSQBY[4S]-JQV+/R
M,;6O]4@<PE#B4&URI8 T21@,J5I!,$4<!U8TJ.W&Y[8:--?DVFU0W^*6_^/_
MP8&?_+_@^E^;;/UB>YW8@M'TXG 8.*-?$1;C,!D>T]?9I5^KZ8FO]]XJ]?8B
M[\@SPV;K;Z2H*MS=K-04$>6Z]H IBW%79$^D>/D@5D)F+%,_-M\BYC'AS*,P
M2,,8HB00,/5T+*!4YU@B_22.C3C'!DLPMWF_50!L-0"U"A<5 5&C!6BI86<(
M[$?(S%J,BOO()L4:\A&LSV#\')DH^_XGM6.#X3DT=L,;LCX5?\P*P=2H;W?Z
M&%$:RC2%:8@#B&3$8!IA#WI!2F-" C_BU/"\>]#TW&S83CSCL],A5KWGTC,0
M&-F:["2S/T$>HF!\-CP#C8E.??V?A,TI[H2^)\]GA\]/=?(Z(6?K3'7J"7L?
MW%$"NLNB4*-0Y7M\>-D_TL1N5:QT]7'B9E6NB^I#**O [\?O9'5;!R[>%3EM
MJE_L+YAN5C4SU/\6V;?OFN#NARC(-_&+ZF[]D:S%)Y(5=54J1A*"0Q["A&%-
M08!22(DR>RGG"0J9'X6Q47K'C'6<F_UM:0/(3IT+L%4$D%H3\$VK K@F Y!*
MF;HR697YR//EDA3@611U$J1Y#N1<!\G USE3R6>TN-4<JA_><*B"%DJ OH#V
M<PU2-;7J1>.^ "VT&NZ;M<(+-(!=@/8WW+K75I_FEDYP]S4WP($*.:"A QJ[
MGJIP?YGOUMQ#/%,-9K@=^;_H.[;R?L_\"SGM8)^KX)/Y\.<*P)%K@KF+.I!\
M4-#U7K9/RJ[4"6N+,&4,QY[V6888(I)Z$",_@82JO6V$$^D+H]";OH[FMLO4
MD@%BD=?8BZ29J]$%/F/[ )2(K97A E18N4IP- 7"%7W?J6ZF)>CK4?8-!5_?
M\P.K-.IJD.6N3% JU(%6AA$,JY(I420AE9Z F*(TD'X0)9[5]<7KYN<VXR^7
MR_R/ZD)>Y^==%8)G:_ Y+TO-ZKUSGM<U;RZ:?P,]E*!-.U??_-_O*F/_AV4E
MQ]<C8&8SAN,ZLJ6H!1NE*M-QG5U597S=^+2%&(\J]J;VXO&G[!UK%26Z$FRE
M&5'NU.@UWEG/CUA",8%I[ N(0L8@%@A!).*0QK$7X="44^M4'W,S #6%7+85
M%#PO+;(03P+9[YAQ ,_8CI&Z[L$.&2WD@!"R4Q"9^P <0#75&7P09%;'W1XP
M3A\W3[TXV7&O1_+V<:OO43=D39]WM)@L2)A/(@1Y*BE$/@X@I2*!/, 1%X)X
M EN5G#S9T]RLWQ$RHL]#&4=/PVNVH7$"VL@V<2!>9Q,XO<%B) ZGS^]#0MJK
M;A^3T]L7AF8S7W*N/IBRJF]Y6]P5^0^]-UBD),7(BRD,*$O4?@AQ2!@.(?,2
MSXMXR(1O%.G0U]'<#$23?ML(>U%77560@JW MKG+)_#M-A$N41O90@P';$"F
M<C<:9^0HGVAXXNSD;O7>YB7W/&^?D:R]O9=LO2'+Y<L=R?AOY1$B*NM$9;M6
MYV817M\M-6H K0?X4?X-G.)",T]GM@2]VW*,B_?(MF0@U"/D0@^#<%"*M&57
MDV5.#X.@G5 ]L(5AAYU/V4J[-2N7T>>LN6+:$EQ]W(@%QISC- Y@&A ?(A0D
MD'J"J9\XHC@5GHCE8JT%-#OS]'5H9<=VW8XWN>K9LUGQ)M='<+#4LH/G1F:[
MTT\OWF:'()<HCFR=&E%!)>L%V$E[H4FTJ:CLE+L3D2DPC@Y&O=U->CXR5?[P
MF&3\WC ;\U6LKTCYO=IH<<$_O/Q:"GZS:@I!K;XI8Y?]R-99ZVZ#Q(S*,(QA
ME# $$2;J'"5X##EGL>^'<9BR9/%#%#0W];78"V$SA]JBC.A6N+N^OWR\^?H+
MN+QZO/GMYO'F^L'._ P8"C.#-"Z\(YLHG8&KI0=;\74 U$]: Y"M?@8[)<!>
MBU'NK8:#Z,B<#1!@4@,W'*!#DW=&2];W:%](\4_57:[V$'J+[F]OT3PB@P#I
M<!E$=%:,A,3W.8R3 $6A)U*/1X:W:,=[F-N14"&9+S=K 1X?[JO8PWPE3"-H
M3L/8>X=V/C@CFY]:0+"3$/CV]V<GP#&^/3L?I(GNSMZ"Y>3"K%O_D]=E)UZ;
MZK*L6^K655G/@Y8<7>OG8G%UN\ ^YC+@ 8P9DA!Y/(28, FE3!**J$]HD)IM
MTIH6Y[?CNKK]?'M_^?'6D#BK :;;) U0=FP'4I^6YA16KW7K\.SH)^LMB?ZI
M14K5M# -U=1K<7<$4@>_/I\6:FN/ QD*R22&3 H,4>0CF'*4PC 0/,*$<&QV
M@]S1Q]Q6_6.L-Z=MMC&2O<N^"WQ&GG='H7% OV2]^KO ZAU)E-QL ?I ,.=
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M=*HF_=]F"T7N)Z>V$A\H^?6W,)I /;Z?TP-4MK=V*CCRDT\II3K]1!WV>9I
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ME_,$AM3!$!$<0D*X"W',B1<F+I<VR232ZBK(V"*N3<7%:7Y&DE5UPE>+*N/
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M"=?=#S8[V(WW-J7JE]Y;G^L6>Q0Y)-_X\F7.;F;OO.#(N/\YD[/H)7VKW2Y
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M-D%A%#B84>C[<F%&2'CJN,R%<4(B)W%"ZL=:3!H'VA[;C*[DD^'H'P8E'7<
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MREW#W'?SO1U\5853\G\\93+R%SR3_=5V5J6'N5(_FL1A'.#()5!X#I.>7N+
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MI<#7,6R.UOIJ;&#HLE_'-#E0 >SH*V;VE?%T4M#I/?+G5-4>F"WOY&!+;S1
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M\N_J=+% NU:$MF>6:#.<>JL&J-7IP-7^3(#8K^9G]/8)"7FU:V558"Q8$(J
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M,US?=/$2F4NO2B[98MSML.HC!3%PAKZY-Z;,'8V:!&$%R4[EH*0VTM4>3W
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MN>_E45CZ.CM4E$&E"(920L$9(@$4AH,B$I6MD1H<&%W;QO7!Q[ 7G6>&\.!
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MS7&+?!ZTQ'WH*DB>@C-(OZ$V$:D,D)"D)L'&Z(11@3XZ$79T(GY^D6%OH\^
MF\IR'A8Q&]?L*\?S@</Y%YBDGV9=&1JWQ:&%J+*0!O<$T,*A)!A_:5)ZXZ$!
M9O!X-NYC)!VY^+!WR.=!V#GTTG(PL.Z]>J3W_^!?5^Z!W:-_O]7*UCOG:(P*
M#QI:!A;S4O<E\-Q!Y/#H0=!<NV5,_4[8L^YA/]U/_OOJ>)V]AM6C"*2?2^DN
MGL%;6$8G#QP'3I)5:$71=I)@DL8XEP;'%421:]]IG$9Q4]VT#T'/[C3.LRBN
M >]\5]OG6V/[_0D6/06=I(QH70TM\WK-BD66#4L@/""C/6#S0#*;ZLQ]*B#[
M5%$#*-SL7?\2:YEC0)(D$*,$$"G0R?16RI** ]I8'7FNW6'K /*&C0 JHJXO
ME32 MB5/;V;S[?1"G57DUJ%_"J;,E%/HKF8HC0NL%LG;8&WMBX@G2!G6RZ]J
MNTX7=<NN^JY6_<<Z[L]\5J^C!7ITZI]H,"^9C%HR(&!%J9XVB@0?$0=..'!2
M:"5K%R/U,V#@/E(MG[_M"3(5M/*<T)R7@Y@$"9D:XM$J2DC@;*P=PCQ'S]!M
MMT]&PM.7YR<*OV4#\WS7_F--S5Z?>J;) [V:G^-[O8/6W#B-IY[,OB2E>>*8
MT41%IKG-T<KJSL" \P<VZC#6<\?+HC!_/XV3&U3$^^FK&&^N;B:E='M9UOUF
M=H6HN(3I?$DO*AM*XN=VQ08>] Z"(N@.,O0,@R V^T0<>*8#CQ2JC_SJB96A
MS>=YD/RTC1T.%PU$#)M'S0Y%O)]^*8D0R^KR^QZWG]8/)'>M0>_9CR9Q%ETF
M1@M))*6.E%1HHH.WFEF?4JB=CEB9A6%O5X;?#N?'0<M>RN.&W$>7WS[U23VV
MP._1 ]EJ>LX%9SYY(-ED='=S8L29+(D*/D5G9!90N[:J<B/\C7K-JZO9="G,
MCS>+^0*#RE+J,9M,?IIUO_IN.U,O)J%24*4A9#!$6@S[O<:]9Z,4HAP TE1O
MC'\LL4TURC\$,\\<WSVJJZD#^IWOILC9_!-T7RY1WJ5I:5P.2Y[<+![ECWH.
M)@M%"4LNE>FHFJ#5%<0;9P3+ 8/1[7;#]5!Y$*G#'KB]8+(_536 R'O/XV.^
MY0Y2\8[1-5[KK?/3BZ6W,'_]_?YWUH^-KY:[\GY#1@',)"""^S(O@Z'O'&0F
M8"RZ+1"D,#U4E=5D8=BGD8H('E*U#2#[?@/O9FQUR"S;$\Z+O[N22$G?O]Z5
M+V8-:!M4&3&%6UKR;-$?AT \<T$S*8WTM5M-UN5@V,>:7BSSV17;**PW]_0[
M#%YFWP&64OATT\7+DA@R\=-UM+G]* I>6%E:1O!<<M"88>A!)4Z<E9JKY#7$
MVFUS*K,P;,%PS\ ^EVJ;0O9?I]U=V=6F ,H+[2^S9?XWI.5>W][,U!AKJ4=Y
M.Q2Z+.4'@4J+$G"12\.IJ-X_L +9P_8([@7!YU%ARY=-+\P3._;F:;^//==4
MM![OI)Z=@:53X,H&BR%_R"5S6A(G$2G:66.DM,GHZME5YYB-]OK[9E^Q/W>S
MFVL,/>\WATI*<8?<"B-Q<U+EB1?<$:V2SMHJ"KYVO>"^M#4\,>T0M#PY,:VF
M:EJV6_OU>'P+"S^>]-:X\O;CS]RY<B=79YB;)D3(5&62J%>EOU DUGA'J(L(
M4< 3-]2V9O5;5^ZJG;^MO?[4S:ZA6]SV!AUQS9V,93Q\*'EU'AP)4DH2G<]<
MI^QH[L]->Y*L9MM6'H*/YUH9U%#'@('"PTZ<NVM"'W\7X!=_!:]^&\]'R0OT
M:5TB-B%WZ-H*@@&2(ME)$Y-/$/8;9K1WK]3#:1P6@]7!LK.':L^:&QBA3_'Q
M=G;EQ]-1#EE&D(&$; 1!ZE&025 2E):*9FIYV.N^Y04,/D_%,"@[+PIFO:AD
MV%+@7;NR%)J^G_[';#Q=_ T%6!S?G^$J0#<*.7AK!1 '%M CC<@2,$X0)RY2
MDY1_Y%8\+@ ^:,GA<%53Q;,SR+N!^[8=O3R6NZS<"S*-Q.-.8\B&S<12+8@0
M2#]X*X2N/;;H"5*&?4SNZS"L*?]&8;1JC76[^7@LXR\#AL(4/5=I)"WM4RF1
M3%B5\3^9UDXG>I&H-GKWG*3Z/>!TO!Z&/>?6V^S[;8?S7V8+#,VANT(.4ZEN
M_MO[=W=6EX%GROIR7ZR)A. )&F%%6)DM9U,6/FZ;J\>GW $+MH><$[0\ZUWD
MPP+I+W<70E^[,F\FO[J";AS]7V:3DE@V__!IS9(-5"?-"TN AES+DDA6#O 8
ME70J"*ZV!QL\1M&^J[71MZDZA'H1]L#1W,=?I_@YE^/KI7VF(*2S*1):6@7)
MTM'1>D 1(<DZL,"1P K!VX-%A\U'ZO-&X'C9M@**]7Y!J^<8L\BQ$H%@0%%"
M )6(LCQJZD*V?B^/>5]8#!W$GZ"X7>H_0HK#GBJ_K#H>XP?B#R]NQ['\996L
MO[9Q+E.(TD9BG<*(,SM# @V&<)8LDS$!I.VA#X\/E#T6:@ %Q^AOUILP!X1&
M@O'H UR@G5S.:5_NCBASD"4EW=" >P(B2L5Y2WQ(B0/8P.AS1\8<XA\O9M]^
MQ(]>F0;\XMXJ[%APV#2_OHZ+4R4[,"A65*_W"9I%)QWR[[5%G\KJ1)R1BGB1
MN7>4!PSS3D+$YFK#F(>3U36K(+O?2>3AA)0I&TI\:5@J(_K9@49!N V"H=O-
MTJ-QRSU''KW X7@U'A%@'"+3@7W)7</&E_M%6D\EZIE0K4JG":>)$\OFMAXX
M5<E1MM?4J!><RJ?6'S:KML^PHXK$&T3->F\I5VK3T<Y2+?BJ+LZG,F^#Q> T
M-SKOUY+Q"-P,'9?4T>P+4#E"S,.>1#O'1GY?6TK-T(_V&+<)H<L%#TABLPN$
M4<6%Y8D[V,[$>7SZ/+="6V@X1GFS^I)LX-EF(Z]QV;[XS<3/5YLE,(RO!*=$
M<_319.D/&B(>TQ04U1AVT02UNSX\2<RPF?%]OP#6T4%+8%IUPOX9?$G 31^G
MGR'>=!WZ9J5H=O[7Z2S,H?NVVD/7-XLR76<:QY/Q4J6;4EAO5$:I5#RA9QB,
MP:"AM.967A+NHJ'" BA3N[U17[PTDA]]&M2> O"0>F\ _\M^A??S0]<G G>9
MJ\PBL5(@$]0'$IC-A $&O(J"8:EVU?Y.0AI!WJ 8F=566 .HVW4H?1A/X?T"
MKN88=#LNN+8D^?)TYZTA5L=$=&E'H(6RHGIGN&<)V@N%YO=ZE-?3Q;#!PNWC
M\,=ON!?'\.M=#KH1D>,6,R2+LMN$T<0&QPC/65&+6S"8[5O+QX'"4Y\^K(6J
MJ+M974$.BX7[K-SWTUTR>C5-/\^ZQ86_@*4]Q1!(2T<A$D/1+,O(-0E0TI>L
MMCD#$TJ_C)%#5QT&.]4T/#N/N =^,+TIY^NF[=V8XC52&9PWG).8<BG/"Q:/
M7>#$"&MPC^$Q#-O=-W<\E3ZWQ# )-SU@I)X@&_!?'C-S#_81EUI3;E09YE:>
MBR0GWGE*'%/&&<<EI[6SD)^C9Y@LG-H(JB[Y5LHA-G;!;2)C24]([Z>WK"Y;
M7LY'PHB@%0T$2J,7-)^,!*X<$=H'+9,W-KUL:PY?=YA7^1X,4,\B/QI/R%Z8
M59C.>'W=S7X;7R'A7_[[!H7[$\!B74^"G+W^7GI9^.GW\H+I68B,>,BX4Y2U
MQ FTO&5\(-7)).%>=G7V76V8M[@>T-.+> >>Y[F+)=P0W\8)TCU#/BCNA;-$
M).F)I*6=KPX82AB3/>=EC,!V7[P]\?)HK6'NS,^%EM-$.ZA]>=AP9[OR\2Z=
M[A-TL6CL D;91YFRM 14Z3].?28^XH:PUBIO14KLT0C/.HUX]R!NF/N<OCRB
M?G321M3U^F:\RH]9GL^OOV_6+HX4!H\F"Y22+;G^*D2TN8$36=Y"F33*FOV#
MK^=6V@LOMG6\]"'6!D*QC]V%GX[_L6[1=?MNOIJ;^VE#51O]XN]ZR-_WJ8C1
M0@I*(Y?6%U8I\9EB^."!V4 %"J!V+\$JA ];CU/_^G$XK38 Y1WE3??6^V/^
MVVRQD68^7U<^I5'2+J'/*=!MX"41A)<A3($2([4*21H??>W'NN,H'?:N? !(
MO5SG6EN_PQ[;*U?DSO7X:=8]$/2:V9'QF1E&,\G>.")!<&*]\T09Y--F"9Z^
MG+FUWUK#VL?A(->/,AJPD1_&5^-%Z9K<+0IC;_SU>.$GZPY4?YV.%_.-Z0LC
M1SVCWENBEE.0L@_$JI0)=]P$@>YP4+7K]P\B<-@*R>$M8G_:; >J=[-]UU'_
MAP]O/G9;C./^O*T F#_ZX=T6OCT:1I&:4@\@2NH(G@@<0SKO6" B<:T9E2'P
MGF!=GYEAJ[Z:V0(#HZ2-<']GEG)YV DR%"$",8DJC'<9QJ3<H*@U9:! 6XR&
M]P[UGUIEV+J107V%J@IH TM;>7(CI3C/DAD"+@6,1O'P\+%,1?0B<!4@6KL=
MX3\-H:T/'S;7NPGDG"+N-@#SH"_:B"L>%01)0/$RQ-")4K?-"+/ETCYIZ_8I
M@M_UT<-F$S8!EN-%W8!;]Q6NKF>=[[ZO JPWONN^EY&85\5G78UM77;"[992
M72RZ<;A9+ <%S'Z93>/CA@'W8I4&3^5(+:%"H22$%\1IKTA*05*CP>OJ]2O]
M<3-L;-/?U60C^O^GW DC(WCD.2CB@I6E#TOIKR0B 8SN/$430V&[F55[.V#8
M>\Y6\-G[MCD(+ ULEV49R'N,[L9=.4W?7/KN8K-5.E@GI73$"SQ.9<#C-(#5
MI0= AIRI<M5[33Y/T;"1>7\&O*(>&D#5/2.;29$C[X))D7I2WH-QJ^9 7'*6
MQ.AUT#;S6'T ^FY*!AY-4%'7L^J";P ^]Y3?SV^WVH/-:.6#+#,;I"EE1:5K
M.<VL^.CJ45)[O?*K@XQ/;Y<Q_1F?$^7=2M;R5KC_"RP0^)):)3R*00/&A#*1
M8,N1;),!ECUC\,* G1=6:*74ZCC%[4I$/E&*#9B/#^#G&_8T.TU#XI9P(RU:
MT5*&&@"(Y2X)X!QLK%VY^9""86_B^C,;)\AY6).QOD6:7MS#_-5D,ONUC",K
M3])(S'CQ83;';5!JJ&$^<L&+6,#ON2M3%$M2;&"E1V>*P8!,[E'CA,=VY.!E
MAS4NIZAW=B99MW%+^_EN-N=29G>7E/<LST>E.@-%98G+J4RSX,A?1M98LC1;
M;5B,VPE1SU7EO;C@L$DF=;#3EWP;.*.^>"3Z*_[RDJ/;ZX/WTSB[6GUKX]DB
M,KX<%4L@E10#;B4>OYH1FP*E)AHM7.UY=@>0-^R5:@6@]:V2!M#VD)F/Z 7X
MDM8W,CG:Y(0E@LGE917&A1$T$4IHQH7U+NW5W.Z0@'PW*</>ZU1$40U1MW*J
M/1$2C+QGF4)0Z#26$YKI1&R96I$<]<8"BHF]/"/DQ66&C;9KGV U9-F )=GA
MSKW[;7U/_BK&[J84'JYVP"^SJ2_?\9-1D)$AO9QDETMI"'CB?43I*:.-<9&+
M7+T'WC&$#ANI5;1"_:OI]S]S>;.A95C-HIZ76=1]#V-^<=TS3VD^3 []CV^6
M8*3T)7N#1\0]&%4L8B)*FLQUE&4^;^TWIS.,;WXJC6W5+ N#%B7+LV$,929Q
M8$!<Z9KFM3:)42E-Z&^$\[.D-3O&^1"</#W&N9Y:&NQAO>Q(*80'%7,DPKA2
MT(UR<DYKDJARSCJ*WN=>]Y]]=CX_PPCFBHK>I_OY(5)O$#GKII I<@J0)8E4
MN-*%F1)K9288OD@7F'+:[666_IFZGQ^DV?VZGQ\BY@:"@-V-NS]UX^)MO(8I
MH*LQQB]O6WDKPYPL&;>.ER<IAB&.3HPH&K63,HGT:*3DJ6?;812V!;)C,#$[
MFX*:A=_]FQ8/TE %&$W'TH+9>Q2: 4&BD=2K;%EBV\UA^L';AX.:M9YA\G+]
M,[ /G30 L55SY?N4' K*0')$&:-Q+]* 47AD)(7L4RK- .->PV,.38,[[ FY
M-R>JJG)W);X=)^D&<+*K?]MM^[:2.9&ET2:B<Y"=DF6&/2LU"88X&W/*,E+J
M:\>R+Y#40.K;D=I^,FGI=-$WT<?JC9]?OIJF\D=)1_[F)\OREL5M5O*RZ_M(
M!D>SL)JX4IU2,IR)E0%] VZ"$YX+IFLGPNU%V+!'7$5<U5?#T/EQ=X_DR-;'
MQ25T*VF-O-0A.X;&.I:G!XU?62W1]\L10!L?N7LY)>')CQ_V7;@"(*K)KH%S
M:DTU]491ISU1JM1*%, &I1,QQBF+J-6.U>[*<P 8>GO>K6@=CA#D\>J?+?RD
M4M>'52'_JNWYE\4L_OUR-1%X5?AR)QJNHRDOU<0E&4K0628#9TLXFKL$F5E;
M?4#0OK0->\#TZ0+WHIT6C,[J[G[^R7]?IOW=6M#5^^,&UR,;)&61V]+UD:$U
M32@]9PP17..6%-)SM=U*H=*3S\O$#9R$V0LVMHU:+XIJ (&/Y35BFGEF.;IK
MF>-&-1@1>&$-25XJJH+1%FJ'\H^I&#@Y\QR8.E'T#8#G)3&-P&0++@$1/G$B
M0Y;$NM(C@'FAG>=4J=IYF2_1-' RYCF 554MU7RSP;)8;AV3\=HQ@=5@\'Y3
M6)Y?],SY*P=(H/_DE>A3C$H'(D0HTSZ4P+C0)*)%QF,3O42=:K\]#)^\PG.*
M()PCP8,M#P>,6,\YL5%ZC:&09-5O.7_OR2N'X.38Y)5#U#)P"L)=.Y\_P^RB
M\]>7N-<GR]=VFX454&J@*2MYTSH3QRV*S&HK$UBIY%[WG2]D(#Q)P.\C?>4@
M5<]JRWUH\,#%-@OK-W1K>70QXRZ3/I0R#46\%)ZHP#P/J7B?>]4WO 2>IP@8
M+K&@DF)GM:4\[%WX7V8W\\5L^A5^\_-U[@/-()E5DGB?$AKB1(FCD F-V@M)
M9<[AY4DRCS]W0,W7T=.LEM"&- Z+ZV[TRYN1QPA34X&!)PNE[Y_-Q)=!%3Q%
M1BD/H/AS66QSB'^\F'W[L7S<R@R4KS9,P&J988+Z^BH_1FI#*_GK?XT45<8%
MXXB3)I0K>2"AM#PQ7$:GI8[*/^=Y[Z7DK_\U3(#=DY(/E-J@K^3/IF0R%E-,
MP$C0OK@_RA%;^GQZF] A8B'Q1^/CSI[B/'AZU[$^8A6IMYOB+*@(&2T=20F#
M,.D,^D.&*I)L, RLE]S\_R[%^2#-[I?B?(B8AW42=S_UK3T?CL:2,0I$:*;*
MNS\C/MA  D#DR$0*?+L7Y&-W\;D5VD+#,<J;U9=D Z\!NWGY9;9X,JLZ)V>!
M)DVX8\L1.1YYRXKP$*03PEJF:[<-/9C(X7S6RF@[CYJ:Q>&'^T0$FBBDJ BU
MCI>AY9XXC[ZAS(EJHS,%7;NE0XWD]][>I/KTCOK021N]'[:[% BGF.4 )$7_
M_['WILMM'4NZZ*N<%\C3-0\1YX\L67NK0[84LMSGGE^(&K(D=%. &B!ENY_^
M9H$3" Z8:F$5N1V.H E27"LK\ZNLS*P<+*V@-MEEAG9*L5DQC=+BL(,*QLMM
MWT=VVT<0[,/(D:%PE_*[O9$GD;-<>$B0N//$#&%IXP@)%C%(9E7*98=V5D^]
MHO-\KP-AT8RIXX)C?5C"QB(<]T::*( .45I$R$A>!)VL03OMA2LJNNT3<!]_
M_KBGR4"P:,3.;LV3*\,__#G]=O&M-OO[^<_O\R4M]FJ1O"BM$AV^DL<"2C/R
M!83*X(L7Q7KCI#M-Q=X60L=-8QX"?*>36P?@O-^-Z;8EZL0G955@"FPPB0S
MF"%88F%264EOO&&E]7#XI^@9M_O5D%!K)H7GWX+HVCF9;]J) ^=O;7WOB5.X
M]N/#"5H0*<RE) 4U$%KCGS7-69IJI5N,0M9$UF>8Q76=Y[UB\OMYF-4,R@=:
MA5UZQ"C1R5@*)%SM;$QD=.@$9'(D4N]<N-WZQAR4U;47J=UF>>V#H\>SO(83
MV]B).X\FJ>C,1(G*@:FY!;0(LGHE2^0KZZP$0YW%3JG5SSWK:T#1[Y0%MH\<
MQ@;3H_?C1C E/%D23 0%JHZ;]=+S5;$>[41?0FR20OB<LL#V$NQ.66#[<'G<
MX,7'^1_AK]>OKN+_%I-<9>)RQPW0VFG3*&6@=D-)V;CH[6;NP/UXQ9U']IC[
MM9=TY@U8-:Z(7\_/R,NX6'[XY_5M(TN<W)3:(I .865=JJ7Z&63P/!AGC=:;
MM_SWI;SYU!XSO@X4]%$,ZR#[*T<?M8X,C% !5/5%O= *'&,V..:%OQ>/?B'9
M7X<(_!"NC2WD7U]/I+9E-;]9)EP-CQ<0LY%0*U(=_4YF]E3M9LL\SN9!OH&$
MO"?7QA;RV_>3F(7TI&1H@>AIJ=(!@=2!TEI&SU.QZ:DXW$Y"?OM^G/#:0$+>
MDVMC"_GUJTFF4S74VL^H/5D266<(60=(5ONBM-.,/Q5;V$G(KU^-T\Y]("'O
MR;4.PNUOPW2QZI;TTU^KMBFOS\+R,K^0Z"]%!$TZJ+81T,0$5Y0%J[/UW-8*
MX-:AI4>)Z25Y=WA7OZU<>@+895>>7S#4NZG\84;<NE@LB&T_A>5T^?ML'NML
ML<L+C>\7YW6>%''U;+H2\SH7KC:I9U$@4PA&TNH5,97,8$,<P62B5YAU;!W_
M'6HMXT:R&D'M,0"/*?=Q'=Q?\'_^)\RF,ZR:XLIEXRD8(42!*!+I!!D5Q*#)
MT(N,+#WCA?7;,R\>>' G$!I5V/-FG!\9-_/%^9?P99UXVHDI2VD@<$W^@5:,
MK(IBB!FE^*"D2VHS8_0!V-Q[[KCG:G>H.8[O'1RV=^P3,DU6)LJM6?+^)C?
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M6XZLN'R95J.TL\*@ 8&1['YF)+CB,Q2M8V8F6=8\R?<I>KKUC_9!Q*82;":
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ML -=>;V623)29*,*>&GJ1%;:@9%Y!\XH@U9J;67K%BG7[QZW6>5@.N\@UG8
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MN%"'1'(?(0H103C/,=N43&@=/GR$E&>6W7W(:=)2&)UBJGZ[0+S>?<(+SU@
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MT_G%\NRO3_A]OKCM_<XY,T*8?#D43?E 7.%DWA9CF*5U%F%W"B1LP<4V.KJ
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M;+PQ!\V?:TUH'S>=+W*?' ^,[AKU'L&->U5:-?.K)*^D9!%R,*&V]TI 6B0
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M9SZ6% ^&['=<3.>9W/W%^;&*[>YJ9_E5_A%F"3_/]UWYN]G'%543#$E(1>K
M1T-^I4VD#B(*T+R04*07XEYD][X>;$[6.*&[X= ZNNBZT+=I_@W?SY?+M\3Q
M1Q@]<2%&LDLL;4%> V">0Q"RT!IUS(E+YW SR'.\7MV!L'%" :?0GZVETD5Q
MY9MIG=D>+ZJ ?@F9MMDC7M#[]Z\OO: ZVWW]KY9O,)V%6J)7&[@57VB+A51
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M-D+@8+FS)]:"QTJHYU;^O\[/<1EF^:?Y+-?DXYIU<G#FYU,/:Y;^N3/%C7)
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M).L&IO# LH'?W5LUPV?7E@8;;B4_$SZM,O"]O8ZWBWIXD\Y;PUU.%Z6XNB$
M#JK.'2VI KO2:LHX&9-Z^Z=5QYIZ+H:<0L@"<-4]9'^/8>+M]$-*$Q]_N0&!
M3V97MW<MG:!:&8J2PW!Z* W2TL$A&UFD"3O*R/&S], '&J1/"3R[XL*MK*SN
MKD3](W97<_OU2U[4VJ<5G&KL,4J,Y$M1P2"C(D;@7'#JG- RE#@1GYQ 6T;7
M>8=>&2G7IDJ\VE["9@M92<#M3!ZQG"OBFC#D! %-+(-SDECIY4E7Q8Y1Y:D)
MU%,VA8#M2DNY<O61[Y;+1;#3^&H^^9]N9C=Z$7,2B8X,J9CKIQ@F.;N8BZBD
M"H8%'>4)94?[!Z_(@3*(=47%UV <^3[+')RBAD2.F" 2<6]@;TAAD'>!N,"8
M!'-MY%#R;VWTB1T_ S%,ZK6C0ZMRW]6;E9M["-\ONJ6=OKN993-K794""_T8
MYY,N7/H0C,8*MAC+W74];#%MB4#!"Q8%;$$?MM^3W1<8ZO71MJ+- U'NGD7D
M=<GT_[K);/D'".EF'C_\.8,AOTR^PBI\QNLJ7F+F8R!&@-\H*2CI_+A2 HO=
M&G ;1:"4T>T>4;OD.?*1M@(X9Y.EI$@;.*@^VN]KY=N]\O^^F<QAU%E^J9TZ
M#/-%/&*5G\/)_?DL*&$EK:.>*VQ*]S_8.Y&V_*#SN%-.XBW2YI>;!4AGL8B+
M?\R[Q>*2)"-"5 E1PC#BECJD$T](<(Y5H,8QA\=FT-:<VK)V1B+3.3@4;$LW
M0LGAYV7G__6EFP),B[>PUN7W3]%W,S^93E;C=^F7>#69S>"HA@WU=G5R9WEW
ML]6__'"S7.3BOM5+30,K$\M/H5@!X\C2*53GN)[977F:"BQ*&@@RQ@#S$Y?(
MV1B0#,%*.# ]]=NVZ[E*XO$,SE6#G_V7&&ZF\4-:2?&7[Z]S]?C:D1$6Y&4Y
M0YC 9N8AYAPE#H@90Y);E=Z5KC([,)VZ)OL9N&]KO%(B;^ 0O0N@K<63L]/=
M[*ZNRH4$UJ/R*"7PAKD$:U)G207,J<[5+]25[M]Z<$)U&50,]FTZ%<.@ 4)M
MK6$3B8O!.^? 714,#O[<T@V9W,<K81XH3X$P7KHIS]Z)5"90.:"[TE)O@#H/
M;(%-Q-60D!QV"I'D\^N5D2+KF4!"4AYY$,3QTM?6=B;1PJEU%K!=22FW0).L
M=3<Z^-Z#<=80$8-"8"CG2\7Y21$!BV!:@_=J'):VM+.W=R)U0TUC'5'GR[QV
M#>Q#1^3#O2/RZK C\JF;3M]U\S_M/%PR0TDD"M:8\MT\I7)4+7%$>4C:">Q!
M29]0*7OV1"I?_CF?"5TU6)IH>O]@29^_@,P7#Q9V2;4/+@?=0B0$\9@8THIR
ML 143!J[2''I_C.'YE.':S68\?0I>1Y(@RGW=97H 9-QOBSDZ<%:?ETL;FYO
ME:\S2>O5O8]_KGZTN!1!4A]30E@%,"VX\> 7FX"("89XGQ)EI2WUTV96YV!M
M@(HC -> %7=P59_B8CF?^&4,J[_V*LOP?5Q^2"#/%"<Y[[6X5!KS%$.^*T\8
M+#@_=.)@%X:D9. VT6BW;S6-RM13)ETGF=0ZB8O#W0"_#QX@6#D1/:R%.P)[
M%7PVY PF"%8"!A1+N7U::Z=\\:Q4 ZPL!M*9ISRL];D35ZL_N9C;V<*NBDX*
M-,T8\I$1DT\]5SA.>LD*[;WF'DG/>0[JF=R(G2(K&8XN)JE%Z4/J^=)+.5QI
MM8@H9H>/*ZN0519VB"'$<.FP%Z6;@+R4]%(?W/NDE_J(O(%3\'#$FT>+O:46
M"3C<$<>1(<<,'.G6*R$2AA._=(G/"TTO]8*]5WJI#P8-$&I_/%QI$Z*,</)[
M HN0/B GK4'&XIQ1L5+ATGUY7EQZJ1?0)Z67^DB] >KL)CZ2Q<(+F]M*,I;O
MB46D)=B/A&%B;.(F%3^_7D1ZJ1>P1]-+?:3< $U>S9:3,)G>9$/Q<_3@K.:+
M^&__\M,;L [?@0BSN&Z6&Y?EK9UGAV4!_NS*A?CE^_X!5GLPB20M9K '6?8K
M0@I(&RM1<C%0YD5TN'2#UQ&7TVZJZYSCLA7\F]T*^1[O;1[:$RER*TEL%;U]
MET<*1(EPEM'@2/'W%H[-J:X^;88\)Y%Z()(-,//M]==I]SW&=6!HU9)@<]IH
MPG.ULD:468VXR1=CC+$(&XV3E()[7SJT]N1D6N3B4,RW+<(B #3 I%6P.;<C
M6.TQ30*/&$ODC<^V2KX"8:) 04;L)+<:3)G2"NWA!.I>-AGM2!TLXP8(LE;,
M=A%#5MUQMMC ,;>SJY6WM?CE^_W?V5R&6*WX?MFS\'%J9P^V'J6.11T]BC3;
MQ"!8I+4S* ;A'<OOV='25>=CK*.R@AM.J^T026V,ZU9'??@:<V!\=O71SI?W
MUPE3-[^V,Q__.9LL[SJ1B6!Q\@9) QJ 4V)!RB&LKD8'$;A,;%M![A9!G?Z]
MR@&5ZK3HQL:H+O'>=[,_XN)1WG>S!F58M();E'!NW4!21([#Z2.-MOE]*:S,
M\5O!3PY?V7-MB%9E$&C@F-ZJ(;AMV9&<MUP(A+7T(!7LD%,8Y$,LEI+@J$3I
M3A=[)U+9KFN%<.7 :J*2<VL9*QW\Z?,_;^.>A)D8P/WQ*5<)>D9 #>>'N"/\
MA%$9E2]=27=P0G7O'K?.P3/ :T#[W<IE'2B*S/EL^C*N GC@B>765PD1V& !
MLY2X+YT->_C]RCP;R8<=+.&&V'';N=@SZ:/2R+@ 8L V@AC@_[0&$1##@M.E
M:U):<AN'(_D$)0:(M:[9_?:OZ&_6#VWFEC'P/Q_GN7G:]4;Y<:P46'@<4>(U
M'+_YIE"N8 $9)4M!*OB$FRY'/M(&!X9 UXTBQ[J,^*V;75W$^?7V0MX\]"N#
MA:.6&/ (9.XY)4A$1N1;AYS9X+G'="==ODN+4[Y4USTKPXWB$JW<4G)5OWVW
M%A#1[1*\L)11C#PW+/=8-,ARQ9%,4@/W#:<[#V;OZ2GYQ.AUW:8R1"@BN<JM
M9S]E(WUU7F(1A<,\(&DQ13R 7:R3<"A0X:D./M%TTOVT(ZUF[SYX$@/$2S$F
MA\NR!0+<)O@<%IB A\Y4K@ZBVB#'),Q=@^J2X(E)>U*&]10*U.XM.Q"L;;@'
M2*[V(PJ3V>3ZYM:0,=H[&D!529T[!!#MD.&<@2$3!1$B&4E/*I0[]D3"PX]6
M!GT(9%T)^=4&WO[U8.(*:V*]E<B*//%($K ^PNR9MTZXE$@LL=<??;2.]5<,
M^,'RJPS\Q629#[I?9V'R;1)N;MNHDZ2%BAZYF"_V!YY?]0 ;2$IKM"!$QW12
M /T( ?9^_"0BR)=T]I\OX]9(\I^3Y9=/<;I"):<D+[JW8.<NOV]LYI"D3R(E
MY#5.6?'EFC58GZ(VN7Q=&?.30DU]Z7-X6O6.E@($.$2G@FC4=3??3.;1PT]O
M'66N'2,Q4D2T".![<8\T7GE-@5+8C-KMM'+=\S3\XT$;8D%)W+HB0JQ<%Q#_
MO"TPO)V[DH9%*9&,*B)N6<Y&)XR"QXZ;P#DUVX;(GGJ [6'KF1K/1('S!-E"
MR&FQN,GU+9OHV3IF[ZA6(AC$G/"YD94":QJT)Y="FP!^6-KID?-4R&EW]),H
MH5Z*T5%*C.TQ8;,ODLK% <P@@[-0& [(<K"W/35*>H<C^.>#N%#34BB&VF$6
M#!!A71X\J'=[W8'F7.G*6T_+\8AS:_%D\^,\25OD$@<MB1.EG >I=SJ,[A+A
MP >:8L(0Y+KB8JS\NJ*=_RLN[Q9 ;A<@\]O;3J(@5WV=8T N,(VP# Q^%EW:
M"57M>5AQ[]C5*% ,L*ZD])J"G][6[8C(?)0:L23SLV^4(>>T1HE%(WCPC-/M
ME@)'X:<UC<5G@7^(]!JH:_G'W,Z6^0Z27=ZL[\A1Q32/0B$L!(;34>6$*K$H
M^N!HP(+%G6=5SRUMV9G$23S1+\6"+"/KULBR.4"9(28PF9#"3.7= \X05B*7
M ,%!FI]8]Z7[V^^91MU2F#.!/423 5)N@"B[5:CW1:KONUE\[$]+'3#QCH*P
M#"A@D0(RUEM$DHU",\O@ X4IU&N"#9%K"!V>O*A5&IL6B'?C%O'?-[F!RS?X
MY>YF&R,)R_RXGXX&U';P(+#@.7*$)^NUD"Z4/M2>F,I)9#(O[6@K(?<VZ;/9
M<<)X3CUC*%&6KV1K#DM2'#'EL2&PW4!2XQ.HA<.N"-3'Z3- [NT1:*-$7?08
M1_ K)(W@$X!"14Y3\ GRK7XI*&/%>WSLG4ASQ!D"\F'J#)!X [39_R* (%%'
MKAR*.@@0"[6Y6A(.?1XI\<(ZCDN;UL/?XR#XI9U9YPN]\A6$5>.Q#PF^F^\T
M;P+<W^QDFD7SKIO?1CPOHS$4H);(4I -MSB N1A 5)0:X:/SD1Z_<7[RYUI\
M7*,7JMW((FY!X=RWF'N3LZ=Q%NXZ*+VVBR\?[21<!IJ,#9XBQ9++*6Y8$W<:
M88MU<-*&I$IWV#AE7G6O-I3CUVA8-,ZO-]%/X3\!]@Q6,K_1%@CU<$C[@+3#
M&E'JK)38,1M'[!WYY+SJWIAX7GX-PJ(!?JTF[PY<A=[<A';;-Z'7?;86[[O9
MMU7/AO<WV5X$>:]ZUU\F9A-.R2"B&:AQ(@2H\2A0Y&!.\JBHW.G-4B0457XI
M=:\0EV=Q"X@W0/PSNR.^NNYN9LM+#;O:L^RA8Z' 6I'Y_[#)SR :&^&W I>.
M9A29>-VK3.5)_?QH5JY".M;!XJD&%FM#_-?98CF_676Z^+#\$N<77^QLL[W7
M4?+PZVS]*,Y%M[33=W8R_\-.;^)EX"Q% G+!<):M*_; :\3(1R$<]2I1MVW)
M[BEQJC/YNB7\1=VIEP!_ SI^9#$M;J5T&2ES(46+I/ ^)W<L,LDRE P/RE 7
MA2D>EWRFM=6M01W)_&F-$TUTD!HLF=4ON7/;W5-JY!);2:SA#DF--XWVG>84
M14%=BM)ZJ4NW/BXY_[IU,PVQ_EQL*]_=V+@H=[=/+CF.P6*:;QOD71F5059H
MBBC1'D>5G$_'([@[P];-11<U+<X362N'_B+'^MYU\PO[5[[,DM]B P+#'^S?
M"+!&@@W5 A&KP/+W-J=;L4(B>6F8(9KK4<(5/>=9.8$TDEX:$ZSJEP1RKQ5[
M%3^D?3W^+HUW(!]'$%-1@RH-&&DK$[+4.*,P#;LO!.R]*7#P*Z>QYF4DDHI*
MM!5M=48T;MTP]S_CY.H+_/<5V(,@FI4E^L8NX[WG1CF'36,-DOEQ<.X)65_5
MB1$SDXO@HBN= G^FI9W&[A>4QFJ1$B\TVK7ZY<&5A8UK)BCX9M%(Q,!:!1V1
M7Q=+.B!)<0*1""WX<2.P\*1.H_$+R)95QNN'T>FW@82[#4LN(XC;)&I0B +D
M8&- UEJ,?$@T*2ND;RZI]M1:3J/[WRBM5@3T8N1_EF>_'Z1DN@2Z8.+M++S)
M69P8;C,TOW6+G*79I-[7F?9B3X*?-X$1GPLO*)EQGA)7D7MN54(1 Q6Y)A:Y
M:"F*+E#M<!(ZGM1ZL8<F*ON4^)9Y]#B7_>%FN5B"Q$',=RN.1%K!80<*RB+B
M3"=D8H)MJ#!ABN@4:.F+#WWGV,+SK8,8LJU+1P6GB5C[P17F6L@85MO^$C/,
M%:>@\XD$(]W :622DD@+C'EDF%*RW6QH5-H]F%M=NHW+D3Z$' I7^T3<"K!<
M>NF-PX(BZ01!')8'IHA@2#.9P'54\,>E7[#I,[^Z]:SM$/(<V/J3TJQ).8M7
M%KYX4<R+.E6>ZXV7@[[,F-RQSDO$B5+(*$(1EUI%+Z6RN'0);*\)UJV%;8>;
M9P$WW+W)92Q%6/GKS,]7[IR=/K"\%Z^6L.,<F.QN&B^ZM2GTKINO8AI7\[A^
M5.A2<>^3H1%ADA_XH"P@YS!%VE,BK.(*L])!V'/F6[?R]5DY^VRPU@VDGK3,
M-YLZRK<I1;_\D#Y\7&=68J*26"9 JKD+L3$*:0FVO:#.&MBK^96KHU'3<V90
MMVCU6?CXG!B]0"H^>NG[X\W<?[&+U3,6ET(S+V.(B 3"$'<21)!#Q#XH$()2
M4L9M][P0.9^<4]UZTZ;I6@;'EAVH3;!N1]R75CCN@[6(\1P7R>_2.Q%AJ=)Z
M+UV0FFPW!1O)4'UJBG4K/ELP58N UX"Q^G'>I<DR!XHO2?1&\> 092X;U]@C
MK42$7X@TD4N54NEZS/NOUW7,"P8F!PJT"47U3Z#P8JV4'R<17DU7_QA\]RZ_
MYSWQDZ^KQ[WO[]&L/;7@L0S>&\0(!4]-4HXL; ;DHU$R<"5(\7YVY\ZYKM==
MD'C/"EX[,:#W<0GV17<=5TM]9%*\[^ 'LR5\%_[QU:\S,$KC8GEI0@PT.@+.
M5^Y!20SLR*0,(ICDUT^\E;%TO+SW).OZU059.2X\[=#PS>[-PK4A.UMMKNW;
MA*N+(9>!:TIM?JLY\5Q>I24R6%N42ZNP B'8G4KS<YDX9)YUG>J"9!P=I-K/
M4#S8:VEUH74&BOX&UO3A*UBOJR*2NXXJR^Y!LX)-:<'Z($C6^LA<0,KE.ZXN
M]^=5V""0=: F&D9B.GX!HLQDZGK(!;A7"9<&7(OM[;1>! 49"0^FL"1<()YX
M!%],.%A.<-XEKYTI[=SNG4A=%[:@4CM?S$WX'MO+V#C8ET(RKL"I1C@_^\(Q
M<\A(Q5&,A.6V8YSXTM;:$U.I>^%O1,8,$75!SCQ+(>'GF^MK.__>)3C37WDP
M N#/P&.*<_C]H]>.[2Q\^OS/V[]2L)+PS!F,6$I84C;CU!)&#<3$3B$A-0&V
M"XV<M0E9[0CG6AKE2J?NR]82/NBK>*SP??%4Y?NZ"Z,VP5,>%#)6YINUN0$)
MN.WY]0.;1 @QRM*B*#;YIJH/^W!JIY*["IP-W%NX?6-^U868!(&Q%![A!&+D
MAM!\A2ZAH!+'A'+K2&DJ/OQ^Y0Z[=2BP'6T>BD=#7-HT)O98*X)U0MJ B\TI
M^#E:.)-?^J-*BNC TAF)32VT^AZ.Y!.4&"#6%I[->VAO;!I,L^2-\@8C96'V
M'!0TLIYZI*@(GGFG@CFAH]03H[>!^A"PME_+.U-R#6B$M5*\;7*?# W<YC:_
M#H,+&Y-#CN?&Y382(IT/QI=6"(\F4#<EV<;Y,AR1!N@T7'#WRYZ%K2WJ0)B6
M@7^,50ZL"# ;K?01&2<(]1P+G)Z]C]> ==15>V?0JF_7HK$Q;H#G^YI<@)^^
M.0,B5<3 .8"2(KE;.I.P_3E#)D:MHR R[KQ%?BYA#TZHLME>G2_=6. UP,3!
MM_I_N[M@+56R@5B)8'DYW18(TF .(QP4S5TG--EY&+=:5[C?>KW:,5H121NF
MPC-C_Y+9?K1/Y%T#[4_==+JY37!)8\12*XX<['XX)C%%)C=98]HG,.:U(3OU
MR^UV$-VWPL9/AL+\?;:FHV>3J8G\X#/(9UW;>REY@G,V 6S16L2#2<ARX1&U
MQD1OK1:RM,'T;(M[H5OL&3C^_-MQ -T&[\2OJY8QGY=VOFQ\-VZW2#:))!$3
MTJL.9*!>D9%@!:=H/8A&1"%>SF8<T#9[O/C2S[UX%ME^\$/Q<:^I2XU)4EHY
M9*E.B'.GD&7$(RTCP5Y$%TCIY\F>:VV5?;>?V_ LLIU; =[N*RL?YYVS;C+-
M-0OAOV\6R_RW[F3$C6&".8&B"6 UX" SD!9)KED&TIN=IC_/^<K*P<G7O=SP
M G;<"^%5U;TW/IR 8(J3AXJ)DN 3DQA%PA5@&2)R+D5D+,#*:?0.OYPW7':6
M5_>:QPO8EJU3[@??C]N.<U(>>Z,=BBY;ZYJ XVRI0,D&SZFRA*87& _M$:<9
M[=K+S[UX)MW.C-.\G;V8O7BTA_Q#H!/6GM"HD,<VMSY,&.D@'=)"<2M]"LR,
MTIRZ'1&\T)C/BTEQC$;'OT>Z\?B+$,1:1S'H:L5SDX#H.#+4!F2#CHF"8+AH
MYM&V@NO^X?,FXVV<!I5 +Q;_[7(NQ\4G+=&.F7P17H'X @[(2)E_8=BF'+V+
MI>_P-K/X%WJ"_ZTTP9A\_J$-@<>!^.."\U8[@W/&VMD$>M0KY+"-*$:9E-..
M2_%R F(]%__#YXU^ $4P)I]?Z'MGY^4'CHM0Z>BD  V*#3>(<YJ;=5N% L=6
MZR# 93SALE:CJ_OA,U>C[_F&P>U%W1_:#.CA23'KI7$,YR9$8#HYP\"3BA*!
MPA06_L@2/,JCH2\A'O"2<V4_P.$_$HN+QO:?I_?-YGY(MW[,\-8V@I6O9;U8
MW%RO_ZQDNYO>'QVSP\UY$ABGJ0T)TOAD#5(RF?Q&N45."8FH@O/'J8 9*7V_
MN=6F-E9Q%N'H14J8@'@B%O:?=HA11C$ADME8_!3Y(9O:].'4>$UM^L#9@"&U
M=1M9>Q6LL<A&HQ#/TG-1, 2"-0K.,T9PZ0N(_=L.O("V-KU(<+CM0 ]$&J#3
M*%>,I9!@98%=X@3S8&+EC1V30$1Q)PPQE/#B;;]^]+8#?6CU'&T'^F#< ,\/
MWUQ/ 5LE8T2!.CB)7#3("JD0\=X;R@16BA0F[-^M[4 OOO1J.] 'O+IQT$T#
MY=E5?MI@!B-^F7S]&.>IFU_;F8^K=6T6Q3'SU 2)@L%YO]O<$E?+57=Y)Y3G
M>.=]D]W(Y.G?:SQ1^%R$&P^C!E1@@8*JJ(W35G.4C)&(<RR0]MPA[%7"/CH=
M_;,?[&7Z7;R UECGV*C/C/U+9OM=H.U!H 6TR^]Q^:4+W;2[NG=@!7$\.K#'
M'-$,<69 )"XEI((##>!PD+R9$M'3E]6X\5&8J:4VRDBT^=%VTMN_OL9LR/W1
M36&8G/SZ9)?Q4N,D>(H2T9!R5;UGR 814(R)>A$Y$ZJ9(JW3E_5"=])85!YS
MJQ7@52M;S1T7B>LCDHLXOR:7,@;"'>/(,IN-5<F0<3@A3@(1D1%BPBBUT*.L
MIG%WI86-59]%K>RG4DA]FBS^]6X>X^WC;VL%8U34#"2@6+2("R:1Q2%D'S &
M;A+Q:3L;V=3!M6]1+[18\"4>6V=SZH46]AW2-.M'M.<3'R^)BY$*&I'1#L/Q
M+2ARRD?8$V#::P)^KSO^N-O(DWRA978C[Y;&R%%LFSSO^T^WKQ?=Y >.GGQD
M?HQWG_I]^3G>>SI#%N.4Q( )A!6E%%D'U..,>F2PL AHYZV**C!9.OK3:DE,
M\(%+9AV2(D@0A1#(1)9K4PTX7BYPGXHWOOLA2V+Z<&J\DI@^<#9@Y3_.E#MC
ML<@G@C827'[IP7KB!".F)!6<ZF#5MLWPLR3F7!(<+(GI@T@#=!HE&VDIMTIZ
MBDB@>6.#3:]QP$B"K:\<F#'2/7N \X67Q/2BU7.4Q/3!N &>/[*A-BEM:;E.
MP>>D.37Y"0>0KJ88&:(89=SD:V6E;9K=:30>-Q^=&]M/X)X)U,ON_OH@KT=]
M,":WN+7&Y6"^!X=/&R2CTE9B(\#E:R76]L-5'YQC#CPS]@WHUL$KWMSV^'"S
M7"SM+$QF5P_O+AD0@Q8X(L\5V3QY8I-&PEOX 4N:T6;>FSFXDL8U?&$^EMH.
MY<CQLH^$73ELVM[1Q*5Q-"$B&)B$1N=Z:>P0TYQ'(;$PL9F"G*<6\4*W1D%N
MCK==!M#DY7=4VMMGYA_S;K&X9"8EKJQ'6/G\A!8H,&W 2 5IJ,A9PM+IQO;+
MGF6\T&J =G?,N51IXW19O3.\6-S$\.9FG@NZUQLR+WSQ\&;MV[_BW$] $I<$
M8^&C%"@8&Q#7WJ+<0QP%3K@VA/B<0RB\'7K/\H5FYT=D^[A G]NH^J(9IV+3
ML/L&Q'+7LEM8+2(18+T:JU%^KQU9S3V22BK*6-1$M.91[%G&"\W!MWL"G$N5
M'V?3O/WKZV2^^C?WDF Q&6:Y0S0_]\(UQLC%Z%%*5GO&L7*V-3=CSS)>:%N8
M=C?-N53Y<3;-KLM%>,)""(PPSS5$.JJ,"TB$6"RQ3 [+9@K\S_+,VWOGH-T-
M<QY-7EYOHU?7W7PY^9_5Z%UZ*+/4S>\Z0*T-UX)%74,^.V)%U]E2&*><2U"#
M@Q0$64H%XM:#@QLE1Q;K9)T6*8K2/0#*E'-]F=]G"./\V\3'_?OR3K2K+;AX
M^*/7W6+YOEO^5UQ^BKZ[FDW^)X9/,2<N ;8/Z=UDX>WTOZ*=7S*<:,)4(\((
MJ(O5\^N<<Y2$2BQ2SAS??L=FMR+WV:;;5&U7'X(]**-M$]NZ=>=CR.0]J)6+
M/^/T6_R]FRV_+"XM"_G)$(U<HA[P G]'VVS$$:H3)99+=OS5PN>8:=WX9[LL
M/PO1ET'P/WJ((^_QBS^[R^2-31&+W#T $,)6("<P09H&:@T'A/1VT'\XKP=,
ML&Z \WGI/#9^/RB+@9;QTB0N@@L!P=$$NUE;V,W,9GR$2UI)S02KQ^,\Q;IA
MR<:9W!O#'Y/+[[J;^26V,EK.-3+@UH 8Y*JH=76WEB:N*?QT.PK_?%3.,ZP;
M*VR;R;T1_/&(_"K!U.YD8;63,5*'E(PT/SX9P(^@$2D56& ,SBJQW2OX>=C\
M:)IUHWGM4GHXE@W470YQ(RZZI9T>D\JE5C9RYPA2Q%K$$X63RJ\>6,6!:<R)
MLJ6O%8VVF).HKQJF?EMP#^=]GLJX0>B[N]1=>C>9V9F?V.F#9P@&1YE/'+=8
M&'G(.@K%B>\^_6:R\--ND9/B]^R-P1&).:(I,,2I2\B(8)$4G!/-I$BZ=%_\
M0_,Y5W^^B?/)-X#H6UQ7_:N L:(,]F50''&5-V? ,C>[9%I0+]E.#.S<Y6U-
MH6X(MQCVVYKK'$$W<,[>R>67[[]'F\6R2O?9Q62QNILGH@/SP!/0EPI$8Z5!
MQDB%E"&4XB0]-J7OD1V94ET>G05W-Y[L6Z+2_1;+5RQ>77<W6;&OK\_Y:!TE
M.2WM!$C)&# 7L)/(I>2BUX8H4EH/G3*O1I13"2(\1;)2J#3 M(\Y[PS0+.\6
MMV>5F_N5QI'(K0@H./#BN4@>:1L\"M:8(+Q(-I4^UWM,KQ'>%>-&]SQ -<#!
MUW8^_YY+<.)76"3X)"NA/;T\263R4F@413XH##7(J02&1A#88P'+HZ7=SIY3
MK,O%T:C2/1]N#=#R[6(YN;;+^"&=(,?@N2$\6128"[D06"#G86LS0H/&41E>
M_!9JG_G538<_%R%'0ZP!-MY;R[_=7[AEL)\8F# RP:'"E1/Y.0>/4HS8!&*M
MV2D\*N>)_M;&;?Z27L2Y,FZ")FYY'P.Z?R"3FT25303Y* CB/C%DK*(H8B:B
MMHF%N)T8/I\J>Z?2BM,Y$.(=RIPO[R:N!OX..OK*7L7?.CM;?)A]BG8*ZA24
MZ>ON^CK?$;/35[/PNILM8*7S]W%Y2;%R*1B-B,]UR<9*I+,4 ]:662UME*7-
ML-Z3;$4WE2';N!C5[P>Z&GL1_?^^ZK[]G^C#>OAUPY7)-5B:]X?X"='YAV1[
M..B:9S[<TVO_%WK&Z0=/OE!(?I369F6W[_C=U_J+;>L=M8VY7';=^[_1]OW,
M,]ARY*FZQR(>K'6FS_;PW-&ZC,)ORM6[7U@ ]$&2K4:"NSJ0%3-7JSP1\Z?_
M9=LWXLI ?%1N=1!]0N-L/20ZJG(?\&CI:%4E%97\?I'79<6^KIHC52?U/.;U
MC\"  ^*M@SL8X9OVN-<KX_L^8C7447AZQ )3_'WV=9('O0"'X!?XX;^*3'-W
MU"KQEZ-8W++I)(E4#+0]FM_J89#">&V-626 ,0RM_=)H!*N/\-GE_'H6WDWM
M51&D'H]8Y8+6()SV2J(1E/*.?SU;A'DYF+:&K.)U#]9^N[)H!*C_Z/Z\GU]9
M#?C$T%4\YT' '99-90#OSM3)=0SONGFV"_^PT[.WVZ%QJWC$O: [02HM;+S%
MZVFWB!?=W71SRK/@[CLR?A5GMO\6/$U*S>(Y$HQU'-%"Z#4"VJ^S,/DV"3=V
MNBJ?/@>HK:'J.F6'9=X=$T#MK32=WL]K?\R^YR;:-V UA)Z0>7>: !JH27G\
M%%C9B%O_9\;&<Y9/VD4'A5(<K*JO43VU]%&#DO7I_B@.NN[J-WZP^=%WVN[]
M/E;(>9^H&Z##.D/V%3[O)RM1?)I<?5DN/K_Z]'D46AS_7MO-T@O2XV31US9@
M]IT><*+G%9;W!FX'/H4&ICU_8$LN+4#WSUF83[]??8[^9CY93N+BU?7R?-SV
MCGK2Z8[KHW9()"U ]O:ON5\_57\V3O=#G01. ZFUG<6W@,CJ@94W=GE_9>-\
M:/:,>1)&#234GA9'9; >[^SOO_]KN:+2ZR^SJX_^/+5W9.B3H*N;8SM-.*U6
M6K^=KP+?(U59[XY>I,+ZR*3/K*[.H.86.-_B_/N'M/.M'3(,XOU)'SACRVY&
MO?W,^5'FO0-6"Y#UP>?A9CTDELI*-E?3@>[/OD\^ \Z.-N\;KQI>!^7>G22$
MOW4>8!3KY%10?F8 ?F8 >F'SOIN]CUT)4!Z/5"]C=DC6W9&%-W2N1!CR>C);
MR2SKUV('S,[ U93:4,O@%#'55GE75\O-HLZ.-CT>JEHEXU"T]HNB,CZW$YK9
MZ??%9%&F2.?)0:M5-9YI>S\IGLKH?5[^Z^/<?YA?+.:;IB*KU%*Y<N^3/E"M
MY'$HJGW$5AGA!^^L%52E3X]:K09R*)9'!=3. ;CN5'Q[4L=2]<BG?*!:262!
MP_*HV"HC_ X&[6;Q=J4E$J)/#%FM-'(HBH=%TQ9N;V[B1??VKYSKC[#._**A
M7YG6YRK;/M^IENPNA/ I0FP0]C\FW70EY@_I/[KK^#HW")Q__\W^.0;V!S]6
M+W%>D@&GR+-!&L"*_WUCIY,T\9O97]B_?HFSF";+LXLE!GVP7JJ^)!U.E6M;
ME  U-K6SS81_O?Z:&\?# MQD.EE^+V.[#?MBO=J 0J3H)]EV/+"2)MZ!8>L5
M$!1PPMJT]?9,L+ ?O3WL22 V%>LZ+J.&L@)=7(!?^"G^^V8RO],K991RC\^<
M!')3H:_^,FRU"NCCM[$J@!Z/7*3ZY\!D"U3^?+3?_U@\:%U6NO#GE/'/V-<@
MG/-K?>X&J99P[8'"PQVYO?K:":&_HK_)O6!?@YJXZN;?SRX=V3]B/9BVY=V=
MN/C:@>3I='MZDUBHB.3I@>M57QV$HNLGE\K0?8Q= 9SN1ZE94W)<UMV!A=<O
M\H$IO2\"Q_98]2[U]@3E"2'\K%5\SI/F9WWBS_K$?MB$_[[H5O[XN=OC\4C5
MRJ@.[8Z]BZT-P'1Z-ZTR6V-[N'K'^EYQ=Z>LO7:;L/7CB6?OB8?C5"M2.[0C
M]BRTME&[F6V9H-ON:/6.[?/\^-;R%Z^[SW$:<\?K#8?.3EWL'['>03(,KX-R
MJ>VGP%3"G5'_(:6)AW'?S<KLM>.CUU.!P[ \65ZU=6:,\W_,NYNOORX6-P41
M/31NM>K<H7KTN(QJ:]0ON0E,N)MH*10/C5NM+G>H=CTNH^I[L;OHEG9:(@^\
M/5:U<MO!>VZO+.HC],HOP1.??O]H)Z$04/N&K%98.QRO Y*I[2AG3Q%FF&=5
M2C4^-6:U>MF!P!V136VS\S8R_.K;53'=^.2@]4I=AUJ91\33$'JKF3W0$"5!
MW#=VO3K5 E@>$%8+JO1NJL45ZI,CUZLP/4>O'A-4[<J*?]],EM]SCZRU*,&]
MN5[U GTS23"9"*LMA6[/3]4K.!T(]S!1UG8;M]3,'XO5(;+J(OJEFX*4/RU+
M>9+]/E6O5G5P[&Z(*)O#_WU<_CKSW76A&/I)'ZA7LEH,ZZ?%UAS".T'FL9 ^
M\*&3$&\J=C1 C)61WZ-^\LHWP:\RH)_ZC9/P;BGZU%-XS6WR#\LO<3[R_M[_
MC9.@;BEPU5-XM7>U=3=3._]MLE@63'4_/>I)<+84SCHJH-H [FJ6<R,A3PQY
M4K5"2\&LPZ*I'OF_5?[E 3PV]DE(MA3*.E%8#;PQ<F>X_]8M2K^P]'CLDT!L
M)8!U4#S5K9TMR_O<[;=WP)/@:BD =4@LM:\Z9X,JKZ@08/O&.PFOE@)&!X32
M0HB_2'O,AP.=!%!+49Y]8JANA'1GETK>CG$2'BW%8+86WT:9]]EP]*U7I2V%
M21HL4^UF_P##93.Q-W'AYY-5&J90G>KQX4\"L:4 R.DBJWXNA4F>EYUR3+_=
MKZY4^OG8Z"<AVU(LY&2!M=I0X]?98@)BO9C;53/5!T\=/I[YF=TU#GRF2*N-
M4Y=1H._&SJ=V"#+P_NJ3PYX3"[L;[I?<G.G\CAM[!ZQXN?,8%H^B7P>$43MF
M>3>ULV^U;0U5#9N#TMZ+2D/WW%Y-IWMT29D;H$\/W !6!RZ#'A7(SV8"M?;0
MS\8"/QL+]/.ME_/I19Q?+SZDBWD ?I6Q\ \,6VT/];,1C@NFNJ609U6B&>GC
MD:K=Y.UKP^U9?BN07$R69YO7CX:J=B5W("B/!%"[<>C--!+L!,E63>B^+F-X
M-[579\'SU)C5KMOVP^F(2.H'%L? [,"PU>[7]H/MN&":4("K>95XKV_/<-7N
MU@Y1A/L$T9 RO)A?SY9E=>&#(:O=JAVN"G<%TI8F+ 38TZ-6NU![EAYL#K9;
MAZ'<RZ7[1ZQWAW:(-GQ"'DU@]>9FOII8 9#NAJIW*W8(.ML2: *6S]'?S"?+
M25R\NKIZ]<U.IF<7\!X8M]Z]UR& '93-R\@R?NRF$P\+^#CO_(A9QD>?&2'+
M^/0RBF<9'WYJAR,%THW[QS\K%K\9/CP<NI1+=WST1C*2!W%[', _45[5<RS[
MYOF^6VZF6B:,?/I7&HDJGXGS ?F-K]$W/\B_.+N(__=__7]02P,$%     @
M4S1C5XE_+-<M P  I18  !0   !H<BTR,#(S.3,P>&5X,C(Q+FAT;>U874_;
M,!1]WZ_P,B%>2)H/2-I0*C'H1B3$I@:$]C0Y\6UKX<:1[12Z7S\[:=E*VTF3
M *VL?:@2^U[[GG/B$^5VQVK">MTQ8-)[UWUOV^B<Y]4$"H5R 5@!096DQ0C=
M$I!WR+;G46>\G DZ&BODNWZ ;KFXHU/<S"NJ&/06ZW1;S7VW56_2S3B9];J$
M3A$E)Q;%H9^1/.J$/NX<AE[4SCW7BT@4AH!=TO&_>Y9.U>%-CE0S!B?6A!;V
M&,S^<>27ZOB>$C6./=?=LY;B2DR(KMYF,%1QT EUJ(('9=."Z-+B0 _HA"$O
ME"Y,Z(V:RY7]_OUUYFF+@)PS+N(/;OT[-C/V$$\HF\7[9YC13-#] XD+:4L0
M=-@$2/H#8L_06=_>S_G5^8P6L.#;\PW)_8<QS:A6WW>\Y2H?:_T3CE<KUHUT
ML9=)>HV^?$+IS<<T.4].!]]0DJ8W_4%J1C_?G Y.KZ[[_7.4]L]N!LEUTD\W
M5/RR:+PG: [7HCF5B ]1"J6"208"!>Y!?0@/T 5@IL8Y%H &YG*&KD4E%4J*
MG(N2B_HX4XG4&-"HP@(7B@NSF!G@E9(*%^:Q0@0R#0?R2E!%H=Z/*HEDE4E*
M*!9Z[ !AB1B59LD,&+]W_I(RA3,&"\XR+@@(6U/'<"DA7EP<$RI+AF<Q+6HB
MZJ3C"18C;0 95XI/XB/-VA2$HCEFMB9X5,3UF6JFY];0Z3AAU#'NH'0UBBPV
MGAN'4QM'2Y'5N<.VTW$W3[N.MW'NF99MU24W96MB9(F+$RNPGGA![)</R%L8
M2L.#L8<5;GAIO>X9]/R]IB@"N7D(*2_B2AN>,%%6[]P\;$DAE9B_+Y;<9$[.
M&\2=2%F!6 /W)?1^)8/2D*U>X+3;>]J@"JK=Y8HK;2"D N-11X]HGUG6UX2W
MZK(7G)F2M2=>.E^=)8S;K^61NU[+<*?EEH$-G.AHO9;13LLM QLX8;!>R_9.
MRRT#&SC>>H\-W)V66P;6=PYW6KX9+=WU[\O VVFY96"UEAO.Y7^J9:MNI:QI
M+?[>5BVYI/5GJP"FOU^GL+'1.N_%N+]2<"8YJ]1JRL:VT-)_TR9NU>WIGU!+
M P04    " !3-&-7;\E]W4 (  #<+   %    &AR+3(P,C,Y,S!X97@S,3$N
M:'1M[5KO4QN[%?W>OT*%:1Z9L8W7-@$,R0P%9^+.-*3$Z>NWCG97BU5V5_LD
MK8W?7]]SI?4OL(D)].$PS0?B75U)5U='YQYI=3JT6?KA="AX_.%/IW^NU]F%
MBLI,Y)9%6G K8E8:F5^S7V-A;EB]7EF=JV*BY?70LE:SU6:_*GTC1]R76VE3
M\6':SNF^?S[==YV<ABJ>?#B-Y8C)^/V.C)I1^_B8QV&SDW2"=G@4B^9AIY,T
MA6BWHL[!OX,=5(6YKV/L)!7O=S*9UX>"^N]V6HW#@\*>C&5LA]V@V?S+SK(I
MU]>P#I6U*D,Y3*M75A7N&?:)RBU<T^C*__0]WNNW;D14%[=6\\AV39FAI<G)
M<@_M68/32I%*E>[N-MV_$RJI)SR3Z:3[RT!FPK#/8LRN5,;S7VJ&YP:=:)EX
M0R-_%]YI]SBNQHQV4IF+:0R"%HWZO'<UZ'_LGY\-^I>?V>5'-OC48^>?^KV/
MK/>OWOFW0?^?/;R&1>^*??EV]?7;V><!&URRK[US5Z7=;"V/?VT8VP]%[:%:
M)Q;1J_-47N==AY_GCM7QG5 =K@Q5[W8H0VE9.V@$/^9\!&@+_3+>?Q(\M<.(
M:\&NZ.>$#71I+.OGD=*%TK1L?[Y1G0MM92(C;J7*?S[WOY3:E!S=6L6^BH@&
M\68W>-<\P:IB*F%V*-A7KD.>"U._O$W%A)U%EDI:S<>LN[7C?<)*_ _0(Y/)
M_SIPJVFK7V,#%<?L;PWV=Z%%+.VPQB('A@FBQNV;W8.CDT<,K.!QC)153T5B
MN^UW*X?J7\D\1@2[]>#H^4E[L\$'C>G _O#.E^,4!(W6 46ASX9\))@6(RG&
M2/]V* W[K>0:2$LG> ^" 6QS]E'IC 7-^C\(PYM0$N;Q^+7.8VOKYO&OW&#V
M,$_9A-WD:IR*^%K4_'16DQ@KN) K2#UTP67.>#YA96YU*3 "3)G3@9A=SC(\
M:<E3EG B+<U4)AW5.;M[!KF(A#$01V22\1OAZ&_6IL&[&,Z@R]2)R(H?(ZDA
M&F&6HSH\B85FXZ&,ALR4]&=>?PRFJ!JA 632I%"7)%3'X \,T!3@8.J=VBW@
MFHHQS!$1# LGBV%XS;!L_SRP%"R1.2:>,#2?Z!HP"7,4ZX5RF2<@'R<4\#M*
MRQAM DP+LUH#$"415@$L$(P)WFDZQVD%$7.G:RP%9" T7".+,H4!P*F (->=
M<?Y$W Q9DJJQF2)7BVMIL"U 1YQ>>K_A96T!@&;JS#UO7S,&.UN'P<'2A+W9
M/6H%AR>F0EFE/(A*5 (Y*O2>>>MFL\\HO1%N@ ,9IH+FEPF -4RE&5(-,LO
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MKJ[RY;N[*^\,KKS-6_WUUY!WW?7G_P%02P,$%     @ 4S1C5X"AY7XG!0
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ML2L*XP@['%I?I5[E<</0HCB4-(@%DSA;H'X<IHK+A,C&+0%_(/M:'6]81K*
MD62C#DJ"& +39?$J_U3*\*5^I9$D5?G?YKE_-37PG"!\S7;O'@61DS#$"=)*
M:*2Z_N':$BE_8IF&I&NY[=W/4-L5C6O7COWKRE=Q<EW;:VH49C&M*S(J$BS/
M +,AT36PK M!/Q9,4#UL2QTJ6=6VZ[\D6(,"W.;+\-4RO)^J:%E!58S=CG^
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M,C R,S Y,S N:'1M4$L! A0#%     @ 4S1C5T1)]>K7'   K%P!  \
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M<BTR,#(S,#DS,%]P<F4N>&UL4$L! A0#%     @ 4S1C5XE_+-<M P  I18
M !0              ( !W\8$ &AR+3(P,C,Y,S!X97@R,C$N:'1M4$L! A0#
M%     @ 4S1C5V_)?=U "   W"P  !0              ( !/LH$ &AR+3(P
M,C,Y,S!X97@S,3$N:'1M4$L! A0#%     @ 4S1C5Y)TP[E5"   !2T  !0
M             ( !L-($ &AR+3(P,C,Y,S!X97@S,3(N:'1M4$L! A0#%
M  @ 4S1C5X"AY7XG!0  +AT  !,              ( !-]L$ &AR+3(P,C,Y
A,S!X97@S,BYH=&U02P4&      H "@"% @  C^ $

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
